data_2kuo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kuo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.534 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 2.6 mpp_? . . . . . 0 C--O 1.236 0.385 0 CA-C-O 121.116 0.484 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 395' ' ' HIS . 4.9 t -98.14 141.09 31.5 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.985 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.3 t -55.96 121.34 9.1 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 123.071 0.232 . . . . 0.0 111.412 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.655 ' SG ' ' NE2' ' A' ' 398' ' ' HIS . 10.6 t -54.18 103.02 0.07 Allowed 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 172.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 20.9 ptm -49.78 -27.64 5.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.836 0.71 . . . . 0.0 111.845 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.557 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 28.9 m-85 -93.68 -19.42 21.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.669 -0.644 . . . . 0.0 111.355 176.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.507 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 64.94 -126.17 31.39 Favored Glycine 0 CA--C 1.501 -0.809 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -80.59 0.29 34.66 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.928 0.394 . . . . 0.0 111.531 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -94.18 -7.29 42.65 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.062 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.706 ' SG ' ' NE2' ' A' ' 392' ' ' HIS . 7.6 p -74.49 128.09 34.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.371 0.605 . . . . 0.0 110.141 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -81.98 2.99 28.25 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.873 -175.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -87.82 115.92 25.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.697 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -117.42 2.35 12.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.01 0.91 . . . . 0.0 109.855 -177.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -63.15 136.57 96.75 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.678 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.69 -28.9 48.91 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.138 2.558 . . . . 0.0 112.921 -173.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.487 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 53.3 t -61.93 -37.04 77.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.338 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.706 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 72.7 t60 -58.42 -29.14 65.87 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.349 0.595 . . . . 0.0 110.997 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -93.3 -18.5 22.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.49 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -74.86 -20.04 59.91 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.374 0.607 . . . . 0.0 110.972 -175.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.466 ' O ' HG22 ' A' ' 377' ' ' THR . 7.2 p80 -121.57 -15.87 7.9 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.313 -0.867 . . . . 0.0 111.554 176.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 377' ' ' THR . 59.1 m-85 -121.07 136.78 54.91 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.135 0.493 . . . . 0.0 112.016 173.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.534 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 19.6 m -93.17 149.86 20.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.661 176.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.655 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 37.9 m80 -124.96 160.64 53.37 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -175.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 25.7 Cg_endo -59.34 93.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.315 2.01 . . . . 0.0 111.446 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 144.41 -13.05 2.04 Favored Glycine 0 CA--C 1.507 -0.443 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -84.02 145.84 28.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.132 -0.534 . . . . 0.0 110.735 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 16.0 m -66.9 -26.38 66.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.084 176.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -86.68 -4.16 59.14 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.756 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 57.5 t80 . . . . . 0 C--O 1.237 0.413 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.575 -178.352 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 22.6 t70 . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 121.359 0.599 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.5 -25.15 0.1 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.004 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.764 ' HG3' ' HG2' ' A' ' 439' ' ' ARG . 16.3 ptt180 -158.99 170.2 9.31 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 119.4 -0.334 . . . . 0.0 110.893 -168.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.496 ' O ' ' HA ' ' A' ' 438' ' ' TYR . 23.3 Cg_endo -61.38 151.34 80.14 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.192 1.928 . . . . 0.0 111.926 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' GLU . . . . . 0.545 ' HG2' ' HE ' ' A' ' 439' ' ' ARG . 44.1 mt-10 -87.67 142.29 27.95 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.998 0.428 . . . . 0.0 110.918 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 9.3 t -66.75 121.7 78.81 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.68 -10.46 24.79 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.67 2.247 . . . . 0.0 112.076 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -104.55 -3.41 23.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.57 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 69.39 -152.04 51.49 Favored Glycine 0 C--O 1.223 -0.559 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.352 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 441' ' ' ASN . 75.1 Cg_endo -76.18 -11.69 19.35 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.8 2.334 . . . . 0.0 111.216 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 32.1 t -85.09 8.14 19.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.238 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 36.5 t -60.17 117.29 4.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.613 0.721 . . . . 0.0 110.851 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -100.16 11.52 39.15 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.311 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.673 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 0.7 OUTLIER -66.41 109.31 2.68 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.264 176.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -85.02 86.81 7.35 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.35 0.66 . . . . 0.0 110.533 -172.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 433' ' ' GLN . 65.0 t30 -166.45 125.69 1.14 Allowed Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 122.559 0.344 . . . . 0.0 110.874 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.428 ' O ' HG13 ' A' ' 436' ' ' ILE . 29.8 Cg_endo -64.67 -35.45 46.81 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.752 1.635 . . . . 0.0 111.864 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.608 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 25.2 tp60 -64.58 -37.66 88.34 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.358 0.599 . . . . 0.0 110.909 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . 0.677 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.6 t60 -57.93 -51.51 69.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.652 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.456 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 24.8 mtpp -58.77 -23.8 60.67 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.716 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 432' ' ' PRO . 82.0 mt -80.31 -36.92 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.194 0.521 . . . . 0.0 110.414 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.608 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 24.0 mt-10 -84.34 -34.79 23.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.346 -173.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 419' ' ' PRO . 57.2 m-85 -108.75 154.87 21.43 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.686 -174.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' ARG . . . . . 0.764 ' HG2' ' HG3' ' A' ' 418' ' ' ARG . 11.9 mtm180 -91.37 120.03 31.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.705 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 78.6 m80 -92.4 78.54 5.03 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 173.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' ASN . . . . . 0.602 HD22 ' NH2' ' A' ' 439' ' ' ARG . 1.7 m-20 -63.37 106.28 0.88 Allowed 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 113.818 -1.537 . . . . 0.0 110.505 -171.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.95 138.36 31.48 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.506 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.8 OUTLIER -108.44 144.93 30.5 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.287 -174.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.61 -44.18 18.58 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.392 2.061 . . . . 0.0 111.342 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 443' ' ' LEU . 8.2 p 41.85 27.73 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 124.686 1.242 . . . . 0.0 110.81 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.46 158.12 16.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 -174.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -116.03 79.76 1.35 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.725 0.774 . . . . 0.0 110.016 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.471 0.6 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.526 -179.812 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.57 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.212 0 N-CA-C 111.373 0.138 . . . . 0.0 111.373 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.452 HG21 ' CD1' ' A' ' 396' ' ' PHE . 9.7 t -108.2 163.3 13.29 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.06 0.85 . . . . 0.0 109.49 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 16.2 m -62.24 119.52 9.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.981 0.896 . . . . 0.0 111.764 -174.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.789 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 33.7 t -52.71 119.48 4.61 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.849 0.86 . . . . 0.0 109.114 174.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 26.3 ptm -56.24 -23.73 37.84 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.327 0.584 . . . . 0.0 111.952 -173.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.56 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 34.6 m-85 -104.96 -16.18 14.91 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.244 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.432 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 64.91 -121.71 22.43 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.6 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . 0.456 ' HB1' ' HG2' ' A' ' 399' ' ' PRO . . . -82.88 4.7 24.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.927 0.363 . . . . 0.0 111.132 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -96.6 -14.7 22.0 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.789 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 1.8 p -73.58 127.12 31.87 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.561 -0.712 . . . . 0.0 110.732 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -81.58 -4.92 57.38 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.084 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -60.05 128.21 35.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.538 0.685 . . . . 0.0 109.623 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.499 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.2 OUTLIER -112.05 -15.71 13.22 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.56 -173.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -62.83 134.76 95.66 Favored Pre-proline 0 C--O 1.243 0.73 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.578 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.59 -22.85 75.45 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.501 2.134 . . . . 0.0 111.343 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.578 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 77.8 t -62.92 -35.9 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.214 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.654 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 83.9 t60 -61.43 -30.58 70.66 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.285 0.365 . . . . 0.0 110.339 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 54.6 m-85 -90.27 -24.79 20.82 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.749 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -71.1 -20.23 62.37 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.804 -175.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.674 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 1.9 p80 -119.68 -11.98 9.33 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.674 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 63.1 m-85 -138.52 126.55 22.62 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 177.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.57 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 58.0 m -86.73 160.66 18.76 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.355 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.713 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 32.4 m80 -127.83 165.63 28.97 Favored Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.668 -173.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.456 ' HG2' ' HB1' ' A' ' 383' ' ' ALA . 50.2 Cg_exo -54.74 -2.56 0.2 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 123.488 2.792 . . . . 0.0 114.152 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 398' ' ' HIS . . . -119.15 13.11 11.29 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 111.964 -0.455 . . . . 0.0 111.964 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -121.85 131.08 53.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.9 t -62.57 -20.63 64.9 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -170.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.513 ' HB2' ' HG ' ' A' ' 397' ' ' SER . 3.8 m-20 -82.18 -7.52 59.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.405 0.621 . . . . 0.0 110.986 -177.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 39.0 t80 . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.61 176.085 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 417' ' ' ASP . 19.4 t70 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.627 0.251 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 416' ' ' ASP . 9.0 t0 78.07 79.04 0.07 Allowed 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.838 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.44 ' HG3' ' CG ' ' A' ' 439' ' ' ARG . 14.7 ptt180 -178.48 157.23 1.02 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.867 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.26 147.02 94.18 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.299 2.0 . . . . 0.0 111.342 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -73.74 159.23 33.26 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . 0.908 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 7.8 t -64.22 132.27 95.27 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.4 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.88 -12.02 29.8 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.371 2.047 . . . . 0.0 112.256 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 37.0 m-85 -106.47 11.79 30.34 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.087 0.555 . . . . 0.0 110.709 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 56.6 -153.22 20.04 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.621 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.99 -9.9 19.51 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.335 2.023 . . . . 0.0 110.817 176.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 35.9 t -70.71 -14.85 62.61 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 173.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' CYS . . . . . 0.908 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 54.0 t -52.43 117.36 2.8 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.143 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -116.31 19.69 14.67 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.561 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 1.7 mmp_? -63.97 103.12 0.55 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.887 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -77.63 105.58 8.88 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.784 0.677 . . . . 0.0 109.69 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . 0.535 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 62.7 t30 -178.36 127.75 0.28 Allowed Pre-proline 0 C--O 1.244 0.768 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.933 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.535 ' HD2' ' OD1' ' A' ' 431' ' ' ASN . 19.9 Cg_endo -58.72 -44.55 35.5 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.339 2.692 . . . . 0.0 111.61 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.441 ' HB3' ' ND2' ' A' ' 431' ' ' ASN . 23.1 tp60 -59.47 -34.12 72.16 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 120.973 0.415 . . . . 0.0 110.398 -177.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . 0.689 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 61.9 t60 -63.06 -62.31 1.79 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.742 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -15.34 24.59 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 432' ' ' PRO . 60.1 mt -75.85 -47.22 33.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.834 174.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -78.54 -45.47 21.77 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.887 -0.508 . . . . 0.0 112.238 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -107.32 155.39 20.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.824 -0.548 . . . . 0.0 112.239 -171.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' ARG . . . . . 0.44 ' CG ' ' HG3' ' A' ' 418' ' ' ARG . 54.2 mtm180 -94.25 153.53 17.99 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.636 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.586 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 75.2 m80 -128.97 80.42 1.97 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 175.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -84.03 139.09 32.74 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.004 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 3.9 p -101.75 130.19 48.1 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 123.311 0.382 . . . . 0.0 111.873 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 443' ' ' LEU . 1.3 pp -108.79 151.01 41.55 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.3 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -63.27 -30.39 73.73 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 C-N-CA 122.075 1.85 . . . . 0.0 112.216 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.2 p 44.27 31.0 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 C-N-CA 124.847 1.259 . . . . 0.0 111.691 -177.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -87.96 165.35 15.28 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.939 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -43.71 -58.35 2.74 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.895 0.878 . . . . 0.0 111.029 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--N 1.343 0.308 0 C-N-CA 122.583 0.353 . . . . 0.0 111.054 -177.0 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.418 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.4 OUTLIER . . . . . 0 C--O 1.241 0.618 0 CA-C-O 121.339 0.59 . . . . 0.0 111.591 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 6.0 t -115.11 152.01 33.31 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 173.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 49.3 m -55.54 123.69 14.82 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.979 0.799 . . . . 0.0 112.032 -172.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 26.5 t -60.36 118.49 6.5 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 22.7 ptm -54.66 -33.49 60.78 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-O 121.464 0.649 . . . . 0.0 111.388 -175.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.558 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 41.3 m-85 -96.92 -10.49 26.27 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.579 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.531 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 62.38 -129.09 42.44 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -80.28 -3.33 48.91 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.063 0.459 . . . . 0.0 111.182 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -84.63 -16.48 41.85 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.227 -175.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 3.0 p -69.43 141.03 54.15 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.451 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -78.93 9.34 4.37 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 122.791 0.437 . . . . 0.0 111.461 -174.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -93.79 111.18 22.83 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.671 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.457 ' HD3' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -105.59 -21.3 13.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.212 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -46.98 131.41 8.88 Favored Pre-proline 0 C--O 1.238 0.451 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.959 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.49 -25.53 58.81 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 123.749 2.966 . . . . 0.0 111.602 -174.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.493 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 64.6 t -65.8 -34.7 72.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.279 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.649 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 73.3 t60 -59.87 -26.5 65.91 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.301 -0.875 . . . . 0.0 110.088 175.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 38.4 m-85 -93.68 -5.49 48.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.586 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -88.67 -23.14 23.09 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.046 -178.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -116.02 -18.68 10.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.067 0.46 . . . . 0.0 111.913 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 393' ' ' PHE . 69.2 m-85 -125.29 128.51 48.35 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.761 174.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 404' ' ' TYR . 14.2 p -80.26 159.04 26.01 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.477 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.704 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 53.7 m80 -139.53 158.15 68.97 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.868 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -51.07 107.9 0.2 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 121.887 1.725 . . . . 0.0 110.379 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 118.45 0.81 15.97 Favored Glycine 0 C--N 1.316 -0.552 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.698 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 404' ' ' TYR . 20.1 t70 -97.63 141.82 30.19 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 123.04 0.536 . . . . 0.0 109.864 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 43.4 t -58.9 -26.18 64.08 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.939 0.774 . . . . 0.0 111.505 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -110.84 19.47 18.53 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.773 -174.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.442 ' HB2' ' HB2' ' A' ' 397' ' ' SER . 63.5 t80 . . . . . 0 C--O 1.237 0.398 0 O-C-N 121.605 -0.684 . . . . 0.0 110.446 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 21.3 t70 . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -175.15 -32.34 0.01 OUTLIER 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.74 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 23.1 ptt180 -128.6 157.27 75.58 Favored Pre-proline 0 C--O 1.245 0.843 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.277 -176.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.9 158.94 38.47 Favored 'Trans proline' 0 C--N 1.326 -0.648 0 C-N-CA 122.16 1.906 . . . . 0.0 111.139 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' GLU . . . . . 0.459 ' HG3' ' HG3' ' A' ' 439' ' ' ARG . 1.9 mp0 -75.29 158.72 32.43 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.93 0.395 . . . . 0.0 110.302 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . 0.98 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 6.6 t -62.76 133.14 94.95 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.899 176.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.91 -6.93 13.68 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.685 2.257 . . . . 0.0 112.698 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . 0.519 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 96.8 m-85 -114.72 11.88 16.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.173 0.511 . . . . 0.0 110.288 177.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 61.21 -157.79 31.68 Favored Glycine 0 N--CA 1.462 0.377 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.731 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.15 -11.39 25.12 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.675 2.917 . . . . 0.0 112.197 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 25.8 t -81.41 -11.63 59.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.785 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' CYS . . . . . 0.98 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 39.8 t -51.26 116.93 2.27 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.955 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -111.6 23.96 13.3 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.154 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -61.83 100.42 0.15 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 122.689 0.396 . . . . 0.0 110.066 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 430' ' ' LYS . 17.9 ptpt -66.12 94.18 0.23 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.229 0.538 . . . . 0.0 111.215 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . 0.546 ' O ' ' HB3' ' A' ' 434' ' ' HIS . 14.7 t30 -173.57 114.13 0.34 Allowed Pre-proline 0 N--CA 1.465 0.296 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.0 -47.01 22.29 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.427 2.085 . . . . 0.0 112.181 -174.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.606 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 26.0 tp60 -57.72 -29.07 64.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.326 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . 0.687 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 41.2 t60 -61.38 -55.99 25.34 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 123.361 0.413 . . . . 0.0 111.736 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -61.37 -25.23 67.03 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.437 0.637 . . . . 0.0 110.839 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 69.0 mt -69.48 -46.51 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.437 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.606 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 10.5 mt-10 -85.31 -22.48 28.51 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.986 -174.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -121.04 126.05 48.87 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 123.618 0.574 . . . . 0.0 110.155 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' ARG . . . . . 0.459 ' HG3' ' HG3' ' A' ' 420' ' ' GLU . 12.0 ptt180 -80.9 122.08 26.79 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 121.281 0.562 . . . . 0.0 110.984 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.7 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 49.3 m80 -98.07 84.45 3.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.154 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -70.26 121.28 17.3 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.177 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.42 146.37 38.5 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.92 156.39 29.67 Favored Pre-proline 0 C--N 1.322 -0.608 0 O-C-N 123.466 0.479 . . . . 0.0 111.083 -173.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' PRO . . . . . 0.546 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 32.1 Cg_endo -62.63 -25.8 75.45 Favored 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 122.302 2.001 . . . . 0.0 112.365 -176.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 14.9 p 40.09 56.26 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 122.958 1.361 . . . . 0.0 111.864 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.546 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 21.0 mmm180 -91.52 140.68 29.51 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 121.31 -0.869 . . . . 0.0 112.201 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 55.6 t30 52.98 85.84 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.639 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 26.6 m . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 121.371 0.605 . . . . 0.0 111.14 -177.645 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.537 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 10.5 t -106.14 153.66 21.78 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.837 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.9 t -53.87 119.81 5.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.515 0.326 . . . . 0.0 111.751 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 24.1 t -53.77 111.06 0.66 Allowed 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 23.3 ptp -58.51 -12.6 4.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.226 0.536 . . . . 0.0 111.925 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.408 ' CD2' ' HB3' ' A' ' 385' ' ' CYS . 15.3 m-85 -110.09 -15.83 13.93 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.612 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 72.76 -133.42 19.07 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -174.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . 0.424 ' HB1' ' HG2' ' A' ' 399' ' ' PRO . . . -88.11 -0.75 57.44 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 121.643 0.735 . . . . 0.0 111.244 177.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -75.82 -24.89 55.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.593 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 0.8 OUTLIER -61.38 129.72 42.58 Favored 'General case' 0 C--O 1.25 1.098 0 O-C-N 122.238 -0.289 . . . . 0.0 111.167 -179.258 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -71.46 -8.49 54.19 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.034 0.534 . . . . 0.0 110.138 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -69.95 113.05 6.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.862 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.41 ' H ' ' HD2' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -113.21 -1.84 14.23 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -61.25 137.11 94.3 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.335 175.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -58.57 -20.89 52.14 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.649 2.233 . . . . 0.0 111.746 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.57 HG12 ' NE2' ' A' ' 395' ' ' HIS . 98.4 t -66.09 -42.36 91.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.22 178.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.699 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 83.9 t60 -57.7 -33.51 68.46 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.702 0.763 . . . . 0.0 110.655 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 34.5 m-85 -88.96 -18.91 26.46 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.877 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.524 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -75.33 -26.95 59.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.641 -178.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.57 ' NE2' HG12 ' A' ' 391' ' ' VAL . 2.2 p80 -114.3 -7.34 12.95 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.502 0.501 . . . . 0.0 112.273 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.561 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 96.5 m-85 -135.45 132.01 36.88 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.206 0.527 . . . . 0.0 111.665 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.537 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 69.3 m -85.38 154.14 22.06 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.606 174.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.662 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 31.5 m80 -128.07 158.21 71.62 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.496 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.424 ' HG2' ' HB1' ' A' ' 383' ' ' ALA . 14.9 Cg_endo -52.96 100.53 0.05 OUTLIER 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 122.951 2.434 . . . . 0.0 111.594 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 119.01 11.86 7.36 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.661 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -106.25 145.06 32.07 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 41.3 t -54.04 -32.81 55.58 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.805 0.69 . . . . 0.0 111.29 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -107.97 17.33 22.53 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 56.2 t80 . . . . . 0 N--CA 1.47 0.556 0 C-N-CA 120.124 -0.631 . . . . 0.0 110.824 178.592 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 C--O 1.239 0.534 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 27.3 t70 63.17 79.75 0.25 Allowed 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 124.736 1.214 . . . . 0.0 113.035 168.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -177.62 154.46 1.04 Allowed Pre-proline 0 N--CA 1.479 0.985 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.812 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -52.49 136.41 56.63 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.034 2.49 . . . . 0.0 111.282 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' GLU . . . . . 0.44 ' HG3' ' HG3' ' A' ' 439' ' ' ARG . 2.3 mp0 -75.62 148.54 38.69 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . 0.962 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 8.3 t -52.18 134.86 40.64 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.412 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 421' ' ' CYS . 53.0 Cg_exo -57.24 -28.15 78.19 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.742 2.294 . . . . 0.0 111.952 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . 0.403 ' HB2' ' HA ' ' A' ' 427' ' ' CYS . 62.3 m-85 -99.1 5.55 46.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.873 -177.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 67.64 -156.03 52.65 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . 0.444 ' HG3' ' HA ' ' A' ' 442' ' ' THR . 55.1 Cg_endo -70.74 -16.53 33.44 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.329 2.02 . . . . 0.0 111.298 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 33.0 t -79.25 3.98 16.38 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.262 176.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' CYS . . . . . 0.962 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 50.5 t -55.1 117.28 3.33 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.108 0.563 . . . . 0.0 110.727 177.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -103.1 13.37 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.685 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -71.99 105.46 3.89 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -87.96 97.45 10.96 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.142 -175.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -173.02 126.37 0.48 Allowed Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.452 ' O ' HG13 ' A' ' 436' ' ' ILE . 28.2 Cg_endo -62.58 -38.28 52.3 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.295 1.997 . . . . 0.0 112.12 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.649 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 26.3 tp60 -63.94 -38.19 90.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.946 0.403 . . . . 0.0 110.34 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . 0.666 ' CE1' ' SG ' ' A' ' 421' ' ' CYS . 15.0 t60 -57.95 -48.3 80.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.262 1.03 . . . . 0.0 110.116 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -68.68 -15.24 63.46 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.345 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 432' ' ' PRO . 79.0 mt -86.67 -34.3 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 123.928 0.767 . . . . 0.0 110.628 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.649 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 21.9 mt-10 -86.62 -25.08 25.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.572 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -127.0 135.6 51.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.234 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' ARG . . . . . 0.44 ' HG3' ' HG3' ' A' ' 420' ' ' GLU . 25.2 ptt180 -91.2 134.94 34.14 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.65 0.594 . . . . 0.0 109.761 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.621 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 24.2 m80 -100.91 83.81 2.59 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.231 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -94.61 157.46 15.97 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.004 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' THR . . . . . 0.444 ' HA ' ' HG3' ' A' ' 425' ' ' PRO . 30.4 p -100.74 171.78 7.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -178.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.41 151.54 71.47 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.0 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' PRO . . . . . 0.495 ' O ' HG12 ' A' ' 445' ' ' VAL . 18.6 Cg_endo -59.29 -24.53 74.66 Favored 'Trans proline' 0 N--CA 1.483 0.868 0 C-N-CA 123.489 2.793 . . . . 0.0 111.24 -174.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 444' ' ' PRO . 3.5 p 56.53 7.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.734 1.614 . . . . 0.0 113.013 171.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -126.88 170.48 12.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.174 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -133.05 -36.59 1.01 Allowed 'General case' 0 C--N 1.306 -1.296 0 O-C-N 125.013 1.446 . . . . 0.0 110.896 173.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.477 0.884 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.421 177.524 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.484 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.639 0 CA-C-O 121.492 0.663 . . . . 0.0 110.032 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.2 t -113.43 159.46 19.46 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 41.0 t -63.68 124.33 21.15 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 121.975 -0.453 . . . . 0.0 111.226 -175.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.67 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 31.9 t -56.39 122.38 11.76 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 174.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 26.5 ptm -55.1 -26.23 36.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.645 0.378 . . . . 0.0 111.566 -173.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.525 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 38.8 m-85 -110.01 -8.86 14.78 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.647 0.592 . . . . 0.0 110.657 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.46 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 69.78 -133.92 25.41 Favored Glycine 0 N--CA 1.436 -1.316 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.61 -176.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . 0.545 ' HB1' ' HG2' ' A' ' 399' ' ' PRO . . . -78.6 0.26 27.05 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 117.589 0.694 . . . . 0.0 111.166 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -94.7 -2.74 50.59 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.582 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.67 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 10.3 p -68.0 134.19 50.29 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 122.065 -0.397 . . . . 0.0 110.391 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -78.98 -14.11 59.4 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 123.26 0.624 . . . . 0.0 111.212 -176.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -72.5 128.31 35.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.049 0.452 . . . . 0.0 110.507 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.415 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.6 OUTLIER -120.27 -6.45 9.87 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.047 -176.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -65.05 137.76 97.2 Favored Pre-proline 0 C--O 1.243 0.737 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.542 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.57 -34.63 73.76 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 123.689 2.926 . . . . 0.0 112.793 -173.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.477 HG13 ' NE2' ' A' ' 395' ' ' HIS . 60.1 t -59.72 -34.68 56.27 Favored 'Isoleucine or valine' 0 C--N 1.348 0.532 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.683 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.649 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 82.6 t60 -55.21 -37.55 67.27 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 121.729 0.776 . . . . 0.0 111.33 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 62.2 m-85 -89.68 -20.86 23.13 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.459 -175.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -71.39 -24.11 62.0 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.878 -0.514 . . . . 0.0 110.035 -177.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.71 ' HD1' ' HD1' ' A' ' 396' ' ' PHE . 1.0 OUTLIER -119.33 -7.71 10.19 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 178.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.71 ' HD1' ' HD1' ' A' ' 395' ' ' HIS . 57.0 m-85 -133.55 126.37 30.86 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 38.1 m -90.06 158.93 17.09 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.66 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 13.3 m80 -129.55 157.69 75.68 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.078 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.545 ' HG2' ' HB1' ' A' ' 383' ' ' ALA . 18.3 Cg_endo -54.31 118.09 4.65 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.898 2.398 . . . . 0.0 110.347 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 111.58 -1.71 27.7 Favored Glycine 0 C--N 1.32 -0.342 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.695 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.76 142.16 34.36 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 14.1 t -70.05 -21.97 63.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.466 ' HB2' ' HG ' ' A' ' 397' ' ' SER . 5.0 m-20 -95.56 -1.39 50.59 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.112 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.6 t80 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.09 179.637 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.989 0.899 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -136.35 -18.9 1.47 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.074 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.512 ' HD2' ' O ' ' A' ' 437' ' ' GLU . 20.9 ptt180 -167.6 160.13 10.1 Favored Pre-proline 0 N--CA 1.467 0.384 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -169.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.59 151.03 72.54 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.83 1.687 . . . . 0.0 111.359 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' GLU . . . . . 0.449 ' HA ' ' HG2' ' A' ' 439' ' ' ARG . 10.7 tt0 -82.94 157.07 23.16 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . 0.955 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 11.3 t -58.98 135.24 87.45 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.261 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.7 -13.28 35.85 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.343 2.029 . . . . 0.0 112.58 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -110.18 8.08 23.57 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.103 0.477 . . . . 0.0 110.429 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 63.94 -152.71 48.39 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.699 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.53 -4.38 15.19 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.847 2.365 . . . . 0.0 111.984 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 16.9 m -83.55 -2.52 56.2 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.583 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' CYS . . . . . 0.955 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 43.0 t -54.89 115.92 2.46 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.498 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -110.96 19.26 18.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.28 0.632 . . . . 0.0 110.482 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.618 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 1.1 mmp_? -69.62 101.87 1.73 Allowed 'General case' 0 C--O 1.255 1.365 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.274 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' LYS . . . . . 0.516 ' HB3' ' HZ3' ' A' ' 430' ' ' LYS . 8.7 mtpm? -75.04 82.83 2.26 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 123.603 0.761 . . . . 0.0 110.184 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -163.23 112.08 1.02 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.694 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.98 -41.4 62.08 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 C-N-CA 123.25 2.633 . . . . 0.0 112.567 -171.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.664 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 25.1 tp60 -57.45 -39.21 75.8 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 121.086 0.47 . . . . 0.0 110.33 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . 0.719 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 19.5 t60 -59.23 -52.27 66.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.677 0.751 . . . . 0.0 110.011 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.422 ' HA ' ' HE1' ' A' ' 440' ' ' HIS . 47.7 mtpt -61.25 -19.79 62.1 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.983 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 93.7 mt -84.47 -35.42 10.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.294 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.664 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 25.7 mt-10 -85.41 -50.92 6.91 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.45 -176.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -98.06 137.85 36.24 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.113 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' ARG . . . . . 0.612 ' NE ' HD22 ' A' ' 441' ' ' ASN . 18.5 ptt-85 -86.24 145.96 26.73 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.42 0.288 . . . . 0.0 110.56 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.639 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 71.7 m80 -118.22 86.04 2.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.387 0.613 . . . . 0.0 109.847 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' ASN . . . . . 0.612 HD22 ' NE ' ' A' ' 439' ' ' ARG . 83.5 m-20 -77.61 117.87 19.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.983 -176.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.2 m -125.79 155.49 40.98 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.463 0.477 . . . . 0.0 110.898 -173.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 1.1 pp -107.21 153.9 40.81 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' PRO . . . . . 0.423 ' O ' HG13 ' A' ' 445' ' ' VAL . 38.1 Cg_endo -64.84 -11.98 32.0 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.167 1.911 . . . . 0.0 113.273 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 444' ' ' PRO . 6.1 p 51.02 28.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.19 0.996 . . . . 0.0 112.309 174.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.419 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 36.9 mmt180 -85.66 144.96 27.53 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.853 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -84.09 85.54 7.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.464 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--N 1.309 -1.188 0 CA-C-O 122.119 0.961 . . . . 0.0 110.202 177.492 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 121.179 0.514 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 9.0 t -120.95 145.52 47.63 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 172.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 46.3 m -47.73 122.24 4.75 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 123.452 0.47 . . . . 0.0 111.218 -175.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.921 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 11.9 t -47.54 120.46 3.31 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 27.6 ptm -61.5 -11.75 12.18 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.08 0.552 . . . . 0.0 110.317 -176.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.51 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 75.0 m-85 -115.27 -13.89 11.71 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.994 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.424 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 65.77 -120.59 17.2 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.076 -1.059 . . . . 0.0 110.793 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . 0.47 ' HB3' ' HG3' ' A' ' 399' ' ' PRO . . . -92.18 5.73 49.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.548 0.689 . . . . 0.0 110.66 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -89.36 -15.23 33.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.302 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.921 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 2.4 p -78.8 123.85 27.61 Favored 'General case' 0 C--O 1.248 0.974 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.881 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -83.44 15.65 2.95 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.92 0.488 . . . . 0.0 111.686 -174.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -84.06 130.14 34.88 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.085 0.469 . . . . 0.0 110.409 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -104.01 -33.22 8.88 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 123.152 0.581 . . . . 0.0 109.676 -178.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -45.91 135.58 6.51 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.683 -177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.74 -17.61 55.85 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 121.914 1.743 . . . . 0.0 112.062 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.462 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 86.3 t -67.9 -37.42 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.904 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.67 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 77.5 t60 -60.96 -29.32 69.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.868 0.842 . . . . 0.0 110.017 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 60.6 m-85 -92.8 -13.07 29.67 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.004 -177.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -78.77 -23.64 45.17 Favored 'General case' 0 C--N 1.343 0.313 0 O-C-N 121.768 -0.583 . . . . 0.0 111.617 -177.451 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.45 ' HD2' ' HG3' ' A' ' 394' ' ' GLN . 5.5 p80 -118.41 -19.76 8.74 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.438 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 377' ' ' THR . 67.7 m-85 -123.54 127.7 48.69 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.512 0.672 . . . . 0.0 110.675 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.536 ' O ' ' HB2' ' A' ' 379' ' ' CYS . 54.2 p -78.36 163.21 25.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.752 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.714 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 61.0 m80 -138.24 161.82 57.18 Favored Pre-proline 0 N--CA 1.465 0.308 0 O-C-N 122.293 -0.254 . . . . 0.0 110.479 -176.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 11.3 Cg_endo -51.58 104.98 0.1 OUTLIER 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 122.937 2.425 . . . . 0.0 112.156 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 124.55 -9.35 8.2 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.701 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -95.8 157.05 16.07 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 122.601 -0.352 . . . . 0.0 111.324 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 20.0 m -69.02 -25.87 64.71 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.831 0.707 . . . . 0.0 112.061 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.67 8.97 40.64 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.318 -0.239 . . . . 0.0 110.524 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 36.5 t80 . . . . . 0 C--N 1.328 -0.367 0 O-C-N 123.447 0.467 . . . . 0.0 110.665 -178.262 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 CA--C 1.528 0.133 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -169.92 -31.73 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.031 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.503 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 29.1 ptt180 -133.01 163.75 48.84 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.758 -173.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.35 151.08 42.56 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.566 2.178 . . . . 0.0 111.18 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.95 158.73 30.08 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.496 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . 0.82 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 49.3 t -69.37 131.25 90.29 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.297 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.87 -16.45 25.93 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.269 2.646 . . . . 0.0 112.647 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -111.86 12.81 20.91 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.63 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 59.83 -151.74 36.91 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.789 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.43 -21.83 11.32 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.547 2.165 . . . . 0.0 112.324 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 36.0 t -76.36 4.16 9.54 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.924 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' CYS . . . . . 0.82 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 49.7 t -49.61 116.73 1.88 Allowed 'General case' 0 C--O 1.219 -0.547 0 O-C-N 124.358 1.036 . . . . 0.0 110.957 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -107.77 16.21 23.82 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.653 0.739 . . . . 0.0 110.347 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -76.64 88.45 3.32 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.027 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -73.79 92.3 2.02 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.305 0.574 . . . . 0.0 111.289 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . 0.477 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 47.4 t30 -153.74 126.41 4.02 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.489 ' O ' HG13 ' A' ' 436' ' ' ILE . 18.4 Cg_endo -58.63 -39.75 79.83 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.804 1.669 . . . . 0.0 111.537 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.408 HE21 ' HG2' ' A' ' 437' ' ' GLU . 23.7 tp60 -69.1 -26.26 64.83 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.695 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . 0.753 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 48.3 t60 -64.61 -61.89 1.92 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.114 0.483 . . . . 0.0 110.518 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.472 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 0.0 OUTLIER -61.39 -18.59 59.48 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.441 -178.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 432' ' ' PRO . 66.1 mt -71.96 -56.38 10.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.192 0.52 . . . . 0.0 111.701 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 418' ' ' ARG . 9.7 mm-40 -76.26 -28.08 56.95 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -112.27 123.09 49.51 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.256 0.347 . . . . 0.0 111.409 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 418' ' ' ARG . 1.2 ptm180 -78.16 126.99 31.61 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.575 0.547 . . . . 0.0 110.346 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.571 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.1 m80 -103.18 85.62 2.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.36 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' ASN . . . . . 0.455 HD22 ' CZ ' ' A' ' 439' ' ' ARG . 93.4 m-20 -68.75 117.59 10.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.616 -176.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.0 m -133.35 154.12 51.0 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -176.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.487 HD13 ' HB ' ' A' ' 445' ' ' VAL . 1.4 pp -108.81 148.02 36.99 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.913 176.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.71 -47.24 5.55 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.49 1.46 . . . . 0.0 113.072 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.487 ' HB ' HD13 ' A' ' 443' ' ' LEU . 9.8 p 44.45 29.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 122.013 0.911 . . . . 0.0 111.425 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 448' ' ' VAL . 24.4 tpt180 -83.95 92.87 7.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.296 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 14.1 m120 47.92 -76.21 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.826 1.251 . . . . 0.0 113.166 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 446' ' ' ARG . 33.5 m . . . . . 0 C--O 1.238 0.496 0 CA-C-O 121.851 0.834 . . . . 0.0 110.299 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.419 HH21 ' CG ' ' A' ' 401' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.865 0.841 . . . . 0.0 110.453 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 9.6 t -98.72 144.53 27.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.611 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 35.4 m -62.56 122.68 16.41 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.081 0.863 . . . . 0.0 112.668 -168.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.79 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 47.1 t -58.2 110.82 1.02 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.915 171.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 23.3 ptm -59.81 -25.98 65.4 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.134 0.271 . . . . 0.0 110.947 -174.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.46 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 53.1 m-85 -95.18 -14.85 23.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.578 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 57.91 -117.7 11.0 Favored Glycine 0 C--O 1.216 -0.985 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.439 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -87.29 -3.71 59.05 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.169 0.509 . . . . 0.0 111.608 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -83.31 -25.17 31.77 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.04 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.79 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.3 p -70.68 120.71 16.69 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 174.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -79.61 1.41 26.23 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.65 0.594 . . . . 0.0 111.763 -170.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.525 ' HA ' ' NE ' ' A' ' 387' ' ' ARG . 2.4 mmp_? -62.98 129.16 39.16 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 123.532 0.52 . . . . 0.0 110.595 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.52 -11.79 13.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.094 -175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -67.06 138.68 95.01 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.497 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.98 -23.74 78.04 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.074 1.849 . . . . 0.0 111.526 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.445 ' HA ' ' HG2' ' A' ' 394' ' ' GLN . 60.1 t -60.69 -41.65 89.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.716 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 48.5 t60 -53.63 -33.91 56.73 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.534 0.521 . . . . 0.0 110.911 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -95.86 -19.31 19.68 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.409 -175.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.445 ' HG2' ' HA ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -70.77 -25.38 62.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.503 0.192 . . . . 0.0 111.25 -177.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.57 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 0.8 OUTLIER -120.85 -8.77 9.38 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.57 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 93.0 m-85 -133.15 133.09 42.4 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.793 176.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 17.6 p -88.34 149.94 23.48 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.151 0.58 . . . . 0.0 110.042 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.613 ' NE2' ' NE2' ' A' ' 392' ' ' HIS . 42.6 m80 -125.56 160.86 53.78 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.213 -174.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.15 93.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.499 2.133 . . . . 0.0 110.374 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 136.6 -23.51 3.25 Favored Glycine 0 C--O 1.238 0.402 0 O-C-N 123.995 0.809 . . . . 0.0 111.473 -175.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . 0.419 ' CG ' HH21 ' A' ' 376' ' ' ARG . 15.2 t70 -76.89 133.57 39.25 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 32.0 t -63.35 -13.82 43.37 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -172.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.71 12.42 31.01 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.402 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 37.4 t80 . . . . . 0 C--O 1.241 0.645 0 CA-C-O 120.478 0.18 . . . . 0.0 110.648 -179.508 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 36.1 t70 . . . . . 0 N--CA 1.463 0.177 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.4 ' OD1' ' HD2' ' A' ' 439' ' ' ARG . 19.2 p-10 -135.95 -32.54 0.88 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.444 174.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.621 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 17.4 ptt180 -146.17 172.46 5.24 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.318 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.583 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 21.1 Cg_endo -62.03 140.52 84.8 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 121.098 1.199 . . . . 0.0 111.687 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' GLU . . . . . 0.663 ' HG3' ' ND2' ' A' ' 441' ' ' ASN . 0.4 OUTLIER -74.02 160.1 31.77 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.392 0.433 . . . . 0.0 110.297 178.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 2.6 t -63.51 135.31 96.2 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.46 -2.88 6.74 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.499 2.133 . . . . 0.0 112.804 -177.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . 0.582 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 65.0 m-85 -125.84 14.96 8.04 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.066 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 64.51 -159.76 41.41 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.777 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.93 -14.48 38.76 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.968 1.779 . . . . 0.0 111.878 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 36.0 t -70.73 -17.82 62.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 17.5 t -57.43 115.4 2.7 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -114.78 25.01 11.29 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.447 0.642 . . . . 0.0 109.416 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.66 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 2.0 mmp_? -59.77 99.31 0.06 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -80.18 96.71 6.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.114 0.959 . . . . 0.0 110.316 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -160.22 125.74 2.29 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.894 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.58 ' O ' HG13 ' A' ' 436' ' ' ILE . 20.1 Cg_endo -59.72 -42.29 47.74 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 121.979 1.786 . . . . 0.0 111.992 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.597 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 25.3 tp60 -64.46 -37.44 87.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.124 0.488 . . . . 0.0 109.895 -177.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . 0.691 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.2 t60 -59.34 -53.89 52.98 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.521 0.676 . . . . 0.0 110.021 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -63.15 -15.65 57.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.681 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 432' ' ' PRO . 85.5 mt -82.59 -37.24 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.219 0.533 . . . . 0.0 111.13 176.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 27.0 mt-10 -82.78 -44.34 15.67 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.474 -175.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 419' ' ' PRO . 96.5 m-85 -111.5 147.19 35.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.523 -171.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' ARG . . . . . 0.682 ' NH2' HD22 ' A' ' 441' ' ' ASN . 0.0 OUTLIER -93.57 141.48 28.42 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.066 174.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.674 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 74.9 m80 -108.35 92.67 4.16 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 123.741 0.651 . . . . 0.0 109.43 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' ASN . . . . . 0.682 HD22 ' NH2' ' A' ' 439' ' ' ARG . 88.4 m-20 -67.97 98.49 0.76 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -174.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.7 m -107.75 151.44 25.69 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 124.412 1.07 . . . . 0.0 109.531 -176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.46 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.6 OUTLIER -119.83 145.11 38.76 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-O 121.009 0.433 . . . . 0.0 110.146 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' PRO . . . . . 0.505 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 54.5 Cg_endo -68.66 -20.13 40.89 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.28 2.654 . . . . 0.0 112.455 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.46 ' HB ' HD13 ' A' ' 443' ' ' LEU . 5.6 p 47.94 30.68 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.883 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.484 177.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.505 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 24.7 mmt180 -87.71 145.33 26.19 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.413 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 64.16 1.19 1.15 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.811 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 121.055 0.455 . . . . 0.0 110.391 -178.807 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.416 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.8 OUTLIER . . . . . 0 C--O 1.214 -0.809 0 CA-C-O 121.556 0.693 . . . . 0.0 111.071 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 15.3 t -117.2 155.3 29.63 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.899 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 15.9 m -57.78 121.64 10.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -170.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 11.5 t -60.74 116.75 4.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.063 173.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 31.6 ttp -50.86 -40.71 56.86 Favored 'General case' 0 C--O 1.25 1.084 0 C-N-CA 122.778 0.431 . . . . 0.0 111.2 -176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.485 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 26.1 m-85 -91.96 -14.52 29.37 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.192 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.441 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 60.69 -119.61 19.38 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -80.92 -5.8 57.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.477 0.656 . . . . 0.0 111.495 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -86.18 -15.39 41.13 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.995 -174.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.9 p -74.74 131.82 41.13 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.133 0.492 . . . . 0.0 110.129 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -87.52 18.22 4.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.533 0.682 . . . . 0.0 111.405 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -87.36 121.93 30.45 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.679 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.49 ' HD3' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -121.99 2.74 9.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.69 0.757 . . . . 0.0 109.681 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -63.37 135.6 96.32 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.305 174.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.93 -29.52 64.44 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.227 2.618 . . . . 0.0 111.408 -172.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.595 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 98.8 t -65.08 -34.07 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.682 -178.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.55 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 84.7 t60 -63.67 -24.66 67.88 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.062 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -95.83 -15.4 22.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.868 0.467 . . . . 0.0 110.807 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.595 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -80.18 -25.68 39.61 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.25 -177.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.628 ' HD1' ' HD1' ' A' ' 396' ' ' PHE . 1.7 p80 -114.31 -19.95 11.05 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.628 ' HD1' ' HD1' ' A' ' 395' ' ' HIS . 59.3 m-85 -126.94 127.76 45.36 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 122.395 1.093 . . . . 0.0 111.614 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.416 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 8.8 p -81.6 158.03 24.51 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.655 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.723 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 46.4 m80 -137.02 159.07 71.43 Favored Pre-proline 0 C--N 1.315 -0.902 0 C-N-CA 123.644 0.778 . . . . 0.0 110.288 -174.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.85 102.24 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.024 1.816 . . . . 0.0 110.546 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 124.75 -0.3 8.5 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.027 -174.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -100.12 143.83 29.86 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.7 t -61.9 -29.95 70.56 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 123.32 0.387 . . . . 0.0 111.5 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.95 9.2 43.34 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.24 0.543 . . . . 0.0 110.776 -174.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 50.1 t80 . . . . . 0 C--O 1.248 0.997 0 O-C-N 121.948 -0.47 . . . . 0.0 110.887 179.549 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 C--O 1.237 0.405 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -139.64 0.12 1.8 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.793 0.806 . . . . 0.0 109.751 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 36.3 ptt180 -170.14 150.99 3.76 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.68 -172.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.61 157.08 40.38 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.413 2.075 . . . . 0.0 112.41 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' GLU . . . . . 0.507 ' HG3' ' HG3' ' A' ' 439' ' ' ARG . 2.1 mp0 -72.9 147.75 45.02 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.395 0.434 . . . . 0.0 111.396 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . 0.984 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 4.3 t -58.96 131.73 86.83 Favored Pre-proline 0 C--O 1.243 0.733 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.959 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -58.23 -22.66 58.19 Favored 'Trans proline' 0 N--CA 1.48 0.714 0 C-N-CA 123.041 2.494 . . . . 0.0 112.631 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -97.04 -5.64 37.11 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.615 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 75.45 -154.31 45.65 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.109 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.4 -16.91 39.39 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 121.996 1.797 . . . . 0.0 111.908 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 22.8 t -79.56 4.38 16.01 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.443 0.64 . . . . 0.0 111.04 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' CYS . . . . . 0.984 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 45.5 t -55.99 116.35 2.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.998 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -107.59 22.54 15.82 Favored 'General case' 0 C--O 1.248 1.018 0 O-C-N 123.61 0.569 . . . . 0.0 110.419 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -69.41 104.44 2.29 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -80.66 98.1 7.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.04 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . 0.52 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 64.7 t30 -176.0 129.06 0.37 Allowed Pre-proline 0 CA--C 1.522 -0.128 0 C-N-CA 123.715 0.806 . . . . 0.0 109.84 176.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.52 ' HD2' ' OD1' ' A' ' 431' ' ' ASN . 18.4 Cg_endo -60.45 -43.66 32.3 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.714 1.609 . . . . 0.0 111.543 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.612 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 22.8 tp60 -60.88 -34.92 75.36 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . 0.702 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 51.5 t60 -56.67 -59.22 5.32 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 123.65 0.594 . . . . 0.0 111.522 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.416 ' O ' ' NH1' ' A' ' 418' ' ' ARG . 0.0 OUTLIER -61.67 -11.42 11.66 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.048 178.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 432' ' ' PRO . 81.0 mt -83.74 -40.98 16.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.369 0.604 . . . . 0.0 110.929 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.612 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 23.4 mt-10 -78.9 -34.25 44.87 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.978 -176.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -114.77 132.11 56.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.84 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' ARG . . . . . 0.507 ' HG3' ' HG3' ' A' ' 420' ' ' GLU . 13.2 ptt180 -84.09 124.5 31.17 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.562 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.762 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.1 m80 -100.14 86.29 3.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.207 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -77.86 135.67 37.95 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.342 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 3.1 p -111.64 133.25 54.02 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 123.703 0.801 . . . . 0.0 110.172 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.89 158.08 34.09 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -176.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' PRO . . . . . 0.534 ' HG3' HG22 ' A' ' 448' ' ' VAL . 17.7 Cg_endo -59.17 -24.75 75.34 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.809 2.339 . . . . 0.0 112.2 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.41 HG11 ' O ' ' A' ' 444' ' ' PRO . 3.7 p 49.62 21.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.491 0.717 . . . . 0.0 111.874 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.426 ' HG2' ' OD1' ' A' ' 447' ' ' ASN . 48.5 ttt180 -166.64 141.23 4.17 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . 0.426 ' OD1' ' HG2' ' A' ' 446' ' ' ARG . 4.2 m-20 63.56 -83.61 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.32 1.013 . . . . 0.0 111.454 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . 0.534 HG22 ' HG3' ' A' ' 444' ' ' PRO . 35.3 m . . . . . 0 N--CA 1.474 0.773 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.884 -174.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 14.9 t -103.69 147.16 27.57 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 21.1 m -54.99 125.92 22.41 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.358 0.599 . . . . 0.0 111.964 -174.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.632 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 45.9 t -56.81 124.09 17.3 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.647 174.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' MET . . . . . 0.481 ' HE3' ' CZ ' ' A' ' 381' ' ' TYR . 34.3 ttp -50.59 -47.6 58.03 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.343 0.592 . . . . 0.0 111.372 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.504 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 56.5 m-85 -88.43 -9.79 51.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.344 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.607 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 67.87 -130.81 28.07 Favored Glycine 0 CA--C 1.501 -0.805 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -172.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . 0.506 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -80.73 -7.87 59.49 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.935 0.874 . . . . 0.0 110.913 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -79.99 -9.59 59.7 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.697 -176.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.785 ' SG ' ' NE2' ' A' ' 392' ' ' HIS . 3.7 p -63.06 136.53 57.85 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 123.583 0.552 . . . . 0.0 110.872 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -79.06 4.9 13.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.249 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -84.81 136.62 33.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.87 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.7 -7.93 7.93 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.311 0.577 . . . . 0.0 110.409 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -66.74 139.27 95.74 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.514 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -60.59 -22.46 72.5 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 122.681 2.254 . . . . 0.0 111.314 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.402 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 99.3 t -63.42 -39.77 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.28 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.785 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 86.1 t60 -59.53 -31.66 69.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 110.131 178.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -91.0 -11.4 39.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.666 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 1.9 pp0? -82.87 -26.77 31.28 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.942 0.401 . . . . 0.0 110.567 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -110.57 -17.2 13.47 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 121.634 -0.666 . . . . 0.0 111.862 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 377' ' ' THR . 20.1 m-30 -125.11 135.23 52.47 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.273 0.488 . . . . 0.0 111.467 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 20.8 p -83.37 156.51 22.96 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 123.648 0.593 . . . . 0.0 110.269 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.585 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 40.7 m80 -135.61 159.89 69.75 Favored Pre-proline 0 C--O 1.221 -0.421 0 C-N-CA 122.51 0.324 . . . . 0.0 110.956 -174.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.506 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 18.7 Cg_endo -56.48 114.75 2.05 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.965 1.777 . . . . 0.0 110.832 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.08 2.98 48.67 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 -174.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -101.62 155.95 17.79 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.381 -0.482 . . . . 0.0 109.915 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 32.0 t -59.49 -37.09 77.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.812 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -106.36 15.05 26.58 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.333 -167.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 18.0 t80 . . . . . 0 C--N 1.311 -1.099 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.728 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' A' ' 417' ' ' ASP . 17.9 t70 . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 416' ' ' ASP . 16.9 t0 80.62 78.81 0.04 OUTLIER 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.066 0.947 . . . . 0.0 111.287 173.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.404 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 25.6 ptt180 178.43 158.7 0.61 Allowed Pre-proline 0 CA--C 1.514 -0.423 0 CA-C-N 113.988 -1.46 . . . . 0.0 108.845 172.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 31.0 Cg_endo -63.15 151.1 86.52 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.263 1.975 . . . . 0.0 111.452 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' GLU . . . . . 0.551 ' HG2' ' HG3' ' A' ' 439' ' ' ARG . 36.7 mt-10 -85.05 154.26 22.2 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.385 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . 0.971 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 8.2 t -58.58 133.69 85.84 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.046 -178.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.48 -29.18 77.1 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.047 2.498 . . . . 0.0 112.715 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . 0.569 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 51.5 m-85 -98.25 6.88 46.97 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.53 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 62.52 -151.27 46.6 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.85 -15.74 29.68 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.287 1.991 . . . . 0.0 112.366 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 31.4 t -73.45 -10.19 59.47 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.624 0.726 . . . . 0.0 110.048 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' CYS . . . . . 0.971 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 42.5 t -62.38 118.62 7.73 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.189 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -125.58 23.0 7.52 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.098 0.874 . . . . 0.0 109.021 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -56.71 117.1 3.58 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.554 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -67.08 97.46 0.51 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.414 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . 0.421 HD22 ' HB3' ' A' ' 433' ' ' GLN . 62.4 t30 -178.06 121.11 0.25 Allowed Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 123.443 0.697 . . . . 0.0 109.7 173.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.15 -27.8 28.97 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.502 1.468 . . . . 0.0 111.866 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.608 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 27.0 tp60 -72.34 -34.18 67.85 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . 0.715 ' CE1' ' SG ' ' A' ' 421' ' ' CYS . 24.5 t60 -57.56 -56.61 19.71 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.859 178.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -63.21 -20.06 65.09 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.242 -177.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 50.2 mt -78.41 -41.45 25.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 122.703 0.401 . . . . 0.0 110.092 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.608 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 22.7 mt-10 -79.41 -45.68 19.03 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.815 -175.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -101.45 138.82 37.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.64 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' ARG . . . . . 0.551 ' HG3' ' HG2' ' A' ' 420' ' ' GLU . 19.1 ptt180 -92.25 145.18 24.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.515 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.677 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 35.8 m80 -119.33 98.86 6.35 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -110.2 168.61 9.31 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 4.1 p -116.99 131.99 56.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.417 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 2.5 pp -120.12 151.0 52.4 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.217 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' PRO . . . . . 0.422 ' O ' HG13 ' A' ' 445' ' ' VAL . 16.5 Cg_endo -56.79 -42.37 65.56 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.898 2.399 . . . . 0.0 112.686 -171.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 444' ' ' PRO . 2.5 p 51.4 12.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 124.582 1.176 . . . . 0.0 111.127 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 446' ' ' ARG . 0.0 OUTLIER -84.06 -43.49 15.04 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -170.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -107.78 24.04 13.53 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.563 0.697 . . . . 0.0 110.955 -175.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 121.021 0.439 . . . . 0.0 110.648 -179.788 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.449 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.2 OUTLIER . . . . . 0 C--O 1.238 0.495 0 CA-C-O 121.325 0.583 . . . . 0.0 110.906 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 13.4 t -127.15 157.47 39.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.876 176.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 69.6 p -50.61 122.37 7.09 Favored 'General case' 0 C--O 1.249 1.028 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -170.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.633 ' SG ' ' NE2' ' A' ' 392' ' ' HIS . 53.0 t -65.13 115.22 5.27 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 168.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' MET . . . . . 0.425 ' HE1' ' CZ ' ' A' ' 381' ' ' TYR . 44.3 ttp -51.89 -42.97 63.13 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.596 0.712 . . . . 0.0 111.624 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.549 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 24.8 m-85 -87.63 -9.06 55.32 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.794 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.629 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 62.5 -130.71 43.75 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-O 119.248 -0.751 . . . . 0.0 112.521 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . 0.657 ' HB1' ' HG2' ' A' ' 399' ' ' PRO . . . -75.82 -10.25 59.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.405 0.621 . . . . 0.0 111.67 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -85.97 -5.65 59.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.676 -174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.703 ' SG ' ' NE2' ' A' ' 392' ' ' HIS . 4.7 p -65.64 132.62 49.27 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.12 0.486 . . . . 0.0 110.897 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -71.39 -11.88 61.12 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.405 0.621 . . . . 0.0 110.375 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -80.34 108.76 14.21 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.592 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.39 -3.3 21.21 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.34 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -63.18 140.41 97.67 Favored Pre-proline 0 C--O 1.233 0.189 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.025 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.72 -22.41 61.11 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.058 1.839 . . . . 0.0 110.901 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.541 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 96.6 t -66.7 -35.63 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.847 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.703 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 47.0 t60 -60.86 -30.82 70.36 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 121.892 -0.505 . . . . 0.0 109.668 177.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -90.82 -15.67 29.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.733 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.541 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -81.73 -19.45 41.4 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.509 -178.265 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.612 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 2.5 p80 -119.04 -10.53 9.81 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.612 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 86.9 m-85 -135.59 126.75 28.09 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 121.491 0.663 . . . . 0.0 111.111 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.449 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 25.3 m -72.15 154.45 41.05 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.004 176.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.591 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 55.2 m80 -134.99 166.26 30.5 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.657 ' HG2' ' HB1' ' A' ' 383' ' ' ALA . 34.7 Cg_exo -40.04 -13.6 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 123.851 3.034 . . . . 0.0 115.782 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 398' ' ' HIS . . . -130.08 34.22 2.77 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -120.19 151.14 39.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.388 0.613 . . . . 0.0 109.823 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 23.3 t -64.42 -18.47 64.75 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -172.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.41 ' HB2' ' HG ' ' A' ' 397' ' ' SER . 48.4 m-20 -111.66 7.67 20.51 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 48.3 t80 . . . . . 0 CA--C 1.532 0.278 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.354 -178.211 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 CA--C 1.537 0.461 0 CA-C-O 120.955 0.407 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -131.23 -20.05 2.74 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.498 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.507 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 13.9 ptt180 -166.63 165.03 10.11 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -175.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 40.6 Cg_endo -66.31 148.12 84.06 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.047 2.498 . . . . 0.0 111.195 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -75.0 151.88 38.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.572 0.701 . . . . 0.0 110.578 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . 0.993 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 12.0 t -63.95 134.86 96.07 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.948 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.63 -5.77 9.3 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.169 1.912 . . . . 0.0 114.028 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -121.52 8.9 10.17 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.24 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 64.49 -154.12 48.5 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 119.835 -0.425 . . . . 0.0 112.527 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.43 -19.3 28.86 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.685 2.257 . . . . 0.0 111.711 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 36.5 t -74.13 -8.71 57.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.596 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' CYS . . . . . 0.993 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 48.7 t -49.84 117.83 2.51 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.277 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -112.68 22.24 14.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.46 0.648 . . . . 0.0 110.623 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -67.97 107.21 2.6 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.534 175.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -77.73 89.99 4.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.286 0.565 . . . . 0.0 111.567 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . 0.403 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 65.1 t30 -165.31 127.21 1.46 Allowed Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.258 176.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.552 ' O ' HG13 ' A' ' 436' ' ' ILE . 31.0 Cg_endo -63.16 -40.99 29.97 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.837 1.691 . . . . 0.0 111.592 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -62.38 -37.09 84.42 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.766 0.317 . . . . 0.0 110.345 -176.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . 0.691 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 39.8 t60 -60.06 -56.78 17.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.958 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.467 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 23.1 mtpp -57.92 -21.6 44.47 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.641 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 432' ' ' PRO . 65.4 mt -81.23 -46.37 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 122.763 0.425 . . . . 0.0 110.797 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 418' ' ' ARG . 7.2 mm-40 -84.02 -27.86 28.08 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -174.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -107.32 129.33 54.91 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.773 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -83.65 111.82 19.47 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.369 0.604 . . . . 0.0 110.859 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.74 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 63.8 m80 -87.53 112.53 22.33 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.525 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -114.66 125.56 53.88 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -171.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.6 p -88.9 124.43 34.2 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.491 ' CD1' ' HB ' ' A' ' 445' ' ' VAL . 1.4 pp -111.25 147.35 36.46 Favored Pre-proline 0 C--O 1.249 1.05 0 O-C-N 123.871 0.732 . . . . 0.0 111.76 -173.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' PRO . . . . . 0.423 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 28.4 Cg_endo -63.41 -30.68 72.61 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.041 2.494 . . . . 0.0 112.211 -175.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.491 ' HB ' ' CD1' ' A' ' 443' ' ' LEU . 8.7 p 43.33 30.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.739 0.816 . . . . 0.0 111.136 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 446' ' ' ARG . 21.9 mmt180 -68.68 137.6 54.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.343 0.592 . . . . 0.0 111.553 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -74.09 86.37 1.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.023 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.448 -0.537 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.635 -179.496 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.468 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.7 t -92.17 149.92 21.21 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.046 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 36.9 t -54.51 117.93 3.74 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.951 0.782 . . . . 0.0 111.752 -174.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.935 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 7.8 t -51.68 115.47 1.65 Allowed 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 170.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 26.0 ptm -57.15 -26.77 61.11 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.451 0.469 . . . . 0.0 111.321 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.56 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 58.9 m-85 -102.78 -17.15 15.72 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.696 0.284 . . . . 0.0 110.677 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.422 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 66.41 -114.37 6.45 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.814 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -83.08 -7.29 59.66 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.996 -0.709 . . . . 0.0 110.745 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 381' ' ' TYR . 36.4 m-80 -83.88 -24.49 30.81 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.632 -176.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.935 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.8 p -67.2 120.99 14.68 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.593 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -78.96 4.32 14.62 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.391 1.057 . . . . 0.0 110.891 -174.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -80.96 119.86 24.02 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.699 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.23 -1.73 11.77 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -176.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -60.99 142.58 92.74 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.352 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.68 -27.7 85.58 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.367 2.045 . . . . 0.0 110.384 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.469 ' O ' ' CD2' ' A' ' 395' ' ' HIS . 96.4 t -64.72 -41.07 91.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 O-C-N 123.79 0.681 . . . . 0.0 110.398 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.662 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 58.2 t60 -56.23 -34.0 65.93 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 39.6 m-85 -88.28 -25.05 23.01 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.198 0.523 . . . . 0.0 110.762 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -66.97 -19.37 65.71 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.595 -175.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.516 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 8.6 p80 -125.86 -17.75 5.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.621 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.516 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 26.3 m-85 -125.64 129.03 48.78 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 120.857 0.361 . . . . 0.0 110.898 174.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.468 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 13.7 p -84.08 160.82 20.86 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.396 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.732 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 43.9 m80 -133.44 159.18 73.58 Favored Pre-proline 0 C--N 1.342 0.271 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.667 -174.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 11.4 Cg_endo -51.6 113.23 1.06 Allowed 'Trans proline' 0 C--O 1.238 0.517 0 C-N-CA 122.625 2.217 . . . . 0.0 112.242 -177.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 110.66 -8.42 30.06 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.957 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -86.76 148.69 25.31 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.598 0.713 . . . . 0.0 110.869 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 46.1 t -56.71 -29.69 62.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.314 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -107.4 17.17 23.12 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.655 -175.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 61.4 t80 . . . . . 0 C--O 1.216 -0.699 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -178.21 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 CA--C 1.507 -0.707 0 CA-C-O 121.115 0.483 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -138.53 -14.64 1.26 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.799 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -171.95 154.15 3.4 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 122.432 0.293 . . . . 0.0 110.314 -173.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.94 147.85 24.8 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.516 2.144 . . . . 0.0 112.317 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.47 152.79 25.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . 0.67 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 17.1 t -59.03 129.41 85.99 Favored Pre-proline 0 C--O 1.244 0.785 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.927 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.89 -6.73 18.83 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 122.351 2.034 . . . . 0.0 111.745 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . 0.557 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 52.8 m-85 -108.27 8.97 28.05 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.027 176.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 62.72 -159.76 34.56 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.914 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.1 -20.74 24.75 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.076 2.517 . . . . 0.0 111.079 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 16.4 t -76.01 -4.25 40.22 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.755 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' CYS . . . . . 0.781 ' SG ' ' NE2' ' A' ' 434' ' ' HIS . 43.2 t -56.97 123.82 16.48 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.426 0.691 . . . . 0.0 112.028 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -126.94 28.97 5.72 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.556 ' HG2' ' SG ' ' A' ' 427' ' ' CYS . 20.9 mmm180 -68.69 101.35 1.29 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.658 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -67.86 90.8 0.3 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.394 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . 0.482 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 59.8 t30 -162.7 127.91 2.14 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.878 174.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.482 ' HD2' ' OD1' ' A' ' 431' ' ' ASN . 18.5 Cg_endo -60.59 -43.06 35.06 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 122.099 1.866 . . . . 0.0 112.392 -177.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -63.44 -32.34 73.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.789 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . 0.781 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 43.8 t60 -58.13 -59.83 4.68 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.828 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -68.13 -12.36 60.76 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.448 -177.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 432' ' ' PRO . 62.8 mt -76.7 -51.27 19.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.198 0.523 . . . . 0.0 110.671 175.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.95 -49.62 28.21 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.061 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -98.59 138.3 35.98 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.412 0.445 . . . . 0.0 111.276 -173.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 439' ' ' ARG . 11.8 ptt180 -94.96 145.27 25.04 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.472 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 31.1 m80 -120.33 108.75 14.54 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -176.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -95.69 131.79 41.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.054 0.454 . . . . 0.0 109.975 -177.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 10.2 p -114.13 147.35 38.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.262 -175.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.467 HD12 ' HB ' ' A' ' 445' ' ' VAL . 1.2 pp -149.99 148.28 24.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.485 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.38 -25.74 11.0 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.962 2.441 . . . . 0.0 112.578 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.467 ' HB ' HD12 ' A' ' 443' ' ' LEU . 7.9 p 46.63 27.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 122.443 1.116 . . . . 0.0 111.932 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -87.81 -28.6 21.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.644 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -63.69 -32.19 73.59 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.5 -176.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 C--N 1.318 -0.772 0 O-C-N 122.218 -0.301 . . . . 0.0 110.514 178.741 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.444 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 120.491 0.186 . . . . 0.0 111.234 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 12.2 t -108.97 152.95 24.27 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.076 0.86 . . . . 0.0 109.29 175.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 45.7 m -51.52 122.73 8.46 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 121.161 0.505 . . . . 0.0 111.483 -174.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.85 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 54.0 t -51.3 123.15 9.0 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.937 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 23.8 ptm -55.42 -25.05 33.72 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.185 0.594 . . . . 0.0 111.324 -174.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 37.5 m-85 -116.88 -8.07 11.35 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.813 177.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 379' ' ' CYS . . . 63.05 -123.98 31.32 Favored Glycine 0 C--O 1.242 0.644 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.863 -177.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -82.06 -9.71 59.46 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.303 0.241 . . . . 0.0 111.056 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -77.05 -30.29 55.57 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.806 0.336 . . . . 0.0 111.193 -175.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.85 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 4.5 p -65.94 115.82 6.43 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.24 176.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -76.28 2.36 13.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.856 0.836 . . . . 0.0 110.944 -175.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -65.92 124.0 21.33 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.048 172.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.43 ' H ' ' HD2' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -125.61 3.02 7.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.168 0.509 . . . . 0.0 110.464 -176.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -61.43 139.86 94.83 Favored Pre-proline 0 C--O 1.247 0.957 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.186 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.69 -25.13 80.34 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 122.934 2.423 . . . . 0.0 112.346 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.546 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 95.9 t -64.24 -37.18 79.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.573 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.762 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 26.0 t60 -58.64 -27.36 64.66 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.143 0.497 . . . . 0.0 110.644 177.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -98.09 -7.96 28.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.668 -177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -84.18 -17.05 41.24 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.041 0.448 . . . . 0.0 110.959 -176.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.476 ' ND1' ' CD1' ' A' ' 396' ' ' PHE . 7.8 p80 -126.58 -16.65 5.25 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 176.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.528 ' CD2' ' HA ' ' A' ' 379' ' ' CYS . 63.5 m-85 -125.07 128.03 47.85 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.675 0.75 . . . . 0.0 112.408 174.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.444 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 20.1 p -80.01 165.38 22.63 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.483 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.531 ' NE2' ' NE2' ' A' ' 392' ' ' HIS . 50.1 m80 -136.97 158.29 73.11 Favored Pre-proline 0 C--O 1.245 0.864 0 O-C-N 123.203 0.314 . . . . 0.0 110.318 -175.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -54.38 97.28 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.153 2.569 . . . . 0.0 110.728 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 121.93 17.14 3.84 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 123.76 0.663 . . . . 0.0 111.457 -174.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -117.24 151.08 37.66 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.215 -0.579 . . . . 0.0 110.208 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 35.2 t -57.76 -36.78 72.57 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.168 -176.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -92.79 9.05 36.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.22 0.533 . . . . 0.0 111.253 -172.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 31.0 t80 . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.789 179.174 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.5 t70 . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -178.92 -26.85 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.242 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 20.9 ptt180 -142.98 160.02 54.3 Favored Pre-proline 0 C--O 1.216 -0.689 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.099 -170.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.76 159.22 48.95 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 121.652 1.568 . . . . 0.0 112.037 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -73.51 155.24 39.39 Favored 'General case' 0 C--O 1.248 0.995 0 O-C-N 121.918 -0.489 . . . . 0.0 110.907 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . 0.77 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 16.1 t -61.7 133.64 93.61 Favored Pre-proline 0 N--CA 1.443 -0.785 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.359 176.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.17 -9.05 22.15 Favored 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 122.41 2.074 . . . . 0.0 112.743 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -116.5 12.2 15.07 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.086 0.554 . . . . 0.0 110.113 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 58.38 -153.55 27.45 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 116.5 -0.318 . . . . 0.0 112.497 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.87 -13.99 24.08 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.158 2.572 . . . . 0.0 112.474 173.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 32.2 t -70.17 -14.06 62.47 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.568 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' CYS . . . . . 0.77 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 51.5 t -49.76 137.02 16.78 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.256 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -138.12 20.57 2.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.501 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -63.96 104.1 0.67 Allowed 'General case' 0 C--O 1.24 0.604 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.676 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 430' ' ' LYS . 18.9 ptpt -62.24 95.88 0.07 Allowed 'General case' 0 C--O 1.249 1.055 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.011 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -177.98 123.2 0.26 Allowed Pre-proline 0 C--O 1.238 0.475 0 CA-C-O 120.659 0.266 . . . . 0.0 110.496 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.412 ' O ' HG13 ' A' ' 436' ' ' ILE . 19.7 Cg_endo -63.08 -39.2 40.99 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.755 2.303 . . . . 0.0 111.83 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.601 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 25.8 tp60 -64.46 -32.79 74.56 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.466 0.65 . . . . 0.0 110.655 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . 0.574 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 35.8 t60 -55.96 -59.95 4.17 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.094 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -19.01 40.73 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.972 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 433' ' ' GLN . 77.3 mt -75.09 -43.84 44.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.596 0.713 . . . . 0.0 110.878 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.601 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 19.6 mt-10 -82.66 -40.4 20.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.28 -174.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -106.78 128.87 54.61 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.224 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' ARG . . . . . . . . . . . . . 15.3 ptt-85 -85.4 116.4 23.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.894 0.854 . . . . 0.0 110.185 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.745 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 37.0 m80 -90.82 86.08 6.21 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.101 178.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -70.49 104.23 2.7 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.464 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 6.8 m -114.06 160.25 19.1 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.702 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.448 HD11 ' HB ' ' A' ' 445' ' ' VAL . 0.5 OUTLIER -135.12 157.24 77.31 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.769 179.157 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' PRO . . . . . 0.415 ' O ' HG12 ' A' ' 445' ' ' VAL . 18.7 Cg_endo -60.0 -42.28 45.72 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 122.06 1.84 . . . . 0.0 112.036 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.448 ' HB ' HD11 ' A' ' 443' ' ' LEU . 2.7 p 50.37 15.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 124.347 1.029 . . . . 0.0 112.513 177.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.41 133.56 46.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -176.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . 0.509 ' N ' HD21 ' A' ' 447' ' ' ASN . 0.8 OUTLIER -73.29 86.23 1.45 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.971 -178.543 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.321 -0.638 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.89 178.542 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.653 0 CA-C-O 120.976 0.417 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.616 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 12.9 m -101.0 139.94 35.99 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.66 173.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 49.7 m -54.83 122.98 11.96 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.609 -0.682 . . . . 0.0 110.023 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.701 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 18.4 t -50.16 123.3 8.12 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.199 0.523 . . . . 0.0 110.296 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 25.8 ptm -60.31 -17.84 45.56 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.188 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.575 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 38.0 m-85 -112.92 -11.05 13.47 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.75 177.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.407 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 65.43 -131.07 35.06 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.262 -177.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -75.75 -11.68 60.04 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.072 0.463 . . . . 0.0 110.71 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -80.22 -9.58 59.73 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -173.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.701 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 8.2 p -75.31 133.52 41.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.765 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -84.08 14.13 4.47 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.552 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -96.51 121.16 38.03 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.698 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.484 ' HD3' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -108.43 -22.16 12.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.328 -178.162 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -44.67 136.84 4.38 Favored Pre-proline 0 N--CA 1.474 0.775 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.087 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -58.7 -23.77 67.68 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.011 2.474 . . . . 0.0 112.348 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.616 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 74.0 t -67.65 -35.42 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.657 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.631 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 62.0 t60 -62.89 -19.85 64.58 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.69 -0.631 . . . . 0.0 109.794 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 90.7 m-85 -97.45 -7.53 31.42 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.74 -178.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.616 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -87.83 -19.81 26.93 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.045 0.45 . . . . 0.0 110.901 -178.029 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.458 ' ND1' ' CD2' ' A' ' 396' ' ' PHE . 7.4 p80 -121.5 -15.23 8.08 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.239 176.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.616 ' HA ' ' O ' ' A' ' 377' ' ' THR . 78.7 m-85 -133.57 127.55 33.35 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.779 0.8 . . . . 0.0 111.753 173.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 46.9 p -80.58 161.05 24.94 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.662 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 53.6 m80 -137.42 157.96 73.03 Favored Pre-proline 0 C--O 1.249 1.044 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -49.77 101.58 0.05 OUTLIER 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.199 2.599 . . . . 0.0 111.553 -176.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 122.41 -0.29 10.37 Favored Glycine 0 C--O 1.243 0.664 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.259 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -93.7 149.15 21.47 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 34.8 m -62.84 -20.53 65.17 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.522 0.514 . . . . 0.0 111.755 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.76 -3.02 28.84 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 51.0 t80 . . . . . 0 C--O 1.24 0.567 0 CA-C-O 120.82 0.343 . . . . 0.0 111.458 -172.402 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 10.8 t70 . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 120.963 0.411 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 37.4 t70 80.7 63.32 0.02 OUTLIER 'General case' 0 C--O 1.243 0.761 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.917 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.484 ' HG3' ' CG ' ' A' ' 439' ' ' ARG . 14.6 ptt180 -179.12 153.8 0.75 Allowed Pre-proline 0 C--O 1.25 1.091 0 C-N-CA 124.001 0.921 . . . . 0.0 108.984 177.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -65.1 153.77 76.67 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.741 2.294 . . . . 0.0 111.163 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -74.44 161.0 30.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . 0.655 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 18.7 t -58.72 134.23 86.4 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.493 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.42 -19.64 65.52 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.158 1.905 . . . . 0.0 112.18 -178.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 18.2 m-85 -93.77 -5.54 48.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.06 0.457 . . . . 0.0 110.169 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 75.05 -162.53 53.82 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -173.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.91 -12.42 26.16 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.366 2.044 . . . . 0.0 111.958 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 51.1 m -73.8 -9.02 58.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.031 0.443 . . . . 0.0 110.336 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' CYS . . . . . 0.742 ' SG ' ' NE2' ' A' ' 434' ' ' HIS . 51.0 t -50.89 117.88 2.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.971 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -106.03 7.99 32.16 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.036 0.922 . . . . 0.0 110.142 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -66.51 109.82 2.92 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' LYS . . . . . 0.689 ' HZ1' ' HB2' ' A' ' 430' ' ' LYS . 10.2 mtmp? -100.46 18.96 17.71 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -171.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . 0.494 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 61.7 t30 -68.44 125.95 92.19 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 172.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.494 ' HD2' ' OD1' ' A' ' 431' ' ' ASN . 17.8 Cg_endo -57.08 -41.27 76.45 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.629 2.219 . . . . 0.0 111.801 -177.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.553 ' O ' ' HG2' ' A' ' 437' ' ' GLU . 24.9 tp60 -64.6 -38.05 89.67 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . 0.742 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 25.0 t60 -59.14 -52.75 64.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.089 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -57.63 -31.0 65.83 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.3 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 432' ' ' PRO . 65.1 mt -70.99 -42.7 76.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.257 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 433' ' ' GLN . 6.8 mm-40 -76.09 -38.18 57.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . 0.521 ' HB3' ' HA ' ' A' ' 421' ' ' CYS . 85.7 m-85 -114.85 150.69 35.16 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -171.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' ARG . . . . . 0.484 ' CG ' ' HG3' ' A' ' 418' ' ' ARG . 36.8 mtm180 -95.25 123.62 38.86 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.248 0.968 . . . . 0.0 110.776 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.477 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 71.4 m80 -99.5 85.78 3.23 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' ASN . . . . . 0.484 HD22 ' NH1' ' A' ' 439' ' ' ARG . 74.4 m-20 -107.52 151.74 25.17 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -176.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 7.5 p -98.12 147.98 24.02 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.996 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 2.6 pp -148.52 156.79 42.13 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 110.728 -0.101 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' PRO . . . . . 0.534 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 21.1 Cg_endo -60.08 -28.53 87.21 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.933 2.422 . . . . 0.0 112.912 -174.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.2 p 47.66 31.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 O-C-N 124.012 0.82 . . . . 0.0 111.183 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.534 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 26.4 mmt180 -86.67 163.01 17.62 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.703 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 60.51 44.24 12.04 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 10.0 m . . . . . 0 C--O 1.235 0.31 0 C-N-CA 124.548 1.139 . . . . 0.0 111.666 177.156 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.481 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.3 OUTLIER . . . . . 0 C--O 1.237 0.44 0 CA-C-O 121.497 0.665 . . . . 0.0 109.548 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 5.2 t -97.27 143.2 28.28 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.904 173.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 58.5 m -54.74 123.08 12.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.319 0.58 . . . . 0.0 112.052 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.837 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 29.3 t -49.47 107.97 0.17 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.226 176.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 22.4 ptp -54.55 -27.3 37.59 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -177.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -93.93 -16.63 23.8 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.083 0.468 . . . . 0.0 109.998 178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.6 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 66.35 -126.43 28.06 Favored Glycine 0 C--O 1.235 0.161 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -176.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -91.27 4.5 52.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.678 0.391 . . . . 0.0 110.829 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -88.52 -15.1 36.11 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.782 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.837 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 0.6 OUTLIER -67.94 131.61 45.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 0.0 110.397 177.848 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -82.65 21.11 1.03 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.281 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -95.99 121.99 38.33 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.653 176.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -107.82 -25.91 11.02 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 124.565 1.166 . . . . 0.0 108.534 -177.39 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -48.07 139.94 9.42 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.845 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.14 -22.34 67.41 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.849 1.699 . . . . 0.0 112.073 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.407 HG12 ' HE2' ' A' ' 395' ' ' HIS . 88.8 t -66.33 -34.73 72.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.865 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.726 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 70.9 t60 -59.82 -37.81 80.24 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.937 0.399 . . . . 0.0 110.153 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -86.23 -18.2 32.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.35 -176.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -29.28 61.08 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -175.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.608 ' HD1' ' HD1' ' A' ' 396' ' ' PHE . 1.0 OUTLIER -109.68 -16.51 13.91 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.575 176.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.608 ' HD1' ' HD1' ' A' ' 395' ' ' HIS . 72.5 m-85 -122.35 127.84 50.26 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 120.74 0.305 . . . . 0.0 110.945 176.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.481 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 16.8 p -78.37 156.43 29.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 122.874 0.47 . . . . 0.0 110.027 175.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.686 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 51.0 m80 -132.02 159.02 73.9 Favored Pre-proline 0 N--CA 1.476 0.836 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.997 -176.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -52.37 102.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.679 2.253 . . . . 0.0 111.954 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 121.23 -1.37 11.56 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.737 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -98.12 151.45 20.37 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 122.035 0.921 . . . . 0.0 110.503 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 29.7 p -63.36 -29.11 70.47 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.163 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -104.73 15.86 27.11 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.226 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.9 t80 . . . . . 0 C--N 1.323 -0.585 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.359 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 21.6 t70 . . . . . 0 C--O 1.239 0.517 0 CA-C-O 121.152 0.501 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -147.42 -43.56 0.17 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.353 175.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.486 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 24.7 ptt180 -122.09 165.89 18.98 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.191 -176.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 61.3 Cg_endo -72.68 146.23 42.96 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.217 1.945 . . . . 0.0 112.052 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' GLU . . . . . 0.574 ' HG2' ' ND2' ' A' ' 441' ' ' ASN . 47.2 mt-10 -61.38 155.24 22.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.884 0.373 . . . . 0.0 111.357 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . 0.956 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 8.3 t -66.62 136.7 94.85 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -53.21 -34.36 69.05 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.146 2.564 . . . . 0.0 112.69 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 74.8 m-85 -102.14 7.79 40.88 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.424 -176.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 71.04 -153.43 51.18 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.429 -0.35 . . . . 0.0 112.573 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.53 -19.02 49.11 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.538 2.159 . . . . 0.0 111.883 175.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 37.9 t -69.82 -19.58 63.47 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.599 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' CYS . . . . . 0.956 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 40.9 t -56.03 115.55 2.48 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.769 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -109.14 16.61 22.38 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 123.835 0.709 . . . . 0.0 109.483 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.477 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 2.4 mmp_? -53.71 93.23 0.01 OUTLIER 'General case' 0 C--O 1.246 0.884 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 173.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -75.95 79.16 2.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.313 -174.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . 0.421 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 48.5 t30 -150.9 123.36 4.09 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.336 174.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.509 ' O ' HG13 ' A' ' 436' ' ' ILE . 23.2 Cg_endo -62.79 -33.16 77.08 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.19 1.926 . . . . 0.0 111.314 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -68.16 -38.65 82.32 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . 0.634 ' CE1' ' SG ' ' A' ' 421' ' ' CYS . 29.8 t60 -59.93 -53.85 53.06 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.948 0.88 . . . . 0.0 109.229 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.426 ' O ' ' NH1' ' A' ' 418' ' ' ARG . 51.1 mtpt -62.99 -14.69 50.8 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.307 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 432' ' ' PRO . 48.3 mt -86.31 -45.33 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 123.235 0.334 . . . . 0.0 110.546 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -76.8 -29.45 56.0 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 122.437 -0.164 . . . . 0.0 111.294 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -113.95 137.29 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.093 0.557 . . . . 0.0 109.87 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' ARG . . . . . 0.486 ' HD3' ' O ' ' A' ' 418' ' ' ARG . 1.0 OUTLIER -94.47 130.3 40.9 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.078 178.167 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.74 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 21.4 m80 -106.17 86.07 2.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.595 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' ASN . . . . . 0.574 ' ND2' ' HG2' ' A' ' 420' ' ' GLU . 46.7 m-80 -69.85 135.47 49.63 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.332 -173.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 28.9 p -135.86 173.14 12.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.601 0.715 . . . . 0.0 110.448 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.457 HD11 ' HB ' ' A' ' 445' ' ' VAL . 1.3 pp -137.12 146.46 54.57 Favored Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 122.028 -0.42 . . . . 0.0 110.284 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' PRO . . . . . 0.49 ' O ' HG13 ' A' ' 445' ' ' VAL . 27.2 Cg_endo -62.14 -44.54 19.17 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 122.901 2.401 . . . . 0.0 112.359 -175.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 444' ' ' PRO . 5.9 p 48.21 26.27 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 124.444 1.098 . . . . 0.0 112.035 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -92.5 167.81 11.69 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 7.3 t30 74.43 -42.71 0.51 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.816 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 C--O 1.244 0.796 0 C-N-CA 123.128 0.571 . . . . 0.0 111.374 178.489 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.599 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.1 OUTLIER . . . . . 0 CA--C 1.514 -0.441 0 CA-C-O 122.009 0.909 . . . . 0.0 111.264 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.4 t -111.51 162.53 15.01 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.491 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 24.8 t -57.59 116.91 3.68 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.954 0.502 . . . . 0.0 111.699 -176.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 25.1 t -51.96 117.28 2.64 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 23.2 ptm -58.93 -21.09 57.45 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.611 0.243 . . . . 0.0 111.005 -170.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.623 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 72.0 m-85 -109.61 -14.81 14.3 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.568 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 72.03 -134.94 22.26 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . 0.469 ' HB3' ' HG2' ' A' ' 399' ' ' PRO . . . -75.92 -1.27 24.68 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.842 0.354 . . . . 0.0 110.409 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -91.77 -10.48 39.82 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.621 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.2 p -73.59 126.05 29.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 122.134 -0.354 . . . . 0.0 110.524 175.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -77.81 10.92 2.41 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.441 0.639 . . . . 0.0 111.896 -175.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -95.31 119.44 33.83 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.083 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.557 ' HD3' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -122.28 5.73 9.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.47 -178.145 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -63.73 136.6 96.79 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.197 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.6 -33.14 30.12 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.499 2.799 . . . . 0.0 112.534 -171.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.471 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 54.1 t -65.59 -34.91 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.702 -177.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.682 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 81.5 t60 -57.22 -31.78 65.85 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 122.068 -0.395 . . . . 0.0 110.208 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -89.78 -10.29 46.06 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 123.337 0.398 . . . . 0.0 111.973 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -82.61 -12.67 57.52 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.584 -0.447 . . . . 0.0 111.117 -175.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.419 ' HD2' ' HG3' ' A' ' 394' ' ' GLN . 3.6 p80 -128.97 -23.41 3.06 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.455 ' CD2' ' HA ' ' A' ' 379' ' ' CYS . 60.2 m-85 -123.12 127.32 48.54 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.317 0.579 . . . . 0.0 111.096 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.599 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 57.4 m -86.95 166.17 15.31 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.037 173.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.64 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 28.1 m80 -131.74 159.11 73.39 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 122.815 0.446 . . . . 0.0 110.667 -174.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.469 ' HG2' ' HB3' ' A' ' 383' ' ' ALA . 19.6 Cg_endo -55.73 97.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.432 2.088 . . . . 0.0 111.885 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.18 -30.43 2.81 Favored Glycine 0 CA--C 1.508 -0.37 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.219 -175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -66.57 143.07 57.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.013 -0.593 . . . . 0.0 109.658 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 12.2 t -64.82 -17.44 64.24 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.91 -174.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.416 ' HB2' ' HG ' ' A' ' 397' ' ' SER . 4.1 m-20 -108.4 7.49 27.07 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.218 0.207 . . . . 0.0 111.091 -174.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 52.5 t80 . . . . . 0 C--O 1.238 0.465 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 178.389 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 N--CA 1.461 0.098 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -129.81 -24.91 2.63 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.68 0.752 . . . . 0.0 109.958 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.531 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 28.0 ptt180 -154.68 165.32 18.36 Favored Pre-proline 0 C--O 1.247 0.97 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.139 -175.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.531 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 39.3 Cg_endo -67.18 143.61 65.59 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.901 2.4 . . . . 0.0 112.541 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -67.18 151.92 46.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 123.248 0.343 . . . . 0.0 110.865 174.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . 0.674 ' SG ' ' NE2' ' A' ' 440' ' ' HIS . 27.9 t -63.55 136.3 96.65 Favored Pre-proline 0 C--N 1.317 -0.813 0 O-C-N 123.622 0.576 . . . . 0.0 109.866 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.78 -13.28 29.58 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.836 2.357 . . . . 0.0 112.365 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -111.59 8.89 21.09 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 57.32 -149.93 30.75 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 -172.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.89 -1.87 11.96 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.436 2.091 . . . . 0.0 111.88 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 17.3 t -84.05 -2.45 56.71 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.825 0.822 . . . . 0.0 109.121 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 44.7 t -49.35 117.49 2.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.386 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -108.29 11.5 27.2 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.998 176.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -75.15 93.8 2.85 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -79.18 83.28 5.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.491 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -144.34 122.94 6.92 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.518 ' O ' HG13 ' A' ' 436' ' ' ILE . 18.3 Cg_endo -59.08 -38.23 88.32 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.822 1.681 . . . . 0.0 112.885 -175.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.583 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 24.9 tp60 -65.45 -40.06 92.77 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.965 -0.46 . . . . 0.0 109.785 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . 0.563 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 26.1 t60 -57.9 -53.77 54.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.699 0.761 . . . . 0.0 110.452 177.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -61.02 -18.22 56.57 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.889 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 432' ' ' PRO . 52.3 mt -84.3 -41.84 16.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.676 178.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 23.8 mt-10 -79.21 -45.5 19.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.135 0.493 . . . . 0.0 110.847 -175.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -97.14 145.41 26.04 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.459 -174.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' ARG . . . . . 0.424 ' NH1' HD22 ' A' ' 441' ' ' ASN . 16.7 ptt180 -92.32 118.31 30.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.354 0.597 . . . . 0.0 110.213 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.674 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 76.2 m80 -92.9 78.55 4.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.002 175.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' ASN . . . . . 0.424 HD22 ' NH1' ' A' ' 439' ' ' ARG . 2.2 m-20 -66.63 105.58 1.57 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.763 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.0 p -81.92 121.89 27.06 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.479 ' O ' HD11 ' A' ' 443' ' ' LEU . 2.2 pp -87.65 145.66 37.57 Favored Pre-proline 0 C--O 1.246 0.89 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.907 -173.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.65 -32.16 19.6 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.103 2.535 . . . . 0.0 112.543 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.429 ' HB ' HD13 ' A' ' 443' ' ' LEU . 9.3 p 43.05 32.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.911 1.339 . . . . 0.0 109.941 -176.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -92.24 158.01 16.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.937 -1.102 . . . . 0.0 110.284 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 59.87 21.62 10.56 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 171.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.224 -0.248 0 O-C-N 123.563 0.539 . . . . 0.0 109.692 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.122 0 CA-C-O 120.989 0.424 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 14.3 t -134.14 162.81 31.1 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 12.4 m -54.59 117.7 3.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.638 0.732 . . . . 0.0 110.679 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.644 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 39.6 t -51.23 120.95 5.48 Favored 'General case' 0 C--N 1.359 0.992 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.085 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 27.2 ptm -58.81 -23.18 60.07 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.609 0.719 . . . . 0.0 111.122 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.595 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 35.1 m-85 -103.23 -15.71 15.92 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 121.075 -1.016 . . . . 0.0 109.902 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.528 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 64.6 -131.74 37.76 Favored Glycine 0 CA--C 1.498 -1.028 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.797 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -75.75 -4.87 42.89 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 122.65 0.38 . . . . 0.0 111.214 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -86.86 -5.33 59.14 Favored 'General case' 0 C--O 1.248 1.022 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.715 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.709 ' SG ' ' NE2' ' A' ' 392' ' ' HIS . 6.4 p -81.2 123.58 28.57 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.649 0.738 . . . . 0.0 111.43 176.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -82.13 10.72 6.22 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.911 0.862 . . . . 0.0 110.95 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.539 HH21 ' ND2' ' A' ' 389' ' ' ASN . 31.4 mmm180 -84.02 124.09 30.7 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.13 174.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.46 -5.3 11.73 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.422 -176.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.539 ' ND2' HH21 ' A' ' 387' ' ' ARG . 20.7 p-10 -58.73 137.59 86.68 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.217 176.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -60.01 -24.19 75.68 Favored 'Trans proline' 0 CA--C 1.518 -0.297 0 C-N-CA 122.178 1.919 . . . . 0.0 111.252 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.528 HG11 ' NE2' ' A' ' 395' ' ' HIS . 93.4 t -66.62 -42.17 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.129 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.709 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 82.3 t60 -54.53 -35.05 62.78 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 120.381 -0.527 . . . . 0.0 110.459 178.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.432 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 24.6 m-85 -88.08 -24.04 23.54 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.771 -176.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -72.83 -20.26 61.17 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.949 -177.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.646 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 1.9 p80 -118.22 -8.71 10.58 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 176.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.646 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 88.0 m-85 -137.65 127.28 25.21 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.333 0.587 . . . . 0.0 110.767 176.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.554 ' HG ' ' HB2' ' A' ' 403' ' ' ASP . 46.2 m -85.78 159.2 19.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.964 175.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.628 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 39.2 m80 -128.1 153.02 78.52 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.811 -174.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -50.77 112.34 0.74 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.311 2.007 . . . . 0.0 112.701 -174.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 117.65 -5.57 16.62 Favored Glycine 0 C--O 1.237 0.34 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.075 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -95.67 145.41 25.29 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.322 0.582 . . . . 0.0 109.922 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 42.0 t -57.81 -30.91 66.08 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.293 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.554 ' HB2' ' HG ' ' A' ' 397' ' ' SER . 21.0 m-20 -94.29 2.61 55.85 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.758 -174.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 59.8 t80 . . . . . 0 C--N 1.321 -0.633 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.421 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.8 t70 . . . . . 0 N--CA 1.468 0.442 0 CA-C-O 121.414 0.626 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 35.8 t70 79.4 57.94 0.02 OUTLIER 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.252 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -175.75 152.89 1.35 Allowed Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.094 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.42 145.53 67.52 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.071 1.847 . . . . 0.0 112.203 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' GLU . . . . . 0.426 ' HG2' ' ND2' ' A' ' 441' ' ' ASN . 42.5 mt-10 -74.37 150.88 39.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 172.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . 0.913 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 5.5 t -59.48 127.37 84.55 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.95 -23.6 35.51 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.344 2.029 . . . . 0.0 113.219 -176.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . 0.468 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 87.7 m-85 -102.34 18.01 22.08 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.239 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 59.03 -156.07 25.46 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.579 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.68 -9.68 22.83 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.654 2.236 . . . . 0.0 111.083 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 32.1 t -73.87 -8.86 57.68 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.52 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' CYS . . . . . 0.913 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 23.1 t -62.94 115.64 4.58 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.399 0.619 . . . . 0.0 109.545 176.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -109.13 21.51 17.07 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.714 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 0.2 OUTLIER -64.02 92.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.207 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -68.79 91.44 0.45 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.851 0.834 . . . . 0.0 111.393 -174.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -161.98 123.54 1.63 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.811 173.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.471 ' O ' HG13 ' A' ' 436' ' ' ILE . 33.4 Cg_endo -63.91 -36.52 49.4 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.752 2.302 . . . . 0.0 110.599 -178.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.65 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 22.4 tp60 -65.31 -37.01 85.82 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . 0.667 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 12.3 t60 -63.3 -49.35 74.37 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 121.683 0.754 . . . . 0.0 109.575 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.498 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 53.8 mtpt -66.72 -7.1 18.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.078 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 432' ' ' PRO . 42.6 mt -94.97 -42.94 12.85 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.752 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.65 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 22.8 mt-10 -68.76 -37.55 79.46 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.83 0.824 . . . . 0.0 110.555 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -117.55 138.66 51.76 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.551 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -89.38 118.61 29.17 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.712 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 22.3 m80 -94.21 99.34 11.62 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' ASN . . . . . 0.426 ' ND2' ' HG2' ' A' ' 420' ' ' GLU . 35.6 m-80 -91.43 106.08 18.24 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.56 -175.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.98 138.32 39.57 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.527 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.5 OUTLIER -118.53 149.81 46.87 Favored Pre-proline 0 C--O 1.248 1.011 0 CA-C-O 120.963 0.411 . . . . 0.0 111.771 -171.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.52 -18.32 12.25 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 123.042 2.494 . . . . 0.0 111.859 175.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.527 ' HB ' HD13 ' A' ' 443' ' ' LEU . 10.0 p 43.03 30.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.245 0 CA-C-O 122.315 1.055 . . . . 0.0 111.715 -178.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -108.39 -33.37 7.1 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.509 -174.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -81.65 -27.79 33.92 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.128 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--O 1.206 -1.237 0 O-C-N 123.755 0.659 . . . . 0.0 109.669 179.508 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.298 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 12.6 t -101.83 149.38 24.25 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 9.7 t -57.93 111.86 1.3 Allowed 'General case' 0 C--O 1.244 0.796 0 O-C-N 123.355 0.41 . . . . 0.0 110.193 -171.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.782 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 30.9 t -51.36 108.96 0.29 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 14.5 ptp -60.43 -13.62 14.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.988 0.423 . . . . 0.0 110.665 -176.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.46 ' CB ' ' HB3' ' A' ' 385' ' ' CYS . 36.3 m-85 -93.59 -27.05 16.83 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.079 175.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.408 ' O ' ' HD2' ' A' ' 398' ' ' HIS . . . 60.28 -117.93 13.05 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.415 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -84.29 -9.67 58.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.17 -0.606 . . . . 0.0 111.505 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -78.95 -26.67 43.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.2 -176.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.782 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 13.5 p -73.87 111.57 9.15 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.426 172.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -84.98 12.39 7.66 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.38 0.609 . . . . 0.0 110.143 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -65.11 125.47 25.04 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 172.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.41 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.5 OUTLIER -119.72 0.75 10.98 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.028 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -66.05 133.86 94.83 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.117 173.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.9 -22.08 67.06 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.547 2.165 . . . . 0.0 112.292 -174.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.56 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 74.9 t -67.85 -38.32 79.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.129 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.585 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 85.0 t60 -62.88 -26.69 68.9 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 120.864 0.364 . . . . 0.0 110.051 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -92.46 -19.57 21.88 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.281 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -73.79 -23.69 59.72 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.872 -177.111 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.537 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 2.4 p80 -116.7 -11.89 10.93 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 177.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.537 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 93.8 m-85 -131.94 131.71 42.88 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 122.126 -0.359 . . . . 0.0 111.549 175.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 22.2 p -84.38 153.95 23.14 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.369 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.594 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 69.3 m80 -136.32 159.87 69.09 Favored Pre-proline 0 C--O 1.221 -0.44 0 O-C-N 122.339 -0.225 . . . . 0.0 110.524 -173.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 17.4 Cg_endo -54.43 103.08 0.09 OUTLIER 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.25 1.966 . . . . 0.0 111.614 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 129.62 -23.68 4.74 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -76.27 151.09 36.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.231 -0.484 . . . . 0.0 110.78 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 13.5 m -67.15 -22.83 65.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.523 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -110.99 15.56 21.66 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.285 -173.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 38.1 t80 . . . . . 0 C--N 1.319 -0.748 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.823 -178.944 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.7 t70 . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 36.7 t70 68.85 74.09 0.26 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.425 0.631 . . . . 0.0 110.181 -174.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.493 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 19.3 ptt180 -162.88 158.82 18.99 Favored Pre-proline 0 C--O 1.246 0.91 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 35.8 Cg_endo -63.32 136.57 56.07 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.644 2.229 . . . . 0.0 111.644 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -70.58 147.76 48.91 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 121.797 -0.564 . . . . 0.0 110.121 175.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . 1.001 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 11.9 t -54.82 137.56 64.34 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.396 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.74 -14.38 26.46 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.158 1.906 . . . . 0.0 112.494 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -113.27 10.31 18.46 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.116 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 59.36 -151.19 36.21 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-O 119.598 -0.557 . . . . 0.0 111.85 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.14 -13.02 28.42 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.664 2.243 . . . . 0.0 112.344 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 38.0 t -79.87 1.24 27.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.485 176.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' CYS . . . . . 1.001 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 48.0 t -60.02 116.72 4.36 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.127 177.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -114.42 23.56 12.68 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.983 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -69.04 108.42 3.54 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.762 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -77.29 84.15 3.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.142 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . 0.414 ' O ' ' HB3' ' A' ' 434' ' ' HIS . 61.5 t30 -156.47 121.07 2.39 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.428 175.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.456 ' O ' HG13 ' A' ' 436' ' ' ILE . 18.7 Cg_endo -58.76 -43.32 45.2 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.423 2.082 . . . . 0.0 112.708 -175.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 437' ' ' GLU . 28.9 tp60 -67.94 -26.35 65.92 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.93 0.769 . . . . 0.0 109.744 -175.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . 0.715 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 59.6 t60 -60.55 -59.37 5.5 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 122.816 0.446 . . . . 0.0 111.494 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -25.6 64.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.668 0.27 . . . . 0.0 111.025 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 432' ' ' PRO . 67.0 mt -70.18 -46.46 72.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.007 0.432 . . . . 0.0 111.09 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 433' ' ' GLN . 11.8 mm-40 -76.31 -53.9 7.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.944 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -91.62 144.62 25.34 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.374 0.421 . . . . 0.0 110.516 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' ARG . . . . . 0.447 ' HB3' ' HG3' ' A' ' 418' ' ' ARG . 17.7 ptt180 -89.94 137.03 32.68 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.663 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 61.7 m80 -111.72 79.9 1.26 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.281 0.562 . . . . 0.0 109.674 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' ASN . . . . . 0.424 HD22 ' NE ' ' A' ' 439' ' ' ARG . 85.8 m-20 -74.86 129.45 37.7 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.069 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 17.2 p -86.56 140.4 29.92 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.804 -0.56 . . . . 0.0 109.841 -177.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.452 HD13 ' HB ' ' A' ' 445' ' ' VAL . 1.2 pp -109.04 151.84 42.15 Favored Pre-proline 0 C--N 1.312 -1.046 0 O-C-N 123.858 0.724 . . . . 0.0 110.114 -175.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.54 -49.06 4.8 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.288 1.992 . . . . 0.0 112.082 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.452 ' HB ' HD13 ' A' ' 443' ' ' LEU . 11.3 p 40.07 39.59 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.87 0.843 . . . . 0.0 109.751 -174.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -89.91 161.66 15.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.368 -173.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -56.52 -35.83 68.5 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.026 0.441 . . . . 0.0 110.739 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 C--O 1.252 1.199 0 CA-C-O 121.128 0.49 . . . . 0.0 111.821 176.751 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.583 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.441 -0.879 0 CA-C-O 121.399 0.619 . . . . 0.0 111.116 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 11.9 t -101.3 152.91 20.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.966 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 14.0 t -54.53 119.48 5.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.741 0.305 . . . . 0.0 111.723 -171.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.89 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 26.3 t -59.29 109.78 0.94 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 24.8 ptm -54.53 -29.86 51.94 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.364 -176.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.542 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 51.9 m-85 -98.23 -16.65 19.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.54 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 62.89 -116.26 9.14 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.874 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -90.34 7.79 36.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.854 0.359 . . . . 0.0 111.221 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -98.49 -22.55 15.95 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.447 0.299 . . . . 0.0 110.852 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.89 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 1.8 p -65.18 131.55 46.82 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.142 176.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -80.59 12.31 3.18 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.383 0.611 . . . . 0.0 112.067 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -92.66 112.16 24.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.649 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -100.05 -24.09 14.7 Favored 'General case' 0 C--O 1.221 -0.419 0 O-C-N 123.855 0.722 . . . . 0.0 109.316 -179.435 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -47.49 138.85 8.57 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.707 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.47 -21.82 69.48 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.453 2.102 . . . . 0.0 111.464 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.559 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 93.3 t -66.7 -36.91 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.436 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.668 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 82.1 t60 -58.66 -38.26 77.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.293 174.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -87.56 -4.99 58.95 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.923 -176.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -85.71 -24.48 26.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.039 -0.413 . . . . 0.0 110.465 178.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -110.96 -23.76 10.77 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.493 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -120.27 129.03 53.86 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.597 0.713 . . . . 0.0 111.997 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.583 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 11.8 p -82.17 157.84 23.84 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.365 175.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.576 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 58.9 m80 -136.09 162.2 58.01 Favored Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -170.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.07 100.63 0.08 OUTLIER 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.778 2.318 . . . . 0.0 111.059 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 109.54 24.33 5.92 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.476 -174.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . 0.433 ' CG ' HH21 ' A' ' 376' ' ' ARG . 20.7 t70 -119.97 150.5 40.42 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 122.303 0.241 . . . . 0.0 110.478 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 17.7 t -54.37 -41.1 68.78 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.277 0.631 . . . . 0.0 111.791 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -104.08 16.41 26.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.759 -167.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 19.9 t80 . . . . . 0 C--O 1.236 0.346 0 CA-C-O 120.531 0.205 . . . . 0.0 110.603 -179.12 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.461 ' HB2' ' HD3' ' A' ' 439' ' ' ARG . 2.1 m-20 . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 12.0 t70 81.98 50.81 0.02 OUTLIER 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.0 -174.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -153.25 158.59 32.77 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.026 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.414 ' O ' ' HA ' ' A' ' 438' ' ' TYR . 80.4 Cg_exo -48.03 141.85 16.63 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.89 2.394 . . . . 0.0 112.69 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -83.27 143.2 30.56 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . 0.607 ' SG ' ' NE2' ' A' ' 434' ' ' HIS . 34.8 t -59.61 126.96 84.18 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.22 7.12 1.21 Allowed 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.576 2.184 . . . . 0.0 112.835 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -120.31 5.1 10.73 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 64.9 -162.99 38.05 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.6 -15.34 27.4 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.008 2.472 . . . . 0.0 112.489 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 40.4 t -70.52 -13.16 62.0 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.044 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 46.6 t -48.66 118.02 2.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.836 0.854 . . . . 0.0 110.612 -178.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -113.84 18.41 17.38 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 122.899 0.479 . . . . 0.0 109.918 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.417 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 4.3 mmp_? -66.52 96.58 0.38 Allowed 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.798 175.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' LYS . . . . . 0.683 ' HB2' ' HZ3' ' A' ' 430' ' ' LYS . 10.1 mtmp? -69.05 93.55 0.59 Allowed 'General case' 0 C--O 1.241 0.614 0 O-C-N 123.371 0.419 . . . . 0.0 110.283 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . 0.45 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 54.6 t30 -157.9 122.91 2.3 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.463 ' O ' HG13 ' A' ' 436' ' ' ILE . 33.4 Cg_endo -63.43 -35.74 59.29 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.487 2.125 . . . . 0.0 112.056 -177.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.621 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 23.4 tp60 -68.45 -41.62 79.97 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -175.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . 0.607 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 5.0 t60 -56.2 -51.2 68.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.433 0.635 . . . . 0.0 110.132 178.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -67.18 -13.76 62.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.402 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 432' ' ' PRO . 40.2 mt -89.84 -34.87 6.94 Favored 'Isoleucine or valine' 0 C--O 1.251 1.153 0 C-N-CA 122.704 0.402 . . . . 0.0 110.146 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.621 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 27.9 mt-10 -83.77 -45.54 13.22 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.298 0.571 . . . . 0.0 111.12 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 419' ' ' PRO . 19.1 m-85 -103.32 147.1 27.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.229 -174.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' ARG . . . . . 0.461 ' HD3' ' HB2' ' A' ' 416' ' ' ASP . 17.0 ptt180 -93.69 114.02 26.23 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.589 177.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.459 ' CD2' ' HB3' ' A' ' 427' ' ' CYS . 79.6 m80 -81.66 85.01 6.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' ASN . . . . . 0.409 HD22 ' NH1' ' A' ' 439' ' ' ARG . 89.0 m-20 -67.32 103.57 1.3 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.361 -173.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 1.5 m -104.47 159.35 15.81 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.132 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.551 HD11 ' HB ' ' A' ' 445' ' ' VAL . 0.5 OUTLIER -135.75 144.83 50.48 Favored Pre-proline 0 C--N 1.32 -0.684 0 O-C-N 121.66 -0.65 . . . . 0.0 111.828 -176.061 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -64.22 -29.21 64.34 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.435 2.757 . . . . 0.0 110.834 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.551 ' HB ' HD11 ' A' ' 443' ' ' LEU . 7.3 p 35.9 69.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 124.823 1.327 . . . . 0.0 110.591 -175.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -56.68 157.34 5.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.455 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -66.78 -26.77 67.12 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.104 0.877 . . . . 0.0 110.54 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.472 0.668 0 O-C-N 123.273 0.358 . . . . 0.0 110.917 179.432 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . 0.56 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 122.039 0.923 . . . . 0.0 110.683 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 5.4 t -96.2 153.65 17.68 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.233 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.1 m -64.22 122.67 17.2 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.075 0.464 . . . . 0.0 111.166 -170.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.973 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 15.4 t -49.92 123.61 8.42 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.729 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 20.8 ptm -56.0 -29.47 60.36 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.217 0.532 . . . . 0.0 111.072 -172.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.536 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 39.2 m-85 -98.73 -14.85 19.58 Favored 'General case' 0 C--O 1.255 1.391 0 CA-C-O 119.051 -0.5 . . . . 0.0 110.439 176.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 62.49 -107.51 1.65 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -84.3 -13.71 51.73 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 381' ' ' TYR . 38.9 m-80 -81.49 -26.01 35.55 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -174.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.973 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.4 p -66.65 113.89 5.15 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.035 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -85.49 9.48 15.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.935 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 387' ' ' ARG . 27.8 mmt180 -62.46 134.13 55.99 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.957 176.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.418 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.3 OUTLIER -118.97 -7.64 10.36 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 124.105 0.878 . . . . 0.0 110.406 -171.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -67.47 137.09 93.33 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.057 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -60.68 -30.67 90.89 Favored 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 121.576 1.517 . . . . 0.0 110.946 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.418 HG13 ' NE2' ' A' ' 395' ' ' HIS . 87.9 t -59.17 -40.68 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.896 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.691 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 85.6 t60 -54.95 -43.9 73.85 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 120.771 0.319 . . . . 0.0 110.441 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -82.23 -25.15 34.4 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.493 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -66.67 -27.88 68.01 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.686 0.279 . . . . 0.0 110.783 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.632 ' HD1' ' HD1' ' A' ' 396' ' ' PHE . 1.1 p80 -119.09 -3.98 10.6 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.632 ' HD1' ' HD1' ' A' ' 395' ' ' HIS . 39.6 m-85 -139.33 126.59 21.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.442 0.639 . . . . 0.0 109.989 177.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.56 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 70.7 m -83.46 158.63 21.98 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 123.261 0.624 . . . . 0.0 111.031 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.614 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 27.0 m80 -127.65 162.03 51.62 Favored Pre-proline 0 C--O 1.222 -0.354 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 14.8 Cg_endo -55.11 106.34 0.18 Allowed 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 121.829 1.686 . . . . 0.0 111.219 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 120.03 -1.14 13.28 Favored Glycine 0 C--N 1.319 -0.368 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.47 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -94.98 148.98 21.74 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.7 t -62.48 -30.4 71.23 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.402 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.435 ' HB2' ' HG ' ' A' ' 397' ' ' SER . 0.9 OUTLIER -96.99 2.4 51.46 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 110.726 -174.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 58.2 t80 . . . . . 0 N--CA 1.465 0.292 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.591 178.927 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 C--O 1.241 0.636 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 21.7 t70 175.32 -27.75 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.66 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . 0.406 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 24.1 ptt180 -138.17 165.67 31.61 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.977 -174.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 62.1 Cg_endo -75.72 162.52 35.15 Favored 'Trans proline' 0 C--O 1.244 0.783 0 C-N-CA 121.221 1.281 . . . . 0.0 110.957 177.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.64 158.27 33.92 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.689 0.757 . . . . 0.0 109.502 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 6.6 t -65.86 136.7 95.81 Favored Pre-proline 0 N--CA 1.453 -0.305 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 175.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.17 -16.92 42.95 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.269 1.313 . . . . 0.0 112.772 -177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -115.11 15.71 17.08 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.851 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 57.72 -152.03 27.97 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.995 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.45 -14.8 34.24 Favored 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 121.973 1.782 . . . . 0.0 111.535 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 19.9 t -82.08 2.2 32.33 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.92 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 49.8 t -60.25 124.17 19.46 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.362 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -121.56 66.42 0.89 Allowed 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.563 0.697 . . . . 0.0 110.117 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.426 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 2.3 mmp_? -108.8 108.79 19.73 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' LYS . . . . . 0.754 ' HZ2' ' HB2' ' A' ' 430' ' ' LYS . 4.8 ttmp? -70.13 82.06 0.51 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.057 -0.402 . . . . 0.0 110.741 -176.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -166.36 123.99 1.04 Allowed Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 123.012 0.525 . . . . 0.0 110.247 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.527 ' O ' HG13 ' A' ' 436' ' ' ILE . 42.6 Cg_endo -68.2 -32.56 26.76 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.088 1.859 . . . . 0.0 112.3 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.635 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 23.6 tp60 -68.94 -36.23 77.72 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.935 -0.478 . . . . 0.0 109.845 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . 0.67 ' CE1' ' SG ' ' A' ' 421' ' ' CYS . 39.9 t60 -53.59 -56.1 20.02 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.023 0.916 . . . . 0.0 110.579 176.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.409 ' HA ' ' HE1' ' A' ' 440' ' ' HIS . 24.2 mtpp -60.46 -16.51 37.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.761 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 432' ' ' PRO . 58.1 mt -87.81 -28.86 5.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.426 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.635 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 29.1 mt-10 -90.33 -32.95 16.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.757 -175.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -114.39 129.75 56.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.13 0.491 . . . . 0.0 109.818 -174.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 419' ' ' PRO . 15.7 ptt180 -79.13 118.9 21.53 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.007 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.761 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 66.5 m80 -98.96 90.58 4.68 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -67.3 107.75 2.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.655 0.74 . . . . 0.0 110.452 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 1.3 p -99.32 122.89 43.08 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.252 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.401 ' CD1' ' HB ' ' A' ' 445' ' ' VAL . 0.4 OUTLIER -133.16 157.09 79.13 Favored Pre-proline 0 C--O 1.215 -0.711 0 O-C-N 123.933 0.771 . . . . 0.0 110.02 -173.51 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.17 -37.68 96.17 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 121.713 1.609 . . . . 0.0 111.584 -174.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.401 ' HB ' ' CD1' ' A' ' 443' ' ' LEU . 5.3 p 46.84 20.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.051 1.34 . . . . 0.0 112.633 177.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.413 ' HB3' HG21 ' A' ' 448' ' ' VAL . 47.0 mmt-85 -68.79 128.99 38.63 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.379 -0.826 . . . . 0.0 110.452 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -84.39 -17.53 39.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.393 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . 0.413 HG21 ' HB3' ' A' ' 446' ' ' ARG . 34.5 m . . . . . 0 C--O 1.237 0.406 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.067 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.296 0 CA-C-O 120.923 0.392 . . . . 0.0 111.57 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 6.2 t -130.89 165.71 22.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.816 175.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 16.4 m -59.53 113.02 2.0 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -172.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 49.1 t -52.55 114.9 1.53 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 26.7 ptm -53.29 -26.94 20.38 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.239 -173.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' TYR . . . . . 0.44 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 91.1 m-85 -91.73 -25.43 19.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 61.55 -115.9 8.58 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.116 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' ALA . . . . . 0.405 ' HB3' ' HG3' ' A' ' 399' ' ' PRO . . . -79.37 -6.25 56.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.919 0.39 . . . . 0.0 111.086 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -87.87 -28.68 21.43 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -173.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 4.8 p -71.39 129.65 39.34 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -94.42 17.22 13.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.449 -174.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -70.26 145.27 51.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' LYS . . . . . 0.444 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -130.52 -1.08 4.4 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.086 0.469 . . . . 0.0 110.136 178.388 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -76.89 134.76 68.1 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.57 -20.49 70.88 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.716 2.277 . . . . 0.0 111.467 -173.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.579 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 59.2 t -66.21 -44.32 91.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.745 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' HIS . . . . . 0.594 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 84.3 t60 -57.47 -28.01 62.99 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.027 0.441 . . . . 0.0 110.111 178.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 81.6 m-85 -96.47 -13.9 22.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.879 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -76.46 -18.68 58.66 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.617 -176.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' HIS . . . . . 0.548 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 6.8 p80 -122.81 -21.66 5.52 Favored 'General case' 0 C--O 1.245 0.816 0 O-C-N 123.167 0.292 . . . . 0.0 111.698 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' PHE . . . . . 0.548 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 48.0 m-85 -128.11 126.82 41.9 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 117.799 0.272 . . . . 0.0 111.044 176.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' SER . . . . . 0.483 ' HG ' ' HB2' ' A' ' 403' ' ' ASP . 68.9 m -87.88 165.17 15.46 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.415 0.626 . . . . 0.0 111.238 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' HIS . . . . . 0.672 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 42.7 m80 -132.72 164.56 42.86 Favored Pre-proline 0 C--O 1.233 0.23 0 C-N-CA 123.173 0.589 . . . . 0.0 110.117 -174.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 19.0 Cg_endo -55.03 93.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.072 2.515 . . . . 0.0 111.152 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 132.58 15.3 1.42 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.07 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 397' ' ' SER . 17.5 t70 -121.46 149.11 43.53 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 34.7 t -63.24 -33.01 74.56 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.481 0.312 . . . . 0.0 111.114 -174.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' ASP . . . . . 0.483 ' HB2' ' HG ' ' A' ' 397' ' ' SER . 1.5 m-20 -90.73 9.73 28.79 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.188 0.518 . . . . 0.0 111.288 -175.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 55.9 t80 . . . . . 0 N--CA 1.456 -0.169 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.343 175.476 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 22.0 t70 . . . . . 0 C--O 1.237 0.403 0 CA-C-O 121.564 0.697 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -142.85 10.61 1.79 Allowed 'General case' 0 C--N 1.347 0.465 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -173.2 159.23 3.39 Favored Pre-proline 0 C--O 1.242 0.683 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.579 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.413 ' O ' ' HG2' ' A' ' 439' ' ' ARG . 55.4 Cg_endo -68.56 154.8 70.88 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.029 2.486 . . . . 0.0 112.38 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -74.54 143.35 44.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.894 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' CYS . . . . . 0.939 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 11.6 t -57.84 133.68 83.2 Favored Pre-proline 0 C--N 1.317 -0.829 0 O-C-N 123.8 0.687 . . . . 0.0 109.571 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.7 -16.09 46.33 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 121.79 1.66 . . . . 0.0 113.092 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' TYR . . . . . 0.501 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 29.3 m-85 -112.94 12.58 19.38 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 122.732 0.413 . . . . 0.0 110.033 179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 56.57 -148.76 29.97 Favored Glycine 0 C--O 1.248 1.006 0 C-N-CA 121.321 -0.466 . . . . 0.0 113.162 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.18 -14.23 28.64 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.883 2.388 . . . . 0.0 112.044 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 34.1 t -76.04 -10.49 59.46 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.609 177.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' CYS . . . . . 0.939 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 51.2 t -58.33 118.48 5.58 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.37 177.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -119.49 22.58 11.63 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 124.101 0.876 . . . . 0.0 109.774 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' ARG . . . . . 0.759 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 0.5 OUTLIER -63.74 109.41 1.7 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -71.51 94.55 1.3 Allowed 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.674 0.608 . . . . 0.0 111.151 -177.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . 0.443 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 63.3 t30 -169.47 124.88 0.73 Allowed Pre-proline 0 N--CA 1.469 0.481 0 O-C-N 124.437 1.086 . . . . 0.0 108.832 176.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.535 ' O ' HG13 ' A' ' 436' ' ' ILE . 34.3 Cg_endo -65.45 -33.58 46.45 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.39 2.06 . . . . 0.0 111.53 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' GLN . . . . . 0.581 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 24.2 tp60 -68.6 -32.3 72.09 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.07 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . 0.723 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 41.8 t60 -62.71 -58.22 8.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.484 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -55.36 -19.74 9.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.501 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 432' ' ' PRO . 64.5 mt -80.64 -42.64 20.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 O-C-N 123.724 0.64 . . . . 0.0 109.812 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.581 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 22.3 mt-10 -78.74 -46.97 17.74 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 -174.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -106.45 135.36 48.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.43 0.633 . . . . 0.0 110.678 -174.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 419' ' ' PRO . 16.0 ptt180 -84.78 133.85 34.34 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.55 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.681 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 63.0 m80 -107.12 85.68 2.18 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.247 0.546 . . . . 0.0 109.853 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -70.65 117.65 12.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.673 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 1.9 m -129.81 152.73 48.99 Favored 'General case' 0 C--O 1.247 0.926 0 O-C-N 123.712 0.632 . . . . 0.0 110.412 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' LEU . . . . . 0.401 ' O ' HD11 ' A' ' 443' ' ' LEU . 1.1 pp -106.22 154.85 39.42 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' PRO . . . . . 0.443 ' O ' HG12 ' A' ' 445' ' ' VAL . 12.7 Cg_endo -55.46 -39.71 89.55 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.475 2.117 . . . . 0.0 112.981 -173.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 444' ' ' PRO . 4.4 p 49.42 21.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 124.497 1.123 . . . . 0.0 111.277 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' ARG . . . . . 0.457 ' HG3' ' ND2' ' A' ' 447' ' ' ASN . 28.3 tpt180 -137.82 149.78 46.63 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -176.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . 0.457 ' ND2' ' HG3' ' A' ' 446' ' ' ARG . 59.7 m-80 65.5 20.28 11.67 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.902 0.881 . . . . 0.0 111.056 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 CA--C 1.542 0.67 0 CA-C-O 120.918 0.39 . . . . 0.0 110.867 -177.377 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.301 0 N-CA-C 112.165 -0.374 . . . . 0.0 112.165 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 12.6 p -96.99 -179.83 4.68 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -67.85 92.09 0.34 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -101.45 114.24 28.07 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 124.451 1.094 . . . . 0.0 110.632 -176.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 65.8 m -88.32 -5.39 58.36 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.935 0.397 . . . . 0.0 110.899 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -53.04 121.45 7.42 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 121.195 0.522 . . . . 0.0 110.255 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 14.3 m -91.3 153.48 19.91 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.373 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 42.9 t -70.37 92.8 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.177 0.513 . . . . 0.0 110.43 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -99.45 -18.58 17.39 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.585 177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -72.44 131.7 42.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.472 0.654 . . . . 0.0 109.943 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 161.0 -166.21 35.55 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 44.1 m -77.2 -18.21 57.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.69 0.396 . . . . 0.0 110.507 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -95.63 31.35 2.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.931 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -79.12 56.43 4.35 Favored Glycine 0 C--O 1.245 0.79 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.71 175.08 9.42 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 122.914 0.486 . . . . 0.0 110.632 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.661 ' HB2' ' HZ3' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -89.41 0.79 56.59 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.96 -172.339 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . 0.536 HG12 ' HD3' ' A' ' 373' ' ' LYS . 12.6 m -147.37 159.47 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 123.85 0.719 . . . . 0.0 109.696 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -101.61 128.4 47.9 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 124.121 0.888 . . . . 0.0 109.412 174.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.534 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 2.6 mpp_? -68.64 172.6 6.05 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.07 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 395' ' ' HIS . 4.9 t -98.14 141.09 31.5 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.985 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 410' ' ' VAL . 19.3 t -55.96 121.34 9.1 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 123.071 0.232 . . . . 0.0 111.412 -176.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.708 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 10.6 t -54.18 103.02 0.07 Allowed 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 172.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' MET . . . . . 0.432 ' HB3' HG11 ' A' ' 410' ' ' VAL . 20.9 ptm -49.78 -27.64 5.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.836 0.71 . . . . 0.0 111.845 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.557 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 28.9 m-85 -93.68 -19.42 21.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.669 -0.644 . . . . 0.0 111.355 176.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.507 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 64.94 -126.17 31.39 Favored Glycine 0 CA--C 1.501 -0.809 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -80.59 0.29 34.66 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.928 0.394 . . . . 0.0 111.531 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -94.18 -7.29 42.65 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.062 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.84 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 7.6 p -74.49 128.09 34.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.371 0.605 . . . . 0.0 110.141 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -81.98 2.99 28.25 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.873 -175.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -87.82 115.92 25.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.697 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -117.42 2.35 12.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.01 0.91 . . . . 0.0 109.855 -177.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -63.15 136.57 96.75 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.678 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.69 -28.9 48.91 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.138 2.558 . . . . 0.0 112.921 -173.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.487 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 53.3 t -61.93 -37.04 77.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.338 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.706 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 72.7 t60 -58.42 -29.14 65.87 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.349 0.595 . . . . 0.0 110.997 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -93.3 -18.5 22.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.49 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -74.86 -20.04 59.91 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.374 0.607 . . . . 0.0 110.972 -175.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.466 ' O ' HG22 ' A' ' 377' ' ' THR . 7.2 p80 -121.57 -15.87 7.9 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.313 -0.867 . . . . 0.0 111.554 176.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 377' ' ' THR . 59.1 m-85 -121.07 136.78 54.91 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.135 0.493 . . . . 0.0 112.016 173.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.534 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 19.6 m -93.17 149.86 20.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.661 176.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.655 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 37.9 m80 -124.96 160.64 53.37 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -175.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 25.7 Cg_endo -59.34 93.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.315 2.01 . . . . 0.0 111.446 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 144.41 -13.05 2.04 Favored Glycine 0 CA--C 1.507 -0.443 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -84.02 145.84 28.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.132 -0.534 . . . . 0.0 110.735 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 16.0 m -66.9 -26.38 66.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.084 176.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -86.68 -4.16 59.14 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.756 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -77.42 138.02 39.03 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.575 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -130.67 -50.2 0.11 Allowed Glycine 0 C--O 1.242 0.622 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 73.91 9.0 79.14 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.746 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.7 m -93.59 -6.37 10.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 CA-C-N 116.975 0.387 . . . . 0.0 111.509 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.475 ' O ' ' HG2' ' A' ' 412' ' ' GLN . 6.3 tt0 -77.64 150.4 34.59 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 123.676 0.79 . . . . 0.0 110.053 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 28.0 pt -51.29 -44.85 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.522 175.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 378' ' ' SER . 46.6 t -75.22 95.61 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.344 171.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 138.57 -31.7 2.38 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.084 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 4.2 pt20 -115.08 -50.08 2.77 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.789 0.294 . . . . 0.0 110.734 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 7.0 t70 174.56 141.56 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.515 0.51 . . . . 0.0 110.074 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -117.4 -9.6 10.86 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.897 -174.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' THR . . . . . 0.602 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 74.1 p -105.36 -49.96 3.33 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -168.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 415' ' ' THR . 22.6 t70 68.27 -64.96 0.28 Allowed 'General case' 0 C--N 1.318 -0.792 0 O-C-N 124.036 0.835 . . . . 0.0 110.906 -172.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.5 -25.15 0.1 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.004 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.764 ' HG3' ' HG2' ' A' ' 439' ' ' ARG . 16.3 ptt180 -158.99 170.2 9.31 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 119.4 -0.334 . . . . 0.0 110.893 -168.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.496 ' O ' ' HA ' ' A' ' 438' ' ' TYR . 23.3 Cg_endo -61.38 151.34 80.14 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.192 1.928 . . . . 0.0 111.926 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' GLU . . . . . 0.545 ' HG2' ' HE ' ' A' ' 439' ' ' ARG . 44.1 mt-10 -87.67 142.29 27.95 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.998 0.428 . . . . 0.0 110.918 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 9.3 t -66.75 121.7 78.81 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.68 -10.46 24.79 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.67 2.247 . . . . 0.0 112.076 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -104.55 -3.41 23.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.57 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 69.39 -152.04 51.49 Favored Glycine 0 C--O 1.223 -0.559 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.352 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 441' ' ' ASN . 75.1 Cg_endo -76.18 -11.69 19.35 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.8 2.334 . . . . 0.0 111.216 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 32.1 t -85.09 8.14 19.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.238 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 36.5 t -60.17 117.29 4.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.613 0.721 . . . . 0.0 110.851 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -100.16 11.52 39.15 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.311 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.673 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 0.7 OUTLIER -66.41 109.31 2.68 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.264 176.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -85.02 86.81 7.35 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.35 0.66 . . . . 0.0 110.533 -172.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 433' ' ' GLN . 65.0 t30 -166.45 125.69 1.14 Allowed Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 122.559 0.344 . . . . 0.0 110.874 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.428 ' O ' HG13 ' A' ' 436' ' ' ILE . 29.8 Cg_endo -64.67 -35.45 46.81 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.752 1.635 . . . . 0.0 111.864 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.608 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 25.2 tp60 -64.58 -37.66 88.34 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.358 0.599 . . . . 0.0 110.909 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . 0.677 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.6 t60 -57.93 -51.51 69.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.652 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.456 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 24.8 mtpp -58.77 -23.8 60.67 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.716 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 432' ' ' PRO . 82.0 mt -80.31 -36.92 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.194 0.521 . . . . 0.0 110.414 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.608 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 24.0 mt-10 -84.34 -34.79 23.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.346 -173.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 419' ' ' PRO . 57.2 m-85 -108.75 154.87 21.43 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.686 -174.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' ARG . . . . . 0.764 ' HG2' ' HG3' ' A' ' 418' ' ' ARG . 11.9 mtm180 -91.37 120.03 31.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.705 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 78.6 m80 -92.4 78.54 5.03 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 173.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' ASN . . . . . 0.602 HD22 ' NH2' ' A' ' 439' ' ' ARG . 1.7 m-20 -63.37 106.28 0.88 Allowed 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 113.818 -1.537 . . . . 0.0 110.505 -171.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.95 138.36 31.48 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.506 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.8 OUTLIER -108.44 144.93 30.5 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.287 -174.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.61 -44.18 18.58 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.392 2.061 . . . . 0.0 111.342 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 443' ' ' LEU . 8.2 p 41.85 27.73 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 124.686 1.242 . . . . 0.0 110.81 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.46 158.12 16.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 -174.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -116.03 79.76 1.35 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.725 0.774 . . . . 0.0 110.016 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.471 0.6 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.526 -179.812 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' ' ZN' . . . . . 0.84 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' ' ZN' . . . . . 0.791 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 417' ' ' ASP . . . . . . . . 0 N--CA 1.484 1.896 0 N-CA-C 112.152 -0.379 . . . . 0.0 112.152 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.1 m -154.59 143.8 21.18 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.927 0.364 . . . . 0.0 111.758 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 360' ' ' LYS . 0.0 OUTLIER -162.94 110.65 1.25 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.47 169.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -133.39 168.43 18.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 122.416 0.286 . . . . 0.0 110.591 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 66.9 p -94.32 139.4 31.12 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 124.048 0.842 . . . . 0.0 110.948 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -83.23 -36.02 24.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.387 0.613 . . . . 0.0 110.37 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 14.5 m -75.28 95.5 3.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.78 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.65 79.85 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 122.031 0.919 . . . . 0.0 109.94 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -84.46 -14.03 50.38 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.162 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -60.6 99.11 0.08 Allowed 'General case' 0 C--O 1.248 1.019 0 O-C-N 123.631 0.582 . . . . 0.0 110.205 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 165.75 43.82 0.02 OUTLIER Glycine 0 C--O 1.238 0.403 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 18.4 m -146.11 19.91 1.41 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.322 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -61.89 134.58 56.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.518 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -150.49 26.38 1.08 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -106.37 149.0 27.42 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.731 ' HE2' ' N ' ' A' ' 373' ' ' LYS . 0.3 OUTLIER -76.17 -27.08 56.82 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 16.3 m -114.26 157.71 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.769 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.67 156.16 25.26 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.806 175.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.57 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -107.93 172.84 6.61 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 122.312 0.245 . . . . 0.0 111.373 -178.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.452 HG21 ' CD1' ' A' ' 396' ' ' PHE . 9.7 t -108.2 163.3 13.29 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.06 0.85 . . . . 0.0 109.49 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 16.2 m -62.24 119.52 9.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.981 0.896 . . . . 0.0 111.764 -174.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.793 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 33.7 t -52.71 119.48 4.61 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.849 0.86 . . . . 0.0 109.114 174.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' MET . . . . . 0.464 ' O ' HG13 ' A' ' 410' ' ' VAL . 26.3 ptm -56.24 -23.73 37.84 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.327 0.584 . . . . 0.0 111.952 -173.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.56 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 34.6 m-85 -104.96 -16.18 14.91 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.244 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.432 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 64.91 -121.71 22.43 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.6 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . 0.456 ' HB1' ' HG2' ' A' ' 399' ' ' PRO . . . -82.88 4.7 24.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.927 0.363 . . . . 0.0 111.132 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -96.6 -14.7 22.0 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.809 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 1.8 p -73.58 127.12 31.87 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.561 -0.712 . . . . 0.0 110.732 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -81.58 -4.92 57.38 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.084 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -60.05 128.21 35.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.538 0.685 . . . . 0.0 109.623 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.499 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.2 OUTLIER -112.05 -15.71 13.22 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.56 -173.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -62.83 134.76 95.66 Favored Pre-proline 0 C--O 1.243 0.73 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.578 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.59 -22.85 75.45 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.501 2.134 . . . . 0.0 111.343 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.578 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 77.8 t -62.92 -35.9 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.214 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.654 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 83.9 t60 -61.43 -30.58 70.66 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.285 0.365 . . . . 0.0 110.339 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 54.6 m-85 -90.27 -24.79 20.82 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.749 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -71.1 -20.23 62.37 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.804 -175.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.674 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 1.9 p80 -119.68 -11.98 9.33 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.674 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 63.1 m-85 -138.52 126.55 22.62 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 177.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.57 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 58.0 m -86.73 160.66 18.76 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.355 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.713 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 32.4 m80 -127.83 165.63 28.97 Favored Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.668 -173.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.456 ' HG2' ' HB1' ' A' ' 383' ' ' ALA . 50.2 Cg_exo -54.74 -2.56 0.2 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 123.488 2.792 . . . . 0.0 114.152 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 398' ' ' HIS . . . -119.15 13.11 11.29 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 111.964 -0.455 . . . . 0.0 111.964 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -121.85 131.08 53.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.9 t -62.57 -20.63 64.9 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -170.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.513 ' HB2' ' HG ' ' A' ' 397' ' ' SER . 3.8 m-20 -82.18 -7.52 59.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.405 0.621 . . . . 0.0 110.986 -177.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -70.73 131.54 44.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.61 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -135.74 5.0 4.03 Favored Glycine 0 C--O 1.22 -0.721 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.065 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 52.7 54.03 29.95 Favored Glycine 0 C--O 1.243 0.712 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.594 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 33.5 m -88.04 -20.79 7.27 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 122.398 0.279 . . . . 0.0 110.824 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -117.06 124.89 50.38 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.641 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 410' ' ' VAL . 13.7 pt -48.3 -43.72 12.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 O-C-N 123.588 0.555 . . . . 0.0 111.217 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.868 ' HA ' ' HG3' ' A' ' 414' ' ' GLU . 8.5 t -68.25 103.09 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.64 -45.13 0.63 Allowed Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.508 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.412 ' HG2' ' OD1' ' A' ' 413' ' ' ASP . 5.8 pm0 -126.4 -30.37 2.87 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.779 -0.248 . . . . 0.0 111.123 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.412 ' OD1' ' HG2' ' A' ' 412' ' ' GLN . 3.8 p30 -155.98 97.52 1.82 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.819 0.819 . . . . 0.0 110.972 175.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . 0.868 ' HG3' ' HA ' ' A' ' 410' ' ' VAL . 17.6 mp0 -87.18 -25.98 23.78 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.079 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 59.9 p -62.98 169.25 3.42 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.044 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 417' ' ' ASP . 19.4 t70 -58.99 -23.26 61.69 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.034 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 416' ' ' ASP . 9.0 t0 78.07 79.04 0.07 Allowed 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.838 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.44 ' HG3' ' CG ' ' A' ' 439' ' ' ARG . 14.7 ptt180 -178.48 157.23 1.02 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.867 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.26 147.02 94.18 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.299 2.0 . . . . 0.0 111.342 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -73.74 159.23 33.26 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.908 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 7.8 t -64.22 132.27 95.27 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.4 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.88 -12.02 29.8 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.371 2.047 . . . . 0.0 112.256 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 37.0 m-85 -106.47 11.79 30.34 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.087 0.555 . . . . 0.0 110.709 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 56.6 -153.22 20.04 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.621 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.99 -9.9 19.51 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.335 2.023 . . . . 0.0 110.817 176.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 35.9 t -70.71 -14.85 62.61 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 173.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' CYS . . . . . 0.908 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 54.0 t -52.43 117.36 2.8 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.143 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -116.31 19.69 14.67 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.561 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 1.7 mmp_? -63.97 103.12 0.55 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.887 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -77.63 105.58 8.88 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.784 0.677 . . . . 0.0 109.69 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . 0.535 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 62.7 t30 -178.36 127.75 0.28 Allowed Pre-proline 0 C--O 1.244 0.768 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.933 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.535 ' HD2' ' OD1' ' A' ' 431' ' ' ASN . 19.9 Cg_endo -58.72 -44.55 35.5 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.339 2.692 . . . . 0.0 111.61 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.441 ' HB3' ' ND2' ' A' ' 431' ' ' ASN . 23.1 tp60 -59.47 -34.12 72.16 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 120.973 0.415 . . . . 0.0 110.398 -177.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . 0.689 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 61.9 t60 -63.06 -62.31 1.79 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.742 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -15.34 24.59 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 432' ' ' PRO . 60.1 mt -75.85 -47.22 33.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.834 174.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -78.54 -45.47 21.77 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.887 -0.508 . . . . 0.0 112.238 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -107.32 155.39 20.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.824 -0.548 . . . . 0.0 112.239 -171.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' ARG . . . . . 0.44 ' CG ' ' HG3' ' A' ' 418' ' ' ARG . 54.2 mtm180 -94.25 153.53 17.99 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.636 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.586 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 75.2 m80 -128.97 80.42 1.97 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 175.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -84.03 139.09 32.74 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.004 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 3.9 p -101.75 130.19 48.1 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 123.311 0.382 . . . . 0.0 111.873 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 443' ' ' LEU . 1.3 pp -108.79 151.01 41.55 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.3 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -63.27 -30.39 73.73 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 C-N-CA 122.075 1.85 . . . . 0.0 112.216 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.2 p 44.27 31.0 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 C-N-CA 124.847 1.259 . . . . 0.0 111.691 -177.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -87.96 165.35 15.28 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.939 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -43.71 -58.35 2.74 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.895 0.878 . . . . 0.0 111.029 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--N 1.343 0.308 0 C-N-CA 122.583 0.353 . . . . 0.0 111.054 -177.0 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' ' ZN' . . . . . 0.809 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' ' ZN' . . . . . 0.789 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.903 0 N-CA-C 111.314 -0.715 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 20.4 m -69.07 -39.97 78.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.002 0.43 . . . . 0.0 110.528 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -82.51 -68.05 0.73 Allowed 'General case' 0 C--O 1.245 0.854 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.886 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -84.45 116.46 23.1 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.967 0.507 . . . . 0.0 109.995 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 33.0 p -62.93 143.81 57.33 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 122.683 0.393 . . . . 0.0 111.029 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.06 -48.35 18.09 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.808 0.443 . . . . 0.0 110.214 -177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 23.1 t -82.34 -177.92 6.85 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.44 129.24 47.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 122.865 0.466 . . . . 0.0 111.316 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 3.6 pp -113.04 -12.62 13.19 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.319 174.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -70.91 -12.48 61.56 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.421 0.629 . . . . 0.0 110.155 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -110.13 53.42 0.58 Allowed Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.411 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 23.1 t -146.99 97.0 2.83 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -120.56 142.47 49.33 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 124.257 0.973 . . . . 0.0 110.053 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 93.44 -50.94 2.39 Favored Glycine 0 C--O 1.236 0.273 0 O-C-N 123.5 0.5 . . . . 0.0 112.234 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -72.28 129.04 37.49 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.633 -0.334 . . . . 0.0 110.908 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.545 ' HG2' HG11 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -107.44 -16.55 14.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.744 0.307 . . . . 0.0 110.63 179.412 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . 0.545 HG11 ' HG2' ' A' ' 373' ' ' LYS . 26.9 m -124.53 171.37 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.274 177.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.77 164.56 30.15 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.329 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.418 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.4 OUTLIER -100.05 166.64 10.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.339 0.59 . . . . 0.0 111.591 -176.474 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 6.0 t -115.11 152.01 33.31 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 173.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 49.3 m -55.54 123.69 14.82 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.979 0.799 . . . . 0.0 112.032 -172.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 26.5 t -60.36 118.49 6.5 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' MET . . . . . 0.492 ' HB3' HG12 ' A' ' 410' ' ' VAL . 22.7 ptm -54.66 -33.49 60.78 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-O 121.464 0.649 . . . . 0.0 111.388 -175.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.558 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 41.3 m-85 -96.92 -10.49 26.27 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.579 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.531 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 62.38 -129.09 42.44 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -80.28 -3.33 48.91 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.063 0.459 . . . . 0.0 111.182 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -84.63 -16.48 41.85 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.227 -175.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 3.0 p -69.43 141.03 54.15 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.451 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -78.93 9.34 4.37 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 122.791 0.437 . . . . 0.0 111.461 -174.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -93.79 111.18 22.83 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.671 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.457 ' HD3' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -105.59 -21.3 13.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.212 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -46.98 131.41 8.88 Favored Pre-proline 0 C--O 1.238 0.451 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.959 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.49 -25.53 58.81 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 123.749 2.966 . . . . 0.0 111.602 -174.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.493 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 64.6 t -65.8 -34.7 72.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.279 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.649 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 73.3 t60 -59.87 -26.5 65.91 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.301 -0.875 . . . . 0.0 110.088 175.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 38.4 m-85 -93.68 -5.49 48.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.586 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -88.67 -23.14 23.09 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.046 -178.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -116.02 -18.68 10.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.067 0.46 . . . . 0.0 111.913 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 393' ' ' PHE . 69.2 m-85 -125.29 128.51 48.35 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.761 174.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 404' ' ' TYR . 14.2 p -80.26 159.04 26.01 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.477 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.704 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 53.7 m80 -139.53 158.15 68.97 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.868 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -51.07 107.9 0.2 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 121.887 1.725 . . . . 0.0 110.379 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 118.45 0.81 15.97 Favored Glycine 0 C--N 1.316 -0.552 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.698 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 404' ' ' TYR . 20.1 t70 -97.63 141.82 30.19 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 123.04 0.536 . . . . 0.0 109.864 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 43.4 t -58.9 -26.18 64.08 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.939 0.774 . . . . 0.0 111.505 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -110.84 19.47 18.53 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.773 -174.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.442 ' HB2' ' HB2' ' A' ' 397' ' ' SER . 63.5 t80 -97.76 132.57 43.26 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.605 -0.684 . . . . 0.0 110.446 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -136.86 -34.12 0.22 Allowed Glycine 0 CA--C 1.505 -0.553 0 O-C-N 123.478 0.486 . . . . 0.0 111.968 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 78.42 14.38 82.23 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.834 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 33.5 m -88.48 -9.03 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 122.624 -0.339 . . . . 0.0 110.259 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 412' ' ' GLN . 6.5 tt0 -68.82 145.76 53.46 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.433 HG13 ' N ' ' A' ' 410' ' ' VAL . 29.6 pt -53.31 -46.25 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.587 ' HA ' ' HG2' ' A' ' 414' ' ' GLU . 65.6 t -72.11 97.49 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.036 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 142.28 -32.61 1.97 Allowed Glycine 0 C--O 1.218 -0.871 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -177.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 408' ' ' GLN . 0.0 OUTLIER -126.15 -41.58 1.92 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 117.286 0.543 . . . . 0.0 111.373 -179.18 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -167.91 114.46 0.71 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.015 0.436 . . . . 0.0 109.906 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . 0.587 ' HG2' ' HA ' ' A' ' 410' ' ' VAL . 24.4 mt-10 -100.29 2.08 42.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.825 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 62.2 p -101.18 -74.05 0.63 Allowed 'General case' 0 C--N 1.315 -0.91 0 O-C-N 123.501 0.5 . . . . 0.0 111.983 -166.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -179.72 -56.33 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -168.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -175.15 -32.34 0.01 OUTLIER 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.74 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 23.1 ptt180 -128.6 157.27 75.58 Favored Pre-proline 0 C--O 1.245 0.843 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.277 -176.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.9 158.94 38.47 Favored 'Trans proline' 0 C--N 1.326 -0.648 0 C-N-CA 122.16 1.906 . . . . 0.0 111.139 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' GLU . . . . . 0.459 ' HG3' ' HG3' ' A' ' 439' ' ' ARG . 1.9 mp0 -75.29 158.72 32.43 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.93 0.395 . . . . 0.0 110.302 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.98 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 6.6 t -62.76 133.14 94.95 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.899 176.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.91 -6.93 13.68 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.685 2.257 . . . . 0.0 112.698 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . 0.519 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 96.8 m-85 -114.72 11.88 16.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.173 0.511 . . . . 0.0 110.288 177.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 61.21 -157.79 31.68 Favored Glycine 0 N--CA 1.462 0.377 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.731 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.15 -11.39 25.12 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.675 2.917 . . . . 0.0 112.197 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 25.8 t -81.41 -11.63 59.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.785 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' CYS . . . . . 0.98 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 39.8 t -51.26 116.93 2.27 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.955 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -111.6 23.96 13.3 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.154 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -61.83 100.42 0.15 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 122.689 0.396 . . . . 0.0 110.066 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 430' ' ' LYS . 17.9 ptpt -66.12 94.18 0.23 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.229 0.538 . . . . 0.0 111.215 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . 0.546 ' O ' ' HB3' ' A' ' 434' ' ' HIS . 14.7 t30 -173.57 114.13 0.34 Allowed Pre-proline 0 N--CA 1.465 0.296 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.0 -47.01 22.29 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.427 2.085 . . . . 0.0 112.181 -174.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.606 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 26.0 tp60 -57.72 -29.07 64.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.326 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . 0.687 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 41.2 t60 -61.38 -55.99 25.34 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 123.361 0.413 . . . . 0.0 111.736 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -61.37 -25.23 67.03 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.437 0.637 . . . . 0.0 110.839 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 69.0 mt -69.48 -46.51 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.437 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.606 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 10.5 mt-10 -85.31 -22.48 28.51 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.986 -174.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -121.04 126.05 48.87 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 123.618 0.574 . . . . 0.0 110.155 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' ARG . . . . . 0.459 ' HG3' ' HG3' ' A' ' 420' ' ' GLU . 12.0 ptt180 -80.9 122.08 26.79 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 121.281 0.562 . . . . 0.0 110.984 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.7 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 49.3 m80 -98.07 84.45 3.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.154 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -70.26 121.28 17.3 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.177 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.42 146.37 38.5 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.92 156.39 29.67 Favored Pre-proline 0 C--N 1.322 -0.608 0 O-C-N 123.466 0.479 . . . . 0.0 111.083 -173.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' PRO . . . . . 0.546 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 32.1 Cg_endo -62.63 -25.8 75.45 Favored 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 122.302 2.001 . . . . 0.0 112.365 -176.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 14.9 p 40.09 56.26 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 122.958 1.361 . . . . 0.0 111.864 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.546 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 21.0 mmm180 -91.52 140.68 29.51 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 121.31 -0.869 . . . . 0.0 112.201 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 55.6 t30 52.98 85.84 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.639 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 26.6 m . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 121.371 0.605 . . . . 0.0 111.14 -177.645 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' ' ZN' . . . . . 0.815 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' ' ZN' . . . . . 0.772 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.462 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 32.2 m -80.15 96.47 6.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.778 0.799 . . . . 0.0 109.628 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -76.03 87.42 2.95 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.802 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -74.36 107.12 6.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.002 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 16.7 p -87.85 113.42 23.49 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 122.668 0.387 . . . . 0.0 110.067 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -83.1 168.35 16.96 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 121.67 0.748 . . . . 0.0 110.949 -173.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 11.7 t -101.78 129.84 48.06 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.855 171.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.91 80.46 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 122.442 1.115 . . . . 0.0 110.292 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . 0.53 HD13 ' N ' ' A' ' 367' ' ' GLN . 3.2 pp -89.76 -24.25 21.56 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.608 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' GLN . . . . . 0.53 ' N ' HD13 ' A' ' 366' ' ' LEU . 28.5 tp60 -82.05 88.08 6.44 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.191 0.996 . . . . 0.0 110.133 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -153.02 39.79 0.72 Allowed Glycine 0 C--O 1.223 -0.538 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.403 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 3.2 p -99.54 -20.43 16.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.608 -0.796 . . . . 0.0 111.187 -177.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -75.91 79.9 2.8 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.408 0.623 . . . . 0.0 110.113 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -147.57 -103.05 0.31 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -79.84 98.48 7.1 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 117.156 0.478 . . . . 0.0 109.826 170.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -93.66 -16.76 23.97 Favored 'General case' 0 C--O 1.238 0.496 0 O-C-N 123.732 0.645 . . . . 0.0 110.15 -177.109 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . 0.433 HG11 ' HG2' ' A' ' 373' ' ' LYS . 30.9 m -114.67 153.35 16.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 O-C-N 123.918 0.761 . . . . 0.0 109.923 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.65 151.2 25.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.155 176.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.537 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.1 OUTLIER -82.94 176.81 8.99 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.095 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 10.5 t -106.14 153.66 21.78 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.837 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.9 t -53.87 119.81 5.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.515 0.326 . . . . 0.0 111.751 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 24.1 t -53.77 111.06 0.66 Allowed 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' MET . . . . . 0.493 ' HB3' HG12 ' A' ' 410' ' ' VAL . 23.3 ptp -58.51 -12.6 4.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.226 0.536 . . . . 0.0 111.925 -175.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.408 ' CD2' ' HB3' ' A' ' 385' ' ' CYS . 15.3 m-85 -110.09 -15.83 13.93 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.612 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 72.76 -133.42 19.07 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -174.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . 0.424 ' HB1' ' HG2' ' A' ' 399' ' ' PRO . . . -88.11 -0.75 57.44 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 121.643 0.735 . . . . 0.0 111.244 177.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -75.82 -24.89 55.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.593 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.814 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 0.8 OUTLIER -61.38 129.72 42.58 Favored 'General case' 0 C--O 1.25 1.098 0 O-C-N 122.238 -0.289 . . . . 0.0 111.167 -179.258 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -71.46 -8.49 54.19 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.034 0.534 . . . . 0.0 110.138 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -69.95 113.05 6.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.862 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.41 ' H ' ' HD2' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -113.21 -1.84 14.23 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -61.25 137.11 94.3 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.335 175.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -58.57 -20.89 52.14 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.649 2.233 . . . . 0.0 111.746 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.57 HG12 ' NE2' ' A' ' 395' ' ' HIS . 98.4 t -66.09 -42.36 91.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.22 178.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.699 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 83.9 t60 -57.7 -33.51 68.46 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.702 0.763 . . . . 0.0 110.655 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 34.5 m-85 -88.96 -18.91 26.46 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.877 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.524 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -75.33 -26.95 59.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.641 -178.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.57 ' NE2' HG12 ' A' ' 391' ' ' VAL . 2.2 p80 -114.3 -7.34 12.95 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.502 0.501 . . . . 0.0 112.273 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.561 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 96.5 m-85 -135.45 132.01 36.88 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.206 0.527 . . . . 0.0 111.665 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.537 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 69.3 m -85.38 154.14 22.06 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.606 174.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.662 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 31.5 m80 -128.07 158.21 71.62 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.496 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.424 ' HG2' ' HB1' ' A' ' 383' ' ' ALA . 14.9 Cg_endo -52.96 100.53 0.05 OUTLIER 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 122.951 2.434 . . . . 0.0 111.594 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 119.01 11.86 7.36 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.661 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -106.25 145.06 32.07 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 41.3 t -54.04 -32.81 55.58 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.805 0.69 . . . . 0.0 111.29 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -107.97 17.33 22.53 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -81.6 136.12 35.55 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.124 -0.631 . . . . 0.0 110.824 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -119.66 -55.62 0.25 Allowed Glycine 0 C--O 1.249 1.071 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.171 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 71.41 24.21 77.16 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.7 m -118.84 3.11 7.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 121.567 0.699 . . . . 0.0 110.986 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.538 ' NE2' ' HB ' ' A' ' 410' ' ' VAL . 6.0 tt0 -84.32 153.03 23.75 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.124 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.426 HG13 ' N ' ' A' ' 410' ' ' VAL . 23.5 pt -55.32 -45.19 77.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-O 121.426 0.632 . . . . 0.0 110.354 175.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.538 ' HB ' ' NE2' ' A' ' 408' ' ' GLN . 39.1 t -66.13 90.06 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 143.21 -42.09 1.11 Allowed Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.45 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 4.1 pt20 -95.64 -43.05 8.1 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.727 0.299 . . . . 0.0 111.155 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -170.49 141.1 1.88 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.681 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -134.43 10.73 3.77 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.364 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 77.5 p -68.29 -54.66 16.03 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.74 0.781 . . . . 0.0 111.076 -176.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 26.9 t70 179.44 -31.8 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.396 -1.274 . . . . 0.0 108.28 -169.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 27.3 t70 63.17 79.75 0.25 Allowed 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 124.736 1.214 . . . . 0.0 113.035 168.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -177.62 154.46 1.04 Allowed Pre-proline 0 N--CA 1.479 0.985 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.812 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -52.49 136.41 56.63 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.034 2.49 . . . . 0.0 111.282 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' GLU . . . . . 0.44 ' HG3' ' HG3' ' A' ' 439' ' ' ARG . 2.3 mp0 -75.62 148.54 38.69 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.962 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 8.3 t -52.18 134.86 40.64 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.412 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 421' ' ' CYS . 53.0 Cg_exo -57.24 -28.15 78.19 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.742 2.294 . . . . 0.0 111.952 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . 0.403 ' HB2' ' HA ' ' A' ' 427' ' ' CYS . 62.3 m-85 -99.1 5.55 46.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.873 -177.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 67.64 -156.03 52.65 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . 0.444 ' HG3' ' HA ' ' A' ' 442' ' ' THR . 55.1 Cg_endo -70.74 -16.53 33.44 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.329 2.02 . . . . 0.0 111.298 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 33.0 t -79.25 3.98 16.38 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.262 176.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' CYS . . . . . 0.962 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 50.5 t -55.1 117.28 3.33 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.108 0.563 . . . . 0.0 110.727 177.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -103.1 13.37 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.685 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -71.99 105.46 3.89 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -87.96 97.45 10.96 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.142 -175.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -173.02 126.37 0.48 Allowed Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.452 ' O ' HG13 ' A' ' 436' ' ' ILE . 28.2 Cg_endo -62.58 -38.28 52.3 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.295 1.997 . . . . 0.0 112.12 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.649 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 26.3 tp60 -63.94 -38.19 90.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.946 0.403 . . . . 0.0 110.34 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . 0.596 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 15.0 t60 -57.95 -48.3 80.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.262 1.03 . . . . 0.0 110.116 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -68.68 -15.24 63.46 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.345 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 432' ' ' PRO . 79.0 mt -86.67 -34.3 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 123.928 0.767 . . . . 0.0 110.628 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.649 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 21.9 mt-10 -86.62 -25.08 25.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.572 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -127.0 135.6 51.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.234 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' ARG . . . . . 0.44 ' HG3' ' HG3' ' A' ' 420' ' ' GLU . 25.2 ptt180 -91.2 134.94 34.14 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.65 0.594 . . . . 0.0 109.761 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.409 ' HD2' ' HB3' ' A' ' 427' ' ' CYS . 24.2 m80 -100.91 83.81 2.59 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.231 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -94.61 157.46 15.97 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.004 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' THR . . . . . 0.444 ' HA ' ' HG3' ' A' ' 425' ' ' PRO . 30.4 p -100.74 171.78 7.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -178.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.41 151.54 71.47 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.0 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' PRO . . . . . 0.495 ' O ' HG12 ' A' ' 445' ' ' VAL . 18.6 Cg_endo -59.29 -24.53 74.66 Favored 'Trans proline' 0 N--CA 1.483 0.868 0 C-N-CA 123.489 2.793 . . . . 0.0 111.24 -174.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 444' ' ' PRO . 3.5 p 56.53 7.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.734 1.614 . . . . 0.0 113.013 171.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -126.88 170.48 12.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.174 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -133.05 -36.59 1.01 Allowed 'General case' 0 C--N 1.306 -1.296 0 O-C-N 125.013 1.446 . . . . 0.0 110.896 173.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.477 0.884 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.421 177.524 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' ' ZN' . . . . . 0.814 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' ' ZN' . . . . . 0.746 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.289 0 CA-C-O 119.87 -0.406 . . . . 0.0 112.588 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 15.7 m -86.53 105.88 17.13 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.27 0.557 . . . . 0.0 109.974 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -106.97 106.02 16.34 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.319 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -137.52 112.38 8.96 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.586 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 4.4 m -137.15 156.32 48.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.154 0.502 . . . . 0.0 110.431 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -145.22 123.5 12.26 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 46.5 t -128.16 153.16 47.18 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 123.342 0.657 . . . . 0.0 110.059 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.04 132.65 32.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 120.736 0.303 . . . . 0.0 111.398 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -132.96 -2.23 3.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.447 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -73.82 139.14 44.91 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.436 0.636 . . . . 0.0 110.692 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -179.89 42.88 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.193 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 22.6 t -130.1 92.09 3.23 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 117.066 0.433 . . . . 0.0 110.938 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -101.7 -28.75 12.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.309 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 94.55 -102.17 2.83 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . 0.515 ' N ' HD21 ' A' ' 372' ' ' ASN . 0.9 OUTLIER -89.82 166.27 13.64 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.596 0.236 . . . . 0.0 111.051 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.53 ' HD2' HG13 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -84.11 -0.43 51.91 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.047 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . 0.53 HG13 ' HD2' ' A' ' 373' ' ' LYS . 20.9 m -136.0 136.46 49.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 123.838 0.855 . . . . 0.0 109.327 166.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -90.38 139.69 30.43 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.958 -175.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.484 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -80.93 -175.67 5.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.492 0.663 . . . . 0.0 110.032 171.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.2 t -113.43 159.46 19.46 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 41.0 t -63.68 124.33 21.15 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 121.975 -0.453 . . . . 0.0 111.226 -175.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.753 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 31.9 t -56.39 122.38 11.76 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 174.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 26.5 ptm -55.1 -26.23 36.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.645 0.378 . . . . 0.0 111.566 -173.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.525 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 38.8 m-85 -110.01 -8.86 14.78 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.647 0.592 . . . . 0.0 110.657 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.46 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 69.78 -133.92 25.41 Favored Glycine 0 N--CA 1.436 -1.316 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.61 -176.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . 0.545 ' HB1' ' HG2' ' A' ' 399' ' ' PRO . . . -78.6 0.26 27.05 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 117.589 0.694 . . . . 0.0 111.166 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -94.7 -2.74 50.59 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.582 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.839 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 10.3 p -68.0 134.19 50.29 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 122.065 -0.397 . . . . 0.0 110.391 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -78.98 -14.11 59.4 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 123.26 0.624 . . . . 0.0 111.212 -176.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -72.5 128.31 35.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.049 0.452 . . . . 0.0 110.507 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.415 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.6 OUTLIER -120.27 -6.45 9.87 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.047 -176.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -65.05 137.76 97.2 Favored Pre-proline 0 C--O 1.243 0.737 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.542 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.57 -34.63 73.76 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 123.689 2.926 . . . . 0.0 112.793 -173.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.477 HG13 ' NE2' ' A' ' 395' ' ' HIS . 60.1 t -59.72 -34.68 56.27 Favored 'Isoleucine or valine' 0 C--N 1.348 0.532 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.683 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.649 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 82.6 t60 -55.21 -37.55 67.27 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 121.729 0.776 . . . . 0.0 111.33 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 62.2 m-85 -89.68 -20.86 23.13 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.459 -175.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -71.39 -24.11 62.0 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.878 -0.514 . . . . 0.0 110.035 -177.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.71 ' HD1' ' HD1' ' A' ' 396' ' ' PHE . 1.0 OUTLIER -119.33 -7.71 10.19 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 178.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.71 ' HD1' ' HD1' ' A' ' 395' ' ' HIS . 57.0 m-85 -133.55 126.37 30.86 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 38.1 m -90.06 158.93 17.09 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.66 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 13.3 m80 -129.55 157.69 75.68 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.078 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.545 ' HG2' ' HB1' ' A' ' 383' ' ' ALA . 18.3 Cg_endo -54.31 118.09 4.65 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.898 2.398 . . . . 0.0 110.347 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 111.58 -1.71 27.7 Favored Glycine 0 C--N 1.32 -0.342 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.695 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.76 142.16 34.36 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 14.1 t -70.05 -21.97 63.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.466 ' HB2' ' HG ' ' A' ' 397' ' ' SER . 5.0 m-20 -95.56 -1.39 50.59 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.112 -177.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -70.64 115.9 10.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.09 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.13 -49.82 3.87 Favored Glycine 0 C--O 1.224 -0.49 0 C-N-CA 120.173 -1.013 . . . . 0.0 111.702 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 65.02 39.01 96.12 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.318 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 21.6 m -129.01 22.1 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.423 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -112.66 145.32 40.65 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.812 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.426 HG13 ' N ' ' A' ' 410' ' ' VAL . 20.6 pt -58.46 -47.83 87.04 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 121.281 0.562 . . . . 0.0 109.843 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.456 ' HA ' ' HG2' ' A' ' 414' ' ' GLU . 18.0 t -66.33 86.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 174.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 156.9 -41.23 0.55 Allowed Glycine 0 CA--C 1.5 -0.905 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.771 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.4 -38.53 5.68 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -173.13 121.58 0.37 Allowed 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.964 176.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' A' ' 410' ' ' VAL . 36.8 mt-10 -86.65 -28.85 22.94 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.847 -175.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 416' ' ' ASP . 82.6 p -65.5 -86.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 415' ' ' THR . 18.9 t70 168.68 -68.87 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.989 0.899 . . . . 0.0 109.025 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -136.35 -18.9 1.47 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.074 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.512 ' HD2' ' O ' ' A' ' 437' ' ' GLU . 20.9 ptt180 -167.6 160.13 10.1 Favored Pre-proline 0 N--CA 1.467 0.384 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -169.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.59 151.03 72.54 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.83 1.687 . . . . 0.0 111.359 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' GLU . . . . . 0.449 ' HA ' ' HG2' ' A' ' 439' ' ' ARG . 10.7 tt0 -82.94 157.07 23.16 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.955 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 11.3 t -58.98 135.24 87.45 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.261 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.7 -13.28 35.85 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.343 2.029 . . . . 0.0 112.58 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -110.18 8.08 23.57 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.103 0.477 . . . . 0.0 110.429 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 63.94 -152.71 48.39 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.699 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.53 -4.38 15.19 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.847 2.365 . . . . 0.0 111.984 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 16.9 m -83.55 -2.52 56.2 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.583 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' CYS . . . . . 0.955 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 43.0 t -54.89 115.92 2.46 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.498 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -110.96 19.26 18.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.28 0.632 . . . . 0.0 110.482 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.618 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 1.1 mmp_? -69.62 101.87 1.73 Allowed 'General case' 0 C--O 1.255 1.365 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.274 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . 0.516 ' HB3' ' HZ3' ' A' ' 430' ' ' LYS . 8.7 mtpm? -75.04 82.83 2.26 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 123.603 0.761 . . . . 0.0 110.184 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -163.23 112.08 1.02 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.694 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.98 -41.4 62.08 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 C-N-CA 123.25 2.633 . . . . 0.0 112.567 -171.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.664 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 25.1 tp60 -57.45 -39.21 75.8 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 121.086 0.47 . . . . 0.0 110.33 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . 0.719 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 19.5 t60 -59.23 -52.27 66.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.677 0.751 . . . . 0.0 110.011 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.422 ' HA ' ' HE1' ' A' ' 440' ' ' HIS . 47.7 mtpt -61.25 -19.79 62.1 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.983 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 93.7 mt -84.47 -35.42 10.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.294 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.664 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 25.7 mt-10 -85.41 -50.92 6.91 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.45 -176.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -98.06 137.85 36.24 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.113 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' ARG . . . . . 0.612 ' NE ' HD22 ' A' ' 441' ' ' ASN . 18.5 ptt-85 -86.24 145.96 26.73 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.42 0.288 . . . . 0.0 110.56 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.639 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 71.7 m80 -118.22 86.04 2.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.387 0.613 . . . . 0.0 109.847 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' ASN . . . . . 0.612 HD22 ' NE ' ' A' ' 439' ' ' ARG . 83.5 m-20 -77.61 117.87 19.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.983 -176.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.2 m -125.79 155.49 40.98 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.463 0.477 . . . . 0.0 110.898 -173.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 1.1 pp -107.21 153.9 40.81 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' PRO . . . . . 0.423 ' O ' HG13 ' A' ' 445' ' ' VAL . 38.1 Cg_endo -64.84 -11.98 32.0 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.167 1.911 . . . . 0.0 113.273 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 444' ' ' PRO . 6.1 p 51.02 28.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.19 0.996 . . . . 0.0 112.309 174.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.419 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 36.9 mmt180 -85.66 144.96 27.53 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.853 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -84.09 85.54 7.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.464 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--N 1.309 -1.188 0 CA-C-O 122.119 0.961 . . . . 0.0 110.202 177.492 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' ' ZN' . . . . . 0.839 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' ' ZN' . . . . . 0.785 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.517 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 25.9 t -77.34 127.25 32.25 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.912 0.419 . . . . 0.0 110.288 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.67 -9.96 17.83 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.089 0.471 . . . . 0.0 110.779 175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -69.74 80.08 0.44 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.237 0.542 . . . . 0.0 110.83 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 11.6 m -82.01 154.02 25.89 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.326 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -125.77 -177.44 3.92 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 40.6 t -139.31 163.53 32.24 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.36 151.9 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . 0.568 ' O ' ' HG3' ' A' ' 367' ' ' GLN . 2.1 pp -54.45 -23.38 15.84 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.635 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' GLN . . . . . 0.568 ' HG3' ' O ' ' A' ' 366' ' ' LEU . 0.8 OUTLIER 55.95 -4.99 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 177.332 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 366' ' ' LEU . . . -76.28 73.97 1.73 Allowed Glycine 0 C--O 1.22 -0.732 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 175.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 19.7 m -136.32 102.75 5.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.707 -0.746 . . . . 0.0 110.208 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -102.01 147.52 26.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.123 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 110.58 31.06 3.09 Favored Glycine 0 C--O 1.224 -0.52 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.474 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -175.17 164.35 3.27 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 122.303 0.241 . . . . 0.0 111.26 -173.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.474 ' HD3' ' N ' ' A' ' 373' ' ' LYS . 3.2 mppt? -90.49 -60.43 1.92 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.9 m -91.93 139.79 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.606 ' N ' ' HD2' ' A' ' 375' ' ' LYS . 8.7 mptt -92.62 -39.99 11.01 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.858 0.837 . . . . 0.0 110.417 -177.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.28 167.54 18.32 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.054 173.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 9.0 t -120.95 145.52 47.63 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 172.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 46.3 m -47.73 122.24 4.75 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 123.452 0.47 . . . . 0.0 111.218 -175.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.921 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 11.9 t -47.54 120.46 3.31 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' MET . . . . . 0.41 ' HB2' HG22 ' A' ' 410' ' ' VAL . 27.6 ptm -61.5 -11.75 12.18 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.08 0.552 . . . . 0.0 110.317 -176.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.51 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 75.0 m-85 -115.27 -13.89 11.71 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.994 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.424 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 65.77 -120.59 17.2 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.076 -1.059 . . . . 0.0 110.793 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . 0.47 ' HB3' ' HG3' ' A' ' 399' ' ' PRO . . . -92.18 5.73 49.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.548 0.689 . . . . 0.0 110.66 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -89.36 -15.23 33.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.302 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.921 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 2.4 p -78.8 123.85 27.61 Favored 'General case' 0 C--O 1.248 0.974 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.881 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -83.44 15.65 2.95 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.92 0.488 . . . . 0.0 111.686 -174.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -84.06 130.14 34.88 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.085 0.469 . . . . 0.0 110.409 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -104.01 -33.22 8.88 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 123.152 0.581 . . . . 0.0 109.676 -178.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -45.91 135.58 6.51 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.683 -177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.74 -17.61 55.85 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 121.914 1.743 . . . . 0.0 112.062 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.462 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 86.3 t -67.9 -37.42 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.904 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.67 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 77.5 t60 -60.96 -29.32 69.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.868 0.842 . . . . 0.0 110.017 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 60.6 m-85 -92.8 -13.07 29.67 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.004 -177.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -78.77 -23.64 45.17 Favored 'General case' 0 C--N 1.343 0.313 0 O-C-N 121.768 -0.583 . . . . 0.0 111.617 -177.451 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.45 ' HD2' ' HG3' ' A' ' 394' ' ' GLN . 5.5 p80 -118.41 -19.76 8.74 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.438 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 377' ' ' THR . 67.7 m-85 -123.54 127.7 48.69 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.512 0.672 . . . . 0.0 110.675 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.536 ' O ' ' HB2' ' A' ' 379' ' ' CYS . 54.2 p -78.36 163.21 25.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.752 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.714 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 61.0 m80 -138.24 161.82 57.18 Favored Pre-proline 0 N--CA 1.465 0.308 0 O-C-N 122.293 -0.254 . . . . 0.0 110.479 -176.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 11.3 Cg_endo -51.58 104.98 0.1 OUTLIER 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 122.937 2.425 . . . . 0.0 112.156 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 124.55 -9.35 8.2 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.701 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -95.8 157.05 16.07 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 122.601 -0.352 . . . . 0.0 111.324 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 20.0 m -69.02 -25.87 64.71 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.831 0.707 . . . . 0.0 112.061 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.67 8.97 40.64 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.318 -0.239 . . . . 0.0 110.524 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -103.09 139.45 38.6 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.447 0.467 . . . . 0.0 110.665 -178.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -172.6 17.24 0.05 OUTLIER Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.609 176.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 52.09 51.83 38.91 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 31.8 m -67.16 -28.61 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.401 0.619 . . . . 0.0 111.384 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -113.72 163.43 15.02 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.554 0.742 . . . . 0.0 109.676 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 410' ' ' VAL . 21.2 pt -60.68 -49.1 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.833 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.487 ' N ' HG13 ' A' ' 409' ' ' ILE . 11.3 p -69.77 115.17 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 O-C-N 124.019 0.824 . . . . 0.0 109.51 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 132.85 -33.34 2.63 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -173.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.443 ' HG3' ' N ' ' A' ' 413' ' ' ASP . 15.0 pt20 -113.2 -48.27 2.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.803 -0.699 . . . . 0.0 110.129 174.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.443 ' N ' ' HG3' ' A' ' 412' ' ' GLN . 19.7 t70 179.83 136.43 0.11 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.081 0.863 . . . . 0.0 109.486 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -107.38 -7.76 16.54 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.806 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 64.4 p -87.8 -81.18 0.25 Allowed 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.638 0.586 . . . . 0.0 112.153 -168.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.8 t70 169.94 -52.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -169.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -169.92 -31.73 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.031 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.503 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 29.1 ptt180 -133.01 163.75 48.84 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.758 -173.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.35 151.08 42.56 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.566 2.178 . . . . 0.0 111.18 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.95 158.73 30.08 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.496 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.82 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 49.3 t -69.37 131.25 90.29 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.297 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.87 -16.45 25.93 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.269 2.646 . . . . 0.0 112.647 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -111.86 12.81 20.91 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.63 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 59.83 -151.74 36.91 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.789 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.43 -21.83 11.32 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.547 2.165 . . . . 0.0 112.324 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 36.0 t -76.36 4.16 9.54 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.924 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' CYS . . . . . 0.82 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 49.7 t -49.61 116.73 1.88 Allowed 'General case' 0 C--O 1.219 -0.547 0 O-C-N 124.358 1.036 . . . . 0.0 110.957 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -107.77 16.21 23.82 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.653 0.739 . . . . 0.0 110.347 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -76.64 88.45 3.32 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.027 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -73.79 92.3 2.02 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.305 0.574 . . . . 0.0 111.289 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . 0.477 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 47.4 t30 -153.74 126.41 4.02 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.489 ' O ' HG13 ' A' ' 436' ' ' ILE . 18.4 Cg_endo -58.63 -39.75 79.83 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.804 1.669 . . . . 0.0 111.537 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.408 HE21 ' HG2' ' A' ' 437' ' ' GLU . 23.7 tp60 -69.1 -26.26 64.83 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.695 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . 0.753 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 48.3 t60 -64.61 -61.89 1.92 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.114 0.483 . . . . 0.0 110.518 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.472 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 0.0 OUTLIER -61.39 -18.59 59.48 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.441 -178.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 432' ' ' PRO . 66.1 mt -71.96 -56.38 10.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.192 0.52 . . . . 0.0 111.701 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 418' ' ' ARG . 9.7 mm-40 -76.26 -28.08 56.95 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -112.27 123.09 49.51 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.256 0.347 . . . . 0.0 111.409 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 418' ' ' ARG . 1.2 ptm180 -78.16 126.99 31.61 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.575 0.547 . . . . 0.0 110.346 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.571 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.1 m80 -103.18 85.62 2.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.36 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' ASN . . . . . 0.455 HD22 ' CZ ' ' A' ' 439' ' ' ARG . 93.4 m-20 -68.75 117.59 10.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.616 -176.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.0 m -133.35 154.12 51.0 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -176.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.487 HD13 ' HB ' ' A' ' 445' ' ' VAL . 1.4 pp -108.81 148.02 36.99 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.913 176.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.71 -47.24 5.55 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.49 1.46 . . . . 0.0 113.072 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.487 ' HB ' HD13 ' A' ' 443' ' ' LEU . 9.8 p 44.45 29.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 122.013 0.911 . . . . 0.0 111.425 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 448' ' ' VAL . 24.4 tpt180 -83.95 92.87 7.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.296 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 14.1 m120 47.92 -76.21 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.826 1.251 . . . . 0.0 113.166 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 446' ' ' ARG . 33.5 m . . . . . 0 C--O 1.238 0.496 0 CA-C-O 121.851 0.834 . . . . 0.0 110.299 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' ' ZN' . . . . . 0.831 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' ' ZN' . . . . . 0.78 'ZN ' ' SG ' ' A' ' 421' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.11 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 34.0 p -67.07 -9.5 40.05 Favored 'General case' 0 C--O 1.242 0.659 0 O-C-N 122.545 -0.385 . . . . 0.0 111.725 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -75.01 -12.56 60.36 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.414 0.686 . . . . 0.0 110.25 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -54.54 97.51 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.355 0.598 . . . . 0.0 110.457 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 6.9 p -140.54 124.35 17.22 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.649 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.78 164.38 17.29 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.364 0.602 . . . . 0.0 111.054 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 14.4 m -60.55 -24.07 65.1 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 122.099 0.952 . . . . 0.0 110.485 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 12.2 p -130.75 156.44 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.543 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 367' ' ' GLN . 1.7 pp -53.36 -27.34 23.2 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 122.151 -0.343 . . . . 0.0 111.017 176.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' GLN . . . . . 0.627 ' N ' HD12 ' A' ' 366' ' ' LEU . 24.3 tp60 67.81 -68.43 0.16 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.44 1.096 . . . . 0.0 111.609 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -171.81 101.23 0.16 Allowed Glycine 0 C--N 1.313 -0.708 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 49.2 m -81.33 71.22 8.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.693 0.759 . . . . 0.0 110.967 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -92.01 41.32 1.07 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.521 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 101.48 -56.23 0.72 Allowed Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -168.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -113.99 125.59 54.19 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.471 ' HG2' HG13 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -88.61 -12.24 43.18 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.983 0.42 . . . . 0.0 110.231 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . 0.471 HG13 ' HG2' ' A' ' 373' ' ' LYS . 32.9 m -117.07 157.49 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.391 176.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.437 ' HD2' ' O ' ' A' ' 375' ' ' LYS . 1.2 pptp? -90.8 152.87 20.61 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.64 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.419 HH21 ' CG ' ' A' ' 401' ' ' ASP . 0.7 OUTLIER -88.86 161.88 16.46 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.865 0.841 . . . . 0.0 110.453 177.747 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 9.6 t -98.72 144.53 27.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.611 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 35.4 m -62.56 122.68 16.41 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.081 0.863 . . . . 0.0 112.668 -168.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.79 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 47.1 t -58.2 110.82 1.02 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.915 171.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' MET . . . . . 0.43 ' HB3' ' CG1' ' A' ' 410' ' ' VAL . 23.3 ptm -59.81 -25.98 65.4 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.134 0.271 . . . . 0.0 110.947 -174.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.46 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 53.1 m-85 -95.18 -14.85 23.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.578 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 57.91 -117.7 11.0 Favored Glycine 0 C--O 1.216 -0.985 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.439 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -87.29 -3.71 59.05 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.169 0.509 . . . . 0.0 111.608 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -83.31 -25.17 31.77 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.04 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.808 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 6.3 p -70.68 120.71 16.69 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 174.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -79.61 1.41 26.23 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.65 0.594 . . . . 0.0 111.763 -170.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.525 ' HA ' ' NE ' ' A' ' 387' ' ' ARG . 2.4 mmp_? -62.98 129.16 39.16 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 123.532 0.52 . . . . 0.0 110.595 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.52 -11.79 13.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.094 -175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -67.06 138.68 95.01 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.497 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.98 -23.74 78.04 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.074 1.849 . . . . 0.0 111.526 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.445 ' HA ' ' HG2' ' A' ' 394' ' ' GLN . 60.1 t -60.69 -41.65 89.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.716 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 48.5 t60 -53.63 -33.91 56.73 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.534 0.521 . . . . 0.0 110.911 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -95.86 -19.31 19.68 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.409 -175.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.445 ' HG2' ' HA ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -70.77 -25.38 62.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.503 0.192 . . . . 0.0 111.25 -177.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.57 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 0.8 OUTLIER -120.85 -8.77 9.38 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.57 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 93.0 m-85 -133.15 133.09 42.4 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.793 176.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 17.6 p -88.34 149.94 23.48 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.151 0.58 . . . . 0.0 110.042 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.408 ' CD2' ' O ' ' A' ' 382' ' ' GLY . 42.6 m80 -125.56 160.86 53.78 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.213 -174.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.15 93.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.499 2.133 . . . . 0.0 110.374 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 136.6 -23.51 3.25 Favored Glycine 0 C--O 1.238 0.402 0 O-C-N 123.995 0.809 . . . . 0.0 111.473 -175.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . 0.419 ' CG ' HH21 ' A' ' 376' ' ' ARG . 15.2 t70 -76.89 133.57 39.25 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 32.0 t -63.35 -13.82 43.37 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -172.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.71 12.42 31.01 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.402 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -73.28 111.2 8.18 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.478 0.18 . . . . 0.0 110.648 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -84.91 -56.58 2.43 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.195 -177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 67.48 16.46 67.44 Favored Glycine 0 CA--C 1.538 1.475 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.9 m -100.92 -9.44 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 121.057 0.456 . . . . 0.0 110.392 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.475 ' O ' ' HG2' ' A' ' 412' ' ' GLN . 6.9 tt0 -83.22 140.75 32.35 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.371 176.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 24.9 pt -49.33 -45.1 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 O-C-N 123.458 0.474 . . . . 0.0 110.675 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.43 ' CG1' ' HB3' ' A' ' 380' ' ' MET . 59.8 t -74.22 82.2 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 173.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 150.8 -51.98 0.51 Allowed Glycine 0 C--N 1.315 -0.587 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.199 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 4.8 pt20 -78.51 -49.93 12.51 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 12.0 t70 177.7 142.4 0.09 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -87.44 -11.1 50.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.766 -170.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 68.7 p -101.15 116.81 33.68 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.782 -0.574 . . . . 0.0 111.067 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -73.38 -52.89 12.19 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.4 ' OD1' ' HD2' ' A' ' 439' ' ' ARG . 19.2 p-10 -135.95 -32.54 0.88 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.444 174.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.621 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 17.4 ptt180 -146.17 172.46 5.24 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.318 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.583 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 21.1 Cg_endo -62.03 140.52 84.8 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 121.098 1.199 . . . . 0.0 111.687 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' GLU . . . . . 0.663 ' HG3' ' ND2' ' A' ' 441' ' ' ASN . 0.4 OUTLIER -74.02 160.1 31.77 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.392 0.433 . . . . 0.0 110.297 178.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 2.6 t -63.51 135.31 96.2 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.46 -2.88 6.74 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.499 2.133 . . . . 0.0 112.804 -177.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . 0.582 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 65.0 m-85 -125.84 14.96 8.04 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.066 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 64.51 -159.76 41.41 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.777 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.93 -14.48 38.76 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.968 1.779 . . . . 0.0 111.878 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 36.0 t -70.73 -17.82 62.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 17.5 t -57.43 115.4 2.7 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -114.78 25.01 11.29 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.447 0.642 . . . . 0.0 109.416 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.66 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 2.0 mmp_? -59.77 99.31 0.06 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -80.18 96.71 6.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.114 0.959 . . . . 0.0 110.316 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -160.22 125.74 2.29 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.894 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.58 ' O ' HG13 ' A' ' 436' ' ' ILE . 20.1 Cg_endo -59.72 -42.29 47.74 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 121.979 1.786 . . . . 0.0 111.992 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.597 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 25.3 tp60 -64.46 -37.44 87.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.124 0.488 . . . . 0.0 109.895 -177.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . 0.691 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.2 t60 -59.34 -53.89 52.98 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.521 0.676 . . . . 0.0 110.021 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -63.15 -15.65 57.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.681 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 432' ' ' PRO . 85.5 mt -82.59 -37.24 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.219 0.533 . . . . 0.0 111.13 176.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 27.0 mt-10 -82.78 -44.34 15.67 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.474 -175.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 419' ' ' PRO . 96.5 m-85 -111.5 147.19 35.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.523 -171.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' ARG . . . . . 0.682 ' NH2' HD22 ' A' ' 441' ' ' ASN . 0.0 OUTLIER -93.57 141.48 28.42 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.066 174.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.674 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 74.9 m80 -108.35 92.67 4.16 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 123.741 0.651 . . . . 0.0 109.43 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' ASN . . . . . 0.682 HD22 ' NH2' ' A' ' 439' ' ' ARG . 88.4 m-20 -67.97 98.49 0.76 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -174.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.7 m -107.75 151.44 25.69 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 124.412 1.07 . . . . 0.0 109.531 -176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.46 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.6 OUTLIER -119.83 145.11 38.76 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-O 121.009 0.433 . . . . 0.0 110.146 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' PRO . . . . . 0.505 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 54.5 Cg_endo -68.66 -20.13 40.89 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.28 2.654 . . . . 0.0 112.455 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.46 ' HB ' HD13 ' A' ' 443' ' ' LEU . 5.6 p 47.94 30.68 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.883 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.484 177.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.505 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 24.7 mmt180 -87.71 145.33 26.19 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.413 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 64.16 1.19 1.15 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.811 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 121.055 0.455 . . . . 0.0 110.391 -178.807 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' ' ZN' . . . . . 0.808 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' ' ZN' . . . . . 0.749 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 32.3 p -117.31 152.77 34.2 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.719 0.407 . . . . 0.0 109.997 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -78.61 93.63 4.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.096 0.474 . . . . 0.0 109.824 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -77.28 94.46 4.16 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.912 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 16.7 p -66.19 119.58 11.73 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 123.872 0.732 . . . . 0.0 111.279 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -129.06 164.74 22.61 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.617 0.573 . . . . 0.0 109.523 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 13.0 p -51.29 145.12 8.61 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.562 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 48.4 t -63.35 83.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.923 0.868 . . . . 0.0 111.908 -174.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -82.28 -24.71 34.58 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 172.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 14.7 tp60 65.79 -74.32 0.06 Allowed 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.5 0.72 . . . . 0.0 112.599 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -52.27 -26.64 21.94 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 115.082 0.793 . . . . 0.0 115.082 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 47.6 m -114.17 22.93 13.35 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.145 -0.621 . . . . 0.0 111.585 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -126.33 147.3 49.76 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 88.43 -69.43 2.76 Favored Glycine 0 CA--C 1.505 -0.585 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.805 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -113.45 97.35 6.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 110.012 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.79 -9.19 14.49 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 123.336 0.654 . . . . 0.0 110.908 -177.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 19.7 m -70.23 142.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.871 0.844 . . . . 0.0 109.26 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.4 154.94 18.87 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.416 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.8 OUTLIER -124.88 162.24 24.84 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 121.556 0.693 . . . . 0.0 111.071 -178.021 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 15.3 t -117.2 155.3 29.63 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.899 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 15.9 m -57.78 121.64 10.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -170.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 11.5 t -60.74 116.75 4.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.063 173.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' MET . . . . . 0.535 ' HB2' HG22 ' A' ' 410' ' ' VAL . 31.6 ttp -50.86 -40.71 56.86 Favored 'General case' 0 C--O 1.25 1.084 0 C-N-CA 122.778 0.431 . . . . 0.0 111.2 -176.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.485 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 26.1 m-85 -91.96 -14.52 29.37 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.192 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.441 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 60.69 -119.61 19.38 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -80.92 -5.8 57.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.477 0.656 . . . . 0.0 111.495 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -86.18 -15.39 41.13 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.995 -174.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.806 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 6.9 p -74.74 131.82 41.13 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.133 0.492 . . . . 0.0 110.129 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -87.52 18.22 4.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.533 0.682 . . . . 0.0 111.405 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -87.36 121.93 30.45 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.679 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.49 ' HD3' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -121.99 2.74 9.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.69 0.757 . . . . 0.0 109.681 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -63.37 135.6 96.32 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.305 174.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.93 -29.52 64.44 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.227 2.618 . . . . 0.0 111.408 -172.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.595 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 98.8 t -65.08 -34.07 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.682 -178.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.55 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 84.7 t60 -63.67 -24.66 67.88 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.062 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -95.83 -15.4 22.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.868 0.467 . . . . 0.0 110.807 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.595 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -80.18 -25.68 39.61 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.25 -177.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.628 ' HD1' ' HD1' ' A' ' 396' ' ' PHE . 1.7 p80 -114.31 -19.95 11.05 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.628 ' HD1' ' HD1' ' A' ' 395' ' ' HIS . 59.3 m-85 -126.94 127.76 45.36 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 122.395 1.093 . . . . 0.0 111.614 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.416 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 8.8 p -81.6 158.03 24.51 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.655 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.723 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 46.4 m80 -137.02 159.07 71.43 Favored Pre-proline 0 C--N 1.315 -0.902 0 C-N-CA 123.644 0.778 . . . . 0.0 110.288 -174.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.85 102.24 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.024 1.816 . . . . 0.0 110.546 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 124.75 -0.3 8.5 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.027 -174.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -100.12 143.83 29.86 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.7 t -61.9 -29.95 70.56 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 123.32 0.387 . . . . 0.0 111.5 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.95 9.2 43.34 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.24 0.543 . . . . 0.0 110.776 -174.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -81.53 151.64 27.65 Favored 'General case' 0 C--O 1.248 0.997 0 O-C-N 121.948 -0.47 . . . . 0.0 110.887 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -160.49 -44.48 0.02 OUTLIER Glycine 0 C--O 1.227 -0.313 0 CA-C-O 121.409 0.45 . . . . 0.0 112.766 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 89.13 38.62 6.71 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -174.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 32.0 m -102.91 -1.05 9.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.729 0 CA-C-O 121.578 0.704 . . . . 0.0 112.127 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' A' ' 412' ' ' GLN . 9.4 tt0 -90.42 133.19 35.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.891 176.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.483 HG13 ' N ' ' A' ' 410' ' ' VAL . 30.2 pt -50.08 -47.41 24.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 O-C-N 123.547 0.529 . . . . 0.0 109.958 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 380' ' ' MET . 7.7 p -78.13 81.78 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.906 0.86 . . . . 0.0 108.821 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.45 -30.24 0.7 Allowed Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.003 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 4.1 pt20 -114.22 -46.24 3.0 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-O 121.174 0.511 . . . . 0.0 110.065 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.412 ' N ' ' HG3' ' A' ' 412' ' ' GLN . 5.1 p-10 179.87 126.52 0.08 Allowed 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . 0.402 ' HA ' ' HB ' ' A' ' 409' ' ' ILE . 46.8 mt-10 -82.45 -47.15 12.58 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 120.855 0.359 . . . . 0.0 111.245 -169.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' THR . . . . . 0.541 ' HA ' ' NH2' ' A' ' 439' ' ' ARG . 46.5 p -139.9 -95.27 0.16 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.901 -176.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 19.0 t70 170.0 -76.3 0.0 OUTLIER 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -171.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -139.64 0.12 1.8 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.793 0.806 . . . . 0.0 109.751 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 36.3 ptt180 -170.14 150.99 3.76 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.68 -172.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.61 157.08 40.38 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.413 2.075 . . . . 0.0 112.41 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' GLU . . . . . 0.507 ' HG3' ' HG3' ' A' ' 439' ' ' ARG . 2.1 mp0 -72.9 147.75 45.02 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.395 0.434 . . . . 0.0 111.396 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.984 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 4.3 t -58.96 131.73 86.83 Favored Pre-proline 0 C--O 1.243 0.733 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.959 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -58.23 -22.66 58.19 Favored 'Trans proline' 0 N--CA 1.48 0.714 0 C-N-CA 123.041 2.494 . . . . 0.0 112.631 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -97.04 -5.64 37.11 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.615 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 75.45 -154.31 45.65 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.109 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.4 -16.91 39.39 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 121.996 1.797 . . . . 0.0 111.908 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 22.8 t -79.56 4.38 16.01 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.443 0.64 . . . . 0.0 111.04 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' CYS . . . . . 0.984 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 45.5 t -55.99 116.35 2.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.998 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -107.59 22.54 15.82 Favored 'General case' 0 C--O 1.248 1.018 0 O-C-N 123.61 0.569 . . . . 0.0 110.419 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -69.41 104.44 2.29 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -80.66 98.1 7.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.04 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . 0.52 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 64.7 t30 -176.0 129.06 0.37 Allowed Pre-proline 0 CA--C 1.522 -0.128 0 C-N-CA 123.715 0.806 . . . . 0.0 109.84 176.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.52 ' HD2' ' OD1' ' A' ' 431' ' ' ASN . 18.4 Cg_endo -60.45 -43.66 32.3 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.714 1.609 . . . . 0.0 111.543 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.612 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 22.8 tp60 -60.88 -34.92 75.36 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . 0.702 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 51.5 t60 -56.67 -59.22 5.32 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 123.65 0.594 . . . . 0.0 111.522 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.416 ' O ' ' NH1' ' A' ' 418' ' ' ARG . 0.0 OUTLIER -61.67 -11.42 11.66 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.048 178.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 432' ' ' PRO . 81.0 mt -83.74 -40.98 16.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.369 0.604 . . . . 0.0 110.929 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.612 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 23.4 mt-10 -78.9 -34.25 44.87 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.978 -176.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -114.77 132.11 56.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.84 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' ARG . . . . . 0.541 ' NH2' ' HA ' ' A' ' 415' ' ' THR . 13.2 ptt180 -84.09 124.5 31.17 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.562 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.762 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.1 m80 -100.14 86.29 3.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.207 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -77.86 135.67 37.95 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.342 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 3.1 p -111.64 133.25 54.02 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 123.703 0.801 . . . . 0.0 110.172 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.89 158.08 34.09 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -176.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' PRO . . . . . 0.534 ' HG3' HG22 ' A' ' 448' ' ' VAL . 17.7 Cg_endo -59.17 -24.75 75.34 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.809 2.339 . . . . 0.0 112.2 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.41 HG11 ' O ' ' A' ' 444' ' ' PRO . 3.7 p 49.62 21.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.491 0.717 . . . . 0.0 111.874 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.426 ' HG2' ' OD1' ' A' ' 447' ' ' ASN . 48.5 ttt180 -166.64 141.23 4.17 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . 0.426 ' OD1' ' HG2' ' A' ' 446' ' ' ARG . 4.2 m-20 63.56 -83.61 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.32 1.013 . . . . 0.0 111.454 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . 0.534 HG22 ' HG3' ' A' ' 444' ' ' PRO . 35.3 m . . . . . 0 N--CA 1.474 0.773 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.884 -174.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' ' ZN' . . . . . 0.806 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' ' ZN' . . . . . 0.75 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.853 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 19.3 t -136.27 150.19 48.81 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 360' ' ' LYS . 0.7 OUTLIER -87.7 169.64 11.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 123.602 0.563 . . . . 0.0 109.626 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -139.03 77.63 1.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.682 0.753 . . . . 0.0 110.188 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 20.2 p -100.0 175.22 5.84 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.249 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -65.98 101.86 0.73 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.359 0.6 . . . . 0.0 109.682 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 33.5 t -62.39 118.85 8.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.914 -176.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.0 p -86.02 71.46 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 122.089 0.947 . . . . 0.0 109.144 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . 0.416 HD12 ' N ' ' A' ' 367' ' ' GLN . 4.6 pp -63.26 -26.57 68.84 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.496 -175.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' GLN . . . . . 0.416 ' N ' HD12 ' A' ' 366' ' ' LEU . 0.4 OUTLIER -113.1 87.64 2.64 Favored 'General case' 0 C--O 1.25 1.087 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 153.71 -19.16 0.68 Allowed Glycine 0 CA--C 1.503 -0.671 0 O-C-N 123.183 0.302 . . . . 0.0 112.881 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 69.6 m -70.09 77.12 0.51 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.405 0.621 . . . . 0.0 110.209 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -86.2 -64.15 1.2 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.692 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -153.45 39.19 0.71 Allowed Glycine 0 C--N 1.316 -0.538 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -155.23 158.06 38.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.131 -0.534 . . . . 0.0 110.074 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -93.06 -45.16 8.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.774 0.797 . . . . 0.0 110.465 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 28.8 m -121.46 156.92 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.287 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -97.59 132.54 43.16 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.263 0.554 . . . . 0.0 110.615 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.16 161.69 14.32 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.308 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 14.9 t -103.69 147.16 27.57 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 21.1 m -54.99 125.92 22.41 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.358 0.599 . . . . 0.0 111.964 -174.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.755 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 45.9 t -56.81 124.09 17.3 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.647 174.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' MET . . . . . 0.481 ' HE3' ' CZ ' ' A' ' 381' ' ' TYR . 34.3 ttp -50.59 -47.6 58.03 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.343 0.592 . . . . 0.0 111.372 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.504 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 56.5 m-85 -88.43 -9.79 51.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.344 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.607 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 67.87 -130.81 28.07 Favored Glycine 0 CA--C 1.501 -0.805 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -172.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . 0.506 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -80.73 -7.87 59.49 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.935 0.874 . . . . 0.0 110.913 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -79.99 -9.59 59.7 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.697 -176.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.79 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 3.7 p -63.06 136.53 57.85 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 123.583 0.552 . . . . 0.0 110.872 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -79.06 4.9 13.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.249 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -84.81 136.62 33.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.87 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.7 -7.93 7.93 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.311 0.577 . . . . 0.0 110.409 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -66.74 139.27 95.74 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.514 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -60.59 -22.46 72.5 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 122.681 2.254 . . . . 0.0 111.314 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.402 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 99.3 t -63.42 -39.77 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.28 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.785 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 86.1 t60 -59.53 -31.66 69.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 110.131 178.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -91.0 -11.4 39.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.666 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 1.9 pp0? -82.87 -26.77 31.28 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.942 0.401 . . . . 0.0 110.567 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -110.57 -17.2 13.47 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 121.634 -0.666 . . . . 0.0 111.862 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 377' ' ' THR . 20.1 m-30 -125.11 135.23 52.47 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.273 0.488 . . . . 0.0 111.467 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 20.8 p -83.37 156.51 22.96 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 123.648 0.593 . . . . 0.0 110.269 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.585 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 40.7 m80 -135.61 159.89 69.75 Favored Pre-proline 0 C--O 1.221 -0.421 0 C-N-CA 122.51 0.324 . . . . 0.0 110.956 -174.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.506 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 18.7 Cg_endo -56.48 114.75 2.05 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.965 1.777 . . . . 0.0 110.832 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.08 2.98 48.67 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 -174.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -101.62 155.95 17.79 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.381 -0.482 . . . . 0.0 109.915 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 32.0 t -59.49 -37.09 77.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.812 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -106.36 15.05 26.58 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.333 -167.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -84.34 149.77 25.82 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -179.93 -16.02 0.03 OUTLIER Glycine 0 C--O 1.239 0.419 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.52 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 80.26 36.36 24.3 Favored Glycine 0 N--CA 1.462 0.393 0 O-C-N 121.357 -1.084 . . . . 0.0 111.561 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 33.7 m -77.72 -6.28 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 124.485 0.756 . . . . 0.0 110.417 -178.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -106.7 134.49 49.77 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.658 0.783 . . . . 0.0 110.506 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 6.3 pt -54.31 -50.2 58.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.18 115.16 5.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 121.822 0.82 . . . . 0.0 110.85 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 125.11 -14.72 7.41 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.04 -172.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.25 -36.54 0.44 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.729 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -165.72 134.6 3.22 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 110.493 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -136.46 31.92 2.83 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.89 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 77.2 p -71.77 -60.98 1.95 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.021 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' A' ' 417' ' ' ASP . 17.9 t70 -168.41 -31.4 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.04 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 416' ' ' ASP . 16.9 t0 80.62 78.81 0.04 OUTLIER 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.066 0.947 . . . . 0.0 111.287 173.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.404 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 25.6 ptt180 178.43 158.7 0.61 Allowed Pre-proline 0 CA--C 1.514 -0.423 0 CA-C-N 113.988 -1.46 . . . . 0.0 108.845 172.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 31.0 Cg_endo -63.15 151.1 86.52 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.263 1.975 . . . . 0.0 111.452 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' GLU . . . . . 0.551 ' HG2' ' HG3' ' A' ' 439' ' ' ARG . 36.7 mt-10 -85.05 154.26 22.2 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.385 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.971 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 8.2 t -58.58 133.69 85.84 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.046 -178.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.48 -29.18 77.1 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.047 2.498 . . . . 0.0 112.715 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . 0.569 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 51.5 m-85 -98.25 6.88 46.97 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.53 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 62.52 -151.27 46.6 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.85 -15.74 29.68 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.287 1.991 . . . . 0.0 112.366 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 31.4 t -73.45 -10.19 59.47 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.624 0.726 . . . . 0.0 110.048 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' CYS . . . . . 0.971 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 42.5 t -62.38 118.62 7.73 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.189 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -125.58 23.0 7.52 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.098 0.874 . . . . 0.0 109.021 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -56.71 117.1 3.58 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.554 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -67.08 97.46 0.51 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.414 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . 0.421 HD22 ' HB3' ' A' ' 433' ' ' GLN . 62.4 t30 -178.06 121.11 0.25 Allowed Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 123.443 0.697 . . . . 0.0 109.7 173.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.15 -27.8 28.97 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.502 1.468 . . . . 0.0 111.866 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.608 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 27.0 tp60 -72.34 -34.18 67.85 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . 0.626 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 24.5 t60 -57.56 -56.61 19.71 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.859 178.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -63.21 -20.06 65.09 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.242 -177.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 50.2 mt -78.41 -41.45 25.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 122.703 0.401 . . . . 0.0 110.092 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.608 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 22.7 mt-10 -79.41 -45.68 19.03 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.815 -175.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -101.45 138.82 37.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.64 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' ARG . . . . . 0.551 ' HG3' ' HG2' ' A' ' 420' ' ' GLU . 19.1 ptt180 -92.25 145.18 24.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.515 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -119.33 98.86 6.35 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -110.2 168.61 9.31 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 4.1 p -116.99 131.99 56.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.417 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 2.5 pp -120.12 151.0 52.4 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.217 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' PRO . . . . . 0.422 ' O ' HG13 ' A' ' 445' ' ' VAL . 16.5 Cg_endo -56.79 -42.37 65.56 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.898 2.399 . . . . 0.0 112.686 -171.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 444' ' ' PRO . 2.5 p 51.4 12.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 124.582 1.176 . . . . 0.0 111.127 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 446' ' ' ARG . 0.0 OUTLIER -84.06 -43.49 15.04 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -170.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -107.78 24.04 13.53 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.563 0.697 . . . . 0.0 110.955 -175.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 121.021 0.439 . . . . 0.0 110.648 -179.788 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' ' ZN' . . . . . 0.79 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' ' ZN' . . . . . 0.76 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 21.4 p -92.18 -21.7 20.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.106 0.479 . . . . 0.0 111.228 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.758 ' HE2' ' HA ' ' A' ' 360' ' ' LYS . 0.6 OUTLIER 62.69 12.21 5.42 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.987 178.216 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -94.79 117.88 30.86 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.828 -173.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 17.2 p -119.18 139.78 51.27 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 173.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -74.49 97.43 3.11 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 120.872 0.368 . . . . 0.0 111.611 -176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 20.5 p -66.28 108.51 2.34 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.995 176.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.401 HG11 ' O ' ' A' ' 365' ' ' VAL . 7.5 p -61.55 107.05 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.055 0.455 . . . . 0.0 110.775 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 3.6 pp -76.59 -16.05 59.69 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.619 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -81.51 157.88 24.68 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 123.768 0.667 . . . . 0.0 109.958 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 91.55 22.43 31.51 Favored Glycine 0 C--O 1.229 -0.211 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.507 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 22.6 t -132.1 24.65 4.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -59.56 -60.67 3.48 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.943 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 62.88 32.15 82.9 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.531 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -152.26 156.9 40.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.788 0.328 . . . . 0.0 110.73 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.433 ' HD3' ' H ' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -134.9 13.83 3.63 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 173.634 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.93 157.45 22.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.687 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.58 164.18 13.08 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.449 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.2 OUTLIER -115.05 174.09 6.16 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.325 0.583 . . . . 0.0 110.906 177.068 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 13.4 t -127.15 157.47 39.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.876 176.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 69.6 p -50.61 122.37 7.09 Favored 'General case' 0 C--O 1.249 1.028 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -170.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.767 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 53.0 t -65.13 115.22 5.27 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 168.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' MET . . . . . 0.781 ' HA ' ' HA2' ' A' ' 411' ' ' GLY . 44.3 ttp -51.89 -42.97 63.13 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.596 0.712 . . . . 0.0 111.624 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.549 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 24.8 m-85 -87.63 -9.06 55.32 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.794 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.629 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 62.5 -130.71 43.75 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-O 119.248 -0.751 . . . . 0.0 112.521 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . 0.657 ' HB1' ' HG2' ' A' ' 399' ' ' PRO . . . -75.82 -10.25 59.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.405 0.621 . . . . 0.0 111.67 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -85.97 -5.65 59.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.676 -174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.797 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 4.7 p -65.64 132.62 49.27 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.12 0.486 . . . . 0.0 110.897 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -71.39 -11.88 61.12 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.405 0.621 . . . . 0.0 110.375 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -80.34 108.76 14.21 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.592 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.39 -3.3 21.21 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.34 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -63.18 140.41 97.67 Favored Pre-proline 0 C--O 1.233 0.189 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.025 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.72 -22.41 61.11 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.058 1.839 . . . . 0.0 110.901 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.541 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 96.6 t -66.7 -35.63 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.847 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.703 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 47.0 t60 -60.86 -30.82 70.36 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 121.892 -0.505 . . . . 0.0 109.668 177.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -90.82 -15.67 29.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.733 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.541 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -81.73 -19.45 41.4 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.509 -178.265 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.612 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 2.5 p80 -119.04 -10.53 9.81 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.612 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 86.9 m-85 -135.59 126.75 28.09 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 121.491 0.663 . . . . 0.0 111.111 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.449 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 25.3 m -72.15 154.45 41.05 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.004 176.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.591 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 55.2 m80 -134.99 166.26 30.5 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.657 ' HG2' ' HB1' ' A' ' 383' ' ' ALA . 34.7 Cg_exo -40.04 -13.6 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 123.851 3.034 . . . . 0.0 115.782 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 398' ' ' HIS . . . -130.08 34.22 2.77 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -120.19 151.14 39.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.388 0.613 . . . . 0.0 109.823 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 23.3 t -64.42 -18.47 64.75 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -172.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.41 ' HB2' ' HG ' ' A' ' 397' ' ' SER . 48.4 m-20 -111.66 7.67 20.51 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -72.28 145.73 47.68 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.354 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -169.62 -45.24 0.03 OUTLIER Glycine 0 C--N 1.32 -0.346 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.859 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 92.72 33.3 7.52 Favored Glycine 0 C--O 1.237 0.338 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.832 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.5 m -86.17 -17.27 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 O-C-N 122.609 -0.348 . . . . 0.0 110.69 -176.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -82.39 146.13 29.51 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.764 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 20.6 pt -52.76 -51.68 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.65 0.738 . . . . 0.0 110.786 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.537 HG23 ' HB2' ' A' ' 380' ' ' MET . 9.5 p -77.88 76.61 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.957 0 CA-C-O 122.651 1.215 . . . . 0.0 108.742 171.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.781 ' HA2' ' HA ' ' A' ' 380' ' ' MET . . . 177.2 -49.43 0.1 Allowed Glycine 0 C--O 1.218 -0.892 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.433 -177.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.468 ' HG3' ' N ' ' A' ' 413' ' ' ASP . 4.2 pt20 -90.77 -54.74 3.85 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 171.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.468 ' N ' ' HG3' ' A' ' 412' ' ' GLN . 9.0 t70 170.65 143.13 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -90.14 5.69 45.81 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -171.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' THR . . . . . 0.506 HG21 ' HA ' ' A' ' 419' ' ' PRO . 43.9 p -94.81 125.74 39.67 Favored 'General case' 0 C--O 1.22 -0.489 0 O-C-N 122.006 -0.434 . . . . 0.0 111.234 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -69.62 -59.52 2.91 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.426 0.454 . . . . 0.0 109.941 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -131.23 -20.05 2.74 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.498 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.507 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 13.9 ptt180 -166.63 165.03 10.11 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -175.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 40.6 Cg_endo -66.31 148.12 84.06 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.047 2.498 . . . . 0.0 111.195 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -75.0 151.88 38.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.572 0.701 . . . . 0.0 110.578 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.993 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 12.0 t -63.95 134.86 96.07 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.948 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.63 -5.77 9.3 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.169 1.912 . . . . 0.0 114.028 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -121.52 8.9 10.17 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.24 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 64.49 -154.12 48.5 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 119.835 -0.425 . . . . 0.0 112.527 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.43 -19.3 28.86 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.685 2.257 . . . . 0.0 111.711 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 36.5 t -74.13 -8.71 57.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.596 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' CYS . . . . . 0.993 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 48.7 t -49.84 117.83 2.51 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.277 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -112.68 22.24 14.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.46 0.648 . . . . 0.0 110.623 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -67.97 107.21 2.6 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.534 175.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -77.73 89.99 4.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.286 0.565 . . . . 0.0 111.567 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . 0.403 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 65.1 t30 -165.31 127.21 1.46 Allowed Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.258 176.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.552 ' O ' HG13 ' A' ' 436' ' ' ILE . 31.0 Cg_endo -63.16 -40.99 29.97 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.837 1.691 . . . . 0.0 111.592 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -62.38 -37.09 84.42 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.766 0.317 . . . . 0.0 110.345 -176.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . 0.691 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 39.8 t60 -60.06 -56.78 17.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.958 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.467 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 23.1 mtpp -57.92 -21.6 44.47 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.641 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 432' ' ' PRO . 65.4 mt -81.23 -46.37 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 122.763 0.425 . . . . 0.0 110.797 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 418' ' ' ARG . 7.2 mm-40 -84.02 -27.86 28.08 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -174.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -107.32 129.33 54.91 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.773 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -83.65 111.82 19.47 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.369 0.604 . . . . 0.0 110.859 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.74 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 63.8 m80 -87.53 112.53 22.33 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.525 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -114.66 125.56 53.88 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -171.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.6 p -88.9 124.43 34.2 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.491 ' CD1' ' HB ' ' A' ' 445' ' ' VAL . 1.4 pp -111.25 147.35 36.46 Favored Pre-proline 0 C--O 1.249 1.05 0 O-C-N 123.871 0.732 . . . . 0.0 111.76 -173.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' PRO . . . . . 0.423 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 28.4 Cg_endo -63.41 -30.68 72.61 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.041 2.494 . . . . 0.0 112.211 -175.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.491 ' HB ' ' CD1' ' A' ' 443' ' ' LEU . 8.7 p 43.33 30.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.739 0.816 . . . . 0.0 111.136 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 446' ' ' ARG . 21.9 mmt180 -68.68 137.6 54.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.343 0.592 . . . . 0.0 111.553 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -74.09 86.37 1.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.023 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.448 -0.537 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.635 -179.496 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' ' ZN' . . . . . 0.797 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' ' ZN' . . . . . 0.755 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.406 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 40.4 t -73.64 146.77 44.34 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -97.31 113.46 25.09 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.908 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -137.82 82.28 1.91 Allowed 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.468 0.652 . . . . 0.0 110.759 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 23.7 p -80.91 142.26 33.73 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.716 0.77 . . . . 0.0 110.357 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -77.03 125.25 29.0 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 121.985 -0.447 . . . . 0.0 110.768 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 14.3 m -70.81 96.54 1.27 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.88 0.848 . . . . 0.0 110.532 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.6 p -69.94 103.32 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.596 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . 0.406 HD13 ' N ' ' A' ' 367' ' ' GLN . 2.9 pp -91.63 -15.96 27.77 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.77 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' GLN . . . . . 0.406 ' N ' HD13 ' A' ' 366' ' ' LEU . 6.3 tp-100 -71.06 87.99 0.77 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.492 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -127.79 16.79 6.13 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-O 122.224 0.902 . . . . 0.0 111.027 175.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 33.3 t -85.36 101.29 12.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.284 -0.458 . . . . 0.0 109.902 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.16 -81.41 0.18 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.487 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 53.84 46.31 68.29 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.895 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -128.96 -174.34 3.23 Favored 'General case' 0 C--O 1.25 1.105 0 CA-C-O 120.809 0.338 . . . . 0.0 111.135 -174.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.474 ' HD3' ' N ' ' A' ' 373' ' ' LYS . 0.6 OUTLIER -115.86 -32.25 5.51 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 122.885 0.474 . . . . 0.0 110.464 175.03 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 m -121.64 -176.99 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -157.81 164.93 36.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.424 0.63 . . . . 0.0 109.525 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.468 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -98.15 153.54 18.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.336 174.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 2.7 t -92.17 149.92 21.21 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.046 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' SER . . . . . 0.406 ' HB3' ' NE2' ' A' ' 408' ' ' GLN . 36.9 t -54.51 117.93 3.74 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.951 0.782 . . . . 0.0 111.752 -174.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.935 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 7.8 t -51.68 115.47 1.65 Allowed 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 170.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' MET . . . . . 0.513 ' O ' HG22 ' A' ' 410' ' ' VAL . 26.0 ptm -57.15 -26.77 61.11 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.451 0.469 . . . . 0.0 111.321 -172.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.56 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 58.9 m-85 -102.78 -17.15 15.72 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.696 0.284 . . . . 0.0 110.677 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.422 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 66.41 -114.37 6.45 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.814 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -83.08 -7.29 59.66 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.996 -0.709 . . . . 0.0 110.745 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 381' ' ' TYR . 36.4 m-80 -83.88 -24.49 30.81 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.632 -176.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.935 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.8 p -67.2 120.99 14.68 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.593 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -78.96 4.32 14.62 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.391 1.057 . . . . 0.0 110.891 -174.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -80.96 119.86 24.02 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.699 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.23 -1.73 11.77 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -176.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -60.99 142.58 92.74 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.352 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.68 -27.7 85.58 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.367 2.045 . . . . 0.0 110.384 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.469 ' O ' ' CD2' ' A' ' 395' ' ' HIS . 96.4 t -64.72 -41.07 91.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 O-C-N 123.79 0.681 . . . . 0.0 110.398 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.662 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 58.2 t60 -56.23 -34.0 65.93 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 39.6 m-85 -88.28 -25.05 23.01 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.198 0.523 . . . . 0.0 110.762 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -66.97 -19.37 65.71 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.595 -175.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.516 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 8.6 p80 -125.86 -17.75 5.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.621 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.516 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 26.3 m-85 -125.64 129.03 48.78 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 120.857 0.361 . . . . 0.0 110.898 174.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.468 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 13.7 p -84.08 160.82 20.86 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.396 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.732 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 43.9 m80 -133.44 159.18 73.58 Favored Pre-proline 0 C--N 1.342 0.271 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.667 -174.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 11.4 Cg_endo -51.6 113.23 1.06 Allowed 'Trans proline' 0 C--O 1.238 0.517 0 C-N-CA 122.625 2.217 . . . . 0.0 112.242 -177.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 110.66 -8.42 30.06 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.957 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -86.76 148.69 25.31 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.598 0.713 . . . . 0.0 110.869 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 46.1 t -56.71 -29.69 62.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.314 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -107.4 17.17 23.12 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.655 -175.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -92.46 120.6 33.1 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -103.26 -57.61 0.76 Allowed Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.501 176.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 66.51 50.12 51.55 Favored Glycine 0 N--CA 1.463 0.494 0 CA-C-N 115.253 -0.473 . . . . 0.0 112.232 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.3 m -112.35 -1.35 9.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 O-C-N 122.008 -0.701 . . . . 0.0 112.405 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.406 ' NE2' ' HB3' ' A' ' 378' ' ' SER . 28.0 pt20 -77.67 175.92 9.47 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.993 176.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.469 HG13 ' H ' ' A' ' 410' ' ' VAL . 4.7 pt -65.48 -61.66 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 120.874 0.369 . . . . 0.0 110.637 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 380' ' ' MET . 8.0 p -64.88 118.98 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-O 121.686 0.755 . . . . 0.0 110.382 -175.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 127.01 -63.64 0.6 Allowed Glycine 0 C--O 1.242 0.608 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -169.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -40.75 15.87 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.006 0.403 . . . . 0.0 110.935 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -168.75 129.57 1.21 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.105 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -100.89 4.64 42.85 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.71 -172.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 54.2 p -103.18 -75.44 0.61 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.254 -0.178 . . . . 0.0 111.418 -175.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -161.08 -62.7 0.06 Allowed 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.064 0.546 . . . . 0.0 109.925 -175.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -138.53 -14.64 1.26 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.799 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -171.95 154.15 3.4 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 122.432 0.293 . . . . 0.0 110.314 -173.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.94 147.85 24.8 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.516 2.144 . . . . 0.0 112.317 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.47 152.79 25.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.67 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 17.1 t -59.03 129.41 85.99 Favored Pre-proline 0 C--O 1.244 0.785 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.927 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.89 -6.73 18.83 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 122.351 2.034 . . . . 0.0 111.745 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . 0.557 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 52.8 m-85 -108.27 8.97 28.05 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.027 176.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 62.72 -159.76 34.56 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.914 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.1 -20.74 24.75 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.076 2.517 . . . . 0.0 111.079 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 16.4 t -76.01 -4.25 40.22 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.755 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' CYS . . . . . 0.781 ' SG ' ' NE2' ' A' ' 434' ' ' HIS . 43.2 t -56.97 123.82 16.48 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.426 0.691 . . . . 0.0 112.028 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -126.94 28.97 5.72 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.556 ' HG2' ' SG ' ' A' ' 427' ' ' CYS . 20.9 mmm180 -68.69 101.35 1.29 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.658 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -67.86 90.8 0.3 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.394 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . 0.482 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 59.8 t30 -162.7 127.91 2.14 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.878 174.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.482 ' HD2' ' OD1' ' A' ' 431' ' ' ASN . 18.5 Cg_endo -60.59 -43.06 35.06 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 122.099 1.866 . . . . 0.0 112.392 -177.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -63.44 -32.34 73.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.789 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . 0.781 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 43.8 t60 -58.13 -59.83 4.68 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.828 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -68.13 -12.36 60.76 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.448 -177.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 432' ' ' PRO . 62.8 mt -76.7 -51.27 19.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.198 0.523 . . . . 0.0 110.671 175.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -72.95 -49.62 28.21 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.061 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -98.59 138.3 35.98 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.412 0.445 . . . . 0.0 111.276 -173.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 439' ' ' ARG . 11.8 ptt180 -94.96 145.27 25.04 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.472 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 31.1 m80 -120.33 108.75 14.54 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -176.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -95.69 131.79 41.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.054 0.454 . . . . 0.0 109.975 -177.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 10.2 p -114.13 147.35 38.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.262 -175.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.467 HD12 ' HB ' ' A' ' 445' ' ' VAL . 1.2 pp -149.99 148.28 24.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.485 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.38 -25.74 11.0 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.962 2.441 . . . . 0.0 112.578 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.467 ' HB ' HD12 ' A' ' 443' ' ' LEU . 7.9 p 46.63 27.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 122.443 1.116 . . . . 0.0 111.932 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -87.81 -28.6 21.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.644 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -63.69 -32.19 73.59 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.5 -176.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 C--N 1.318 -0.772 0 O-C-N 122.218 -0.301 . . . . 0.0 110.514 178.741 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' ' ZN' . . . . . 0.817 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' ' ZN' . . . . . 0.752 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.043 0 N-CA-C 112.376 -0.289 . . . . 0.0 112.376 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 38.1 m -65.74 134.55 53.4 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 117.25 0.525 . . . . 0.0 110.176 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -119.87 148.94 42.87 Favored 'General case' 0 C--O 1.248 1.019 0 C-N-CA 122.651 0.38 . . . . 0.0 110.368 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -161.47 129.04 4.12 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 123.451 0.469 . . . . 0.0 110.804 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 25.1 p -103.71 131.83 50.52 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.08 176.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -70.35 111.18 5.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.496 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 28.9 t -69.79 107.67 3.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 35.9 t -75.31 80.29 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -60.38 -33.58 72.67 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.708 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -152.42 156.77 40.15 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.754 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -174.98 125.67 1.11 Allowed Glycine 0 CA--C 1.508 -0.396 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.8 m -62.4 -52.37 63.85 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.618 0.246 . . . . 0.0 110.464 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 44.47 86.01 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 O-C-N 123.953 0.783 . . . . 0.0 110.172 -176.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 150.55 -64.9 0.38 Allowed Glycine 0 C--N 1.309 -0.971 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -101.75 103.23 13.97 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 122.108 0.956 . . . . 0.0 109.281 171.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.464 ' HB3' ' HZ3' ' A' ' 373' ' ' LYS . 7.0 mtpm? -76.3 -28.64 57.04 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 5.3 m -139.08 161.18 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 113.53 -1.668 . . . . 0.0 108.019 175.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.578 ' N ' ' HD2' ' A' ' 375' ' ' LYS . 8.9 mptt -90.11 -31.22 17.2 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.431 0.634 . . . . 0.0 109.393 -172.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.444 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.1 OUTLIER -114.47 155.76 25.8 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.234 172.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 12.2 t -108.97 152.95 24.27 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.076 0.86 . . . . 0.0 109.29 175.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' SER . . . . . 0.404 ' OG ' HG22 ' A' ' 407' ' ' VAL . 45.7 m -51.52 122.73 8.46 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 121.161 0.505 . . . . 0.0 111.483 -174.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.85 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 54.0 t -51.3 123.15 9.0 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.937 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 23.8 ptm -55.42 -25.05 33.72 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.185 0.594 . . . . 0.0 111.324 -174.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 37.5 m-85 -116.88 -8.07 11.35 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.813 177.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 379' ' ' CYS . . . 63.05 -123.98 31.32 Favored Glycine 0 C--O 1.242 0.644 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.863 -177.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -82.06 -9.71 59.46 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.303 0.241 . . . . 0.0 111.056 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -77.05 -30.29 55.57 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.806 0.336 . . . . 0.0 111.193 -175.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.85 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 4.5 p -65.94 115.82 6.43 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.24 176.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -76.28 2.36 13.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.856 0.836 . . . . 0.0 110.944 -175.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -65.92 124.0 21.33 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.048 172.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.43 ' H ' ' HD2' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -125.61 3.02 7.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.168 0.509 . . . . 0.0 110.464 -176.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -61.43 139.86 94.83 Favored Pre-proline 0 C--O 1.247 0.957 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.186 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.69 -25.13 80.34 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 122.934 2.423 . . . . 0.0 112.346 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.546 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 95.9 t -64.24 -37.18 79.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.573 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.762 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 26.0 t60 -58.64 -27.36 64.66 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.143 0.497 . . . . 0.0 110.644 177.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -98.09 -7.96 28.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.668 -177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -84.18 -17.05 41.24 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.041 0.448 . . . . 0.0 110.959 -176.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.476 ' ND1' ' CD1' ' A' ' 396' ' ' PHE . 7.8 p80 -126.58 -16.65 5.25 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 176.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.528 ' CD2' ' HA ' ' A' ' 379' ' ' CYS . 63.5 m-85 -125.07 128.03 47.85 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.675 0.75 . . . . 0.0 112.408 174.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.444 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 20.1 p -80.01 165.38 22.63 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.483 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -136.97 158.29 73.11 Favored Pre-proline 0 C--O 1.245 0.864 0 O-C-N 123.203 0.314 . . . . 0.0 110.318 -175.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -54.38 97.28 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.153 2.569 . . . . 0.0 110.728 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 121.93 17.14 3.84 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 123.76 0.663 . . . . 0.0 111.457 -174.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -117.24 151.08 37.66 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.215 -0.579 . . . . 0.0 110.208 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 35.2 t -57.76 -36.78 72.57 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.168 -176.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -92.79 9.05 36.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.22 0.533 . . . . 0.0 111.253 -172.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -96.9 146.81 24.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.789 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 160.81 41.82 0.02 OUTLIER Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.55 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . 0.417 ' HA2' ' OE1' ' A' ' 412' ' ' GLN . . . 57.89 41.52 94.23 Favored Glycine 0 N--CA 1.464 0.501 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.69 -177.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.404 HG22 ' OG ' ' A' ' 378' ' ' SER . 9.7 m -80.74 -13.66 12.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.428 0.632 . . . . 0.0 109.496 -175.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -139.39 129.77 25.54 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 9.1 pt -48.59 -45.95 14.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.97 0.891 . . . . 0.0 110.614 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 19.3 t -67.54 105.84 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 379' ' ' CYS . . . 157.37 -48.95 0.44 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -175.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.539 ' NE2' ' H ' ' A' ' 412' ' ' GLN . 0.7 OUTLIER -118.07 -42.49 2.81 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 122.925 0.49 . . . . 0.0 110.616 177.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -170.17 136.45 1.42 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.848 0.459 . . . . 0.0 110.585 173.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.9 21.67 3.06 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.113 0.965 . . . . 0.0 110.751 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 35.5 p -127.38 -71.8 0.66 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.388 0.614 . . . . 0.0 110.655 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.5 t70 170.33 -51.83 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.101 -172.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -178.92 -26.85 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.242 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 20.9 ptt180 -142.98 160.02 54.3 Favored Pre-proline 0 C--O 1.216 -0.689 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.099 -170.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.76 159.22 48.95 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 121.652 1.568 . . . . 0.0 112.037 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -73.51 155.24 39.39 Favored 'General case' 0 C--O 1.248 0.995 0 O-C-N 121.918 -0.489 . . . . 0.0 110.907 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.77 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 16.1 t -61.7 133.64 93.61 Favored Pre-proline 0 N--CA 1.443 -0.785 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.359 176.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.17 -9.05 22.15 Favored 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 122.41 2.074 . . . . 0.0 112.743 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -116.5 12.2 15.07 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.086 0.554 . . . . 0.0 110.113 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 58.38 -153.55 27.45 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 116.5 -0.318 . . . . 0.0 112.497 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.87 -13.99 24.08 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.158 2.572 . . . . 0.0 112.474 173.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 32.2 t -70.17 -14.06 62.47 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.568 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' CYS . . . . . 0.81 ' SG ' 'ZN ' ' A' ' 450' ' ' ' ZN' . 51.5 t -49.76 137.02 16.78 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.256 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -138.12 20.57 2.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.501 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -63.96 104.1 0.67 Allowed 'General case' 0 C--O 1.24 0.604 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.676 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 430' ' ' LYS . 18.9 ptpt -62.24 95.88 0.07 Allowed 'General case' 0 C--O 1.249 1.055 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.011 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -177.98 123.2 0.26 Allowed Pre-proline 0 C--O 1.238 0.475 0 CA-C-O 120.659 0.266 . . . . 0.0 110.496 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.412 ' O ' HG13 ' A' ' 436' ' ' ILE . 19.7 Cg_endo -63.08 -39.2 40.99 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.755 2.303 . . . . 0.0 111.83 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.601 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 25.8 tp60 -64.46 -32.79 74.56 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.466 0.65 . . . . 0.0 110.655 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . 0.574 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 35.8 t60 -55.96 -59.95 4.17 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.094 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -19.01 40.73 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.972 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 433' ' ' GLN . 77.3 mt -75.09 -43.84 44.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.596 0.713 . . . . 0.0 110.878 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.601 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 19.6 mt-10 -82.66 -40.4 20.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.28 -174.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -106.78 128.87 54.61 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.224 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' ARG . . . . . . . . . . . . . 15.3 ptt-85 -85.4 116.4 23.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.894 0.854 . . . . 0.0 110.185 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.745 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 37.0 m80 -90.82 86.08 6.21 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.101 178.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -70.49 104.23 2.7 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.464 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 6.8 m -114.06 160.25 19.1 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.702 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.448 HD11 ' HB ' ' A' ' 445' ' ' VAL . 0.5 OUTLIER -135.12 157.24 77.31 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.769 179.157 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' PRO . . . . . 0.415 ' O ' HG12 ' A' ' 445' ' ' VAL . 18.7 Cg_endo -60.0 -42.28 45.72 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 122.06 1.84 . . . . 0.0 112.036 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.448 ' HB ' HD11 ' A' ' 443' ' ' LEU . 2.7 p 50.37 15.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 124.347 1.029 . . . . 0.0 112.513 177.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.41 133.56 46.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -176.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . 0.509 ' N ' HD21 ' A' ' 447' ' ' ASN . 0.8 OUTLIER -73.29 86.23 1.45 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.971 -178.543 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.321 -0.638 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.89 178.542 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' ' ZN' . . . . . 0.765 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' ' ZN' . . . . . 0.81 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.858 0 N-CA-C 112.201 -0.36 . . . . 0.0 112.201 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 39.3 t -159.76 122.95 3.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.812 0.339 . . . . 0.0 111.321 -176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.48 108.81 18.94 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 172.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -105.18 101.12 10.69 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.829 0.347 . . . . 0.0 110.432 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 16.5 p -70.86 129.79 39.97 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.175 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -87.87 123.11 32.29 Favored 'General case' 0 C--O 1.249 1.075 0 C-N-CA 122.668 0.387 . . . . 0.0 110.412 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 30.8 p -73.46 173.7 9.25 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 123.736 0.648 . . . . 0.0 110.355 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.45 117.09 47.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.177 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 367' ' ' GLN . 3.1 pp -109.87 -23.13 11.53 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' GLN . . . . . 0.495 ' N ' HD12 ' A' ' 366' ' ' LEU . 35.1 tt0 -62.87 98.57 0.13 Allowed 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 151.53 -39.77 0.79 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -175.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 30.6 m -81.94 88.59 6.36 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 172.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . 0.551 ' HG3' ' ND2' ' A' ' 372' ' ' ASN . 9.9 pt-20 -132.56 35.79 3.6 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.425 0.631 . . . . 0.0 110.949 -170.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 74.21 -77.57 1.01 Allowed Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . 0.551 ' ND2' ' HG3' ' A' ' 370' ' ' GLU . 0.1 OUTLIER -63.62 152.71 38.15 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 110.664 -0.125 . . . . 0.0 110.664 178.059 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.508 ' HD3' ' N ' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -92.13 -51.68 5.06 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 20.1 m -110.08 140.17 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.952 0.882 . . . . 0.0 109.588 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.767 ' HD3' ' N ' ' A' ' 375' ' ' LYS . 0.0 OUTLIER -98.8 -25.35 14.68 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.823 -178.69 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.7 158.86 33.74 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.212 173.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.616 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 12.9 m -101.0 139.94 35.99 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.66 173.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 49.7 m -54.83 122.98 11.96 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.609 -0.682 . . . . 0.0 110.023 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.772 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 18.4 t -50.16 123.3 8.12 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.199 0.523 . . . . 0.0 110.296 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 25.8 ptm -60.31 -17.84 45.56 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.188 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.575 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 38.0 m-85 -112.92 -11.05 13.47 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.75 177.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.407 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 65.43 -131.07 35.06 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.262 -177.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -75.75 -11.68 60.04 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.072 0.463 . . . . 0.0 110.71 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -80.22 -9.58 59.73 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -173.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.848 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 8.2 p -75.31 133.52 41.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.765 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -84.08 14.13 4.47 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.552 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -96.51 121.16 38.03 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.698 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.484 ' HD3' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -108.43 -22.16 12.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.328 -178.162 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -44.67 136.84 4.38 Favored Pre-proline 0 N--CA 1.474 0.775 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.087 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -58.7 -23.77 67.68 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.011 2.474 . . . . 0.0 112.348 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.616 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 74.0 t -67.65 -35.42 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.657 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.631 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 62.0 t60 -62.89 -19.85 64.58 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.69 -0.631 . . . . 0.0 109.794 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 90.7 m-85 -97.45 -7.53 31.42 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.74 -178.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.616 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -87.83 -19.81 26.93 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.045 0.45 . . . . 0.0 110.901 -178.029 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.458 ' ND1' ' CD2' ' A' ' 396' ' ' PHE . 7.4 p80 -121.5 -15.23 8.08 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.239 176.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.616 ' HA ' ' O ' ' A' ' 377' ' ' THR . 78.7 m-85 -133.57 127.55 33.35 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.779 0.8 . . . . 0.0 111.753 173.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 46.9 p -80.58 161.05 24.94 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.662 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 53.6 m80 -137.42 157.96 73.03 Favored Pre-proline 0 C--O 1.249 1.044 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -49.77 101.58 0.05 OUTLIER 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.199 2.599 . . . . 0.0 111.553 -176.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 122.41 -0.29 10.37 Favored Glycine 0 C--O 1.243 0.664 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.259 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -93.7 149.15 21.47 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 34.8 m -62.84 -20.53 65.17 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.522 0.514 . . . . 0.0 111.755 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.76 -3.02 28.84 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -78.49 123.04 26.62 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 120.82 0.343 . . . . 0.0 111.458 -172.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -118.03 -30.67 1.72 Allowed Glycine 0 C--O 1.244 0.776 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 70.15 29.93 70.08 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.41 -6.08 10.36 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 C-N-CA 123.559 0.744 . . . . 0.0 110.989 -174.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.527 ' O ' ' HG2' ' A' ' 412' ' ' GLN . 9.8 tt0 -83.61 131.66 34.95 Favored 'General case' 0 C--O 1.217 -0.611 0 O-C-N 122.176 -0.328 . . . . 0.0 110.322 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 12.6 pt -46.64 -47.56 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 122.989 0.516 . . . . 0.0 110.442 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 13.3 t -77.81 109.86 12.87 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 130.78 -43.02 1.33 Allowed Glycine 0 C--N 1.319 -0.371 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -173.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.527 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 15.3 pt20 -97.86 -52.59 3.68 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.5 ' N ' ' HG3' ' A' ' 412' ' ' GLN . 31.1 t70 -169.64 118.45 0.63 Allowed 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -90.98 11.18 23.69 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.126 -166.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 76.5 p -65.61 166.95 9.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.197 0.522 . . . . 0.0 111.52 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -66.44 -11.84 54.04 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.317 -175.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 37.4 t70 80.7 63.32 0.02 OUTLIER 'General case' 0 C--O 1.243 0.761 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.917 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.484 ' HG3' ' CG ' ' A' ' 439' ' ' ARG . 14.6 ptt180 -179.12 153.8 0.75 Allowed Pre-proline 0 C--O 1.25 1.091 0 C-N-CA 124.001 0.921 . . . . 0.0 108.984 177.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -65.1 153.77 76.67 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.741 2.294 . . . . 0.0 111.163 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -74.44 161.0 30.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.655 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 18.7 t -58.72 134.23 86.4 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.493 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.42 -19.64 65.52 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.158 1.905 . . . . 0.0 112.18 -178.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 18.2 m-85 -93.77 -5.54 48.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.06 0.457 . . . . 0.0 110.169 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 75.05 -162.53 53.82 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -173.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.91 -12.42 26.16 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.366 2.044 . . . . 0.0 111.958 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 51.1 m -73.8 -9.02 58.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.031 0.443 . . . . 0.0 110.336 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' CYS . . . . . 0.797 ' SG ' 'ZN ' ' A' ' 450' ' ' ' ZN' . 51.0 t -50.89 117.88 2.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.971 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -106.03 7.99 32.16 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.036 0.922 . . . . 0.0 110.142 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -66.51 109.82 2.92 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . 0.689 ' HZ1' ' HB2' ' A' ' 430' ' ' LYS . 10.2 mtmp? -100.46 18.96 17.71 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -171.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . 0.494 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 61.7 t30 -68.44 125.95 92.19 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 172.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.494 ' HD2' ' OD1' ' A' ' 431' ' ' ASN . 17.8 Cg_endo -57.08 -41.27 76.45 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.629 2.219 . . . . 0.0 111.801 -177.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.553 ' O ' ' HG2' ' A' ' 437' ' ' GLU . 24.9 tp60 -64.6 -38.05 89.67 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . 0.742 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 25.0 t60 -59.14 -52.75 64.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.089 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -57.63 -31.0 65.83 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.3 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 432' ' ' PRO . 65.1 mt -70.99 -42.7 76.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.257 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 433' ' ' GLN . 6.8 mm-40 -76.09 -38.18 57.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . 0.521 ' HB3' ' HA ' ' A' ' 421' ' ' CYS . 85.7 m-85 -114.85 150.69 35.16 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -171.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' ARG . . . . . 0.484 ' CG ' ' HG3' ' A' ' 418' ' ' ARG . 36.8 mtm180 -95.25 123.62 38.86 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.248 0.968 . . . . 0.0 110.776 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.477 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 71.4 m80 -99.5 85.78 3.23 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' ASN . . . . . 0.484 HD22 ' NH1' ' A' ' 439' ' ' ARG . 74.4 m-20 -107.52 151.74 25.17 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -176.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 7.5 p -98.12 147.98 24.02 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.996 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 2.6 pp -148.52 156.79 42.13 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 110.728 -0.101 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' PRO . . . . . 0.534 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 21.1 Cg_endo -60.08 -28.53 87.21 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.933 2.422 . . . . 0.0 112.912 -174.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 7.2 p 47.66 31.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 O-C-N 124.012 0.82 . . . . 0.0 111.183 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.534 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 26.4 mmt180 -86.67 163.01 17.62 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.703 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 60.51 44.24 12.04 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 10.0 m . . . . . 0 C--O 1.235 0.31 0 C-N-CA 124.548 1.139 . . . . 0.0 111.666 177.156 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' ' ZN' . . . . . 0.848 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' ' ZN' . . . . . 0.797 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.78 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 13.0 p -60.93 102.22 0.19 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.276 0.56 . . . . 0.0 111.528 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -143.66 95.36 2.73 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 123.54 0.736 . . . . 0.0 110.093 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -170.4 107.2 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.63 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 9.2 m -71.31 161.64 30.74 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.46 125.15 22.75 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 4.5 p -59.16 98.13 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.1 0.476 . . . . 0.0 111.291 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 35.7 t -73.13 90.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.458 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.3 pp -94.17 18.45 10.84 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.216 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -56.81 101.15 0.05 Allowed 'General case' 0 C--O 1.222 -0.343 0 O-C-N 123.752 0.657 . . . . 0.0 111.138 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -86.08 71.66 2.81 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.706 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 48.8 m -130.68 93.87 3.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.574 0.702 . . . . 0.0 110.552 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -108.48 156.61 19.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.85 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 104.2 43.15 1.79 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -175.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' A' ' 374' ' ' VAL . 65.0 m-20 -113.86 134.31 54.88 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 114.661 -0.769 . . . . 0.0 111.342 -171.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.593 ' HB2' ' HZ3' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -88.35 -25.16 22.88 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.55 1.167 . . . . 0.0 109.133 171.103 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . 0.558 HG13 ' HD3' ' A' ' 373' ' ' LYS . 19.9 m -139.5 153.98 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 166.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.567 ' N ' ' HD2' ' A' ' 375' ' ' LYS . 3.6 mptp? -66.83 -49.67 65.01 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.531 0.682 . . . . 0.0 109.312 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.481 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.3 OUTLIER -143.23 144.23 32.07 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.548 174.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 5.2 t -97.27 143.2 28.28 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.904 173.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 58.5 m -54.74 123.08 12.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.319 0.58 . . . . 0.0 112.052 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.837 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 29.3 t -49.47 107.97 0.17 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.226 176.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' MET . . . . . 0.516 ' HB3' HG13 ' A' ' 410' ' ' VAL . 22.4 ptp -54.55 -27.3 37.59 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -93.93 -16.63 23.8 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.083 0.468 . . . . 0.0 109.998 178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.6 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 66.35 -126.43 28.06 Favored Glycine 0 C--O 1.235 0.161 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -176.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -91.27 4.5 52.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.678 0.391 . . . . 0.0 110.829 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -88.52 -15.1 36.11 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.782 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.837 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 0.6 OUTLIER -67.94 131.61 45.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 0.0 110.397 177.848 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -82.65 21.11 1.03 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.281 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -95.99 121.99 38.33 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.653 176.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -107.82 -25.91 11.02 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 124.565 1.166 . . . . 0.0 108.534 -177.39 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -48.07 139.94 9.42 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.845 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.14 -22.34 67.41 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.849 1.699 . . . . 0.0 112.073 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.407 HG12 ' HE2' ' A' ' 395' ' ' HIS . 88.8 t -66.33 -34.73 72.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.865 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.726 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 70.9 t60 -59.82 -37.81 80.24 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.937 0.399 . . . . 0.0 110.153 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -86.23 -18.2 32.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.35 -176.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -29.28 61.08 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -175.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.608 ' HD1' ' HD1' ' A' ' 396' ' ' PHE . 1.0 OUTLIER -109.68 -16.51 13.91 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.575 176.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.608 ' HD1' ' HD1' ' A' ' 395' ' ' HIS . 72.5 m-85 -122.35 127.84 50.26 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 120.74 0.305 . . . . 0.0 110.945 176.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.481 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 16.8 p -78.37 156.43 29.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 122.874 0.47 . . . . 0.0 110.027 175.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.686 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 51.0 m80 -132.02 159.02 73.9 Favored Pre-proline 0 N--CA 1.476 0.836 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.997 -176.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -52.37 102.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.679 2.253 . . . . 0.0 111.954 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 121.23 -1.37 11.56 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.737 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -98.12 151.45 20.37 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 122.035 0.921 . . . . 0.0 110.503 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 29.7 p -63.36 -29.11 70.47 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.163 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -104.73 15.86 27.11 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.226 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -83.97 148.75 26.73 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -142.13 -50.18 0.04 OUTLIER Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.37 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 68.35 24.05 74.97 Favored Glycine 0 C--O 1.221 -0.668 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.652 -173.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 35.3 m -104.73 11.55 8.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 CA-C-O 121.741 0.782 . . . . 0.0 110.234 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 412' ' ' GLN . 8.0 tt0 -104.26 141.54 36.12 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 123.676 0.791 . . . . 0.0 110.235 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.462 HG13 ' N ' ' A' ' 410' ' ' VAL . 35.5 pt -53.92 -45.02 63.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.521 ' HA ' ' HG2' ' A' ' 414' ' ' GLU . 57.6 t -68.0 91.79 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 143.94 -51.83 0.63 Allowed Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 4.3 pt20 -90.79 -46.42 8.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.626 0.727 . . . . 0.0 110.3 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -177.67 121.01 0.11 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 410' ' ' VAL . 25.6 mt-10 -88.39 -35.88 16.88 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.571 -169.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 56.8 p -135.04 136.1 41.81 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 122.783 0.433 . . . . 0.0 111.187 -173.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -49.28 -59.15 3.94 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.318 1.011 . . . . 0.0 110.168 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -147.42 -43.56 0.17 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.353 175.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.486 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 24.7 ptt180 -122.09 165.89 18.98 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.191 -176.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 61.3 Cg_endo -72.68 146.23 42.96 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.217 1.945 . . . . 0.0 112.052 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' GLU . . . . . 0.574 ' HG2' ' ND2' ' A' ' 441' ' ' ASN . 47.2 mt-10 -61.38 155.24 22.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.884 0.373 . . . . 0.0 111.357 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.956 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 8.3 t -66.62 136.7 94.85 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -53.21 -34.36 69.05 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.146 2.564 . . . . 0.0 112.69 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 74.8 m-85 -102.14 7.79 40.88 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.424 -176.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 71.04 -153.43 51.18 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.429 -0.35 . . . . 0.0 112.573 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.53 -19.02 49.11 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.538 2.159 . . . . 0.0 111.883 175.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 37.9 t -69.82 -19.58 63.47 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.599 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' CYS . . . . . 0.956 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 40.9 t -56.03 115.55 2.48 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.769 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -109.14 16.61 22.38 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 123.835 0.709 . . . . 0.0 109.483 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.477 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 2.4 mmp_? -53.71 93.23 0.01 OUTLIER 'General case' 0 C--O 1.246 0.884 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 173.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -75.95 79.16 2.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.313 -174.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . 0.421 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 48.5 t30 -150.9 123.36 4.09 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.336 174.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.509 ' O ' HG13 ' A' ' 436' ' ' ILE . 23.2 Cg_endo -62.79 -33.16 77.08 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.19 1.926 . . . . 0.0 111.314 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -68.16 -38.65 82.32 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . 0.577 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 29.8 t60 -59.93 -53.85 53.06 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.948 0.88 . . . . 0.0 109.229 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.426 ' O ' ' NH1' ' A' ' 418' ' ' ARG . 51.1 mtpt -62.99 -14.69 50.8 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.307 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 432' ' ' PRO . 48.3 mt -86.31 -45.33 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 123.235 0.334 . . . . 0.0 110.546 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -76.8 -29.45 56.0 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 122.437 -0.164 . . . . 0.0 111.294 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -113.95 137.29 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.093 0.557 . . . . 0.0 109.87 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' ARG . . . . . 0.486 ' HD3' ' O ' ' A' ' 418' ' ' ARG . 1.0 OUTLIER -94.47 130.3 40.9 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.078 178.167 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -106.17 86.07 2.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.595 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' ASN . . . . . 0.574 ' ND2' ' HG2' ' A' ' 420' ' ' GLU . 46.7 m-80 -69.85 135.47 49.63 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.332 -173.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 28.9 p -135.86 173.14 12.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.601 0.715 . . . . 0.0 110.448 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.457 HD11 ' HB ' ' A' ' 445' ' ' VAL . 1.3 pp -137.12 146.46 54.57 Favored Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 122.028 -0.42 . . . . 0.0 110.284 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' PRO . . . . . 0.49 ' O ' HG13 ' A' ' 445' ' ' VAL . 27.2 Cg_endo -62.14 -44.54 19.17 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 122.901 2.401 . . . . 0.0 112.359 -175.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 444' ' ' PRO . 5.9 p 48.21 26.27 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 124.444 1.098 . . . . 0.0 112.035 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -92.5 167.81 11.69 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 7.3 t30 74.43 -42.71 0.51 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.816 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 C--O 1.244 0.796 0 C-N-CA 123.128 0.571 . . . . 0.0 111.374 178.489 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' ' ZN' . . . . . 0.785 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' ' ZN' . . . . . 0.719 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.119 0 CA-C-O 119.495 -0.614 . . . . 0.0 111.651 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.5 m -73.73 98.88 3.01 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.079 0.517 . . . . 0.0 110.271 -177.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -125.46 156.29 39.14 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.97 0.414 . . . . 0.0 110.044 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -82.03 53.33 2.19 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 122.293 1.044 . . . . 0.0 110.579 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 31.3 p -74.81 120.28 20.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.279 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -70.07 108.77 4.23 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 23.3 t -82.57 108.0 15.63 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.22 100.9 8.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 123.728 0.643 . . . . 0.0 110.224 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.6 pp -93.44 -4.82 50.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.652 0.739 . . . . 0.0 110.659 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -58.44 108.66 0.65 Allowed 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.495 0.718 . . . . 0.0 110.553 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 68.98 43.53 72.53 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 51.0 m -147.59 107.61 4.02 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.263 0.225 . . . . 0.0 110.644 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.82 -22.77 20.83 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 123.94 0.775 . . . . 0.0 110.057 177.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 168.19 -30.98 0.18 Allowed Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -87.84 174.04 8.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.105 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.408 ' H ' ' HD2' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -127.96 0.42 5.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.604 171.526 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 30.4 m -149.54 175.91 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.483 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.56 168.08 18.3 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.266 0.555 . . . . 0.0 110.897 173.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.599 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.1 OUTLIER -77.57 167.43 21.63 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 122.009 0.909 . . . . 0.0 111.264 -177.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.4 t -111.51 162.53 15.01 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.491 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 24.8 t -57.59 116.91 3.68 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.954 0.502 . . . . 0.0 111.699 -176.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 25.1 t -51.96 117.28 2.64 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' MET . . . . . 0.41 ' HB2' HG12 ' A' ' 410' ' ' VAL . 23.2 ptm -58.93 -21.09 57.45 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.611 0.243 . . . . 0.0 111.005 -170.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.623 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 72.0 m-85 -109.61 -14.81 14.3 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.568 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 72.03 -134.94 22.26 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . 0.469 ' HB3' ' HG2' ' A' ' 399' ' ' PRO . . . -75.92 -1.27 24.68 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.842 0.354 . . . . 0.0 110.409 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -91.77 -10.48 39.82 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.621 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.2 p -73.59 126.05 29.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 122.134 -0.354 . . . . 0.0 110.524 175.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -77.81 10.92 2.41 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.441 0.639 . . . . 0.0 111.896 -175.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -95.31 119.44 33.83 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.083 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.557 ' HD3' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -122.28 5.73 9.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.47 -178.145 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -63.73 136.6 96.79 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.197 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.6 -33.14 30.12 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.499 2.799 . . . . 0.0 112.534 -171.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.471 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 54.1 t -65.59 -34.91 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.702 -177.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.682 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 81.5 t60 -57.22 -31.78 65.85 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 122.068 -0.395 . . . . 0.0 110.208 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -89.78 -10.29 46.06 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 123.337 0.398 . . . . 0.0 111.973 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -82.61 -12.67 57.52 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.584 -0.447 . . . . 0.0 111.117 -175.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.419 ' HD2' ' HG3' ' A' ' 394' ' ' GLN . 3.6 p80 -128.97 -23.41 3.06 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.455 ' CD2' ' HA ' ' A' ' 379' ' ' CYS . 60.2 m-85 -123.12 127.32 48.54 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.317 0.579 . . . . 0.0 111.096 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.599 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 57.4 m -86.95 166.17 15.31 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.037 173.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.64 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 28.1 m80 -131.74 159.11 73.39 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 122.815 0.446 . . . . 0.0 110.667 -174.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.469 ' HG2' ' HB3' ' A' ' 383' ' ' ALA . 19.6 Cg_endo -55.73 97.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.432 2.088 . . . . 0.0 111.885 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.18 -30.43 2.81 Favored Glycine 0 CA--C 1.508 -0.37 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.219 -175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -66.57 143.07 57.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.013 -0.593 . . . . 0.0 109.658 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 12.2 t -64.82 -17.44 64.24 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.91 -174.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.416 ' HB2' ' HG ' ' A' ' 397' ' ' SER . 4.1 m-20 -108.4 7.49 27.07 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.218 0.207 . . . . 0.0 111.091 -174.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -86.65 127.77 34.96 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -126.47 -43.44 0.27 Allowed Glycine 0 CA--C 1.5 -0.874 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 89.55 25.47 27.88 Favored Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 111.914 -0.474 . . . . 0.0 111.914 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 20.3 m -72.92 -16.23 17.71 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.17 0 CA-C-O 121.573 0.701 . . . . 0.0 110.1 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -81.13 138.44 35.9 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.943 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.472 HG13 HG21 ' A' ' 410' ' ' VAL . 23.3 pt -57.53 -47.66 84.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.784 0.802 . . . . 0.0 110.924 174.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.472 HG21 HG13 ' A' ' 409' ' ' ILE . 25.7 t -72.67 123.85 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.791 -178.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 123.41 -25.4 6.29 Favored Glycine 0 CA--C 1.505 -0.576 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.194 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.55 -53.37 1.69 Allowed 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 115.086 -0.557 . . . . 0.0 109.694 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -171.29 127.04 0.67 Allowed 'General case' 0 C--O 1.243 0.738 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.39 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . 0.406 ' O ' ' NH2' ' A' ' 439' ' ' ARG . 7.5 mp0 -95.69 -14.92 23.02 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.251 -173.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 419' ' ' PRO . 52.0 p -79.5 145.65 33.1 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -91.99 -57.21 2.8 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 123.688 0.617 . . . . 0.0 109.61 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -129.81 -24.91 2.63 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.68 0.752 . . . . 0.0 109.958 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.531 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 28.0 ptt180 -154.68 165.32 18.36 Favored Pre-proline 0 C--O 1.247 0.97 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.139 -175.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.531 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 39.3 Cg_endo -67.18 143.61 65.59 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.901 2.4 . . . . 0.0 112.541 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -67.18 151.92 46.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 123.248 0.343 . . . . 0.0 110.865 174.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.8 ' SG ' 'ZN ' ' A' ' 450' ' ' ' ZN' . 27.9 t -63.55 136.3 96.65 Favored Pre-proline 0 C--N 1.317 -0.813 0 O-C-N 123.622 0.576 . . . . 0.0 109.866 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.78 -13.28 29.58 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.836 2.357 . . . . 0.0 112.365 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -111.59 8.89 21.09 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 57.32 -149.93 30.75 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 -172.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.89 -1.87 11.96 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.436 2.091 . . . . 0.0 111.88 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 17.3 t -84.05 -2.45 56.71 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.825 0.822 . . . . 0.0 109.121 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' CYS . . . . . 0.753 ' SG ' 'ZN ' ' A' ' 450' ' ' ' ZN' . 44.7 t -49.35 117.49 2.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.386 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -108.29 11.5 27.2 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.998 176.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -75.15 93.8 2.85 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -79.18 83.28 5.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.491 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -144.34 122.94 6.92 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.518 ' O ' HG13 ' A' ' 436' ' ' ILE . 18.3 Cg_endo -59.08 -38.23 88.32 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.822 1.681 . . . . 0.0 112.885 -175.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.583 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 24.9 tp60 -65.45 -40.06 92.77 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.965 -0.46 . . . . 0.0 109.785 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . 0.563 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 26.1 t60 -57.9 -53.77 54.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.699 0.761 . . . . 0.0 110.452 177.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -61.02 -18.22 56.57 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.889 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 432' ' ' PRO . 52.3 mt -84.3 -41.84 16.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.676 178.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 23.8 mt-10 -79.21 -45.5 19.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.135 0.493 . . . . 0.0 110.847 -175.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -97.14 145.41 26.04 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.459 -174.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' ARG . . . . . 0.424 ' NH1' HD22 ' A' ' 441' ' ' ASN . 16.7 ptt180 -92.32 118.31 30.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.354 0.597 . . . . 0.0 110.213 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.674 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 76.2 m80 -92.9 78.55 4.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.002 175.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' ASN . . . . . 0.424 HD22 ' NH1' ' A' ' 439' ' ' ARG . 2.2 m-20 -66.63 105.58 1.57 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.763 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.0 p -81.92 121.89 27.06 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.479 ' O ' HD11 ' A' ' 443' ' ' LEU . 2.2 pp -87.65 145.66 37.57 Favored Pre-proline 0 C--O 1.246 0.89 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.907 -173.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.65 -32.16 19.6 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.103 2.535 . . . . 0.0 112.543 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.429 ' HB ' HD13 ' A' ' 443' ' ' LEU . 9.3 p 43.05 32.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.911 1.339 . . . . 0.0 109.941 -176.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -92.24 158.01 16.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.937 -1.102 . . . . 0.0 110.284 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 59.87 21.62 10.56 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 171.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.224 -0.248 0 O-C-N 123.563 0.539 . . . . 0.0 109.692 179.928 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' ' ZN' . . . . . 0.818 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' ' ZN' . . . . . 0.8 'ZN ' ' SG ' ' A' ' 421' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.472 0 CA-C-O 120.7 0.056 . . . . 0.0 113.083 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.5 t -109.33 -55.8 2.37 Favored 'General case' 0 C--O 1.246 0.92 0 O-C-N 122.195 -0.591 . . . . 0.0 110.996 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.77 9.74 3.06 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.793 0.837 . . . . 0.0 111.48 -177.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -85.26 76.93 10.1 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 174.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 27.2 p -92.29 119.36 31.8 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 125.376 1.673 . . . . 0.0 111.714 -172.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -112.58 141.54 46.22 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.052 175.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 6.1 p -136.9 151.08 48.66 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.691 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 23.0 t -81.49 89.44 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.758 0 O-C-N 123.265 0.353 . . . . 0.0 110.077 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 4.1 pp -77.82 -18.38 56.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.195 0.522 . . . . 0.0 110.497 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -98.0 -165.02 1.2 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.394 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 93.71 -59.56 2.14 Favored Glycine 0 C--O 1.239 0.455 0 CA-C-O 122.067 0.815 . . . . 0.0 111.285 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 33.0 t -84.27 84.81 7.49 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -91.47 -31.33 16.02 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.995 -173.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 94.6 32.08 7.49 Favored Glycine 0 CA--C 1.505 -0.569 0 CA-C-O 122.042 0.801 . . . . 0.0 111.386 -175.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -161.83 145.44 12.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.176 -1.012 . . . . 0.0 108.289 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.431 ' H ' ' HD2' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -79.73 -23.51 42.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.487 0.492 . . . . 0.0 111.418 -175.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 23.7 m -84.15 162.76 2.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 173.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.596 ' HG2' ' H ' ' A' ' 376' ' ' ARG . 0.1 OUTLIER -130.73 -66.43 0.76 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.287 0.565 . . . . 0.0 110.89 177.229 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.596 ' H ' ' HG2' ' A' ' 375' ' ' LYS . 0.1 OUTLIER -145.2 165.87 27.11 Favored 'General case' 0 C--O 1.25 1.122 0 O-C-N 121.779 -0.576 . . . . 0.0 111.184 178.701 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 14.3 t -134.14 162.81 31.1 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 12.4 m -54.59 117.7 3.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.638 0.732 . . . . 0.0 110.679 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.769 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 39.6 t -51.23 120.95 5.48 Favored 'General case' 0 C--N 1.359 0.992 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.085 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' MET . . . . . 0.577 ' O ' HG12 ' A' ' 410' ' ' VAL . 27.2 ptm -58.81 -23.18 60.07 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.609 0.719 . . . . 0.0 111.122 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.595 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 35.1 m-85 -103.23 -15.71 15.92 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 121.075 -1.016 . . . . 0.0 109.902 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.528 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 64.6 -131.74 37.76 Favored Glycine 0 CA--C 1.498 -1.028 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.797 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -75.75 -4.87 42.89 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 122.65 0.38 . . . . 0.0 111.214 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -86.86 -5.33 59.14 Favored 'General case' 0 C--O 1.248 1.022 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.715 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.819 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 6.4 p -81.2 123.58 28.57 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.649 0.738 . . . . 0.0 111.43 176.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -82.13 10.72 6.22 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.911 0.862 . . . . 0.0 110.95 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.539 HH21 ' ND2' ' A' ' 389' ' ' ASN . 31.4 mmm180 -84.02 124.09 30.7 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.13 174.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.46 -5.3 11.73 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.422 -176.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.539 ' ND2' HH21 ' A' ' 387' ' ' ARG . 20.7 p-10 -58.73 137.59 86.68 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.217 176.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -60.01 -24.19 75.68 Favored 'Trans proline' 0 CA--C 1.518 -0.297 0 C-N-CA 122.178 1.919 . . . . 0.0 111.252 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.528 HG11 ' NE2' ' A' ' 395' ' ' HIS . 93.4 t -66.62 -42.17 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.129 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.709 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 82.3 t60 -54.53 -35.05 62.78 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 120.381 -0.527 . . . . 0.0 110.459 178.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.432 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 24.6 m-85 -88.08 -24.04 23.54 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.771 -176.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -72.83 -20.26 61.17 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.949 -177.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.646 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 1.9 p80 -118.22 -8.71 10.58 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 176.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.646 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 88.0 m-85 -137.65 127.28 25.21 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.333 0.587 . . . . 0.0 110.767 176.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.554 ' HG ' ' HB2' ' A' ' 403' ' ' ASP . 46.2 m -85.78 159.2 19.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.964 175.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.628 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 39.2 m80 -128.1 153.02 78.52 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.811 -174.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -50.77 112.34 0.74 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.311 2.007 . . . . 0.0 112.701 -174.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 117.65 -5.57 16.62 Favored Glycine 0 C--O 1.237 0.34 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.075 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -95.67 145.41 25.29 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.322 0.582 . . . . 0.0 109.922 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 42.0 t -57.81 -30.91 66.08 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.293 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.554 ' HB2' ' HG ' ' A' ' 397' ' ' SER . 21.0 m-20 -94.29 2.61 55.85 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.758 -174.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -82.54 153.59 25.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -141.18 -37.42 0.09 OUTLIER Glycine 0 C--O 1.24 0.516 0 CA-C-O 121.805 0.669 . . . . 0.0 113.099 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 74.13 23.44 76.02 Favored Glycine 0 C--O 1.212 -1.233 0 CA-C-O 122.489 1.049 . . . . 0.0 111.867 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 33.8 m -79.27 -16.11 13.32 Favored 'Isoleucine or valine' 0 C--N 1.35 0.616 0 CA-C-O 121.765 0.793 . . . . 0.0 110.678 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -90.9 121.86 33.1 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.507 HG13 HG21 ' A' ' 410' ' ' VAL . 12.7 pt -45.65 -47.93 4.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 123.205 0.315 . . . . 0.0 111.331 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.665 ' HA ' ' HG2' ' A' ' 414' ' ' GLU . 17.3 t -72.84 115.28 13.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 O-C-N 123.776 0.673 . . . . 0.0 109.954 -177.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 144.05 -49.77 0.69 Allowed Glycine 0 CA--C 1.498 -1.029 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.892 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.407 ' HG2' ' N ' ' A' ' 413' ' ' ASP . 5.1 pm0 -127.75 -46.04 1.44 Allowed 'General case' 0 C--O 1.238 0.475 0 O-C-N 122.162 -0.611 . . . . 0.0 111.321 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.407 ' N ' ' HG2' ' A' ' 412' ' ' GLN . 7.4 m-20 -125.19 92.79 3.71 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 122.518 0.327 . . . . 0.0 110.383 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . 0.665 ' HG2' ' HA ' ' A' ' 410' ' ' VAL . 43.0 mt-10 -94.52 36.01 1.19 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.525 -177.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 54.0 p -64.17 130.68 44.89 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.906 -175.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -59.46 -18.32 38.67 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.414 0.626 . . . . 0.0 110.754 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 35.8 t70 79.4 57.94 0.02 OUTLIER 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.252 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -175.75 152.89 1.35 Allowed Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.094 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.42 145.53 67.52 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.071 1.847 . . . . 0.0 112.203 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' GLU . . . . . 0.426 ' HG2' ' ND2' ' A' ' 441' ' ' ASN . 42.5 mt-10 -74.37 150.88 39.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 172.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.913 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 5.5 t -59.48 127.37 84.55 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.95 -23.6 35.51 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.344 2.029 . . . . 0.0 113.219 -176.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . 0.468 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 87.7 m-85 -102.34 18.01 22.08 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.239 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 59.03 -156.07 25.46 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.579 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.68 -9.68 22.83 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.654 2.236 . . . . 0.0 111.083 175.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 32.1 t -73.87 -8.86 57.68 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.52 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' CYS . . . . . 0.913 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 23.1 t -62.94 115.64 4.58 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.399 0.619 . . . . 0.0 109.545 176.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -109.13 21.51 17.07 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.714 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 0.2 OUTLIER -64.02 92.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.207 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -68.79 91.44 0.45 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.851 0.834 . . . . 0.0 111.393 -174.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -161.98 123.54 1.63 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.811 173.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.471 ' O ' HG13 ' A' ' 436' ' ' ILE . 33.4 Cg_endo -63.91 -36.52 49.4 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.752 2.302 . . . . 0.0 110.599 -178.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.65 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 22.4 tp60 -65.31 -37.01 85.82 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . 0.667 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 12.3 t60 -63.3 -49.35 74.37 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 121.683 0.754 . . . . 0.0 109.575 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.498 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 53.8 mtpt -66.72 -7.1 18.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.078 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 432' ' ' PRO . 42.6 mt -94.97 -42.94 12.85 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.752 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.65 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 22.8 mt-10 -68.76 -37.55 79.46 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.83 0.824 . . . . 0.0 110.555 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -117.55 138.66 51.76 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.551 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -89.38 118.61 29.17 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.712 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 22.3 m80 -94.21 99.34 11.62 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' ASN . . . . . 0.426 ' ND2' ' HG2' ' A' ' 420' ' ' GLU . 35.6 m-80 -91.43 106.08 18.24 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.56 -175.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.98 138.32 39.57 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.527 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.5 OUTLIER -118.53 149.81 46.87 Favored Pre-proline 0 C--O 1.248 1.011 0 CA-C-O 120.963 0.411 . . . . 0.0 111.771 -171.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.52 -18.32 12.25 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 123.042 2.494 . . . . 0.0 111.859 175.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.527 ' HB ' HD13 ' A' ' 443' ' ' LEU . 10.0 p 43.03 30.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.245 0 CA-C-O 122.315 1.055 . . . . 0.0 111.715 -178.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -108.39 -33.37 7.1 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.509 -174.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -81.65 -27.79 33.92 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.128 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--O 1.206 -1.237 0 O-C-N 123.755 0.659 . . . . 0.0 109.669 179.508 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' ' ZN' . . . . . 0.819 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' ' ZN' . . . . . 0.789 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.443 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 32.6 t 70.77 -65.96 0.31 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.296 1.038 . . . . 0.0 111.197 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -73.43 89.12 1.62 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.871 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -82.95 115.44 21.8 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 7.0 m -57.98 156.43 9.24 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 124.009 0.818 . . . . 0.0 110.951 -176.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -102.69 136.46 42.48 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.145 0.578 . . . . 0.0 110.072 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 11.3 p -72.63 149.22 44.1 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.446 -176.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.03 118.65 59.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 C-N-CA 122.965 0.506 . . . . 0.0 110.445 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.6 pp -100.42 -4.46 28.91 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 122.155 -0.341 . . . . 0.0 111.336 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -53.59 137.91 35.68 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 119.05 -8.07 12.63 Favored Glycine 0 N--CA 1.468 0.819 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -174.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 48.0 t -104.11 119.02 38.05 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -54.47 -28.96 48.24 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.219 0.949 . . . . 0.0 109.782 174.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 120.19 -93.37 0.54 Allowed Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -170.66 171.94 6.04 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.452 ' HD2' HG13 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -83.05 -6.9 59.67 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-O 121.518 0.675 . . . . 0.0 110.079 176.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . 0.452 HG13 ' HD2' ' A' ' 373' ' ' LYS . 35.8 m -120.19 155.02 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 171.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.11 162.6 13.96 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.1 159.23 20.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.136 174.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 12.6 t -101.83 149.38 24.25 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 9.7 t -57.93 111.86 1.3 Allowed 'General case' 0 C--O 1.244 0.796 0 O-C-N 123.355 0.41 . . . . 0.0 110.193 -171.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.782 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 30.9 t -51.36 108.96 0.29 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' MET . . . . . 0.504 ' HB2' HG22 ' A' ' 410' ' ' VAL . 14.5 ptp -60.43 -13.62 14.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.988 0.423 . . . . 0.0 110.665 -176.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.46 ' CB ' ' HB3' ' A' ' 385' ' ' CYS . 36.3 m-85 -93.59 -27.05 16.83 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.079 175.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.408 ' O ' ' HD2' ' A' ' 398' ' ' HIS . . . 60.28 -117.93 13.05 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.415 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -84.29 -9.67 58.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.17 -0.606 . . . . 0.0 111.505 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -78.95 -26.67 43.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.2 -176.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.796 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 13.5 p -73.87 111.57 9.15 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.426 172.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -84.98 12.39 7.66 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.38 0.609 . . . . 0.0 110.143 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -65.11 125.47 25.04 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 172.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.41 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.5 OUTLIER -119.72 0.75 10.98 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.028 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -66.05 133.86 94.83 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.117 173.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.9 -22.08 67.06 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.547 2.165 . . . . 0.0 112.292 -174.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.56 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 74.9 t -67.85 -38.32 79.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.129 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.585 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 85.0 t60 -62.88 -26.69 68.9 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 120.864 0.364 . . . . 0.0 110.051 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -92.46 -19.57 21.88 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.281 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -73.79 -23.69 59.72 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.872 -177.111 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.537 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 2.4 p80 -116.7 -11.89 10.93 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 177.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.537 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 93.8 m-85 -131.94 131.71 42.88 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 122.126 -0.359 . . . . 0.0 111.549 175.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 22.2 p -84.38 153.95 23.14 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.369 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.437 ' HB3' ' HD2' ' A' ' 399' ' ' PRO . 69.3 m80 -136.32 159.87 69.09 Favored Pre-proline 0 C--O 1.221 -0.44 0 O-C-N 122.339 -0.225 . . . . 0.0 110.524 -173.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 17.4 Cg_endo -54.43 103.08 0.09 OUTLIER 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.25 1.966 . . . . 0.0 111.614 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 129.62 -23.68 4.74 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -76.27 151.09 36.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.231 -0.484 . . . . 0.0 110.78 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 13.5 m -67.15 -22.83 65.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.523 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -110.99 15.56 21.66 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.285 -173.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -74.03 141.7 45.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.823 -178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -114.27 -57.46 0.38 Allowed Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.962 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 64.0 14.82 57.13 Favored Glycine 0 C--O 1.216 -1.001 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -174.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 35.9 m -89.56 -15.14 8.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-N 115.497 -0.351 . . . . 0.0 111.383 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -75.61 132.45 40.65 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.784 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.478 HG13 ' H ' ' A' ' 410' ' ' VAL . 5.1 pt -46.59 -56.95 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 123.089 0.243 . . . . 0.0 111.03 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.504 HG22 ' HB2' ' A' ' 380' ' ' MET . 11.0 p -76.4 116.06 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 134.64 -49.39 0.9 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -168.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.402 ' HG3' ' N ' ' A' ' 413' ' ' ASP . 3.8 pt20 -102.3 -52.36 3.15 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 176.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.402 ' N ' ' HG3' ' A' ' 412' ' ' GLN . 35.1 t70 -165.7 125.35 1.73 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.845 0.831 . . . . 0.0 110.187 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -87.58 13.37 10.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.852 -162.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 72.6 p -85.77 -178.43 6.61 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 117.85 0.295 . . . . 0.0 110.514 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -68.15 -13.9 62.57 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.335 -177.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 36.7 t70 68.85 74.09 0.26 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.425 0.631 . . . . 0.0 110.181 -174.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.493 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 19.3 ptt180 -162.88 158.82 18.99 Favored Pre-proline 0 C--O 1.246 0.91 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 35.8 Cg_endo -63.32 136.57 56.07 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.644 2.229 . . . . 0.0 111.644 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -70.58 147.76 48.91 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 121.797 -0.564 . . . . 0.0 110.121 175.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 1.001 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 11.9 t -54.82 137.56 64.34 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.396 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.74 -14.38 26.46 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.158 1.906 . . . . 0.0 112.494 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -113.27 10.31 18.46 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.116 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 59.36 -151.19 36.21 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-O 119.598 -0.557 . . . . 0.0 111.85 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.14 -13.02 28.42 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.664 2.243 . . . . 0.0 112.344 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 38.0 t -79.87 1.24 27.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.485 176.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' CYS . . . . . 1.001 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 48.0 t -60.02 116.72 4.36 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.127 177.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -114.42 23.56 12.68 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.983 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -69.04 108.42 3.54 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.762 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -77.29 84.15 3.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.142 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . 0.414 ' O ' ' HB3' ' A' ' 434' ' ' HIS . 61.5 t30 -156.47 121.07 2.39 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.428 175.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.456 ' O ' HG13 ' A' ' 436' ' ' ILE . 18.7 Cg_endo -58.76 -43.32 45.2 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.423 2.082 . . . . 0.0 112.708 -175.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 437' ' ' GLU . 28.9 tp60 -67.94 -26.35 65.92 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.93 0.769 . . . . 0.0 109.744 -175.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . 0.715 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 59.6 t60 -60.55 -59.37 5.5 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 122.816 0.446 . . . . 0.0 111.494 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -25.6 64.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.668 0.27 . . . . 0.0 111.025 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 432' ' ' PRO . 67.0 mt -70.18 -46.46 72.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.007 0.432 . . . . 0.0 111.09 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 433' ' ' GLN . 11.8 mm-40 -76.31 -53.9 7.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.944 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -91.62 144.62 25.34 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.374 0.421 . . . . 0.0 110.516 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' ARG . . . . . 0.447 ' HB3' ' HG3' ' A' ' 418' ' ' ARG . 17.7 ptt180 -89.94 137.03 32.68 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.663 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 61.7 m80 -111.72 79.9 1.26 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.281 0.562 . . . . 0.0 109.674 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' ASN . . . . . 0.424 HD22 ' NE ' ' A' ' 439' ' ' ARG . 85.8 m-20 -74.86 129.45 37.7 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.069 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 17.2 p -86.56 140.4 29.92 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.804 -0.56 . . . . 0.0 109.841 -177.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.452 HD13 ' HB ' ' A' ' 445' ' ' VAL . 1.2 pp -109.04 151.84 42.15 Favored Pre-proline 0 C--N 1.312 -1.046 0 O-C-N 123.858 0.724 . . . . 0.0 110.114 -175.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.54 -49.06 4.8 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.288 1.992 . . . . 0.0 112.082 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.452 ' HB ' HD13 ' A' ' 443' ' ' LEU . 11.3 p 40.07 39.59 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.87 0.843 . . . . 0.0 109.751 -174.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -89.91 161.66 15.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.368 -173.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -56.52 -35.83 68.5 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.026 0.441 . . . . 0.0 110.739 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 C--O 1.252 1.199 0 CA-C-O 121.128 0.49 . . . . 0.0 111.821 176.751 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' ' ZN' . . . . . 0.796 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' ' ZN' . . . . . 0.772 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 46.6 t -145.33 162.1 38.04 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.408 ' HZ1' ' HB3' ' A' ' 360' ' ' LYS . 0.7 OUTLIER -105.69 111.37 24.02 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 172.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -78.67 8.68 4.96 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 124.167 0.917 . . . . 0.0 112.079 -174.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 24.8 p -58.87 108.7 0.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.486 0.66 . . . . 0.0 109.342 169.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -121.56 100.7 7.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.258 -167.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 10.8 t -166.13 173.95 9.78 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.568 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.416 HG12 ' HB3' ' A' ' 375' ' ' LYS . 19.7 t -96.84 142.4 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.522 -172.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 367' ' ' GLN . 3.8 pp -89.57 -49.91 6.39 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.544 0.527 . . . . 0.0 109.609 174.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' GLN . . . . . 0.516 ' N ' HD12 ' A' ' 366' ' ' LEU . 23.8 tp60 -96.96 81.97 3.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.406 0.622 . . . . 0.0 109.426 174.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 138.54 34.97 0.17 Allowed Glycine 0 C--O 1.241 0.568 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.024 -172.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 22.0 t -75.77 111.07 10.73 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.242 0.544 . . . . 0.0 111.077 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -146.2 -70.14 0.26 Allowed 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.357 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -177.71 32.92 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 CA-C-O 121.455 0.475 . . . . 0.0 112.326 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -118.37 161.37 20.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.752 -0.724 . . . . 0.0 109.612 -174.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.428 ' HD3' HG11 ' A' ' 374' ' ' VAL . 0.1 OUTLIER -101.04 -16.52 17.09 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.091 178.591 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . 0.428 HG11 ' HD3' ' A' ' 373' ' ' LYS . 27.6 m -136.65 154.48 32.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.667 170.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.416 ' HB3' HG12 ' A' ' 365' ' ' VAL . 1.5 pptp? -91.9 157.75 16.67 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 121.62 -0.675 . . . . 0.0 109.99 175.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.583 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.8 OUTLIER -81.31 148.52 29.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.399 0.619 . . . . 0.0 111.116 -178.02 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 11.9 t -101.3 152.91 20.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.966 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' SER . . . . . 0.433 ' HB3' ' O ' ' A' ' 410' ' ' VAL . 14.0 t -54.53 119.48 5.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.741 0.305 . . . . 0.0 111.723 -171.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.89 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 26.3 t -59.29 109.78 0.94 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' MET . . . . . 0.591 ' HA ' ' HA2' ' A' ' 411' ' ' GLY . 24.8 ptm -54.53 -29.86 51.94 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.364 -176.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.542 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 51.9 m-85 -98.23 -16.65 19.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.54 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 62.89 -116.26 9.14 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.874 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -90.34 7.79 36.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.854 0.359 . . . . 0.0 111.221 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -98.49 -22.55 15.95 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.447 0.299 . . . . 0.0 110.852 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.89 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 1.8 p -65.18 131.55 46.82 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.142 176.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -80.59 12.31 3.18 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.383 0.611 . . . . 0.0 112.067 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -92.66 112.16 24.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.649 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -100.05 -24.09 14.7 Favored 'General case' 0 C--O 1.221 -0.419 0 O-C-N 123.855 0.722 . . . . 0.0 109.316 -179.435 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -47.49 138.85 8.57 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.707 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.47 -21.82 69.48 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.453 2.102 . . . . 0.0 111.464 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.559 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 93.3 t -66.7 -36.91 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.436 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.668 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 82.1 t60 -58.66 -38.26 77.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.293 174.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -87.56 -4.99 58.95 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.923 -176.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -85.71 -24.48 26.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.039 -0.413 . . . . 0.0 110.465 178.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -110.96 -23.76 10.77 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.493 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -120.27 129.03 53.86 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.597 0.713 . . . . 0.0 111.997 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.583 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 11.8 p -82.17 157.84 23.84 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.365 175.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.408 ' H ' ' HB3' ' A' ' 401' ' ' ASP . 58.9 m80 -136.09 162.2 58.01 Favored Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -170.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.07 100.63 0.08 OUTLIER 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.778 2.318 . . . . 0.0 111.059 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 109.54 24.33 5.92 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.476 -174.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . 0.433 ' CG ' HH21 ' A' ' 376' ' ' ARG . 20.7 t70 -119.97 150.5 40.42 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 122.303 0.241 . . . . 0.0 110.478 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 17.7 t -54.37 -41.1 68.78 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.277 0.631 . . . . 0.0 111.791 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -104.08 16.41 26.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.759 -167.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -72.5 154.43 40.83 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.531 0.205 . . . . 0.0 110.603 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -146.15 -55.36 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.096 -1.049 . . . . 0.0 110.939 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 65.26 22.11 68.88 Favored Glycine 0 C--O 1.238 0.347 0 CA-C-O 119.935 -0.369 . . . . 0.0 112.911 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 24.9 m -106.97 -11.43 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 121.939 0.876 . . . . 0.0 111.436 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . 0.521 ' O ' ' HG2' ' A' ' 412' ' ' GLN . 6.7 tt0 -83.45 151.49 25.44 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.487 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 20.2 pt -48.53 -46.08 14.7 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-O 122.066 0.936 . . . . 0.0 109.75 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.506 HG11 ' HB3' ' A' ' 380' ' ' MET . 48.5 t -75.59 82.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 172.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.591 ' HA2' ' HA ' ' A' ' 380' ' ' MET . . . 147.55 -48.17 0.65 Allowed Glycine 0 C--O 1.243 0.719 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.183 177.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 4.2 pt20 -83.11 -47.21 11.88 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 117.16 0.48 . . . . 0.0 109.733 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 10.8 t70 178.18 148.06 0.17 Allowed 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -75.57 -11.29 59.99 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 123.501 0.5 . . . . 0.0 111.76 -172.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 24.5 p -72.56 141.84 48.43 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.953 0.883 . . . . 0.0 111.574 -176.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.461 ' HB2' ' HD3' ' A' ' 439' ' ' ARG . 2.1 m-20 -68.43 -39.75 81.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.072 -177.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 12.0 t70 81.98 50.81 0.02 OUTLIER 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.0 -174.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -153.25 158.59 32.77 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.026 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.414 ' O ' ' HA ' ' A' ' 438' ' ' TYR . 80.4 Cg_exo -48.03 141.85 16.63 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.89 2.394 . . . . 0.0 112.69 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -83.27 143.2 30.56 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.753 ' SG ' 'ZN ' ' A' ' 450' ' ' ' ZN' . 34.8 t -59.61 126.96 84.18 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.22 7.12 1.21 Allowed 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.576 2.184 . . . . 0.0 112.835 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -120.31 5.1 10.73 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 64.9 -162.99 38.05 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.6 -15.34 27.4 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.008 2.472 . . . . 0.0 112.489 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 40.4 t -70.52 -13.16 62.0 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.044 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' CYS . . . . . 0.788 ' SG ' 'ZN ' ' A' ' 450' ' ' ' ZN' . 46.6 t -48.66 118.02 2.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.836 0.854 . . . . 0.0 110.612 -178.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -113.84 18.41 17.38 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 122.899 0.479 . . . . 0.0 109.918 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.417 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 4.3 mmp_? -66.52 96.58 0.38 Allowed 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.798 175.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . 0.683 ' HB2' ' HZ3' ' A' ' 430' ' ' LYS . 10.1 mtmp? -69.05 93.55 0.59 Allowed 'General case' 0 C--O 1.241 0.614 0 O-C-N 123.371 0.419 . . . . 0.0 110.283 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . 0.45 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 54.6 t30 -157.9 122.91 2.3 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.463 ' O ' HG13 ' A' ' 436' ' ' ILE . 33.4 Cg_endo -63.43 -35.74 59.29 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.487 2.125 . . . . 0.0 112.056 -177.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.621 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 23.4 tp60 -68.45 -41.62 79.97 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -175.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . 0.607 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 5.0 t60 -56.2 -51.2 68.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.433 0.635 . . . . 0.0 110.132 178.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -67.18 -13.76 62.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.402 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 432' ' ' PRO . 40.2 mt -89.84 -34.87 6.94 Favored 'Isoleucine or valine' 0 C--O 1.251 1.153 0 C-N-CA 122.704 0.402 . . . . 0.0 110.146 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.621 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 27.9 mt-10 -83.77 -45.54 13.22 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.298 0.571 . . . . 0.0 111.12 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 419' ' ' PRO . 19.1 m-85 -103.32 147.1 27.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.229 -174.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' ARG . . . . . 0.461 ' HD3' ' HB2' ' A' ' 416' ' ' ASP . 17.0 ptt180 -93.69 114.02 26.23 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.589 177.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.459 ' CD2' ' HB3' ' A' ' 427' ' ' CYS . 79.6 m80 -81.66 85.01 6.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' ASN . . . . . 0.409 HD22 ' NH1' ' A' ' 439' ' ' ARG . 89.0 m-20 -67.32 103.57 1.3 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.361 -173.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 1.5 m -104.47 159.35 15.81 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.132 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.551 HD11 ' HB ' ' A' ' 445' ' ' VAL . 0.5 OUTLIER -135.75 144.83 50.48 Favored Pre-proline 0 C--N 1.32 -0.684 0 O-C-N 121.66 -0.65 . . . . 0.0 111.828 -176.061 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -64.22 -29.21 64.34 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.435 2.757 . . . . 0.0 110.834 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.551 ' HB ' HD11 ' A' ' 443' ' ' LEU . 7.3 p 35.9 69.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 124.823 1.327 . . . . 0.0 110.591 -175.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -56.68 157.34 5.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.455 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -66.78 -26.77 67.12 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.104 0.877 . . . . 0.0 110.54 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.472 0.668 0 O-C-N 123.273 0.358 . . . . 0.0 110.917 179.432 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' ' ZN' . . . . . 0.773 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' ' ZN' . . . . . 0.788 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.859 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 10.0 p -163.28 132.96 4.21 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -122.57 58.1 1.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -65.9 126.55 28.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 40.8 p -91.49 139.03 31.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.337 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.38 89.69 0.06 Allowed 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 12.5 t -79.1 80.49 5.45 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.892 0.854 . . . . 0.0 110.876 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.9 p -72.49 112.17 7.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.428 174.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.2 pp -142.88 2.86 1.38 Allowed 'General case' 0 C--O 1.244 0.768 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -170.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -47.13 147.85 1.34 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-O 120.483 0.182 . . . . 0.0 111.295 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -63.52 149.58 50.12 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 116.433 -0.349 . . . . 0.0 112.909 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 34.0 m -131.2 3.42 4.32 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 121.147 0.499 . . . . 0.0 109.949 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.07 -0.86 57.57 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.782 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 78.58 23.48 64.79 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.262 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -135.93 158.31 44.71 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 122.668 0.387 . . . . 0.0 110.403 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.588 ' HG2' HG13 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -84.91 -13.04 52.06 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 122.118 -0.364 . . . . 0.0 110.133 176.744 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . 0.588 HG13 ' HG2' ' A' ' 373' ' ' LYS . 28.5 m -130.96 158.84 43.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.173 0.511 . . . . 0.0 110.116 177.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.99 154.39 27.72 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 170.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . 0.56 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.8 OUTLIER -69.5 148.42 49.52 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-O 122.039 0.923 . . . . 0.0 110.683 -175.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 5.4 t -96.2 153.65 17.68 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.233 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.1 m -64.22 122.67 17.2 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.075 0.464 . . . . 0.0 111.166 -170.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.973 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 15.4 t -49.92 123.61 8.42 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.729 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' MET . . . . . 0.451 ' O ' HG12 ' A' ' 410' ' ' VAL . 20.8 ptm -56.0 -29.47 60.36 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.217 0.532 . . . . 0.0 111.072 -172.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.536 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 39.2 m-85 -98.73 -14.85 19.58 Favored 'General case' 0 C--O 1.255 1.391 0 CA-C-O 119.051 -0.5 . . . . 0.0 110.439 176.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 62.49 -107.51 1.65 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -84.3 -13.71 51.73 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 381' ' ' TYR . 38.9 m-80 -81.49 -26.01 35.55 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -174.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.973 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.4 p -66.65 113.89 5.15 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.035 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -85.49 9.48 15.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.935 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 387' ' ' ARG . 27.8 mmt180 -62.46 134.13 55.99 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.957 176.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.418 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.3 OUTLIER -118.97 -7.64 10.36 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 124.105 0.878 . . . . 0.0 110.406 -171.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -67.47 137.09 93.33 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.057 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -60.68 -30.67 90.89 Favored 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 121.576 1.517 . . . . 0.0 110.946 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.418 HG13 ' NE2' ' A' ' 395' ' ' HIS . 87.9 t -59.17 -40.68 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.896 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.691 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 85.6 t60 -54.95 -43.9 73.85 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 120.771 0.319 . . . . 0.0 110.441 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -82.23 -25.15 34.4 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.493 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -66.67 -27.88 68.01 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.686 0.279 . . . . 0.0 110.783 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.632 ' HD1' ' HD1' ' A' ' 396' ' ' PHE . 1.1 p80 -119.09 -3.98 10.6 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.632 ' HD1' ' HD1' ' A' ' 395' ' ' HIS . 39.6 m-85 -139.33 126.59 21.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.442 0.639 . . . . 0.0 109.989 177.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.56 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 70.7 m -83.46 158.63 21.98 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 123.261 0.624 . . . . 0.0 111.031 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.614 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 27.0 m80 -127.65 162.03 51.62 Favored Pre-proline 0 C--O 1.222 -0.354 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 14.8 Cg_endo -55.11 106.34 0.18 Allowed 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 121.829 1.686 . . . . 0.0 111.219 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 120.03 -1.14 13.28 Favored Glycine 0 C--N 1.319 -0.368 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.47 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -94.98 148.98 21.74 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.7 t -62.48 -30.4 71.23 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.402 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.435 ' HB2' ' HG ' ' A' ' 397' ' ' SER . 0.9 OUTLIER -96.99 2.4 51.46 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 110.726 -174.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -80.52 140.29 35.93 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.591 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -168.93 25.51 0.11 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.579 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 52.66 43.98 59.85 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.778 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 19.5 m -74.9 -10.79 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.302 0.573 . . . . 0.0 109.766 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -122.38 136.66 54.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.441 HG13 HG21 ' A' ' 410' ' ' VAL . 13.0 pt -55.53 -47.93 78.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.3 0.571 . . . . 0.0 110.671 176.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.593 ' HA ' ' HG2' ' A' ' 414' ' ' GLU . 13.3 t -70.27 113.88 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.872 177.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 130.75 -40.6 1.63 Allowed Glycine 0 N--CA 1.443 -0.866 0 O-C-N 123.839 0.712 . . . . 0.0 111.691 -173.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.41 -43.89 4.23 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 122.918 0.487 . . . . 0.0 110.711 178.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -167.91 124.94 1.12 Allowed 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.004 0.522 . . . . 0.0 109.804 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . 0.593 ' HG2' ' HA ' ' A' ' 410' ' ' VAL . 21.1 mt-10 -101.28 0.1 36.69 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 122.646 0.378 . . . . 0.0 111.985 -170.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 41.4 p -133.99 -77.17 0.47 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.063 0.458 . . . . 0.0 111.501 -170.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.8 t70 177.39 -42.95 0.01 OUTLIER 'General case' 0 C--O 1.241 0.636 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -172.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 21.7 t70 175.32 -27.75 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.66 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . 0.406 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 24.1 ptt180 -138.17 165.67 31.61 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.977 -174.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 62.1 Cg_endo -75.72 162.52 35.15 Favored 'Trans proline' 0 C--O 1.244 0.783 0 C-N-CA 121.221 1.281 . . . . 0.0 110.957 177.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.64 158.27 33.92 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.689 0.757 . . . . 0.0 109.502 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 6.6 t -65.86 136.7 95.81 Favored Pre-proline 0 N--CA 1.453 -0.305 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 175.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.17 -16.92 42.95 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.269 1.313 . . . . 0.0 112.772 -177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -115.11 15.71 17.08 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.851 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 57.72 -152.03 27.97 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.995 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.45 -14.8 34.24 Favored 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 121.973 1.782 . . . . 0.0 111.535 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 19.9 t -82.08 2.2 32.33 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.92 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 49.8 t -60.25 124.17 19.46 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.362 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -121.56 66.42 0.89 Allowed 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.563 0.697 . . . . 0.0 110.117 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.426 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 2.3 mmp_? -108.8 108.79 19.73 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . 0.754 ' HZ2' ' HB2' ' A' ' 430' ' ' LYS . 4.8 ttmp? -70.13 82.06 0.51 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.057 -0.402 . . . . 0.0 110.741 -176.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -166.36 123.99 1.04 Allowed Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 123.012 0.525 . . . . 0.0 110.247 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.527 ' O ' HG13 ' A' ' 436' ' ' ILE . 42.6 Cg_endo -68.2 -32.56 26.76 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.088 1.859 . . . . 0.0 112.3 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.635 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 23.6 tp60 -68.94 -36.23 77.72 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.935 -0.478 . . . . 0.0 109.845 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . 0.636 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 39.9 t60 -53.59 -56.1 20.02 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.023 0.916 . . . . 0.0 110.579 176.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.409 ' HA ' ' HE1' ' A' ' 440' ' ' HIS . 24.2 mtpp -60.46 -16.51 37.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.761 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 432' ' ' PRO . 58.1 mt -87.81 -28.86 5.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.426 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.635 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 29.1 mt-10 -90.33 -32.95 16.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.757 -175.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -114.39 129.75 56.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.13 0.491 . . . . 0.0 109.818 -174.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 419' ' ' PRO . 15.7 ptt180 -79.13 118.9 21.53 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.007 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.409 ' HE1' ' HA ' ' A' ' 435' ' ' LYS . 66.5 m80 -98.96 90.58 4.68 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -67.3 107.75 2.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.655 0.74 . . . . 0.0 110.452 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 1.3 p -99.32 122.89 43.08 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.252 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.401 ' CD1' ' HB ' ' A' ' 445' ' ' VAL . 0.4 OUTLIER -133.16 157.09 79.13 Favored Pre-proline 0 C--O 1.215 -0.711 0 O-C-N 123.933 0.771 . . . . 0.0 110.02 -173.51 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.17 -37.68 96.17 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 121.713 1.609 . . . . 0.0 111.584 -174.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.401 ' HB ' ' CD1' ' A' ' 443' ' ' LEU . 5.3 p 46.84 20.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.051 1.34 . . . . 0.0 112.633 177.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.413 ' HB3' HG21 ' A' ' 448' ' ' VAL . 47.0 mmt-85 -68.79 128.99 38.63 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.379 -0.826 . . . . 0.0 110.452 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -84.39 -17.53 39.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.393 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . 0.413 HG21 ' HB3' ' A' ' 446' ' ' ARG . 34.5 m . . . . . 0 C--O 1.237 0.406 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.067 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' ' ZN' . . . . . 0.799 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' ' ZN' . . . . . 0.746 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.753 0 CA-C-O 119.954 -0.359 . . . . 0.0 112.262 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 7.1 p -68.76 98.5 0.92 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 117.534 0.667 . . . . 0.0 110.063 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -109.77 91.98 3.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.523 0.678 . . . . 0.0 109.878 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -146.25 113.0 6.02 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.749 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 42.1 p -70.74 133.72 46.83 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.801 0.688 . . . . 0.0 112.269 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -98.57 -11.88 21.72 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.029 177.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 50.2 m 74.21 -40.16 0.44 Allowed 'General case' 0 C--O 1.249 1.057 0 C-N-CA 124.267 1.027 . . . . 0.0 110.625 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 23.7 t -76.82 80.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.779 0.799 . . . . 0.0 110.17 175.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -60.85 -25.92 66.99 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.896 -176.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -80.89 -17.47 50.51 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 93.79 132.67 6.49 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.81 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 34.1 t -83.28 9.16 11.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.793 0.33 . . . . 0.0 110.632 -176.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -69.6 111.32 5.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.376 0.608 . . . . 0.0 110.96 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -100.0 -135.07 8.76 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.024 -0.989 . . . . 0.0 113.053 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -161.85 151.65 16.6 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 117.868 0.834 . . . . 0.0 111.399 -169.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' LYS . . . . . 0.435 ' HD3' ' H ' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -99.69 11.98 37.79 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 123.914 0.759 . . . . 0.0 110.791 -179.086 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 25.2 m -125.23 162.98 26.84 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 119.359 -0.353 . . . . 0.0 110.859 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -122.14 166.84 13.93 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 123.993 0.808 . . . . 0.0 109.605 175.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.46 169.48 10.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.57 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 6.2 t -130.89 165.71 22.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.816 175.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 411' ' ' GLY . 16.4 m -59.53 113.02 2.0 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -172.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 49.1 t -52.55 114.9 1.53 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' MET . . . . . 0.551 ' HA ' ' O ' ' A' ' 410' ' ' VAL . 26.7 ptm -53.29 -26.94 20.38 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.239 -173.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' TYR . . . . . 0.44 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 91.1 m-85 -91.73 -25.43 19.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 61.55 -115.9 8.58 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.116 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' ALA . . . . . 0.405 ' HB3' ' HG3' ' A' ' 399' ' ' PRO . . . -79.37 -6.25 56.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.919 0.39 . . . . 0.0 111.086 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -87.87 -28.68 21.43 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -173.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 4.8 p -71.39 129.65 39.34 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -94.42 17.22 13.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.449 -174.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -70.26 145.27 51.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' LYS . . . . . 0.444 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -130.52 -1.08 4.4 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.086 0.469 . . . . 0.0 110.136 178.388 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -76.89 134.76 68.1 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.57 -20.49 70.88 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.716 2.277 . . . . 0.0 111.467 -173.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.579 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 59.2 t -66.21 -44.32 91.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.745 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' HIS . . . . . 0.594 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 84.3 t60 -57.47 -28.01 62.99 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.027 0.441 . . . . 0.0 110.111 178.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 81.6 m-85 -96.47 -13.9 22.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.879 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.579 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -76.46 -18.68 58.66 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.617 -176.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' HIS . . . . . 0.548 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 6.8 p80 -122.81 -21.66 5.52 Favored 'General case' 0 C--O 1.245 0.816 0 O-C-N 123.167 0.292 . . . . 0.0 111.698 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' PHE . . . . . 0.548 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 48.0 m-85 -128.11 126.82 41.9 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 117.799 0.272 . . . . 0.0 111.044 176.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.483 ' HG ' ' HB2' ' A' ' 403' ' ' ASP . 68.9 m -87.88 165.17 15.46 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.415 0.626 . . . . 0.0 111.238 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' HIS . . . . . 0.672 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 42.7 m80 -132.72 164.56 42.86 Favored Pre-proline 0 C--O 1.233 0.23 0 C-N-CA 123.173 0.589 . . . . 0.0 110.117 -174.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 19.0 Cg_endo -55.03 93.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.072 2.515 . . . . 0.0 111.152 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 132.58 15.3 1.42 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.07 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' A' ' 397' ' ' SER . 17.5 t70 -121.46 149.11 43.53 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 34.7 t -63.24 -33.01 74.56 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.481 0.312 . . . . 0.0 111.114 -174.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' ASP . . . . . 0.483 ' HB2' ' HG ' ' A' ' 397' ' ' SER . 1.5 m-20 -90.73 9.73 28.79 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.188 0.518 . . . . 0.0 111.288 -175.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -91.82 129.25 37.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.343 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -156.07 9.04 0.28 Allowed Glycine 0 CA--C 1.505 -0.574 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.675 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 60.06 41.91 98.21 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.365 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.9 m -70.69 -18.76 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 115.096 -0.552 . . . . 0.0 110.247 -177.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -125.36 126.95 45.84 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.216 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 3.0 pt -49.57 -48.06 20.39 Favored 'Isoleucine or valine' 0 C--N 1.353 0.748 0 C-N-CA 122.941 0.497 . . . . 0.0 110.539 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 380' ' ' MET . 5.9 t -78.89 81.58 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 172.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' ' 378' ' ' SER . . . 160.8 28.22 0.02 OUTLIER Glycine 0 CA--C 1.495 -1.178 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.634 -172.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' GLN . . . . . 0.415 ' O ' ' HB2' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -179.27 -50.45 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -176.24 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 412' ' ' GLN . 53.7 t0 172.68 131.65 0.02 OUTLIER 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.778 1.231 . . . . 0.0 108.939 175.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.39 -1.23 52.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.971 -171.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' THR . . . . . 0.614 HG23 ' HA ' ' A' ' 419' ' ' PRO . 41.6 p -60.12 131.81 52.0 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -70.76 -64.79 0.83 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.204 171.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -142.85 10.61 1.79 Allowed 'General case' 0 C--N 1.347 0.465 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -173.2 159.23 3.39 Favored Pre-proline 0 C--O 1.242 0.683 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.579 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.614 ' HA ' HG23 ' A' ' 415' ' ' THR . 55.4 Cg_endo -68.56 154.8 70.88 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.029 2.486 . . . . 0.0 112.38 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -74.54 143.35 44.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.894 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' CYS . . . . . 0.939 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 11.6 t -57.84 133.68 83.2 Favored Pre-proline 0 C--N 1.317 -0.829 0 O-C-N 123.8 0.687 . . . . 0.0 109.571 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.7 -16.09 46.33 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 121.79 1.66 . . . . 0.0 113.092 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' TYR . . . . . 0.501 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 29.3 m-85 -112.94 12.58 19.38 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 122.732 0.413 . . . . 0.0 110.033 179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 56.57 -148.76 29.97 Favored Glycine 0 C--O 1.248 1.006 0 C-N-CA 121.321 -0.466 . . . . 0.0 113.162 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.18 -14.23 28.64 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.883 2.388 . . . . 0.0 112.044 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 34.1 t -76.04 -10.49 59.46 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.609 177.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' CYS . . . . . 0.939 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 51.2 t -58.33 118.48 5.58 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.37 177.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -119.49 22.58 11.63 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 124.101 0.876 . . . . 0.0 109.774 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' ARG . . . . . 0.759 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 0.5 OUTLIER -63.74 109.41 1.7 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -71.51 94.55 1.3 Allowed 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.674 0.608 . . . . 0.0 111.151 -177.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . 0.443 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 63.3 t30 -169.47 124.88 0.73 Allowed Pre-proline 0 N--CA 1.469 0.481 0 O-C-N 124.437 1.086 . . . . 0.0 108.832 176.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.535 ' O ' HG13 ' A' ' 436' ' ' ILE . 34.3 Cg_endo -65.45 -33.58 46.45 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.39 2.06 . . . . 0.0 111.53 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' GLN . . . . . 0.581 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 24.2 tp60 -68.6 -32.3 72.09 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.07 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . 0.723 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 41.8 t60 -62.71 -58.22 8.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.484 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -55.36 -19.74 9.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.501 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 432' ' ' PRO . 64.5 mt -80.64 -42.64 20.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 O-C-N 123.724 0.64 . . . . 0.0 109.812 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.581 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 22.3 mt-10 -78.74 -46.97 17.74 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 -174.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -106.45 135.36 48.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.43 0.633 . . . . 0.0 110.678 -174.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 419' ' ' PRO . 16.0 ptt180 -84.78 133.85 34.34 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.55 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -107.12 85.68 2.18 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.247 0.546 . . . . 0.0 109.853 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -70.65 117.65 12.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.673 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 1.9 m -129.81 152.73 48.99 Favored 'General case' 0 C--O 1.247 0.926 0 O-C-N 123.712 0.632 . . . . 0.0 110.412 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' LEU . . . . . 0.401 ' O ' HD11 ' A' ' 443' ' ' LEU . 1.1 pp -106.22 154.85 39.42 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' PRO . . . . . 0.443 ' O ' HG12 ' A' ' 445' ' ' VAL . 12.7 Cg_endo -55.46 -39.71 89.55 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.475 2.117 . . . . 0.0 112.981 -173.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 444' ' ' PRO . 4.4 p 49.42 21.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 124.497 1.123 . . . . 0.0 111.277 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' ARG . . . . . 0.457 ' HG3' ' ND2' ' A' ' 447' ' ' ASN . 28.3 tpt180 -137.82 149.78 46.63 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -176.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . 0.457 ' ND2' ' HG3' ' A' ' 446' ' ' ARG . 59.7 m-80 65.5 20.28 11.67 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.902 0.881 . . . . 0.0 111.056 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 CA--C 1.542 0.67 0 CA-C-O 120.918 0.39 . . . . 0.0 110.867 -177.377 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' ' ZN' . . . . . 0.764 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' ' ZN' . . . . . 0.737 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.545 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 2.6 mpp_? . . . . . 0 C--O 1.236 0.385 0 CA-C-O 121.116 0.484 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 395' ' ' HIS . 4.9 t -98.14 141.09 31.5 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.985 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.3 t -55.96 121.34 9.1 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 123.071 0.232 . . . . 0.0 111.412 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.655 ' SG ' ' NE2' ' A' ' 398' ' ' HIS . 10.6 t -54.18 103.02 0.07 Allowed 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 172.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 20.9 ptm -49.78 -27.64 5.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.836 0.71 . . . . 0.0 111.845 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.567 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 28.9 m-85 -93.68 -19.42 21.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.669 -0.644 . . . . 0.0 111.355 176.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.507 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 64.94 -126.17 31.39 Favored Glycine 0 CA--C 1.501 -0.809 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -80.59 0.29 34.66 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.928 0.394 . . . . 0.0 111.531 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -94.18 -7.29 42.65 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.062 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.697 ' SG ' ' NE2' ' A' ' 392' ' ' HIS . 7.6 p -74.49 128.09 34.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.371 0.605 . . . . 0.0 110.141 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -81.98 2.99 28.25 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.873 -175.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -87.82 115.92 25.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.697 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.443 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -117.42 2.35 12.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.01 0.91 . . . . 0.0 109.855 -177.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -63.15 136.57 96.75 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.678 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.69 -28.9 48.91 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.138 2.558 . . . . 0.0 112.921 -173.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.509 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 53.3 t -61.93 -37.04 77.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.338 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.725 ' HE2' ' HE2' ' A' ' 398' ' ' HIS . 72.7 t60 -58.42 -29.14 65.87 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.349 0.595 . . . . 0.0 110.997 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -93.3 -18.5 22.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.49 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -74.86 -20.04 59.91 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.374 0.607 . . . . 0.0 110.972 -175.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.467 ' O ' HG22 ' A' ' 377' ' ' THR . 7.2 p80 -121.57 -15.87 7.9 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.313 -0.867 . . . . 0.0 111.554 176.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 377' ' ' THR . 59.1 m-85 -121.07 136.78 54.91 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.135 0.493 . . . . 0.0 112.016 173.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.545 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 19.6 m -93.17 149.86 20.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.661 176.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.725 ' HE2' ' HE2' ' A' ' 392' ' ' HIS . 37.9 m80 -124.96 160.64 53.37 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -175.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 25.7 Cg_endo -59.34 93.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.315 2.01 . . . . 0.0 111.446 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 144.41 -13.05 2.04 Favored Glycine 0 CA--C 1.507 -0.443 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -84.02 145.84 28.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.132 -0.534 . . . . 0.0 110.735 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 16.0 m -66.9 -26.38 66.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.084 176.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -86.68 -4.16 59.14 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.756 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 57.5 t80 . . . . . 0 C--O 1.237 0.413 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.575 -178.352 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 22.6 t70 . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 121.359 0.599 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.5 -25.15 0.1 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.004 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.792 ' HG3' ' HG2' ' A' ' 439' ' ' ARG . 16.3 ptt180 -158.99 170.2 9.31 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 119.4 -0.334 . . . . 0.0 110.893 -168.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 23.3 Cg_endo -61.38 151.34 80.14 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.192 1.928 . . . . 0.0 111.926 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 420' ' ' GLU . . . . . 0.631 ' HG2' ' HE ' ' A' ' 439' ' ' ARG . 44.1 mt-10 -87.67 142.29 27.95 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.998 0.428 . . . . 0.0 110.918 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 9.3 t -66.75 121.7 78.81 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.68 -10.46 24.79 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.67 2.247 . . . . 0.0 112.076 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -104.55 -3.41 23.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.57 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 69.39 -152.04 51.49 Favored Glycine 0 C--O 1.223 -0.559 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.352 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -76.18 -11.69 19.35 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.8 2.334 . . . . 0.0 111.216 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 32.1 t -85.09 8.14 19.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.238 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 36.5 t -60.17 117.29 4.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.613 0.721 . . . . 0.0 110.851 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -100.16 11.52 39.15 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.311 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.681 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 0.7 OUTLIER -66.41 109.31 2.68 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.264 176.432 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -85.02 86.81 7.35 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.35 0.66 . . . . 0.0 110.533 -172.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' ASN . . . . . 0.494 HD21 ' HB3' ' A' ' 433' ' ' GLN . 65.0 t30 -166.45 125.69 1.14 Allowed Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 122.559 0.344 . . . . 0.0 110.874 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.454 ' O ' HG13 ' A' ' 436' ' ' ILE . 29.8 Cg_endo -64.67 -35.45 46.81 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.752 1.635 . . . . 0.0 111.864 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.63 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 6.7 tp-100 -64.58 -37.66 88.34 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.358 0.599 . . . . 0.0 110.909 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 434' ' ' HIS . . . . . 0.677 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.6 t60 -57.93 -51.51 69.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.652 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.452 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 24.8 mtpp -58.77 -23.8 60.67 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.716 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 432' ' ' PRO . 82.0 mt -80.31 -36.92 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.194 0.521 . . . . 0.0 110.414 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.63 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 24.0 mt-10 -84.34 -34.79 23.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.346 -173.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 438' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 419' ' ' PRO . 57.2 m-85 -108.75 154.87 21.43 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.686 -174.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 439' ' ' ARG . . . . . 0.792 ' HG2' ' HG3' ' A' ' 418' ' ' ARG . 11.9 mtm180 -91.37 120.03 31.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.705 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 78.6 m80 -92.4 78.54 5.03 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 173.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 441' ' ' ASN . . . . . 0.623 HD21 ' NH2' ' A' ' 439' ' ' ARG . 1.7 m-20 -63.37 106.28 0.88 Allowed 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 113.818 -1.537 . . . . 0.0 110.505 -171.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.95 138.36 31.48 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.52 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.8 OUTLIER -108.44 144.93 30.5 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.287 -174.492 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.61 -44.18 18.58 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.392 2.061 . . . . 0.0 111.342 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.52 ' HB ' HD13 ' A' ' 443' ' ' LEU . 8.2 p 41.85 27.73 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 124.686 1.242 . . . . 0.0 110.81 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.46 158.12 16.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 -174.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -116.03 79.76 1.35 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.725 0.774 . . . . 0.0 110.016 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.471 0.6 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.526 -179.812 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.584 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.212 0 N-CA-C 111.373 0.138 . . . . 0.0 111.373 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.467 HG23 ' CD1' ' A' ' 396' ' ' PHE . 9.7 t -108.2 163.3 13.29 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.06 0.85 . . . . 0.0 109.49 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 16.2 m -62.24 119.52 9.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.981 0.896 . . . . 0.0 111.764 -174.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.789 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 33.7 t -52.71 119.48 4.61 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.849 0.86 . . . . 0.0 109.114 174.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 26.3 ptm -56.24 -23.73 37.84 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.327 0.584 . . . . 0.0 111.952 -173.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 34.6 m-85 -104.96 -16.18 14.91 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.244 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.432 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 64.91 -121.71 22.43 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.6 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 383' ' ' ALA . . . . . 0.446 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -82.88 4.7 24.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.927 0.363 . . . . 0.0 111.132 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -96.6 -14.7 22.0 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.789 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 1.8 p -73.58 127.12 31.87 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.561 -0.712 . . . . 0.0 110.732 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -81.58 -4.92 57.38 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.084 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -60.05 128.21 35.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.538 0.685 . . . . 0.0 109.623 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.617 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.2 OUTLIER -112.05 -15.71 13.22 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.56 -173.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -62.83 134.76 95.66 Favored Pre-proline 0 C--O 1.243 0.73 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.578 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.59 -22.85 75.45 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.501 2.134 . . . . 0.0 111.343 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.596 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 77.8 t -62.92 -35.9 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.214 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.71 ' HE2' ' HE2' ' A' ' 398' ' ' HIS . 83.9 t60 -61.43 -30.58 70.66 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.285 0.365 . . . . 0.0 110.339 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 54.6 m-85 -90.27 -24.79 20.82 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.749 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.596 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -71.1 -20.23 62.37 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.804 -175.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.563 ' ND1' ' HD2' ' A' ' 396' ' ' PHE . 1.9 p80 -119.68 -11.98 9.33 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.563 ' HD2' ' ND1' ' A' ' 395' ' ' HIS . 63.1 m-85 -138.52 126.55 22.62 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 177.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.584 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 58.0 m -86.73 160.66 18.76 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.355 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.713 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 32.4 m80 -127.83 165.63 28.97 Favored Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.668 -173.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.446 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 50.2 Cg_exo -54.74 -2.56 0.2 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 123.488 2.792 . . . . 0.0 114.152 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -119.15 13.11 11.29 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 111.964 -0.455 . . . . 0.0 111.964 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -121.85 131.08 53.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.9 t -62.57 -20.63 64.9 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -170.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.18 -7.52 59.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.405 0.621 . . . . 0.0 110.986 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 39.0 t80 . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.61 176.085 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 417' ' ' ASP . 19.4 t70 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.627 0.251 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.458 ' HB3' ' O ' ' A' ' 416' ' ' ASP . 9.0 t0 78.07 79.04 0.07 Allowed 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.838 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.455 ' HG3' ' CG ' ' A' ' 439' ' ' ARG . 14.7 ptt180 -178.48 157.23 1.02 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.867 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.26 147.02 94.18 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.299 2.0 . . . . 0.0 111.342 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -73.74 159.23 33.26 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' CYS . . . . . 0.908 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 7.8 t -64.22 132.27 95.27 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.4 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.88 -12.02 29.8 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.371 2.047 . . . . 0.0 112.256 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 37.0 m-85 -106.47 11.79 30.34 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.087 0.555 . . . . 0.0 110.709 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 56.6 -153.22 20.04 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.621 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.99 -9.9 19.51 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.335 2.023 . . . . 0.0 110.817 176.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 35.9 t -70.71 -14.85 62.61 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 173.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' CYS . . . . . 0.908 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 54.0 t -52.43 117.36 2.8 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.143 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -116.31 19.69 14.67 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.542 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 1.7 mmp_? -63.97 103.12 0.55 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.887 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -77.63 105.58 8.88 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.784 0.677 . . . . 0.0 109.69 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' ASN . . . . . 0.528 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 62.7 t30 -178.36 127.75 0.28 Allowed Pre-proline 0 C--O 1.244 0.768 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.933 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.528 ' HD2' ' OD1' ' A' ' 431' ' ' ASN . 19.9 Cg_endo -58.72 -44.55 35.5 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.339 2.692 . . . . 0.0 111.61 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.45 ' HB3' ' ND2' ' A' ' 431' ' ' ASN . 6.3 tp-100 -59.47 -34.12 72.16 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 120.973 0.415 . . . . 0.0 110.398 -177.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' HIS . . . . . 0.782 ' CE1' ' HG ' ' A' ' 421' ' ' CYS . 61.9 t60 -63.06 -62.31 1.79 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.742 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -60.33 -15.34 24.59 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 432' ' ' PRO . 60.1 mt -75.85 -47.22 33.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.834 174.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -78.54 -45.47 21.77 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.887 -0.508 . . . . 0.0 112.238 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -107.32 155.39 20.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.824 -0.548 . . . . 0.0 112.239 -171.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' ARG . . . . . 0.455 ' CG ' ' HG3' ' A' ' 418' ' ' ARG . 54.2 mtm180 -94.25 153.53 17.99 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.636 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.586 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 75.2 m80 -128.97 80.42 1.97 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 175.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -84.03 139.09 32.74 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.004 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 3.9 p -101.75 130.19 48.1 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 123.311 0.382 . . . . 0.0 111.873 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 443' ' ' LEU . 1.3 pp -108.79 151.01 41.55 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.3 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -63.27 -30.39 73.73 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 C-N-CA 122.075 1.85 . . . . 0.0 112.216 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.2 p 44.27 31.0 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 C-N-CA 124.847 1.259 . . . . 0.0 111.691 -177.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -87.96 165.35 15.28 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.939 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -43.71 -58.35 2.74 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.895 0.878 . . . . 0.0 111.029 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--N 1.343 0.308 0 C-N-CA 122.583 0.353 . . . . 0.0 111.054 -177.0 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.42 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.4 OUTLIER . . . . . 0 C--O 1.241 0.618 0 CA-C-O 121.339 0.59 . . . . 0.0 111.591 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 6.0 t -115.11 152.01 33.31 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 173.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 49.3 m -55.54 123.69 14.82 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.979 0.799 . . . . 0.0 112.032 -172.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 26.5 t -60.36 118.49 6.5 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 22.7 ptm -54.66 -33.49 60.78 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-O 121.464 0.649 . . . . 0.0 111.388 -175.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.578 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 41.3 m-85 -96.92 -10.49 26.27 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.579 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.531 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 62.38 -129.09 42.44 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' ALA . . . . . 0.421 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -80.28 -3.33 48.91 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.063 0.459 . . . . 0.0 111.182 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -84.63 -16.48 41.85 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.227 -175.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 3.0 p -69.43 141.03 54.15 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.451 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -78.93 9.34 4.37 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 122.791 0.437 . . . . 0.0 111.461 -174.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -93.79 111.18 22.83 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.671 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.441 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -105.59 -21.3 13.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.212 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -46.98 131.41 8.88 Favored Pre-proline 0 C--O 1.238 0.451 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.959 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.49 -25.53 58.81 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 123.749 2.966 . . . . 0.0 111.602 -174.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.516 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 64.6 t -65.8 -34.7 72.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.279 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.647 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 73.3 t60 -59.87 -26.5 65.91 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.301 -0.875 . . . . 0.0 110.088 175.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 38.4 m-85 -93.68 -5.49 48.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.586 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -88.67 -23.14 23.09 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.046 -178.026 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.43 ' HD2' ' HG3' ' A' ' 394' ' ' GLN . 4.9 p80 -116.02 -18.68 10.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.067 0.46 . . . . 0.0 111.913 175.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 393' ' ' PHE . 69.2 m-85 -125.29 128.51 48.35 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.761 174.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' A' ' 404' ' ' TYR . 14.2 p -80.26 159.04 26.01 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.477 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.704 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 53.7 m80 -139.53 158.15 68.97 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.868 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.421 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 10.6 Cg_endo -51.07 107.9 0.2 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 121.887 1.725 . . . . 0.0 110.379 -177.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 118.45 0.81 15.97 Favored Glycine 0 C--N 1.316 -0.552 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.698 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ASP . . . . . 0.428 ' HB3' ' HB2' ' A' ' 404' ' ' TYR . 20.1 t70 -97.63 141.82 30.19 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 123.04 0.536 . . . . 0.0 109.864 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 43.4 t -58.9 -26.18 64.08 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.939 0.774 . . . . 0.0 111.505 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -110.84 19.47 18.53 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.773 -174.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' TYR . . . . . 0.452 ' HB2' ' HB2' ' A' ' 397' ' ' SER . 63.5 t80 . . . . . 0 C--O 1.237 0.398 0 O-C-N 121.605 -0.684 . . . . 0.0 110.446 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 21.3 t70 . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -175.15 -32.34 0.01 OUTLIER 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.74 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 23.1 ptt180 -128.6 157.27 75.58 Favored Pre-proline 0 C--O 1.245 0.843 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.277 -176.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.9 158.94 38.47 Favored 'Trans proline' 0 C--N 1.326 -0.648 0 C-N-CA 122.16 1.906 . . . . 0.0 111.139 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' GLU . . . . . 0.484 ' HG3' ' HG3' ' A' ' 439' ' ' ARG . 1.9 mp0 -75.29 158.72 32.43 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.93 0.395 . . . . 0.0 110.302 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' CYS . . . . . 0.98 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 6.6 t -62.76 133.14 94.95 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.899 176.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.91 -6.93 13.68 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.685 2.257 . . . . 0.0 112.698 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 96.8 m-85 -114.72 11.88 16.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.173 0.511 . . . . 0.0 110.288 177.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 61.21 -157.79 31.68 Favored Glycine 0 N--CA 1.462 0.377 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.731 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.15 -11.39 25.12 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.675 2.917 . . . . 0.0 112.197 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 25.8 t -81.41 -11.63 59.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.785 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' CYS . . . . . 0.98 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 39.8 t -51.26 116.93 2.27 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.955 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -111.6 23.96 13.3 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.154 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -61.83 100.42 0.15 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 122.689 0.396 . . . . 0.0 110.066 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 430' ' ' LYS . 17.9 ptpt -66.12 94.18 0.23 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.229 0.538 . . . . 0.0 111.215 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' ASN . . . . . 0.552 ' O ' ' HB3' ' A' ' 434' ' ' HIS . 20.0 t-20 -173.57 114.13 0.34 Allowed Pre-proline 0 N--CA 1.465 0.296 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.0 -47.01 22.29 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.427 2.085 . . . . 0.0 112.181 -174.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.631 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 6.6 tp-100 -57.72 -29.07 64.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.326 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' HIS . . . . . 0.687 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 41.2 t60 -61.38 -55.99 25.34 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 123.361 0.413 . . . . 0.0 111.736 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -61.37 -25.23 67.03 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.437 0.637 . . . . 0.0 110.839 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 69.0 mt -69.48 -46.51 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.437 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.631 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 10.5 mt-10 -85.31 -22.48 28.51 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.986 -174.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -121.04 126.05 48.87 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 123.618 0.574 . . . . 0.0 110.155 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' ARG . . . . . 0.484 ' HG3' ' HG3' ' A' ' 420' ' ' GLU . 12.0 ptt180 -80.9 122.08 26.79 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 121.281 0.562 . . . . 0.0 110.984 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.7 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 49.3 m80 -98.07 84.45 3.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.154 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -70.26 121.28 17.3 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.177 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.42 146.37 38.5 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.92 156.39 29.67 Favored Pre-proline 0 C--N 1.322 -0.608 0 O-C-N 123.466 0.479 . . . . 0.0 111.083 -173.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 444' ' ' PRO . . . . . 0.576 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 32.1 Cg_endo -62.63 -25.8 75.45 Favored 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 122.302 2.001 . . . . 0.0 112.365 -176.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 14.9 p 40.09 56.26 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 122.958 1.361 . . . . 0.0 111.864 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.576 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 21.0 mmm180 -91.52 140.68 29.51 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 121.31 -0.869 . . . . 0.0 112.201 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 55.6 t30 52.98 85.84 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.639 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 26.6 m . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 121.371 0.605 . . . . 0.0 111.14 -177.645 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.553 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 10.5 t -106.14 153.66 21.78 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.837 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.9 t -53.87 119.81 5.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.515 0.326 . . . . 0.0 111.751 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 24.1 t -53.77 111.06 0.66 Allowed 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 23.3 ptp -58.51 -12.6 4.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.226 0.536 . . . . 0.0 111.925 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.414 ' CD2' ' HB3' ' A' ' 385' ' ' CYS . 15.3 m-85 -110.09 -15.83 13.93 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.612 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 72.76 -133.42 19.07 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -174.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 383' ' ' ALA . . . . . 0.438 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -88.11 -0.75 57.44 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 121.643 0.735 . . . . 0.0 111.244 177.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -75.82 -24.89 55.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.593 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 0.8 OUTLIER -61.38 129.72 42.58 Favored 'General case' 0 C--O 1.25 1.098 0 O-C-N 122.238 -0.289 . . . . 0.0 111.167 -179.258 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -71.46 -8.49 54.19 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.034 0.534 . . . . 0.0 110.138 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -69.95 113.05 6.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.862 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.501 ' HD2' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -113.21 -1.84 14.23 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -61.25 137.11 94.3 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.335 175.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -58.57 -20.89 52.14 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.649 2.233 . . . . 0.0 111.746 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.579 HG12 ' NE2' ' A' ' 395' ' ' HIS . 98.4 t -66.09 -42.36 91.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.22 178.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.776 ' HE2' ' HE2' ' A' ' 398' ' ' HIS . 83.9 t60 -57.7 -33.51 68.46 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.702 0.763 . . . . 0.0 110.655 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 34.5 m-85 -88.96 -18.91 26.46 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.877 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -75.33 -26.95 59.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.641 -178.521 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.63 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 2.2 p80 -114.3 -7.34 12.95 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.502 0.501 . . . . 0.0 112.273 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.63 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 96.5 m-85 -135.45 132.01 36.88 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.206 0.527 . . . . 0.0 111.665 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.553 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 69.3 m -85.38 154.14 22.06 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.606 174.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.776 ' HE2' ' HE2' ' A' ' 392' ' ' HIS . 31.5 m80 -128.07 158.21 71.62 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.496 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 14.9 Cg_endo -52.96 100.53 0.05 OUTLIER 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 122.951 2.434 . . . . 0.0 111.594 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 119.01 11.86 7.36 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.661 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -106.25 145.06 32.07 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 41.3 t -54.04 -32.81 55.58 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.805 0.69 . . . . 0.0 111.29 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -107.97 17.33 22.53 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 56.2 t80 . . . . . 0 N--CA 1.47 0.556 0 C-N-CA 120.124 -0.631 . . . . 0.0 110.824 178.592 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 C--O 1.239 0.534 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 27.3 t70 63.17 79.75 0.25 Allowed 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 124.736 1.214 . . . . 0.0 113.035 168.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -177.62 154.46 1.04 Allowed Pre-proline 0 N--CA 1.479 0.985 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.812 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -52.49 136.41 56.63 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.034 2.49 . . . . 0.0 111.282 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' GLU . . . . . 0.454 ' HG3' ' HG3' ' A' ' 439' ' ' ARG . 2.3 mp0 -75.62 148.54 38.69 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' CYS . . . . . 0.949 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 8.3 t -52.18 134.86 40.64 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.412 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 421' ' ' CYS . 53.0 Cg_exo -57.24 -28.15 78.19 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.742 2.294 . . . . 0.0 111.952 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' TYR . . . . . 0.413 ' HB2' ' HA ' ' A' ' 427' ' ' CYS . 62.3 m-85 -99.1 5.55 46.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.873 -177.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 67.64 -156.03 52.65 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' PRO . . . . . 0.441 ' HG3' ' HA ' ' A' ' 442' ' ' THR . 55.1 Cg_endo -70.74 -16.53 33.44 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.329 2.02 . . . . 0.0 111.298 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 33.0 t -79.25 3.98 16.38 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.262 176.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' CYS . . . . . 0.949 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 50.5 t -55.1 117.28 3.33 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.108 0.563 . . . . 0.0 110.727 177.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -103.1 13.37 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.685 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 429' ' ' ARG . 8.4 mmm180 -71.99 105.46 3.89 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -87.96 97.45 10.96 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.142 -175.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -173.02 126.37 0.48 Allowed Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.458 ' O ' HG13 ' A' ' 436' ' ' ILE . 28.2 Cg_endo -62.58 -38.28 52.3 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.295 1.997 . . . . 0.0 112.12 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.651 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 26.3 tp60 -63.94 -38.19 90.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.946 0.403 . . . . 0.0 110.34 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' HIS . . . . . 0.666 ' CE1' ' SG ' ' A' ' 421' ' ' CYS . 15.0 t60 -57.95 -48.3 80.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.262 1.03 . . . . 0.0 110.116 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -68.68 -15.24 63.46 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.345 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 432' ' ' PRO . 79.0 mt -86.67 -34.3 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 123.928 0.767 . . . . 0.0 110.628 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.651 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 21.9 mt-10 -86.62 -25.08 25.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.572 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -127.0 135.6 51.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.234 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' ARG . . . . . 0.454 ' HG3' ' HG3' ' A' ' 420' ' ' GLU . 25.2 ptt180 -91.2 134.94 34.14 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.65 0.594 . . . . 0.0 109.761 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.62 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 24.2 m80 -100.91 83.81 2.59 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.231 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -94.61 157.46 15.97 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.004 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' THR . . . . . 0.441 ' HA ' ' HG3' ' A' ' 425' ' ' PRO . 30.4 p -100.74 171.78 7.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -178.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.41 151.54 71.47 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.0 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 444' ' ' PRO . . . . . 0.514 ' O ' HG12 ' A' ' 445' ' ' VAL . 18.6 Cg_endo -59.29 -24.53 74.66 Favored 'Trans proline' 0 N--CA 1.483 0.868 0 C-N-CA 123.489 2.793 . . . . 0.0 111.24 -174.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 444' ' ' PRO . 3.5 p 56.53 7.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.734 1.614 . . . . 0.0 113.013 171.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 446' ' ' ARG . 15.0 ptt180 -126.88 170.48 12.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.174 -176.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -133.05 -36.59 1.01 Allowed 'General case' 0 C--N 1.306 -1.296 0 O-C-N 125.013 1.446 . . . . 0.0 110.896 173.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.477 0.884 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.421 177.524 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.487 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.639 0 CA-C-O 121.492 0.663 . . . . 0.0 110.032 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.2 t -113.43 159.46 19.46 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 41.0 t -63.68 124.33 21.15 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 121.975 -0.453 . . . . 0.0 111.226 -175.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.663 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 31.9 t -56.39 122.38 11.76 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 174.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 26.5 ptm -55.1 -26.23 36.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.645 0.378 . . . . 0.0 111.566 -173.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.541 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 38.8 m-85 -110.01 -8.86 14.78 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.647 0.592 . . . . 0.0 110.657 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.46 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 69.78 -133.92 25.41 Favored Glycine 0 N--CA 1.436 -1.316 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.61 -176.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' ALA . . . . . 0.583 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -78.6 0.26 27.05 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 117.589 0.694 . . . . 0.0 111.166 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -94.7 -2.74 50.59 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.582 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.663 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 10.3 p -68.0 134.19 50.29 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 122.065 -0.397 . . . . 0.0 110.391 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -78.98 -14.11 59.4 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 123.26 0.624 . . . . 0.0 111.212 -176.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -72.5 128.31 35.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.049 0.452 . . . . 0.0 110.507 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.443 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.6 OUTLIER -120.27 -6.45 9.87 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.047 -176.397 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -65.05 137.76 97.2 Favored Pre-proline 0 C--O 1.243 0.737 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.542 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.57 -34.63 73.76 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 123.689 2.926 . . . . 0.0 112.793 -173.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.455 HG12 ' NE2' ' A' ' 395' ' ' HIS . 60.1 t -59.72 -34.68 56.27 Favored 'Isoleucine or valine' 0 C--N 1.348 0.532 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.683 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.644 ' HE2' ' HG ' ' A' ' 379' ' ' CYS . 82.6 t60 -55.21 -37.55 67.27 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 121.729 0.776 . . . . 0.0 111.33 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 62.2 m-85 -89.68 -20.86 23.13 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.459 -175.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -71.39 -24.11 62.0 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.878 -0.514 . . . . 0.0 110.035 -177.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.606 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 1.0 OUTLIER -119.33 -7.71 10.19 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 178.762 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.606 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 57.0 m-85 -133.55 126.37 30.86 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.487 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 38.1 m -90.06 158.93 17.09 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.66 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 13.3 m80 -129.55 157.69 75.68 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.078 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.583 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 18.3 Cg_endo -54.31 118.09 4.65 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.898 2.398 . . . . 0.0 110.347 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 111.58 -1.71 27.7 Favored Glycine 0 C--N 1.32 -0.342 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.695 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.76 142.16 34.36 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 14.1 t -70.05 -21.97 63.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -95.56 -1.39 50.59 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.112 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.6 t80 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.09 179.637 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.989 0.899 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -136.35 -18.9 1.47 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.074 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.523 ' HD2' ' O ' ' A' ' 437' ' ' GLU . 20.9 ptt180 -167.6 160.13 10.1 Favored Pre-proline 0 N--CA 1.467 0.384 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -169.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.59 151.03 72.54 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.83 1.687 . . . . 0.0 111.359 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' GLU . . . . . 0.479 ' HA ' ' HG2' ' A' ' 439' ' ' ARG . 10.7 tt0 -82.94 157.07 23.16 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' CYS . . . . . 0.948 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 11.3 t -58.98 135.24 87.45 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.261 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.7 -13.28 35.85 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.343 2.029 . . . . 0.0 112.58 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -110.18 8.08 23.57 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.103 0.477 . . . . 0.0 110.429 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 63.94 -152.71 48.39 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.699 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.53 -4.38 15.19 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.847 2.365 . . . . 0.0 111.984 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 16.9 m -83.55 -2.52 56.2 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.583 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' CYS . . . . . 0.948 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 43.0 t -54.89 115.92 2.46 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.498 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -110.96 19.26 18.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.28 0.632 . . . . 0.0 110.482 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.645 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 1.1 mmp_? -69.62 101.87 1.73 Allowed 'General case' 0 C--O 1.255 1.365 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.274 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -75.04 82.83 2.26 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 123.603 0.761 . . . . 0.0 110.184 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 434' ' ' HIS . 26.9 t-20 -163.23 112.08 1.02 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.694 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.98 -41.4 62.08 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 C-N-CA 123.25 2.633 . . . . 0.0 112.567 -171.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.675 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 25.1 tp60 -57.45 -39.21 75.8 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 121.086 0.47 . . . . 0.0 110.33 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' HIS . . . . . 0.715 ' CE1' ' HG ' ' A' ' 421' ' ' CYS . 19.5 t60 -59.23 -52.27 66.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.677 0.751 . . . . 0.0 110.011 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.41 ' HA ' ' HE1' ' A' ' 440' ' ' HIS . 47.7 mtpt -61.25 -19.79 62.1 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.983 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 93.7 mt -84.47 -35.42 10.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.294 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.675 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 25.7 mt-10 -85.41 -50.92 6.91 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.45 -176.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -98.06 137.85 36.24 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.113 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' ARG . . . . . 0.479 ' HG2' ' HA ' ' A' ' 420' ' ' GLU . 18.5 ptt-85 -86.24 145.96 26.73 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.42 0.288 . . . . 0.0 110.56 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.639 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 71.7 m80 -118.22 86.04 2.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.387 0.613 . . . . 0.0 109.847 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -77.61 117.87 19.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.983 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.2 m -125.79 155.49 40.98 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.463 0.477 . . . . 0.0 110.898 -173.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 443' ' ' LEU . 1.1 pp -107.21 153.9 40.81 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 444' ' ' PRO . . . . . 0.426 ' O ' HG12 ' A' ' 445' ' ' VAL . 38.1 Cg_endo -64.84 -11.98 32.0 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.167 1.911 . . . . 0.0 113.273 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 444' ' ' PRO . 6.1 p 51.02 28.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.19 0.996 . . . . 0.0 112.309 174.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.426 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 36.9 mmt180 -85.66 144.96 27.53 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.853 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -84.09 85.54 7.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.464 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--N 1.309 -1.188 0 CA-C-O 122.119 0.961 . . . . 0.0 110.202 177.492 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 121.179 0.514 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 9.0 t -120.95 145.52 47.63 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 172.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 46.3 m -47.73 122.24 4.75 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 123.452 0.47 . . . . 0.0 111.218 -175.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 11.9 t -47.54 120.46 3.31 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 27.6 ptm -61.5 -11.75 12.18 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.08 0.552 . . . . 0.0 110.317 -176.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.494 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 75.0 m-85 -115.27 -13.89 11.71 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.994 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.424 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 65.77 -120.59 17.2 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.076 -1.059 . . . . 0.0 110.793 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 383' ' ' ALA . . . . . 0.467 ' HB2' ' HG3' ' A' ' 399' ' ' PRO . . . -92.18 5.73 49.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.548 0.689 . . . . 0.0 110.66 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -89.36 -15.23 33.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.302 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 2.4 p -78.8 123.85 27.61 Favored 'General case' 0 C--O 1.248 0.974 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.881 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -83.44 15.65 2.95 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.92 0.488 . . . . 0.0 111.686 -174.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -84.06 130.14 34.88 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.085 0.469 . . . . 0.0 110.409 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -104.01 -33.22 8.88 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 123.152 0.581 . . . . 0.0 109.676 -178.791 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -45.91 135.58 6.51 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.683 -177.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.74 -17.61 55.85 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 121.914 1.743 . . . . 0.0 112.062 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.482 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 86.3 t -67.9 -37.42 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.904 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.741 ' HE2' ' HE2' ' A' ' 398' ' ' HIS . 77.5 t60 -60.96 -29.32 69.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.868 0.842 . . . . 0.0 110.017 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 60.6 m-85 -92.8 -13.07 29.67 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.004 -177.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -78.77 -23.64 45.17 Favored 'General case' 0 C--N 1.343 0.313 0 O-C-N 121.768 -0.583 . . . . 0.0 111.617 -177.451 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.447 ' HD2' ' HG3' ' A' ' 394' ' ' GLN . 5.5 p80 -118.41 -19.76 8.74 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.438 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 377' ' ' THR . 67.7 m-85 -123.54 127.7 48.69 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.512 0.672 . . . . 0.0 110.675 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.556 ' O ' ' HB2' ' A' ' 379' ' ' CYS . 54.2 p -78.36 163.21 25.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.752 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.741 ' HE2' ' HE2' ' A' ' 392' ' ' HIS . 61.0 m80 -138.24 161.82 57.18 Favored Pre-proline 0 N--CA 1.465 0.308 0 O-C-N 122.293 -0.254 . . . . 0.0 110.479 -176.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 11.3 Cg_endo -51.58 104.98 0.1 OUTLIER 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 122.937 2.425 . . . . 0.0 112.156 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 124.55 -9.35 8.2 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.701 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -95.8 157.05 16.07 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 122.601 -0.352 . . . . 0.0 111.324 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 20.0 m -69.02 -25.87 64.71 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.831 0.707 . . . . 0.0 112.061 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.67 8.97 40.64 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.318 -0.239 . . . . 0.0 110.524 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 36.5 t80 . . . . . 0 C--N 1.328 -0.367 0 O-C-N 123.447 0.467 . . . . 0.0 110.665 -178.262 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 CA--C 1.528 0.133 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -169.92 -31.73 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.031 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.516 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 29.1 ptt180 -133.01 163.75 48.84 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.758 -173.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.35 151.08 42.56 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.566 2.178 . . . . 0.0 111.18 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.95 158.73 30.08 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.496 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' CYS . . . . . 0.82 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 49.3 t -69.37 131.25 90.29 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.297 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.87 -16.45 25.93 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.269 2.646 . . . . 0.0 112.647 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -111.86 12.81 20.91 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.63 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 59.83 -151.74 36.91 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.789 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.43 -21.83 11.32 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.547 2.165 . . . . 0.0 112.324 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 36.0 t -76.36 4.16 9.54 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.924 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' CYS . . . . . 0.82 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 49.7 t -49.61 116.73 1.88 Allowed 'General case' 0 C--O 1.219 -0.547 0 O-C-N 124.358 1.036 . . . . 0.0 110.957 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -107.77 16.21 23.82 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.653 0.739 . . . . 0.0 110.347 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -76.64 88.45 3.32 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.027 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -73.79 92.3 2.02 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.305 0.574 . . . . 0.0 111.289 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' ASN . . . . . 0.48 HD21 ' HB3' ' A' ' 433' ' ' GLN . 47.4 t30 -153.74 126.41 4.02 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.484 ' O ' HG13 ' A' ' 436' ' ' ILE . 18.4 Cg_endo -58.63 -39.75 79.83 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.804 1.669 . . . . 0.0 111.537 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.48 ' HB3' HD21 ' A' ' 431' ' ' ASN . 6.4 tp-100 -69.1 -26.26 64.83 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.695 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 434' ' ' HIS . . . . . 0.753 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 48.3 t60 -64.61 -61.89 1.92 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.114 0.483 . . . . 0.0 110.518 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.477 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 0.0 OUTLIER -61.39 -18.59 59.48 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.441 -178.68 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 432' ' ' PRO . 66.1 mt -71.96 -56.38 10.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.192 0.52 . . . . 0.0 111.701 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 418' ' ' ARG . 9.7 mm-40 -76.26 -28.08 56.95 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -112.27 123.09 49.51 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.256 0.347 . . . . 0.0 111.409 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 439' ' ' ARG . . . . . 0.516 ' HD3' ' O ' ' A' ' 418' ' ' ARG . 1.2 ptm180 -78.16 126.99 31.61 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.575 0.547 . . . . 0.0 110.346 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.571 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.1 m80 -103.18 85.62 2.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.36 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -68.75 117.59 10.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.616 -176.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.0 m -133.35 154.12 51.0 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -176.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.502 HD13 ' HB ' ' A' ' 445' ' ' VAL . 1.4 pp -108.81 148.02 36.99 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.913 176.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.71 -47.24 5.55 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.49 1.46 . . . . 0.0 113.072 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.502 ' HB ' HD13 ' A' ' 443' ' ' LEU . 9.8 p 44.45 29.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 122.013 0.911 . . . . 0.0 111.425 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 448' ' ' VAL . 24.4 tpt180 -83.95 92.87 7.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.296 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 47.92 -76.21 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.826 1.251 . . . . 0.0 113.166 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 446' ' ' ARG . 33.5 m . . . . . 0 C--O 1.238 0.496 0 CA-C-O 121.851 0.834 . . . . 0.0 110.299 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.43 HH21 ' CG ' ' A' ' 401' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.865 0.841 . . . . 0.0 110.453 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 9.6 t -98.72 144.53 27.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.611 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 35.4 m -62.56 122.68 16.41 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.081 0.863 . . . . 0.0 112.668 -168.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.79 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 47.1 t -58.2 110.82 1.02 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.915 171.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 23.3 ptm -59.81 -25.98 65.4 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.134 0.271 . . . . 0.0 110.947 -174.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 53.1 m-85 -95.18 -14.85 23.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.578 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 57.91 -117.7 11.0 Favored Glycine 0 C--O 1.216 -0.985 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.439 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -87.29 -3.71 59.05 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.169 0.509 . . . . 0.0 111.608 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -83.31 -25.17 31.77 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.04 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.79 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.3 p -70.68 120.71 16.69 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 174.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -79.61 1.41 26.23 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.65 0.594 . . . . 0.0 111.763 -170.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.53 ' HA ' ' NE ' ' A' ' 387' ' ' ARG . 2.4 mmp_? -62.98 129.16 39.16 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 123.532 0.52 . . . . 0.0 110.595 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.494 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -112.52 -11.79 13.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.094 -175.177 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -67.06 138.68 95.01 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.497 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.98 -23.74 78.04 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.074 1.849 . . . . 0.0 111.526 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.467 ' HA ' ' HG2' ' A' ' 394' ' ' GLN . 60.1 t -60.69 -41.65 89.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.716 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 48.5 t60 -53.63 -33.91 56.73 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.534 0.521 . . . . 0.0 110.911 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -95.86 -19.31 19.68 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.409 -175.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.467 ' HG2' ' HA ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -70.77 -25.38 62.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.503 0.192 . . . . 0.0 111.25 -177.535 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.585 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 0.8 OUTLIER -120.85 -8.77 9.38 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.585 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 93.0 m-85 -133.15 133.09 42.4 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.793 176.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 17.6 p -88.34 149.94 23.48 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.151 0.58 . . . . 0.0 110.042 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.613 ' NE2' ' NE2' ' A' ' 392' ' ' HIS . 42.6 m80 -125.56 160.86 53.78 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.213 -174.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.15 93.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.499 2.133 . . . . 0.0 110.374 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 136.6 -23.51 3.25 Favored Glycine 0 C--O 1.238 0.402 0 O-C-N 123.995 0.809 . . . . 0.0 111.473 -175.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' ASP . . . . . 0.455 ' HB3' ' H ' ' A' ' 398' ' ' HIS . 15.2 t70 -76.89 133.57 39.25 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 32.0 t -63.35 -13.82 43.37 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -172.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.71 12.42 31.01 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.402 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 37.4 t80 . . . . . 0 C--O 1.241 0.645 0 CA-C-O 120.478 0.18 . . . . 0.0 110.648 -179.508 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 36.1 t70 . . . . . 0 N--CA 1.463 0.177 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.411 ' OD1' ' HD2' ' A' ' 439' ' ' ARG . 19.2 p-10 -135.95 -32.54 0.88 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.444 174.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.631 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 17.4 ptt180 -146.17 172.46 5.24 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.318 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.599 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 21.1 Cg_endo -62.03 140.52 84.8 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 121.098 1.199 . . . . 0.0 111.687 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 420' ' ' GLU . . . . . 0.54 ' HG3' ' OD1' ' A' ' 441' ' ' ASN . 0.4 OUTLIER -74.02 160.1 31.77 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.392 0.433 . . . . 0.0 110.297 178.705 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 421' ' ' CYS . . . . . 0.983 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 2.6 t -63.51 135.31 96.2 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.46 -2.88 6.74 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.499 2.133 . . . . 0.0 112.804 -177.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' TYR . . . . . 0.622 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 65.0 m-85 -125.84 14.96 8.04 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.066 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 64.51 -159.76 41.41 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.777 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.93 -14.48 38.76 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.968 1.779 . . . . 0.0 111.878 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 36.0 t -70.73 -17.82 62.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' CYS . . . . . 0.983 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 17.5 t -57.43 115.4 2.7 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -114.78 25.01 11.29 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.447 0.642 . . . . 0.0 109.416 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.705 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 2.0 mmp_? -59.77 99.31 0.06 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -80.18 96.71 6.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.114 0.959 . . . . 0.0 110.316 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -160.22 125.74 2.29 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.894 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.589 ' O ' HG13 ' A' ' 436' ' ' ILE . 20.1 Cg_endo -59.72 -42.29 47.74 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 121.979 1.786 . . . . 0.0 111.992 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.606 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 25.3 tp60 -64.46 -37.44 87.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.124 0.488 . . . . 0.0 109.895 -177.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 434' ' ' HIS . . . . . 0.691 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.2 t60 -59.34 -53.89 52.98 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.521 0.676 . . . . 0.0 110.021 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -63.15 -15.65 57.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.681 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 432' ' ' PRO . 85.5 mt -82.59 -37.24 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.219 0.533 . . . . 0.0 111.13 176.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.606 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 27.0 mt-10 -82.78 -44.34 15.67 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.474 -175.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 438' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 419' ' ' PRO . 96.5 m-85 -111.5 147.19 35.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.523 -171.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' ARG . . . . . 0.631 ' HD3' ' O ' ' A' ' 418' ' ' ARG . 0.0 OUTLIER -93.57 141.48 28.42 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.066 174.352 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.674 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 74.9 m80 -108.35 92.67 4.16 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 123.741 0.651 . . . . 0.0 109.43 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 441' ' ' ASN . . . . . 0.566 HD22 ' HE ' ' A' ' 439' ' ' ARG . 12.2 m120 -67.97 98.49 0.76 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -174.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.7 m -107.75 151.44 25.69 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 124.412 1.07 . . . . 0.0 109.531 -176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.463 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.6 OUTLIER -119.83 145.11 38.76 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-O 121.009 0.433 . . . . 0.0 110.146 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 444' ' ' PRO . . . . . 0.536 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 54.5 Cg_endo -68.66 -20.13 40.89 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.28 2.654 . . . . 0.0 112.455 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.463 ' HB ' HD13 ' A' ' 443' ' ' LEU . 5.6 p 47.94 30.68 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.883 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.484 177.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.536 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 24.7 mmt180 -87.71 145.33 26.19 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.413 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 64.16 1.19 1.15 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.811 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 121.055 0.455 . . . . 0.0 110.391 -178.807 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.427 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.8 OUTLIER . . . . . 0 C--O 1.214 -0.809 0 CA-C-O 121.556 0.693 . . . . 0.0 111.071 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 15.3 t -117.2 155.3 29.63 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.899 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 15.9 m -57.78 121.64 10.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -170.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 11.5 t -60.74 116.75 4.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.063 173.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 31.6 ttp -50.86 -40.71 56.86 Favored 'General case' 0 C--O 1.25 1.084 0 C-N-CA 122.778 0.431 . . . . 0.0 111.2 -176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.475 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 26.1 m-85 -91.96 -14.52 29.37 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.192 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.441 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 60.69 -119.61 19.38 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -80.92 -5.8 57.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.477 0.656 . . . . 0.0 111.495 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -86.18 -15.39 41.13 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.995 -174.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.9 p -74.74 131.82 41.13 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.133 0.492 . . . . 0.0 110.129 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -87.52 18.22 4.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.533 0.682 . . . . 0.0 111.405 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -87.36 121.93 30.45 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.679 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.483 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -121.99 2.74 9.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.69 0.757 . . . . 0.0 109.681 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.415 HD22 ' HB ' ' A' ' 391' ' ' VAL . 5.2 p-10 -63.37 135.6 96.32 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.305 174.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.93 -29.52 64.44 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.227 2.618 . . . . 0.0 111.408 -172.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.608 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 98.8 t -65.08 -34.07 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.682 -178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.783 ' HE2' ' HE2' ' A' ' 398' ' ' HIS . 84.7 t60 -63.67 -24.66 67.88 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.062 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -95.83 -15.4 22.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.868 0.467 . . . . 0.0 110.807 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.608 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -80.18 -25.68 39.61 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.25 -177.746 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.615 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 1.7 p80 -114.31 -19.95 11.05 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.615 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 59.3 m-85 -126.94 127.76 45.36 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 122.395 1.093 . . . . 0.0 111.614 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.427 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 8.8 p -81.6 158.03 24.51 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.655 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.783 ' HE2' ' HE2' ' A' ' 392' ' ' HIS . 46.4 m80 -137.02 159.07 71.43 Favored Pre-proline 0 C--N 1.315 -0.902 0 C-N-CA 123.644 0.778 . . . . 0.0 110.288 -174.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.85 102.24 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.024 1.816 . . . . 0.0 110.546 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 124.75 -0.3 8.5 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.027 -174.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -100.12 143.83 29.86 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.7 t -61.9 -29.95 70.56 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 123.32 0.387 . . . . 0.0 111.5 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.95 9.2 43.34 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.24 0.543 . . . . 0.0 110.776 -174.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 50.1 t80 . . . . . 0 C--O 1.248 0.997 0 O-C-N 121.948 -0.47 . . . . 0.0 110.887 179.549 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 C--O 1.237 0.405 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -139.64 0.12 1.8 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.793 0.806 . . . . 0.0 109.751 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 36.3 ptt180 -170.14 150.99 3.76 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.68 -172.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.61 157.08 40.38 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.413 2.075 . . . . 0.0 112.41 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' GLU . . . . . 0.527 ' HG3' ' HG3' ' A' ' 439' ' ' ARG . 2.1 mp0 -72.9 147.75 45.02 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.395 0.434 . . . . 0.0 111.396 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' CYS . . . . . 0.974 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 4.3 t -58.96 131.73 86.83 Favored Pre-proline 0 C--O 1.243 0.733 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.959 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -58.23 -22.66 58.19 Favored 'Trans proline' 0 N--CA 1.48 0.714 0 C-N-CA 123.041 2.494 . . . . 0.0 112.631 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -97.04 -5.64 37.11 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.615 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 75.45 -154.31 45.65 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.109 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.4 -16.91 39.39 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 121.996 1.797 . . . . 0.0 111.908 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 22.8 t -79.56 4.38 16.01 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.443 0.64 . . . . 0.0 111.04 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' CYS . . . . . 0.974 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 45.5 t -55.99 116.35 2.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.998 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -107.59 22.54 15.82 Favored 'General case' 0 C--O 1.248 1.018 0 O-C-N 123.61 0.569 . . . . 0.0 110.419 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -69.41 104.44 2.29 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -80.66 98.1 7.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.04 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' ASN . . . . . 0.524 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 64.7 t30 -176.0 129.06 0.37 Allowed Pre-proline 0 CA--C 1.522 -0.128 0 C-N-CA 123.715 0.806 . . . . 0.0 109.84 176.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.524 ' HD2' ' OD1' ' A' ' 431' ' ' ASN . 18.4 Cg_endo -60.45 -43.66 32.3 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.714 1.609 . . . . 0.0 111.543 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.628 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 22.8 tp60 -60.88 -34.92 75.36 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 434' ' ' HIS . . . . . 0.702 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 51.5 t60 -56.67 -59.22 5.32 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 123.65 0.594 . . . . 0.0 111.522 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.434 ' HD3' ' H ' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -61.67 -11.42 11.66 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.048 178.819 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 432' ' ' PRO . 81.0 mt -83.74 -40.98 16.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.369 0.604 . . . . 0.0 110.929 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.628 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 23.4 mt-10 -78.9 -34.25 44.87 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.978 -176.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -114.77 132.11 56.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.84 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' ARG . . . . . 0.527 ' HG3' ' HG3' ' A' ' 420' ' ' GLU . 13.2 ptt180 -84.09 124.5 31.17 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.562 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.762 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.1 m80 -100.14 86.29 3.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.207 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -77.86 135.67 37.95 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.342 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 3.1 p -111.64 133.25 54.02 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 123.703 0.801 . . . . 0.0 110.172 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.89 158.08 34.09 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -176.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 444' ' ' PRO . . . . . 0.561 ' HG3' HG23 ' A' ' 448' ' ' VAL . 17.7 Cg_endo -59.17 -24.75 75.34 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.809 2.339 . . . . 0.0 112.2 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 444' ' ' PRO . 3.7 p 49.62 21.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.491 0.717 . . . . 0.0 111.874 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.436 ' HG2' ' OD1' ' A' ' 447' ' ' ASN . 48.5 ttt180 -166.64 141.23 4.17 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 447' ' ' ASN . . . . . 0.436 ' OD1' ' HG2' ' A' ' 446' ' ' ARG . 4.2 m-20 63.56 -83.61 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.32 1.013 . . . . 0.0 111.454 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.561 HG23 ' HG3' ' A' ' 444' ' ' PRO . 35.3 m . . . . . 0 N--CA 1.474 0.773 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.884 -174.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 14.9 t -103.69 147.16 27.57 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 21.1 m -54.99 125.92 22.41 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.358 0.599 . . . . 0.0 111.964 -174.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.632 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 45.9 t -56.81 124.09 17.3 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.647 174.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 34.3 ttp -50.59 -47.6 58.03 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.343 0.592 . . . . 0.0 111.372 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.515 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 56.5 m-85 -88.43 -9.79 51.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.344 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.522 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 67.87 -130.81 28.07 Favored Glycine 0 CA--C 1.501 -0.805 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -172.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 383' ' ' ALA . . . . . 0.505 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -80.73 -7.87 59.49 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.935 0.874 . . . . 0.0 110.913 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -79.99 -9.59 59.7 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.697 -176.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.785 ' SG ' ' NE2' ' A' ' 392' ' ' HIS . 3.7 p -63.06 136.53 57.85 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 123.583 0.552 . . . . 0.0 110.872 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -79.06 4.9 13.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.249 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -84.81 136.62 33.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.87 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.422 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.7 OUTLIER -123.7 -7.93 7.93 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.311 0.577 . . . . 0.0 110.409 179.11 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -66.74 139.27 95.74 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.514 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -60.59 -22.46 72.5 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 122.681 2.254 . . . . 0.0 111.314 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.422 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 99.3 t -63.42 -39.77 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.28 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.785 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 86.1 t60 -59.53 -31.66 69.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 110.131 178.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -91.0 -11.4 39.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.666 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 1.9 pp0? -82.87 -26.77 31.28 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.942 0.401 . . . . 0.0 110.567 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -110.57 -17.2 13.47 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 121.634 -0.666 . . . . 0.0 111.862 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 377' ' ' THR . 20.1 m-30 -125.11 135.23 52.47 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.273 0.488 . . . . 0.0 111.467 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 20.8 p -83.37 156.51 22.96 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 123.648 0.593 . . . . 0.0 110.269 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.585 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 40.7 m80 -135.61 159.89 69.75 Favored Pre-proline 0 C--O 1.221 -0.421 0 C-N-CA 122.51 0.324 . . . . 0.0 110.956 -174.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.505 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 18.7 Cg_endo -56.48 114.75 2.05 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.965 1.777 . . . . 0.0 110.832 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.08 2.98 48.67 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 -174.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' ASP . . . . . 0.441 ' HB3' ' H ' ' A' ' 398' ' ' HIS . 20.7 t70 -101.62 155.95 17.79 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.381 -0.482 . . . . 0.0 109.915 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 32.0 t -59.49 -37.09 77.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.812 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -106.36 15.05 26.58 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.333 -167.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 18.0 t80 . . . . . 0 C--N 1.311 -1.099 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.728 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 417' ' ' ASP . 17.9 t70 . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 416' ' ' ASP . 16.9 t0 80.62 78.81 0.04 OUTLIER 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.066 0.947 . . . . 0.0 111.287 173.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.4 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 25.6 ptt180 178.43 158.7 0.61 Allowed Pre-proline 0 CA--C 1.514 -0.423 0 CA-C-N 113.988 -1.46 . . . . 0.0 108.845 172.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 31.0 Cg_endo -63.15 151.1 86.52 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.263 1.975 . . . . 0.0 111.452 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 420' ' ' GLU . . . . . 0.583 ' HG2' ' HG3' ' A' ' 439' ' ' ARG . 36.7 mt-10 -85.05 154.26 22.2 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.385 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' CYS . . . . . 0.961 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 8.2 t -58.58 133.69 85.84 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.046 -178.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 421' ' ' CYS . 52.6 Cg_exo -56.48 -29.18 77.1 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.047 2.498 . . . . 0.0 112.715 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 423' ' ' TYR . . . . . 0.563 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 51.5 m-85 -98.25 6.88 46.97 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.53 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 62.52 -151.27 46.6 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.85 -15.74 29.68 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.287 1.991 . . . . 0.0 112.366 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 31.4 t -73.45 -10.19 59.47 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.624 0.726 . . . . 0.0 110.048 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' CYS . . . . . 0.961 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 42.5 t -62.38 118.62 7.73 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.189 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -125.58 23.0 7.52 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.098 0.874 . . . . 0.0 109.021 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -56.71 117.1 3.58 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.554 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -67.08 97.46 0.51 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.414 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' ASN . . . . . 0.518 HD21 ' HB3' ' A' ' 433' ' ' GLN . 62.4 t30 -178.06 121.11 0.25 Allowed Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 123.443 0.697 . . . . 0.0 109.7 173.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.15 -27.8 28.97 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.502 1.468 . . . . 0.0 111.866 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.623 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 27.0 tp60 -72.34 -34.18 67.85 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' HIS . . . . . 0.715 ' CE1' ' SG ' ' A' ' 421' ' ' CYS . 24.5 t60 -57.56 -56.61 19.71 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.859 178.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -63.21 -20.06 65.09 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.242 -177.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 50.2 mt -78.41 -41.45 25.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 122.703 0.401 . . . . 0.0 110.092 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.623 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 22.7 mt-10 -79.41 -45.68 19.03 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.815 -175.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -101.45 138.82 37.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.64 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' ARG . . . . . 0.583 ' HG3' ' HG2' ' A' ' 420' ' ' GLU . 19.1 ptt180 -92.25 145.18 24.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.515 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.677 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 35.8 m80 -119.33 98.86 6.35 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -110.2 168.61 9.31 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 4.1 p -116.99 131.99 56.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.417 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 2.5 pp -120.12 151.0 52.4 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.217 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' PRO . . . . . 0.542 ' O ' HG12 ' A' ' 445' ' ' VAL . 16.5 Cg_endo -56.79 -42.37 65.56 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.898 2.399 . . . . 0.0 112.686 -171.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 444' ' ' PRO . 2.5 p 51.4 12.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 124.582 1.176 . . . . 0.0 111.127 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 446' ' ' ARG . 0.0 OUTLIER -84.06 -43.49 15.04 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -170.172 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -107.78 24.04 13.53 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.563 0.697 . . . . 0.0 110.955 -175.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 121.021 0.439 . . . . 0.0 110.648 -179.788 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.472 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.2 OUTLIER . . . . . 0 C--O 1.238 0.495 0 CA-C-O 121.325 0.583 . . . . 0.0 110.906 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 13.4 t -127.15 157.47 39.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.876 176.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 69.6 p -50.61 122.37 7.09 Favored 'General case' 0 C--O 1.249 1.028 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -170.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.633 ' SG ' ' NE2' ' A' ' 392' ' ' HIS . 53.0 t -65.13 115.22 5.27 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 168.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 44.3 ttp -51.89 -42.97 63.13 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.596 0.712 . . . . 0.0 111.624 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.563 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 24.8 m-85 -87.63 -9.06 55.32 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.794 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.47 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 62.5 -130.71 43.75 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-O 119.248 -0.751 . . . . 0.0 112.521 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 383' ' ' ALA . . . . . 0.649 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -75.82 -10.25 59.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.405 0.621 . . . . 0.0 111.67 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -85.97 -5.65 59.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.676 -174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.703 ' SG ' ' NE2' ' A' ' 392' ' ' HIS . 4.7 p -65.64 132.62 49.27 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.12 0.486 . . . . 0.0 110.897 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -71.39 -11.88 61.12 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.405 0.621 . . . . 0.0 110.375 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -80.34 108.76 14.21 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.592 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.39 -3.3 21.21 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.34 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -63.18 140.41 97.67 Favored Pre-proline 0 C--O 1.233 0.189 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.025 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.72 -22.41 61.11 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.058 1.839 . . . . 0.0 110.901 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.57 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 96.6 t -66.7 -35.63 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.847 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.703 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 47.0 t60 -60.86 -30.82 70.36 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 121.892 -0.505 . . . . 0.0 109.668 177.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -90.82 -15.67 29.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.733 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -81.73 -19.45 41.4 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.509 -178.265 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.656 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 2.5 p80 -119.04 -10.53 9.81 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.656 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 86.9 m-85 -135.59 126.75 28.09 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 121.491 0.663 . . . . 0.0 111.111 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.472 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 25.3 m -72.15 154.45 41.05 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.004 176.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.648 ' HE2' ' HE2' ' A' ' 392' ' ' HIS . 55.2 m80 -134.99 166.26 30.5 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.649 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 34.7 Cg_exo -40.04 -13.6 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 123.851 3.034 . . . . 0.0 115.782 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 400' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 398' ' ' HIS . . . -130.08 34.22 2.77 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 401' ' ' ASP . . . . . 0.428 ' HB3' ' H ' ' A' ' 398' ' ' HIS . 18.5 t70 -120.19 151.14 39.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.388 0.613 . . . . 0.0 109.823 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 23.3 t -64.42 -18.47 64.75 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -172.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -111.66 7.67 20.51 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 48.3 t80 . . . . . 0 CA--C 1.532 0.278 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.354 -178.211 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 CA--C 1.537 0.461 0 CA-C-O 120.955 0.407 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.406 ' CG ' ' HG2' ' A' ' 418' ' ' ARG . 19.2 p-10 -131.23 -20.05 2.74 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.498 177.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.51 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 13.9 ptt180 -166.63 165.03 10.11 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -175.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 40.6 Cg_endo -66.31 148.12 84.06 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.047 2.498 . . . . 0.0 111.195 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -75.0 151.88 38.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.572 0.701 . . . . 0.0 110.578 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' CYS . . . . . 0.987 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 12.0 t -63.95 134.86 96.07 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.948 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.63 -5.77 9.3 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.169 1.912 . . . . 0.0 114.028 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -121.52 8.9 10.17 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.24 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 64.49 -154.12 48.5 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 119.835 -0.425 . . . . 0.0 112.527 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.43 -19.3 28.86 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.685 2.257 . . . . 0.0 111.711 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 36.5 t -74.13 -8.71 57.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.596 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' CYS . . . . . 0.987 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 48.7 t -49.84 117.83 2.51 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.277 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -112.68 22.24 14.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.46 0.648 . . . . 0.0 110.623 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -67.97 107.21 2.6 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.534 175.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -77.73 89.99 4.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.286 0.565 . . . . 0.0 111.567 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -165.31 127.21 1.46 Allowed Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.258 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.558 ' O ' HG13 ' A' ' 436' ' ' ILE . 31.0 Cg_endo -63.16 -40.99 29.97 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.837 1.691 . . . . 0.0 111.592 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -62.38 -37.09 84.42 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.766 0.317 . . . . 0.0 110.345 -176.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' HIS . . . . . 0.691 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 39.8 t60 -60.06 -56.78 17.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.958 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.466 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 23.1 mtpp -57.92 -21.6 44.47 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.641 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 432' ' ' PRO . 65.4 mt -81.23 -46.37 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 122.763 0.425 . . . . 0.0 110.797 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 418' ' ' ARG . 7.2 mm-40 -84.02 -27.86 28.08 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -174.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -107.32 129.33 54.91 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.773 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -83.65 111.82 19.47 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.369 0.604 . . . . 0.0 110.859 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.725 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 63.8 m80 -87.53 112.53 22.33 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.525 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -114.66 125.56 53.88 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -171.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.6 p -88.9 124.43 34.2 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.504 ' CD1' ' HB ' ' A' ' 445' ' ' VAL . 1.4 pp -111.25 147.35 36.46 Favored Pre-proline 0 C--O 1.249 1.05 0 O-C-N 123.871 0.732 . . . . 0.0 111.76 -173.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 444' ' ' PRO . . . . . 0.424 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 28.4 Cg_endo -63.41 -30.68 72.61 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.041 2.494 . . . . 0.0 112.211 -175.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.504 ' HB ' ' CD1' ' A' ' 443' ' ' LEU . 8.7 p 43.33 30.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.739 0.816 . . . . 0.0 111.136 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.424 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 21.9 mmt180 -68.68 137.6 54.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.343 0.592 . . . . 0.0 111.553 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -74.09 86.37 1.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.023 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.448 -0.537 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.635 -179.496 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.477 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.4 HG23 ' CD2' ' A' ' 396' ' ' PHE . 2.7 t -92.17 149.92 21.21 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.046 178.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 36.9 t -54.51 117.93 3.74 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.951 0.782 . . . . 0.0 111.752 -174.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.934 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 7.8 t -51.68 115.47 1.65 Allowed 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 170.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 26.0 ptm -57.15 -26.77 61.11 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.451 0.469 . . . . 0.0 111.321 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.553 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 58.9 m-85 -102.78 -17.15 15.72 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.696 0.284 . . . . 0.0 110.677 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.422 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 66.41 -114.37 6.45 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.814 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -83.08 -7.29 59.66 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.996 -0.709 . . . . 0.0 110.745 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 381' ' ' TYR . 36.4 m-80 -83.88 -24.49 30.81 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.632 -176.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.934 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.8 p -67.2 120.99 14.68 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.593 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -78.96 4.32 14.62 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.391 1.057 . . . . 0.0 110.891 -174.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -80.96 119.86 24.02 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.699 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.457 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.9 OUTLIER -117.23 -1.73 11.77 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -176.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -60.99 142.58 92.74 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.352 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.68 -27.7 85.58 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.367 2.045 . . . . 0.0 110.384 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.469 ' O ' ' CD2' ' A' ' 395' ' ' HIS . 96.4 t -64.72 -41.07 91.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 O-C-N 123.79 0.681 . . . . 0.0 110.398 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.662 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 58.2 t60 -56.23 -34.0 65.93 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 39.6 m-85 -88.28 -25.05 23.01 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.198 0.523 . . . . 0.0 110.762 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -66.97 -19.37 65.71 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.595 -175.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.513 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 8.6 p80 -125.86 -17.75 5.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.621 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.513 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 26.3 m-85 -125.64 129.03 48.78 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 120.857 0.361 . . . . 0.0 110.898 174.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.477 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 13.7 p -84.08 160.82 20.86 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.396 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.732 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 43.9 m80 -133.44 159.18 73.58 Favored Pre-proline 0 C--N 1.342 0.271 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.667 -174.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -51.6 113.23 1.06 Allowed 'Trans proline' 0 C--O 1.238 0.517 0 C-N-CA 122.625 2.217 . . . . 0.0 112.242 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 110.66 -8.42 30.06 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.957 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -86.76 148.69 25.31 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.598 0.713 . . . . 0.0 110.869 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 46.1 t -56.71 -29.69 62.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.314 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -107.4 17.17 23.12 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.655 -175.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 61.4 t80 . . . . . 0 C--O 1.216 -0.699 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -178.21 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 CA--C 1.507 -0.707 0 CA-C-O 121.115 0.483 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -138.53 -14.64 1.26 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.799 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 13.7 ptt180 -171.95 154.15 3.4 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 122.432 0.293 . . . . 0.0 110.314 -173.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.94 147.85 24.8 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.516 2.144 . . . . 0.0 112.317 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.47 152.79 25.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' CYS . . . . . 0.67 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 17.1 t -59.03 129.41 85.99 Favored Pre-proline 0 C--O 1.244 0.785 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.927 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.89 -6.73 18.83 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 122.351 2.034 . . . . 0.0 111.745 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' TYR . . . . . 0.587 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 52.8 m-85 -108.27 8.97 28.05 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.027 176.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 62.72 -159.76 34.56 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.914 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.1 -20.74 24.75 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.076 2.517 . . . . 0.0 111.079 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 16.4 t -76.01 -4.25 40.22 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.755 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' CYS . . . . . 0.772 ' SG ' ' NE2' ' A' ' 434' ' ' HIS . 43.2 t -56.97 123.82 16.48 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.426 0.691 . . . . 0.0 112.028 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -126.94 28.97 5.72 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.573 ' HG2' ' SG ' ' A' ' 427' ' ' CYS . 20.9 mmm180 -68.69 101.35 1.29 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.658 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -67.86 90.8 0.3 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.394 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' ASN . . . . . 0.486 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 59.8 t30 -162.7 127.91 2.14 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.878 174.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.486 ' HD2' ' OD1' ' A' ' 431' ' ' ASN . 18.5 Cg_endo -60.59 -43.06 35.06 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 122.099 1.866 . . . . 0.0 112.392 -177.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -63.44 -32.34 73.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.789 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 434' ' ' HIS . . . . . 0.772 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 43.8 t60 -58.13 -59.83 4.68 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.828 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -12.36 60.76 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.448 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 432' ' ' PRO . 62.8 mt -76.7 -51.27 19.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.198 0.523 . . . . 0.0 110.671 175.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 418' ' ' ARG . 7.9 mm-40 -72.95 -49.62 28.21 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.061 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -98.59 138.3 35.98 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.412 0.445 . . . . 0.0 111.276 -173.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' ARG . . . . . 0.458 HH11 ' HD2' ' A' ' 439' ' ' ARG . 11.8 ptt180 -94.96 145.27 25.04 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.472 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 31.1 m80 -120.33 108.75 14.54 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -176.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -95.69 131.79 41.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.054 0.454 . . . . 0.0 109.975 -177.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 10.2 p -114.13 147.35 38.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.262 -175.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.489 HD13 ' HB ' ' A' ' 445' ' ' VAL . 1.2 pp -149.99 148.28 24.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.485 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.38 -25.74 11.0 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.962 2.441 . . . . 0.0 112.578 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.489 ' HB ' HD13 ' A' ' 443' ' ' LEU . 7.9 p 46.63 27.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 122.443 1.116 . . . . 0.0 111.932 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -87.81 -28.6 21.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.644 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -63.69 -32.19 73.59 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.5 -176.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 C--N 1.318 -0.772 0 O-C-N 122.218 -0.301 . . . . 0.0 110.514 178.741 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.474 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 120.491 0.186 . . . . 0.0 111.234 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 12.2 t -108.97 152.95 24.27 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.076 0.86 . . . . 0.0 109.29 175.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 45.7 m -51.52 122.73 8.46 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 121.161 0.505 . . . . 0.0 111.483 -174.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.842 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 54.0 t -51.3 123.15 9.0 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.937 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 23.8 ptm -55.42 -25.05 33.72 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.185 0.594 . . . . 0.0 111.324 -174.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.543 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 37.5 m-85 -116.88 -8.07 11.35 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.813 177.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 379' ' ' CYS . . . 63.05 -123.98 31.32 Favored Glycine 0 C--O 1.242 0.644 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.863 -177.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -82.06 -9.71 59.46 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.303 0.241 . . . . 0.0 111.056 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -77.05 -30.29 55.57 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.806 0.336 . . . . 0.0 111.193 -175.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.842 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 4.5 p -65.94 115.82 6.43 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.24 176.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -76.28 2.36 13.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.856 0.836 . . . . 0.0 110.944 -175.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -65.92 124.0 21.33 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.048 172.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.512 ' HD2' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -125.61 3.02 7.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.168 0.509 . . . . 0.0 110.464 -176.485 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -61.43 139.86 94.83 Favored Pre-proline 0 C--O 1.247 0.957 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.186 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.69 -25.13 80.34 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 122.934 2.423 . . . . 0.0 112.346 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.564 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 95.9 t -64.24 -37.18 79.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.573 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.752 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 26.0 t60 -58.64 -27.36 64.66 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.143 0.497 . . . . 0.0 110.644 177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -98.09 -7.96 28.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.668 -177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -84.18 -17.05 41.24 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.041 0.448 . . . . 0.0 110.959 -176.599 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.476 ' ND1' ' CD1' ' A' ' 396' ' ' PHE . 7.8 p80 -126.58 -16.65 5.25 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 176.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.532 ' CD2' ' HA ' ' A' ' 379' ' ' CYS . 63.5 m-85 -125.07 128.03 47.85 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.675 0.75 . . . . 0.0 112.408 174.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.474 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 20.1 p -80.01 165.38 22.63 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.483 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.531 ' NE2' ' NE2' ' A' ' 392' ' ' HIS . 50.1 m80 -136.97 158.29 73.11 Favored Pre-proline 0 C--O 1.245 0.864 0 O-C-N 123.203 0.314 . . . . 0.0 110.318 -175.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -54.38 97.28 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.153 2.569 . . . . 0.0 110.728 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 121.93 17.14 3.84 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 123.76 0.663 . . . . 0.0 111.457 -174.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -117.24 151.08 37.66 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.215 -0.579 . . . . 0.0 110.208 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 35.2 t -57.76 -36.78 72.57 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.168 -176.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -92.79 9.05 36.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.22 0.533 . . . . 0.0 111.253 -172.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 31.0 t80 . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.789 179.174 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.5 t70 . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -178.92 -26.85 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.242 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 20.9 ptt180 -142.98 160.02 54.3 Favored Pre-proline 0 C--O 1.216 -0.689 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.099 -170.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.76 159.22 48.95 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 121.652 1.568 . . . . 0.0 112.037 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' GLU . . . . . 0.406 ' HG3' ' CZ ' ' A' ' 439' ' ' ARG . 40.8 mt-10 -73.51 155.24 39.39 Favored 'General case' 0 C--O 1.248 0.995 0 O-C-N 121.918 -0.489 . . . . 0.0 110.907 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 421' ' ' CYS . . . . . 0.77 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 16.1 t -61.7 133.64 93.61 Favored Pre-proline 0 N--CA 1.443 -0.785 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.359 176.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.17 -9.05 22.15 Favored 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 122.41 2.074 . . . . 0.0 112.743 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -116.5 12.2 15.07 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.086 0.554 . . . . 0.0 110.113 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 58.38 -153.55 27.45 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 116.5 -0.318 . . . . 0.0 112.497 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.87 -13.99 24.08 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.158 2.572 . . . . 0.0 112.474 173.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 32.2 t -70.17 -14.06 62.47 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.568 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 427' ' ' CYS . . . . . 0.77 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 51.5 t -49.76 137.02 16.78 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.256 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -138.12 20.57 2.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.501 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -63.96 104.1 0.67 Allowed 'General case' 0 C--O 1.24 0.604 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.676 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 430' ' ' LYS . 18.9 ptpt -62.24 95.88 0.07 Allowed 'General case' 0 C--O 1.249 1.055 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.011 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 431' ' ' ASN . . . . . 0.465 HD21 ' HB3' ' A' ' 433' ' ' GLN . 61.4 t30 -177.98 123.2 0.26 Allowed Pre-proline 0 C--O 1.238 0.475 0 CA-C-O 120.659 0.266 . . . . 0.0 110.496 176.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.08 -39.2 40.99 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.755 2.303 . . . . 0.0 111.83 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.617 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 6.6 tp-100 -64.46 -32.79 74.56 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.466 0.65 . . . . 0.0 110.655 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 434' ' ' HIS . . . . . 0.574 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 35.8 t60 -55.96 -59.95 4.17 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.094 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.404 ' H ' ' HD3' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -59.11 -19.01 40.73 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.972 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.487 HD12 ' HA ' ' A' ' 433' ' ' GLN . 77.3 mt -75.09 -43.84 44.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.596 0.713 . . . . 0.0 110.878 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.617 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 19.6 mt-10 -82.66 -40.4 20.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.28 -174.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -106.78 128.87 54.61 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.224 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 439' ' ' ARG . . . . . 0.406 ' CZ ' ' HG3' ' A' ' 420' ' ' GLU . 15.3 ptt-85 -85.4 116.4 23.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.894 0.854 . . . . 0.0 110.185 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.745 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 37.0 m80 -90.82 86.08 6.21 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.101 178.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -70.49 104.23 2.7 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.464 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 6.8 m -114.06 160.25 19.1 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.702 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.476 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.5 OUTLIER -135.12 157.24 77.31 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.769 179.157 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 444' ' ' PRO . . . . . 0.41 ' O ' HG12 ' A' ' 445' ' ' VAL . 18.7 Cg_endo -60.0 -42.28 45.72 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 122.06 1.84 . . . . 0.0 112.036 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.476 ' HB ' HD13 ' A' ' 443' ' ' LEU . 2.7 p 50.37 15.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 124.347 1.029 . . . . 0.0 112.513 177.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.41 133.56 46.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -176.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -73.29 86.23 1.45 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.971 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.321 -0.638 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.89 178.542 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.653 0 CA-C-O 120.976 0.417 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 12.9 m -101.0 139.94 35.99 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.66 173.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 49.7 m -54.83 122.98 11.96 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.609 -0.682 . . . . 0.0 110.023 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.701 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 18.4 t -50.16 123.3 8.12 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.199 0.523 . . . . 0.0 110.296 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 25.8 ptm -60.31 -17.84 45.56 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.188 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.591 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 38.0 m-85 -112.92 -11.05 13.47 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.75 177.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.407 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 65.43 -131.07 35.06 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.262 -177.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -75.75 -11.68 60.04 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.072 0.463 . . . . 0.0 110.71 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -80.22 -9.58 59.73 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -173.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.701 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 8.2 p -75.31 133.52 41.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.765 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -84.08 14.13 4.47 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.552 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -96.51 121.16 38.03 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.698 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.474 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -108.43 -22.16 12.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.328 -178.162 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -44.67 136.84 4.38 Favored Pre-proline 0 N--CA 1.474 0.775 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.087 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -58.7 -23.77 67.68 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.011 2.474 . . . . 0.0 112.348 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.629 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 74.0 t -67.65 -35.42 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.657 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.733 ' HE2' ' HE2' ' A' ' 398' ' ' HIS . 62.0 t60 -62.89 -19.85 64.58 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.69 -0.631 . . . . 0.0 109.794 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 90.7 m-85 -97.45 -7.53 31.42 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.74 -178.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.629 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -87.83 -19.81 26.93 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.045 0.45 . . . . 0.0 110.901 -178.029 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.458 ' ND1' ' CD2' ' A' ' 396' ' ' PHE . 7.4 p80 -121.5 -15.23 8.08 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.239 176.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.629 ' HA ' ' O ' ' A' ' 377' ' ' THR . 78.7 m-85 -133.57 127.55 33.35 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.779 0.8 . . . . 0.0 111.753 173.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 46.9 p -80.58 161.05 24.94 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.733 ' HE2' ' HE2' ' A' ' 392' ' ' HIS . 53.6 m80 -137.42 157.96 73.03 Favored Pre-proline 0 C--O 1.249 1.044 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -49.77 101.58 0.05 OUTLIER 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.199 2.599 . . . . 0.0 111.553 -176.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 122.41 -0.29 10.37 Favored Glycine 0 C--O 1.243 0.664 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.259 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -93.7 149.15 21.47 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 34.8 m -62.84 -20.53 65.17 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.522 0.514 . . . . 0.0 111.755 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.76 -3.02 28.84 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 51.0 t80 . . . . . 0 C--O 1.24 0.567 0 CA-C-O 120.82 0.343 . . . . 0.0 111.458 -172.402 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 417' ' ' ASP . 10.8 t70 . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 120.963 0.411 . . . . 0.0 111.317 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 416' ' ' ASP . 37.4 t70 80.7 63.32 0.02 OUTLIER 'General case' 0 C--O 1.243 0.761 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.917 173.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.515 ' HG3' ' CG ' ' A' ' 439' ' ' ARG . 14.6 ptt180 -179.12 153.8 0.75 Allowed Pre-proline 0 C--O 1.25 1.091 0 C-N-CA 124.001 0.921 . . . . 0.0 108.984 177.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -65.1 153.77 76.67 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.741 2.294 . . . . 0.0 111.163 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -74.44 161.0 30.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 421' ' ' CYS . . . . . 0.655 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 18.7 t -58.72 134.23 86.4 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.493 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.42 -19.64 65.52 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.158 1.905 . . . . 0.0 112.18 -178.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 18.2 m-85 -93.77 -5.54 48.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.06 0.457 . . . . 0.0 110.169 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 75.05 -162.53 53.82 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -173.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.91 -12.42 26.16 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.366 2.044 . . . . 0.0 111.958 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 51.1 m -73.8 -9.02 58.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.031 0.443 . . . . 0.0 110.336 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 427' ' ' CYS . . . . . 0.742 ' SG ' ' NE2' ' A' ' 434' ' ' HIS . 51.0 t -50.89 117.88 2.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.971 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -106.03 7.99 32.16 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.036 0.922 . . . . 0.0 110.142 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -66.51 109.82 2.92 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' LYS . . . . . 0.465 ' HB2' ' NZ ' ' A' ' 430' ' ' LYS . 10.2 mtmp? -100.46 18.96 17.71 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -171.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 431' ' ' ASN . . . . . 0.493 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 61.7 t30 -68.44 125.95 92.19 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 172.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.515 ' O ' HG13 ' A' ' 436' ' ' ILE . 17.8 Cg_endo -57.08 -41.27 76.45 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.629 2.219 . . . . 0.0 111.801 -177.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.575 ' O ' ' HG2' ' A' ' 437' ' ' GLU . 24.9 tp60 -64.6 -38.05 89.67 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' HIS . . . . . 0.742 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 25.0 t60 -59.14 -52.75 64.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.089 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -57.63 -31.0 65.83 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.3 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 432' ' ' PRO . 65.1 mt -70.99 -42.7 76.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.257 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 433' ' ' GLN . 6.8 mm-40 -76.09 -38.18 57.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 438' ' ' TYR . . . . . 0.49 ' HB3' ' HA ' ' A' ' 421' ' ' CYS . 85.7 m-85 -114.85 150.69 35.16 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -171.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 439' ' ' ARG . . . . . 0.515 ' CG ' ' HG3' ' A' ' 418' ' ' ARG . 36.8 mtm180 -95.25 123.62 38.86 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.248 0.968 . . . . 0.0 110.776 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.468 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 71.4 m80 -99.5 85.78 3.23 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -107.52 151.74 25.17 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -176.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 7.5 p -98.12 147.98 24.02 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.996 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 2.6 pp -148.52 156.79 42.13 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 110.728 -0.101 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' PRO . . . . . 0.55 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 21.1 Cg_endo -60.08 -28.53 87.21 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.933 2.422 . . . . 0.0 112.912 -174.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 444' ' ' PRO . 7.2 p 47.66 31.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 O-C-N 124.012 0.82 . . . . 0.0 111.183 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.55 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 26.4 mmt180 -86.67 163.01 17.62 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.703 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 60.51 44.24 12.04 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 10.0 m . . . . . 0 C--O 1.235 0.31 0 C-N-CA 124.548 1.139 . . . . 0.0 111.666 177.156 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.488 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.3 OUTLIER . . . . . 0 C--O 1.237 0.44 0 CA-C-O 121.497 0.665 . . . . 0.0 109.548 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 5.2 t -97.27 143.2 28.28 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.904 173.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 58.5 m -54.74 123.08 12.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.319 0.58 . . . . 0.0 112.052 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.837 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 29.3 t -49.47 107.97 0.17 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.226 176.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 22.4 ptp -54.55 -27.3 37.59 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -177.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -93.93 -16.63 23.8 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.083 0.468 . . . . 0.0 109.998 178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.6 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 66.35 -126.43 28.06 Favored Glycine 0 C--O 1.235 0.161 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -176.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -91.27 4.5 52.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.678 0.391 . . . . 0.0 110.829 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -88.52 -15.1 36.11 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.782 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.837 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 0.6 OUTLIER -67.94 131.61 45.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 0.0 110.397 177.848 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -82.65 21.11 1.03 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.281 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -95.99 121.99 38.33 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.653 176.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.418 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -107.82 -25.91 11.02 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 124.565 1.166 . . . . 0.0 108.534 -177.39 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -48.07 139.94 9.42 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.845 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.14 -22.34 67.41 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.849 1.699 . . . . 0.0 112.073 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.417 HG12 ' NE2' ' A' ' 395' ' ' HIS . 88.8 t -66.33 -34.73 72.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.865 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.714 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 70.9 t60 -59.82 -37.81 80.24 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.937 0.399 . . . . 0.0 110.153 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -86.23 -18.2 32.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.35 -176.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -29.28 61.08 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -175.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.677 ' HD1' ' HD1' ' A' ' 396' ' ' PHE . 1.0 OUTLIER -109.68 -16.51 13.91 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.575 176.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.677 ' HD1' ' HD1' ' A' ' 395' ' ' HIS . 72.5 m-85 -122.35 127.84 50.26 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 120.74 0.305 . . . . 0.0 110.945 176.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.488 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 16.8 p -78.37 156.43 29.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 122.874 0.47 . . . . 0.0 110.027 175.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.686 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 51.0 m80 -132.02 159.02 73.9 Favored Pre-proline 0 N--CA 1.476 0.836 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.997 -176.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -52.37 102.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.679 2.253 . . . . 0.0 111.954 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 121.23 -1.37 11.56 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.737 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -98.12 151.45 20.37 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 122.035 0.921 . . . . 0.0 110.503 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 29.7 p -63.36 -29.11 70.47 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.163 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -104.73 15.86 27.11 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.226 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.9 t80 . . . . . 0 C--N 1.323 -0.585 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.359 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 21.6 t70 . . . . . 0 C--O 1.239 0.517 0 CA-C-O 121.152 0.501 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -147.42 -43.56 0.17 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.353 175.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.492 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 24.7 ptt180 -122.09 165.89 18.98 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.191 -176.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 61.3 Cg_endo -72.68 146.23 42.96 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.217 1.945 . . . . 0.0 112.052 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 420' ' ' GLU . . . . . 0.581 ' HG2' ' ND2' ' A' ' 441' ' ' ASN . 47.2 mt-10 -61.38 155.24 22.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.884 0.373 . . . . 0.0 111.357 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 421' ' ' CYS . . . . . 0.956 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 8.3 t -66.62 136.7 94.85 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 421' ' ' CYS . 55.9 Cg_exo -53.21 -34.36 69.05 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.146 2.564 . . . . 0.0 112.69 -175.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 423' ' ' TYR . . . . . 0.501 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 74.8 m-85 -102.14 7.79 40.88 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.424 -176.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 71.04 -153.43 51.18 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.429 -0.35 . . . . 0.0 112.573 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.53 -19.02 49.11 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.538 2.159 . . . . 0.0 111.883 175.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 37.9 t -69.82 -19.58 63.47 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.599 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' CYS . . . . . 0.956 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 40.9 t -56.03 115.55 2.48 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.769 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -109.14 16.61 22.38 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 123.835 0.709 . . . . 0.0 109.483 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.527 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 2.4 mmp_? -53.71 93.23 0.01 OUTLIER 'General case' 0 C--O 1.246 0.884 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 173.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 430' ' ' LYS . . . . . 0.413 ' H ' ' HG2' ' A' ' 430' ' ' LYS . 14.4 ptpt -75.95 79.16 2.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.313 -174.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 431' ' ' ASN . . . . . 0.486 HD21 ' HB3' ' A' ' 433' ' ' GLN . 48.5 t30 -150.9 123.36 4.09 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.336 174.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.509 ' O ' HG13 ' A' ' 436' ' ' ILE . 23.2 Cg_endo -62.79 -33.16 77.08 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.19 1.926 . . . . 0.0 111.314 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.486 ' HB3' HD21 ' A' ' 431' ' ' ASN . 6.3 tp-100 -68.16 -38.65 82.32 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 434' ' ' HIS . . . . . 0.634 ' CE1' ' SG ' ' A' ' 421' ' ' CYS . 29.8 t60 -59.93 -53.85 53.06 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.948 0.88 . . . . 0.0 109.229 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.426 ' O ' ' NH1' ' A' ' 418' ' ' ARG . 51.1 mtpt -62.99 -14.69 50.8 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.307 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 432' ' ' PRO . 48.3 mt -86.31 -45.33 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 123.235 0.334 . . . . 0.0 110.546 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -76.8 -29.45 56.0 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 122.437 -0.164 . . . . 0.0 111.294 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -113.95 137.29 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.093 0.557 . . . . 0.0 109.87 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 439' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 418' ' ' ARG . 1.0 OUTLIER -94.47 130.3 40.9 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.078 178.167 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.74 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 21.4 m80 -106.17 86.07 2.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.595 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' ASN . . . . . 0.581 ' ND2' ' HG2' ' A' ' 420' ' ' GLU . 46.7 m-80 -69.85 135.47 49.63 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.332 -173.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 28.9 p -135.86 173.14 12.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.601 0.715 . . . . 0.0 110.448 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 443' ' ' LEU . 1.3 pp -137.12 146.46 54.57 Favored Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 122.028 -0.42 . . . . 0.0 110.284 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' PRO . . . . . 0.417 ' O ' HG12 ' A' ' 445' ' ' VAL . 27.2 Cg_endo -62.14 -44.54 19.17 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 122.901 2.401 . . . . 0.0 112.359 -175.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.453 ' HB ' HD13 ' A' ' 443' ' ' LEU . 5.9 p 48.21 26.27 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 124.444 1.098 . . . . 0.0 112.035 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 446' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 447' ' ' ASN . 27.8 mmm180 -92.5 167.81 11.69 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 447' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 446' ' ' ARG . 7.3 t30 74.43 -42.71 0.51 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.816 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 C--O 1.244 0.796 0 C-N-CA 123.128 0.571 . . . . 0.0 111.374 178.489 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.617 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.1 OUTLIER . . . . . 0 CA--C 1.514 -0.441 0 CA-C-O 122.009 0.909 . . . . 0.0 111.264 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.4 t -111.51 162.53 15.01 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.491 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 24.8 t -57.59 116.91 3.68 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.954 0.502 . . . . 0.0 111.699 -176.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 25.1 t -51.96 117.28 2.64 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 23.2 ptm -58.93 -21.09 57.45 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.611 0.243 . . . . 0.0 111.005 -170.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.621 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 72.0 m-85 -109.61 -14.81 14.3 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 379' ' ' CYS . . . 72.03 -134.94 22.26 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 383' ' ' ALA . . . . . 0.477 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -75.92 -1.27 24.68 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.842 0.354 . . . . 0.0 110.409 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -91.77 -10.48 39.82 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.621 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.2 p -73.59 126.05 29.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 122.134 -0.354 . . . . 0.0 110.524 175.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -77.81 10.92 2.41 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.441 0.639 . . . . 0.0 111.896 -175.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -95.31 119.44 33.83 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.083 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.549 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -122.28 5.73 9.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.47 -178.145 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -63.73 136.6 96.79 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.197 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.6 -33.14 30.12 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.499 2.799 . . . . 0.0 112.534 -171.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.488 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 54.1 t -65.59 -34.91 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.702 -177.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.682 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 81.5 t60 -57.22 -31.78 65.85 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 122.068 -0.395 . . . . 0.0 110.208 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -89.78 -10.29 46.06 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 123.337 0.398 . . . . 0.0 111.973 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -82.61 -12.67 57.52 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.584 -0.447 . . . . 0.0 111.117 -175.737 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.431 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 3.6 p80 -128.97 -23.41 3.06 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.45 ' CD2' ' HA ' ' A' ' 379' ' ' CYS . 60.2 m-85 -123.12 127.32 48.54 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.317 0.579 . . . . 0.0 111.096 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.617 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 57.4 m -86.95 166.17 15.31 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.037 173.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.64 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 28.1 m80 -131.74 159.11 73.39 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 122.815 0.446 . . . . 0.0 110.667 -174.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.477 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 19.6 Cg_endo -55.73 97.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.432 2.088 . . . . 0.0 111.885 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.18 -30.43 2.81 Favored Glycine 0 CA--C 1.508 -0.37 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.219 -175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -66.57 143.07 57.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.013 -0.593 . . . . 0.0 109.658 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 12.2 t -64.82 -17.44 64.24 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.91 -174.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -108.4 7.49 27.07 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.218 0.207 . . . . 0.0 111.091 -174.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 52.5 t80 . . . . . 0 C--O 1.238 0.465 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 178.389 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 N--CA 1.461 0.098 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -129.81 -24.91 2.63 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.68 0.752 . . . . 0.0 109.958 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.541 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 28.0 ptt180 -154.68 165.32 18.36 Favored Pre-proline 0 C--O 1.247 0.97 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.139 -175.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.541 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 39.3 Cg_endo -67.18 143.61 65.59 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.901 2.4 . . . . 0.0 112.541 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -67.18 151.92 46.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 123.248 0.343 . . . . 0.0 110.865 174.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' CYS . . . . . 0.674 ' SG ' ' NE2' ' A' ' 440' ' ' HIS . 27.9 t -63.55 136.3 96.65 Favored Pre-proline 0 C--N 1.317 -0.813 0 O-C-N 123.622 0.576 . . . . 0.0 109.866 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.78 -13.28 29.58 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.836 2.357 . . . . 0.0 112.365 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -111.59 8.89 21.09 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 57.32 -149.93 30.75 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 -172.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.89 -1.87 11.96 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.436 2.091 . . . . 0.0 111.88 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 17.3 t -84.05 -2.45 56.71 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.825 0.822 . . . . 0.0 109.121 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 427' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 44.7 t -49.35 117.49 2.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.386 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -108.29 11.5 27.2 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.998 176.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -75.15 93.8 2.85 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -79.18 83.28 5.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.491 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -144.34 122.94 6.92 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.522 ' O ' HG13 ' A' ' 436' ' ' ILE . 18.3 Cg_endo -59.08 -38.23 88.32 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.822 1.681 . . . . 0.0 112.885 -175.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.599 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 24.9 tp60 -65.45 -40.06 92.77 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.965 -0.46 . . . . 0.0 109.785 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 434' ' ' HIS . . . . . 0.658 ' CE1' ' HG ' ' A' ' 421' ' ' CYS . 26.1 t60 -57.9 -53.77 54.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.699 0.761 . . . . 0.0 110.452 177.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -61.02 -18.22 56.57 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.889 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 432' ' ' PRO . 52.3 mt -84.3 -41.84 16.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.676 178.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.599 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 23.8 mt-10 -79.21 -45.5 19.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.135 0.493 . . . . 0.0 110.847 -175.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -97.14 145.41 26.04 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.459 -174.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 439' ' ' ARG . . . . . 0.481 ' NH1' HD21 ' A' ' 441' ' ' ASN . 16.7 ptt180 -92.32 118.31 30.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.354 0.597 . . . . 0.0 110.213 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.674 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 76.2 m80 -92.9 78.55 4.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.002 175.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' ASN . . . . . 0.481 HD21 ' NH1' ' A' ' 439' ' ' ARG . 2.2 m-20 -66.63 105.58 1.57 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.763 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.0 p -81.92 121.89 27.06 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 443' ' ' LEU . 2.2 pp -87.65 145.66 37.57 Favored Pre-proline 0 C--O 1.246 0.89 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.907 -173.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.65 -32.16 19.6 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.103 2.535 . . . . 0.0 112.543 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.443 ' HB ' HD13 ' A' ' 443' ' ' LEU . 9.3 p 43.05 32.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.911 1.339 . . . . 0.0 109.941 -176.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -92.24 158.01 16.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.937 -1.102 . . . . 0.0 110.284 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 59.87 21.62 10.56 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 171.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.224 -0.248 0 O-C-N 123.563 0.539 . . . . 0.0 109.692 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.122 0 CA-C-O 120.989 0.424 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 14.3 t -134.14 162.81 31.1 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 12.4 m -54.59 117.7 3.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.638 0.732 . . . . 0.0 110.679 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.64 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 39.6 t -51.23 120.95 5.48 Favored 'General case' 0 C--N 1.359 0.992 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.085 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 27.2 ptm -58.81 -23.18 60.07 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.609 0.719 . . . . 0.0 111.122 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.605 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 35.1 m-85 -103.23 -15.71 15.92 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 121.075 -1.016 . . . . 0.0 109.902 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.528 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 64.6 -131.74 37.76 Favored Glycine 0 CA--C 1.498 -1.028 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.797 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -75.75 -4.87 42.89 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 122.65 0.38 . . . . 0.0 111.214 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -86.86 -5.33 59.14 Favored 'General case' 0 C--O 1.248 1.022 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.715 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.701 ' SG ' ' NE2' ' A' ' 392' ' ' HIS . 6.4 p -81.2 123.58 28.57 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.649 0.738 . . . . 0.0 111.43 176.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -82.13 10.72 6.22 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.911 0.862 . . . . 0.0 110.95 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.55 HH21 ' ND2' ' A' ' 389' ' ' ASN . 31.4 mmm180 -84.02 124.09 30.7 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.13 174.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.491 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -116.46 -5.3 11.73 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.422 -176.595 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.55 ' ND2' HH21 ' A' ' 387' ' ' ARG . 20.7 p-10 -58.73 137.59 86.68 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.217 176.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -60.01 -24.19 75.68 Favored 'Trans proline' 0 CA--C 1.518 -0.297 0 C-N-CA 122.178 1.919 . . . . 0.0 111.252 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.546 HG12 ' NE2' ' A' ' 395' ' ' HIS . 93.4 t -66.62 -42.17 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.129 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.781 ' HE2' ' HE2' ' A' ' 398' ' ' HIS . 82.3 t60 -54.53 -35.05 62.78 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 120.381 -0.527 . . . . 0.0 110.459 178.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 24.6 m-85 -88.08 -24.04 23.54 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.771 -176.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -72.83 -20.26 61.17 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.949 -177.52 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.698 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 1.9 p80 -118.22 -8.71 10.58 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 176.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.698 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 88.0 m-85 -137.65 127.28 25.21 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.333 0.587 . . . . 0.0 110.767 176.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 46.2 m -85.78 159.2 19.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.964 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.781 ' HE2' ' HE2' ' A' ' 392' ' ' HIS . 39.2 m80 -128.1 153.02 78.52 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.811 -174.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -50.77 112.34 0.74 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.311 2.007 . . . . 0.0 112.701 -174.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 117.65 -5.57 16.62 Favored Glycine 0 C--O 1.237 0.34 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.075 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -95.67 145.41 25.29 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.322 0.582 . . . . 0.0 109.922 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 42.0 t -57.81 -30.91 66.08 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.293 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -94.29 2.61 55.85 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.758 -174.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 59.8 t80 . . . . . 0 C--N 1.321 -0.633 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.421 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.8 t70 . . . . . 0 N--CA 1.468 0.442 0 CA-C-O 121.414 0.626 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 35.8 t70 79.4 57.94 0.02 OUTLIER 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.252 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -175.75 152.89 1.35 Allowed Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.094 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.42 145.53 67.52 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.071 1.847 . . . . 0.0 112.203 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.37 150.88 39.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 172.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 5.5 t -59.48 127.37 84.55 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 421' ' ' CYS . 50.9 Cg_exo -54.95 -23.6 35.51 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.344 2.029 . . . . 0.0 113.219 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 423' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 87.7 m-85 -102.34 18.01 22.08 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.239 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 59.03 -156.07 25.46 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.579 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' PRO . . . . . 0.411 ' HG3' ' HG ' ' A' ' 443' ' ' LEU . 57.0 Cg_endo -73.68 -9.68 22.83 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.654 2.236 . . . . 0.0 111.083 175.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 32.1 t -73.87 -8.86 57.68 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.52 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 427' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 23.1 t -62.94 115.64 4.58 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.399 0.619 . . . . 0.0 109.545 176.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -109.13 21.51 17.07 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.782 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 0.2 OUTLIER -64.02 92.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.207 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -68.79 91.44 0.45 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.851 0.834 . . . . 0.0 111.393 -174.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 431' ' ' ASN . . . . . 0.441 HD21 ' HB3' ' A' ' 433' ' ' GLN . 63.1 t30 -161.98 123.54 1.63 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.811 173.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.478 ' O ' HG13 ' A' ' 436' ' ' ILE . 33.4 Cg_endo -63.91 -36.52 49.4 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.752 2.302 . . . . 0.0 110.599 -178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.668 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 22.4 tp60 -65.31 -37.01 85.82 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 434' ' ' HIS . . . . . 0.66 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 12.3 t60 -63.3 -49.35 74.37 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 121.683 0.754 . . . . 0.0 109.575 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.481 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 53.8 mtpt -66.72 -7.1 18.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.078 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 432' ' ' PRO . 42.6 mt -94.97 -42.94 12.85 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.752 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.668 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 22.8 mt-10 -68.76 -37.55 79.46 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.83 0.824 . . . . 0.0 110.555 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -117.55 138.66 51.76 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.551 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -89.38 118.61 29.17 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.712 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 22.3 m80 -94.21 99.34 11.62 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -91.43 106.08 18.24 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.56 -175.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.98 138.32 39.57 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.552 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.5 OUTLIER -118.53 149.81 46.87 Favored Pre-proline 0 C--O 1.248 1.011 0 CA-C-O 120.963 0.411 . . . . 0.0 111.771 -171.634 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.52 -18.32 12.25 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 123.042 2.494 . . . . 0.0 111.859 175.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.552 ' HB ' HD13 ' A' ' 443' ' ' LEU . 10.0 p 43.03 30.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.245 0 CA-C-O 122.315 1.055 . . . . 0.0 111.715 -178.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -108.39 -33.37 7.1 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.509 -174.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -81.65 -27.79 33.92 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.128 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--O 1.206 -1.237 0 O-C-N 123.755 0.659 . . . . 0.0 109.669 179.508 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.298 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 12.6 t -101.83 149.38 24.25 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 9.7 t -57.93 111.86 1.3 Allowed 'General case' 0 C--O 1.244 0.796 0 O-C-N 123.355 0.41 . . . . 0.0 110.193 -171.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.782 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 30.9 t -51.36 108.96 0.29 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 14.5 ptp -60.43 -13.62 14.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.988 0.423 . . . . 0.0 110.665 -176.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.448 ' CB ' ' HB3' ' A' ' 385' ' ' CYS . 36.3 m-85 -93.59 -27.05 16.83 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.079 175.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.411 ' O ' ' HD2' ' A' ' 398' ' ' HIS . . . 60.28 -117.93 13.05 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.415 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -84.29 -9.67 58.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.17 -0.606 . . . . 0.0 111.505 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -78.95 -26.67 43.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.2 -176.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.782 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 13.5 p -73.87 111.57 9.15 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.426 172.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -84.98 12.39 7.66 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.38 0.609 . . . . 0.0 110.143 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -65.11 125.47 25.04 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 172.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.5 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.5 OUTLIER -119.72 0.75 10.98 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.028 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -66.05 133.86 94.83 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.117 173.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.9 -22.08 67.06 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.547 2.165 . . . . 0.0 112.292 -174.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.576 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 74.9 t -67.85 -38.32 79.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.129 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.75 ' HE2' ' HE2' ' A' ' 398' ' ' HIS . 85.0 t60 -62.88 -26.69 68.9 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 120.864 0.364 . . . . 0.0 110.051 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -92.46 -19.57 21.88 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.281 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -73.79 -23.69 59.72 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.872 -177.111 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.595 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 2.4 p80 -116.7 -11.89 10.93 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 177.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.595 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 93.8 m-85 -131.94 131.71 42.88 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 122.126 -0.359 . . . . 0.0 111.549 175.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 22.2 p -84.38 153.95 23.14 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.369 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.75 ' HE2' ' HE2' ' A' ' 392' ' ' HIS . 69.3 m80 -136.32 159.87 69.09 Favored Pre-proline 0 C--O 1.221 -0.44 0 O-C-N 122.339 -0.225 . . . . 0.0 110.524 -173.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 17.4 Cg_endo -54.43 103.08 0.09 OUTLIER 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.25 1.966 . . . . 0.0 111.614 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 129.62 -23.68 4.74 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -76.27 151.09 36.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.231 -0.484 . . . . 0.0 110.78 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 13.5 m -67.15 -22.83 65.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.523 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -110.99 15.56 21.66 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.285 -173.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 38.1 t80 . . . . . 0 C--N 1.319 -0.748 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.823 -178.944 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.7 t70 . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 36.7 t70 68.85 74.09 0.26 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.425 0.631 . . . . 0.0 110.181 -174.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.493 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 19.3 ptt180 -162.88 158.82 18.99 Favored Pre-proline 0 C--O 1.246 0.91 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 35.8 Cg_endo -63.32 136.57 56.07 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.644 2.229 . . . . 0.0 111.644 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 420' ' ' GLU . . . . . 0.435 ' HG2' ' HE ' ' A' ' 439' ' ' ARG . 51.7 mt-10 -70.58 147.76 48.91 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 121.797 -0.564 . . . . 0.0 110.121 175.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 421' ' ' CYS . . . . . 1.001 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 11.9 t -54.82 137.56 64.34 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.396 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.74 -14.38 26.46 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.158 1.906 . . . . 0.0 112.494 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -113.27 10.31 18.46 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.116 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 59.36 -151.19 36.21 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-O 119.598 -0.557 . . . . 0.0 111.85 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.14 -13.02 28.42 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.664 2.243 . . . . 0.0 112.344 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 38.0 t -79.87 1.24 27.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.485 176.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 427' ' ' CYS . . . . . 1.001 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 48.0 t -60.02 116.72 4.36 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.127 177.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -114.42 23.56 12.68 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.983 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -69.04 108.42 3.54 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.762 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -77.29 84.15 3.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.142 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 431' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 434' ' ' HIS . 61.5 t30 -156.47 121.07 2.39 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.428 175.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.445 ' O ' HG13 ' A' ' 436' ' ' ILE . 18.7 Cg_endo -58.76 -43.32 45.2 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.423 2.082 . . . . 0.0 112.708 -175.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.44 ' O ' ' HG2' ' A' ' 437' ' ' GLU . 6.8 tp-100 -67.94 -26.35 65.92 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.93 0.769 . . . . 0.0 109.744 -175.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 434' ' ' HIS . . . . . 0.705 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 59.6 t60 -60.55 -59.37 5.5 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 122.816 0.446 . . . . 0.0 111.494 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -59.47 -25.6 64.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.668 0.27 . . . . 0.0 111.025 179.395 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 432' ' ' PRO . 67.0 mt -70.18 -46.46 72.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.007 0.432 . . . . 0.0 111.09 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 433' ' ' GLN . 11.8 mm-40 -76.31 -53.9 7.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.944 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -91.62 144.62 25.34 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.374 0.421 . . . . 0.0 110.516 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' ARG . . . . . 0.47 ' HB3' ' HG3' ' A' ' 418' ' ' ARG . 17.7 ptt180 -89.94 137.03 32.68 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.663 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 61.7 m80 -111.72 79.9 1.26 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.281 0.562 . . . . 0.0 109.674 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -74.86 129.45 37.7 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.069 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 17.2 p -86.56 140.4 29.92 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.804 -0.56 . . . . 0.0 109.841 -177.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.472 HD13 ' HB ' ' A' ' 445' ' ' VAL . 1.2 pp -109.04 151.84 42.15 Favored Pre-proline 0 C--N 1.312 -1.046 0 O-C-N 123.858 0.724 . . . . 0.0 110.114 -175.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.54 -49.06 4.8 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.288 1.992 . . . . 0.0 112.082 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.472 ' HB ' HD13 ' A' ' 443' ' ' LEU . 11.3 p 40.07 39.59 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.87 0.843 . . . . 0.0 109.751 -174.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -89.91 161.66 15.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.368 -173.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -56.52 -35.83 68.5 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.026 0.441 . . . . 0.0 110.739 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 C--O 1.252 1.199 0 CA-C-O 121.128 0.49 . . . . 0.0 111.821 176.751 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.592 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.441 -0.879 0 CA-C-O 121.399 0.619 . . . . 0.0 111.116 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 11.9 t -101.3 152.91 20.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.966 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 14.0 t -54.53 119.48 5.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.741 0.305 . . . . 0.0 111.723 -171.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 26.3 t -59.29 109.78 0.94 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 24.8 ptm -54.53 -29.86 51.94 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.364 -176.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.534 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 51.9 m-85 -98.23 -16.65 19.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.54 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 382' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 62.89 -116.26 9.14 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.874 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -90.34 7.79 36.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.854 0.359 . . . . 0.0 111.221 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -98.49 -22.55 15.95 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.447 0.299 . . . . 0.0 110.852 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 1.8 p -65.18 131.55 46.82 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.142 176.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -80.59 12.31 3.18 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.383 0.611 . . . . 0.0 112.067 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -92.66 112.16 24.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.649 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.442 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -100.05 -24.09 14.7 Favored 'General case' 0 C--O 1.221 -0.419 0 O-C-N 123.855 0.722 . . . . 0.0 109.316 -179.435 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -47.49 138.85 8.57 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.707 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.47 -21.82 69.48 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.453 2.102 . . . . 0.0 111.464 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.577 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 93.3 t -66.7 -36.91 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.436 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.656 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 82.1 t60 -58.66 -38.26 77.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.293 174.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -87.56 -4.99 58.95 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.923 -176.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.577 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -85.71 -24.48 26.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.039 -0.413 . . . . 0.0 110.465 178.637 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.422 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 1.2 p80 -110.96 -23.76 10.77 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.493 175.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.422 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 90.8 m-85 -120.27 129.03 53.86 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.597 0.713 . . . . 0.0 111.997 178.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.592 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 11.8 p -82.17 157.84 23.84 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.365 175.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.576 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 58.9 m80 -136.09 162.2 58.01 Favored Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -170.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.07 100.63 0.08 OUTLIER 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.778 2.318 . . . . 0.0 111.059 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 109.54 24.33 5.92 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.476 -174.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' ASP . . . . . 0.463 ' HB3' ' H ' ' A' ' 398' ' ' HIS . 20.7 t70 -119.97 150.5 40.42 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 122.303 0.241 . . . . 0.0 110.478 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 17.7 t -54.37 -41.1 68.78 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.277 0.631 . . . . 0.0 111.791 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -104.08 16.41 26.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.759 -167.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 19.9 t80 . . . . . 0 C--O 1.236 0.346 0 CA-C-O 120.531 0.205 . . . . 0.0 110.603 -179.12 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.48 ' HB2' ' HD3' ' A' ' 439' ' ' ARG . 2.1 m-20 . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 12.0 t70 81.98 50.81 0.02 OUTLIER 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.0 -174.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -153.25 158.59 32.77 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.026 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' A' ' 438' ' ' TYR . 80.4 Cg_exo -48.03 141.85 16.63 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.89 2.394 . . . . 0.0 112.69 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 420' ' ' GLU . . . . . 0.434 ' HG2' HD21 ' A' ' 441' ' ' ASN . 38.5 mt-10 -83.27 143.2 30.56 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 421' ' ' CYS . . . . . 0.777 ' HG ' ' CE1' ' A' ' 434' ' ' HIS . 34.8 t -59.61 126.96 84.18 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.22 7.12 1.21 Allowed 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.576 2.184 . . . . 0.0 112.835 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -120.31 5.1 10.73 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 64.9 -162.99 38.05 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.6 -15.34 27.4 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.008 2.472 . . . . 0.0 112.489 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 40.4 t -70.52 -13.16 62.0 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.044 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 427' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 46.6 t -48.66 118.02 2.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.836 0.854 . . . . 0.0 110.612 -178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -113.84 18.41 17.38 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 122.899 0.479 . . . . 0.0 109.918 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.478 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 4.3 mmp_? -66.52 96.58 0.38 Allowed 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.798 175.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 430' ' ' LYS . . . . . 0.525 ' HB2' ' NZ ' ' A' ' 430' ' ' LYS . 10.1 mtmp? -69.05 93.55 0.59 Allowed 'General case' 0 C--O 1.241 0.614 0 O-C-N 123.371 0.419 . . . . 0.0 110.283 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 431' ' ' ASN . . . . . 0.482 HD21 ' HB3' ' A' ' 433' ' ' GLN . 54.6 t30 -157.9 122.91 2.3 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.463 ' O ' HG13 ' A' ' 436' ' ' ILE . 33.4 Cg_endo -63.43 -35.74 59.29 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.487 2.125 . . . . 0.0 112.056 -177.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.64 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 23.4 tp60 -68.45 -41.62 79.97 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -175.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 434' ' ' HIS . . . . . 0.777 ' CE1' ' HG ' ' A' ' 421' ' ' CYS . 5.0 t60 -56.2 -51.2 68.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.433 0.635 . . . . 0.0 110.132 178.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -67.18 -13.76 62.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.402 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 432' ' ' PRO . 40.2 mt -89.84 -34.87 6.94 Favored 'Isoleucine or valine' 0 C--O 1.251 1.153 0 C-N-CA 122.704 0.402 . . . . 0.0 110.146 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.64 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 27.9 mt-10 -83.77 -45.54 13.22 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.298 0.571 . . . . 0.0 111.12 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 438' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 419' ' ' PRO . 19.1 m-85 -103.32 147.1 27.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.229 -174.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 439' ' ' ARG . . . . . 0.48 ' HD3' ' HB2' ' A' ' 416' ' ' ASP . 17.0 ptt180 -93.69 114.02 26.23 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.589 177.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.456 ' CD2' ' HB3' ' A' ' 427' ' ' CYS . 79.6 m80 -81.66 85.01 6.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 441' ' ' ASN . . . . . 0.434 HD21 ' HG2' ' A' ' 420' ' ' GLU . 89.0 m-20 -67.32 103.57 1.3 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.361 -173.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 1.5 m -104.47 159.35 15.81 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.132 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.557 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.5 OUTLIER -135.75 144.83 50.48 Favored Pre-proline 0 C--N 1.32 -0.684 0 O-C-N 121.66 -0.65 . . . . 0.0 111.828 -176.061 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -64.22 -29.21 64.34 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.435 2.757 . . . . 0.0 110.834 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.557 ' HB ' HD13 ' A' ' 443' ' ' LEU . 7.3 p 35.9 69.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 124.823 1.327 . . . . 0.0 110.591 -175.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -56.68 157.34 5.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.455 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -66.78 -26.77 67.12 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.104 0.877 . . . . 0.0 110.54 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.472 0.668 0 O-C-N 123.273 0.358 . . . . 0.0 110.917 179.432 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 376' ' ' ARG . . . . . 0.568 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 122.039 0.923 . . . . 0.0 110.683 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 5.4 t -96.2 153.65 17.68 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.233 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.1 m -64.22 122.67 17.2 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.075 0.464 . . . . 0.0 111.166 -170.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 15.4 t -49.92 123.61 8.42 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.729 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 20.8 ptm -56.0 -29.47 60.36 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.217 0.532 . . . . 0.0 111.072 -172.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' TYR . . . . . 0.554 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 39.2 m-85 -98.73 -14.85 19.58 Favored 'General case' 0 C--O 1.255 1.391 0 CA-C-O 119.051 -0.5 . . . . 0.0 110.439 176.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 62.49 -107.51 1.65 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -84.3 -13.71 51.73 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' ASN . . . . . 0.526 ' HB2' ' HB3' ' A' ' 381' ' ' TYR . 38.9 m-80 -81.49 -26.01 35.55 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -174.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.4 p -66.65 113.89 5.15 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.035 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -85.49 9.48 15.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.935 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 387' ' ' ARG . 27.8 mmt180 -62.46 134.13 55.99 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.957 176.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.527 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.3 OUTLIER -118.97 -7.64 10.36 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 124.105 0.878 . . . . 0.0 110.406 -171.725 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -67.47 137.09 93.33 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.057 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -60.68 -30.67 90.89 Favored 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 121.576 1.517 . . . . 0.0 110.946 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.402 HG12 ' NE2' ' A' ' 395' ' ' HIS . 87.9 t -59.17 -40.68 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.896 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.691 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 85.6 t60 -54.95 -43.9 73.85 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 120.771 0.319 . . . . 0.0 110.441 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -82.23 -25.15 34.4 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.493 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -66.67 -27.88 68.01 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.686 0.279 . . . . 0.0 110.783 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.634 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 1.1 p80 -119.09 -3.98 10.6 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.634 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 39.6 m-85 -139.33 126.59 21.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.442 0.639 . . . . 0.0 109.989 177.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.568 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 70.7 m -83.46 158.63 21.98 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 123.261 0.624 . . . . 0.0 111.031 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.614 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 27.0 m80 -127.65 162.03 51.62 Favored Pre-proline 0 C--O 1.222 -0.354 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 14.8 Cg_endo -55.11 106.34 0.18 Allowed 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 121.829 1.686 . . . . 0.0 111.219 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 120.03 -1.14 13.28 Favored Glycine 0 C--N 1.319 -0.368 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.47 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -94.98 148.98 21.74 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.7 t -62.48 -30.4 71.23 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.402 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.99 2.4 51.46 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 110.726 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 58.2 t80 . . . . . 0 N--CA 1.465 0.292 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.591 178.927 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 C--O 1.241 0.636 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 21.7 t70 175.32 -27.75 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.66 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.422 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 24.1 ptt180 -138.17 165.67 31.61 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.977 -174.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 62.1 Cg_endo -75.72 162.52 35.15 Favored 'Trans proline' 0 C--O 1.244 0.783 0 C-N-CA 121.221 1.281 . . . . 0.0 110.957 177.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.64 158.27 33.92 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.689 0.757 . . . . 0.0 109.502 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 6.6 t -65.86 136.7 95.81 Favored Pre-proline 0 N--CA 1.453 -0.305 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 175.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.17 -16.92 42.95 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.269 1.313 . . . . 0.0 112.772 -177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -115.11 15.71 17.08 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.851 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 57.72 -152.03 27.97 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.995 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.45 -14.8 34.24 Favored 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 121.973 1.782 . . . . 0.0 111.535 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 19.9 t -82.08 2.2 32.33 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.92 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 49.8 t -60.25 124.17 19.46 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.362 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -121.56 66.42 0.89 Allowed 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.563 0.697 . . . . 0.0 110.117 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.463 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 2.3 mmp_? -108.8 108.79 19.73 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 430' ' ' LYS . . . . . 0.469 ' HB2' ' NZ ' ' A' ' 430' ' ' LYS . 4.8 ttmp? -70.13 82.06 0.51 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.057 -0.402 . . . . 0.0 110.741 -176.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 431' ' ' ASN . . . . . 0.517 ' ND2' ' HD2' ' A' ' 432' ' ' PRO . 8.7 t-20 -166.36 123.99 1.04 Allowed Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 123.012 0.525 . . . . 0.0 110.247 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.517 ' HD2' ' ND2' ' A' ' 431' ' ' ASN . 42.6 Cg_endo -68.2 -32.56 26.76 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.088 1.859 . . . . 0.0 112.3 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.647 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 6.6 tp-100 -68.94 -36.23 77.72 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.935 -0.478 . . . . 0.0 109.845 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 434' ' ' HIS . . . . . 0.67 ' CE1' ' SG ' ' A' ' 421' ' ' CYS . 39.9 t60 -53.59 -56.1 20.02 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.023 0.916 . . . . 0.0 110.579 176.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.4 ' HA ' ' HE1' ' A' ' 440' ' ' HIS . 24.2 mtpp -60.46 -16.51 37.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.761 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 432' ' ' PRO . 58.1 mt -87.81 -28.86 5.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.426 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.647 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 29.1 mt-10 -90.33 -32.95 16.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.757 -175.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -114.39 129.75 56.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.13 0.491 . . . . 0.0 109.818 -174.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 439' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 419' ' ' PRO . 15.7 ptt180 -79.13 118.9 21.53 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.007 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.761 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 66.5 m80 -98.96 90.58 4.68 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -67.3 107.75 2.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.655 0.74 . . . . 0.0 110.452 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 1.3 p -99.32 122.89 43.08 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.252 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 443' ' ' LEU . . . . . 0.42 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.4 OUTLIER -133.16 157.09 79.13 Favored Pre-proline 0 C--O 1.215 -0.711 0 O-C-N 123.933 0.771 . . . . 0.0 110.02 -173.51 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 444' ' ' PRO . . . . . 0.404 ' O ' HG12 ' A' ' 445' ' ' VAL . 18.5 Cg_endo -56.17 -37.68 96.17 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 121.713 1.609 . . . . 0.0 111.584 -174.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.42 ' HB ' HD13 ' A' ' 443' ' ' LEU . 5.3 p 46.84 20.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.051 1.34 . . . . 0.0 112.633 177.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 47.0 mmt-85 -68.79 128.99 38.63 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.379 -0.826 . . . . 0.0 110.452 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -84.39 -17.53 39.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.393 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 C--O 1.237 0.406 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.067 178.482 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.296 0 CA-C-O 120.923 0.392 . . . . 0.0 111.57 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 6.2 t -130.89 165.71 22.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.816 175.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 16.4 m -59.53 113.02 2.0 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -172.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 49.1 t -52.55 114.9 1.53 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 26.7 ptm -53.29 -26.94 20.38 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.239 -173.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -91.73 -25.43 19.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 61.55 -115.9 8.58 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.116 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' ALA . . . . . 0.44 ' HB2' ' HG3' ' A' ' 399' ' ' PRO . . . -79.37 -6.25 56.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.919 0.39 . . . . 0.0 111.086 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -87.87 -28.68 21.43 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -173.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 385' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 4.8 p -71.39 129.65 39.34 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -94.42 17.22 13.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.449 -174.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -70.26 145.27 51.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' LYS . . . . . 0.561 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -130.52 -1.08 4.4 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.086 0.469 . . . . 0.0 110.136 178.388 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -76.89 134.76 68.1 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.57 -20.49 70.88 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.716 2.277 . . . . 0.0 111.467 -173.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.591 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 59.2 t -66.21 -44.32 91.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.745 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 392' ' ' HIS . . . . . 0.581 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 84.3 t60 -57.47 -28.01 62.99 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.027 0.441 . . . . 0.0 110.111 178.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 81.6 m-85 -96.47 -13.9 22.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.879 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.591 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -76.46 -18.68 58.66 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.617 -176.125 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 395' ' ' HIS . . . . . 0.558 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 6.8 p80 -122.81 -21.66 5.52 Favored 'General case' 0 C--O 1.245 0.816 0 O-C-N 123.167 0.292 . . . . 0.0 111.698 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 396' ' ' PHE . . . . . 0.558 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 48.0 m-85 -128.11 126.82 41.9 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 117.799 0.272 . . . . 0.0 111.044 176.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 397' ' ' SER . . . . . 0.422 ' OG ' ' HB2' ' A' ' 403' ' ' ASP . 68.9 m -87.88 165.17 15.46 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.415 0.626 . . . . 0.0 111.238 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 398' ' ' HIS . . . . . 0.668 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 42.7 m80 -132.72 164.56 42.86 Favored Pre-proline 0 C--O 1.233 0.23 0 C-N-CA 123.173 0.589 . . . . 0.0 110.117 -174.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 399' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 19.0 Cg_endo -55.03 93.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.072 2.515 . . . . 0.0 111.152 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 132.58 15.3 1.42 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.07 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -121.46 149.11 43.53 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 34.7 t -63.24 -33.01 74.56 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.481 0.312 . . . . 0.0 111.114 -174.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 403' ' ' ASP . . . . . 0.422 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 1.5 m-20 -90.73 9.73 28.79 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.188 0.518 . . . . 0.0 111.288 -175.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 55.9 t80 . . . . . 0 N--CA 1.456 -0.169 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.343 175.476 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 22.0 t70 . . . . . 0 C--O 1.237 0.403 0 CA-C-O 121.564 0.697 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -142.85 10.61 1.79 Allowed 'General case' 0 C--N 1.347 0.465 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 29.1 ptt180 -173.2 159.23 3.39 Favored Pre-proline 0 C--O 1.242 0.683 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.579 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.423 ' O ' ' HG2' ' A' ' 439' ' ' ARG . 55.4 Cg_endo -68.56 154.8 70.88 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.029 2.486 . . . . 0.0 112.38 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -74.54 143.35 44.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.894 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 11.6 t -57.84 133.68 83.2 Favored Pre-proline 0 C--N 1.317 -0.829 0 O-C-N 123.8 0.687 . . . . 0.0 109.571 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.7 -16.09 46.33 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 121.79 1.66 . . . . 0.0 113.092 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 29.3 m-85 -112.94 12.58 19.38 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 122.732 0.413 . . . . 0.0 110.033 179.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 56.57 -148.76 29.97 Favored Glycine 0 C--O 1.248 1.006 0 C-N-CA 121.321 -0.466 . . . . 0.0 113.162 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.18 -14.23 28.64 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.883 2.388 . . . . 0.0 112.044 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 34.1 t -76.04 -10.49 59.46 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.609 177.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 427' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 51.2 t -58.33 118.48 5.58 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.37 177.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -119.49 22.58 11.63 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 124.101 0.876 . . . . 0.0 109.774 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' ARG . . . . . 0.811 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 0.5 OUTLIER -63.74 109.41 1.7 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -71.51 94.55 1.3 Allowed 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.674 0.608 . . . . 0.0 111.151 -177.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' ASN . . . . . 0.52 HD21 ' HB3' ' A' ' 433' ' ' GLN . 63.3 t30 -169.47 124.88 0.73 Allowed Pre-proline 0 N--CA 1.469 0.481 0 O-C-N 124.437 1.086 . . . . 0.0 108.832 176.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.509 ' O ' HG13 ' A' ' 436' ' ' ILE . 34.3 Cg_endo -65.45 -33.58 46.45 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.39 2.06 . . . . 0.0 111.53 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' GLN . . . . . 0.587 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 24.2 tp60 -68.6 -32.3 72.09 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.07 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 434' ' ' HIS . . . . . 0.723 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 41.8 t60 -62.71 -58.22 8.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.484 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -55.36 -19.74 9.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.501 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 432' ' ' PRO . 64.5 mt -80.64 -42.64 20.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 O-C-N 123.724 0.64 . . . . 0.0 109.812 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 22.3 mt-10 -78.74 -46.97 17.74 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 -174.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -106.45 135.36 48.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.43 0.633 . . . . 0.0 110.678 -174.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 419' ' ' PRO . 16.0 ptt180 -84.78 133.85 34.34 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.55 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.681 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 63.0 m80 -107.12 85.68 2.18 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.247 0.546 . . . . 0.0 109.853 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -70.65 117.65 12.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.673 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 1.9 m -129.81 152.73 48.99 Favored 'General case' 0 C--O 1.247 0.926 0 O-C-N 123.712 0.632 . . . . 0.0 110.412 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 1.1 pp -106.22 154.85 39.42 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 444' ' ' PRO . . . . . 0.443 ' O ' HG12 ' A' ' 445' ' ' VAL . 12.7 Cg_endo -55.46 -39.71 89.55 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.475 2.117 . . . . 0.0 112.981 -173.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 445' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 444' ' ' PRO . 4.4 p 49.42 21.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 124.497 1.123 . . . . 0.0 111.277 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -137.82 149.78 46.63 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 26.8 m120 65.5 20.28 11.67 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.902 0.881 . . . . 0.0 111.056 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 CA--C 1.542 0.67 0 CA-C-O 120.918 0.39 . . . . 0.0 110.867 -177.377 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.301 0 N-CA-C 112.165 -0.374 . . . . 0.0 112.165 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 12.6 p -96.99 -179.83 4.68 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -67.85 92.09 0.34 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -101.45 114.24 28.07 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 124.451 1.094 . . . . 0.0 110.632 -176.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 65.8 m -88.32 -5.39 58.36 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.935 0.397 . . . . 0.0 110.899 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -53.04 121.45 7.42 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 121.195 0.522 . . . . 0.0 110.255 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 14.3 m -91.3 153.48 19.91 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.373 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 42.9 t -70.37 92.8 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.177 0.513 . . . . 0.0 110.43 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' LEU . . . . . 0.572 ' H ' HD23 ' A' ' 366' ' ' LEU . 2.5 pt? -99.45 -18.58 17.39 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.585 177.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -72.44 131.7 42.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.472 0.654 . . . . 0.0 109.943 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 161.0 -166.21 35.55 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 44.1 m -77.2 -18.21 57.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.69 0.396 . . . . 0.0 110.507 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -95.63 31.35 2.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.931 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -79.12 56.43 4.35 Favored Glycine 0 C--O 1.245 0.79 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ASN . . . . . 0.4 ' ND2' ' H ' ' A' ' 372' ' ' ASN . 0.2 OUTLIER -84.71 175.08 9.42 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 122.914 0.486 . . . . 0.0 110.632 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.561 ' HD3' HG13 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -89.41 0.79 56.59 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.96 -172.339 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.561 HG13 ' HD3' ' A' ' 373' ' ' LYS . 12.6 m -147.37 159.47 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 123.85 0.719 . . . . 0.0 109.696 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -101.61 128.4 47.9 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 124.121 0.888 . . . . 0.0 109.412 174.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.545 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 2.6 mpp_? -68.64 172.6 6.05 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.07 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 395' ' ' HIS . 4.9 t -98.14 141.09 31.5 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.985 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.485 ' HB3' ' O ' ' A' ' 410' ' ' VAL . 19.3 t -55.96 121.34 9.1 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 123.071 0.232 . . . . 0.0 111.412 -176.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.708 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 10.6 t -54.18 103.02 0.07 Allowed 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 172.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' MET . . . . . 0.48 ' HB3' HG13 ' A' ' 410' ' ' VAL . 20.9 ptm -49.78 -27.64 5.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.836 0.71 . . . . 0.0 111.845 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.567 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 28.9 m-85 -93.68 -19.42 21.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.669 -0.644 . . . . 0.0 111.355 176.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.507 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 64.94 -126.17 31.39 Favored Glycine 0 CA--C 1.501 -0.809 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -80.59 0.29 34.66 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.928 0.394 . . . . 0.0 111.531 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -94.18 -7.29 42.65 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.062 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.84 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 7.6 p -74.49 128.09 34.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.371 0.605 . . . . 0.0 110.141 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -81.98 2.99 28.25 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.873 -175.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -87.82 115.92 25.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.697 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.443 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -117.42 2.35 12.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.01 0.91 . . . . 0.0 109.855 -177.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -63.15 136.57 96.75 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.678 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.69 -28.9 48.91 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.138 2.558 . . . . 0.0 112.921 -173.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.509 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 53.3 t -61.93 -37.04 77.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.338 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.706 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 72.7 t60 -58.42 -29.14 65.87 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.349 0.595 . . . . 0.0 110.997 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -93.3 -18.5 22.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.49 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -74.86 -20.04 59.91 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.374 0.607 . . . . 0.0 110.972 -175.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.467 ' O ' HG22 ' A' ' 377' ' ' THR . 7.2 p80 -121.57 -15.87 7.9 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.313 -0.867 . . . . 0.0 111.554 176.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 377' ' ' THR . 59.1 m-85 -121.07 136.78 54.91 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.135 0.493 . . . . 0.0 112.016 173.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.545 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 19.6 m -93.17 149.86 20.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.661 176.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.655 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 37.9 m80 -124.96 160.64 53.37 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -175.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 25.7 Cg_endo -59.34 93.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.315 2.01 . . . . 0.0 111.446 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 144.41 -13.05 2.04 Favored Glycine 0 CA--C 1.507 -0.443 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -84.02 145.84 28.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.132 -0.534 . . . . 0.0 110.735 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 16.0 m -66.9 -26.38 66.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.084 176.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -86.68 -4.16 59.14 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.756 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -77.42 138.02 39.03 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.575 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -130.67 -50.2 0.11 Allowed Glycine 0 C--O 1.242 0.622 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 73.91 9.0 79.14 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.746 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.7 m -93.59 -6.37 10.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 CA-C-N 116.975 0.387 . . . . 0.0 111.509 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.467 ' O ' ' HG2' ' A' ' 412' ' ' GLN . 46.7 tt0 -77.64 150.4 34.59 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 123.676 0.79 . . . . 0.0 110.053 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 410' ' ' VAL . 28.0 pt -51.29 -44.85 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.522 175.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 378' ' ' SER . 46.6 t -75.22 95.61 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.344 171.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 138.57 -31.7 2.38 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.084 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 4.2 pt20 -115.08 -50.08 2.77 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.789 0.294 . . . . 0.0 110.734 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.4 ' N ' ' HG3' ' A' ' 412' ' ' GLN . 7.0 t70 174.56 141.56 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.515 0.51 . . . . 0.0 110.074 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -117.4 -9.6 10.86 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.897 -174.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.613 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 74.1 p -105.36 -49.96 3.33 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -168.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 415' ' ' THR . 22.6 t70 68.27 -64.96 0.28 Allowed 'General case' 0 C--N 1.318 -0.792 0 O-C-N 124.036 0.835 . . . . 0.0 110.906 -172.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.5 -25.15 0.1 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.004 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.792 ' HG3' ' HG2' ' A' ' 439' ' ' ARG . 16.3 ptt180 -158.99 170.2 9.31 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 119.4 -0.334 . . . . 0.0 110.893 -168.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 23.3 Cg_endo -61.38 151.34 80.14 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.192 1.928 . . . . 0.0 111.926 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' GLU . . . . . 0.631 ' HG2' ' HE ' ' A' ' 439' ' ' ARG . 44.1 mt-10 -87.67 142.29 27.95 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.998 0.428 . . . . 0.0 110.918 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 9.3 t -66.75 121.7 78.81 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.68 -10.46 24.79 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.67 2.247 . . . . 0.0 112.076 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -104.55 -3.41 23.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.57 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 69.39 -152.04 51.49 Favored Glycine 0 C--O 1.223 -0.559 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.352 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -76.18 -11.69 19.35 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.8 2.334 . . . . 0.0 111.216 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 32.1 t -85.09 8.14 19.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.238 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 36.5 t -60.17 117.29 4.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.613 0.721 . . . . 0.0 110.851 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -100.16 11.52 39.15 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.311 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.681 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 0.7 OUTLIER -66.41 109.31 2.68 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.264 176.432 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -85.02 86.81 7.35 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.35 0.66 . . . . 0.0 110.533 -172.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' ASN . . . . . 0.494 HD21 ' HB3' ' A' ' 433' ' ' GLN . 65.0 t30 -166.45 125.69 1.14 Allowed Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 122.559 0.344 . . . . 0.0 110.874 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.454 ' O ' HG13 ' A' ' 436' ' ' ILE . 29.8 Cg_endo -64.67 -35.45 46.81 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.752 1.635 . . . . 0.0 111.864 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.63 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 6.7 tp-100 -64.58 -37.66 88.34 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.358 0.599 . . . . 0.0 110.909 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 434' ' ' HIS . . . . . 0.677 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.6 t60 -57.93 -51.51 69.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.652 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.452 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 24.8 mtpp -58.77 -23.8 60.67 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.716 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 432' ' ' PRO . 82.0 mt -80.31 -36.92 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.194 0.521 . . . . 0.0 110.414 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.63 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 24.0 mt-10 -84.34 -34.79 23.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.346 -173.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 419' ' ' PRO . 57.2 m-85 -108.75 154.87 21.43 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.686 -174.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' ARG . . . . . 0.792 ' HG2' ' HG3' ' A' ' 418' ' ' ARG . 11.9 mtm180 -91.37 120.03 31.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.705 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 78.6 m80 -92.4 78.54 5.03 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 173.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' ASN . . . . . 0.623 HD21 ' NH2' ' A' ' 439' ' ' ARG . 1.7 m-20 -63.37 106.28 0.88 Allowed 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 113.818 -1.537 . . . . 0.0 110.505 -171.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.95 138.36 31.48 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.52 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.8 OUTLIER -108.44 144.93 30.5 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.287 -174.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.61 -44.18 18.58 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.392 2.061 . . . . 0.0 111.342 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.52 ' HB ' HD13 ' A' ' 443' ' ' LEU . 8.2 p 41.85 27.73 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 124.686 1.242 . . . . 0.0 110.81 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.46 158.12 16.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 -174.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -116.03 79.76 1.35 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.725 0.774 . . . . 0.0 110.016 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.471 0.6 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.526 -179.812 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 449' ' ' ' ZN' . . . . . 0.84 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' ' ZN' . . . . . 0.833 'ZN ' ' HG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -2' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 417' ' ' ASP . . . . . . . . 0 N--CA 1.484 1.896 0 N-CA-C 112.152 -0.379 . . . . 0.0 112.152 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.1 m -154.59 143.8 21.18 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.927 0.364 . . . . 0.0 111.758 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 360' ' ' LYS . 0.0 OUTLIER -162.94 110.65 1.25 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.47 169.677 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -133.39 168.43 18.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 122.416 0.286 . . . . 0.0 110.591 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 66.9 p -94.32 139.4 31.12 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 124.048 0.842 . . . . 0.0 110.948 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -83.23 -36.02 24.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.387 0.613 . . . . 0.0 110.37 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 14.5 m -75.28 95.5 3.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.78 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 365' ' ' VAL . 7.7 p -81.65 79.85 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 122.031 0.919 . . . . 0.0 109.94 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 366' ' ' LEU . 2.5 pt? -84.46 -14.03 50.38 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.162 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -60.6 99.11 0.08 Allowed 'General case' 0 C--O 1.248 1.019 0 O-C-N 123.631 0.582 . . . . 0.0 110.205 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 165.75 43.82 0.02 OUTLIER Glycine 0 C--O 1.238 0.403 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 18.4 m -146.11 19.91 1.41 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.322 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -61.89 134.58 56.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.518 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -150.49 26.38 1.08 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -106.37 149.0 27.42 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.738 ' N ' ' HE2' ' A' ' 373' ' ' LYS . 0.3 OUTLIER -76.17 -27.08 56.82 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.578 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 16.3 m -114.26 157.71 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.769 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.67 156.16 25.26 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.806 175.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.584 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -107.93 172.84 6.61 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 122.312 0.245 . . . . 0.0 111.373 -178.684 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.467 HG23 ' CD1' ' A' ' 396' ' ' PHE . 9.7 t -108.2 163.3 13.29 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.06 0.85 . . . . 0.0 109.49 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 16.2 m -62.24 119.52 9.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.981 0.896 . . . . 0.0 111.764 -174.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.793 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 33.7 t -52.71 119.48 4.61 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.849 0.86 . . . . 0.0 109.114 174.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 380' ' ' MET . . . . . 0.499 ' O ' HG12 ' A' ' 410' ' ' VAL . 26.3 ptm -56.24 -23.73 37.84 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.327 0.584 . . . . 0.0 111.952 -173.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 34.6 m-85 -104.96 -16.18 14.91 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.244 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.432 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 64.91 -121.71 22.43 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.6 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' ALA . . . . . 0.446 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -82.88 4.7 24.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.927 0.363 . . . . 0.0 111.132 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -96.6 -14.7 22.0 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.809 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 1.8 p -73.58 127.12 31.87 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.561 -0.712 . . . . 0.0 110.732 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -81.58 -4.92 57.38 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.084 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -60.05 128.21 35.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.538 0.685 . . . . 0.0 109.623 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.617 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.2 OUTLIER -112.05 -15.71 13.22 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.56 -173.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -62.83 134.76 95.66 Favored Pre-proline 0 C--O 1.243 0.73 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.578 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.59 -22.85 75.45 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.501 2.134 . . . . 0.0 111.343 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.596 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 77.8 t -62.92 -35.9 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.214 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.654 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 83.9 t60 -61.43 -30.58 70.66 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.285 0.365 . . . . 0.0 110.339 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 54.6 m-85 -90.27 -24.79 20.82 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.749 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.596 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -71.1 -20.23 62.37 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.804 -175.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.563 ' ND1' ' HD2' ' A' ' 396' ' ' PHE . 1.9 p80 -119.68 -11.98 9.33 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.563 ' HD2' ' ND1' ' A' ' 395' ' ' HIS . 63.1 m-85 -138.52 126.55 22.62 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 177.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.584 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 58.0 m -86.73 160.66 18.76 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.355 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.713 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 32.4 m80 -127.83 165.63 28.97 Favored Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.668 -173.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.446 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 50.2 Cg_exo -54.74 -2.56 0.2 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 123.488 2.792 . . . . 0.0 114.152 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -119.15 13.11 11.29 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 111.964 -0.455 . . . . 0.0 111.964 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -121.85 131.08 53.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.9 t -62.57 -20.63 64.9 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -170.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.18 -7.52 59.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.405 0.621 . . . . 0.0 110.986 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -70.73 131.54 44.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.61 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -135.74 5.0 4.03 Favored Glycine 0 C--O 1.22 -0.721 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.065 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 52.7 54.03 29.95 Favored Glycine 0 C--O 1.243 0.712 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.594 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 33.5 m -88.04 -20.79 7.27 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 122.398 0.279 . . . . 0.0 110.824 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -117.06 124.89 50.38 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.641 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.433 HG13 ' N ' ' A' ' 410' ' ' VAL . 13.7 pt -48.3 -43.72 12.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 O-C-N 123.588 0.555 . . . . 0.0 111.217 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.889 ' HA ' ' HG3' ' A' ' 414' ' ' GLU . 8.5 t -68.25 103.09 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.64 -45.13 0.63 Allowed Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.508 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.445 ' HG2' ' OD1' ' A' ' 413' ' ' ASP . 5.8 pm0 -126.4 -30.37 2.87 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.779 -0.248 . . . . 0.0 111.123 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.445 ' OD1' ' HG2' ' A' ' 412' ' ' GLN . 3.8 p30 -155.98 97.52 1.82 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.819 0.819 . . . . 0.0 110.972 175.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' GLU . . . . . 0.889 ' HG3' ' HA ' ' A' ' 410' ' ' VAL . 17.6 mp0 -87.18 -25.98 23.78 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.079 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 59.9 p -62.98 169.25 3.42 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.044 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 417' ' ' ASP . 19.4 t70 -58.99 -23.26 61.69 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.034 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.458 ' HB3' ' O ' ' A' ' 416' ' ' ASP . 9.0 t0 78.07 79.04 0.07 Allowed 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.838 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.455 ' HG3' ' CG ' ' A' ' 439' ' ' ARG . 14.7 ptt180 -178.48 157.23 1.02 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.867 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.26 147.02 94.18 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.299 2.0 . . . . 0.0 111.342 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -73.74 159.23 33.26 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.908 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 7.8 t -64.22 132.27 95.27 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.4 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.88 -12.02 29.8 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.371 2.047 . . . . 0.0 112.256 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 37.0 m-85 -106.47 11.79 30.34 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.087 0.555 . . . . 0.0 110.709 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 56.6 -153.22 20.04 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.621 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.99 -9.9 19.51 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.335 2.023 . . . . 0.0 110.817 176.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 35.9 t -70.71 -14.85 62.61 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 173.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' CYS . . . . . 0.908 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 54.0 t -52.43 117.36 2.8 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.143 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -116.31 19.69 14.67 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.542 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 1.7 mmp_? -63.97 103.12 0.55 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.887 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -77.63 105.58 8.88 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.784 0.677 . . . . 0.0 109.69 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' ASN . . . . . 0.528 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 62.7 t30 -178.36 127.75 0.28 Allowed Pre-proline 0 C--O 1.244 0.768 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.933 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.528 ' HD2' ' OD1' ' A' ' 431' ' ' ASN . 19.9 Cg_endo -58.72 -44.55 35.5 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.339 2.692 . . . . 0.0 111.61 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.45 ' HB3' ' ND2' ' A' ' 431' ' ' ASN . 6.3 tp-100 -59.47 -34.12 72.16 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 120.973 0.415 . . . . 0.0 110.398 -177.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' HIS . . . . . 0.689 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 61.9 t60 -63.06 -62.31 1.79 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.742 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -60.33 -15.34 24.59 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 432' ' ' PRO . 60.1 mt -75.85 -47.22 33.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.834 174.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -78.54 -45.47 21.77 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.887 -0.508 . . . . 0.0 112.238 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -107.32 155.39 20.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.824 -0.548 . . . . 0.0 112.239 -171.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' ARG . . . . . 0.455 ' CG ' ' HG3' ' A' ' 418' ' ' ARG . 54.2 mtm180 -94.25 153.53 17.99 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.636 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.581 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 75.2 m80 -128.97 80.42 1.97 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 175.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -84.03 139.09 32.74 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.004 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 3.9 p -101.75 130.19 48.1 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 123.311 0.382 . . . . 0.0 111.873 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 443' ' ' LEU . 1.3 pp -108.79 151.01 41.55 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.3 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -63.27 -30.39 73.73 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 C-N-CA 122.075 1.85 . . . . 0.0 112.216 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.2 p 44.27 31.0 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 C-N-CA 124.847 1.259 . . . . 0.0 111.691 -177.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -87.96 165.35 15.28 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.939 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -43.71 -58.35 2.74 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.895 0.878 . . . . 0.0 111.029 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--N 1.343 0.308 0 C-N-CA 122.583 0.353 . . . . 0.0 111.054 -177.0 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 449' ' ' ' ZN' . . . . . 0.809 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' ' ZN' . . . . . 0.843 'ZN ' ' HG ' ' A' ' 421' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.903 0 N-CA-C 111.314 -0.715 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 20.4 m -69.07 -39.97 78.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.002 0.43 . . . . 0.0 110.528 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -82.51 -68.05 0.73 Allowed 'General case' 0 C--O 1.245 0.854 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.886 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -84.45 116.46 23.1 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.967 0.507 . . . . 0.0 109.995 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 33.0 p -62.93 143.81 57.33 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 122.683 0.393 . . . . 0.0 111.029 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.06 -48.35 18.09 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.808 0.443 . . . . 0.0 110.214 -177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 23.1 t -82.34 -177.92 6.85 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.44 129.24 47.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 122.865 0.466 . . . . 0.0 111.316 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 3.6 pp -113.04 -12.62 13.19 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.319 174.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -70.91 -12.48 61.56 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.421 0.629 . . . . 0.0 110.155 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -110.13 53.42 0.58 Allowed Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.411 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 23.1 t -146.99 97.0 2.83 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -120.56 142.47 49.33 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 124.257 0.973 . . . . 0.0 110.053 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 93.44 -50.94 2.39 Favored Glycine 0 C--O 1.236 0.273 0 O-C-N 123.5 0.5 . . . . 0.0 112.234 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -72.28 129.04 37.49 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.633 -0.334 . . . . 0.0 110.908 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.574 ' HG2' HG13 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -107.44 -16.55 14.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.744 0.307 . . . . 0.0 110.63 179.412 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.574 HG13 ' HG2' ' A' ' 373' ' ' LYS . 26.9 m -124.53 171.37 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.274 177.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.77 164.56 30.15 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.329 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.42 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.4 OUTLIER -100.05 166.64 10.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.339 0.59 . . . . 0.0 111.591 -176.474 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 6.0 t -115.11 152.01 33.31 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 173.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 49.3 m -55.54 123.69 14.82 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.979 0.799 . . . . 0.0 112.032 -172.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.875 ' HG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 26.5 t -60.36 118.49 6.5 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 380' ' ' MET . . . . . 0.519 ' HB3' HG12 ' A' ' 410' ' ' VAL . 22.7 ptm -54.66 -33.49 60.78 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-O 121.464 0.649 . . . . 0.0 111.388 -175.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.578 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 41.3 m-85 -96.92 -10.49 26.27 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.579 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.531 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 62.38 -129.09 42.44 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' ALA . . . . . 0.421 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -80.28 -3.33 48.91 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.063 0.459 . . . . 0.0 111.182 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -84.63 -16.48 41.85 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.227 -175.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 3.0 p -69.43 141.03 54.15 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.451 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -78.93 9.34 4.37 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 122.791 0.437 . . . . 0.0 111.461 -174.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -93.79 111.18 22.83 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.671 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.441 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -105.59 -21.3 13.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.212 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -46.98 131.41 8.88 Favored Pre-proline 0 C--O 1.238 0.451 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.959 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.49 -25.53 58.81 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 123.749 2.966 . . . . 0.0 111.602 -174.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.516 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 64.6 t -65.8 -34.7 72.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.279 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.638 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 73.3 t60 -59.87 -26.5 65.91 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.301 -0.875 . . . . 0.0 110.088 175.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 38.4 m-85 -93.68 -5.49 48.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.586 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -88.67 -23.14 23.09 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.046 -178.026 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.43 ' HD2' ' HG3' ' A' ' 394' ' ' GLN . 4.9 p80 -116.02 -18.68 10.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.067 0.46 . . . . 0.0 111.913 175.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 393' ' ' PHE . 69.2 m-85 -125.29 128.51 48.35 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.761 174.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' A' ' 404' ' ' TYR . 14.2 p -80.26 159.04 26.01 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.477 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.704 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 53.7 m80 -139.53 158.15 68.97 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.868 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.421 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 10.6 Cg_endo -51.07 107.9 0.2 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 121.887 1.725 . . . . 0.0 110.379 -177.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 118.45 0.81 15.97 Favored Glycine 0 C--N 1.316 -0.552 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.698 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ASP . . . . . 0.428 ' HB3' ' HB2' ' A' ' 404' ' ' TYR . 20.1 t70 -97.63 141.82 30.19 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 123.04 0.536 . . . . 0.0 109.864 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 43.4 t -58.9 -26.18 64.08 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.939 0.774 . . . . 0.0 111.505 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -110.84 19.47 18.53 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.773 -174.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.452 ' HB2' ' HB2' ' A' ' 397' ' ' SER . 63.5 t80 -97.76 132.57 43.26 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.605 -0.684 . . . . 0.0 110.446 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -136.86 -34.12 0.22 Allowed Glycine 0 CA--C 1.505 -0.553 0 O-C-N 123.478 0.486 . . . . 0.0 111.968 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 78.42 14.38 82.23 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.834 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 33.5 m -88.48 -9.03 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 122.624 -0.339 . . . . 0.0 110.259 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' A' ' 412' ' ' GLN . 6.5 tt0 -68.82 145.76 53.46 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.453 HG13 ' N ' ' A' ' 410' ' ' VAL . 29.6 pt -53.31 -46.25 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.616 ' HA ' ' HG2' ' A' ' 414' ' ' GLU . 65.6 t -72.11 97.49 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.036 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 142.28 -32.61 1.97 Allowed Glycine 0 C--O 1.218 -0.871 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -177.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 408' ' ' GLN . 0.0 OUTLIER -126.15 -41.58 1.92 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 117.286 0.543 . . . . 0.0 111.373 -179.18 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -167.91 114.46 0.71 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.015 0.436 . . . . 0.0 109.906 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' GLU . . . . . 0.616 ' HG2' ' HA ' ' A' ' 410' ' ' VAL . 24.4 mt-10 -100.29 2.08 42.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.825 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 62.2 p -101.18 -74.05 0.63 Allowed 'General case' 0 C--N 1.315 -0.91 0 O-C-N 123.501 0.5 . . . . 0.0 111.983 -166.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -179.72 -56.33 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -168.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -175.15 -32.34 0.01 OUTLIER 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.74 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 23.1 ptt180 -128.6 157.27 75.58 Favored Pre-proline 0 C--O 1.245 0.843 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.277 -176.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.9 158.94 38.47 Favored 'Trans proline' 0 C--N 1.326 -0.648 0 C-N-CA 122.16 1.906 . . . . 0.0 111.139 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' GLU . . . . . 0.484 ' HG3' ' HG3' ' A' ' 439' ' ' ARG . 1.9 mp0 -75.29 158.72 32.43 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.93 0.395 . . . . 0.0 110.302 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.975 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 6.6 t -62.76 133.14 94.95 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.899 176.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.91 -6.93 13.68 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.685 2.257 . . . . 0.0 112.698 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 96.8 m-85 -114.72 11.88 16.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.173 0.511 . . . . 0.0 110.288 177.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 61.21 -157.79 31.68 Favored Glycine 0 N--CA 1.462 0.377 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.731 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.15 -11.39 25.12 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.675 2.917 . . . . 0.0 112.197 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 25.8 t -81.41 -11.63 59.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.785 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' CYS . . . . . 0.975 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 39.8 t -51.26 116.93 2.27 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.955 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -111.6 23.96 13.3 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.154 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -61.83 100.42 0.15 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 122.689 0.396 . . . . 0.0 110.066 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 430' ' ' LYS . 17.9 ptpt -66.12 94.18 0.23 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.229 0.538 . . . . 0.0 111.215 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' ASN . . . . . 0.552 ' O ' ' HB3' ' A' ' 434' ' ' HIS . 20.0 t-20 -173.57 114.13 0.34 Allowed Pre-proline 0 N--CA 1.465 0.296 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.0 -47.01 22.29 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.427 2.085 . . . . 0.0 112.181 -174.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.631 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 6.6 tp-100 -57.72 -29.07 64.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.326 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' HIS . . . . . 0.687 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 41.2 t60 -61.38 -55.99 25.34 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 123.361 0.413 . . . . 0.0 111.736 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -61.37 -25.23 67.03 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.437 0.637 . . . . 0.0 110.839 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 69.0 mt -69.48 -46.51 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.437 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.631 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 10.5 mt-10 -85.31 -22.48 28.51 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.986 -174.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -121.04 126.05 48.87 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 123.618 0.574 . . . . 0.0 110.155 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' ARG . . . . . 0.484 ' HG3' ' HG3' ' A' ' 420' ' ' GLU . 12.0 ptt180 -80.9 122.08 26.79 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 121.281 0.562 . . . . 0.0 110.984 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.694 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 49.3 m80 -98.07 84.45 3.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.154 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -70.26 121.28 17.3 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.177 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.42 146.37 38.5 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.92 156.39 29.67 Favored Pre-proline 0 C--N 1.322 -0.608 0 O-C-N 123.466 0.479 . . . . 0.0 111.083 -173.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' PRO . . . . . 0.576 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 32.1 Cg_endo -62.63 -25.8 75.45 Favored 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 122.302 2.001 . . . . 0.0 112.365 -176.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 14.9 p 40.09 56.26 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 122.958 1.361 . . . . 0.0 111.864 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.576 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 21.0 mmm180 -91.52 140.68 29.51 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 121.31 -0.869 . . . . 0.0 112.201 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 55.6 t30 52.98 85.84 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.639 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 26.6 m . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 121.371 0.605 . . . . 0.0 111.14 -177.645 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 449' ' ' ' ZN' . . . . . 0.875 'ZN ' ' HG ' ' A' ' 379' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' ' ZN' . . . . . 0.836 'ZN ' ' HG ' ' A' ' 421' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.462 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 32.2 m -80.15 96.47 6.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.778 0.799 . . . . 0.0 109.628 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -76.03 87.42 2.95 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.802 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -74.36 107.12 6.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.002 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 16.7 p -87.85 113.42 23.49 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 122.668 0.387 . . . . 0.0 110.067 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -83.1 168.35 16.96 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 121.67 0.748 . . . . 0.0 110.949 -173.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 11.7 t -101.78 129.84 48.06 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.855 171.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.91 80.46 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 122.442 1.115 . . . . 0.0 110.292 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 367' ' ' GLN . 3.2 pp -89.76 -24.25 21.56 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.608 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' GLN . . . . . 0.54 ' N ' HD12 ' A' ' 366' ' ' LEU . 28.5 tp60 -82.05 88.08 6.44 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.191 0.996 . . . . 0.0 110.133 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -153.02 39.79 0.72 Allowed Glycine 0 C--O 1.223 -0.538 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.403 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 3.2 p -99.54 -20.43 16.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.608 -0.796 . . . . 0.0 111.187 -177.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 370' ' ' GLU . 1.9 pm0 -75.91 79.9 2.8 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.408 0.623 . . . . 0.0 110.113 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -147.57 -103.05 0.31 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -79.84 98.48 7.1 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 117.156 0.478 . . . . 0.0 109.826 170.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.567 ' H ' ' HD2' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -93.66 -16.76 23.97 Favored 'General case' 0 C--O 1.238 0.496 0 O-C-N 123.732 0.645 . . . . 0.0 110.15 -177.109 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.453 HG13 ' HG2' ' A' ' 373' ' ' LYS . 30.9 m -114.67 153.35 16.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 O-C-N 123.918 0.761 . . . . 0.0 109.923 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.65 151.2 25.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.155 176.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.553 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.1 OUTLIER -82.94 176.81 8.99 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.095 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 10.5 t -106.14 153.66 21.78 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.837 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.9 t -53.87 119.81 5.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.515 0.326 . . . . 0.0 111.751 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 24.1 t -53.77 111.06 0.66 Allowed 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' MET . . . . . 0.522 ' HB3' HG12 ' A' ' 410' ' ' VAL . 23.3 ptp -58.51 -12.6 4.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.226 0.536 . . . . 0.0 111.925 -175.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.414 ' CD2' ' HB3' ' A' ' 385' ' ' CYS . 15.3 m-85 -110.09 -15.83 13.93 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.612 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 72.76 -133.42 19.07 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -174.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' ALA . . . . . 0.438 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -88.11 -0.75 57.44 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 121.643 0.735 . . . . 0.0 111.244 177.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -75.82 -24.89 55.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.593 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.814 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 0.8 OUTLIER -61.38 129.72 42.58 Favored 'General case' 0 C--O 1.25 1.098 0 O-C-N 122.238 -0.289 . . . . 0.0 111.167 -179.258 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -71.46 -8.49 54.19 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.034 0.534 . . . . 0.0 110.138 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -69.95 113.05 6.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.862 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.501 ' HD2' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -113.21 -1.84 14.23 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -61.25 137.11 94.3 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.335 175.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -58.57 -20.89 52.14 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.649 2.233 . . . . 0.0 111.746 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.579 HG12 ' NE2' ' A' ' 395' ' ' HIS . 98.4 t -66.09 -42.36 91.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.22 178.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.699 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 83.9 t60 -57.7 -33.51 68.46 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.702 0.763 . . . . 0.0 110.655 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 34.5 m-85 -88.96 -18.91 26.46 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.877 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -75.33 -26.95 59.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.641 -178.521 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.63 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 2.2 p80 -114.3 -7.34 12.95 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.502 0.501 . . . . 0.0 112.273 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.63 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 96.5 m-85 -135.45 132.01 36.88 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.206 0.527 . . . . 0.0 111.665 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.553 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 69.3 m -85.38 154.14 22.06 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.606 174.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.662 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 31.5 m80 -128.07 158.21 71.62 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.496 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 14.9 Cg_endo -52.96 100.53 0.05 OUTLIER 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 122.951 2.434 . . . . 0.0 111.594 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 119.01 11.86 7.36 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.661 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -106.25 145.06 32.07 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 41.3 t -54.04 -32.81 55.58 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.805 0.69 . . . . 0.0 111.29 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -107.97 17.33 22.53 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -81.6 136.12 35.55 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.124 -0.631 . . . . 0.0 110.824 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -119.66 -55.62 0.25 Allowed Glycine 0 C--O 1.249 1.071 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.171 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 71.41 24.21 77.16 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.7 m -118.84 3.11 7.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 121.567 0.699 . . . . 0.0 110.986 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.499 ' O ' ' HG2' ' A' ' 412' ' ' GLN . 44.5 tt0 -84.32 153.03 23.75 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.124 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.465 HG13 ' N ' ' A' ' 410' ' ' VAL . 23.5 pt -55.32 -45.19 77.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-O 121.426 0.632 . . . . 0.0 110.354 175.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.522 HG12 ' HB3' ' A' ' 380' ' ' MET . 39.1 t -66.13 90.06 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 143.21 -42.09 1.11 Allowed Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.45 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 26.9 pt20 -95.64 -43.05 8.1 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.727 0.299 . . . . 0.0 111.155 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -170.49 141.1 1.88 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.681 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -134.43 10.73 3.77 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.364 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 77.5 p -68.29 -54.66 16.03 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.74 0.781 . . . . 0.0 111.076 -176.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 26.9 t70 179.44 -31.8 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.396 -1.274 . . . . 0.0 108.28 -169.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 27.3 t70 63.17 79.75 0.25 Allowed 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 124.736 1.214 . . . . 0.0 113.035 168.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -177.62 154.46 1.04 Allowed Pre-proline 0 N--CA 1.479 0.985 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.812 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -52.49 136.41 56.63 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.034 2.49 . . . . 0.0 111.282 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' GLU . . . . . 0.454 ' HG3' ' HG3' ' A' ' 439' ' ' ARG . 2.3 mp0 -75.62 148.54 38.69 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.949 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 8.3 t -52.18 134.86 40.64 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.412 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 421' ' ' CYS . 53.0 Cg_exo -57.24 -28.15 78.19 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.742 2.294 . . . . 0.0 111.952 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' TYR . . . . . 0.413 ' HB2' ' HA ' ' A' ' 427' ' ' CYS . 62.3 m-85 -99.1 5.55 46.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.873 -177.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 67.64 -156.03 52.65 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' PRO . . . . . 0.441 ' HG3' ' HA ' ' A' ' 442' ' ' THR . 55.1 Cg_endo -70.74 -16.53 33.44 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.329 2.02 . . . . 0.0 111.298 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 33.0 t -79.25 3.98 16.38 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.262 176.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' CYS . . . . . 0.949 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 50.5 t -55.1 117.28 3.33 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.108 0.563 . . . . 0.0 110.727 177.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -103.1 13.37 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.685 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 429' ' ' ARG . 8.4 mmm180 -71.99 105.46 3.89 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -87.96 97.45 10.96 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.142 -175.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -173.02 126.37 0.48 Allowed Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.458 ' O ' HG13 ' A' ' 436' ' ' ILE . 28.2 Cg_endo -62.58 -38.28 52.3 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.295 1.997 . . . . 0.0 112.12 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.651 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 26.3 tp60 -63.94 -38.19 90.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.946 0.403 . . . . 0.0 110.34 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' HIS . . . . . 0.596 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 15.0 t60 -57.95 -48.3 80.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.262 1.03 . . . . 0.0 110.116 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -68.68 -15.24 63.46 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.345 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 432' ' ' PRO . 79.0 mt -86.67 -34.3 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 123.928 0.767 . . . . 0.0 110.628 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.651 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 21.9 mt-10 -86.62 -25.08 25.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.572 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -127.0 135.6 51.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.234 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' ARG . . . . . 0.454 ' HG3' ' HG3' ' A' ' 420' ' ' GLU . 25.2 ptt180 -91.2 134.94 34.14 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.65 0.594 . . . . 0.0 109.761 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.43 ' HD2' ' HB3' ' A' ' 427' ' ' CYS . 24.2 m80 -100.91 83.81 2.59 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.231 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -94.61 157.46 15.97 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.004 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' THR . . . . . 0.441 ' HA ' ' HG3' ' A' ' 425' ' ' PRO . 30.4 p -100.74 171.78 7.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -178.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.41 151.54 71.47 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.0 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 444' ' ' PRO . . . . . 0.514 ' O ' HG12 ' A' ' 445' ' ' VAL . 18.6 Cg_endo -59.29 -24.53 74.66 Favored 'Trans proline' 0 N--CA 1.483 0.868 0 C-N-CA 123.489 2.793 . . . . 0.0 111.24 -174.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 444' ' ' PRO . 3.5 p 56.53 7.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.734 1.614 . . . . 0.0 113.013 171.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 446' ' ' ARG . 15.0 ptt180 -126.88 170.48 12.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.174 -176.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -133.05 -36.59 1.01 Allowed 'General case' 0 C--N 1.306 -1.296 0 O-C-N 125.013 1.446 . . . . 0.0 110.896 173.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.477 0.884 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.421 177.524 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 449' ' ' ' ZN' . . . . . 0.814 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' ' ZN' . . . . . 0.746 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.289 0 CA-C-O 119.87 -0.406 . . . . 0.0 112.588 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 15.7 m -86.53 105.88 17.13 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.27 0.557 . . . . 0.0 109.974 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -106.97 106.02 16.34 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.319 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -137.52 112.38 8.96 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.586 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 4.4 m -137.15 156.32 48.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.154 0.502 . . . . 0.0 110.431 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -145.22 123.5 12.26 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 46.5 t -128.16 153.16 47.18 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 123.342 0.657 . . . . 0.0 110.059 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.04 132.65 32.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 120.736 0.303 . . . . 0.0 111.398 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 366' ' ' LEU . 2.5 pt? -132.96 -2.23 3.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.447 176.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -73.82 139.14 44.91 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.436 0.636 . . . . 0.0 110.692 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -179.89 42.88 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.193 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 22.6 t -130.1 92.09 3.23 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 117.066 0.433 . . . . 0.0 110.938 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -101.7 -28.75 12.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.309 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 94.55 -102.17 2.83 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -89.82 166.27 13.64 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.596 0.236 . . . . 0.0 111.051 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.558 ' HD2' HG13 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -84.11 -0.43 51.91 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.047 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.558 HG13 ' HD2' ' A' ' 373' ' ' LYS . 20.9 m -136.0 136.46 49.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 123.838 0.855 . . . . 0.0 109.327 166.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -90.38 139.69 30.43 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.958 -175.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.487 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -80.93 -175.67 5.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.492 0.663 . . . . 0.0 110.032 171.422 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.2 t -113.43 159.46 19.46 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 41.0 t -63.68 124.33 21.15 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 121.975 -0.453 . . . . 0.0 111.226 -175.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.753 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 31.9 t -56.39 122.38 11.76 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 174.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 380' ' ' MET . . . . . 0.418 ' HB3' HG12 ' A' ' 410' ' ' VAL . 26.5 ptm -55.1 -26.23 36.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.645 0.378 . . . . 0.0 111.566 -173.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.541 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 38.8 m-85 -110.01 -8.86 14.78 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.647 0.592 . . . . 0.0 110.657 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.46 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 69.78 -133.92 25.41 Favored Glycine 0 N--CA 1.436 -1.316 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.61 -176.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' ALA . . . . . 0.583 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -78.6 0.26 27.05 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 117.589 0.694 . . . . 0.0 111.166 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -94.7 -2.74 50.59 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.582 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.839 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 10.3 p -68.0 134.19 50.29 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 122.065 -0.397 . . . . 0.0 110.391 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -78.98 -14.11 59.4 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 123.26 0.624 . . . . 0.0 111.212 -176.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -72.5 128.31 35.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.049 0.452 . . . . 0.0 110.507 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.443 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.6 OUTLIER -120.27 -6.45 9.87 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.047 -176.397 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -65.05 137.76 97.2 Favored Pre-proline 0 C--O 1.243 0.737 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.542 178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.57 -34.63 73.76 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 123.689 2.926 . . . . 0.0 112.793 -173.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.455 HG12 ' NE2' ' A' ' 395' ' ' HIS . 60.1 t -59.72 -34.68 56.27 Favored 'Isoleucine or valine' 0 C--N 1.348 0.532 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.683 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.649 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 82.6 t60 -55.21 -37.55 67.27 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 121.729 0.776 . . . . 0.0 111.33 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 62.2 m-85 -89.68 -20.86 23.13 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.459 -175.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -71.39 -24.11 62.0 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.878 -0.514 . . . . 0.0 110.035 -177.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.606 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 1.0 OUTLIER -119.33 -7.71 10.19 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 178.762 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.606 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 57.0 m-85 -133.55 126.37 30.86 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.487 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 38.1 m -90.06 158.93 17.09 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.66 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 13.3 m80 -129.55 157.69 75.68 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.078 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.583 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 18.3 Cg_endo -54.31 118.09 4.65 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.898 2.398 . . . . 0.0 110.347 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 111.58 -1.71 27.7 Favored Glycine 0 C--N 1.32 -0.342 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.695 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.76 142.16 34.36 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 14.1 t -70.05 -21.97 63.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -95.56 -1.39 50.59 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.112 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -70.64 115.9 10.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.09 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.13 -49.82 3.87 Favored Glycine 0 C--O 1.224 -0.49 0 C-N-CA 120.173 -1.013 . . . . 0.0 111.702 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 65.02 39.01 96.12 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.318 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 21.6 m -129.01 22.1 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.423 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -112.66 145.32 40.65 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.812 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.455 HG13 ' N ' ' A' ' 410' ' ' VAL . 20.6 pt -58.46 -47.83 87.04 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 121.281 0.562 . . . . 0.0 109.843 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.498 ' HA ' ' HG2' ' A' ' 414' ' ' GLU . 18.0 t -66.33 86.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 174.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 156.9 -41.23 0.55 Allowed Glycine 0 CA--C 1.5 -0.905 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.771 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.4 -38.53 5.68 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -173.13 121.58 0.37 Allowed 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.964 176.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' GLU . . . . . 0.498 ' HG2' ' HA ' ' A' ' 410' ' ' VAL . 36.8 mt-10 -86.65 -28.85 22.94 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.847 -175.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 416' ' ' ASP . 82.6 p -65.5 -86.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 415' ' ' THR . 18.9 t70 168.68 -68.87 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.989 0.899 . . . . 0.0 109.025 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -136.35 -18.9 1.47 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.074 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.523 ' HD2' ' O ' ' A' ' 437' ' ' GLU . 20.9 ptt180 -167.6 160.13 10.1 Favored Pre-proline 0 N--CA 1.467 0.384 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -169.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.59 151.03 72.54 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.83 1.687 . . . . 0.0 111.359 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' GLU . . . . . 0.479 ' HA ' ' HG2' ' A' ' 439' ' ' ARG . 10.7 tt0 -82.94 157.07 23.16 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.948 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 11.3 t -58.98 135.24 87.45 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.261 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.7 -13.28 35.85 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.343 2.029 . . . . 0.0 112.58 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -110.18 8.08 23.57 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.103 0.477 . . . . 0.0 110.429 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 63.94 -152.71 48.39 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.699 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.53 -4.38 15.19 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.847 2.365 . . . . 0.0 111.984 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 16.9 m -83.55 -2.52 56.2 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.583 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' CYS . . . . . 0.948 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 43.0 t -54.89 115.92 2.46 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.498 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -110.96 19.26 18.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.28 0.632 . . . . 0.0 110.482 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.645 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 1.1 mmp_? -69.62 101.87 1.73 Allowed 'General case' 0 C--O 1.255 1.365 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.274 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -75.04 82.83 2.26 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 123.603 0.761 . . . . 0.0 110.184 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 434' ' ' HIS . 26.9 t-20 -163.23 112.08 1.02 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.694 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.98 -41.4 62.08 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 C-N-CA 123.25 2.633 . . . . 0.0 112.567 -171.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.675 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 25.1 tp60 -57.45 -39.21 75.8 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 121.086 0.47 . . . . 0.0 110.33 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' HIS . . . . . 0.719 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 19.5 t60 -59.23 -52.27 66.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.677 0.751 . . . . 0.0 110.011 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.41 ' HA ' ' HE1' ' A' ' 440' ' ' HIS . 47.7 mtpt -61.25 -19.79 62.1 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.983 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 93.7 mt -84.47 -35.42 10.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.294 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.675 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 25.7 mt-10 -85.41 -50.92 6.91 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.45 -176.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -98.06 137.85 36.24 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.113 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' ARG . . . . . 0.479 ' HG2' ' HA ' ' A' ' 420' ' ' GLU . 18.5 ptt-85 -86.24 145.96 26.73 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.42 0.288 . . . . 0.0 110.56 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.629 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 71.7 m80 -118.22 86.04 2.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.387 0.613 . . . . 0.0 109.847 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -77.61 117.87 19.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.983 -176.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.2 m -125.79 155.49 40.98 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.463 0.477 . . . . 0.0 110.898 -173.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 443' ' ' LEU . 1.1 pp -107.21 153.9 40.81 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 444' ' ' PRO . . . . . 0.426 ' O ' HG12 ' A' ' 445' ' ' VAL . 38.1 Cg_endo -64.84 -11.98 32.0 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.167 1.911 . . . . 0.0 113.273 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 444' ' ' PRO . 6.1 p 51.02 28.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.19 0.996 . . . . 0.0 112.309 174.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.426 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 36.9 mmt180 -85.66 144.96 27.53 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.853 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -84.09 85.54 7.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.464 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--N 1.309 -1.188 0 CA-C-O 122.119 0.961 . . . . 0.0 110.202 177.492 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 449' ' ' ' ZN' . . . . . 0.839 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' ' ZN' . . . . . 0.812 'ZN ' ' HG ' ' A' ' 421' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.517 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 25.9 t -77.34 127.25 32.25 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.912 0.419 . . . . 0.0 110.288 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.67 -9.96 17.83 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.089 0.471 . . . . 0.0 110.779 175.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -69.74 80.08 0.44 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.237 0.542 . . . . 0.0 110.83 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 11.6 m -82.01 154.02 25.89 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.326 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -125.77 -177.44 3.92 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 40.6 t -139.31 163.53 32.24 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.36 151.9 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' LEU . . . . . 0.549 ' O ' ' HG3' ' A' ' 367' ' ' GLN . 2.1 pp -54.45 -23.38 15.84 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.635 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 366' ' ' LEU . 0.8 OUTLIER 55.95 -4.99 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 177.332 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 366' ' ' LEU . . . -76.28 73.97 1.73 Allowed Glycine 0 C--O 1.22 -0.732 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 175.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 19.7 m -136.32 102.75 5.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.707 -0.746 . . . . 0.0 110.208 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -102.01 147.52 26.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.123 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 110.58 31.06 3.09 Favored Glycine 0 C--O 1.224 -0.52 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.474 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -175.17 164.35 3.27 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 122.303 0.241 . . . . 0.0 111.26 -173.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.462 ' N ' ' HD3' ' A' ' 373' ' ' LYS . 3.2 mppt? -90.49 -60.43 1.92 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.9 m -91.93 139.79 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.623 ' N ' ' HD2' ' A' ' 375' ' ' LYS . 8.7 mptt -92.62 -39.99 11.01 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.858 0.837 . . . . 0.0 110.417 -177.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.28 167.54 18.32 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.054 173.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 9.0 t -120.95 145.52 47.63 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 172.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 46.3 m -47.73 122.24 4.75 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 123.452 0.47 . . . . 0.0 111.218 -175.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.921 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 11.9 t -47.54 120.46 3.31 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 27.6 ptm -61.5 -11.75 12.18 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.08 0.552 . . . . 0.0 110.317 -176.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.494 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 75.0 m-85 -115.27 -13.89 11.71 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.994 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.424 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 65.77 -120.59 17.2 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.076 -1.059 . . . . 0.0 110.793 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' ALA . . . . . 0.467 ' HB2' ' HG3' ' A' ' 399' ' ' PRO . . . -92.18 5.73 49.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.548 0.689 . . . . 0.0 110.66 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -89.36 -15.23 33.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.302 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.921 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 2.4 p -78.8 123.85 27.61 Favored 'General case' 0 C--O 1.248 0.974 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.881 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -83.44 15.65 2.95 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.92 0.488 . . . . 0.0 111.686 -174.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -84.06 130.14 34.88 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.085 0.469 . . . . 0.0 110.409 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -104.01 -33.22 8.88 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 123.152 0.581 . . . . 0.0 109.676 -178.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -45.91 135.58 6.51 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.683 -177.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.74 -17.61 55.85 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 121.914 1.743 . . . . 0.0 112.062 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.482 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 86.3 t -67.9 -37.42 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.904 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.67 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 77.5 t60 -60.96 -29.32 69.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.868 0.842 . . . . 0.0 110.017 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 60.6 m-85 -92.8 -13.07 29.67 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.004 -177.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -78.77 -23.64 45.17 Favored 'General case' 0 C--N 1.343 0.313 0 O-C-N 121.768 -0.583 . . . . 0.0 111.617 -177.451 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.447 ' HD2' ' HG3' ' A' ' 394' ' ' GLN . 5.5 p80 -118.41 -19.76 8.74 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.438 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 377' ' ' THR . 67.7 m-85 -123.54 127.7 48.69 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.512 0.672 . . . . 0.0 110.675 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.556 ' O ' ' HB2' ' A' ' 379' ' ' CYS . 54.2 p -78.36 163.21 25.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.752 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.714 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 61.0 m80 -138.24 161.82 57.18 Favored Pre-proline 0 N--CA 1.465 0.308 0 O-C-N 122.293 -0.254 . . . . 0.0 110.479 -176.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 11.3 Cg_endo -51.58 104.98 0.1 OUTLIER 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 122.937 2.425 . . . . 0.0 112.156 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 124.55 -9.35 8.2 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.701 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -95.8 157.05 16.07 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 122.601 -0.352 . . . . 0.0 111.324 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 20.0 m -69.02 -25.87 64.71 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.831 0.707 . . . . 0.0 112.061 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.67 8.97 40.64 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.318 -0.239 . . . . 0.0 110.524 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -103.09 139.45 38.6 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.447 0.467 . . . . 0.0 110.665 -178.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -172.6 17.24 0.05 OUTLIER Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.609 176.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 52.09 51.83 38.91 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 31.8 m -67.16 -28.61 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.401 0.619 . . . . 0.0 111.384 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -113.72 163.43 15.02 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.554 0.742 . . . . 0.0 109.676 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 410' ' ' VAL . 21.2 pt -60.68 -49.1 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.833 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.51 ' N ' HG13 ' A' ' 409' ' ' ILE . 11.3 p -69.77 115.17 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 O-C-N 124.019 0.824 . . . . 0.0 109.51 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 132.85 -33.34 2.63 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -173.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.446 ' HG3' ' N ' ' A' ' 413' ' ' ASP . 15.0 pt20 -113.2 -48.27 2.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.803 -0.699 . . . . 0.0 110.129 174.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.446 ' N ' ' HG3' ' A' ' 412' ' ' GLN . 19.7 t70 179.83 136.43 0.11 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.081 0.863 . . . . 0.0 109.486 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -107.38 -7.76 16.54 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.806 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 64.4 p -87.8 -81.18 0.25 Allowed 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.638 0.586 . . . . 0.0 112.153 -168.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.8 t70 169.94 -52.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -169.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -169.92 -31.73 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.031 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.516 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 29.1 ptt180 -133.01 163.75 48.84 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.758 -173.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.35 151.08 42.56 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.566 2.178 . . . . 0.0 111.18 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.95 158.73 30.08 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.496 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.82 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 49.3 t -69.37 131.25 90.29 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.297 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.87 -16.45 25.93 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.269 2.646 . . . . 0.0 112.647 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -111.86 12.81 20.91 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.63 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 59.83 -151.74 36.91 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.789 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.43 -21.83 11.32 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.547 2.165 . . . . 0.0 112.324 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 36.0 t -76.36 4.16 9.54 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.924 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' CYS . . . . . 0.82 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 49.7 t -49.61 116.73 1.88 Allowed 'General case' 0 C--O 1.219 -0.547 0 O-C-N 124.358 1.036 . . . . 0.0 110.957 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -107.77 16.21 23.82 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.653 0.739 . . . . 0.0 110.347 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -76.64 88.45 3.32 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.027 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -73.79 92.3 2.02 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.305 0.574 . . . . 0.0 111.289 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' ASN . . . . . 0.48 HD21 ' HB3' ' A' ' 433' ' ' GLN . 47.4 t30 -153.74 126.41 4.02 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.484 ' O ' HG13 ' A' ' 436' ' ' ILE . 18.4 Cg_endo -58.63 -39.75 79.83 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.804 1.669 . . . . 0.0 111.537 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.48 ' HB3' HD21 ' A' ' 431' ' ' ASN . 6.4 tp-100 -69.1 -26.26 64.83 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.695 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 434' ' ' HIS . . . . . 0.753 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 48.3 t60 -64.61 -61.89 1.92 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.114 0.483 . . . . 0.0 110.518 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.477 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 0.0 OUTLIER -61.39 -18.59 59.48 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.441 -178.68 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 432' ' ' PRO . 66.1 mt -71.96 -56.38 10.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.192 0.52 . . . . 0.0 111.701 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 418' ' ' ARG . 9.7 mm-40 -76.26 -28.08 56.95 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -112.27 123.09 49.51 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.256 0.347 . . . . 0.0 111.409 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' ARG . . . . . 0.516 ' HD3' ' O ' ' A' ' 418' ' ' ARG . 1.2 ptm180 -78.16 126.99 31.61 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.575 0.547 . . . . 0.0 110.346 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.565 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.1 m80 -103.18 85.62 2.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.36 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -68.75 117.59 10.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.616 -176.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.0 m -133.35 154.12 51.0 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -176.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.502 HD13 ' HB ' ' A' ' 445' ' ' VAL . 1.4 pp -108.81 148.02 36.99 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.913 176.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.71 -47.24 5.55 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.49 1.46 . . . . 0.0 113.072 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.502 ' HB ' HD13 ' A' ' 443' ' ' LEU . 9.8 p 44.45 29.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 122.013 0.911 . . . . 0.0 111.425 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 448' ' ' VAL . 24.4 tpt180 -83.95 92.87 7.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.296 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 47.92 -76.21 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.826 1.251 . . . . 0.0 113.166 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 446' ' ' ARG . 33.5 m . . . . . 0 C--O 1.238 0.496 0 CA-C-O 121.851 0.834 . . . . 0.0 110.299 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' ' ZN' . . . . . 0.843 'ZN ' ' HG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' ' ZN' . . . . . 0.78 'ZN ' ' SG ' ' A' ' 421' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.11 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 34.0 p -67.07 -9.5 40.05 Favored 'General case' 0 C--O 1.242 0.659 0 O-C-N 122.545 -0.385 . . . . 0.0 111.725 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -75.01 -12.56 60.36 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.414 0.686 . . . . 0.0 110.25 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -54.54 97.51 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.355 0.598 . . . . 0.0 110.457 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 6.9 p -140.54 124.35 17.22 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.649 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.78 164.38 17.29 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.364 0.602 . . . . 0.0 111.054 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 14.4 m -60.55 -24.07 65.1 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 122.099 0.952 . . . . 0.0 110.485 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 12.2 p -130.75 156.44 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.543 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' LEU . . . . . 0.644 HD12 ' N ' ' A' ' 367' ' ' GLN . 1.7 pp -53.36 -27.34 23.2 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 122.151 -0.343 . . . . 0.0 111.017 176.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' GLN . . . . . 0.644 ' N ' HD12 ' A' ' 366' ' ' LEU . 24.3 tp60 67.81 -68.43 0.16 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.44 1.096 . . . . 0.0 111.609 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -171.81 101.23 0.16 Allowed Glycine 0 C--N 1.313 -0.708 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 49.2 m -81.33 71.22 8.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.693 0.759 . . . . 0.0 110.967 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -92.01 41.32 1.07 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.521 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 101.48 -56.23 0.72 Allowed Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -168.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -113.99 125.59 54.19 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.534 ' HD3' ' H ' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -88.61 -12.24 43.18 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.983 0.42 . . . . 0.0 110.231 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.442 HG13 ' HG2' ' A' ' 373' ' ' LYS . 32.9 m -117.07 157.49 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.391 176.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.444 ' O ' ' HD2' ' A' ' 375' ' ' LYS . 1.2 pptp? -90.8 152.87 20.61 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.64 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.43 HH21 ' CG ' ' A' ' 401' ' ' ASP . 0.7 OUTLIER -88.86 161.88 16.46 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.865 0.841 . . . . 0.0 110.453 177.747 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 9.6 t -98.72 144.53 27.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.611 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 35.4 m -62.56 122.68 16.41 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.081 0.863 . . . . 0.0 112.668 -168.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.79 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 47.1 t -58.2 110.82 1.02 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.915 171.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 380' ' ' MET . . . . . 0.5 ' HB3' HG12 ' A' ' 410' ' ' VAL . 23.3 ptm -59.81 -25.98 65.4 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.134 0.271 . . . . 0.0 110.947 -174.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 53.1 m-85 -95.18 -14.85 23.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.578 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 57.91 -117.7 11.0 Favored Glycine 0 C--O 1.216 -0.985 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.439 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -87.29 -3.71 59.05 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.169 0.509 . . . . 0.0 111.608 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -83.31 -25.17 31.77 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.04 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.808 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 6.3 p -70.68 120.71 16.69 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 174.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -79.61 1.41 26.23 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.65 0.594 . . . . 0.0 111.763 -170.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.53 ' HA ' ' NE ' ' A' ' 387' ' ' ARG . 2.4 mmp_? -62.98 129.16 39.16 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 123.532 0.52 . . . . 0.0 110.595 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.494 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -112.52 -11.79 13.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.094 -175.177 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -67.06 138.68 95.01 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.497 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.98 -23.74 78.04 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.074 1.849 . . . . 0.0 111.526 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.467 ' HA ' ' HG2' ' A' ' 394' ' ' GLN . 60.1 t -60.69 -41.65 89.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.716 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 48.5 t60 -53.63 -33.91 56.73 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.534 0.521 . . . . 0.0 110.911 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -95.86 -19.31 19.68 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.409 -175.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.467 ' HG2' ' HA ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -70.77 -25.38 62.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.503 0.192 . . . . 0.0 111.25 -177.535 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.585 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 0.8 OUTLIER -120.85 -8.77 9.38 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.585 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 93.0 m-85 -133.15 133.09 42.4 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.793 176.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 17.6 p -88.34 149.94 23.48 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.151 0.58 . . . . 0.0 110.042 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.455 ' H ' ' HB3' ' A' ' 401' ' ' ASP . 42.6 m80 -125.56 160.86 53.78 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.213 -174.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.15 93.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.499 2.133 . . . . 0.0 110.374 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 136.6 -23.51 3.25 Favored Glycine 0 C--O 1.238 0.402 0 O-C-N 123.995 0.809 . . . . 0.0 111.473 -175.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ASP . . . . . 0.455 ' HB3' ' H ' ' A' ' 398' ' ' HIS . 15.2 t70 -76.89 133.57 39.25 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 32.0 t -63.35 -13.82 43.37 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -172.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.71 12.42 31.01 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.402 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -73.28 111.2 8.18 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.478 0.18 . . . . 0.0 110.648 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -84.91 -56.58 2.43 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.195 -177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 67.48 16.46 67.44 Favored Glycine 0 CA--C 1.538 1.475 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.9 m -100.92 -9.44 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 121.057 0.456 . . . . 0.0 110.392 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 412' ' ' GLN . 51.9 tt0 -83.22 140.75 32.35 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.371 176.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 24.9 pt -49.33 -45.1 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 O-C-N 123.458 0.474 . . . . 0.0 110.675 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.5 HG12 ' HB3' ' A' ' 380' ' ' MET . 59.8 t -74.22 82.2 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 173.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 150.8 -51.98 0.51 Allowed Glycine 0 C--N 1.315 -0.587 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.199 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 30.0 pt20 -78.51 -49.93 12.51 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 12.0 t70 177.7 142.4 0.09 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -87.44 -11.1 50.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.766 -170.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 68.7 p -101.15 116.81 33.68 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.782 -0.574 . . . . 0.0 111.067 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -73.38 -52.89 12.19 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.411 ' OD1' ' HD2' ' A' ' 439' ' ' ARG . 19.2 p-10 -135.95 -32.54 0.88 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.444 174.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.631 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 17.4 ptt180 -146.17 172.46 5.24 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.318 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.599 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 21.1 Cg_endo -62.03 140.52 84.8 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 121.098 1.199 . . . . 0.0 111.687 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 420' ' ' GLU . . . . . 0.54 ' HG3' ' OD1' ' A' ' 441' ' ' ASN . 0.4 OUTLIER -74.02 160.1 31.77 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.392 0.433 . . . . 0.0 110.297 178.705 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.983 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 2.6 t -63.51 135.31 96.2 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.46 -2.88 6.74 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.499 2.133 . . . . 0.0 112.804 -177.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' TYR . . . . . 0.622 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 65.0 m-85 -125.84 14.96 8.04 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.066 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 64.51 -159.76 41.41 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.777 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.93 -14.48 38.76 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.968 1.779 . . . . 0.0 111.878 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 36.0 t -70.73 -17.82 62.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' CYS . . . . . 0.983 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 17.5 t -57.43 115.4 2.7 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -114.78 25.01 11.29 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.447 0.642 . . . . 0.0 109.416 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.705 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 2.0 mmp_? -59.77 99.31 0.06 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -80.18 96.71 6.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.114 0.959 . . . . 0.0 110.316 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -160.22 125.74 2.29 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.894 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.589 ' O ' HG13 ' A' ' 436' ' ' ILE . 20.1 Cg_endo -59.72 -42.29 47.74 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 121.979 1.786 . . . . 0.0 111.992 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.606 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 25.3 tp60 -64.46 -37.44 87.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.124 0.488 . . . . 0.0 109.895 -177.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' HIS . . . . . 0.691 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.2 t60 -59.34 -53.89 52.98 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.521 0.676 . . . . 0.0 110.021 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -63.15 -15.65 57.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.681 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 432' ' ' PRO . 85.5 mt -82.59 -37.24 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.219 0.533 . . . . 0.0 111.13 176.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.606 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 27.0 mt-10 -82.78 -44.34 15.67 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.474 -175.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 419' ' ' PRO . 96.5 m-85 -111.5 147.19 35.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.523 -171.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' ARG . . . . . 0.631 ' HD3' ' O ' ' A' ' 418' ' ' ARG . 0.0 OUTLIER -93.57 141.48 28.42 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.066 174.352 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.673 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 74.9 m80 -108.35 92.67 4.16 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 123.741 0.651 . . . . 0.0 109.43 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' ASN . . . . . 0.566 HD22 ' HE ' ' A' ' 439' ' ' ARG . 12.2 m120 -67.97 98.49 0.76 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -174.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.7 m -107.75 151.44 25.69 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 124.412 1.07 . . . . 0.0 109.531 -176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.463 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.6 OUTLIER -119.83 145.11 38.76 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-O 121.009 0.433 . . . . 0.0 110.146 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 444' ' ' PRO . . . . . 0.536 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 54.5 Cg_endo -68.66 -20.13 40.89 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.28 2.654 . . . . 0.0 112.455 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.463 ' HB ' HD13 ' A' ' 443' ' ' LEU . 5.6 p 47.94 30.68 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.883 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.484 177.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.536 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 24.7 mmt180 -87.71 145.33 26.19 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.413 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 64.16 1.19 1.15 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.811 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 121.055 0.455 . . . . 0.0 110.391 -178.807 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 449' ' ' ' ZN' . . . . . 0.808 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' ' ZN' . . . . . 0.749 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 32.3 p -117.31 152.77 34.2 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.719 0.407 . . . . 0.0 109.997 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -78.61 93.63 4.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.096 0.474 . . . . 0.0 109.824 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -77.28 94.46 4.16 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.912 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 16.7 p -66.19 119.58 11.73 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 123.872 0.732 . . . . 0.0 111.279 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -129.06 164.74 22.61 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.617 0.573 . . . . 0.0 109.523 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 13.0 p -51.29 145.12 8.61 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.562 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 48.4 t -63.35 83.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.923 0.868 . . . . 0.0 111.908 -174.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' LEU . . . . . 0.488 ' H ' HD23 ' A' ' 366' ' ' LEU . 2.1 pt? -82.28 -24.71 34.58 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 172.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 14.7 tp60 65.79 -74.32 0.06 Allowed 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.5 0.72 . . . . 0.0 112.599 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -52.27 -26.64 21.94 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 115.082 0.793 . . . . 0.0 115.082 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 47.6 m -114.17 22.93 13.35 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.145 -0.621 . . . . 0.0 111.585 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -126.33 147.3 49.76 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 88.43 -69.43 2.76 Favored Glycine 0 CA--C 1.505 -0.585 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.805 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -113.45 97.35 6.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 110.012 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.79 -9.19 14.49 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 123.336 0.654 . . . . 0.0 110.908 -177.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 19.7 m -70.23 142.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.871 0.844 . . . . 0.0 109.26 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.4 154.94 18.87 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.427 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.8 OUTLIER -124.88 162.24 24.84 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 121.556 0.693 . . . . 0.0 111.071 -178.021 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 15.3 t -117.2 155.3 29.63 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.899 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 15.9 m -57.78 121.64 10.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -170.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 11.5 t -60.74 116.75 4.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.063 173.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 380' ' ' MET . . . . . 0.564 ' HB2' HG22 ' A' ' 410' ' ' VAL . 31.6 ttp -50.86 -40.71 56.86 Favored 'General case' 0 C--O 1.25 1.084 0 C-N-CA 122.778 0.431 . . . . 0.0 111.2 -176.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.475 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 26.1 m-85 -91.96 -14.52 29.37 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.192 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.441 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 60.69 -119.61 19.38 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -80.92 -5.8 57.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.477 0.656 . . . . 0.0 111.495 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -86.18 -15.39 41.13 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.995 -174.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.924 ' HG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 6.9 p -74.74 131.82 41.13 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.133 0.492 . . . . 0.0 110.129 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -87.52 18.22 4.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.533 0.682 . . . . 0.0 111.405 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -87.36 121.93 30.45 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.679 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.483 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -121.99 2.74 9.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.69 0.757 . . . . 0.0 109.681 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.415 HD22 ' HB ' ' A' ' 391' ' ' VAL . 5.2 p-10 -63.37 135.6 96.32 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.305 174.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.93 -29.52 64.44 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.227 2.618 . . . . 0.0 111.408 -172.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.608 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 98.8 t -65.08 -34.07 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.682 -178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.55 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 84.7 t60 -63.67 -24.66 67.88 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.062 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -95.83 -15.4 22.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.868 0.467 . . . . 0.0 110.807 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.608 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -80.18 -25.68 39.61 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.25 -177.746 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.615 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 1.7 p80 -114.31 -19.95 11.05 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.615 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 59.3 m-85 -126.94 127.76 45.36 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 122.395 1.093 . . . . 0.0 111.614 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.427 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 8.8 p -81.6 158.03 24.51 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.655 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.723 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 46.4 m80 -137.02 159.07 71.43 Favored Pre-proline 0 C--N 1.315 -0.902 0 C-N-CA 123.644 0.778 . . . . 0.0 110.288 -174.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.85 102.24 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.024 1.816 . . . . 0.0 110.546 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 124.75 -0.3 8.5 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.027 -174.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -100.12 143.83 29.86 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.7 t -61.9 -29.95 70.56 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 123.32 0.387 . . . . 0.0 111.5 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.95 9.2 43.34 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.24 0.543 . . . . 0.0 110.776 -174.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -81.53 151.64 27.65 Favored 'General case' 0 C--O 1.248 0.997 0 O-C-N 121.948 -0.47 . . . . 0.0 110.887 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -160.49 -44.48 0.02 OUTLIER Glycine 0 C--O 1.227 -0.313 0 CA-C-O 121.409 0.45 . . . . 0.0 112.766 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 89.13 38.62 6.71 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -174.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 32.0 m -102.91 -1.05 9.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.729 0 CA-C-O 121.578 0.704 . . . . 0.0 112.127 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.475 ' O ' ' HG2' ' A' ' 412' ' ' GLN . 55.8 tt0 -90.42 133.19 35.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.891 176.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.496 HG13 ' N ' ' A' ' 410' ' ' VAL . 30.2 pt -50.08 -47.41 24.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 O-C-N 123.547 0.529 . . . . 0.0 109.958 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.564 HG22 ' HB2' ' A' ' 380' ' ' MET . 7.7 p -78.13 81.78 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.906 0.86 . . . . 0.0 108.821 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.45 -30.24 0.7 Allowed Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.003 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 27.6 pt20 -114.22 -46.24 3.0 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-O 121.174 0.511 . . . . 0.0 110.065 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.426 ' N ' ' HG3' ' A' ' 412' ' ' GLN . 5.1 p-10 179.87 126.52 0.08 Allowed 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' GLU . . . . . 0.422 ' HA ' ' HB ' ' A' ' 409' ' ' ILE . 46.8 mt-10 -82.45 -47.15 12.58 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 120.855 0.359 . . . . 0.0 111.245 -169.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.554 ' HA ' ' NH2' ' A' ' 439' ' ' ARG . 46.5 p -139.9 -95.27 0.16 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.901 -176.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 19.0 t70 170.0 -76.3 0.0 OUTLIER 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -171.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -139.64 0.12 1.8 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.793 0.806 . . . . 0.0 109.751 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.518 ' O ' ' HB ' ' A' ' 415' ' ' THR . 36.3 ptt180 -170.14 150.99 3.76 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.68 -172.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.61 157.08 40.38 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.413 2.075 . . . . 0.0 112.41 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' GLU . . . . . 0.527 ' HG3' ' HG3' ' A' ' 439' ' ' ARG . 2.1 mp0 -72.9 147.75 45.02 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.395 0.434 . . . . 0.0 111.396 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.974 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 4.3 t -58.96 131.73 86.83 Favored Pre-proline 0 C--O 1.243 0.733 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.959 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -58.23 -22.66 58.19 Favored 'Trans proline' 0 N--CA 1.48 0.714 0 C-N-CA 123.041 2.494 . . . . 0.0 112.631 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -97.04 -5.64 37.11 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.615 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 75.45 -154.31 45.65 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.109 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.4 -16.91 39.39 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 121.996 1.797 . . . . 0.0 111.908 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 22.8 t -79.56 4.38 16.01 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.443 0.64 . . . . 0.0 111.04 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' CYS . . . . . 0.974 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 45.5 t -55.99 116.35 2.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.998 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -107.59 22.54 15.82 Favored 'General case' 0 C--O 1.248 1.018 0 O-C-N 123.61 0.569 . . . . 0.0 110.419 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -69.41 104.44 2.29 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -80.66 98.1 7.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.04 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' ASN . . . . . 0.524 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 64.7 t30 -176.0 129.06 0.37 Allowed Pre-proline 0 CA--C 1.522 -0.128 0 C-N-CA 123.715 0.806 . . . . 0.0 109.84 176.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.524 ' HD2' ' OD1' ' A' ' 431' ' ' ASN . 18.4 Cg_endo -60.45 -43.66 32.3 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.714 1.609 . . . . 0.0 111.543 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.628 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 22.8 tp60 -60.88 -34.92 75.36 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 434' ' ' HIS . . . . . 0.702 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 51.5 t60 -56.67 -59.22 5.32 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 123.65 0.594 . . . . 0.0 111.522 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.434 ' HD3' ' H ' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -61.67 -11.42 11.66 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.048 178.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 432' ' ' PRO . 81.0 mt -83.74 -40.98 16.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.369 0.604 . . . . 0.0 110.929 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.628 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 23.4 mt-10 -78.9 -34.25 44.87 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.978 -176.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -114.77 132.11 56.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.84 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' ARG . . . . . 0.554 ' NH2' ' HA ' ' A' ' 415' ' ' THR . 13.2 ptt180 -84.09 124.5 31.17 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.562 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.751 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.1 m80 -100.14 86.29 3.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.207 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -77.86 135.67 37.95 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.342 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 3.1 p -111.64 133.25 54.02 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 123.703 0.801 . . . . 0.0 110.172 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.89 158.08 34.09 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -176.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' PRO . . . . . 0.561 ' HG3' HG23 ' A' ' 448' ' ' VAL . 17.7 Cg_endo -59.17 -24.75 75.34 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.809 2.339 . . . . 0.0 112.2 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 444' ' ' PRO . 3.7 p 49.62 21.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.491 0.717 . . . . 0.0 111.874 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.436 ' HG2' ' OD1' ' A' ' 447' ' ' ASN . 48.5 ttt180 -166.64 141.23 4.17 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 447' ' ' ASN . . . . . 0.436 ' OD1' ' HG2' ' A' ' 446' ' ' ARG . 4.2 m-20 63.56 -83.61 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.32 1.013 . . . . 0.0 111.454 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.561 HG23 ' HG3' ' A' ' 444' ' ' PRO . 35.3 m . . . . . 0 N--CA 1.474 0.773 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.884 -174.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' ' ZN' . . . . . 0.924 'ZN ' ' HG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' ' ZN' . . . . . 0.821 'ZN ' ' HG ' ' A' ' 421' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.853 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 19.3 t -136.27 150.19 48.81 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 360' ' ' LYS . 0.7 OUTLIER -87.7 169.64 11.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 123.602 0.563 . . . . 0.0 109.626 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -139.03 77.63 1.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.682 0.753 . . . . 0.0 110.188 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 20.2 p -100.0 175.22 5.84 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.249 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -65.98 101.86 0.73 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.359 0.6 . . . . 0.0 109.682 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 33.5 t -62.39 118.85 8.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.914 -176.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.0 p -86.02 71.46 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 122.089 0.947 . . . . 0.0 109.144 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' LEU . . . . . 0.427 HD12 ' N ' ' A' ' 367' ' ' GLN . 4.6 pp -63.26 -26.57 68.84 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.496 -175.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' GLN . . . . . 0.427 ' N ' HD12 ' A' ' 366' ' ' LEU . 10.2 tm0? -113.1 87.64 2.64 Favored 'General case' 0 C--O 1.25 1.087 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 153.71 -19.16 0.68 Allowed Glycine 0 CA--C 1.503 -0.671 0 O-C-N 123.183 0.302 . . . . 0.0 112.881 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 69.6 m -70.09 77.12 0.51 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.405 0.621 . . . . 0.0 110.209 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -86.2 -64.15 1.2 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.692 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -153.45 39.19 0.71 Allowed Glycine 0 C--N 1.316 -0.538 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -155.23 158.06 38.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.131 -0.534 . . . . 0.0 110.074 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -93.06 -45.16 8.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.774 0.797 . . . . 0.0 110.465 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 28.8 m -121.46 156.92 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.287 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -97.59 132.54 43.16 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.263 0.554 . . . . 0.0 110.615 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.16 161.69 14.32 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.308 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 14.9 t -103.69 147.16 27.57 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 21.1 m -54.99 125.92 22.41 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.358 0.599 . . . . 0.0 111.964 -174.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.755 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 45.9 t -56.81 124.09 17.3 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.647 174.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 34.3 ttp -50.59 -47.6 58.03 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.343 0.592 . . . . 0.0 111.372 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.515 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 56.5 m-85 -88.43 -9.79 51.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.344 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.607 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 67.87 -130.81 28.07 Favored Glycine 0 CA--C 1.501 -0.805 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -172.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' ALA . . . . . 0.505 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -80.73 -7.87 59.49 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.935 0.874 . . . . 0.0 110.913 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -79.99 -9.59 59.7 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.697 -176.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.79 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 3.7 p -63.06 136.53 57.85 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 123.583 0.552 . . . . 0.0 110.872 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -79.06 4.9 13.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.249 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -84.81 136.62 33.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.87 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.422 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.7 OUTLIER -123.7 -7.93 7.93 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.311 0.577 . . . . 0.0 110.409 179.11 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -66.74 139.27 95.74 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.514 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -60.59 -22.46 72.5 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 122.681 2.254 . . . . 0.0 111.314 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.422 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 99.3 t -63.42 -39.77 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.28 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.768 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 86.1 t60 -59.53 -31.66 69.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 110.131 178.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -91.0 -11.4 39.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.666 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 1.9 pp0? -82.87 -26.77 31.28 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.942 0.401 . . . . 0.0 110.567 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -110.57 -17.2 13.47 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 121.634 -0.666 . . . . 0.0 111.862 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 377' ' ' THR . 20.1 m-30 -125.11 135.23 52.47 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.273 0.488 . . . . 0.0 111.467 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 20.8 p -83.37 156.51 22.96 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 123.648 0.593 . . . . 0.0 110.269 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.585 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 40.7 m80 -135.61 159.89 69.75 Favored Pre-proline 0 C--O 1.221 -0.421 0 C-N-CA 122.51 0.324 . . . . 0.0 110.956 -174.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.505 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 18.7 Cg_endo -56.48 114.75 2.05 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.965 1.777 . . . . 0.0 110.832 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.08 2.98 48.67 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 -174.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ASP . . . . . 0.441 ' HB3' ' H ' ' A' ' 398' ' ' HIS . 20.7 t70 -101.62 155.95 17.79 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.381 -0.482 . . . . 0.0 109.915 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 32.0 t -59.49 -37.09 77.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.812 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -106.36 15.05 26.58 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.333 -167.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -84.34 149.77 25.82 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -179.93 -16.02 0.03 OUTLIER Glycine 0 C--O 1.239 0.419 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.52 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 80.26 36.36 24.3 Favored Glycine 0 N--CA 1.462 0.393 0 O-C-N 121.357 -1.084 . . . . 0.0 111.561 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 33.7 m -77.72 -6.28 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 124.485 0.756 . . . . 0.0 110.417 -178.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -106.7 134.49 49.77 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.658 0.783 . . . . 0.0 110.506 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 6.3 pt -54.31 -50.2 58.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.18 115.16 5.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 121.822 0.82 . . . . 0.0 110.85 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 125.11 -14.72 7.41 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.04 -172.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.25 -36.54 0.44 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.729 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -165.72 134.6 3.22 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 110.493 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -136.46 31.92 2.83 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.89 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 77.2 p -71.77 -60.98 1.95 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.021 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 417' ' ' ASP . 17.9 t70 -168.41 -31.4 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.04 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 416' ' ' ASP . 16.9 t0 80.62 78.81 0.04 OUTLIER 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.066 0.947 . . . . 0.0 111.287 173.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.4 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 25.6 ptt180 178.43 158.7 0.61 Allowed Pre-proline 0 CA--C 1.514 -0.423 0 CA-C-N 113.988 -1.46 . . . . 0.0 108.845 172.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 31.0 Cg_endo -63.15 151.1 86.52 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.263 1.975 . . . . 0.0 111.452 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' GLU . . . . . 0.583 ' HG2' ' HG3' ' A' ' 439' ' ' ARG . 36.7 mt-10 -85.05 154.26 22.2 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.385 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.971 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 8.2 t -58.58 133.69 85.84 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.046 -178.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 421' ' ' CYS . 52.6 Cg_exo -56.48 -29.18 77.1 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.047 2.498 . . . . 0.0 112.715 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' TYR . . . . . 0.563 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 51.5 m-85 -98.25 6.88 46.97 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.53 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 62.52 -151.27 46.6 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.85 -15.74 29.68 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.287 1.991 . . . . 0.0 112.366 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 31.4 t -73.45 -10.19 59.47 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.624 0.726 . . . . 0.0 110.048 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' CYS . . . . . 0.971 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 42.5 t -62.38 118.62 7.73 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.189 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -125.58 23.0 7.52 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.098 0.874 . . . . 0.0 109.021 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -56.71 117.1 3.58 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.554 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -67.08 97.46 0.51 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.414 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' ASN . . . . . 0.518 HD21 ' HB3' ' A' ' 433' ' ' GLN . 62.4 t30 -178.06 121.11 0.25 Allowed Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 123.443 0.697 . . . . 0.0 109.7 173.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.15 -27.8 28.97 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.502 1.468 . . . . 0.0 111.866 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.623 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 27.0 tp60 -72.34 -34.18 67.85 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' HIS . . . . . 0.626 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 24.5 t60 -57.56 -56.61 19.71 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.859 178.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -63.21 -20.06 65.09 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.242 -177.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 50.2 mt -78.41 -41.45 25.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 122.703 0.401 . . . . 0.0 110.092 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.623 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 22.7 mt-10 -79.41 -45.68 19.03 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.815 -175.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -101.45 138.82 37.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.64 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' ARG . . . . . 0.583 ' HG3' ' HG2' ' A' ' 420' ' ' GLU . 19.1 ptt180 -92.25 145.18 24.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.515 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -119.33 98.86 6.35 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -110.2 168.61 9.31 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 4.1 p -116.99 131.99 56.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.417 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 2.5 pp -120.12 151.0 52.4 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.217 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' PRO . . . . . 0.542 ' O ' HG12 ' A' ' 445' ' ' VAL . 16.5 Cg_endo -56.79 -42.37 65.56 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.898 2.399 . . . . 0.0 112.686 -171.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 444' ' ' PRO . 2.5 p 51.4 12.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 124.582 1.176 . . . . 0.0 111.127 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 446' ' ' ARG . 0.0 OUTLIER -84.06 -43.49 15.04 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -170.172 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -107.78 24.04 13.53 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.563 0.697 . . . . 0.0 110.955 -175.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 121.021 0.439 . . . . 0.0 110.648 -179.788 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 449' ' ' ' ZN' . . . . . 0.79 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' ' ZN' . . . . . 0.931 'ZN ' ' HG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 21.4 p -92.18 -21.7 20.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.106 0.479 . . . . 0.0 111.228 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.754 ' HA ' ' HE2' ' A' ' 360' ' ' LYS . 0.6 OUTLIER 62.69 12.21 5.42 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.987 178.216 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -94.79 117.88 30.86 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.828 -173.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 17.2 p -119.18 139.78 51.27 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 173.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -74.49 97.43 3.11 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 120.872 0.368 . . . . 0.0 111.611 -176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 20.5 p -66.28 108.51 2.34 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.995 176.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 365' ' ' VAL . 7.5 p -61.55 107.05 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.055 0.455 . . . . 0.0 110.775 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 3.6 pp -76.59 -16.05 59.69 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.619 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -81.51 157.88 24.68 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 123.768 0.667 . . . . 0.0 109.958 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 91.55 22.43 31.51 Favored Glycine 0 C--O 1.229 -0.211 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.507 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 22.6 t -132.1 24.65 4.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.479 ' CD ' ' H ' ' A' ' 370' ' ' GLU . 4.6 mp0 -59.56 -60.67 3.48 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.943 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 62.88 32.15 82.9 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.531 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -152.26 156.9 40.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.788 0.328 . . . . 0.0 110.73 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.514 ' HD3' ' H ' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -134.9 13.83 3.63 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 173.634 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.93 157.45 22.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.687 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.58 164.18 13.08 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.472 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.2 OUTLIER -115.05 174.09 6.16 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.325 0.583 . . . . 0.0 110.906 177.068 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 13.4 t -127.15 157.47 39.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.876 176.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 69.6 p -50.61 122.37 7.09 Favored 'General case' 0 C--O 1.249 1.028 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -170.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.845 ' HG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 53.0 t -65.13 115.22 5.27 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 168.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 380' ' ' MET . . . . . 0.802 ' HA ' ' HA2' ' A' ' 411' ' ' GLY . 44.3 ttp -51.89 -42.97 63.13 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.596 0.712 . . . . 0.0 111.624 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.563 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 24.8 m-85 -87.63 -9.06 55.32 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.794 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.617 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 62.5 -130.71 43.75 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-O 119.248 -0.751 . . . . 0.0 112.521 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' ALA . . . . . 0.649 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -75.82 -10.25 59.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.405 0.621 . . . . 0.0 111.67 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -85.97 -5.65 59.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.676 -174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.797 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 4.7 p -65.64 132.62 49.27 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.12 0.486 . . . . 0.0 110.897 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -71.39 -11.88 61.12 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.405 0.621 . . . . 0.0 110.375 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -80.34 108.76 14.21 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.592 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.39 -3.3 21.21 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.34 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -63.18 140.41 97.67 Favored Pre-proline 0 C--O 1.233 0.189 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.025 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.72 -22.41 61.11 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.058 1.839 . . . . 0.0 110.901 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.57 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 96.6 t -66.7 -35.63 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.847 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.703 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 47.0 t60 -60.86 -30.82 70.36 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 121.892 -0.505 . . . . 0.0 109.668 177.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -90.82 -15.67 29.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.733 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -81.73 -19.45 41.4 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.509 -178.265 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.656 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 2.5 p80 -119.04 -10.53 9.81 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.656 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 86.9 m-85 -135.59 126.75 28.09 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 121.491 0.663 . . . . 0.0 111.111 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.472 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 25.3 m -72.15 154.45 41.05 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.004 176.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.591 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 55.2 m80 -134.99 166.26 30.5 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.649 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 34.7 Cg_exo -40.04 -13.6 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 123.851 3.034 . . . . 0.0 115.782 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 398' ' ' HIS . . . -130.08 34.22 2.77 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ASP . . . . . 0.428 ' HB3' ' H ' ' A' ' 398' ' ' HIS . 18.5 t70 -120.19 151.14 39.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.388 0.613 . . . . 0.0 109.823 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 23.3 t -64.42 -18.47 64.75 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -172.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -111.66 7.67 20.51 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -72.28 145.73 47.68 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.354 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -169.62 -45.24 0.03 OUTLIER Glycine 0 C--N 1.32 -0.346 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.859 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 92.72 33.3 7.52 Favored Glycine 0 C--O 1.237 0.338 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.832 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.5 m -86.17 -17.27 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 O-C-N 122.609 -0.348 . . . . 0.0 110.69 -176.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -82.39 146.13 29.51 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.764 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 410' ' ' VAL . 20.6 pt -52.76 -51.68 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.65 0.738 . . . . 0.0 110.786 178.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.548 HG22 ' HB2' ' A' ' 380' ' ' MET . 9.5 p -77.88 76.61 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.957 0 CA-C-O 122.651 1.215 . . . . 0.0 108.742 171.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.802 ' HA2' ' HA ' ' A' ' 380' ' ' MET . . . 177.2 -49.43 0.1 Allowed Glycine 0 C--O 1.218 -0.892 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.433 -177.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 413' ' ' ASP . 27.0 pt20 -90.77 -54.74 3.85 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 171.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.491 ' N ' ' HG3' ' A' ' 412' ' ' GLN . 9.0 t70 170.65 143.13 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -90.14 5.69 45.81 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -171.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.453 HG22 ' HA ' ' A' ' 419' ' ' PRO . 43.9 p -94.81 125.74 39.67 Favored 'General case' 0 C--O 1.22 -0.489 0 O-C-N 122.006 -0.434 . . . . 0.0 111.234 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -69.62 -59.52 2.91 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.426 0.454 . . . . 0.0 109.941 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.406 ' CG ' ' HG2' ' A' ' 418' ' ' ARG . 19.2 p-10 -131.23 -20.05 2.74 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.498 177.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.51 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 13.9 ptt180 -166.63 165.03 10.11 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -175.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 40.6 Cg_endo -66.31 148.12 84.06 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.047 2.498 . . . . 0.0 111.195 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -75.0 151.88 38.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.572 0.701 . . . . 0.0 110.578 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.987 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 12.0 t -63.95 134.86 96.07 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.948 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.63 -5.77 9.3 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.169 1.912 . . . . 0.0 114.028 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -121.52 8.9 10.17 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.24 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 64.49 -154.12 48.5 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 119.835 -0.425 . . . . 0.0 112.527 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.43 -19.3 28.86 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.685 2.257 . . . . 0.0 111.711 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 36.5 t -74.13 -8.71 57.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.596 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' CYS . . . . . 0.987 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 48.7 t -49.84 117.83 2.51 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.277 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -112.68 22.24 14.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.46 0.648 . . . . 0.0 110.623 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -67.97 107.21 2.6 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.534 175.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -77.73 89.99 4.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.286 0.565 . . . . 0.0 111.567 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -165.31 127.21 1.46 Allowed Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.258 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.558 ' O ' HG13 ' A' ' 436' ' ' ILE . 31.0 Cg_endo -63.16 -40.99 29.97 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.837 1.691 . . . . 0.0 111.592 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -62.38 -37.09 84.42 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.766 0.317 . . . . 0.0 110.345 -176.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' HIS . . . . . 0.691 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 39.8 t60 -60.06 -56.78 17.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.958 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.466 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 23.1 mtpp -57.92 -21.6 44.47 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.641 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 432' ' ' PRO . 65.4 mt -81.23 -46.37 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 122.763 0.425 . . . . 0.0 110.797 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 418' ' ' ARG . 7.2 mm-40 -84.02 -27.86 28.08 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -174.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -107.32 129.33 54.91 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.773 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -83.65 111.82 19.47 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.369 0.604 . . . . 0.0 110.859 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.725 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 63.8 m80 -87.53 112.53 22.33 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.525 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -114.66 125.56 53.88 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -171.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.6 p -88.9 124.43 34.2 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.504 ' CD1' ' HB ' ' A' ' 445' ' ' VAL . 1.4 pp -111.25 147.35 36.46 Favored Pre-proline 0 C--O 1.249 1.05 0 O-C-N 123.871 0.732 . . . . 0.0 111.76 -173.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 444' ' ' PRO . . . . . 0.424 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 28.4 Cg_endo -63.41 -30.68 72.61 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.041 2.494 . . . . 0.0 112.211 -175.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.504 ' HB ' ' CD1' ' A' ' 443' ' ' LEU . 8.7 p 43.33 30.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.739 0.816 . . . . 0.0 111.136 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.424 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 21.9 mmt180 -68.68 137.6 54.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.343 0.592 . . . . 0.0 111.553 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -74.09 86.37 1.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.023 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.448 -0.537 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.635 -179.496 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 449' ' ' ' ZN' . . . . . 0.845 'ZN ' ' HG ' ' A' ' 379' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' ' ZN' . . . . . 0.91 'ZN ' ' HG ' ' A' ' 421' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.406 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 40.4 t -73.64 146.77 44.34 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -97.31 113.46 25.09 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.908 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -137.82 82.28 1.91 Allowed 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.468 0.652 . . . . 0.0 110.759 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 23.7 p -80.91 142.26 33.73 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.716 0.77 . . . . 0.0 110.357 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -77.03 125.25 29.0 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 121.985 -0.447 . . . . 0.0 110.768 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 14.3 m -70.81 96.54 1.27 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.88 0.848 . . . . 0.0 110.532 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.6 p -69.94 103.32 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.596 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 367' ' ' GLN . 2.9 pp -91.63 -15.96 27.77 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.77 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 367' ' ' GLN . . . . . 0.406 ' N ' HD12 ' A' ' 366' ' ' LEU . 6.3 tp-100 -71.06 87.99 0.77 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.492 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -127.79 16.79 6.13 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-O 122.224 0.902 . . . . 0.0 111.027 175.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 33.3 t -85.36 101.29 12.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.284 -0.458 . . . . 0.0 109.902 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.16 -81.41 0.18 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.487 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 53.84 46.31 68.29 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.895 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -128.96 -174.34 3.23 Favored 'General case' 0 C--O 1.25 1.105 0 CA-C-O 120.809 0.338 . . . . 0.0 111.135 -174.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.52 ' HD3' ' H ' ' A' ' 373' ' ' LYS . 0.6 OUTLIER -115.86 -32.25 5.51 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 122.885 0.474 . . . . 0.0 110.464 175.03 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 m -121.64 -176.99 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -157.81 164.93 36.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.424 0.63 . . . . 0.0 109.525 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.477 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -98.15 153.54 18.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.336 174.418 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.4 HG23 ' CD2' ' A' ' 396' ' ' PHE . 2.7 t -92.17 149.92 21.21 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.046 178.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.405 ' HB3' ' NE2' ' A' ' 408' ' ' GLN . 36.9 t -54.51 117.93 3.74 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.951 0.782 . . . . 0.0 111.752 -174.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.935 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 7.8 t -51.68 115.47 1.65 Allowed 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 170.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 380' ' ' MET . . . . . 0.512 ' O ' HG22 ' A' ' 410' ' ' VAL . 26.0 ptm -57.15 -26.77 61.11 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.451 0.469 . . . . 0.0 111.321 -172.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.553 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 58.9 m-85 -102.78 -17.15 15.72 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.696 0.284 . . . . 0.0 110.677 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.422 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 66.41 -114.37 6.45 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.814 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -83.08 -7.29 59.66 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.996 -0.709 . . . . 0.0 110.745 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 381' ' ' TYR . 36.4 m-80 -83.88 -24.49 30.81 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.632 -176.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.935 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.8 p -67.2 120.99 14.68 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.593 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -78.96 4.32 14.62 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.391 1.057 . . . . 0.0 110.891 -174.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -80.96 119.86 24.02 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.699 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.457 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.9 OUTLIER -117.23 -1.73 11.77 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -176.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -60.99 142.58 92.74 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.352 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.68 -27.7 85.58 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.367 2.045 . . . . 0.0 110.384 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.469 ' O ' ' CD2' ' A' ' 395' ' ' HIS . 96.4 t -64.72 -41.07 91.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 O-C-N 123.79 0.681 . . . . 0.0 110.398 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.662 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 58.2 t60 -56.23 -34.0 65.93 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 39.6 m-85 -88.28 -25.05 23.01 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.198 0.523 . . . . 0.0 110.762 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -66.97 -19.37 65.71 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.595 -175.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.513 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 8.6 p80 -125.86 -17.75 5.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.621 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.513 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 26.3 m-85 -125.64 129.03 48.78 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 120.857 0.361 . . . . 0.0 110.898 174.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.477 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 13.7 p -84.08 160.82 20.86 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.396 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.732 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 43.9 m80 -133.44 159.18 73.58 Favored Pre-proline 0 C--N 1.342 0.271 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.667 -174.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -51.6 113.23 1.06 Allowed 'Trans proline' 0 C--O 1.238 0.517 0 C-N-CA 122.625 2.217 . . . . 0.0 112.242 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 110.66 -8.42 30.06 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.957 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -86.76 148.69 25.31 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.598 0.713 . . . . 0.0 110.869 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 46.1 t -56.71 -29.69 62.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.314 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -107.4 17.17 23.12 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.655 -175.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -92.46 120.6 33.1 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -103.26 -57.61 0.76 Allowed Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.501 176.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 66.51 50.12 51.55 Favored Glycine 0 N--CA 1.463 0.494 0 CA-C-N 115.253 -0.473 . . . . 0.0 112.232 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.3 m -112.35 -1.35 9.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 O-C-N 122.008 -0.701 . . . . 0.0 112.405 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.405 ' NE2' ' HB3' ' A' ' 378' ' ' SER . 28.0 pt20 -77.67 175.92 9.47 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.993 176.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.505 HG13 ' H ' ' A' ' 410' ' ' VAL . 4.7 pt -65.48 -61.66 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 120.874 0.369 . . . . 0.0 110.637 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 380' ' ' MET . 8.0 p -64.88 118.98 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-O 121.686 0.755 . . . . 0.0 110.382 -175.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 127.01 -63.64 0.6 Allowed Glycine 0 C--O 1.242 0.608 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -169.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -40.75 15.87 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.006 0.403 . . . . 0.0 110.935 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -168.75 129.57 1.21 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.105 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 410' ' ' VAL . 40.1 mt-10 -100.89 4.64 42.85 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.71 -172.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 54.2 p -103.18 -75.44 0.61 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.254 -0.178 . . . . 0.0 111.418 -175.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -161.08 -62.7 0.06 Allowed 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.064 0.546 . . . . 0.0 109.925 -175.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -138.53 -14.64 1.26 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.799 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 13.7 ptt180 -171.95 154.15 3.4 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 122.432 0.293 . . . . 0.0 110.314 -173.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.94 147.85 24.8 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.516 2.144 . . . . 0.0 112.317 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.47 152.79 25.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.67 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 17.1 t -59.03 129.41 85.99 Favored Pre-proline 0 C--O 1.244 0.785 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.927 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.89 -6.73 18.83 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 122.351 2.034 . . . . 0.0 111.745 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' TYR . . . . . 0.587 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 52.8 m-85 -108.27 8.97 28.05 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.027 176.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 62.72 -159.76 34.56 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.914 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.1 -20.74 24.75 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.076 2.517 . . . . 0.0 111.079 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 16.4 t -76.01 -4.25 40.22 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.755 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' CYS . . . . . 0.781 ' SG ' ' NE2' ' A' ' 434' ' ' HIS . 43.2 t -56.97 123.82 16.48 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.426 0.691 . . . . 0.0 112.028 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -126.94 28.97 5.72 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.573 ' HG2' ' SG ' ' A' ' 427' ' ' CYS . 20.9 mmm180 -68.69 101.35 1.29 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.658 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -67.86 90.8 0.3 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.394 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' ASN . . . . . 0.486 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 59.8 t30 -162.7 127.91 2.14 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.878 174.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.486 ' HD2' ' OD1' ' A' ' 431' ' ' ASN . 18.5 Cg_endo -60.59 -43.06 35.06 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 122.099 1.866 . . . . 0.0 112.392 -177.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 433' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -63.44 -32.34 73.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.789 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' HIS . . . . . 0.781 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 43.8 t60 -58.13 -59.83 4.68 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.828 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -12.36 60.76 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.448 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 432' ' ' PRO . 62.8 mt -76.7 -51.27 19.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.198 0.523 . . . . 0.0 110.671 175.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 418' ' ' ARG . 7.9 mm-40 -72.95 -49.62 28.21 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.061 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -98.59 138.3 35.98 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.412 0.445 . . . . 0.0 111.276 -173.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' ARG . . . . . 0.458 HH11 ' HD2' ' A' ' 439' ' ' ARG . 11.8 ptt180 -94.96 145.27 25.04 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.463 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 31.1 m80 -120.33 108.75 14.54 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -176.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -95.69 131.79 41.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.054 0.454 . . . . 0.0 109.975 -177.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 10.2 p -114.13 147.35 38.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.262 -175.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.489 HD13 ' HB ' ' A' ' 445' ' ' VAL . 1.2 pp -149.99 148.28 24.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.485 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.38 -25.74 11.0 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.962 2.441 . . . . 0.0 112.578 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.489 ' HB ' HD13 ' A' ' 443' ' ' LEU . 7.9 p 46.63 27.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 122.443 1.116 . . . . 0.0 111.932 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -87.81 -28.6 21.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.644 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -63.69 -32.19 73.59 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.5 -176.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 C--N 1.318 -0.772 0 O-C-N 122.218 -0.301 . . . . 0.0 110.514 178.741 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 449' ' ' ' ZN' . . . . . 0.817 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' ' ZN' . . . . . 0.752 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.043 0 N-CA-C 112.376 -0.289 . . . . 0.0 112.376 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 38.1 m -65.74 134.55 53.4 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 117.25 0.525 . . . . 0.0 110.176 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -119.87 148.94 42.87 Favored 'General case' 0 C--O 1.248 1.019 0 C-N-CA 122.651 0.38 . . . . 0.0 110.368 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -161.47 129.04 4.12 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 123.451 0.469 . . . . 0.0 110.804 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 25.1 p -103.71 131.83 50.52 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.08 176.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -70.35 111.18 5.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.496 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 28.9 t -69.79 107.67 3.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 35.9 t -75.31 80.29 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 366' ' ' LEU . 2.3 pt? -60.38 -33.58 72.67 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.708 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -152.42 156.77 40.15 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.754 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -174.98 125.67 1.11 Allowed Glycine 0 CA--C 1.508 -0.396 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.8 m -62.4 -52.37 63.85 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.618 0.246 . . . . 0.0 110.464 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 44.47 86.01 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 O-C-N 123.953 0.783 . . . . 0.0 110.172 -176.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 150.55 -64.9 0.38 Allowed Glycine 0 C--N 1.309 -0.971 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -101.75 103.23 13.97 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 122.108 0.956 . . . . 0.0 109.281 171.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -76.3 -28.64 57.04 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 5.3 m -139.08 161.18 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 113.53 -1.668 . . . . 0.0 108.019 175.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.584 ' N ' ' HD2' ' A' ' 375' ' ' LYS . 8.9 mptt -90.11 -31.22 17.2 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.431 0.634 . . . . 0.0 109.393 -172.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.474 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.1 OUTLIER -114.47 155.76 25.8 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.234 172.121 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 12.2 t -108.97 152.95 24.27 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.076 0.86 . . . . 0.0 109.29 175.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.404 ' OG ' HG22 ' A' ' 407' ' ' VAL . 45.7 m -51.52 122.73 8.46 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 121.161 0.505 . . . . 0.0 111.483 -174.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.85 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 54.0 t -51.3 123.15 9.0 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.937 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 23.8 ptm -55.42 -25.05 33.72 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.185 0.594 . . . . 0.0 111.324 -174.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.543 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 37.5 m-85 -116.88 -8.07 11.35 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.813 177.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 379' ' ' CYS . . . 63.05 -123.98 31.32 Favored Glycine 0 C--O 1.242 0.644 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.863 -177.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -82.06 -9.71 59.46 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.303 0.241 . . . . 0.0 111.056 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -77.05 -30.29 55.57 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.806 0.336 . . . . 0.0 111.193 -175.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.85 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 4.5 p -65.94 115.82 6.43 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.24 176.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -76.28 2.36 13.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.856 0.836 . . . . 0.0 110.944 -175.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -65.92 124.0 21.33 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.048 172.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.512 ' HD2' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -125.61 3.02 7.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.168 0.509 . . . . 0.0 110.464 -176.485 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -61.43 139.86 94.83 Favored Pre-proline 0 C--O 1.247 0.957 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.186 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.69 -25.13 80.34 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 122.934 2.423 . . . . 0.0 112.346 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.564 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 95.9 t -64.24 -37.18 79.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.573 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.762 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 26.0 t60 -58.64 -27.36 64.66 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.143 0.497 . . . . 0.0 110.644 177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -98.09 -7.96 28.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.668 -177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -84.18 -17.05 41.24 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.041 0.448 . . . . 0.0 110.959 -176.599 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.476 ' ND1' ' CD1' ' A' ' 396' ' ' PHE . 7.8 p80 -126.58 -16.65 5.25 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 176.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.532 ' CD2' ' HA ' ' A' ' 379' ' ' CYS . 63.5 m-85 -125.07 128.03 47.85 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.675 0.75 . . . . 0.0 112.408 174.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.474 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 20.1 p -80.01 165.38 22.63 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.483 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -136.97 158.29 73.11 Favored Pre-proline 0 C--O 1.245 0.864 0 O-C-N 123.203 0.314 . . . . 0.0 110.318 -175.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -54.38 97.28 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.153 2.569 . . . . 0.0 110.728 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 121.93 17.14 3.84 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 123.76 0.663 . . . . 0.0 111.457 -174.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -117.24 151.08 37.66 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.215 -0.579 . . . . 0.0 110.208 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 35.2 t -57.76 -36.78 72.57 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.168 -176.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -92.79 9.05 36.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.22 0.533 . . . . 0.0 111.253 -172.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -96.9 146.81 24.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.789 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 160.81 41.82 0.02 OUTLIER Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.55 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' GLY . . . . . 0.432 ' HA2' ' OE1' ' A' ' 412' ' ' GLN . . . 57.89 41.52 94.23 Favored Glycine 0 N--CA 1.464 0.501 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.69 -177.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.404 HG22 ' OG ' ' A' ' 378' ' ' SER . 9.7 m -80.74 -13.66 12.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.428 0.632 . . . . 0.0 109.496 -175.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -139.39 129.77 25.54 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 9.1 pt -48.59 -45.95 14.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.97 0.891 . . . . 0.0 110.614 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 19.3 t -67.54 105.84 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 379' ' ' CYS . . . 157.37 -48.95 0.44 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -175.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.588 ' H ' ' NE2' ' A' ' 412' ' ' GLN . 0.7 OUTLIER -118.07 -42.49 2.81 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 122.925 0.49 . . . . 0.0 110.616 177.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -170.17 136.45 1.42 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.848 0.459 . . . . 0.0 110.585 173.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.9 21.67 3.06 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.113 0.965 . . . . 0.0 110.751 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 35.5 p -127.38 -71.8 0.66 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.388 0.614 . . . . 0.0 110.655 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.5 t70 170.33 -51.83 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.101 -172.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -178.92 -26.85 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.242 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 20.9 ptt180 -142.98 160.02 54.3 Favored Pre-proline 0 C--O 1.216 -0.689 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.099 -170.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.76 159.22 48.95 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 121.652 1.568 . . . . 0.0 112.037 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' GLU . . . . . 0.406 ' HG3' ' CZ ' ' A' ' 439' ' ' ARG . 40.8 mt-10 -73.51 155.24 39.39 Favored 'General case' 0 C--O 1.248 0.995 0 O-C-N 121.918 -0.489 . . . . 0.0 110.907 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.77 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 16.1 t -61.7 133.64 93.61 Favored Pre-proline 0 N--CA 1.443 -0.785 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.359 176.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.17 -9.05 22.15 Favored 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 122.41 2.074 . . . . 0.0 112.743 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -116.5 12.2 15.07 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.086 0.554 . . . . 0.0 110.113 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 58.38 -153.55 27.45 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 116.5 -0.318 . . . . 0.0 112.497 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.87 -13.99 24.08 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.158 2.572 . . . . 0.0 112.474 173.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 32.2 t -70.17 -14.06 62.47 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.568 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' CYS . . . . . 0.81 ' SG ' 'ZN ' ' A' ' 450' ' ' ' ZN' . 51.5 t -49.76 137.02 16.78 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.256 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -138.12 20.57 2.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.501 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -63.96 104.1 0.67 Allowed 'General case' 0 C--O 1.24 0.604 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.676 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 430' ' ' LYS . 18.9 ptpt -62.24 95.88 0.07 Allowed 'General case' 0 C--O 1.249 1.055 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.011 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 431' ' ' ASN . . . . . 0.465 HD21 ' HB3' ' A' ' 433' ' ' GLN . 61.4 t30 -177.98 123.2 0.26 Allowed Pre-proline 0 C--O 1.238 0.475 0 CA-C-O 120.659 0.266 . . . . 0.0 110.496 176.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.08 -39.2 40.99 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.755 2.303 . . . . 0.0 111.83 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.617 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 6.6 tp-100 -64.46 -32.79 74.56 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.466 0.65 . . . . 0.0 110.655 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' HIS . . . . . 0.574 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 35.8 t60 -55.96 -59.95 4.17 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.094 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.404 ' H ' ' HD3' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -59.11 -19.01 40.73 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.972 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.487 HD12 ' HA ' ' A' ' 433' ' ' GLN . 77.3 mt -75.09 -43.84 44.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.596 0.713 . . . . 0.0 110.878 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.617 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 19.6 mt-10 -82.66 -40.4 20.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.28 -174.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -106.78 128.87 54.61 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.224 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' ARG . . . . . 0.406 ' CZ ' ' HG3' ' A' ' 420' ' ' GLU . 15.3 ptt-85 -85.4 116.4 23.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.894 0.854 . . . . 0.0 110.185 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.745 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 37.0 m80 -90.82 86.08 6.21 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.101 178.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -70.49 104.23 2.7 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.464 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 6.8 m -114.06 160.25 19.1 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.702 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.476 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.5 OUTLIER -135.12 157.24 77.31 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.769 179.157 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 444' ' ' PRO . . . . . 0.41 ' O ' HG12 ' A' ' 445' ' ' VAL . 18.7 Cg_endo -60.0 -42.28 45.72 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 122.06 1.84 . . . . 0.0 112.036 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.476 ' HB ' HD13 ' A' ' 443' ' ' LEU . 2.7 p 50.37 15.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 124.347 1.029 . . . . 0.0 112.513 177.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.41 133.56 46.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -176.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -73.29 86.23 1.45 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.971 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.321 -0.638 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.89 178.542 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 449' ' ' ' ZN' . . . . . 0.765 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' ' ZN' . . . . . 0.81 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.858 0 N-CA-C 112.201 -0.36 . . . . 0.0 112.201 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 39.3 t -159.76 122.95 3.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.812 0.339 . . . . 0.0 111.321 -176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.48 108.81 18.94 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 172.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -105.18 101.12 10.69 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.829 0.347 . . . . 0.0 110.432 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 16.5 p -70.86 129.79 39.97 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.175 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -87.87 123.11 32.29 Favored 'General case' 0 C--O 1.249 1.075 0 C-N-CA 122.668 0.387 . . . . 0.0 110.412 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 30.8 p -73.46 173.7 9.25 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 123.736 0.648 . . . . 0.0 110.355 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.45 117.09 47.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.177 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 367' ' ' GLN . 3.1 pp -109.87 -23.13 11.53 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' GLN . . . . . 0.513 ' N ' HD12 ' A' ' 366' ' ' LEU . 35.1 tt0 -62.87 98.57 0.13 Allowed 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 151.53 -39.77 0.79 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -175.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 30.6 m -81.94 88.59 6.36 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 172.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.541 ' HG3' ' ND2' ' A' ' 372' ' ' ASN . 9.9 pt-20 -132.56 35.79 3.6 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.425 0.631 . . . . 0.0 110.949 -170.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 74.21 -77.57 1.01 Allowed Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ASN . . . . . 0.541 ' ND2' ' HG3' ' A' ' 370' ' ' GLU . 0.1 OUTLIER -63.62 152.71 38.15 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 110.664 -0.125 . . . . 0.0 110.664 178.059 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.517 ' N ' ' HD3' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -92.13 -51.68 5.06 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.682 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 20.1 m -110.08 140.17 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.952 0.882 . . . . 0.0 109.588 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.726 ' N ' ' HD3' ' A' ' 375' ' ' LYS . 0.0 OUTLIER -98.8 -25.35 14.68 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.823 -178.69 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.7 158.86 33.74 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.212 173.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 12.9 m -101.0 139.94 35.99 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.66 173.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 49.7 m -54.83 122.98 11.96 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.609 -0.682 . . . . 0.0 110.023 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.772 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 18.4 t -50.16 123.3 8.12 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.199 0.523 . . . . 0.0 110.296 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 25.8 ptm -60.31 -17.84 45.56 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.188 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.591 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 38.0 m-85 -112.92 -11.05 13.47 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.75 177.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.407 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 65.43 -131.07 35.06 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.262 -177.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -75.75 -11.68 60.04 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.072 0.463 . . . . 0.0 110.71 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -80.22 -9.58 59.73 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -173.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.848 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 8.2 p -75.31 133.52 41.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.765 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -84.08 14.13 4.47 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.552 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -96.51 121.16 38.03 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.698 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.474 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -108.43 -22.16 12.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.328 -178.162 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -44.67 136.84 4.38 Favored Pre-proline 0 N--CA 1.474 0.775 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.087 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -58.7 -23.77 67.68 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.011 2.474 . . . . 0.0 112.348 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.629 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 74.0 t -67.65 -35.42 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.657 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.631 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 62.0 t60 -62.89 -19.85 64.58 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.69 -0.631 . . . . 0.0 109.794 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 90.7 m-85 -97.45 -7.53 31.42 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.74 -178.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.629 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -87.83 -19.81 26.93 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.045 0.45 . . . . 0.0 110.901 -178.029 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.458 ' ND1' ' CD2' ' A' ' 396' ' ' PHE . 7.4 p80 -121.5 -15.23 8.08 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.239 176.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.629 ' HA ' ' O ' ' A' ' 377' ' ' THR . 78.7 m-85 -133.57 127.55 33.35 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.779 0.8 . . . . 0.0 111.753 173.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 46.9 p -80.58 161.05 24.94 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.662 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 53.6 m80 -137.42 157.96 73.03 Favored Pre-proline 0 C--O 1.249 1.044 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -49.77 101.58 0.05 OUTLIER 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.199 2.599 . . . . 0.0 111.553 -176.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 122.41 -0.29 10.37 Favored Glycine 0 C--O 1.243 0.664 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.259 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -93.7 149.15 21.47 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 34.8 m -62.84 -20.53 65.17 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.522 0.514 . . . . 0.0 111.755 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.76 -3.02 28.84 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -78.49 123.04 26.62 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 120.82 0.343 . . . . 0.0 111.458 -172.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -118.03 -30.67 1.72 Allowed Glycine 0 C--O 1.244 0.776 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 70.15 29.93 70.08 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.41 -6.08 10.36 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 C-N-CA 123.559 0.744 . . . . 0.0 110.989 -174.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.529 ' O ' ' HG2' ' A' ' 412' ' ' GLN . 63.0 tt0 -83.61 131.66 34.95 Favored 'General case' 0 C--O 1.217 -0.611 0 O-C-N 122.176 -0.328 . . . . 0.0 110.322 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 12.6 pt -46.64 -47.56 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 122.989 0.516 . . . . 0.0 110.442 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 13.3 t -77.81 109.86 12.87 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 130.78 -43.02 1.33 Allowed Glycine 0 C--N 1.319 -0.371 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -173.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 15.3 pt20 -97.86 -52.59 3.68 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.508 ' N ' ' HG3' ' A' ' 412' ' ' GLN . 31.1 t70 -169.64 118.45 0.63 Allowed 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -90.98 11.18 23.69 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.126 -166.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 76.5 p -65.61 166.95 9.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.197 0.522 . . . . 0.0 111.52 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 417' ' ' ASP . 10.8 t70 -66.44 -11.84 54.04 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.317 -175.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 416' ' ' ASP . 37.4 t70 80.7 63.32 0.02 OUTLIER 'General case' 0 C--O 1.243 0.761 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.917 173.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.515 ' HG3' ' CG ' ' A' ' 439' ' ' ARG . 14.6 ptt180 -179.12 153.8 0.75 Allowed Pre-proline 0 C--O 1.25 1.091 0 C-N-CA 124.001 0.921 . . . . 0.0 108.984 177.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -65.1 153.77 76.67 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.741 2.294 . . . . 0.0 111.163 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -74.44 161.0 30.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.655 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 18.7 t -58.72 134.23 86.4 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.493 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.42 -19.64 65.52 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.158 1.905 . . . . 0.0 112.18 -178.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 18.2 m-85 -93.77 -5.54 48.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.06 0.457 . . . . 0.0 110.169 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 75.05 -162.53 53.82 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -173.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.91 -12.42 26.16 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.366 2.044 . . . . 0.0 111.958 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 51.1 m -73.8 -9.02 58.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.031 0.443 . . . . 0.0 110.336 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' CYS . . . . . 0.797 ' SG ' 'ZN ' ' A' ' 450' ' ' ' ZN' . 51.0 t -50.89 117.88 2.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.971 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -106.03 7.99 32.16 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.036 0.922 . . . . 0.0 110.142 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -66.51 109.82 2.92 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' LYS . . . . . 0.465 ' HB2' ' NZ ' ' A' ' 430' ' ' LYS . 10.2 mtmp? -100.46 18.96 17.71 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -171.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 431' ' ' ASN . . . . . 0.493 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 61.7 t30 -68.44 125.95 92.19 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 172.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.515 ' O ' HG13 ' A' ' 436' ' ' ILE . 17.8 Cg_endo -57.08 -41.27 76.45 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.629 2.219 . . . . 0.0 111.801 -177.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.575 ' O ' ' HG2' ' A' ' 437' ' ' GLU . 24.9 tp60 -64.6 -38.05 89.67 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' HIS . . . . . 0.726 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 25.0 t60 -59.14 -52.75 64.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.089 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -57.63 -31.0 65.83 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.3 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 432' ' ' PRO . 65.1 mt -70.99 -42.7 76.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.257 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 433' ' ' GLN . 6.8 mm-40 -76.09 -38.18 57.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 438' ' ' TYR . . . . . 0.49 ' HB3' ' HA ' ' A' ' 421' ' ' CYS . 85.7 m-85 -114.85 150.69 35.16 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -171.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' ARG . . . . . 0.515 ' CG ' ' HG3' ' A' ' 418' ' ' ARG . 36.8 mtm180 -95.25 123.62 38.86 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.248 0.968 . . . . 0.0 110.776 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.477 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 71.4 m80 -99.5 85.78 3.23 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -107.52 151.74 25.17 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -176.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 7.5 p -98.12 147.98 24.02 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.996 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 2.6 pp -148.52 156.79 42.13 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 110.728 -0.101 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' PRO . . . . . 0.55 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 21.1 Cg_endo -60.08 -28.53 87.21 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.933 2.422 . . . . 0.0 112.912 -174.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 444' ' ' PRO . 7.2 p 47.66 31.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 O-C-N 124.012 0.82 . . . . 0.0 111.183 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.55 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 26.4 mmt180 -86.67 163.01 17.62 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.703 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 60.51 44.24 12.04 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 10.0 m . . . . . 0 C--O 1.235 0.31 0 C-N-CA 124.548 1.139 . . . . 0.0 111.666 177.156 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 449' ' ' ' ZN' . . . . . 0.848 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' ' ZN' . . . . . 0.797 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.78 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 13.0 p -60.93 102.22 0.19 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.276 0.56 . . . . 0.0 111.528 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -143.66 95.36 2.73 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 123.54 0.736 . . . . 0.0 110.093 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -170.4 107.2 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.63 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 9.2 m -71.31 161.64 30.74 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.46 125.15 22.75 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 4.5 p -59.16 98.13 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.1 0.476 . . . . 0.0 111.291 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 35.7 t -73.13 90.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.458 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.3 pp -94.17 18.45 10.84 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.216 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -56.81 101.15 0.05 Allowed 'General case' 0 C--O 1.222 -0.343 0 O-C-N 123.752 0.657 . . . . 0.0 111.138 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -86.08 71.66 2.81 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.706 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 48.8 m -130.68 93.87 3.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.574 0.702 . . . . 0.0 110.552 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -108.48 156.61 19.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.85 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 104.2 43.15 1.79 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -175.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ASN . . . . . 0.536 ' HB3' ' O ' ' A' ' 374' ' ' VAL . 65.0 m-20 -113.86 134.31 54.88 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 114.661 -0.769 . . . . 0.0 111.342 -171.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.606 ' HD3' HG13 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -88.35 -25.16 22.88 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.55 1.167 . . . . 0.0 109.133 171.103 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.606 HG13 ' HD3' ' A' ' 373' ' ' LYS . 19.9 m -139.5 153.98 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 166.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.573 ' N ' ' HD2' ' A' ' 375' ' ' LYS . 3.6 mptp? -66.83 -49.67 65.01 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.531 0.682 . . . . 0.0 109.312 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.488 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.3 OUTLIER -143.23 144.23 32.07 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.548 174.516 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 5.2 t -97.27 143.2 28.28 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.904 173.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 58.5 m -54.74 123.08 12.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.319 0.58 . . . . 0.0 112.052 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.837 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 29.3 t -49.47 107.97 0.17 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.226 176.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 380' ' ' MET . . . . . 0.546 ' HB3' HG12 ' A' ' 410' ' ' VAL . 22.4 ptp -54.55 -27.3 37.59 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -93.93 -16.63 23.8 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.083 0.468 . . . . 0.0 109.998 178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.6 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 66.35 -126.43 28.06 Favored Glycine 0 C--O 1.235 0.161 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -176.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -91.27 4.5 52.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.678 0.391 . . . . 0.0 110.829 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -88.52 -15.1 36.11 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.782 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.837 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 0.6 OUTLIER -67.94 131.61 45.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 0.0 110.397 177.848 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -82.65 21.11 1.03 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.281 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -95.99 121.99 38.33 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.653 176.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.418 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -107.82 -25.91 11.02 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 124.565 1.166 . . . . 0.0 108.534 -177.39 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -48.07 139.94 9.42 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.845 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.14 -22.34 67.41 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.849 1.699 . . . . 0.0 112.073 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.417 HG12 ' NE2' ' A' ' 395' ' ' HIS . 88.8 t -66.33 -34.73 72.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.865 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.726 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 70.9 t60 -59.82 -37.81 80.24 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.937 0.399 . . . . 0.0 110.153 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -86.23 -18.2 32.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.35 -176.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -29.28 61.08 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -175.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.677 ' HD1' ' HD1' ' A' ' 396' ' ' PHE . 1.0 OUTLIER -109.68 -16.51 13.91 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.575 176.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.677 ' HD1' ' HD1' ' A' ' 395' ' ' HIS . 72.5 m-85 -122.35 127.84 50.26 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 120.74 0.305 . . . . 0.0 110.945 176.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.488 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 16.8 p -78.37 156.43 29.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 122.874 0.47 . . . . 0.0 110.027 175.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.686 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 51.0 m80 -132.02 159.02 73.9 Favored Pre-proline 0 N--CA 1.476 0.836 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.997 -176.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -52.37 102.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.679 2.253 . . . . 0.0 111.954 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 121.23 -1.37 11.56 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.737 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -98.12 151.45 20.37 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 122.035 0.921 . . . . 0.0 110.503 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 29.7 p -63.36 -29.11 70.47 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.163 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -104.73 15.86 27.11 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.226 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -83.97 148.75 26.73 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -142.13 -50.18 0.04 OUTLIER Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.37 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 68.35 24.05 74.97 Favored Glycine 0 C--O 1.221 -0.668 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.652 -173.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 35.3 m -104.73 11.55 8.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 CA-C-O 121.741 0.782 . . . . 0.0 110.234 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.485 ' O ' ' HG2' ' A' ' 412' ' ' GLN . 54.7 tt0 -104.26 141.54 36.12 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 123.676 0.791 . . . . 0.0 110.235 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.479 HG13 ' N ' ' A' ' 410' ' ' VAL . 35.5 pt -53.92 -45.02 63.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.547 ' HA ' ' HG2' ' A' ' 414' ' ' GLU . 57.6 t -68.0 91.79 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 143.94 -51.83 0.63 Allowed Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 29.5 pt20 -90.79 -46.42 8.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.626 0.727 . . . . 0.0 110.3 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -177.67 121.01 0.11 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' GLU . . . . . 0.547 ' HG2' ' HA ' ' A' ' 410' ' ' VAL . 25.6 mt-10 -88.39 -35.88 16.88 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.571 -169.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 56.8 p -135.04 136.1 41.81 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 122.783 0.433 . . . . 0.0 111.187 -173.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -49.28 -59.15 3.94 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.318 1.011 . . . . 0.0 110.168 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -147.42 -43.56 0.17 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.353 175.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.492 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 24.7 ptt180 -122.09 165.89 18.98 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.191 -176.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 61.3 Cg_endo -72.68 146.23 42.96 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.217 1.945 . . . . 0.0 112.052 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 420' ' ' GLU . . . . . 0.581 ' HG2' ' ND2' ' A' ' 441' ' ' ASN . 47.2 mt-10 -61.38 155.24 22.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.884 0.373 . . . . 0.0 111.357 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.956 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 8.3 t -66.62 136.7 94.85 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 421' ' ' CYS . 55.9 Cg_exo -53.21 -34.36 69.05 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.146 2.564 . . . . 0.0 112.69 -175.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' TYR . . . . . 0.501 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 74.8 m-85 -102.14 7.79 40.88 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.424 -176.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 71.04 -153.43 51.18 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.429 -0.35 . . . . 0.0 112.573 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.53 -19.02 49.11 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.538 2.159 . . . . 0.0 111.883 175.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 37.9 t -69.82 -19.58 63.47 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.599 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' CYS . . . . . 0.956 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 40.9 t -56.03 115.55 2.48 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.769 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -109.14 16.61 22.38 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 123.835 0.709 . . . . 0.0 109.483 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.527 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 2.4 mmp_? -53.71 93.23 0.01 OUTLIER 'General case' 0 C--O 1.246 0.884 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 173.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 430' ' ' LYS . . . . . 0.413 ' H ' ' HG2' ' A' ' 430' ' ' LYS . 14.4 ptpt -75.95 79.16 2.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.313 -174.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 431' ' ' ASN . . . . . 0.486 HD21 ' HB3' ' A' ' 433' ' ' GLN . 48.5 t30 -150.9 123.36 4.09 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.336 174.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.509 ' O ' HG13 ' A' ' 436' ' ' ILE . 23.2 Cg_endo -62.79 -33.16 77.08 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.19 1.926 . . . . 0.0 111.314 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.486 ' HB3' HD21 ' A' ' 431' ' ' ASN . 6.3 tp-100 -68.16 -38.65 82.32 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 434' ' ' HIS . . . . . 0.574 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 29.8 t60 -59.93 -53.85 53.06 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.948 0.88 . . . . 0.0 109.229 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.426 ' O ' ' NH1' ' A' ' 418' ' ' ARG . 51.1 mtpt -62.99 -14.69 50.8 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.307 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 432' ' ' PRO . 48.3 mt -86.31 -45.33 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 123.235 0.334 . . . . 0.0 110.546 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -76.8 -29.45 56.0 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 122.437 -0.164 . . . . 0.0 111.294 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -113.95 137.29 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.093 0.557 . . . . 0.0 109.87 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 418' ' ' ARG . 1.0 OUTLIER -94.47 130.3 40.9 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.078 178.167 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -106.17 86.07 2.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.595 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 441' ' ' ASN . . . . . 0.581 ' ND2' ' HG2' ' A' ' 420' ' ' GLU . 46.7 m-80 -69.85 135.47 49.63 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.332 -173.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 28.9 p -135.86 173.14 12.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.601 0.715 . . . . 0.0 110.448 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 443' ' ' LEU . 1.3 pp -137.12 146.46 54.57 Favored Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 122.028 -0.42 . . . . 0.0 110.284 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' PRO . . . . . 0.417 ' O ' HG12 ' A' ' 445' ' ' VAL . 27.2 Cg_endo -62.14 -44.54 19.17 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 122.901 2.401 . . . . 0.0 112.359 -175.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.453 ' HB ' HD13 ' A' ' 443' ' ' LEU . 5.9 p 48.21 26.27 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 124.444 1.098 . . . . 0.0 112.035 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 446' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 447' ' ' ASN . 27.8 mmm180 -92.5 167.81 11.69 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 447' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 446' ' ' ARG . 7.3 t30 74.43 -42.71 0.51 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.816 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 C--O 1.244 0.796 0 C-N-CA 123.128 0.571 . . . . 0.0 111.374 178.489 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 449' ' ' ' ZN' . . . . . 0.785 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' ' ZN' . . . . . 0.833 'ZN ' ' HG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.119 0 CA-C-O 119.495 -0.614 . . . . 0.0 111.651 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.5 m -73.73 98.88 3.01 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.079 0.517 . . . . 0.0 110.271 -177.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -125.46 156.29 39.14 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.97 0.414 . . . . 0.0 110.044 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -82.03 53.33 2.19 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 122.293 1.044 . . . . 0.0 110.579 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 31.3 p -74.81 120.28 20.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.279 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -70.07 108.77 4.23 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 23.3 t -82.57 108.0 15.63 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.22 100.9 8.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 123.728 0.643 . . . . 0.0 110.224 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.6 pp -93.44 -4.82 50.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.652 0.739 . . . . 0.0 110.659 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -58.44 108.66 0.65 Allowed 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.495 0.718 . . . . 0.0 110.553 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 68.98 43.53 72.53 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 51.0 m -147.59 107.61 4.02 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.263 0.225 . . . . 0.0 110.644 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' ' 370' ' ' GLU . 0.0 OUTLIER -90.82 -22.77 20.83 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 123.94 0.775 . . . . 0.0 110.057 177.244 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 168.19 -30.98 0.18 Allowed Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -87.84 174.04 8.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.105 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.439 ' H ' ' HD2' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -127.96 0.42 5.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.604 171.526 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 30.4 m -149.54 175.91 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.483 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.56 168.08 18.3 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.266 0.555 . . . . 0.0 110.897 173.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.617 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.1 OUTLIER -77.57 167.43 21.63 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 122.009 0.909 . . . . 0.0 111.264 -177.607 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.4 t -111.51 162.53 15.01 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.491 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 24.8 t -57.59 116.91 3.68 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.954 0.502 . . . . 0.0 111.699 -176.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 25.1 t -51.96 117.28 2.64 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 380' ' ' MET . . . . . 0.426 ' HB2' HG12 ' A' ' 410' ' ' VAL . 23.2 ptm -58.93 -21.09 57.45 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.611 0.243 . . . . 0.0 111.005 -170.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.621 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 72.0 m-85 -109.61 -14.81 14.3 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.568 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 72.03 -134.94 22.26 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' ALA . . . . . 0.477 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -75.92 -1.27 24.68 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.842 0.354 . . . . 0.0 110.409 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -91.77 -10.48 39.82 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.621 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.2 p -73.59 126.05 29.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 122.134 -0.354 . . . . 0.0 110.524 175.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -77.81 10.92 2.41 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.441 0.639 . . . . 0.0 111.896 -175.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -95.31 119.44 33.83 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.083 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.549 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -122.28 5.73 9.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.47 -178.145 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -63.73 136.6 96.79 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.197 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.6 -33.14 30.12 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.499 2.799 . . . . 0.0 112.534 -171.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.488 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 54.1 t -65.59 -34.91 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.702 -177.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.682 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 81.5 t60 -57.22 -31.78 65.85 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 122.068 -0.395 . . . . 0.0 110.208 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -89.78 -10.29 46.06 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 123.337 0.398 . . . . 0.0 111.973 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -82.61 -12.67 57.52 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.584 -0.447 . . . . 0.0 111.117 -175.737 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.431 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 3.6 p80 -128.97 -23.41 3.06 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.45 ' CD2' ' HA ' ' A' ' 379' ' ' CYS . 60.2 m-85 -123.12 127.32 48.54 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.317 0.579 . . . . 0.0 111.096 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.617 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 57.4 m -86.95 166.17 15.31 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.037 173.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.64 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 28.1 m80 -131.74 159.11 73.39 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 122.815 0.446 . . . . 0.0 110.667 -174.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.477 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 19.6 Cg_endo -55.73 97.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.432 2.088 . . . . 0.0 111.885 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.18 -30.43 2.81 Favored Glycine 0 CA--C 1.508 -0.37 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.219 -175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -66.57 143.07 57.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.013 -0.593 . . . . 0.0 109.658 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 12.2 t -64.82 -17.44 64.24 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.91 -174.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -108.4 7.49 27.07 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.218 0.207 . . . . 0.0 111.091 -174.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -86.65 127.77 34.96 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -126.47 -43.44 0.27 Allowed Glycine 0 CA--C 1.5 -0.874 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 89.55 25.47 27.88 Favored Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 111.914 -0.474 . . . . 0.0 111.914 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 20.3 m -72.92 -16.23 17.71 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.17 0 CA-C-O 121.573 0.701 . . . . 0.0 110.1 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -81.13 138.44 35.9 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.943 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.516 HG13 HG23 ' A' ' 410' ' ' VAL . 23.3 pt -57.53 -47.66 84.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.784 0.802 . . . . 0.0 110.924 174.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.516 HG23 HG13 ' A' ' 409' ' ' ILE . 25.7 t -72.67 123.85 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.791 -178.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 123.41 -25.4 6.29 Favored Glycine 0 CA--C 1.505 -0.576 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.194 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.55 -53.37 1.69 Allowed 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 115.086 -0.557 . . . . 0.0 109.694 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -171.29 127.04 0.67 Allowed 'General case' 0 C--O 1.243 0.738 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.39 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' GLU . . . . . 0.406 ' O ' ' NH2' ' A' ' 439' ' ' ARG . 7.5 mp0 -95.69 -14.92 23.02 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.251 -173.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 419' ' ' PRO . 52.0 p -79.5 145.65 33.1 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -91.99 -57.21 2.8 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 123.688 0.617 . . . . 0.0 109.61 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -129.81 -24.91 2.63 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.68 0.752 . . . . 0.0 109.958 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.541 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 28.0 ptt180 -154.68 165.32 18.36 Favored Pre-proline 0 C--O 1.247 0.97 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.139 -175.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.541 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 39.3 Cg_endo -67.18 143.61 65.59 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.901 2.4 . . . . 0.0 112.541 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -67.18 151.92 46.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 123.248 0.343 . . . . 0.0 110.865 174.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.8 ' SG ' 'ZN ' ' A' ' 450' ' ' ' ZN' . 27.9 t -63.55 136.3 96.65 Favored Pre-proline 0 C--N 1.317 -0.813 0 O-C-N 123.622 0.576 . . . . 0.0 109.866 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.78 -13.28 29.58 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.836 2.357 . . . . 0.0 112.365 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -111.59 8.89 21.09 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 57.32 -149.93 30.75 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 -172.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.89 -1.87 11.96 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.436 2.091 . . . . 0.0 111.88 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 17.3 t -84.05 -2.45 56.71 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.825 0.822 . . . . 0.0 109.121 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' CYS . . . . . 0.832 ' HG ' 'ZN ' ' A' ' 450' ' ' ' ZN' . 44.7 t -49.35 117.49 2.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.386 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -108.29 11.5 27.2 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.998 176.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -75.15 93.8 2.85 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -79.18 83.28 5.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.491 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -144.34 122.94 6.92 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.522 ' O ' HG13 ' A' ' 436' ' ' ILE . 18.3 Cg_endo -59.08 -38.23 88.32 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.822 1.681 . . . . 0.0 112.885 -175.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.599 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 24.9 tp60 -65.45 -40.06 92.77 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.965 -0.46 . . . . 0.0 109.785 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 434' ' ' HIS . . . . . 0.563 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 26.1 t60 -57.9 -53.77 54.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.699 0.761 . . . . 0.0 110.452 177.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -61.02 -18.22 56.57 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.889 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 432' ' ' PRO . 52.3 mt -84.3 -41.84 16.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.676 178.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.599 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 23.8 mt-10 -79.21 -45.5 19.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.135 0.493 . . . . 0.0 110.847 -175.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -97.14 145.41 26.04 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.459 -174.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' ARG . . . . . 0.481 ' NH1' HD21 ' A' ' 441' ' ' ASN . 16.7 ptt180 -92.32 118.31 30.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.354 0.597 . . . . 0.0 110.213 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.67 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 76.2 m80 -92.9 78.55 4.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.002 175.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' ASN . . . . . 0.481 HD21 ' NH1' ' A' ' 439' ' ' ARG . 2.2 m-20 -66.63 105.58 1.57 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.763 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.0 p -81.92 121.89 27.06 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 443' ' ' LEU . 2.2 pp -87.65 145.66 37.57 Favored Pre-proline 0 C--O 1.246 0.89 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.907 -173.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.65 -32.16 19.6 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.103 2.535 . . . . 0.0 112.543 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.443 ' HB ' HD13 ' A' ' 443' ' ' LEU . 9.3 p 43.05 32.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.911 1.339 . . . . 0.0 109.941 -176.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -92.24 158.01 16.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.937 -1.102 . . . . 0.0 110.284 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 59.87 21.62 10.56 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 171.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.224 -0.248 0 O-C-N 123.563 0.539 . . . . 0.0 109.692 179.928 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 449' ' ' ' ZN' . . . . . 0.818 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' ' ZN' . . . . . 0.832 'ZN ' ' HG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.472 0 CA-C-O 120.7 0.056 . . . . 0.0 113.083 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.5 t -109.33 -55.8 2.37 Favored 'General case' 0 C--O 1.246 0.92 0 O-C-N 122.195 -0.591 . . . . 0.0 110.996 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.77 9.74 3.06 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.793 0.837 . . . . 0.0 111.48 -177.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -85.26 76.93 10.1 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 174.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 27.2 p -92.29 119.36 31.8 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 125.376 1.673 . . . . 0.0 111.714 -172.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -112.58 141.54 46.22 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.052 175.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 6.1 p -136.9 151.08 48.66 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.691 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 23.0 t -81.49 89.44 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.758 0 O-C-N 123.265 0.353 . . . . 0.0 110.077 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 4.1 pp -77.82 -18.38 56.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.195 0.522 . . . . 0.0 110.497 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -98.0 -165.02 1.2 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.394 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 93.71 -59.56 2.14 Favored Glycine 0 C--O 1.239 0.455 0 CA-C-O 122.067 0.815 . . . . 0.0 111.285 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 33.0 t -84.27 84.81 7.49 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -91.47 -31.33 16.02 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.995 -173.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 94.6 32.08 7.49 Favored Glycine 0 CA--C 1.505 -0.569 0 CA-C-O 122.042 0.801 . . . . 0.0 111.386 -175.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -161.83 145.44 12.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.176 -1.012 . . . . 0.0 108.289 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.482 ' H ' ' HD2' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -79.73 -23.51 42.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.487 0.492 . . . . 0.0 111.418 -175.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 23.7 m -84.15 162.76 2.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 173.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.575 ' HG2' ' H ' ' A' ' 376' ' ' ARG . 0.1 OUTLIER -130.73 -66.43 0.76 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.287 0.565 . . . . 0.0 110.89 177.229 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.575 ' H ' ' HG2' ' A' ' 375' ' ' LYS . 0.1 OUTLIER -145.2 165.87 27.11 Favored 'General case' 0 C--O 1.25 1.122 0 O-C-N 121.779 -0.576 . . . . 0.0 111.184 178.701 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 14.3 t -134.14 162.81 31.1 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 12.4 m -54.59 117.7 3.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.638 0.732 . . . . 0.0 110.679 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.769 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 39.6 t -51.23 120.95 5.48 Favored 'General case' 0 C--N 1.359 0.992 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.085 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 380' ' ' MET . . . . . 0.587 ' O ' HG12 ' A' ' 410' ' ' VAL . 27.2 ptm -58.81 -23.18 60.07 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.609 0.719 . . . . 0.0 111.122 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.605 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 35.1 m-85 -103.23 -15.71 15.92 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 121.075 -1.016 . . . . 0.0 109.902 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.528 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 64.6 -131.74 37.76 Favored Glycine 0 CA--C 1.498 -1.028 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.797 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -75.75 -4.87 42.89 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 122.65 0.38 . . . . 0.0 111.214 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -86.86 -5.33 59.14 Favored 'General case' 0 C--O 1.248 1.022 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.715 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.819 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 6.4 p -81.2 123.58 28.57 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.649 0.738 . . . . 0.0 111.43 176.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -82.13 10.72 6.22 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.911 0.862 . . . . 0.0 110.95 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.55 HH21 ' ND2' ' A' ' 389' ' ' ASN . 31.4 mmm180 -84.02 124.09 30.7 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.13 174.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.491 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -116.46 -5.3 11.73 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.422 -176.595 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.55 ' ND2' HH21 ' A' ' 387' ' ' ARG . 20.7 p-10 -58.73 137.59 86.68 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.217 176.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -60.01 -24.19 75.68 Favored 'Trans proline' 0 CA--C 1.518 -0.297 0 C-N-CA 122.178 1.919 . . . . 0.0 111.252 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.546 HG12 ' NE2' ' A' ' 395' ' ' HIS . 93.4 t -66.62 -42.17 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.129 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.709 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 82.3 t60 -54.53 -35.05 62.78 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 120.381 -0.527 . . . . 0.0 110.459 178.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 24.6 m-85 -88.08 -24.04 23.54 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.771 -176.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -72.83 -20.26 61.17 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.949 -177.52 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.698 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 1.9 p80 -118.22 -8.71 10.58 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 176.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.698 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 88.0 m-85 -137.65 127.28 25.21 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.333 0.587 . . . . 0.0 110.767 176.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 46.2 m -85.78 159.2 19.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.964 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.628 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 39.2 m80 -128.1 153.02 78.52 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.811 -174.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -50.77 112.34 0.74 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.311 2.007 . . . . 0.0 112.701 -174.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 117.65 -5.57 16.62 Favored Glycine 0 C--O 1.237 0.34 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.075 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -95.67 145.41 25.29 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.322 0.582 . . . . 0.0 109.922 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 42.0 t -57.81 -30.91 66.08 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.293 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -94.29 2.61 55.85 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.758 -174.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -82.54 153.59 25.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -141.18 -37.42 0.09 OUTLIER Glycine 0 C--O 1.24 0.516 0 CA-C-O 121.805 0.669 . . . . 0.0 113.099 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 74.13 23.44 76.02 Favored Glycine 0 C--O 1.212 -1.233 0 CA-C-O 122.489 1.049 . . . . 0.0 111.867 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 33.8 m -79.27 -16.11 13.32 Favored 'Isoleucine or valine' 0 C--N 1.35 0.616 0 CA-C-O 121.765 0.793 . . . . 0.0 110.678 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -90.9 121.86 33.1 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.525 HG13 HG23 ' A' ' 410' ' ' VAL . 12.7 pt -45.65 -47.93 4.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 123.205 0.315 . . . . 0.0 111.331 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.687 ' HA ' ' HG2' ' A' ' 414' ' ' GLU . 17.3 t -72.84 115.28 13.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 O-C-N 123.776 0.673 . . . . 0.0 109.954 -177.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 144.05 -49.77 0.69 Allowed Glycine 0 CA--C 1.498 -1.029 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.892 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.401 ' HG2' ' N ' ' A' ' 413' ' ' ASP . 5.1 pm0 -127.75 -46.04 1.44 Allowed 'General case' 0 C--O 1.238 0.475 0 O-C-N 122.162 -0.611 . . . . 0.0 111.321 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.401 ' N ' ' HG2' ' A' ' 412' ' ' GLN . 7.4 m-20 -125.19 92.79 3.71 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 122.518 0.327 . . . . 0.0 110.383 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 414' ' ' GLU . . . . . 0.687 ' HG2' ' HA ' ' A' ' 410' ' ' VAL . 43.0 mt-10 -94.52 36.01 1.19 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.525 -177.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 54.0 p -64.17 130.68 44.89 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.906 -175.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -59.46 -18.32 38.67 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.414 0.626 . . . . 0.0 110.754 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 35.8 t70 79.4 57.94 0.02 OUTLIER 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.252 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -175.75 152.89 1.35 Allowed Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.094 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.42 145.53 67.52 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.071 1.847 . . . . 0.0 112.203 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -74.37 150.88 39.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 172.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 5.5 t -59.48 127.37 84.55 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 421' ' ' CYS . 50.9 Cg_exo -54.95 -23.6 35.51 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.344 2.029 . . . . 0.0 113.219 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 423' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 87.7 m-85 -102.34 18.01 22.08 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.239 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 59.03 -156.07 25.46 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.579 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' PRO . . . . . 0.411 ' HG3' ' HG ' ' A' ' 443' ' ' LEU . 57.0 Cg_endo -73.68 -9.68 22.83 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.654 2.236 . . . . 0.0 111.083 175.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 32.1 t -73.87 -8.86 57.68 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.52 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 23.1 t -62.94 115.64 4.58 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.399 0.619 . . . . 0.0 109.545 176.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -109.13 21.51 17.07 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.782 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 0.2 OUTLIER -64.02 92.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.207 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -68.79 91.44 0.45 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.851 0.834 . . . . 0.0 111.393 -174.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' ASN . . . . . 0.441 HD21 ' HB3' ' A' ' 433' ' ' GLN . 63.1 t30 -161.98 123.54 1.63 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.811 173.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.478 ' O ' HG13 ' A' ' 436' ' ' ILE . 33.4 Cg_endo -63.91 -36.52 49.4 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.752 2.302 . . . . 0.0 110.599 -178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.668 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 22.4 tp60 -65.31 -37.01 85.82 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 434' ' ' HIS . . . . . 0.667 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 12.3 t60 -63.3 -49.35 74.37 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 121.683 0.754 . . . . 0.0 109.575 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.481 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 53.8 mtpt -66.72 -7.1 18.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.078 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 432' ' ' PRO . 42.6 mt -94.97 -42.94 12.85 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.752 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.668 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 22.8 mt-10 -68.76 -37.55 79.46 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.83 0.824 . . . . 0.0 110.555 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -117.55 138.66 51.76 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.551 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -89.38 118.61 29.17 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.712 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 22.3 m80 -94.21 99.34 11.62 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -91.43 106.08 18.24 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.56 -175.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.98 138.32 39.57 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.552 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.5 OUTLIER -118.53 149.81 46.87 Favored Pre-proline 0 C--O 1.248 1.011 0 CA-C-O 120.963 0.411 . . . . 0.0 111.771 -171.634 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.52 -18.32 12.25 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 123.042 2.494 . . . . 0.0 111.859 175.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.552 ' HB ' HD13 ' A' ' 443' ' ' LEU . 10.0 p 43.03 30.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.245 0 CA-C-O 122.315 1.055 . . . . 0.0 111.715 -178.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -108.39 -33.37 7.1 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.509 -174.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -81.65 -27.79 33.92 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.128 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--O 1.206 -1.237 0 O-C-N 123.755 0.659 . . . . 0.0 109.669 179.508 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 449' ' ' ' ZN' . . . . . 0.819 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' ' ZN' . . . . . 0.789 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.443 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 32.6 t 70.77 -65.96 0.31 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.296 1.038 . . . . 0.0 111.197 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -73.43 89.12 1.62 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.871 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -82.95 115.44 21.8 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 7.0 m -57.98 156.43 9.24 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 124.009 0.818 . . . . 0.0 110.951 -176.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -102.69 136.46 42.48 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.145 0.578 . . . . 0.0 110.072 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 11.3 p -72.63 149.22 44.1 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.446 -176.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.03 118.65 59.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 C-N-CA 122.965 0.506 . . . . 0.0 110.445 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.6 pp -100.42 -4.46 28.91 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 122.155 -0.341 . . . . 0.0 111.336 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -53.59 137.91 35.68 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 119.05 -8.07 12.63 Favored Glycine 0 N--CA 1.468 0.819 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -174.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 48.0 t -104.11 119.02 38.05 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -54.47 -28.96 48.24 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.219 0.949 . . . . 0.0 109.782 174.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 120.19 -93.37 0.54 Allowed Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -170.66 171.94 6.04 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.478 ' HD2' HG13 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -83.05 -6.9 59.67 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-O 121.518 0.675 . . . . 0.0 110.079 176.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.478 HG13 ' HD2' ' A' ' 373' ' ' LYS . 35.8 m -120.19 155.02 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 171.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.11 162.6 13.96 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.1 159.23 20.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.136 174.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 12.6 t -101.83 149.38 24.25 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 9.7 t -57.93 111.86 1.3 Allowed 'General case' 0 C--O 1.244 0.796 0 O-C-N 123.355 0.41 . . . . 0.0 110.193 -171.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.782 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 30.9 t -51.36 108.96 0.29 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 380' ' ' MET . . . . . 0.63 ' HB2' HG22 ' A' ' 410' ' ' VAL . 14.5 ptp -60.43 -13.62 14.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.988 0.423 . . . . 0.0 110.665 -176.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.448 ' CB ' ' HB3' ' A' ' 385' ' ' CYS . 36.3 m-85 -93.59 -27.05 16.83 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.079 175.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.411 ' O ' ' HD2' ' A' ' 398' ' ' HIS . . . 60.28 -117.93 13.05 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.415 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -84.29 -9.67 58.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.17 -0.606 . . . . 0.0 111.505 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -78.95 -26.67 43.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.2 -176.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.796 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 13.5 p -73.87 111.57 9.15 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.426 172.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -84.98 12.39 7.66 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.38 0.609 . . . . 0.0 110.143 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -65.11 125.47 25.04 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 172.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.5 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.5 OUTLIER -119.72 0.75 10.98 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.028 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -66.05 133.86 94.83 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.117 173.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.9 -22.08 67.06 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.547 2.165 . . . . 0.0 112.292 -174.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.576 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 74.9 t -67.85 -38.32 79.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.129 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.576 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 85.0 t60 -62.88 -26.69 68.9 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 120.864 0.364 . . . . 0.0 110.051 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -92.46 -19.57 21.88 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.281 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -73.79 -23.69 59.72 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.872 -177.111 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.595 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 2.4 p80 -116.7 -11.89 10.93 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 177.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.595 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 93.8 m-85 -131.94 131.71 42.88 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 122.126 -0.359 . . . . 0.0 111.549 175.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 22.2 p -84.38 153.95 23.14 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.369 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 399' ' ' PRO . 69.3 m80 -136.32 159.87 69.09 Favored Pre-proline 0 C--O 1.221 -0.44 0 O-C-N 122.339 -0.225 . . . . 0.0 110.524 -173.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 17.4 Cg_endo -54.43 103.08 0.09 OUTLIER 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.25 1.966 . . . . 0.0 111.614 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 129.62 -23.68 4.74 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -76.27 151.09 36.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.231 -0.484 . . . . 0.0 110.78 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 13.5 m -67.15 -22.83 65.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.523 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -110.99 15.56 21.66 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.285 -173.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -74.03 141.7 45.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.823 -178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -114.27 -57.46 0.38 Allowed Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.962 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 64.0 14.82 57.13 Favored Glycine 0 C--O 1.216 -1.001 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -174.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 35.9 m -89.56 -15.14 8.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-N 115.497 -0.351 . . . . 0.0 111.383 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -75.61 132.45 40.65 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.784 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.49 HG13 ' H ' ' A' ' 410' ' ' VAL . 5.1 pt -46.59 -56.95 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 123.089 0.243 . . . . 0.0 111.03 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 380' ' ' MET . 11.0 p -76.4 116.06 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 134.64 -49.39 0.9 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -168.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.416 ' HG3' ' N ' ' A' ' 413' ' ' ASP . 22.3 pt20 -102.3 -52.36 3.15 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 176.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.416 ' N ' ' HG3' ' A' ' 412' ' ' GLN . 35.1 t70 -165.7 125.35 1.73 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.845 0.831 . . . . 0.0 110.187 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -87.58 13.37 10.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.852 -162.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 72.6 p -85.77 -178.43 6.61 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 117.85 0.295 . . . . 0.0 110.514 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -68.15 -13.9 62.57 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.335 -177.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 36.7 t70 68.85 74.09 0.26 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.425 0.631 . . . . 0.0 110.181 -174.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.493 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 19.3 ptt180 -162.88 158.82 18.99 Favored Pre-proline 0 C--O 1.246 0.91 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 35.8 Cg_endo -63.32 136.57 56.07 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.644 2.229 . . . . 0.0 111.644 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 420' ' ' GLU . . . . . 0.435 ' HG2' ' HE ' ' A' ' 439' ' ' ARG . 51.7 mt-10 -70.58 147.76 48.91 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 121.797 -0.564 . . . . 0.0 110.121 175.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 1.001 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 11.9 t -54.82 137.56 64.34 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.396 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.74 -14.38 26.46 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.158 1.906 . . . . 0.0 112.494 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -113.27 10.31 18.46 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.116 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 59.36 -151.19 36.21 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-O 119.598 -0.557 . . . . 0.0 111.85 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.14 -13.02 28.42 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.664 2.243 . . . . 0.0 112.344 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 38.0 t -79.87 1.24 27.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.485 176.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' CYS . . . . . 1.001 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 48.0 t -60.02 116.72 4.36 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.127 177.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -114.42 23.56 12.68 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.983 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -69.04 108.42 3.54 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.762 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -77.29 84.15 3.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.142 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 434' ' ' HIS . 61.5 t30 -156.47 121.07 2.39 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.428 175.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.445 ' O ' HG13 ' A' ' 436' ' ' ILE . 18.7 Cg_endo -58.76 -43.32 45.2 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.423 2.082 . . . . 0.0 112.708 -175.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.44 ' O ' ' HG2' ' A' ' 437' ' ' GLU . 6.8 tp-100 -67.94 -26.35 65.92 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.93 0.769 . . . . 0.0 109.744 -175.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 434' ' ' HIS . . . . . 0.715 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 59.6 t60 -60.55 -59.37 5.5 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 122.816 0.446 . . . . 0.0 111.494 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -59.47 -25.6 64.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.668 0.27 . . . . 0.0 111.025 179.395 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 432' ' ' PRO . 67.0 mt -70.18 -46.46 72.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.007 0.432 . . . . 0.0 111.09 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 433' ' ' GLN . 11.8 mm-40 -76.31 -53.9 7.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.944 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -91.62 144.62 25.34 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.374 0.421 . . . . 0.0 110.516 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' ARG . . . . . 0.47 ' HB3' ' HG3' ' A' ' 418' ' ' ARG . 17.7 ptt180 -89.94 137.03 32.68 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.663 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 61.7 m80 -111.72 79.9 1.26 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.281 0.562 . . . . 0.0 109.674 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -74.86 129.45 37.7 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.069 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 17.2 p -86.56 140.4 29.92 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.804 -0.56 . . . . 0.0 109.841 -177.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.472 HD13 ' HB ' ' A' ' 445' ' ' VAL . 1.2 pp -109.04 151.84 42.15 Favored Pre-proline 0 C--N 1.312 -1.046 0 O-C-N 123.858 0.724 . . . . 0.0 110.114 -175.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.54 -49.06 4.8 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.288 1.992 . . . . 0.0 112.082 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.472 ' HB ' HD13 ' A' ' 443' ' ' LEU . 11.3 p 40.07 39.59 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.87 0.843 . . . . 0.0 109.751 -174.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -89.91 161.66 15.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.368 -173.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -56.52 -35.83 68.5 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.026 0.441 . . . . 0.0 110.739 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 C--O 1.252 1.199 0 CA-C-O 121.128 0.49 . . . . 0.0 111.821 176.751 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 449' ' ' ' ZN' . . . . . 0.796 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' ' ZN' . . . . . 0.842 'ZN ' ' HG ' ' A' ' 421' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 46.6 t -145.33 162.1 38.04 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.69 111.37 24.02 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 172.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -78.67 8.68 4.96 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 124.167 0.917 . . . . 0.0 112.079 -174.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 24.8 p -58.87 108.7 0.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.486 0.66 . . . . 0.0 109.342 169.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -121.56 100.7 7.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.258 -167.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 10.8 t -166.13 173.95 9.78 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.568 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 375' ' ' LYS . 19.7 t -96.84 142.4 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.522 -172.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 366' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 367' ' ' GLN . 3.8 pp -89.57 -49.91 6.39 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.544 0.527 . . . . 0.0 109.609 174.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 367' ' ' GLN . . . . . 0.516 ' N ' HD12 ' A' ' 366' ' ' LEU . 23.8 tp60 -96.96 81.97 3.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.406 0.622 . . . . 0.0 109.426 174.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 138.54 34.97 0.17 Allowed Glycine 0 C--O 1.241 0.568 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.024 -172.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 22.0 t -75.77 111.07 10.73 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.242 0.544 . . . . 0.0 111.077 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -146.2 -70.14 0.26 Allowed 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.357 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -177.71 32.92 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 CA-C-O 121.455 0.475 . . . . 0.0 112.326 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -118.37 161.37 20.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.752 -0.724 . . . . 0.0 109.612 -174.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.42 ' HD3' HG13 ' A' ' 374' ' ' VAL . 0.1 OUTLIER -101.04 -16.52 17.09 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.091 178.591 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.42 HG13 ' HD3' ' A' ' 373' ' ' LYS . 27.6 m -136.65 154.48 32.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.667 170.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.515 ' HB3' HG11 ' A' ' 365' ' ' VAL . 1.5 pptp? -91.9 157.75 16.67 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 121.62 -0.675 . . . . 0.0 109.99 175.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.592 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.8 OUTLIER -81.31 148.52 29.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.399 0.619 . . . . 0.0 111.116 -178.02 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 11.9 t -101.3 152.91 20.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.966 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 410' ' ' VAL . 14.0 t -54.53 119.48 5.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.741 0.305 . . . . 0.0 111.723 -171.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.89 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 26.3 t -59.29 109.78 0.94 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' MET . . . . . 0.606 ' HA ' ' HA2' ' A' ' 411' ' ' GLY . 24.8 ptm -54.53 -29.86 51.94 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.364 -176.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.534 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 51.9 m-85 -98.23 -16.65 19.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.54 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 62.89 -116.26 9.14 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.874 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -90.34 7.79 36.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.854 0.359 . . . . 0.0 111.221 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -98.49 -22.55 15.95 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.447 0.299 . . . . 0.0 110.852 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.89 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 1.8 p -65.18 131.55 46.82 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.142 176.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -80.59 12.31 3.18 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.383 0.611 . . . . 0.0 112.067 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -92.66 112.16 24.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.649 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.442 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -100.05 -24.09 14.7 Favored 'General case' 0 C--O 1.221 -0.419 0 O-C-N 123.855 0.722 . . . . 0.0 109.316 -179.435 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -47.49 138.85 8.57 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.707 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.47 -21.82 69.48 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.453 2.102 . . . . 0.0 111.464 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.577 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 93.3 t -66.7 -36.91 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.436 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.668 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 82.1 t60 -58.66 -38.26 77.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.293 174.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -87.56 -4.99 58.95 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.923 -176.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.577 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -85.71 -24.48 26.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.039 -0.413 . . . . 0.0 110.465 178.637 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.422 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 1.2 p80 -110.96 -23.76 10.77 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.493 175.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.422 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 90.8 m-85 -120.27 129.03 53.86 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.597 0.713 . . . . 0.0 111.997 178.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.592 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 11.8 p -82.17 157.84 23.84 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.365 175.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.463 ' H ' ' HB3' ' A' ' 401' ' ' ASP . 58.9 m80 -136.09 162.2 58.01 Favored Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -170.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.07 100.63 0.08 OUTLIER 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.778 2.318 . . . . 0.0 111.059 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 109.54 24.33 5.92 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.476 -174.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ASP . . . . . 0.463 ' HB3' ' H ' ' A' ' 398' ' ' HIS . 20.7 t70 -119.97 150.5 40.42 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 122.303 0.241 . . . . 0.0 110.478 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 17.7 t -54.37 -41.1 68.78 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.277 0.631 . . . . 0.0 111.791 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -104.08 16.41 26.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.759 -167.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -72.5 154.43 40.83 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.531 0.205 . . . . 0.0 110.603 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -146.15 -55.36 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.096 -1.049 . . . . 0.0 110.939 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 65.26 22.11 68.88 Favored Glycine 0 C--O 1.238 0.347 0 CA-C-O 119.935 -0.369 . . . . 0.0 112.911 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 24.9 m -106.97 -11.43 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 121.939 0.876 . . . . 0.0 111.436 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' GLN . . . . . 0.521 ' O ' ' HG2' ' A' ' 412' ' ' GLN . 49.8 tt0 -83.45 151.49 25.44 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.487 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 20.2 pt -48.53 -46.08 14.7 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-O 122.066 0.936 . . . . 0.0 109.75 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.511 HG13 ' HB3' ' A' ' 380' ' ' MET . 48.5 t -75.59 82.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 172.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 380' ' ' MET . . . 147.55 -48.17 0.65 Allowed Glycine 0 C--O 1.243 0.719 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.183 177.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 29.9 pt20 -83.11 -47.21 11.88 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 117.16 0.48 . . . . 0.0 109.733 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.409 ' N ' ' HG3' ' A' ' 412' ' ' GLN . 10.8 t70 178.18 148.06 0.17 Allowed 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -75.57 -11.29 59.99 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 123.501 0.5 . . . . 0.0 111.76 -172.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 24.5 p -72.56 141.84 48.43 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.953 0.883 . . . . 0.0 111.574 -176.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.48 ' HB2' ' HD3' ' A' ' 439' ' ' ARG . 2.1 m-20 -68.43 -39.75 81.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.072 -177.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 12.0 t70 81.98 50.81 0.02 OUTLIER 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.0 -174.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -153.25 158.59 32.77 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.026 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' A' ' 438' ' ' TYR . 80.4 Cg_exo -48.03 141.85 16.63 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.89 2.394 . . . . 0.0 112.69 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 420' ' ' GLU . . . . . 0.434 ' HG2' HD21 ' A' ' 441' ' ' ASN . 38.5 mt-10 -83.27 143.2 30.56 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.753 ' SG ' 'ZN ' ' A' ' 450' ' ' ' ZN' . 34.8 t -59.61 126.96 84.18 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.22 7.12 1.21 Allowed 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.576 2.184 . . . . 0.0 112.835 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -120.31 5.1 10.73 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 64.9 -162.99 38.05 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.6 -15.34 27.4 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.008 2.472 . . . . 0.0 112.489 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 40.4 t -70.52 -13.16 62.0 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.044 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' CYS . . . . . 0.788 ' SG ' 'ZN ' ' A' ' 450' ' ' ' ZN' . 46.6 t -48.66 118.02 2.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.836 0.854 . . . . 0.0 110.612 -178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -113.84 18.41 17.38 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 122.899 0.479 . . . . 0.0 109.918 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.478 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 4.3 mmp_? -66.52 96.58 0.38 Allowed 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.798 175.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 430' ' ' LYS . . . . . 0.525 ' HB2' ' NZ ' ' A' ' 430' ' ' LYS . 10.1 mtmp? -69.05 93.55 0.59 Allowed 'General case' 0 C--O 1.241 0.614 0 O-C-N 123.371 0.419 . . . . 0.0 110.283 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 431' ' ' ASN . . . . . 0.482 HD21 ' HB3' ' A' ' 433' ' ' GLN . 54.6 t30 -157.9 122.91 2.3 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.463 ' O ' HG13 ' A' ' 436' ' ' ILE . 33.4 Cg_endo -63.43 -35.74 59.29 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.487 2.125 . . . . 0.0 112.056 -177.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.64 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 23.4 tp60 -68.45 -41.62 79.97 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -175.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 434' ' ' HIS . . . . . 0.607 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 5.0 t60 -56.2 -51.2 68.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.433 0.635 . . . . 0.0 110.132 178.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -67.18 -13.76 62.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.402 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 432' ' ' PRO . 40.2 mt -89.84 -34.87 6.94 Favored 'Isoleucine or valine' 0 C--O 1.251 1.153 0 C-N-CA 122.704 0.402 . . . . 0.0 110.146 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.64 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 27.9 mt-10 -83.77 -45.54 13.22 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.298 0.571 . . . . 0.0 111.12 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 438' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 419' ' ' PRO . 19.1 m-85 -103.32 147.1 27.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.229 -174.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 439' ' ' ARG . . . . . 0.48 ' HD3' ' HB2' ' A' ' 416' ' ' ASP . 17.0 ptt180 -93.69 114.02 26.23 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.589 177.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.659 ' HE2' ' HG ' ' A' ' 421' ' ' CYS . 79.6 m80 -81.66 85.01 6.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' ASN . . . . . 0.434 HD21 ' HG2' ' A' ' 420' ' ' GLU . 89.0 m-20 -67.32 103.57 1.3 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.361 -173.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 1.5 m -104.47 159.35 15.81 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.132 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.557 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.5 OUTLIER -135.75 144.83 50.48 Favored Pre-proline 0 C--N 1.32 -0.684 0 O-C-N 121.66 -0.65 . . . . 0.0 111.828 -176.061 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -64.22 -29.21 64.34 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.435 2.757 . . . . 0.0 110.834 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.557 ' HB ' HD13 ' A' ' 443' ' ' LEU . 7.3 p 35.9 69.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 124.823 1.327 . . . . 0.0 110.591 -175.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -56.68 157.34 5.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.455 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -66.78 -26.77 67.12 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.104 0.877 . . . . 0.0 110.54 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.472 0.668 0 O-C-N 123.273 0.358 . . . . 0.0 110.917 179.432 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 449' ' ' ' ZN' . . . . . 0.773 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' ' ZN' . . . . . 0.788 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.859 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 10.0 p -163.28 132.96 4.21 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -122.57 58.1 1.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -65.9 126.55 28.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 40.8 p -91.49 139.03 31.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.337 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.38 89.69 0.06 Allowed 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 12.5 t -79.1 80.49 5.45 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.892 0.854 . . . . 0.0 110.876 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.9 p -72.49 112.17 7.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.428 174.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.2 pp -142.88 2.86 1.38 Allowed 'General case' 0 C--O 1.244 0.768 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -170.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -47.13 147.85 1.34 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-O 120.483 0.182 . . . . 0.0 111.295 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -63.52 149.58 50.12 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 116.433 -0.349 . . . . 0.0 112.909 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 34.0 m -131.2 3.42 4.32 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 121.147 0.499 . . . . 0.0 109.949 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 370' ' ' GLU . 0.0 OUTLIER -88.07 -0.86 57.57 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.782 -178.334 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 78.58 23.48 64.79 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.262 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -135.93 158.31 44.71 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 122.668 0.387 . . . . 0.0 110.403 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.612 ' HG2' HG13 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -84.91 -13.04 52.06 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 122.118 -0.364 . . . . 0.0 110.133 176.744 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 374' ' ' VAL . . . . . 0.612 HG13 ' HG2' ' A' ' 373' ' ' LYS . 28.5 m -130.96 158.84 43.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.173 0.511 . . . . 0.0 110.116 177.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.99 154.39 27.72 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 170.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 376' ' ' ARG . . . . . 0.568 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.8 OUTLIER -69.5 148.42 49.52 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-O 122.039 0.923 . . . . 0.0 110.683 -175.881 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 5.4 t -96.2 153.65 17.68 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.233 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.1 m -64.22 122.67 17.2 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.075 0.464 . . . . 0.0 111.166 -170.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.94 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 15.4 t -49.92 123.61 8.42 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.729 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 380' ' ' MET . . . . . 0.45 ' O ' HG12 ' A' ' 410' ' ' VAL . 20.8 ptm -56.0 -29.47 60.36 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.217 0.532 . . . . 0.0 111.072 -172.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 381' ' ' TYR . . . . . 0.554 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 39.2 m-85 -98.73 -14.85 19.58 Favored 'General case' 0 C--O 1.255 1.391 0 CA-C-O 119.051 -0.5 . . . . 0.0 110.439 176.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 62.49 -107.51 1.65 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -84.3 -13.71 51.73 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' ASN . . . . . 0.526 ' HB2' ' HB3' ' A' ' 381' ' ' TYR . 38.9 m-80 -81.49 -26.01 35.55 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -174.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.94 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.4 p -66.65 113.89 5.15 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.035 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -85.49 9.48 15.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.935 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 387' ' ' ARG . 27.8 mmt180 -62.46 134.13 55.99 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.957 176.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.527 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.3 OUTLIER -118.97 -7.64 10.36 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 124.105 0.878 . . . . 0.0 110.406 -171.725 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -67.47 137.09 93.33 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.057 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -60.68 -30.67 90.89 Favored 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 121.576 1.517 . . . . 0.0 110.946 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.402 HG12 ' NE2' ' A' ' 395' ' ' HIS . 87.9 t -59.17 -40.68 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.896 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.691 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 85.6 t60 -54.95 -43.9 73.85 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 120.771 0.319 . . . . 0.0 110.441 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -82.23 -25.15 34.4 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.493 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -66.67 -27.88 68.01 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.686 0.279 . . . . 0.0 110.783 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.634 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 1.1 p80 -119.09 -3.98 10.6 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.634 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 39.6 m-85 -139.33 126.59 21.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.442 0.639 . . . . 0.0 109.989 177.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.568 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 70.7 m -83.46 158.63 21.98 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 123.261 0.624 . . . . 0.0 111.031 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.614 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 27.0 m80 -127.65 162.03 51.62 Favored Pre-proline 0 C--O 1.222 -0.354 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 14.8 Cg_endo -55.11 106.34 0.18 Allowed 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 121.829 1.686 . . . . 0.0 111.219 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 120.03 -1.14 13.28 Favored Glycine 0 C--N 1.319 -0.368 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.47 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -94.98 148.98 21.74 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.7 t -62.48 -30.4 71.23 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.402 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.99 2.4 51.46 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 110.726 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -80.52 140.29 35.93 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.591 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -168.93 25.51 0.11 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.579 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 52.66 43.98 59.85 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.778 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 19.5 m -74.9 -10.79 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.302 0.573 . . . . 0.0 109.766 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -122.38 136.66 54.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.431 HG13 ' N ' ' A' ' 410' ' ' VAL . 13.0 pt -55.53 -47.93 78.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.3 0.571 . . . . 0.0 110.671 176.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.606 ' HA ' ' HG2' ' A' ' 414' ' ' GLU . 13.3 t -70.27 113.88 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.872 177.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 130.75 -40.6 1.63 Allowed Glycine 0 N--CA 1.443 -0.866 0 O-C-N 123.839 0.712 . . . . 0.0 111.691 -173.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -108.41 -43.89 4.23 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 122.918 0.487 . . . . 0.0 110.711 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -167.91 124.94 1.12 Allowed 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.004 0.522 . . . . 0.0 109.804 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' GLU . . . . . 0.606 ' HG2' ' HA ' ' A' ' 410' ' ' VAL . 21.1 mt-10 -101.28 0.1 36.69 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 122.646 0.378 . . . . 0.0 111.985 -170.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 41.4 p -133.99 -77.17 0.47 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.063 0.458 . . . . 0.0 111.501 -170.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.8 t70 177.39 -42.95 0.01 OUTLIER 'General case' 0 C--O 1.241 0.636 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -172.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 21.7 t70 175.32 -27.75 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.66 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.422 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 24.1 ptt180 -138.17 165.67 31.61 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.977 -174.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 62.1 Cg_endo -75.72 162.52 35.15 Favored 'Trans proline' 0 C--O 1.244 0.783 0 C-N-CA 121.221 1.281 . . . . 0.0 110.957 177.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.64 158.27 33.92 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.689 0.757 . . . . 0.0 109.502 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 6.6 t -65.86 136.7 95.81 Favored Pre-proline 0 N--CA 1.453 -0.305 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 175.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.17 -16.92 42.95 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.269 1.313 . . . . 0.0 112.772 -177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -115.11 15.71 17.08 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.851 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 57.72 -152.03 27.97 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.995 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.45 -14.8 34.24 Favored 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 121.973 1.782 . . . . 0.0 111.535 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 19.9 t -82.08 2.2 32.33 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.92 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 49.8 t -60.25 124.17 19.46 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.362 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -121.56 66.42 0.89 Allowed 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.563 0.697 . . . . 0.0 110.117 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.463 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 2.3 mmp_? -108.8 108.79 19.73 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 430' ' ' LYS . . . . . 0.469 ' HB2' ' NZ ' ' A' ' 430' ' ' LYS . 4.8 ttmp? -70.13 82.06 0.51 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.057 -0.402 . . . . 0.0 110.741 -176.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 431' ' ' ASN . . . . . 0.517 ' ND2' ' HD2' ' A' ' 432' ' ' PRO . 8.7 t-20 -166.36 123.99 1.04 Allowed Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 123.012 0.525 . . . . 0.0 110.247 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.517 ' HD2' ' ND2' ' A' ' 431' ' ' ASN . 42.6 Cg_endo -68.2 -32.56 26.76 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.088 1.859 . . . . 0.0 112.3 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.647 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 6.6 tp-100 -68.94 -36.23 77.72 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.935 -0.478 . . . . 0.0 109.845 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' HIS . . . . . 0.636 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 39.9 t60 -53.59 -56.1 20.02 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.023 0.916 . . . . 0.0 110.579 176.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.4 ' HA ' ' HE1' ' A' ' 440' ' ' HIS . 24.2 mtpp -60.46 -16.51 37.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.761 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 432' ' ' PRO . 58.1 mt -87.81 -28.86 5.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.426 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.647 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 29.1 mt-10 -90.33 -32.95 16.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.757 -175.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -114.39 129.75 56.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.13 0.491 . . . . 0.0 109.818 -174.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 419' ' ' PRO . 15.7 ptt180 -79.13 118.9 21.53 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.007 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.4 ' HE1' ' HA ' ' A' ' 435' ' ' LYS . 66.5 m80 -98.96 90.58 4.68 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -67.3 107.75 2.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.655 0.74 . . . . 0.0 110.452 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 1.3 p -99.32 122.89 43.08 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.252 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' LEU . . . . . 0.42 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.4 OUTLIER -133.16 157.09 79.13 Favored Pre-proline 0 C--O 1.215 -0.711 0 O-C-N 123.933 0.771 . . . . 0.0 110.02 -173.51 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 444' ' ' PRO . . . . . 0.404 ' O ' HG12 ' A' ' 445' ' ' VAL . 18.5 Cg_endo -56.17 -37.68 96.17 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 121.713 1.609 . . . . 0.0 111.584 -174.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.42 ' HB ' HD13 ' A' ' 443' ' ' LEU . 5.3 p 46.84 20.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.051 1.34 . . . . 0.0 112.633 177.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 47.0 mmt-85 -68.79 128.99 38.63 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.379 -0.826 . . . . 0.0 110.452 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -84.39 -17.53 39.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.393 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 C--O 1.237 0.406 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.067 178.482 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 449' ' ' ' ZN' . . . . . 0.799 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' ' ZN' . . . . . 0.763 'ZN ' ' HG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.753 0 CA-C-O 119.954 -0.359 . . . . 0.0 112.262 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 7.1 p -68.76 98.5 0.92 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 117.534 0.667 . . . . 0.0 110.063 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -109.77 91.98 3.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.523 0.678 . . . . 0.0 109.878 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -146.25 113.0 6.02 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.749 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 42.1 p -70.74 133.72 46.83 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.801 0.688 . . . . 0.0 112.269 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -98.57 -11.88 21.72 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.029 177.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 50.2 m 74.21 -40.16 0.44 Allowed 'General case' 0 C--O 1.249 1.057 0 C-N-CA 124.267 1.027 . . . . 0.0 110.625 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 23.7 t -76.82 80.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.779 0.799 . . . . 0.0 110.17 175.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -60.85 -25.92 66.99 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.896 -176.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -80.89 -17.47 50.51 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 93.79 132.67 6.49 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.81 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 34.1 t -83.28 9.16 11.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.793 0.33 . . . . 0.0 110.632 -176.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -69.6 111.32 5.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.376 0.608 . . . . 0.0 110.96 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -100.0 -135.07 8.76 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.024 -0.989 . . . . 0.0 113.053 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -161.85 151.65 16.6 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 117.868 0.834 . . . . 0.0 111.399 -169.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' LYS . . . . . 0.519 ' HD3' ' H ' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -99.69 11.98 37.79 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 123.914 0.759 . . . . 0.0 110.791 -179.086 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 25.2 m -125.23 162.98 26.84 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 119.359 -0.353 . . . . 0.0 110.859 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -122.14 166.84 13.93 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 123.993 0.808 . . . . 0.0 109.605 175.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.46 169.48 10.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.57 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 6.2 t -130.89 165.71 22.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.816 175.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 378' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 411' ' ' GLY . 16.4 m -59.53 113.02 2.0 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -172.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.865 ' HG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 49.1 t -52.55 114.9 1.53 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 380' ' ' MET . . . . . 0.633 ' HB2' HG12 ' A' ' 410' ' ' VAL . 26.7 ptm -53.29 -26.94 20.38 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.239 -173.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -91.73 -25.43 19.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 61.55 -115.9 8.58 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.116 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' ALA . . . . . 0.44 ' HB2' ' HG3' ' A' ' 399' ' ' PRO . . . -79.37 -6.25 56.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.919 0.39 . . . . 0.0 111.086 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -87.87 -28.68 21.43 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -173.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' CYS . . . . . 0.834 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 4.8 p -71.39 129.65 39.34 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -94.42 17.22 13.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.449 -174.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -70.26 145.27 51.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' LYS . . . . . 0.561 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -130.52 -1.08 4.4 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.086 0.469 . . . . 0.0 110.136 178.388 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -76.89 134.76 68.1 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.57 -20.49 70.88 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.716 2.277 . . . . 0.0 111.467 -173.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.591 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 59.2 t -66.21 -44.32 91.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.745 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' HIS . . . . . 0.594 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 84.3 t60 -57.47 -28.01 62.99 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.027 0.441 . . . . 0.0 110.111 178.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 81.6 m-85 -96.47 -13.9 22.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.879 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.591 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -76.46 -18.68 58.66 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.617 -176.125 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 395' ' ' HIS . . . . . 0.558 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 6.8 p80 -122.81 -21.66 5.52 Favored 'General case' 0 C--O 1.245 0.816 0 O-C-N 123.167 0.292 . . . . 0.0 111.698 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 396' ' ' PHE . . . . . 0.558 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 48.0 m-85 -128.11 126.82 41.9 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 117.799 0.272 . . . . 0.0 111.044 176.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.422 ' OG ' ' HB2' ' A' ' 403' ' ' ASP . 68.9 m -87.88 165.17 15.46 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.415 0.626 . . . . 0.0 111.238 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' HIS . . . . . 0.668 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 42.7 m80 -132.72 164.56 42.86 Favored Pre-proline 0 C--O 1.233 0.23 0 C-N-CA 123.173 0.589 . . . . 0.0 110.117 -174.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 399' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 19.0 Cg_endo -55.03 93.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.072 2.515 . . . . 0.0 111.152 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 132.58 15.3 1.42 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.07 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -121.46 149.11 43.53 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 34.7 t -63.24 -33.01 74.56 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.481 0.312 . . . . 0.0 111.114 -174.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 403' ' ' ASP . . . . . 0.422 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 1.5 m-20 -90.73 9.73 28.79 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.188 0.518 . . . . 0.0 111.288 -175.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -91.82 129.25 37.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.343 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -156.07 9.04 0.28 Allowed Glycine 0 CA--C 1.505 -0.574 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.675 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 60.06 41.91 98.21 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.365 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.9 m -70.69 -18.76 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 115.096 -0.552 . . . . 0.0 110.247 -177.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -125.36 126.95 45.84 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.216 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 3.0 pt -49.57 -48.06 20.39 Favored 'Isoleucine or valine' 0 C--N 1.353 0.748 0 C-N-CA 122.941 0.497 . . . . 0.0 110.539 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' VAL . . . . . 0.633 HG12 ' HB2' ' A' ' 380' ' ' MET . 5.9 t -78.89 81.58 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 172.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 378' ' ' SER . . . 160.8 28.22 0.02 OUTLIER Glycine 0 CA--C 1.495 -1.178 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.634 -172.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 412' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 413' ' ' ASP . 1.5 pp0? -179.27 -50.45 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -176.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 413' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 412' ' ' GLN . 53.7 t0 172.68 131.65 0.02 OUTLIER 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.778 1.231 . . . . 0.0 108.939 175.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.39 -1.23 52.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.971 -171.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' THR . . . . . 0.606 HG22 ' HA ' ' A' ' 419' ' ' PRO . 41.6 p -60.12 131.81 52.0 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -70.76 -64.79 0.83 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.204 171.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -142.85 10.61 1.79 Allowed 'General case' 0 C--N 1.347 0.465 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 29.1 ptt180 -173.2 159.23 3.39 Favored Pre-proline 0 C--O 1.242 0.683 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.579 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.606 ' HA ' HG22 ' A' ' 415' ' ' THR . 55.4 Cg_endo -68.56 154.8 70.88 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.029 2.486 . . . . 0.0 112.38 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -74.54 143.35 44.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.894 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 11.6 t -57.84 133.68 83.2 Favored Pre-proline 0 C--N 1.317 -0.829 0 O-C-N 123.8 0.687 . . . . 0.0 109.571 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.7 -16.09 46.33 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 121.79 1.66 . . . . 0.0 113.092 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 29.3 m-85 -112.94 12.58 19.38 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 122.732 0.413 . . . . 0.0 110.033 179.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 56.57 -148.76 29.97 Favored Glycine 0 C--O 1.248 1.006 0 C-N-CA 121.321 -0.466 . . . . 0.0 113.162 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.18 -14.23 28.64 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.883 2.388 . . . . 0.0 112.044 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 34.1 t -76.04 -10.49 59.46 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.609 177.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 51.2 t -58.33 118.48 5.58 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.37 177.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -119.49 22.58 11.63 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 124.101 0.876 . . . . 0.0 109.774 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' ARG . . . . . 0.811 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 0.5 OUTLIER -63.74 109.41 1.7 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -71.51 94.55 1.3 Allowed 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.674 0.608 . . . . 0.0 111.151 -177.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' ASN . . . . . 0.52 HD21 ' HB3' ' A' ' 433' ' ' GLN . 63.3 t30 -169.47 124.88 0.73 Allowed Pre-proline 0 N--CA 1.469 0.481 0 O-C-N 124.437 1.086 . . . . 0.0 108.832 176.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.509 ' O ' HG13 ' A' ' 436' ' ' ILE . 34.3 Cg_endo -65.45 -33.58 46.45 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.39 2.06 . . . . 0.0 111.53 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' GLN . . . . . 0.587 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 24.2 tp60 -68.6 -32.3 72.09 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.07 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 434' ' ' HIS . . . . . 0.715 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 41.8 t60 -62.71 -58.22 8.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.484 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -55.36 -19.74 9.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.501 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 432' ' ' PRO . 64.5 mt -80.64 -42.64 20.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 O-C-N 123.724 0.64 . . . . 0.0 109.812 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 22.3 mt-10 -78.74 -46.97 17.74 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 -174.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -106.45 135.36 48.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.43 0.633 . . . . 0.0 110.678 -174.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 419' ' ' PRO . 16.0 ptt180 -84.78 133.85 34.34 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.55 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -107.12 85.68 2.18 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.247 0.546 . . . . 0.0 109.853 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -70.65 117.65 12.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.673 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 1.9 m -129.81 152.73 48.99 Favored 'General case' 0 C--O 1.247 0.926 0 O-C-N 123.712 0.632 . . . . 0.0 110.412 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 1.1 pp -106.22 154.85 39.42 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 444' ' ' PRO . . . . . 0.443 ' O ' HG12 ' A' ' 445' ' ' VAL . 12.7 Cg_endo -55.46 -39.71 89.55 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.475 2.117 . . . . 0.0 112.981 -173.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 445' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 444' ' ' PRO . 4.4 p 49.42 21.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 124.497 1.123 . . . . 0.0 111.277 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -137.82 149.78 46.63 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 26.8 m120 65.5 20.28 11.67 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.902 0.881 . . . . 0.0 111.056 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 CA--C 1.542 0.67 0 CA-C-O 120.918 0.39 . . . . 0.0 110.867 -177.377 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 449' ' ' ' ZN' . . . . . 0.865 'ZN ' ' HG ' ' A' ' 379' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' ' ZN' . . . . . 0.737 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.545 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 2.6 mpp_? . . . . . 0 C--O 1.236 0.385 0 CA-C-O 121.116 0.484 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 395' ' ' HIS . 4.9 t -98.14 141.09 31.5 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.985 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.3 t -55.96 121.34 9.1 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 123.071 0.232 . . . . 0.0 111.412 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.655 ' SG ' ' NE2' ' A' ' 398' ' ' HIS . 10.6 t -54.18 103.02 0.07 Allowed 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 172.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 20.9 ptm -49.78 -27.64 5.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.836 0.71 . . . . 0.0 111.845 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.567 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 28.9 m-85 -93.68 -19.42 21.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.669 -0.644 . . . . 0.0 111.355 176.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.507 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 64.94 -126.17 31.39 Favored Glycine 0 CA--C 1.501 -0.809 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -80.59 0.29 34.66 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.928 0.394 . . . . 0.0 111.531 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -94.18 -7.29 42.65 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.062 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.697 ' SG ' ' NE2' ' A' ' 392' ' ' HIS . 7.6 p -74.49 128.09 34.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.371 0.605 . . . . 0.0 110.141 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -81.98 2.99 28.25 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.873 -175.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -87.82 115.92 25.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.697 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.443 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -117.42 2.35 12.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.01 0.91 . . . . 0.0 109.855 -177.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -63.15 136.57 96.75 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.678 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.69 -28.9 48.91 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.138 2.558 . . . . 0.0 112.921 -173.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.509 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 53.3 t -61.93 -37.04 77.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.338 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.725 ' HE2' ' HE2' ' A' ' 398' ' ' HIS . 72.7 t60 -58.42 -29.14 65.87 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.349 0.595 . . . . 0.0 110.997 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -93.3 -18.5 22.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.49 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -74.86 -20.04 59.91 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.374 0.607 . . . . 0.0 110.972 -175.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.467 ' O ' HG22 ' A' ' 377' ' ' THR . 7.2 p80 -121.57 -15.87 7.9 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.313 -0.867 . . . . 0.0 111.554 176.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 377' ' ' THR . 59.1 m-85 -121.07 136.78 54.91 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.135 0.493 . . . . 0.0 112.016 173.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.545 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 19.6 m -93.17 149.86 20.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.661 176.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.725 ' HE2' ' HE2' ' A' ' 392' ' ' HIS . 37.9 m80 -124.96 160.64 53.37 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -175.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 25.7 Cg_endo -59.34 93.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.315 2.01 . . . . 0.0 111.446 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 144.41 -13.05 2.04 Favored Glycine 0 CA--C 1.507 -0.443 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -84.02 145.84 28.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.132 -0.534 . . . . 0.0 110.735 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 16.0 m -66.9 -26.38 66.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.084 176.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -86.68 -4.16 59.14 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.756 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 57.5 t80 . . . . . 0 C--O 1.237 0.413 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.575 -178.352 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 22.6 t70 . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 121.359 0.599 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.5 -25.15 0.1 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.004 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.792 ' HG3' ' HG2' ' A' ' 439' ' ' ARG . 16.3 ptt180 -158.99 170.2 9.31 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 119.4 -0.334 . . . . 0.0 110.893 -168.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 23.3 Cg_endo -61.38 151.34 80.14 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.192 1.928 . . . . 0.0 111.926 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' GLU . . . . . 0.631 ' HG2' ' HE ' ' A' ' 439' ' ' ARG . 44.1 mt-10 -87.67 142.29 27.95 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.998 0.428 . . . . 0.0 110.918 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 9.3 t -66.75 121.7 78.81 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.68 -10.46 24.79 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.67 2.247 . . . . 0.0 112.076 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -104.55 -3.41 23.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.57 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 69.39 -152.04 51.49 Favored Glycine 0 C--O 1.223 -0.559 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.352 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -76.18 -11.69 19.35 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.8 2.334 . . . . 0.0 111.216 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 32.1 t -85.09 8.14 19.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.238 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 36.5 t -60.17 117.29 4.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.613 0.721 . . . . 0.0 110.851 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -100.16 11.52 39.15 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.311 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.681 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 0.7 OUTLIER -66.41 109.31 2.68 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.264 176.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -85.02 86.81 7.35 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.35 0.66 . . . . 0.0 110.533 -172.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . 0.494 HD21 ' HB3' ' A' ' 433' ' ' GLN . 65.0 t30 -166.45 125.69 1.14 Allowed Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 122.559 0.344 . . . . 0.0 110.874 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.454 ' O ' HG13 ' A' ' 436' ' ' ILE . 29.8 Cg_endo -64.67 -35.45 46.81 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.752 1.635 . . . . 0.0 111.864 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.63 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 25.2 tp60 -64.58 -37.66 88.34 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.358 0.599 . . . . 0.0 110.909 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . 0.677 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.6 t60 -57.93 -51.51 69.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.652 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.452 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 24.8 mtpp -58.77 -23.8 60.67 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.716 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 432' ' ' PRO . 82.0 mt -80.31 -36.92 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.194 0.521 . . . . 0.0 110.414 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.63 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 24.0 mt-10 -84.34 -34.79 23.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.346 -173.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 419' ' ' PRO . 57.2 m-85 -108.75 154.87 21.43 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.686 -174.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' ARG . . . . . 0.792 ' HG2' ' HG3' ' A' ' 418' ' ' ARG . 11.9 mtm180 -91.37 120.03 31.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.705 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 78.6 m80 -92.4 78.54 5.03 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 173.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' ASN . . . . . 0.623 HD21 ' NH2' ' A' ' 439' ' ' ARG . 1.7 m-20 -63.37 106.28 0.88 Allowed 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 113.818 -1.537 . . . . 0.0 110.505 -171.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.95 138.36 31.48 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.52 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.8 OUTLIER -108.44 144.93 30.5 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.287 -174.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.61 -44.18 18.58 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.392 2.061 . . . . 0.0 111.342 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.52 ' HB ' HD13 ' A' ' 443' ' ' LEU . 8.2 p 41.85 27.73 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 124.686 1.242 . . . . 0.0 110.81 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.46 158.12 16.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 -174.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -116.03 79.76 1.35 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.725 0.774 . . . . 0.0 110.016 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.471 0.6 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.526 -179.812 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.584 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.212 0 N-CA-C 111.373 0.138 . . . . 0.0 111.373 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.467 HG23 ' CD1' ' A' ' 396' ' ' PHE . 9.7 t -108.2 163.3 13.29 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.06 0.85 . . . . 0.0 109.49 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 16.2 m -62.24 119.52 9.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.981 0.896 . . . . 0.0 111.764 -174.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.789 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 33.7 t -52.71 119.48 4.61 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.849 0.86 . . . . 0.0 109.114 174.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 26.3 ptm -56.24 -23.73 37.84 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.327 0.584 . . . . 0.0 111.952 -173.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 34.6 m-85 -104.96 -16.18 14.91 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.244 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.432 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 64.91 -121.71 22.43 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.6 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . 0.446 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -82.88 4.7 24.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.927 0.363 . . . . 0.0 111.132 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -96.6 -14.7 22.0 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.789 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 1.8 p -73.58 127.12 31.87 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.561 -0.712 . . . . 0.0 110.732 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -81.58 -4.92 57.38 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.084 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -60.05 128.21 35.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.538 0.685 . . . . 0.0 109.623 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.617 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.2 OUTLIER -112.05 -15.71 13.22 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.56 -173.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -62.83 134.76 95.66 Favored Pre-proline 0 C--O 1.243 0.73 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.578 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.59 -22.85 75.45 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.501 2.134 . . . . 0.0 111.343 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.596 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 77.8 t -62.92 -35.9 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.214 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.71 ' HE2' ' HE2' ' A' ' 398' ' ' HIS . 83.9 t60 -61.43 -30.58 70.66 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.285 0.365 . . . . 0.0 110.339 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 54.6 m-85 -90.27 -24.79 20.82 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.749 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.596 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -71.1 -20.23 62.37 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.804 -175.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.563 ' ND1' ' HD2' ' A' ' 396' ' ' PHE . 1.9 p80 -119.68 -11.98 9.33 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.563 ' HD2' ' ND1' ' A' ' 395' ' ' HIS . 63.1 m-85 -138.52 126.55 22.62 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 177.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.584 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 58.0 m -86.73 160.66 18.76 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.355 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.713 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 32.4 m80 -127.83 165.63 28.97 Favored Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.668 -173.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.446 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 50.2 Cg_exo -54.74 -2.56 0.2 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 123.488 2.792 . . . . 0.0 114.152 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -119.15 13.11 11.29 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 111.964 -0.455 . . . . 0.0 111.964 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -121.85 131.08 53.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.9 t -62.57 -20.63 64.9 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -170.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.18 -7.52 59.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.405 0.621 . . . . 0.0 110.986 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 39.0 t80 . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.61 176.085 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 417' ' ' ASP . 19.4 t70 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.627 0.251 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.458 ' HB3' ' O ' ' A' ' 416' ' ' ASP . 9.0 t0 78.07 79.04 0.07 Allowed 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.838 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.455 ' HG3' ' CG ' ' A' ' 439' ' ' ARG . 14.7 ptt180 -178.48 157.23 1.02 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.867 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.26 147.02 94.18 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.299 2.0 . . . . 0.0 111.342 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -73.74 159.23 33.26 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . 0.908 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 7.8 t -64.22 132.27 95.27 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.4 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.88 -12.02 29.8 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.371 2.047 . . . . 0.0 112.256 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 37.0 m-85 -106.47 11.79 30.34 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.087 0.555 . . . . 0.0 110.709 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 56.6 -153.22 20.04 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.621 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.99 -9.9 19.51 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.335 2.023 . . . . 0.0 110.817 176.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 35.9 t -70.71 -14.85 62.61 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 173.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' CYS . . . . . 0.908 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 54.0 t -52.43 117.36 2.8 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.143 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -116.31 19.69 14.67 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.542 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 1.7 mmp_? -63.97 103.12 0.55 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.887 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -77.63 105.58 8.88 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.784 0.677 . . . . 0.0 109.69 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . 0.528 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 62.7 t30 -178.36 127.75 0.28 Allowed Pre-proline 0 C--O 1.244 0.768 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.933 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.528 ' HD2' ' OD1' ' A' ' 431' ' ' ASN . 19.9 Cg_endo -58.72 -44.55 35.5 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.339 2.692 . . . . 0.0 111.61 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.45 ' HB3' ' ND2' ' A' ' 431' ' ' ASN . 23.1 tp60 -59.47 -34.12 72.16 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 120.973 0.415 . . . . 0.0 110.398 -177.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . 0.782 ' CE1' ' HG ' ' A' ' 421' ' ' CYS . 61.9 t60 -63.06 -62.31 1.79 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.742 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -60.33 -15.34 24.59 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 432' ' ' PRO . 60.1 mt -75.85 -47.22 33.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.834 174.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -78.54 -45.47 21.77 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.887 -0.508 . . . . 0.0 112.238 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -107.32 155.39 20.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.824 -0.548 . . . . 0.0 112.239 -171.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' ARG . . . . . 0.455 ' CG ' ' HG3' ' A' ' 418' ' ' ARG . 54.2 mtm180 -94.25 153.53 17.99 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.636 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.586 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 75.2 m80 -128.97 80.42 1.97 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 175.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -84.03 139.09 32.74 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.004 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 3.9 p -101.75 130.19 48.1 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 123.311 0.382 . . . . 0.0 111.873 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 443' ' ' LEU . 1.3 pp -108.79 151.01 41.55 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.3 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -63.27 -30.39 73.73 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 C-N-CA 122.075 1.85 . . . . 0.0 112.216 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.2 p 44.27 31.0 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 C-N-CA 124.847 1.259 . . . . 0.0 111.691 -177.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -87.96 165.35 15.28 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.939 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -43.71 -58.35 2.74 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.895 0.878 . . . . 0.0 111.029 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--N 1.343 0.308 0 C-N-CA 122.583 0.353 . . . . 0.0 111.054 -177.0 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.42 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.4 OUTLIER . . . . . 0 C--O 1.241 0.618 0 CA-C-O 121.339 0.59 . . . . 0.0 111.591 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 6.0 t -115.11 152.01 33.31 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 173.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 49.3 m -55.54 123.69 14.82 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.979 0.799 . . . . 0.0 112.032 -172.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 26.5 t -60.36 118.49 6.5 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 22.7 ptm -54.66 -33.49 60.78 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-O 121.464 0.649 . . . . 0.0 111.388 -175.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.578 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 41.3 m-85 -96.92 -10.49 26.27 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.579 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.531 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 62.38 -129.09 42.44 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . 0.421 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -80.28 -3.33 48.91 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.063 0.459 . . . . 0.0 111.182 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -84.63 -16.48 41.85 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.227 -175.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 3.0 p -69.43 141.03 54.15 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.451 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -78.93 9.34 4.37 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 122.791 0.437 . . . . 0.0 111.461 -174.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -93.79 111.18 22.83 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.671 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.441 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -105.59 -21.3 13.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.212 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -46.98 131.41 8.88 Favored Pre-proline 0 C--O 1.238 0.451 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.959 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.49 -25.53 58.81 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 123.749 2.966 . . . . 0.0 111.602 -174.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.516 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 64.6 t -65.8 -34.7 72.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.279 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.647 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 73.3 t60 -59.87 -26.5 65.91 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.301 -0.875 . . . . 0.0 110.088 175.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 38.4 m-85 -93.68 -5.49 48.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.586 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -88.67 -23.14 23.09 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.046 -178.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.43 ' HD2' ' HG3' ' A' ' 394' ' ' GLN . 4.9 p80 -116.02 -18.68 10.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.067 0.46 . . . . 0.0 111.913 175.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 393' ' ' PHE . 69.2 m-85 -125.29 128.51 48.35 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.761 174.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' A' ' 404' ' ' TYR . 14.2 p -80.26 159.04 26.01 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.477 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.704 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 53.7 m80 -139.53 158.15 68.97 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.868 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.421 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 10.6 Cg_endo -51.07 107.9 0.2 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 121.887 1.725 . . . . 0.0 110.379 -177.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 118.45 0.81 15.97 Favored Glycine 0 C--N 1.316 -0.552 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.698 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . 0.428 ' HB3' ' HB2' ' A' ' 404' ' ' TYR . 20.1 t70 -97.63 141.82 30.19 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 123.04 0.536 . . . . 0.0 109.864 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 43.4 t -58.9 -26.18 64.08 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.939 0.774 . . . . 0.0 111.505 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -110.84 19.47 18.53 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.773 -174.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . 0.452 ' HB2' ' HB2' ' A' ' 397' ' ' SER . 63.5 t80 . . . . . 0 C--O 1.237 0.398 0 O-C-N 121.605 -0.684 . . . . 0.0 110.446 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 21.3 t70 . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -175.15 -32.34 0.01 OUTLIER 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.74 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 23.1 ptt180 -128.6 157.27 75.58 Favored Pre-proline 0 C--O 1.245 0.843 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.277 -176.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.9 158.94 38.47 Favored 'Trans proline' 0 C--N 1.326 -0.648 0 C-N-CA 122.16 1.906 . . . . 0.0 111.139 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' GLU . . . . . 0.484 ' HG3' ' HG3' ' A' ' 439' ' ' ARG . 1.9 mp0 -75.29 158.72 32.43 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.93 0.395 . . . . 0.0 110.302 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . 0.98 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 6.6 t -62.76 133.14 94.95 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.899 176.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.91 -6.93 13.68 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.685 2.257 . . . . 0.0 112.698 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 96.8 m-85 -114.72 11.88 16.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.173 0.511 . . . . 0.0 110.288 177.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 61.21 -157.79 31.68 Favored Glycine 0 N--CA 1.462 0.377 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.731 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.15 -11.39 25.12 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.675 2.917 . . . . 0.0 112.197 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 25.8 t -81.41 -11.63 59.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.785 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' CYS . . . . . 0.98 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 39.8 t -51.26 116.93 2.27 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.955 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -111.6 23.96 13.3 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.154 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -61.83 100.42 0.15 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 122.689 0.396 . . . . 0.0 110.066 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 430' ' ' LYS . 17.9 ptpt -66.12 94.18 0.23 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.229 0.538 . . . . 0.0 111.215 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . 0.552 ' O ' ' HB3' ' A' ' 434' ' ' HIS . 14.7 t30 -173.57 114.13 0.34 Allowed Pre-proline 0 N--CA 1.465 0.296 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.0 -47.01 22.29 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.427 2.085 . . . . 0.0 112.181 -174.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.631 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 26.0 tp60 -57.72 -29.07 64.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.326 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . 0.687 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 41.2 t60 -61.38 -55.99 25.34 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 123.361 0.413 . . . . 0.0 111.736 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -61.37 -25.23 67.03 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.437 0.637 . . . . 0.0 110.839 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 69.0 mt -69.48 -46.51 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.437 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.631 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 10.5 mt-10 -85.31 -22.48 28.51 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.986 -174.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -121.04 126.05 48.87 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 123.618 0.574 . . . . 0.0 110.155 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' ARG . . . . . 0.484 ' HG3' ' HG3' ' A' ' 420' ' ' GLU . 12.0 ptt180 -80.9 122.08 26.79 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 121.281 0.562 . . . . 0.0 110.984 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.7 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 49.3 m80 -98.07 84.45 3.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.154 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -70.26 121.28 17.3 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.177 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.42 146.37 38.5 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.92 156.39 29.67 Favored Pre-proline 0 C--N 1.322 -0.608 0 O-C-N 123.466 0.479 . . . . 0.0 111.083 -173.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' PRO . . . . . 0.576 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 32.1 Cg_endo -62.63 -25.8 75.45 Favored 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 122.302 2.001 . . . . 0.0 112.365 -176.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 14.9 p 40.09 56.26 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 122.958 1.361 . . . . 0.0 111.864 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.576 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 21.0 mmm180 -91.52 140.68 29.51 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 121.31 -0.869 . . . . 0.0 112.201 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 55.6 t30 52.98 85.84 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.639 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 26.6 m . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 121.371 0.605 . . . . 0.0 111.14 -177.645 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.553 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 10.5 t -106.14 153.66 21.78 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.837 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.9 t -53.87 119.81 5.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.515 0.326 . . . . 0.0 111.751 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 24.1 t -53.77 111.06 0.66 Allowed 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 23.3 ptp -58.51 -12.6 4.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.226 0.536 . . . . 0.0 111.925 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.414 ' CD2' ' HB3' ' A' ' 385' ' ' CYS . 15.3 m-85 -110.09 -15.83 13.93 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.612 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 72.76 -133.42 19.07 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -174.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . 0.438 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -88.11 -0.75 57.44 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 121.643 0.735 . . . . 0.0 111.244 177.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -75.82 -24.89 55.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.593 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 0.8 OUTLIER -61.38 129.72 42.58 Favored 'General case' 0 C--O 1.25 1.098 0 O-C-N 122.238 -0.289 . . . . 0.0 111.167 -179.258 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -71.46 -8.49 54.19 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.034 0.534 . . . . 0.0 110.138 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -69.95 113.05 6.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.862 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.501 ' HD2' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -113.21 -1.84 14.23 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -61.25 137.11 94.3 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.335 175.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -58.57 -20.89 52.14 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.649 2.233 . . . . 0.0 111.746 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.579 HG12 ' NE2' ' A' ' 395' ' ' HIS . 98.4 t -66.09 -42.36 91.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.22 178.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.776 ' HE2' ' HE2' ' A' ' 398' ' ' HIS . 83.9 t60 -57.7 -33.51 68.46 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.702 0.763 . . . . 0.0 110.655 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 34.5 m-85 -88.96 -18.91 26.46 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.877 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -75.33 -26.95 59.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.641 -178.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.63 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 2.2 p80 -114.3 -7.34 12.95 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.502 0.501 . . . . 0.0 112.273 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.63 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 96.5 m-85 -135.45 132.01 36.88 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.206 0.527 . . . . 0.0 111.665 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.553 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 69.3 m -85.38 154.14 22.06 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.606 174.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.776 ' HE2' ' HE2' ' A' ' 392' ' ' HIS . 31.5 m80 -128.07 158.21 71.62 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.496 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 14.9 Cg_endo -52.96 100.53 0.05 OUTLIER 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 122.951 2.434 . . . . 0.0 111.594 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 119.01 11.86 7.36 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.661 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -106.25 145.06 32.07 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 41.3 t -54.04 -32.81 55.58 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.805 0.69 . . . . 0.0 111.29 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -107.97 17.33 22.53 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 56.2 t80 . . . . . 0 N--CA 1.47 0.556 0 C-N-CA 120.124 -0.631 . . . . 0.0 110.824 178.592 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 C--O 1.239 0.534 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 27.3 t70 63.17 79.75 0.25 Allowed 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 124.736 1.214 . . . . 0.0 113.035 168.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -177.62 154.46 1.04 Allowed Pre-proline 0 N--CA 1.479 0.985 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.812 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -52.49 136.41 56.63 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.034 2.49 . . . . 0.0 111.282 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' GLU . . . . . 0.454 ' HG3' ' HG3' ' A' ' 439' ' ' ARG . 2.3 mp0 -75.62 148.54 38.69 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . 0.949 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 8.3 t -52.18 134.86 40.64 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.412 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 421' ' ' CYS . 53.0 Cg_exo -57.24 -28.15 78.19 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.742 2.294 . . . . 0.0 111.952 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . 0.413 ' HB2' ' HA ' ' A' ' 427' ' ' CYS . 62.3 m-85 -99.1 5.55 46.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.873 -177.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 67.64 -156.03 52.65 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . 0.441 ' HG3' ' HA ' ' A' ' 442' ' ' THR . 55.1 Cg_endo -70.74 -16.53 33.44 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.329 2.02 . . . . 0.0 111.298 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 33.0 t -79.25 3.98 16.38 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.262 176.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' CYS . . . . . 0.949 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 50.5 t -55.1 117.28 3.33 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.108 0.563 . . . . 0.0 110.727 177.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -103.1 13.37 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.685 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 429' ' ' ARG . 8.4 mmm180 -71.99 105.46 3.89 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -87.96 97.45 10.96 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.142 -175.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -173.02 126.37 0.48 Allowed Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.458 ' O ' HG13 ' A' ' 436' ' ' ILE . 28.2 Cg_endo -62.58 -38.28 52.3 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.295 1.997 . . . . 0.0 112.12 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.651 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 26.3 tp60 -63.94 -38.19 90.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.946 0.403 . . . . 0.0 110.34 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . 0.666 ' CE1' ' SG ' ' A' ' 421' ' ' CYS . 15.0 t60 -57.95 -48.3 80.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.262 1.03 . . . . 0.0 110.116 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -68.68 -15.24 63.46 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.345 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 432' ' ' PRO . 79.0 mt -86.67 -34.3 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 123.928 0.767 . . . . 0.0 110.628 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.651 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 21.9 mt-10 -86.62 -25.08 25.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.572 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -127.0 135.6 51.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.234 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' ARG . . . . . 0.454 ' HG3' ' HG3' ' A' ' 420' ' ' GLU . 25.2 ptt180 -91.2 134.94 34.14 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.65 0.594 . . . . 0.0 109.761 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.62 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 24.2 m80 -100.91 83.81 2.59 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.231 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -94.61 157.46 15.97 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.004 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' THR . . . . . 0.441 ' HA ' ' HG3' ' A' ' 425' ' ' PRO . 30.4 p -100.74 171.78 7.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -178.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.41 151.54 71.47 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.0 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' PRO . . . . . 0.514 ' O ' HG12 ' A' ' 445' ' ' VAL . 18.6 Cg_endo -59.29 -24.53 74.66 Favored 'Trans proline' 0 N--CA 1.483 0.868 0 C-N-CA 123.489 2.793 . . . . 0.0 111.24 -174.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 444' ' ' PRO . 3.5 p 56.53 7.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.734 1.614 . . . . 0.0 113.013 171.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 446' ' ' ARG . 15.0 ptt180 -126.88 170.48 12.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.174 -176.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -133.05 -36.59 1.01 Allowed 'General case' 0 C--N 1.306 -1.296 0 O-C-N 125.013 1.446 . . . . 0.0 110.896 173.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.477 0.884 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.421 177.524 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.487 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.639 0 CA-C-O 121.492 0.663 . . . . 0.0 110.032 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.2 t -113.43 159.46 19.46 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 41.0 t -63.68 124.33 21.15 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 121.975 -0.453 . . . . 0.0 111.226 -175.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.663 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 31.9 t -56.39 122.38 11.76 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 174.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 26.5 ptm -55.1 -26.23 36.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.645 0.378 . . . . 0.0 111.566 -173.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.541 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 38.8 m-85 -110.01 -8.86 14.78 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.647 0.592 . . . . 0.0 110.657 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.46 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 69.78 -133.92 25.41 Favored Glycine 0 N--CA 1.436 -1.316 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.61 -176.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . 0.583 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -78.6 0.26 27.05 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 117.589 0.694 . . . . 0.0 111.166 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -94.7 -2.74 50.59 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.582 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.663 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 10.3 p -68.0 134.19 50.29 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 122.065 -0.397 . . . . 0.0 110.391 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -78.98 -14.11 59.4 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 123.26 0.624 . . . . 0.0 111.212 -176.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -72.5 128.31 35.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.049 0.452 . . . . 0.0 110.507 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.443 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.6 OUTLIER -120.27 -6.45 9.87 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.047 -176.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.413 HD22 ' HB ' ' A' ' 391' ' ' VAL . 5.2 p-10 -65.05 137.76 97.2 Favored Pre-proline 0 C--O 1.243 0.737 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.542 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.57 -34.63 73.76 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 123.689 2.926 . . . . 0.0 112.793 -173.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.455 HG12 ' NE2' ' A' ' 395' ' ' HIS . 60.1 t -59.72 -34.68 56.27 Favored 'Isoleucine or valine' 0 C--N 1.348 0.532 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.683 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.644 ' HE2' ' HG ' ' A' ' 379' ' ' CYS . 82.6 t60 -55.21 -37.55 67.27 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 121.729 0.776 . . . . 0.0 111.33 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 62.2 m-85 -89.68 -20.86 23.13 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.459 -175.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -71.39 -24.11 62.0 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.878 -0.514 . . . . 0.0 110.035 -177.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.606 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 1.0 OUTLIER -119.33 -7.71 10.19 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 178.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.606 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 57.0 m-85 -133.55 126.37 30.86 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.487 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 38.1 m -90.06 158.93 17.09 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.66 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 13.3 m80 -129.55 157.69 75.68 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.078 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.583 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 18.3 Cg_endo -54.31 118.09 4.65 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.898 2.398 . . . . 0.0 110.347 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 111.58 -1.71 27.7 Favored Glycine 0 C--N 1.32 -0.342 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.695 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.76 142.16 34.36 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 14.1 t -70.05 -21.97 63.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -95.56 -1.39 50.59 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.112 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.6 t80 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.09 179.637 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 18.9 t70 . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.989 0.899 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -136.35 -18.9 1.47 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.074 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.523 ' HD2' ' O ' ' A' ' 437' ' ' GLU . 20.9 ptt180 -167.6 160.13 10.1 Favored Pre-proline 0 N--CA 1.467 0.384 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -169.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.59 151.03 72.54 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.83 1.687 . . . . 0.0 111.359 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' GLU . . . . . 0.479 ' HA ' ' HG2' ' A' ' 439' ' ' ARG . 10.7 tt0 -82.94 157.07 23.16 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . 0.948 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 11.3 t -58.98 135.24 87.45 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.261 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.7 -13.28 35.85 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.343 2.029 . . . . 0.0 112.58 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -110.18 8.08 23.57 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.103 0.477 . . . . 0.0 110.429 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 63.94 -152.71 48.39 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.699 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.53 -4.38 15.19 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.847 2.365 . . . . 0.0 111.984 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 16.9 m -83.55 -2.52 56.2 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.583 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' CYS . . . . . 0.948 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 43.0 t -54.89 115.92 2.46 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.498 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -110.96 19.26 18.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.28 0.632 . . . . 0.0 110.482 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.645 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 1.1 mmp_? -69.62 101.87 1.73 Allowed 'General case' 0 C--O 1.255 1.365 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.274 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -75.04 82.83 2.26 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 123.603 0.761 . . . . 0.0 110.184 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 434' ' ' HIS . 16.5 t30 -163.23 112.08 1.02 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.694 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.98 -41.4 62.08 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 C-N-CA 123.25 2.633 . . . . 0.0 112.567 -171.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.675 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 25.1 tp60 -57.45 -39.21 75.8 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 121.086 0.47 . . . . 0.0 110.33 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . 0.715 ' CE1' ' HG ' ' A' ' 421' ' ' CYS . 19.5 t60 -59.23 -52.27 66.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.677 0.751 . . . . 0.0 110.011 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.41 ' HA ' ' HE1' ' A' ' 440' ' ' HIS . 47.7 mtpt -61.25 -19.79 62.1 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.983 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 93.7 mt -84.47 -35.42 10.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.294 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.675 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 25.7 mt-10 -85.41 -50.92 6.91 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.45 -176.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -98.06 137.85 36.24 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.113 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' ARG . . . . . 0.663 ' NE ' HD21 ' A' ' 441' ' ' ASN . 18.5 ptt-85 -86.24 145.96 26.73 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.42 0.288 . . . . 0.0 110.56 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.639 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 71.7 m80 -118.22 86.04 2.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.387 0.613 . . . . 0.0 109.847 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' ASN . . . . . 0.663 HD21 ' NE ' ' A' ' 439' ' ' ARG . 83.5 m-20 -77.61 117.87 19.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.983 -176.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.2 m -125.79 155.49 40.98 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.463 0.477 . . . . 0.0 110.898 -173.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 443' ' ' LEU . 1.1 pp -107.21 153.9 40.81 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' PRO . . . . . 0.426 ' O ' HG12 ' A' ' 445' ' ' VAL . 38.1 Cg_endo -64.84 -11.98 32.0 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.167 1.911 . . . . 0.0 113.273 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 444' ' ' PRO . 6.1 p 51.02 28.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.19 0.996 . . . . 0.0 112.309 174.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.426 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 36.9 mmt180 -85.66 144.96 27.53 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.853 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -84.09 85.54 7.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.464 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--N 1.309 -1.188 0 CA-C-O 122.119 0.961 . . . . 0.0 110.202 177.492 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 121.179 0.514 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 9.0 t -120.95 145.52 47.63 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 172.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 46.3 m -47.73 122.24 4.75 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 123.452 0.47 . . . . 0.0 111.218 -175.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 11.9 t -47.54 120.46 3.31 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 27.6 ptm -61.5 -11.75 12.18 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.08 0.552 . . . . 0.0 110.317 -176.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.494 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 75.0 m-85 -115.27 -13.89 11.71 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.994 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.424 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 65.77 -120.59 17.2 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.076 -1.059 . . . . 0.0 110.793 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . 0.467 ' HB2' ' HG3' ' A' ' 399' ' ' PRO . . . -92.18 5.73 49.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.548 0.689 . . . . 0.0 110.66 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -89.36 -15.23 33.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.302 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 2.4 p -78.8 123.85 27.61 Favored 'General case' 0 C--O 1.248 0.974 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.881 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -83.44 15.65 2.95 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.92 0.488 . . . . 0.0 111.686 -174.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -84.06 130.14 34.88 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.085 0.469 . . . . 0.0 110.409 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -104.01 -33.22 8.88 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 123.152 0.581 . . . . 0.0 109.676 -178.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -45.91 135.58 6.51 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.683 -177.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.74 -17.61 55.85 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 121.914 1.743 . . . . 0.0 112.062 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.482 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 86.3 t -67.9 -37.42 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.904 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.741 ' HE2' ' HE2' ' A' ' 398' ' ' HIS . 77.5 t60 -60.96 -29.32 69.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.868 0.842 . . . . 0.0 110.017 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 60.6 m-85 -92.8 -13.07 29.67 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.004 -177.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -78.77 -23.64 45.17 Favored 'General case' 0 C--N 1.343 0.313 0 O-C-N 121.768 -0.583 . . . . 0.0 111.617 -177.451 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.447 ' HD2' ' HG3' ' A' ' 394' ' ' GLN . 5.5 p80 -118.41 -19.76 8.74 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.438 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 377' ' ' THR . 67.7 m-85 -123.54 127.7 48.69 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.512 0.672 . . . . 0.0 110.675 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.556 ' O ' ' HB2' ' A' ' 379' ' ' CYS . 54.2 p -78.36 163.21 25.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.752 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.741 ' HE2' ' HE2' ' A' ' 392' ' ' HIS . 61.0 m80 -138.24 161.82 57.18 Favored Pre-proline 0 N--CA 1.465 0.308 0 O-C-N 122.293 -0.254 . . . . 0.0 110.479 -176.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 11.3 Cg_endo -51.58 104.98 0.1 OUTLIER 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 122.937 2.425 . . . . 0.0 112.156 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 124.55 -9.35 8.2 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.701 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -95.8 157.05 16.07 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 122.601 -0.352 . . . . 0.0 111.324 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 20.0 m -69.02 -25.87 64.71 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.831 0.707 . . . . 0.0 112.061 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.67 8.97 40.64 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.318 -0.239 . . . . 0.0 110.524 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 36.5 t80 . . . . . 0 C--N 1.328 -0.367 0 O-C-N 123.447 0.467 . . . . 0.0 110.665 -178.262 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 CA--C 1.528 0.133 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -169.92 -31.73 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.031 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.516 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 29.1 ptt180 -133.01 163.75 48.84 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.758 -173.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.35 151.08 42.56 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.566 2.178 . . . . 0.0 111.18 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.95 158.73 30.08 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.496 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . 0.82 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 49.3 t -69.37 131.25 90.29 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.297 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.87 -16.45 25.93 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.269 2.646 . . . . 0.0 112.647 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -111.86 12.81 20.91 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.63 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 59.83 -151.74 36.91 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.789 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.43 -21.83 11.32 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.547 2.165 . . . . 0.0 112.324 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 36.0 t -76.36 4.16 9.54 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.924 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' CYS . . . . . 0.82 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 49.7 t -49.61 116.73 1.88 Allowed 'General case' 0 C--O 1.219 -0.547 0 O-C-N 124.358 1.036 . . . . 0.0 110.957 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -107.77 16.21 23.82 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.653 0.739 . . . . 0.0 110.347 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -76.64 88.45 3.32 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.027 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -73.79 92.3 2.02 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.305 0.574 . . . . 0.0 111.289 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . 0.48 HD21 ' HB3' ' A' ' 433' ' ' GLN . 47.4 t30 -153.74 126.41 4.02 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.484 ' O ' HG13 ' A' ' 436' ' ' ILE . 18.4 Cg_endo -58.63 -39.75 79.83 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.804 1.669 . . . . 0.0 111.537 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.48 ' HB3' HD21 ' A' ' 431' ' ' ASN . 23.7 tp60 -69.1 -26.26 64.83 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.695 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . 0.753 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 48.3 t60 -64.61 -61.89 1.92 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.114 0.483 . . . . 0.0 110.518 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.477 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 0.0 OUTLIER -61.39 -18.59 59.48 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.441 -178.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 432' ' ' PRO . 66.1 mt -71.96 -56.38 10.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.192 0.52 . . . . 0.0 111.701 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 418' ' ' ARG . 9.7 mm-40 -76.26 -28.08 56.95 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -112.27 123.09 49.51 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.256 0.347 . . . . 0.0 111.409 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' ARG . . . . . 0.516 ' HD3' ' O ' ' A' ' 418' ' ' ARG . 1.2 ptm180 -78.16 126.99 31.61 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.575 0.547 . . . . 0.0 110.346 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.571 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.1 m80 -103.18 85.62 2.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.36 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' ASN . . . . . 0.502 HD21 ' CZ ' ' A' ' 439' ' ' ARG . 93.4 m-20 -68.75 117.59 10.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.616 -176.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.0 m -133.35 154.12 51.0 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -176.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.502 HD13 ' HB ' ' A' ' 445' ' ' VAL . 1.4 pp -108.81 148.02 36.99 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.913 176.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.71 -47.24 5.55 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.49 1.46 . . . . 0.0 113.072 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.502 ' HB ' HD13 ' A' ' 443' ' ' LEU . 9.8 p 44.45 29.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 122.013 0.911 . . . . 0.0 111.425 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 448' ' ' VAL . 24.4 tpt180 -83.95 92.87 7.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.296 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 14.1 m120 47.92 -76.21 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.826 1.251 . . . . 0.0 113.166 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 446' ' ' ARG . 33.5 m . . . . . 0 C--O 1.238 0.496 0 CA-C-O 121.851 0.834 . . . . 0.0 110.299 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.43 HH21 ' CG ' ' A' ' 401' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.865 0.841 . . . . 0.0 110.453 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 9.6 t -98.72 144.53 27.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.611 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 35.4 m -62.56 122.68 16.41 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.081 0.863 . . . . 0.0 112.668 -168.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.79 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 47.1 t -58.2 110.82 1.02 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.915 171.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 23.3 ptm -59.81 -25.98 65.4 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.134 0.271 . . . . 0.0 110.947 -174.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 53.1 m-85 -95.18 -14.85 23.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.578 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 57.91 -117.7 11.0 Favored Glycine 0 C--O 1.216 -0.985 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.439 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -87.29 -3.71 59.05 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.169 0.509 . . . . 0.0 111.608 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -83.31 -25.17 31.77 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.04 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.79 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.3 p -70.68 120.71 16.69 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 174.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -79.61 1.41 26.23 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.65 0.594 . . . . 0.0 111.763 -170.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.53 ' HA ' ' NE ' ' A' ' 387' ' ' ARG . 2.4 mmp_? -62.98 129.16 39.16 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 123.532 0.52 . . . . 0.0 110.595 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.494 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -112.52 -11.79 13.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.094 -175.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -67.06 138.68 95.01 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.497 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.98 -23.74 78.04 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.074 1.849 . . . . 0.0 111.526 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.467 ' HA ' ' HG2' ' A' ' 394' ' ' GLN . 60.1 t -60.69 -41.65 89.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.716 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 48.5 t60 -53.63 -33.91 56.73 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.534 0.521 . . . . 0.0 110.911 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -95.86 -19.31 19.68 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.409 -175.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.467 ' HG2' ' HA ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -70.77 -25.38 62.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.503 0.192 . . . . 0.0 111.25 -177.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.585 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 0.8 OUTLIER -120.85 -8.77 9.38 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.585 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 93.0 m-85 -133.15 133.09 42.4 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.793 176.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 17.6 p -88.34 149.94 23.48 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.151 0.58 . . . . 0.0 110.042 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.613 ' NE2' ' NE2' ' A' ' 392' ' ' HIS . 42.6 m80 -125.56 160.86 53.78 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.213 -174.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.15 93.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.499 2.133 . . . . 0.0 110.374 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 136.6 -23.51 3.25 Favored Glycine 0 C--O 1.238 0.402 0 O-C-N 123.995 0.809 . . . . 0.0 111.473 -175.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . 0.455 ' HB3' ' H ' ' A' ' 398' ' ' HIS . 15.2 t70 -76.89 133.57 39.25 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 32.0 t -63.35 -13.82 43.37 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -172.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.71 12.42 31.01 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.402 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 37.4 t80 . . . . . 0 C--O 1.241 0.645 0 CA-C-O 120.478 0.18 . . . . 0.0 110.648 -179.508 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 36.1 t70 . . . . . 0 N--CA 1.463 0.177 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.411 ' OD1' ' HD2' ' A' ' 439' ' ' ARG . 19.2 p-10 -135.95 -32.54 0.88 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.444 174.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.631 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 17.4 ptt180 -146.17 172.46 5.24 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.318 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.599 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 21.1 Cg_endo -62.03 140.52 84.8 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 121.098 1.199 . . . . 0.0 111.687 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' GLU . . . . . 0.68 ' HG3' ' ND2' ' A' ' 441' ' ' ASN . 0.4 OUTLIER -74.02 160.1 31.77 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.392 0.433 . . . . 0.0 110.297 178.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . 0.983 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 2.6 t -63.51 135.31 96.2 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.46 -2.88 6.74 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.499 2.133 . . . . 0.0 112.804 -177.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . 0.622 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 65.0 m-85 -125.84 14.96 8.04 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.066 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 64.51 -159.76 41.41 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.777 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.93 -14.48 38.76 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.968 1.779 . . . . 0.0 111.878 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 36.0 t -70.73 -17.82 62.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' CYS . . . . . 0.983 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 17.5 t -57.43 115.4 2.7 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -114.78 25.01 11.29 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.447 0.642 . . . . 0.0 109.416 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.705 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 2.0 mmp_? -59.77 99.31 0.06 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -80.18 96.71 6.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.114 0.959 . . . . 0.0 110.316 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -160.22 125.74 2.29 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.894 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.589 ' O ' HG13 ' A' ' 436' ' ' ILE . 20.1 Cg_endo -59.72 -42.29 47.74 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 121.979 1.786 . . . . 0.0 111.992 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.606 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 25.3 tp60 -64.46 -37.44 87.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.124 0.488 . . . . 0.0 109.895 -177.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . 0.691 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.2 t60 -59.34 -53.89 52.98 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.521 0.676 . . . . 0.0 110.021 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -63.15 -15.65 57.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.681 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 432' ' ' PRO . 85.5 mt -82.59 -37.24 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.219 0.533 . . . . 0.0 111.13 176.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.606 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 27.0 mt-10 -82.78 -44.34 15.67 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.474 -175.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 419' ' ' PRO . 96.5 m-85 -111.5 147.19 35.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.523 -171.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' ARG . . . . . 0.683 ' NH2' HD21 ' A' ' 441' ' ' ASN . 0.0 OUTLIER -93.57 141.48 28.42 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.066 174.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.674 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 74.9 m80 -108.35 92.67 4.16 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 123.741 0.651 . . . . 0.0 109.43 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' ASN . . . . . 0.683 HD21 ' NH2' ' A' ' 439' ' ' ARG . 88.4 m-20 -67.97 98.49 0.76 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -174.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.7 m -107.75 151.44 25.69 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 124.412 1.07 . . . . 0.0 109.531 -176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.463 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.6 OUTLIER -119.83 145.11 38.76 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-O 121.009 0.433 . . . . 0.0 110.146 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' PRO . . . . . 0.536 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 54.5 Cg_endo -68.66 -20.13 40.89 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.28 2.654 . . . . 0.0 112.455 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.463 ' HB ' HD13 ' A' ' 443' ' ' LEU . 5.6 p 47.94 30.68 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.883 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.484 177.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.536 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 24.7 mmt180 -87.71 145.33 26.19 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.413 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 64.16 1.19 1.15 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.811 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 121.055 0.455 . . . . 0.0 110.391 -178.807 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.427 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.8 OUTLIER . . . . . 0 C--O 1.214 -0.809 0 CA-C-O 121.556 0.693 . . . . 0.0 111.071 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 15.3 t -117.2 155.3 29.63 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.899 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 15.9 m -57.78 121.64 10.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -170.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 11.5 t -60.74 116.75 4.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.063 173.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 31.6 ttp -50.86 -40.71 56.86 Favored 'General case' 0 C--O 1.25 1.084 0 C-N-CA 122.778 0.431 . . . . 0.0 111.2 -176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.475 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 26.1 m-85 -91.96 -14.52 29.37 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.192 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.441 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 60.69 -119.61 19.38 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -80.92 -5.8 57.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.477 0.656 . . . . 0.0 111.495 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -86.18 -15.39 41.13 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.995 -174.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.9 p -74.74 131.82 41.13 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.133 0.492 . . . . 0.0 110.129 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -87.52 18.22 4.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.533 0.682 . . . . 0.0 111.405 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -87.36 121.93 30.45 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.679 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.483 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -121.99 2.74 9.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.69 0.757 . . . . 0.0 109.681 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.415 HD22 ' HB ' ' A' ' 391' ' ' VAL . 5.2 p-10 -63.37 135.6 96.32 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.305 174.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.93 -29.52 64.44 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.227 2.618 . . . . 0.0 111.408 -172.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.608 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 98.8 t -65.08 -34.07 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.682 -178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.783 ' HE2' ' HE2' ' A' ' 398' ' ' HIS . 84.7 t60 -63.67 -24.66 67.88 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.062 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -95.83 -15.4 22.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.868 0.467 . . . . 0.0 110.807 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.608 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -80.18 -25.68 39.61 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.25 -177.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.615 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 1.7 p80 -114.31 -19.95 11.05 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.615 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 59.3 m-85 -126.94 127.76 45.36 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 122.395 1.093 . . . . 0.0 111.614 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.427 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 8.8 p -81.6 158.03 24.51 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.655 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.783 ' HE2' ' HE2' ' A' ' 392' ' ' HIS . 46.4 m80 -137.02 159.07 71.43 Favored Pre-proline 0 C--N 1.315 -0.902 0 C-N-CA 123.644 0.778 . . . . 0.0 110.288 -174.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.85 102.24 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.024 1.816 . . . . 0.0 110.546 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 124.75 -0.3 8.5 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.027 -174.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -100.12 143.83 29.86 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.7 t -61.9 -29.95 70.56 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 123.32 0.387 . . . . 0.0 111.5 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.95 9.2 43.34 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.24 0.543 . . . . 0.0 110.776 -174.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 50.1 t80 . . . . . 0 C--O 1.248 0.997 0 O-C-N 121.948 -0.47 . . . . 0.0 110.887 179.549 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 C--O 1.237 0.405 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -139.64 0.12 1.8 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.793 0.806 . . . . 0.0 109.751 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 36.3 ptt180 -170.14 150.99 3.76 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.68 -172.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.61 157.08 40.38 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.413 2.075 . . . . 0.0 112.41 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' GLU . . . . . 0.527 ' HG3' ' HG3' ' A' ' 439' ' ' ARG . 2.1 mp0 -72.9 147.75 45.02 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.395 0.434 . . . . 0.0 111.396 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . 0.974 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 4.3 t -58.96 131.73 86.83 Favored Pre-proline 0 C--O 1.243 0.733 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.959 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -58.23 -22.66 58.19 Favored 'Trans proline' 0 N--CA 1.48 0.714 0 C-N-CA 123.041 2.494 . . . . 0.0 112.631 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -97.04 -5.64 37.11 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.615 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 75.45 -154.31 45.65 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.109 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.4 -16.91 39.39 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 121.996 1.797 . . . . 0.0 111.908 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 22.8 t -79.56 4.38 16.01 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.443 0.64 . . . . 0.0 111.04 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' CYS . . . . . 0.974 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 45.5 t -55.99 116.35 2.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.998 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -107.59 22.54 15.82 Favored 'General case' 0 C--O 1.248 1.018 0 O-C-N 123.61 0.569 . . . . 0.0 110.419 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -69.41 104.44 2.29 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -80.66 98.1 7.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.04 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . 0.524 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 64.7 t30 -176.0 129.06 0.37 Allowed Pre-proline 0 CA--C 1.522 -0.128 0 C-N-CA 123.715 0.806 . . . . 0.0 109.84 176.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.524 ' HD2' ' OD1' ' A' ' 431' ' ' ASN . 18.4 Cg_endo -60.45 -43.66 32.3 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.714 1.609 . . . . 0.0 111.543 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.628 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 22.8 tp60 -60.88 -34.92 75.36 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . 0.702 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 51.5 t60 -56.67 -59.22 5.32 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 123.65 0.594 . . . . 0.0 111.522 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.434 ' HD3' ' H ' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -61.67 -11.42 11.66 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.048 178.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 432' ' ' PRO . 81.0 mt -83.74 -40.98 16.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.369 0.604 . . . . 0.0 110.929 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.628 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 23.4 mt-10 -78.9 -34.25 44.87 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.978 -176.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -114.77 132.11 56.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.84 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' ARG . . . . . 0.527 ' HG3' ' HG3' ' A' ' 420' ' ' GLU . 13.2 ptt180 -84.09 124.5 31.17 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.562 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.762 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.1 m80 -100.14 86.29 3.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.207 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -77.86 135.67 37.95 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.342 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 3.1 p -111.64 133.25 54.02 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 123.703 0.801 . . . . 0.0 110.172 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.89 158.08 34.09 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -176.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' PRO . . . . . 0.561 ' HG3' HG23 ' A' ' 448' ' ' VAL . 17.7 Cg_endo -59.17 -24.75 75.34 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.809 2.339 . . . . 0.0 112.2 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 444' ' ' PRO . 3.7 p 49.62 21.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.491 0.717 . . . . 0.0 111.874 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.436 ' HG2' ' OD1' ' A' ' 447' ' ' ASN . 48.5 ttt180 -166.64 141.23 4.17 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . 0.436 ' OD1' ' HG2' ' A' ' 446' ' ' ARG . 4.2 m-20 63.56 -83.61 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.32 1.013 . . . . 0.0 111.454 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.561 HG23 ' HG3' ' A' ' 444' ' ' PRO . 35.3 m . . . . . 0 N--CA 1.474 0.773 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.884 -174.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 14.9 t -103.69 147.16 27.57 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 21.1 m -54.99 125.92 22.41 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.358 0.599 . . . . 0.0 111.964 -174.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.632 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 45.9 t -56.81 124.09 17.3 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.647 174.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 34.3 ttp -50.59 -47.6 58.03 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.343 0.592 . . . . 0.0 111.372 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.515 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 56.5 m-85 -88.43 -9.79 51.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.344 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.522 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 67.87 -130.81 28.07 Favored Glycine 0 CA--C 1.501 -0.805 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -172.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . 0.505 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -80.73 -7.87 59.49 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.935 0.874 . . . . 0.0 110.913 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -79.99 -9.59 59.7 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.697 -176.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.785 ' SG ' ' NE2' ' A' ' 392' ' ' HIS . 3.7 p -63.06 136.53 57.85 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 123.583 0.552 . . . . 0.0 110.872 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -79.06 4.9 13.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.249 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -84.81 136.62 33.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.87 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.422 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.7 OUTLIER -123.7 -7.93 7.93 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.311 0.577 . . . . 0.0 110.409 179.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -66.74 139.27 95.74 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.514 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -60.59 -22.46 72.5 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 122.681 2.254 . . . . 0.0 111.314 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.422 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 99.3 t -63.42 -39.77 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.28 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.785 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 86.1 t60 -59.53 -31.66 69.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 110.131 178.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -91.0 -11.4 39.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.666 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 1.9 pp0? -82.87 -26.77 31.28 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.942 0.401 . . . . 0.0 110.567 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -110.57 -17.2 13.47 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 121.634 -0.666 . . . . 0.0 111.862 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 377' ' ' THR . 20.1 m-30 -125.11 135.23 52.47 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.273 0.488 . . . . 0.0 111.467 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 20.8 p -83.37 156.51 22.96 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 123.648 0.593 . . . . 0.0 110.269 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.585 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 40.7 m80 -135.61 159.89 69.75 Favored Pre-proline 0 C--O 1.221 -0.421 0 C-N-CA 122.51 0.324 . . . . 0.0 110.956 -174.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.505 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 18.7 Cg_endo -56.48 114.75 2.05 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.965 1.777 . . . . 0.0 110.832 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.08 2.98 48.67 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 -174.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . 0.441 ' HB3' ' H ' ' A' ' 398' ' ' HIS . 20.7 t70 -101.62 155.95 17.79 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.381 -0.482 . . . . 0.0 109.915 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 32.0 t -59.49 -37.09 77.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.812 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -106.36 15.05 26.58 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.333 -167.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 18.0 t80 . . . . . 0 C--N 1.311 -1.099 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.728 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 417' ' ' ASP . 17.9 t70 . . . . . 0 N--CA 1.468 0.445 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 416' ' ' ASP . 16.9 t0 80.62 78.81 0.04 OUTLIER 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.066 0.947 . . . . 0.0 111.287 173.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.4 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 25.6 ptt180 178.43 158.7 0.61 Allowed Pre-proline 0 CA--C 1.514 -0.423 0 CA-C-N 113.988 -1.46 . . . . 0.0 108.845 172.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 31.0 Cg_endo -63.15 151.1 86.52 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.263 1.975 . . . . 0.0 111.452 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' GLU . . . . . 0.583 ' HG2' ' HG3' ' A' ' 439' ' ' ARG . 36.7 mt-10 -85.05 154.26 22.2 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.385 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . 0.961 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 8.2 t -58.58 133.69 85.84 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.046 -178.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 421' ' ' CYS . 52.6 Cg_exo -56.48 -29.18 77.1 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.047 2.498 . . . . 0.0 112.715 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . 0.563 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 51.5 m-85 -98.25 6.88 46.97 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.53 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 62.52 -151.27 46.6 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.85 -15.74 29.68 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.287 1.991 . . . . 0.0 112.366 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 31.4 t -73.45 -10.19 59.47 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.624 0.726 . . . . 0.0 110.048 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' CYS . . . . . 0.961 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 42.5 t -62.38 118.62 7.73 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.189 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -125.58 23.0 7.52 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.098 0.874 . . . . 0.0 109.021 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -56.71 117.1 3.58 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.554 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -67.08 97.46 0.51 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.414 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . 0.518 HD21 ' HB3' ' A' ' 433' ' ' GLN . 62.4 t30 -178.06 121.11 0.25 Allowed Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 123.443 0.697 . . . . 0.0 109.7 173.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.15 -27.8 28.97 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.502 1.468 . . . . 0.0 111.866 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.623 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 27.0 tp60 -72.34 -34.18 67.85 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . 0.715 ' CE1' ' SG ' ' A' ' 421' ' ' CYS . 24.5 t60 -57.56 -56.61 19.71 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.859 178.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -63.21 -20.06 65.09 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.242 -177.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 50.2 mt -78.41 -41.45 25.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 122.703 0.401 . . . . 0.0 110.092 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.623 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 22.7 mt-10 -79.41 -45.68 19.03 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.815 -175.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -101.45 138.82 37.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.64 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' ARG . . . . . 0.583 ' HG3' ' HG2' ' A' ' 420' ' ' GLU . 19.1 ptt180 -92.25 145.18 24.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.515 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.677 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 35.8 m80 -119.33 98.86 6.35 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -110.2 168.61 9.31 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 4.1 p -116.99 131.99 56.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.417 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 2.5 pp -120.12 151.0 52.4 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.217 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' PRO . . . . . 0.542 ' O ' HG12 ' A' ' 445' ' ' VAL . 16.5 Cg_endo -56.79 -42.37 65.56 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.898 2.399 . . . . 0.0 112.686 -171.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 444' ' ' PRO . 2.5 p 51.4 12.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 124.582 1.176 . . . . 0.0 111.127 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 446' ' ' ARG . 0.0 OUTLIER -84.06 -43.49 15.04 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -170.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -107.78 24.04 13.53 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.563 0.697 . . . . 0.0 110.955 -175.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 121.021 0.439 . . . . 0.0 110.648 -179.788 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.472 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.2 OUTLIER . . . . . 0 C--O 1.238 0.495 0 CA-C-O 121.325 0.583 . . . . 0.0 110.906 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 13.4 t -127.15 157.47 39.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.876 176.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 69.6 p -50.61 122.37 7.09 Favored 'General case' 0 C--O 1.249 1.028 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -170.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.633 ' SG ' ' NE2' ' A' ' 392' ' ' HIS . 53.0 t -65.13 115.22 5.27 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 168.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 44.3 ttp -51.89 -42.97 63.13 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.596 0.712 . . . . 0.0 111.624 -175.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.563 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 24.8 m-85 -87.63 -9.06 55.32 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.794 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.47 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 62.5 -130.71 43.75 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-O 119.248 -0.751 . . . . 0.0 112.521 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . 0.649 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -75.82 -10.25 59.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.405 0.621 . . . . 0.0 111.67 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -85.97 -5.65 59.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.676 -174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.703 ' SG ' ' NE2' ' A' ' 392' ' ' HIS . 4.7 p -65.64 132.62 49.27 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.12 0.486 . . . . 0.0 110.897 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -71.39 -11.88 61.12 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.405 0.621 . . . . 0.0 110.375 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -80.34 108.76 14.21 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.592 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.39 -3.3 21.21 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.34 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -63.18 140.41 97.67 Favored Pre-proline 0 C--O 1.233 0.189 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.025 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.72 -22.41 61.11 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.058 1.839 . . . . 0.0 110.901 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.57 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 96.6 t -66.7 -35.63 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.847 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.703 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 47.0 t60 -60.86 -30.82 70.36 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 121.892 -0.505 . . . . 0.0 109.668 177.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -90.82 -15.67 29.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.733 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -81.73 -19.45 41.4 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.509 -178.265 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.656 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 2.5 p80 -119.04 -10.53 9.81 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.656 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 86.9 m-85 -135.59 126.75 28.09 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 121.491 0.663 . . . . 0.0 111.111 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.472 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 25.3 m -72.15 154.45 41.05 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.004 176.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.648 ' HE2' ' HE2' ' A' ' 392' ' ' HIS . 55.2 m80 -134.99 166.26 30.5 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.649 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 34.7 Cg_exo -40.04 -13.6 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 123.851 3.034 . . . . 0.0 115.782 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 398' ' ' HIS . . . -130.08 34.22 2.77 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . 0.428 ' HB3' ' H ' ' A' ' 398' ' ' HIS . 18.5 t70 -120.19 151.14 39.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.388 0.613 . . . . 0.0 109.823 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 23.3 t -64.42 -18.47 64.75 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -172.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -111.66 7.67 20.51 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 48.3 t80 . . . . . 0 CA--C 1.532 0.278 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.354 -178.211 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 CA--C 1.537 0.461 0 CA-C-O 120.955 0.407 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.406 ' CG ' ' HG2' ' A' ' 418' ' ' ARG . 19.2 p-10 -131.23 -20.05 2.74 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.498 177.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.51 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 13.9 ptt180 -166.63 165.03 10.11 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -175.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 40.6 Cg_endo -66.31 148.12 84.06 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.047 2.498 . . . . 0.0 111.195 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -75.0 151.88 38.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.572 0.701 . . . . 0.0 110.578 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . 0.987 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 12.0 t -63.95 134.86 96.07 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.948 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.63 -5.77 9.3 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.169 1.912 . . . . 0.0 114.028 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -121.52 8.9 10.17 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.24 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 64.49 -154.12 48.5 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 119.835 -0.425 . . . . 0.0 112.527 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.43 -19.3 28.86 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.685 2.257 . . . . 0.0 111.711 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 36.5 t -74.13 -8.71 57.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.596 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' CYS . . . . . 0.987 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 48.7 t -49.84 117.83 2.51 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.277 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -112.68 22.24 14.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.46 0.648 . . . . 0.0 110.623 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -67.97 107.21 2.6 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.534 175.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -77.73 89.99 4.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.286 0.565 . . . . 0.0 111.567 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -165.31 127.21 1.46 Allowed Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.258 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.558 ' O ' HG13 ' A' ' 436' ' ' ILE . 31.0 Cg_endo -63.16 -40.99 29.97 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.837 1.691 . . . . 0.0 111.592 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.448 HE21 ' HG2' ' A' ' 437' ' ' GLU . 23.8 tp60 -62.38 -37.09 84.42 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.766 0.317 . . . . 0.0 110.345 -176.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . 0.691 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 39.8 t60 -60.06 -56.78 17.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.958 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.466 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 23.1 mtpp -57.92 -21.6 44.47 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.641 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 432' ' ' PRO . 65.4 mt -81.23 -46.37 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 122.763 0.425 . . . . 0.0 110.797 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.448 ' HG2' HE21 ' A' ' 433' ' ' GLN . 7.2 mm-40 -84.02 -27.86 28.08 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -174.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -107.32 129.33 54.91 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.773 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -83.65 111.82 19.47 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.369 0.604 . . . . 0.0 110.859 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.725 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 63.8 m80 -87.53 112.53 22.33 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.525 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -114.66 125.56 53.88 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -171.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.6 p -88.9 124.43 34.2 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.504 ' CD1' ' HB ' ' A' ' 445' ' ' VAL . 1.4 pp -111.25 147.35 36.46 Favored Pre-proline 0 C--O 1.249 1.05 0 O-C-N 123.871 0.732 . . . . 0.0 111.76 -173.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' PRO . . . . . 0.424 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 28.4 Cg_endo -63.41 -30.68 72.61 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.041 2.494 . . . . 0.0 112.211 -175.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.504 ' HB ' ' CD1' ' A' ' 443' ' ' LEU . 8.7 p 43.33 30.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.739 0.816 . . . . 0.0 111.136 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.424 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 21.9 mmt180 -68.68 137.6 54.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.343 0.592 . . . . 0.0 111.553 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -74.09 86.37 1.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.023 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.448 -0.537 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.635 -179.496 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.477 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.4 HG23 ' CD2' ' A' ' 396' ' ' PHE . 2.7 t -92.17 149.92 21.21 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.046 178.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 36.9 t -54.51 117.93 3.74 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.951 0.782 . . . . 0.0 111.752 -174.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.934 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 7.8 t -51.68 115.47 1.65 Allowed 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 170.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 26.0 ptm -57.15 -26.77 61.11 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.451 0.469 . . . . 0.0 111.321 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.553 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 58.9 m-85 -102.78 -17.15 15.72 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.696 0.284 . . . . 0.0 110.677 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.422 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 66.41 -114.37 6.45 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.814 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -83.08 -7.29 59.66 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.996 -0.709 . . . . 0.0 110.745 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 381' ' ' TYR . 36.4 m-80 -83.88 -24.49 30.81 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.632 -176.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.934 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.8 p -67.2 120.99 14.68 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.593 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -78.96 4.32 14.62 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.391 1.057 . . . . 0.0 110.891 -174.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -80.96 119.86 24.02 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.699 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.457 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.9 OUTLIER -117.23 -1.73 11.77 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -176.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -60.99 142.58 92.74 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.352 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.68 -27.7 85.58 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.367 2.045 . . . . 0.0 110.384 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.469 ' O ' ' CD2' ' A' ' 395' ' ' HIS . 96.4 t -64.72 -41.07 91.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 O-C-N 123.79 0.681 . . . . 0.0 110.398 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.662 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 58.2 t60 -56.23 -34.0 65.93 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 39.6 m-85 -88.28 -25.05 23.01 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.198 0.523 . . . . 0.0 110.762 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -66.97 -19.37 65.71 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.595 -175.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.513 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 8.6 p80 -125.86 -17.75 5.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.621 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.513 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 26.3 m-85 -125.64 129.03 48.78 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 120.857 0.361 . . . . 0.0 110.898 174.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.477 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 13.7 p -84.08 160.82 20.86 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.396 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.732 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 43.9 m80 -133.44 159.18 73.58 Favored Pre-proline 0 C--N 1.342 0.271 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.667 -174.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -51.6 113.23 1.06 Allowed 'Trans proline' 0 C--O 1.238 0.517 0 C-N-CA 122.625 2.217 . . . . 0.0 112.242 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 110.66 -8.42 30.06 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.957 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -86.76 148.69 25.31 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.598 0.713 . . . . 0.0 110.869 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 46.1 t -56.71 -29.69 62.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.314 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -107.4 17.17 23.12 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.655 -175.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 61.4 t80 . . . . . 0 C--O 1.216 -0.699 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -178.21 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 CA--C 1.507 -0.707 0 CA-C-O 121.115 0.483 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -138.53 -14.64 1.26 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.799 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 13.7 ptt180 -171.95 154.15 3.4 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 122.432 0.293 . . . . 0.0 110.314 -173.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.94 147.85 24.8 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.516 2.144 . . . . 0.0 112.317 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.47 152.79 25.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . 0.67 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 17.1 t -59.03 129.41 85.99 Favored Pre-proline 0 C--O 1.244 0.785 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.927 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.89 -6.73 18.83 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 122.351 2.034 . . . . 0.0 111.745 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . 0.587 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 52.8 m-85 -108.27 8.97 28.05 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.027 176.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 62.72 -159.76 34.56 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.914 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.1 -20.74 24.75 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.076 2.517 . . . . 0.0 111.079 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 16.4 t -76.01 -4.25 40.22 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.755 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' CYS . . . . . 0.772 ' SG ' ' NE2' ' A' ' 434' ' ' HIS . 43.2 t -56.97 123.82 16.48 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.426 0.691 . . . . 0.0 112.028 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -126.94 28.97 5.72 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.573 ' HG2' ' SG ' ' A' ' 427' ' ' CYS . 20.9 mmm180 -68.69 101.35 1.29 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.658 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -67.86 90.8 0.3 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.394 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . 0.486 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 59.8 t30 -162.7 127.91 2.14 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.878 174.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.486 ' HD2' ' OD1' ' A' ' 431' ' ' ASN . 18.5 Cg_endo -60.59 -43.06 35.06 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 122.099 1.866 . . . . 0.0 112.392 -177.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.429 HE21 ' HG2' ' A' ' 437' ' ' GLU . 22.4 tp60 -63.44 -32.34 73.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.789 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . 0.772 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 43.8 t60 -58.13 -59.83 4.68 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.828 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -12.36 60.76 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.448 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 432' ' ' PRO . 62.8 mt -76.7 -51.27 19.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.198 0.523 . . . . 0.0 110.671 175.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.429 ' HG2' HE21 ' A' ' 433' ' ' GLN . 7.9 mm-40 -72.95 -49.62 28.21 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.061 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -98.59 138.3 35.98 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.412 0.445 . . . . 0.0 111.276 -173.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' ARG . . . . . 0.458 HH11 ' HD2' ' A' ' 439' ' ' ARG . 11.8 ptt180 -94.96 145.27 25.04 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.472 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 31.1 m80 -120.33 108.75 14.54 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -176.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -95.69 131.79 41.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.054 0.454 . . . . 0.0 109.975 -177.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 10.2 p -114.13 147.35 38.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.262 -175.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.489 HD13 ' HB ' ' A' ' 445' ' ' VAL . 1.2 pp -149.99 148.28 24.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.485 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.38 -25.74 11.0 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.962 2.441 . . . . 0.0 112.578 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.489 ' HB ' HD13 ' A' ' 443' ' ' LEU . 7.9 p 46.63 27.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 122.443 1.116 . . . . 0.0 111.932 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -87.81 -28.6 21.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.644 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -63.69 -32.19 73.59 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.5 -176.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 C--N 1.318 -0.772 0 O-C-N 122.218 -0.301 . . . . 0.0 110.514 178.741 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.474 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 120.491 0.186 . . . . 0.0 111.234 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 12.2 t -108.97 152.95 24.27 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.076 0.86 . . . . 0.0 109.29 175.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 45.7 m -51.52 122.73 8.46 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 121.161 0.505 . . . . 0.0 111.483 -174.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.842 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 54.0 t -51.3 123.15 9.0 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.937 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 23.8 ptm -55.42 -25.05 33.72 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.185 0.594 . . . . 0.0 111.324 -174.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.543 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 37.5 m-85 -116.88 -8.07 11.35 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.813 177.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 379' ' ' CYS . . . 63.05 -123.98 31.32 Favored Glycine 0 C--O 1.242 0.644 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.863 -177.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -82.06 -9.71 59.46 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.303 0.241 . . . . 0.0 111.056 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -77.05 -30.29 55.57 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.806 0.336 . . . . 0.0 111.193 -175.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.842 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 4.5 p -65.94 115.82 6.43 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.24 176.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -76.28 2.36 13.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.856 0.836 . . . . 0.0 110.944 -175.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -65.92 124.0 21.33 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.048 172.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.512 ' HD2' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -125.61 3.02 7.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.168 0.509 . . . . 0.0 110.464 -176.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -61.43 139.86 94.83 Favored Pre-proline 0 C--O 1.247 0.957 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.186 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.69 -25.13 80.34 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 122.934 2.423 . . . . 0.0 112.346 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.564 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 95.9 t -64.24 -37.18 79.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.573 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.752 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 26.0 t60 -58.64 -27.36 64.66 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.143 0.497 . . . . 0.0 110.644 177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -98.09 -7.96 28.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.668 -177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -84.18 -17.05 41.24 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.041 0.448 . . . . 0.0 110.959 -176.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.476 ' ND1' ' CD1' ' A' ' 396' ' ' PHE . 7.8 p80 -126.58 -16.65 5.25 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 176.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.532 ' CD2' ' HA ' ' A' ' 379' ' ' CYS . 63.5 m-85 -125.07 128.03 47.85 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.675 0.75 . . . . 0.0 112.408 174.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.474 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 20.1 p -80.01 165.38 22.63 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.483 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.531 ' NE2' ' NE2' ' A' ' 392' ' ' HIS . 50.1 m80 -136.97 158.29 73.11 Favored Pre-proline 0 C--O 1.245 0.864 0 O-C-N 123.203 0.314 . . . . 0.0 110.318 -175.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -54.38 97.28 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.153 2.569 . . . . 0.0 110.728 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 121.93 17.14 3.84 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 123.76 0.663 . . . . 0.0 111.457 -174.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -117.24 151.08 37.66 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.215 -0.579 . . . . 0.0 110.208 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 35.2 t -57.76 -36.78 72.57 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.168 -176.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -92.79 9.05 36.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.22 0.533 . . . . 0.0 111.253 -172.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 31.0 t80 . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.789 179.174 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.5 t70 . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -178.92 -26.85 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.242 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 20.9 ptt180 -142.98 160.02 54.3 Favored Pre-proline 0 C--O 1.216 -0.689 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.099 -170.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.76 159.22 48.95 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 121.652 1.568 . . . . 0.0 112.037 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' GLU . . . . . 0.406 ' HG3' ' CZ ' ' A' ' 439' ' ' ARG . 40.8 mt-10 -73.51 155.24 39.39 Favored 'General case' 0 C--O 1.248 0.995 0 O-C-N 121.918 -0.489 . . . . 0.0 110.907 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . 0.77 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 16.1 t -61.7 133.64 93.61 Favored Pre-proline 0 N--CA 1.443 -0.785 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.359 176.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.17 -9.05 22.15 Favored 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 122.41 2.074 . . . . 0.0 112.743 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -116.5 12.2 15.07 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.086 0.554 . . . . 0.0 110.113 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 58.38 -153.55 27.45 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 116.5 -0.318 . . . . 0.0 112.497 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.87 -13.99 24.08 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.158 2.572 . . . . 0.0 112.474 173.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 32.2 t -70.17 -14.06 62.47 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.568 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' CYS . . . . . 0.77 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 51.5 t -49.76 137.02 16.78 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.256 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -138.12 20.57 2.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.501 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -63.96 104.1 0.67 Allowed 'General case' 0 C--O 1.24 0.604 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.676 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 430' ' ' LYS . 18.9 ptpt -62.24 95.88 0.07 Allowed 'General case' 0 C--O 1.249 1.055 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.011 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . 0.465 HD21 ' HB3' ' A' ' 433' ' ' GLN . 61.4 t30 -177.98 123.2 0.26 Allowed Pre-proline 0 C--O 1.238 0.475 0 CA-C-O 120.659 0.266 . . . . 0.0 110.496 176.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.08 -39.2 40.99 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.755 2.303 . . . . 0.0 111.83 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.617 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 25.8 tp60 -64.46 -32.79 74.56 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.466 0.65 . . . . 0.0 110.655 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . 0.574 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 35.8 t60 -55.96 -59.95 4.17 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.094 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.404 ' H ' ' HD3' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -59.11 -19.01 40.73 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.972 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.487 HD12 ' HA ' ' A' ' 433' ' ' GLN . 77.3 mt -75.09 -43.84 44.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.596 0.713 . . . . 0.0 110.878 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.617 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 19.6 mt-10 -82.66 -40.4 20.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.28 -174.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -106.78 128.87 54.61 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.224 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' ARG . . . . . 0.406 ' CZ ' ' HG3' ' A' ' 420' ' ' GLU . 15.3 ptt-85 -85.4 116.4 23.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.894 0.854 . . . . 0.0 110.185 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.745 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 37.0 m80 -90.82 86.08 6.21 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.101 178.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -70.49 104.23 2.7 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.464 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 6.8 m -114.06 160.25 19.1 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.702 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.476 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.5 OUTLIER -135.12 157.24 77.31 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.769 179.157 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' PRO . . . . . 0.41 ' O ' HG12 ' A' ' 445' ' ' VAL . 18.7 Cg_endo -60.0 -42.28 45.72 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 122.06 1.84 . . . . 0.0 112.036 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.476 ' HB ' HD13 ' A' ' 443' ' ' LEU . 2.7 p 50.37 15.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 124.347 1.029 . . . . 0.0 112.513 177.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.41 133.56 46.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -176.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . 0.525 HD22 ' N ' ' A' ' 447' ' ' ASN . 0.8 OUTLIER -73.29 86.23 1.45 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.971 -178.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.321 -0.638 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.89 178.542 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.653 0 CA-C-O 120.976 0.417 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 12.9 m -101.0 139.94 35.99 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.66 173.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 49.7 m -54.83 122.98 11.96 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.609 -0.682 . . . . 0.0 110.023 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.701 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 18.4 t -50.16 123.3 8.12 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.199 0.523 . . . . 0.0 110.296 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 25.8 ptm -60.31 -17.84 45.56 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.188 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.591 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 38.0 m-85 -112.92 -11.05 13.47 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.75 177.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.407 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 65.43 -131.07 35.06 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.262 -177.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -75.75 -11.68 60.04 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.072 0.463 . . . . 0.0 110.71 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -80.22 -9.58 59.73 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -173.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.701 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 8.2 p -75.31 133.52 41.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.765 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -84.08 14.13 4.47 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.552 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -96.51 121.16 38.03 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.698 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.474 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -108.43 -22.16 12.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.328 -178.162 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -44.67 136.84 4.38 Favored Pre-proline 0 N--CA 1.474 0.775 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.087 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -58.7 -23.77 67.68 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.011 2.474 . . . . 0.0 112.348 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.629 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 74.0 t -67.65 -35.42 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.657 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.733 ' HE2' ' HE2' ' A' ' 398' ' ' HIS . 62.0 t60 -62.89 -19.85 64.58 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.69 -0.631 . . . . 0.0 109.794 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 90.7 m-85 -97.45 -7.53 31.42 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.74 -178.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.629 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -87.83 -19.81 26.93 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.045 0.45 . . . . 0.0 110.901 -178.029 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.458 ' ND1' ' CD2' ' A' ' 396' ' ' PHE . 7.4 p80 -121.5 -15.23 8.08 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.239 176.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.629 ' HA ' ' O ' ' A' ' 377' ' ' THR . 78.7 m-85 -133.57 127.55 33.35 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.779 0.8 . . . . 0.0 111.753 173.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 46.9 p -80.58 161.05 24.94 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.733 ' HE2' ' HE2' ' A' ' 392' ' ' HIS . 53.6 m80 -137.42 157.96 73.03 Favored Pre-proline 0 C--O 1.249 1.044 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -49.77 101.58 0.05 OUTLIER 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.199 2.599 . . . . 0.0 111.553 -176.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 122.41 -0.29 10.37 Favored Glycine 0 C--O 1.243 0.664 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.259 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -93.7 149.15 21.47 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 34.8 m -62.84 -20.53 65.17 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.522 0.514 . . . . 0.0 111.755 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.76 -3.02 28.84 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 51.0 t80 . . . . . 0 C--O 1.24 0.567 0 CA-C-O 120.82 0.343 . . . . 0.0 111.458 -172.402 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 417' ' ' ASP . 10.8 t70 . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 120.963 0.411 . . . . 0.0 111.317 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 416' ' ' ASP . 37.4 t70 80.7 63.32 0.02 OUTLIER 'General case' 0 C--O 1.243 0.761 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.917 173.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.515 ' HG3' ' CG ' ' A' ' 439' ' ' ARG . 14.6 ptt180 -179.12 153.8 0.75 Allowed Pre-proline 0 C--O 1.25 1.091 0 C-N-CA 124.001 0.921 . . . . 0.0 108.984 177.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -65.1 153.77 76.67 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.741 2.294 . . . . 0.0 111.163 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -74.44 161.0 30.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . 0.655 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 18.7 t -58.72 134.23 86.4 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.493 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.42 -19.64 65.52 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.158 1.905 . . . . 0.0 112.18 -178.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 18.2 m-85 -93.77 -5.54 48.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.06 0.457 . . . . 0.0 110.169 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 75.05 -162.53 53.82 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -173.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.91 -12.42 26.16 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.366 2.044 . . . . 0.0 111.958 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 51.1 m -73.8 -9.02 58.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.031 0.443 . . . . 0.0 110.336 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' CYS . . . . . 0.742 ' SG ' ' NE2' ' A' ' 434' ' ' HIS . 51.0 t -50.89 117.88 2.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.971 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -106.03 7.99 32.16 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.036 0.922 . . . . 0.0 110.142 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -66.51 109.82 2.92 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' LYS . . . . . 0.465 ' HB2' ' NZ ' ' A' ' 430' ' ' LYS . 10.2 mtmp? -100.46 18.96 17.71 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -171.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . 0.493 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 61.7 t30 -68.44 125.95 92.19 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 172.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.515 ' O ' HG13 ' A' ' 436' ' ' ILE . 17.8 Cg_endo -57.08 -41.27 76.45 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.629 2.219 . . . . 0.0 111.801 -177.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.575 ' O ' ' HG2' ' A' ' 437' ' ' GLU . 24.9 tp60 -64.6 -38.05 89.67 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . 0.742 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 25.0 t60 -59.14 -52.75 64.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.089 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -57.63 -31.0 65.83 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.3 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 432' ' ' PRO . 65.1 mt -70.99 -42.7 76.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.257 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 433' ' ' GLN . 6.8 mm-40 -76.09 -38.18 57.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . 0.49 ' HB3' ' HA ' ' A' ' 421' ' ' CYS . 85.7 m-85 -114.85 150.69 35.16 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -171.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' ARG . . . . . 0.54 ' NH1' HD21 ' A' ' 441' ' ' ASN . 36.8 mtm180 -95.25 123.62 38.86 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.248 0.968 . . . . 0.0 110.776 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.468 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 71.4 m80 -99.5 85.78 3.23 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' ASN . . . . . 0.54 HD21 ' NH1' ' A' ' 439' ' ' ARG . 74.4 m-20 -107.52 151.74 25.17 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -176.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 7.5 p -98.12 147.98 24.02 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.996 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 2.6 pp -148.52 156.79 42.13 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 110.728 -0.101 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' PRO . . . . . 0.55 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 21.1 Cg_endo -60.08 -28.53 87.21 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.933 2.422 . . . . 0.0 112.912 -174.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 444' ' ' PRO . 7.2 p 47.66 31.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 O-C-N 124.012 0.82 . . . . 0.0 111.183 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.55 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 26.4 mmt180 -86.67 163.01 17.62 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.703 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 60.51 44.24 12.04 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 10.0 m . . . . . 0 C--O 1.235 0.31 0 C-N-CA 124.548 1.139 . . . . 0.0 111.666 177.156 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.488 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.3 OUTLIER . . . . . 0 C--O 1.237 0.44 0 CA-C-O 121.497 0.665 . . . . 0.0 109.548 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 5.2 t -97.27 143.2 28.28 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.904 173.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 58.5 m -54.74 123.08 12.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.319 0.58 . . . . 0.0 112.052 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.837 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 29.3 t -49.47 107.97 0.17 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.226 176.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 22.4 ptp -54.55 -27.3 37.59 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -177.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -93.93 -16.63 23.8 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.083 0.468 . . . . 0.0 109.998 178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.6 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 66.35 -126.43 28.06 Favored Glycine 0 C--O 1.235 0.161 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -176.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -91.27 4.5 52.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.678 0.391 . . . . 0.0 110.829 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -88.52 -15.1 36.11 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.782 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.837 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 0.6 OUTLIER -67.94 131.61 45.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 0.0 110.397 177.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -82.65 21.11 1.03 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.281 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -95.99 121.99 38.33 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.653 176.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.418 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -107.82 -25.91 11.02 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 124.565 1.166 . . . . 0.0 108.534 -177.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -48.07 139.94 9.42 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.845 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.14 -22.34 67.41 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.849 1.699 . . . . 0.0 112.073 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.417 HG12 ' NE2' ' A' ' 395' ' ' HIS . 88.8 t -66.33 -34.73 72.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.865 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.714 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 70.9 t60 -59.82 -37.81 80.24 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.937 0.399 . . . . 0.0 110.153 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -86.23 -18.2 32.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.35 -176.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -29.28 61.08 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -175.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.677 ' HD1' ' HD1' ' A' ' 396' ' ' PHE . 1.0 OUTLIER -109.68 -16.51 13.91 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.575 176.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.677 ' HD1' ' HD1' ' A' ' 395' ' ' HIS . 72.5 m-85 -122.35 127.84 50.26 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 120.74 0.305 . . . . 0.0 110.945 176.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.488 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 16.8 p -78.37 156.43 29.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 122.874 0.47 . . . . 0.0 110.027 175.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.686 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 51.0 m80 -132.02 159.02 73.9 Favored Pre-proline 0 N--CA 1.476 0.836 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.997 -176.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -52.37 102.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.679 2.253 . . . . 0.0 111.954 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 121.23 -1.37 11.56 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.737 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -98.12 151.45 20.37 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 122.035 0.921 . . . . 0.0 110.503 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 29.7 p -63.36 -29.11 70.47 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.163 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -104.73 15.86 27.11 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.226 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.9 t80 . . . . . 0 C--N 1.323 -0.585 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.359 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 21.6 t70 . . . . . 0 C--O 1.239 0.517 0 CA-C-O 121.152 0.501 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -147.42 -43.56 0.17 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.353 175.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.492 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 24.7 ptt180 -122.09 165.89 18.98 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.191 -176.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 61.3 Cg_endo -72.68 146.23 42.96 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.217 1.945 . . . . 0.0 112.052 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' GLU . . . . . 0.581 ' HG2' ' ND2' ' A' ' 441' ' ' ASN . 47.2 mt-10 -61.38 155.24 22.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.884 0.373 . . . . 0.0 111.357 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . 0.956 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 8.3 t -66.62 136.7 94.85 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 421' ' ' CYS . 55.9 Cg_exo -53.21 -34.36 69.05 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.146 2.564 . . . . 0.0 112.69 -175.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . 0.501 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 74.8 m-85 -102.14 7.79 40.88 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.424 -176.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 71.04 -153.43 51.18 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.429 -0.35 . . . . 0.0 112.573 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.53 -19.02 49.11 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.538 2.159 . . . . 0.0 111.883 175.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 37.9 t -69.82 -19.58 63.47 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.599 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' CYS . . . . . 0.956 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 40.9 t -56.03 115.55 2.48 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.769 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -109.14 16.61 22.38 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 123.835 0.709 . . . . 0.0 109.483 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.527 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 2.4 mmp_? -53.71 93.23 0.01 OUTLIER 'General case' 0 C--O 1.246 0.884 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 173.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' LYS . . . . . 0.413 ' H ' ' HG2' ' A' ' 430' ' ' LYS . 14.4 ptpt -75.95 79.16 2.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.313 -174.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . 0.486 HD21 ' HB3' ' A' ' 433' ' ' GLN . 48.5 t30 -150.9 123.36 4.09 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.336 174.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.509 ' O ' HG13 ' A' ' 436' ' ' ILE . 23.2 Cg_endo -62.79 -33.16 77.08 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.19 1.926 . . . . 0.0 111.314 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.486 ' HB3' HD21 ' A' ' 431' ' ' ASN . 21.4 tp60 -68.16 -38.65 82.32 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . 0.634 ' CE1' ' SG ' ' A' ' 421' ' ' CYS . 29.8 t60 -59.93 -53.85 53.06 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.948 0.88 . . . . 0.0 109.229 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.426 ' O ' ' NH1' ' A' ' 418' ' ' ARG . 51.1 mtpt -62.99 -14.69 50.8 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.307 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 432' ' ' PRO . 48.3 mt -86.31 -45.33 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 123.235 0.334 . . . . 0.0 110.546 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.448 ' HG2' HE21 ' A' ' 433' ' ' GLN . 30.1 mm-40 -76.8 -29.45 56.0 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 122.437 -0.164 . . . . 0.0 111.294 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -113.95 137.29 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.093 0.557 . . . . 0.0 109.87 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 418' ' ' ARG . 1.0 OUTLIER -94.47 130.3 40.9 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.078 178.167 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.74 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 21.4 m80 -106.17 86.07 2.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.595 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' ASN . . . . . 0.581 ' ND2' ' HG2' ' A' ' 420' ' ' GLU . 46.7 m-80 -69.85 135.47 49.63 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.332 -173.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 28.9 p -135.86 173.14 12.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.601 0.715 . . . . 0.0 110.448 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 443' ' ' LEU . 1.3 pp -137.12 146.46 54.57 Favored Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 122.028 -0.42 . . . . 0.0 110.284 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' PRO . . . . . 0.417 ' O ' HG12 ' A' ' 445' ' ' VAL . 27.2 Cg_endo -62.14 -44.54 19.17 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 122.901 2.401 . . . . 0.0 112.359 -175.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.453 ' HB ' HD13 ' A' ' 443' ' ' LEU . 5.9 p 48.21 26.27 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 124.444 1.098 . . . . 0.0 112.035 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 447' ' ' ASN . 27.8 mmm180 -92.5 167.81 11.69 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 446' ' ' ARG . 7.3 t30 74.43 -42.71 0.51 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.816 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 C--O 1.244 0.796 0 C-N-CA 123.128 0.571 . . . . 0.0 111.374 178.489 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.617 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.1 OUTLIER . . . . . 0 CA--C 1.514 -0.441 0 CA-C-O 122.009 0.909 . . . . 0.0 111.264 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.4 t -111.51 162.53 15.01 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.491 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 24.8 t -57.59 116.91 3.68 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.954 0.502 . . . . 0.0 111.699 -176.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 25.1 t -51.96 117.28 2.64 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 23.2 ptm -58.93 -21.09 57.45 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.611 0.243 . . . . 0.0 111.005 -170.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.621 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 72.0 m-85 -109.61 -14.81 14.3 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 379' ' ' CYS . . . 72.03 -134.94 22.26 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . 0.477 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -75.92 -1.27 24.68 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.842 0.354 . . . . 0.0 110.409 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -91.77 -10.48 39.82 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.621 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.2 p -73.59 126.05 29.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 122.134 -0.354 . . . . 0.0 110.524 175.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -77.81 10.92 2.41 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.441 0.639 . . . . 0.0 111.896 -175.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -95.31 119.44 33.83 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.083 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.549 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -122.28 5.73 9.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.47 -178.145 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -63.73 136.6 96.79 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.197 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.6 -33.14 30.12 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.499 2.799 . . . . 0.0 112.534 -171.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.488 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 54.1 t -65.59 -34.91 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.702 -177.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.682 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 81.5 t60 -57.22 -31.78 65.85 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 122.068 -0.395 . . . . 0.0 110.208 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -89.78 -10.29 46.06 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 123.337 0.398 . . . . 0.0 111.973 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -82.61 -12.67 57.52 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.584 -0.447 . . . . 0.0 111.117 -175.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.431 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 3.6 p80 -128.97 -23.41 3.06 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.45 ' CD2' ' HA ' ' A' ' 379' ' ' CYS . 60.2 m-85 -123.12 127.32 48.54 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.317 0.579 . . . . 0.0 111.096 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.617 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 57.4 m -86.95 166.17 15.31 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.037 173.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.64 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 28.1 m80 -131.74 159.11 73.39 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 122.815 0.446 . . . . 0.0 110.667 -174.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.477 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 19.6 Cg_endo -55.73 97.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.432 2.088 . . . . 0.0 111.885 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.18 -30.43 2.81 Favored Glycine 0 CA--C 1.508 -0.37 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.219 -175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -66.57 143.07 57.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.013 -0.593 . . . . 0.0 109.658 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 12.2 t -64.82 -17.44 64.24 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.91 -174.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -108.4 7.49 27.07 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.218 0.207 . . . . 0.0 111.091 -174.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 52.5 t80 . . . . . 0 C--O 1.238 0.465 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 178.389 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 N--CA 1.461 0.098 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -129.81 -24.91 2.63 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.68 0.752 . . . . 0.0 109.958 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.541 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 28.0 ptt180 -154.68 165.32 18.36 Favored Pre-proline 0 C--O 1.247 0.97 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.139 -175.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.541 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 39.3 Cg_endo -67.18 143.61 65.59 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.901 2.4 . . . . 0.0 112.541 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -67.18 151.92 46.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 123.248 0.343 . . . . 0.0 110.865 174.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . 0.674 ' SG ' ' NE2' ' A' ' 440' ' ' HIS . 27.9 t -63.55 136.3 96.65 Favored Pre-proline 0 C--N 1.317 -0.813 0 O-C-N 123.622 0.576 . . . . 0.0 109.866 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.78 -13.28 29.58 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.836 2.357 . . . . 0.0 112.365 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -111.59 8.89 21.09 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 57.32 -149.93 30.75 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 -172.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.89 -1.87 11.96 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.436 2.091 . . . . 0.0 111.88 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 17.3 t -84.05 -2.45 56.71 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.825 0.822 . . . . 0.0 109.121 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 44.7 t -49.35 117.49 2.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.386 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -108.29 11.5 27.2 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.998 176.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -75.15 93.8 2.85 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -79.18 83.28 5.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.491 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -144.34 122.94 6.92 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.522 ' O ' HG13 ' A' ' 436' ' ' ILE . 18.3 Cg_endo -59.08 -38.23 88.32 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.822 1.681 . . . . 0.0 112.885 -175.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.599 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 24.9 tp60 -65.45 -40.06 92.77 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.965 -0.46 . . . . 0.0 109.785 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . 0.658 ' CE1' ' HG ' ' A' ' 421' ' ' CYS . 26.1 t60 -57.9 -53.77 54.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.699 0.761 . . . . 0.0 110.452 177.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -61.02 -18.22 56.57 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.889 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 432' ' ' PRO . 52.3 mt -84.3 -41.84 16.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.676 178.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.599 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 23.8 mt-10 -79.21 -45.5 19.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.135 0.493 . . . . 0.0 110.847 -175.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -97.14 145.41 26.04 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.459 -174.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' ARG . . . . . 0.481 ' NH1' HD21 ' A' ' 441' ' ' ASN . 16.7 ptt180 -92.32 118.31 30.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.354 0.597 . . . . 0.0 110.213 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.674 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 76.2 m80 -92.9 78.55 4.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.002 175.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' ASN . . . . . 0.481 HD21 ' NH1' ' A' ' 439' ' ' ARG . 2.2 m-20 -66.63 105.58 1.57 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.763 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.0 p -81.92 121.89 27.06 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 443' ' ' LEU . 2.2 pp -87.65 145.66 37.57 Favored Pre-proline 0 C--O 1.246 0.89 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.907 -173.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.65 -32.16 19.6 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.103 2.535 . . . . 0.0 112.543 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.443 ' HB ' HD13 ' A' ' 443' ' ' LEU . 9.3 p 43.05 32.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.911 1.339 . . . . 0.0 109.941 -176.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -92.24 158.01 16.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.937 -1.102 . . . . 0.0 110.284 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 59.87 21.62 10.56 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 171.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.224 -0.248 0 O-C-N 123.563 0.539 . . . . 0.0 109.692 179.928 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.122 0 CA-C-O 120.989 0.424 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 14.3 t -134.14 162.81 31.1 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 12.4 m -54.59 117.7 3.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.638 0.732 . . . . 0.0 110.679 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.64 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 39.6 t -51.23 120.95 5.48 Favored 'General case' 0 C--N 1.359 0.992 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.085 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 27.2 ptm -58.81 -23.18 60.07 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.609 0.719 . . . . 0.0 111.122 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.605 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 35.1 m-85 -103.23 -15.71 15.92 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 121.075 -1.016 . . . . 0.0 109.902 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.528 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 64.6 -131.74 37.76 Favored Glycine 0 CA--C 1.498 -1.028 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.797 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -75.75 -4.87 42.89 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 122.65 0.38 . . . . 0.0 111.214 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -86.86 -5.33 59.14 Favored 'General case' 0 C--O 1.248 1.022 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.715 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.701 ' SG ' ' NE2' ' A' ' 392' ' ' HIS . 6.4 p -81.2 123.58 28.57 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.649 0.738 . . . . 0.0 111.43 176.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -82.13 10.72 6.22 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.911 0.862 . . . . 0.0 110.95 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.55 HH21 ' ND2' ' A' ' 389' ' ' ASN . 31.4 mmm180 -84.02 124.09 30.7 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.13 174.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.491 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -116.46 -5.3 11.73 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.422 -176.595 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.55 ' ND2' HH21 ' A' ' 387' ' ' ARG . 20.7 p-10 -58.73 137.59 86.68 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.217 176.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -60.01 -24.19 75.68 Favored 'Trans proline' 0 CA--C 1.518 -0.297 0 C-N-CA 122.178 1.919 . . . . 0.0 111.252 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.546 HG12 ' NE2' ' A' ' 395' ' ' HIS . 93.4 t -66.62 -42.17 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.129 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.781 ' HE2' ' HE2' ' A' ' 398' ' ' HIS . 82.3 t60 -54.53 -35.05 62.78 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 120.381 -0.527 . . . . 0.0 110.459 178.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 24.6 m-85 -88.08 -24.04 23.54 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.771 -176.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -72.83 -20.26 61.17 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.949 -177.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.698 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 1.9 p80 -118.22 -8.71 10.58 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 176.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.698 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 88.0 m-85 -137.65 127.28 25.21 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.333 0.587 . . . . 0.0 110.767 176.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 46.2 m -85.78 159.2 19.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.964 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.781 ' HE2' ' HE2' ' A' ' 392' ' ' HIS . 39.2 m80 -128.1 153.02 78.52 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.811 -174.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -50.77 112.34 0.74 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.311 2.007 . . . . 0.0 112.701 -174.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 117.65 -5.57 16.62 Favored Glycine 0 C--O 1.237 0.34 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.075 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -95.67 145.41 25.29 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.322 0.582 . . . . 0.0 109.922 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 42.0 t -57.81 -30.91 66.08 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.293 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -94.29 2.61 55.85 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.758 -174.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 59.8 t80 . . . . . 0 C--N 1.321 -0.633 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.421 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.8 t70 . . . . . 0 N--CA 1.468 0.442 0 CA-C-O 121.414 0.626 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 35.8 t70 79.4 57.94 0.02 OUTLIER 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.252 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -175.75 152.89 1.35 Allowed Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.094 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.42 145.53 67.52 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.071 1.847 . . . . 0.0 112.203 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' GLU . . . . . 0.431 ' HG2' ' ND2' ' A' ' 441' ' ' ASN . 42.5 mt-10 -74.37 150.88 39.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 172.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 5.5 t -59.48 127.37 84.55 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 421' ' ' CYS . 50.9 Cg_exo -54.95 -23.6 35.51 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.344 2.029 . . . . 0.0 113.219 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 87.7 m-85 -102.34 18.01 22.08 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.239 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 59.03 -156.07 25.46 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.579 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . 0.411 ' HG3' ' HG ' ' A' ' 443' ' ' LEU . 57.0 Cg_endo -73.68 -9.68 22.83 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.654 2.236 . . . . 0.0 111.083 175.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 32.1 t -73.87 -8.86 57.68 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.52 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 23.1 t -62.94 115.64 4.58 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.399 0.619 . . . . 0.0 109.545 176.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -109.13 21.51 17.07 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.782 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 0.2 OUTLIER -64.02 92.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -68.79 91.44 0.45 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.851 0.834 . . . . 0.0 111.393 -174.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . 0.441 HD21 ' HB3' ' A' ' 433' ' ' GLN . 63.1 t30 -161.98 123.54 1.63 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.811 173.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.478 ' O ' HG13 ' A' ' 436' ' ' ILE . 33.4 Cg_endo -63.91 -36.52 49.4 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.752 2.302 . . . . 0.0 110.599 -178.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.668 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 22.4 tp60 -65.31 -37.01 85.82 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . 0.66 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 12.3 t60 -63.3 -49.35 74.37 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 121.683 0.754 . . . . 0.0 109.575 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.481 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 53.8 mtpt -66.72 -7.1 18.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.078 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 432' ' ' PRO . 42.6 mt -94.97 -42.94 12.85 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.752 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.668 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 22.8 mt-10 -68.76 -37.55 79.46 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.83 0.824 . . . . 0.0 110.555 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -117.55 138.66 51.76 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.551 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' ARG . . . . . 0.403 ' HG3' HD21 ' A' ' 441' ' ' ASN . 15.2 ptt180 -89.38 118.61 29.17 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.712 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 22.3 m80 -94.21 99.34 11.62 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' ASN . . . . . 0.431 ' ND2' ' HG2' ' A' ' 420' ' ' GLU . 35.6 m-80 -91.43 106.08 18.24 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.56 -175.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.98 138.32 39.57 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.552 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.5 OUTLIER -118.53 149.81 46.87 Favored Pre-proline 0 C--O 1.248 1.011 0 CA-C-O 120.963 0.411 . . . . 0.0 111.771 -171.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.52 -18.32 12.25 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 123.042 2.494 . . . . 0.0 111.859 175.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.552 ' HB ' HD13 ' A' ' 443' ' ' LEU . 10.0 p 43.03 30.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.245 0 CA-C-O 122.315 1.055 . . . . 0.0 111.715 -178.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -108.39 -33.37 7.1 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.509 -174.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -81.65 -27.79 33.92 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.128 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--O 1.206 -1.237 0 O-C-N 123.755 0.659 . . . . 0.0 109.669 179.508 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.235 0.298 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 12.6 t -101.83 149.38 24.25 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 9.7 t -57.93 111.86 1.3 Allowed 'General case' 0 C--O 1.244 0.796 0 O-C-N 123.355 0.41 . . . . 0.0 110.193 -171.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.782 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 30.9 t -51.36 108.96 0.29 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 14.5 ptp -60.43 -13.62 14.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.988 0.423 . . . . 0.0 110.665 -176.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.448 ' CB ' ' HB3' ' A' ' 385' ' ' CYS . 36.3 m-85 -93.59 -27.05 16.83 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.079 175.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.411 ' O ' ' HD2' ' A' ' 398' ' ' HIS . . . 60.28 -117.93 13.05 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.415 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -84.29 -9.67 58.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.17 -0.606 . . . . 0.0 111.505 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -78.95 -26.67 43.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.2 -176.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.782 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 13.5 p -73.87 111.57 9.15 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.426 172.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -84.98 12.39 7.66 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.38 0.609 . . . . 0.0 110.143 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -65.11 125.47 25.04 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 172.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.5 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.5 OUTLIER -119.72 0.75 10.98 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.028 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -66.05 133.86 94.83 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.117 173.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.9 -22.08 67.06 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.547 2.165 . . . . 0.0 112.292 -174.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.576 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 74.9 t -67.85 -38.32 79.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.129 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.75 ' HE2' ' HE2' ' A' ' 398' ' ' HIS . 85.0 t60 -62.88 -26.69 68.9 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 120.864 0.364 . . . . 0.0 110.051 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -92.46 -19.57 21.88 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.281 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -73.79 -23.69 59.72 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.872 -177.111 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.595 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 2.4 p80 -116.7 -11.89 10.93 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 177.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.595 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 93.8 m-85 -131.94 131.71 42.88 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 122.126 -0.359 . . . . 0.0 111.549 175.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 22.2 p -84.38 153.95 23.14 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.369 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.75 ' HE2' ' HE2' ' A' ' 392' ' ' HIS . 69.3 m80 -136.32 159.87 69.09 Favored Pre-proline 0 C--O 1.221 -0.44 0 O-C-N 122.339 -0.225 . . . . 0.0 110.524 -173.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 17.4 Cg_endo -54.43 103.08 0.09 OUTLIER 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.25 1.966 . . . . 0.0 111.614 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 129.62 -23.68 4.74 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -76.27 151.09 36.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.231 -0.484 . . . . 0.0 110.78 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 13.5 m -67.15 -22.83 65.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.523 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -110.99 15.56 21.66 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.285 -173.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 38.1 t80 . . . . . 0 C--N 1.319 -0.748 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.823 -178.944 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.7 t70 . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 36.7 t70 68.85 74.09 0.26 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.425 0.631 . . . . 0.0 110.181 -174.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.493 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 19.3 ptt180 -162.88 158.82 18.99 Favored Pre-proline 0 C--O 1.246 0.91 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 35.8 Cg_endo -63.32 136.57 56.07 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.644 2.229 . . . . 0.0 111.644 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' GLU . . . . . 0.435 ' HG2' ' HE ' ' A' ' 439' ' ' ARG . 51.7 mt-10 -70.58 147.76 48.91 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 121.797 -0.564 . . . . 0.0 110.121 175.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . 1.001 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 11.9 t -54.82 137.56 64.34 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.396 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.74 -14.38 26.46 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.158 1.906 . . . . 0.0 112.494 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -113.27 10.31 18.46 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.116 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 59.36 -151.19 36.21 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-O 119.598 -0.557 . . . . 0.0 111.85 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.14 -13.02 28.42 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.664 2.243 . . . . 0.0 112.344 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 38.0 t -79.87 1.24 27.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.485 176.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' CYS . . . . . 1.001 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 48.0 t -60.02 116.72 4.36 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.127 177.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -114.42 23.56 12.68 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.983 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -69.04 108.42 3.54 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.762 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -77.29 84.15 3.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.142 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 434' ' ' HIS . 61.5 t30 -156.47 121.07 2.39 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.428 175.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.445 ' O ' HG13 ' A' ' 436' ' ' ILE . 18.7 Cg_endo -58.76 -43.32 45.2 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.423 2.082 . . . . 0.0 112.708 -175.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.44 ' O ' ' HG2' ' A' ' 437' ' ' GLU . 28.9 tp60 -67.94 -26.35 65.92 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.93 0.769 . . . . 0.0 109.744 -175.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . 0.705 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 59.6 t60 -60.55 -59.37 5.5 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 122.816 0.446 . . . . 0.0 111.494 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -59.47 -25.6 64.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.668 0.27 . . . . 0.0 111.025 179.395 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 432' ' ' PRO . 67.0 mt -70.18 -46.46 72.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.007 0.432 . . . . 0.0 111.09 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 433' ' ' GLN . 11.8 mm-40 -76.31 -53.9 7.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.944 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -91.62 144.62 25.34 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.374 0.421 . . . . 0.0 110.516 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' ARG . . . . . 0.47 ' HB3' ' HG3' ' A' ' 418' ' ' ARG . 17.7 ptt180 -89.94 137.03 32.68 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.663 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 61.7 m80 -111.72 79.9 1.26 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.281 0.562 . . . . 0.0 109.674 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' ASN . . . . . 0.47 HD21 ' NE ' ' A' ' 439' ' ' ARG . 85.8 m-20 -74.86 129.45 37.7 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.069 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 17.2 p -86.56 140.4 29.92 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.804 -0.56 . . . . 0.0 109.841 -177.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.472 HD13 ' HB ' ' A' ' 445' ' ' VAL . 1.2 pp -109.04 151.84 42.15 Favored Pre-proline 0 C--N 1.312 -1.046 0 O-C-N 123.858 0.724 . . . . 0.0 110.114 -175.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.54 -49.06 4.8 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.288 1.992 . . . . 0.0 112.082 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.472 ' HB ' HD13 ' A' ' 443' ' ' LEU . 11.3 p 40.07 39.59 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.87 0.843 . . . . 0.0 109.751 -174.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -89.91 161.66 15.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.368 -173.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -56.52 -35.83 68.5 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.026 0.441 . . . . 0.0 110.739 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 C--O 1.252 1.199 0 CA-C-O 121.128 0.49 . . . . 0.0 111.821 176.751 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.592 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.441 -0.879 0 CA-C-O 121.399 0.619 . . . . 0.0 111.116 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 11.9 t -101.3 152.91 20.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.966 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 14.0 t -54.53 119.48 5.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.741 0.305 . . . . 0.0 111.723 -171.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 26.3 t -59.29 109.78 0.94 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 24.8 ptm -54.53 -29.86 51.94 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.364 -176.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.534 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 51.9 m-85 -98.23 -16.65 19.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.54 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 62.89 -116.26 9.14 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.874 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -90.34 7.79 36.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.854 0.359 . . . . 0.0 111.221 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -98.49 -22.55 15.95 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.447 0.299 . . . . 0.0 110.852 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 1.8 p -65.18 131.55 46.82 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.142 176.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -80.59 12.31 3.18 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.383 0.611 . . . . 0.0 112.067 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -92.66 112.16 24.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.649 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.442 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -100.05 -24.09 14.7 Favored 'General case' 0 C--O 1.221 -0.419 0 O-C-N 123.855 0.722 . . . . 0.0 109.316 -179.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -47.49 138.85 8.57 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.707 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.47 -21.82 69.48 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.453 2.102 . . . . 0.0 111.464 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.577 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 93.3 t -66.7 -36.91 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.436 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.656 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 82.1 t60 -58.66 -38.26 77.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.293 174.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -87.56 -4.99 58.95 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.923 -176.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.577 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -85.71 -24.48 26.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.039 -0.413 . . . . 0.0 110.465 178.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.422 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 1.2 p80 -110.96 -23.76 10.77 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.493 175.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.422 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 90.8 m-85 -120.27 129.03 53.86 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.597 0.713 . . . . 0.0 111.997 178.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.592 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 11.8 p -82.17 157.84 23.84 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.365 175.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.576 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 58.9 m80 -136.09 162.2 58.01 Favored Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -170.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.07 100.63 0.08 OUTLIER 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.778 2.318 . . . . 0.0 111.059 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 109.54 24.33 5.92 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.476 -174.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . 0.463 ' HB3' ' H ' ' A' ' 398' ' ' HIS . 20.7 t70 -119.97 150.5 40.42 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 122.303 0.241 . . . . 0.0 110.478 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 17.7 t -54.37 -41.1 68.78 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.277 0.631 . . . . 0.0 111.791 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -104.08 16.41 26.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.759 -167.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 19.9 t80 . . . . . 0 C--O 1.236 0.346 0 CA-C-O 120.531 0.205 . . . . 0.0 110.603 -179.12 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.48 ' HB2' ' HD3' ' A' ' 439' ' ' ARG . 2.1 m-20 . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 12.0 t70 81.98 50.81 0.02 OUTLIER 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.0 -174.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -153.25 158.59 32.77 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.026 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' A' ' 438' ' ' TYR . 80.4 Cg_exo -48.03 141.85 16.63 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.89 2.394 . . . . 0.0 112.69 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' GLU . . . . . 0.434 ' HG2' HD21 ' A' ' 441' ' ' ASN . 38.5 mt-10 -83.27 143.2 30.56 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . 0.777 ' HG ' ' CE1' ' A' ' 434' ' ' HIS . 34.8 t -59.61 126.96 84.18 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.22 7.12 1.21 Allowed 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.576 2.184 . . . . 0.0 112.835 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -120.31 5.1 10.73 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 64.9 -162.99 38.05 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.6 -15.34 27.4 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.008 2.472 . . . . 0.0 112.489 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 40.4 t -70.52 -13.16 62.0 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.044 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 46.6 t -48.66 118.02 2.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.836 0.854 . . . . 0.0 110.612 -178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -113.84 18.41 17.38 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 122.899 0.479 . . . . 0.0 109.918 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.478 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 4.3 mmp_? -66.52 96.58 0.38 Allowed 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.798 175.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' LYS . . . . . 0.525 ' HB2' ' NZ ' ' A' ' 430' ' ' LYS . 10.1 mtmp? -69.05 93.55 0.59 Allowed 'General case' 0 C--O 1.241 0.614 0 O-C-N 123.371 0.419 . . . . 0.0 110.283 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . 0.482 HD21 ' HB3' ' A' ' 433' ' ' GLN . 54.6 t30 -157.9 122.91 2.3 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.463 ' O ' HG13 ' A' ' 436' ' ' ILE . 33.4 Cg_endo -63.43 -35.74 59.29 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.487 2.125 . . . . 0.0 112.056 -177.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.64 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 23.4 tp60 -68.45 -41.62 79.97 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -175.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . 0.777 ' CE1' ' HG ' ' A' ' 421' ' ' CYS . 5.0 t60 -56.2 -51.2 68.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.433 0.635 . . . . 0.0 110.132 178.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -67.18 -13.76 62.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.402 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 432' ' ' PRO . 40.2 mt -89.84 -34.87 6.94 Favored 'Isoleucine or valine' 0 C--O 1.251 1.153 0 C-N-CA 122.704 0.402 . . . . 0.0 110.146 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.64 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 27.9 mt-10 -83.77 -45.54 13.22 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.298 0.571 . . . . 0.0 111.12 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 419' ' ' PRO . 19.1 m-85 -103.32 147.1 27.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.229 -174.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' ARG . . . . . 0.48 ' HD3' ' HB2' ' A' ' 416' ' ' ASP . 17.0 ptt180 -93.69 114.02 26.23 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.589 177.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.456 ' CD2' ' HB3' ' A' ' 427' ' ' CYS . 79.6 m80 -81.66 85.01 6.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' ASN . . . . . 0.434 HD21 ' HG2' ' A' ' 420' ' ' GLU . 89.0 m-20 -67.32 103.57 1.3 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.361 -173.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 1.5 m -104.47 159.35 15.81 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.132 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.557 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.5 OUTLIER -135.75 144.83 50.48 Favored Pre-proline 0 C--N 1.32 -0.684 0 O-C-N 121.66 -0.65 . . . . 0.0 111.828 -176.061 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -64.22 -29.21 64.34 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.435 2.757 . . . . 0.0 110.834 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.557 ' HB ' HD13 ' A' ' 443' ' ' LEU . 7.3 p 35.9 69.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 124.823 1.327 . . . . 0.0 110.591 -175.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -56.68 157.34 5.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.455 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -66.78 -26.77 67.12 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.104 0.877 . . . . 0.0 110.54 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.472 0.668 0 O-C-N 123.273 0.358 . . . . 0.0 110.917 179.432 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . 0.568 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 122.039 0.923 . . . . 0.0 110.683 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 5.4 t -96.2 153.65 17.68 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.233 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.1 m -64.22 122.67 17.2 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.075 0.464 . . . . 0.0 111.166 -170.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 15.4 t -49.92 123.61 8.42 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.729 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 20.8 ptm -56.0 -29.47 60.36 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.217 0.532 . . . . 0.0 111.072 -172.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . 0.554 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 39.2 m-85 -98.73 -14.85 19.58 Favored 'General case' 0 C--O 1.255 1.391 0 CA-C-O 119.051 -0.5 . . . . 0.0 110.439 176.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 62.49 -107.51 1.65 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -84.3 -13.71 51.73 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . 0.526 ' HB2' ' HB3' ' A' ' 381' ' ' TYR . 38.9 m-80 -81.49 -26.01 35.55 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -174.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.4 p -66.65 113.89 5.15 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.035 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -85.49 9.48 15.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.935 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 387' ' ' ARG . 27.8 mmt180 -62.46 134.13 55.99 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.957 176.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.527 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.3 OUTLIER -118.97 -7.64 10.36 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 124.105 0.878 . . . . 0.0 110.406 -171.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -67.47 137.09 93.33 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.057 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -60.68 -30.67 90.89 Favored 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 121.576 1.517 . . . . 0.0 110.946 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.402 HG12 ' NE2' ' A' ' 395' ' ' HIS . 87.9 t -59.17 -40.68 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.896 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.691 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 85.6 t60 -54.95 -43.9 73.85 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 120.771 0.319 . . . . 0.0 110.441 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -82.23 -25.15 34.4 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.493 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -66.67 -27.88 68.01 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.686 0.279 . . . . 0.0 110.783 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.634 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 1.1 p80 -119.09 -3.98 10.6 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.634 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 39.6 m-85 -139.33 126.59 21.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.442 0.639 . . . . 0.0 109.989 177.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.568 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 70.7 m -83.46 158.63 21.98 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 123.261 0.624 . . . . 0.0 111.031 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.614 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 27.0 m80 -127.65 162.03 51.62 Favored Pre-proline 0 C--O 1.222 -0.354 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 14.8 Cg_endo -55.11 106.34 0.18 Allowed 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 121.829 1.686 . . . . 0.0 111.219 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 120.03 -1.14 13.28 Favored Glycine 0 C--N 1.319 -0.368 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.47 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -94.98 148.98 21.74 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.7 t -62.48 -30.4 71.23 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.402 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.99 2.4 51.46 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 110.726 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 58.2 t80 . . . . . 0 N--CA 1.465 0.292 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.591 178.927 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 C--O 1.241 0.636 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 21.7 t70 175.32 -27.75 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.66 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.422 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 24.1 ptt180 -138.17 165.67 31.61 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.977 -174.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 62.1 Cg_endo -75.72 162.52 35.15 Favored 'Trans proline' 0 C--O 1.244 0.783 0 C-N-CA 121.221 1.281 . . . . 0.0 110.957 177.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.64 158.27 33.92 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.689 0.757 . . . . 0.0 109.502 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 6.6 t -65.86 136.7 95.81 Favored Pre-proline 0 N--CA 1.453 -0.305 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 175.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.17 -16.92 42.95 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.269 1.313 . . . . 0.0 112.772 -177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -115.11 15.71 17.08 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.851 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 57.72 -152.03 27.97 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.995 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.45 -14.8 34.24 Favored 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 121.973 1.782 . . . . 0.0 111.535 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 19.9 t -82.08 2.2 32.33 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.92 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 49.8 t -60.25 124.17 19.46 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.362 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -121.56 66.42 0.89 Allowed 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.563 0.697 . . . . 0.0 110.117 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.463 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 2.3 mmp_? -108.8 108.79 19.73 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' LYS . . . . . 0.469 ' HB2' ' NZ ' ' A' ' 430' ' ' LYS . 4.8 ttmp? -70.13 82.06 0.51 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.057 -0.402 . . . . 0.0 110.741 -176.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . 0.526 HD21 ' HB3' ' A' ' 433' ' ' GLN . 60.8 t30 -166.36 123.99 1.04 Allowed Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 123.012 0.525 . . . . 0.0 110.247 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.517 ' O ' HG13 ' A' ' 436' ' ' ILE . 42.6 Cg_endo -68.2 -32.56 26.76 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.088 1.859 . . . . 0.0 112.3 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.647 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 23.6 tp60 -68.94 -36.23 77.72 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.935 -0.478 . . . . 0.0 109.845 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . 0.67 ' CE1' ' SG ' ' A' ' 421' ' ' CYS . 39.9 t60 -53.59 -56.1 20.02 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.023 0.916 . . . . 0.0 110.579 176.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.4 ' HA ' ' HE1' ' A' ' 440' ' ' HIS . 24.2 mtpp -60.46 -16.51 37.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.761 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 432' ' ' PRO . 58.1 mt -87.81 -28.86 5.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.426 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.647 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 29.1 mt-10 -90.33 -32.95 16.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.757 -175.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -114.39 129.75 56.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.13 0.491 . . . . 0.0 109.818 -174.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 419' ' ' PRO . 15.7 ptt180 -79.13 118.9 21.53 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.007 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.761 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 66.5 m80 -98.96 90.58 4.68 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -67.3 107.75 2.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.655 0.74 . . . . 0.0 110.452 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 1.3 p -99.32 122.89 43.08 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.252 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . 0.42 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.4 OUTLIER -133.16 157.09 79.13 Favored Pre-proline 0 C--O 1.215 -0.711 0 O-C-N 123.933 0.771 . . . . 0.0 110.02 -173.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' PRO . . . . . 0.404 ' O ' HG12 ' A' ' 445' ' ' VAL . 18.5 Cg_endo -56.17 -37.68 96.17 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 121.713 1.609 . . . . 0.0 111.584 -174.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.42 ' HB ' HD13 ' A' ' 443' ' ' LEU . 5.3 p 46.84 20.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.051 1.34 . . . . 0.0 112.633 177.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 47.0 mmt-85 -68.79 128.99 38.63 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.379 -0.826 . . . . 0.0 110.452 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -84.39 -17.53 39.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.393 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 C--O 1.237 0.406 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.067 178.482 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.296 0 CA-C-O 120.923 0.392 . . . . 0.0 111.57 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 6.2 t -130.89 165.71 22.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.816 175.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 16.4 m -59.53 113.02 2.0 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -172.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 49.1 t -52.55 114.9 1.53 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 26.7 ptm -53.29 -26.94 20.38 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.239 -173.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -91.73 -25.43 19.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 61.55 -115.9 8.58 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.116 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' ALA . . . . . 0.44 ' HB2' ' HG3' ' A' ' 399' ' ' PRO . . . -79.37 -6.25 56.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.919 0.39 . . . . 0.0 111.086 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -87.87 -28.68 21.43 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -173.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 4.8 p -71.39 129.65 39.34 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -94.42 17.22 13.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.449 -174.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -70.26 145.27 51.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' LYS . . . . . 0.561 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -130.52 -1.08 4.4 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.086 0.469 . . . . 0.0 110.136 178.388 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -76.89 134.76 68.1 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.57 -20.49 70.88 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.716 2.277 . . . . 0.0 111.467 -173.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.591 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 59.2 t -66.21 -44.32 91.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.745 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' HIS . . . . . 0.581 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 84.3 t60 -57.47 -28.01 62.99 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.027 0.441 . . . . 0.0 110.111 178.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 81.6 m-85 -96.47 -13.9 22.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.879 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.591 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -76.46 -18.68 58.66 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.617 -176.125 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' HIS . . . . . 0.558 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 6.8 p80 -122.81 -21.66 5.52 Favored 'General case' 0 C--O 1.245 0.816 0 O-C-N 123.167 0.292 . . . . 0.0 111.698 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' PHE . . . . . 0.558 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 48.0 m-85 -128.11 126.82 41.9 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 117.799 0.272 . . . . 0.0 111.044 176.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' SER . . . . . 0.422 ' OG ' ' HB2' ' A' ' 403' ' ' ASP . 68.9 m -87.88 165.17 15.46 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.415 0.626 . . . . 0.0 111.238 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' HIS . . . . . 0.668 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 42.7 m80 -132.72 164.56 42.86 Favored Pre-proline 0 C--O 1.233 0.23 0 C-N-CA 123.173 0.589 . . . . 0.0 110.117 -174.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 19.0 Cg_endo -55.03 93.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.072 2.515 . . . . 0.0 111.152 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 132.58 15.3 1.42 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.07 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -121.46 149.11 43.53 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 34.7 t -63.24 -33.01 74.56 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.481 0.312 . . . . 0.0 111.114 -174.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' ASP . . . . . 0.422 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 1.5 m-20 -90.73 9.73 28.79 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.188 0.518 . . . . 0.0 111.288 -175.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 55.9 t80 . . . . . 0 N--CA 1.456 -0.169 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.343 175.476 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 22.0 t70 . . . . . 0 C--O 1.237 0.403 0 CA-C-O 121.564 0.697 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -142.85 10.61 1.79 Allowed 'General case' 0 C--N 1.347 0.465 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 29.1 ptt180 -173.2 159.23 3.39 Favored Pre-proline 0 C--O 1.242 0.683 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.579 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.423 ' O ' ' HG2' ' A' ' 439' ' ' ARG . 55.4 Cg_endo -68.56 154.8 70.88 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.029 2.486 . . . . 0.0 112.38 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -74.54 143.35 44.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.894 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 11.6 t -57.84 133.68 83.2 Favored Pre-proline 0 C--N 1.317 -0.829 0 O-C-N 123.8 0.687 . . . . 0.0 109.571 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.7 -16.09 46.33 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 121.79 1.66 . . . . 0.0 113.092 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 29.3 m-85 -112.94 12.58 19.38 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 122.732 0.413 . . . . 0.0 110.033 179.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 56.57 -148.76 29.97 Favored Glycine 0 C--O 1.248 1.006 0 C-N-CA 121.321 -0.466 . . . . 0.0 113.162 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.18 -14.23 28.64 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.883 2.388 . . . . 0.0 112.044 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 34.1 t -76.04 -10.49 59.46 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.609 177.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 51.2 t -58.33 118.48 5.58 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.37 177.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -119.49 22.58 11.63 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 124.101 0.876 . . . . 0.0 109.774 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' ARG . . . . . 0.811 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 0.5 OUTLIER -63.74 109.41 1.7 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -71.51 94.55 1.3 Allowed 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.674 0.608 . . . . 0.0 111.151 -177.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . 0.52 HD21 ' HB3' ' A' ' 433' ' ' GLN . 63.3 t30 -169.47 124.88 0.73 Allowed Pre-proline 0 N--CA 1.469 0.481 0 O-C-N 124.437 1.086 . . . . 0.0 108.832 176.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.509 ' O ' HG13 ' A' ' 436' ' ' ILE . 34.3 Cg_endo -65.45 -33.58 46.45 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.39 2.06 . . . . 0.0 111.53 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' GLN . . . . . 0.587 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 24.2 tp60 -68.6 -32.3 72.09 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.07 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . 0.723 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 41.8 t60 -62.71 -58.22 8.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.484 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -55.36 -19.74 9.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.501 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 432' ' ' PRO . 64.5 mt -80.64 -42.64 20.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 O-C-N 123.724 0.64 . . . . 0.0 109.812 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 22.3 mt-10 -78.74 -46.97 17.74 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 -174.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -106.45 135.36 48.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.43 0.633 . . . . 0.0 110.678 -174.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 419' ' ' PRO . 16.0 ptt180 -84.78 133.85 34.34 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.55 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.681 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 63.0 m80 -107.12 85.68 2.18 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.247 0.546 . . . . 0.0 109.853 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -70.65 117.65 12.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.673 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 1.9 m -129.81 152.73 48.99 Favored 'General case' 0 C--O 1.247 0.926 0 O-C-N 123.712 0.632 . . . . 0.0 110.412 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 1.1 pp -106.22 154.85 39.42 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' PRO . . . . . 0.443 ' O ' HG12 ' A' ' 445' ' ' VAL . 12.7 Cg_endo -55.46 -39.71 89.55 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.475 2.117 . . . . 0.0 112.981 -173.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 444' ' ' PRO . 4.4 p 49.42 21.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 124.497 1.123 . . . . 0.0 111.277 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' ARG . . . . . 0.461 ' HG3' ' ND2' ' A' ' 447' ' ' ASN . 28.3 tpt180 -137.82 149.78 46.63 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -176.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . 0.461 ' ND2' ' HG3' ' A' ' 446' ' ' ARG . 59.7 m-80 65.5 20.28 11.67 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.902 0.881 . . . . 0.0 111.056 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 CA--C 1.542 0.67 0 CA-C-O 120.918 0.39 . . . . 0.0 110.867 -177.377 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.301 0 N-CA-C 112.165 -0.374 . . . . 0.0 112.165 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 12.6 p -96.99 -179.83 4.68 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -67.85 92.09 0.34 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -101.45 114.24 28.07 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 124.451 1.094 . . . . 0.0 110.632 -176.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 65.8 m -88.32 -5.39 58.36 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.935 0.397 . . . . 0.0 110.899 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -53.04 121.45 7.42 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 121.195 0.522 . . . . 0.0 110.255 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 14.3 m -91.3 153.48 19.91 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.373 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 42.9 t -70.37 92.8 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 CA-C-O 121.177 0.513 . . . . 0.0 110.43 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . 0.572 ' H ' HD23 ' A' ' 366' ' ' LEU . 2.5 pt? -99.45 -18.58 17.39 Favored 'General case' 0 C--O 1.25 1.1 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.585 177.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -72.44 131.7 42.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.472 0.654 . . . . 0.0 109.943 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 161.0 -166.21 35.55 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 44.1 m -77.2 -18.21 57.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.69 0.396 . . . . 0.0 110.507 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -95.63 31.35 2.06 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.931 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -79.12 56.43 4.35 Favored Glycine 0 C--O 1.245 0.79 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 175.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . 0.4 ' ND2' ' H ' ' A' ' 372' ' ' ASN . 0.2 OUTLIER -84.71 175.08 9.42 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 122.914 0.486 . . . . 0.0 110.632 179.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.561 ' HD3' HG13 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -89.41 0.79 56.59 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.96 -172.339 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.561 HG13 ' HD3' ' A' ' 373' ' ' LYS . 12.6 m -147.37 159.47 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 123.85 0.719 . . . . 0.0 109.696 175.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -101.61 128.4 47.9 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 124.121 0.888 . . . . 0.0 109.412 174.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.545 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 2.6 mpp_? -68.64 172.6 6.05 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.07 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 395' ' ' HIS . 4.9 t -98.14 141.09 31.5 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.985 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.485 ' HB3' ' O ' ' A' ' 410' ' ' VAL . 19.3 t -55.96 121.34 9.1 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 123.071 0.232 . . . . 0.0 111.412 -176.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.708 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 10.6 t -54.18 103.02 0.07 Allowed 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 172.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . 0.48 ' HB3' HG13 ' A' ' 410' ' ' VAL . 20.9 ptm -49.78 -27.64 5.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.836 0.71 . . . . 0.0 111.845 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.567 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 28.9 m-85 -93.68 -19.42 21.12 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.669 -0.644 . . . . 0.0 111.355 176.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.507 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 64.94 -126.17 31.39 Favored Glycine 0 CA--C 1.501 -0.809 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -80.59 0.29 34.66 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.928 0.394 . . . . 0.0 111.531 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -94.18 -7.29 42.65 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.062 -177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.84 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 7.6 p -74.49 128.09 34.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.371 0.605 . . . . 0.0 110.141 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -81.98 2.99 28.25 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.873 -175.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -87.82 115.92 25.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.697 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.443 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -117.42 2.35 12.44 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.01 0.91 . . . . 0.0 109.855 -177.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -63.15 136.57 96.75 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.678 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.69 -28.9 48.91 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.138 2.558 . . . . 0.0 112.921 -173.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.509 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 53.3 t -61.93 -37.04 77.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.338 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.706 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 72.7 t60 -58.42 -29.14 65.87 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.349 0.595 . . . . 0.0 110.997 178.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -93.3 -18.5 22.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.49 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -74.86 -20.04 59.91 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.374 0.607 . . . . 0.0 110.972 -175.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.467 ' O ' HG22 ' A' ' 377' ' ' THR . 7.2 p80 -121.57 -15.87 7.9 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.313 -0.867 . . . . 0.0 111.554 176.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 377' ' ' THR . 59.1 m-85 -121.07 136.78 54.91 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.135 0.493 . . . . 0.0 112.016 173.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.545 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 19.6 m -93.17 149.86 20.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.661 176.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.655 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 37.9 m80 -124.96 160.64 53.37 Favored Pre-proline 0 N--CA 1.466 0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.19 -175.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 25.7 Cg_endo -59.34 93.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.315 2.01 . . . . 0.0 111.446 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 144.41 -13.05 2.04 Favored Glycine 0 CA--C 1.507 -0.443 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -84.02 145.84 28.28 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.132 -0.534 . . . . 0.0 110.735 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 16.0 m -66.9 -26.38 66.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.084 176.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -86.68 -4.16 59.14 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.756 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -77.42 138.02 39.03 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.575 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -130.67 -50.2 0.11 Allowed Glycine 0 C--O 1.242 0.622 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 73.91 9.0 79.14 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.49 -0.386 . . . . 0.0 112.746 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.7 m -93.59 -6.37 10.44 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 CA-C-N 116.975 0.387 . . . . 0.0 111.509 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.47 ' NE2' ' HB ' ' A' ' 410' ' ' VAL . 6.3 tt0 -77.64 150.4 34.59 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 123.676 0.79 . . . . 0.0 110.053 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 410' ' ' VAL . 28.0 pt -51.29 -44.85 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.522 175.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 378' ' ' SER . 46.6 t -75.22 95.61 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.344 171.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 138.57 -31.7 2.38 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.084 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 4.2 pt20 -115.08 -50.08 2.77 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.789 0.294 . . . . 0.0 110.734 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.4 ' N ' ' HG3' ' A' ' 412' ' ' GLN . 7.0 t70 174.56 141.56 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.515 0.51 . . . . 0.0 110.074 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -117.4 -9.6 10.86 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.897 -174.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.613 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 74.1 p -105.36 -49.96 3.33 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -168.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 415' ' ' THR . 22.6 t70 68.27 -64.96 0.28 Allowed 'General case' 0 C--N 1.318 -0.792 0 O-C-N 124.036 0.835 . . . . 0.0 110.906 -172.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -156.5 -25.15 0.1 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.004 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.792 ' HG3' ' HG2' ' A' ' 439' ' ' ARG . 16.3 ptt180 -158.99 170.2 9.31 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 119.4 -0.334 . . . . 0.0 110.893 -168.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 23.3 Cg_endo -61.38 151.34 80.14 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.192 1.928 . . . . 0.0 111.926 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' GLU . . . . . 0.631 ' HG2' ' HE ' ' A' ' 439' ' ' ARG . 44.1 mt-10 -87.67 142.29 27.95 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.998 0.428 . . . . 0.0 110.918 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 9.3 t -66.75 121.7 78.81 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.68 -10.46 24.79 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.67 2.247 . . . . 0.0 112.076 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -104.55 -3.41 23.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.57 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 69.39 -152.04 51.49 Favored Glycine 0 C--O 1.223 -0.559 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.352 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -76.18 -11.69 19.35 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.8 2.334 . . . . 0.0 111.216 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 32.1 t -85.09 8.14 19.09 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.238 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 36.5 t -60.17 117.29 4.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.613 0.721 . . . . 0.0 110.851 177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -100.16 11.52 39.15 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.311 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.681 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 0.7 OUTLIER -66.41 109.31 2.68 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.264 176.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -85.02 86.81 7.35 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.35 0.66 . . . . 0.0 110.533 -172.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . 0.494 HD21 ' HB3' ' A' ' 433' ' ' GLN . 65.0 t30 -166.45 125.69 1.14 Allowed Pre-proline 0 C--N 1.329 -0.287 0 C-N-CA 122.559 0.344 . . . . 0.0 110.874 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.454 ' O ' HG13 ' A' ' 436' ' ' ILE . 29.8 Cg_endo -64.67 -35.45 46.81 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.752 1.635 . . . . 0.0 111.864 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.63 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 25.2 tp60 -64.58 -37.66 88.34 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.358 0.599 . . . . 0.0 110.909 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . 0.677 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.6 t60 -57.93 -51.51 69.32 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.652 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.452 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 24.8 mtpp -58.77 -23.8 60.67 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.716 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 432' ' ' PRO . 82.0 mt -80.31 -36.92 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.194 0.521 . . . . 0.0 110.414 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.63 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 24.0 mt-10 -84.34 -34.79 23.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.346 -173.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 419' ' ' PRO . 57.2 m-85 -108.75 154.87 21.43 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.686 -174.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' ARG . . . . . 0.792 ' HG2' ' HG3' ' A' ' 418' ' ' ARG . 11.9 mtm180 -91.37 120.03 31.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.705 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 78.6 m80 -92.4 78.54 5.03 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 173.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' ASN . . . . . 0.623 HD21 ' NH2' ' A' ' 439' ' ' ARG . 1.7 m-20 -63.37 106.28 0.88 Allowed 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 113.818 -1.537 . . . . 0.0 110.505 -171.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.95 138.36 31.48 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.52 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.8 OUTLIER -108.44 144.93 30.5 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.287 -174.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.61 -44.18 18.58 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.392 2.061 . . . . 0.0 111.342 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.52 ' HB ' HD13 ' A' ' 443' ' ' LEU . 8.2 p 41.85 27.73 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 124.686 1.242 . . . . 0.0 110.81 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.46 158.12 16.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.677 -174.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -116.03 79.76 1.35 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.725 0.774 . . . . 0.0 110.016 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.471 0.6 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.526 -179.812 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' ' ZN' . . . . . 0.84 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' ' ZN' . . . . . 0.833 'ZN ' ' HG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 417' ' ' ASP . . . . . . . . 0 N--CA 1.484 1.896 0 N-CA-C 112.152 -0.379 . . . . 0.0 112.152 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.1 m -154.59 143.8 21.18 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.927 0.364 . . . . 0.0 111.758 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 360' ' ' LYS . 0.0 OUTLIER -162.94 110.65 1.25 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.47 169.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -133.39 168.43 18.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 122.416 0.286 . . . . 0.0 110.591 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 66.9 p -94.32 139.4 31.12 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 124.048 0.842 . . . . 0.0 110.948 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -83.23 -36.02 24.93 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.387 0.613 . . . . 0.0 110.37 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 14.5 m -75.28 95.5 3.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.78 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 365' ' ' VAL . 7.7 p -81.65 79.85 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 122.031 0.919 . . . . 0.0 109.94 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 366' ' ' LEU . 2.5 pt? -84.46 -14.03 50.38 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.162 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -60.6 99.11 0.08 Allowed 'General case' 0 C--O 1.248 1.019 0 O-C-N 123.631 0.582 . . . . 0.0 110.205 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 165.75 43.82 0.02 OUTLIER Glycine 0 C--O 1.238 0.403 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 18.4 m -146.11 19.91 1.41 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.322 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -61.89 134.58 56.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.518 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -150.49 26.38 1.08 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -106.37 149.0 27.42 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.738 ' N ' ' HE2' ' A' ' 373' ' ' LYS . 0.3 OUTLIER -76.17 -27.08 56.82 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 16.3 m -114.26 157.71 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.769 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.67 156.16 25.26 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.806 175.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.584 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -107.93 172.84 6.61 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 122.312 0.245 . . . . 0.0 111.373 -178.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.467 HG23 ' CD1' ' A' ' 396' ' ' PHE . 9.7 t -108.2 163.3 13.29 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.06 0.85 . . . . 0.0 109.49 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 16.2 m -62.24 119.52 9.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.981 0.896 . . . . 0.0 111.764 -174.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.793 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 33.7 t -52.71 119.48 4.61 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.849 0.86 . . . . 0.0 109.114 174.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . 0.499 ' O ' HG12 ' A' ' 410' ' ' VAL . 26.3 ptm -56.24 -23.73 37.84 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.327 0.584 . . . . 0.0 111.952 -173.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 34.6 m-85 -104.96 -16.18 14.91 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.244 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.432 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 64.91 -121.71 22.43 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.6 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . 0.446 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -82.88 4.7 24.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.927 0.363 . . . . 0.0 111.132 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -96.6 -14.7 22.0 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.809 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 1.8 p -73.58 127.12 31.87 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.561 -0.712 . . . . 0.0 110.732 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -81.58 -4.92 57.38 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.084 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -60.05 128.21 35.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.538 0.685 . . . . 0.0 109.623 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.617 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.2 OUTLIER -112.05 -15.71 13.22 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.56 -173.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -62.83 134.76 95.66 Favored Pre-proline 0 C--O 1.243 0.73 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.578 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.59 -22.85 75.45 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.501 2.134 . . . . 0.0 111.343 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.596 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 77.8 t -62.92 -35.9 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.214 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.654 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 83.9 t60 -61.43 -30.58 70.66 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.285 0.365 . . . . 0.0 110.339 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 54.6 m-85 -90.27 -24.79 20.82 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.749 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.596 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -71.1 -20.23 62.37 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.804 -175.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.563 ' ND1' ' HD2' ' A' ' 396' ' ' PHE . 1.9 p80 -119.68 -11.98 9.33 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.563 ' HD2' ' ND1' ' A' ' 395' ' ' HIS . 63.1 m-85 -138.52 126.55 22.62 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 177.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.584 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 58.0 m -86.73 160.66 18.76 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.355 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.713 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 32.4 m80 -127.83 165.63 28.97 Favored Pre-proline 0 N--CA 1.466 0.371 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.668 -173.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.446 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 50.2 Cg_exo -54.74 -2.56 0.2 Allowed 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 123.488 2.792 . . . . 0.0 114.152 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -119.15 13.11 11.29 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 111.964 -0.455 . . . . 0.0 111.964 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -121.85 131.08 53.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.9 t -62.57 -20.63 64.9 Favored 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -170.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.18 -7.52 59.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.405 0.621 . . . . 0.0 110.986 -177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -70.73 131.54 44.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.61 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -135.74 5.0 4.03 Favored Glycine 0 C--O 1.22 -0.721 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.065 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 52.7 54.03 29.95 Favored Glycine 0 C--O 1.243 0.712 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.594 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 33.5 m -88.04 -20.79 7.27 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 122.398 0.279 . . . . 0.0 110.824 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -117.06 124.89 50.38 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.641 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.433 HG13 ' N ' ' A' ' 410' ' ' VAL . 13.7 pt -48.3 -43.72 12.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 O-C-N 123.588 0.555 . . . . 0.0 111.217 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.889 ' HA ' ' HG3' ' A' ' 414' ' ' GLU . 8.5 t -68.25 103.09 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 151.64 -45.13 0.63 Allowed Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.508 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.445 ' HG2' ' OD1' ' A' ' 413' ' ' ASP . 5.8 pm0 -126.4 -30.37 2.87 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.779 -0.248 . . . . 0.0 111.123 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.445 ' OD1' ' HG2' ' A' ' 412' ' ' GLN . 3.8 p30 -155.98 97.52 1.82 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.819 0.819 . . . . 0.0 110.972 175.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . 0.889 ' HG3' ' HA ' ' A' ' 410' ' ' VAL . 17.6 mp0 -87.18 -25.98 23.78 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.079 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 59.9 p -62.98 169.25 3.42 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.044 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 417' ' ' ASP . 19.4 t70 -58.99 -23.26 61.69 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.034 -178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.458 ' HB3' ' O ' ' A' ' 416' ' ' ASP . 9.0 t0 78.07 79.04 0.07 Allowed 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.838 175.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.455 ' HG3' ' CG ' ' A' ' 439' ' ' ARG . 14.7 ptt180 -178.48 157.23 1.02 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.867 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.26 147.02 94.18 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.299 2.0 . . . . 0.0 111.342 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -73.74 159.23 33.26 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.908 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 7.8 t -64.22 132.27 95.27 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.4 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.88 -12.02 29.8 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.371 2.047 . . . . 0.0 112.256 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 37.0 m-85 -106.47 11.79 30.34 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.087 0.555 . . . . 0.0 110.709 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 56.6 -153.22 20.04 Favored Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.621 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.99 -9.9 19.51 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.335 2.023 . . . . 0.0 110.817 176.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 35.9 t -70.71 -14.85 62.61 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 173.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' CYS . . . . . 0.908 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 54.0 t -52.43 117.36 2.8 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.143 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -116.31 19.69 14.67 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.542 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 1.7 mmp_? -63.97 103.12 0.55 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.887 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -77.63 105.58 8.88 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.784 0.677 . . . . 0.0 109.69 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . 0.528 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 62.7 t30 -178.36 127.75 0.28 Allowed Pre-proline 0 C--O 1.244 0.768 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.933 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.528 ' HD2' ' OD1' ' A' ' 431' ' ' ASN . 19.9 Cg_endo -58.72 -44.55 35.5 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.339 2.692 . . . . 0.0 111.61 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.45 ' HB3' ' ND2' ' A' ' 431' ' ' ASN . 23.1 tp60 -59.47 -34.12 72.16 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-O 120.973 0.415 . . . . 0.0 110.398 -177.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . 0.689 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 61.9 t60 -63.06 -62.31 1.79 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.742 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -60.33 -15.34 24.59 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 178.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 432' ' ' PRO . 60.1 mt -75.85 -47.22 33.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.834 174.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -78.54 -45.47 21.77 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.887 -0.508 . . . . 0.0 112.238 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -107.32 155.39 20.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.824 -0.548 . . . . 0.0 112.239 -171.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' ARG . . . . . 0.455 ' CG ' ' HG3' ' A' ' 418' ' ' ARG . 54.2 mtm180 -94.25 153.53 17.99 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.636 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.581 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 75.2 m80 -128.97 80.42 1.97 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 175.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -84.03 139.09 32.74 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.004 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 3.9 p -101.75 130.19 48.1 Favored 'General case' 0 C--O 1.247 0.948 0 O-C-N 123.311 0.382 . . . . 0.0 111.873 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 443' ' ' LEU . 1.3 pp -108.79 151.01 41.55 Favored Pre-proline 0 C--N 1.315 -0.913 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.3 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -63.27 -30.39 73.73 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 C-N-CA 122.075 1.85 . . . . 0.0 112.216 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 9.2 p 44.27 31.0 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 C-N-CA 124.847 1.259 . . . . 0.0 111.691 -177.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -87.96 165.35 15.28 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.939 -175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -43.71 -58.35 2.74 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.895 0.878 . . . . 0.0 111.029 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--N 1.343 0.308 0 C-N-CA 122.583 0.353 . . . . 0.0 111.054 -177.0 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' ' ZN' . . . . . 0.809 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' ' ZN' . . . . . 0.843 'ZN ' ' HG ' ' A' ' 421' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.903 0 N-CA-C 111.314 -0.715 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 20.4 m -69.07 -39.97 78.76 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.002 0.43 . . . . 0.0 110.528 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -82.51 -68.05 0.73 Allowed 'General case' 0 C--O 1.245 0.854 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.886 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -84.45 116.46 23.1 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 122.967 0.507 . . . . 0.0 109.995 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 33.0 p -62.93 143.81 57.33 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 122.683 0.393 . . . . 0.0 111.029 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.06 -48.35 18.09 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 122.808 0.443 . . . . 0.0 110.214 -177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 23.1 t -82.34 -177.92 6.85 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.1 p -97.44 129.24 47.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 122.865 0.466 . . . . 0.0 111.316 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 3.6 pp -113.04 -12.62 13.19 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.319 174.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -70.91 -12.48 61.56 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.421 0.629 . . . . 0.0 110.155 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -110.13 53.42 0.58 Allowed Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.411 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 23.1 t -146.99 97.0 2.83 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -120.56 142.47 49.33 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 124.257 0.973 . . . . 0.0 110.053 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 93.44 -50.94 2.39 Favored Glycine 0 C--O 1.236 0.273 0 O-C-N 123.5 0.5 . . . . 0.0 112.234 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -72.28 129.04 37.49 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.633 -0.334 . . . . 0.0 110.908 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.574 ' HG2' HG13 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -107.44 -16.55 14.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.744 0.307 . . . . 0.0 110.63 179.412 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.574 HG13 ' HG2' ' A' ' 373' ' ' LYS . 26.9 m -124.53 171.37 13.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.274 177.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.77 164.56 30.15 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.329 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.42 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.4 OUTLIER -100.05 166.64 10.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.339 0.59 . . . . 0.0 111.591 -176.474 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 6.0 t -115.11 152.01 33.31 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 173.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 49.3 m -55.54 123.69 14.82 Favored 'General case' 0 C--N 1.32 -0.691 0 O-C-N 123.979 0.799 . . . . 0.0 112.032 -172.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.875 ' HG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 26.5 t -60.36 118.49 6.5 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . 0.519 ' HB3' HG12 ' A' ' 410' ' ' VAL . 22.7 ptm -54.66 -33.49 60.78 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-O 121.464 0.649 . . . . 0.0 111.388 -175.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.578 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 41.3 m-85 -96.92 -10.49 26.27 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.579 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.531 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 62.38 -129.09 42.44 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . 0.421 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -80.28 -3.33 48.91 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.063 0.459 . . . . 0.0 111.182 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -84.63 -16.48 41.85 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.227 -175.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.823 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 3.0 p -69.43 141.03 54.15 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.451 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -78.93 9.34 4.37 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 122.791 0.437 . . . . 0.0 111.461 -174.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -93.79 111.18 22.83 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.671 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.441 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -105.59 -21.3 13.23 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.212 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -46.98 131.41 8.88 Favored Pre-proline 0 C--O 1.238 0.451 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.959 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.49 -25.53 58.81 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 123.749 2.966 . . . . 0.0 111.602 -174.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.516 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 64.6 t -65.8 -34.7 72.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.279 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.638 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 73.3 t60 -59.87 -26.5 65.91 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.301 -0.875 . . . . 0.0 110.088 175.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 38.4 m-85 -93.68 -5.49 48.44 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.586 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -88.67 -23.14 23.09 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.046 -178.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.43 ' HD2' ' HG3' ' A' ' 394' ' ' GLN . 4.9 p80 -116.02 -18.68 10.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.067 0.46 . . . . 0.0 111.913 175.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 393' ' ' PHE . 69.2 m-85 -125.29 128.51 48.35 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.761 174.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' A' ' 404' ' ' TYR . 14.2 p -80.26 159.04 26.01 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.477 176.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.704 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 53.7 m80 -139.53 158.15 68.97 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.868 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.421 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 10.6 Cg_endo -51.07 107.9 0.2 Allowed 'Trans proline' 0 C--N 1.359 1.098 0 C-N-CA 121.887 1.725 . . . . 0.0 110.379 -177.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 118.45 0.81 15.97 Favored Glycine 0 C--N 1.316 -0.552 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.698 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . 0.428 ' HB3' ' HB2' ' A' ' 404' ' ' TYR . 20.1 t70 -97.63 141.82 30.19 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 123.04 0.536 . . . . 0.0 109.864 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 43.4 t -58.9 -26.18 64.08 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.939 0.774 . . . . 0.0 111.505 -176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -110.84 19.47 18.53 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.773 -174.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.452 ' HB2' ' HB2' ' A' ' 397' ' ' SER . 63.5 t80 -97.76 132.57 43.26 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.605 -0.684 . . . . 0.0 110.446 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -136.86 -34.12 0.22 Allowed Glycine 0 CA--C 1.505 -0.553 0 O-C-N 123.478 0.486 . . . . 0.0 111.968 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 78.42 14.38 82.23 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.834 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 33.5 m -88.48 -9.03 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 122.624 -0.339 . . . . 0.0 110.259 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' A' ' 412' ' ' GLN . 6.5 tt0 -68.82 145.76 53.46 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.453 HG13 ' N ' ' A' ' 410' ' ' VAL . 29.6 pt -53.31 -46.25 57.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.616 ' HA ' ' HG2' ' A' ' 414' ' ' GLU . 65.6 t -72.11 97.49 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.036 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 142.28 -32.61 1.97 Allowed Glycine 0 C--O 1.218 -0.871 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -177.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 408' ' ' GLN . 0.0 OUTLIER -126.15 -41.58 1.92 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 117.286 0.543 . . . . 0.0 111.373 -179.18 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -167.91 114.46 0.71 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.015 0.436 . . . . 0.0 109.906 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . 0.616 ' HG2' ' HA ' ' A' ' 410' ' ' VAL . 24.4 mt-10 -100.29 2.08 42.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.825 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 62.2 p -101.18 -74.05 0.63 Allowed 'General case' 0 C--N 1.315 -0.91 0 O-C-N 123.501 0.5 . . . . 0.0 111.983 -166.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -179.72 -56.33 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -168.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -175.15 -32.34 0.01 OUTLIER 'General case' 0 C--O 1.24 0.575 0 CA-C-N 114.223 -1.353 . . . . 0.0 108.74 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 23.1 ptt180 -128.6 157.27 75.58 Favored Pre-proline 0 C--O 1.245 0.843 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.277 -176.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.9 158.94 38.47 Favored 'Trans proline' 0 C--N 1.326 -0.648 0 C-N-CA 122.16 1.906 . . . . 0.0 111.139 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' GLU . . . . . 0.484 ' HG3' ' HG3' ' A' ' 439' ' ' ARG . 1.9 mp0 -75.29 158.72 32.43 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.93 0.395 . . . . 0.0 110.302 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.975 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 6.6 t -62.76 133.14 94.95 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.899 176.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.91 -6.93 13.68 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.685 2.257 . . . . 0.0 112.698 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 96.8 m-85 -114.72 11.88 16.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.173 0.511 . . . . 0.0 110.288 177.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 61.21 -157.79 31.68 Favored Glycine 0 N--CA 1.462 0.377 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.731 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.15 -11.39 25.12 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.675 2.917 . . . . 0.0 112.197 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 25.8 t -81.41 -11.63 59.2 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.785 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' CYS . . . . . 0.975 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 39.8 t -51.26 116.93 2.27 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.955 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -111.6 23.96 13.3 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.154 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -61.83 100.42 0.15 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 122.689 0.396 . . . . 0.0 110.066 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 430' ' ' LYS . 17.9 ptpt -66.12 94.18 0.23 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.229 0.538 . . . . 0.0 111.215 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . 0.552 ' O ' ' HB3' ' A' ' 434' ' ' HIS . 14.7 t30 -173.57 114.13 0.34 Allowed Pre-proline 0 N--CA 1.465 0.296 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.0 -47.01 22.29 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.427 2.085 . . . . 0.0 112.181 -174.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.631 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 26.0 tp60 -57.72 -29.07 64.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.326 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . 0.687 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 41.2 t60 -61.38 -55.99 25.34 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 123.361 0.413 . . . . 0.0 111.736 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -61.37 -25.23 67.03 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.437 0.637 . . . . 0.0 110.839 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 69.0 mt -69.48 -46.51 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.437 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.631 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 10.5 mt-10 -85.31 -22.48 28.51 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.986 -174.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -121.04 126.05 48.87 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 123.618 0.574 . . . . 0.0 110.155 -177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' ARG . . . . . 0.484 ' HG3' ' HG3' ' A' ' 420' ' ' GLU . 12.0 ptt180 -80.9 122.08 26.79 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 121.281 0.562 . . . . 0.0 110.984 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.694 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 49.3 m80 -98.07 84.45 3.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.154 177.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -70.26 121.28 17.3 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.177 -174.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.42 146.37 38.5 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.92 156.39 29.67 Favored Pre-proline 0 C--N 1.322 -0.608 0 O-C-N 123.466 0.479 . . . . 0.0 111.083 -173.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' PRO . . . . . 0.576 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 32.1 Cg_endo -62.63 -25.8 75.45 Favored 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 122.302 2.001 . . . . 0.0 112.365 -176.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . . . . . . . . . 14.9 p 40.09 56.26 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 122.958 1.361 . . . . 0.0 111.864 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.576 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 21.0 mmm180 -91.52 140.68 29.51 Favored 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 121.31 -0.869 . . . . 0.0 112.201 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 55.6 t30 52.98 85.84 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.639 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 26.6 m . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 121.371 0.605 . . . . 0.0 111.14 -177.645 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' ' ZN' . . . . . 0.875 'ZN ' ' HG ' ' A' ' 379' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' ' ZN' . . . . . 0.836 'ZN ' ' HG ' ' A' ' 421' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.462 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 32.2 m -80.15 96.47 6.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.778 0.799 . . . . 0.0 109.628 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -76.03 87.42 2.95 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.802 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -74.36 107.12 6.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.002 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 16.7 p -87.85 113.42 23.49 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 122.668 0.387 . . . . 0.0 110.067 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -83.1 168.35 16.96 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 121.67 0.748 . . . . 0.0 110.949 -173.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 11.7 t -101.78 129.84 48.06 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.855 171.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.91 80.46 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 122.442 1.115 . . . . 0.0 110.292 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 367' ' ' GLN . 3.2 pp -89.76 -24.25 21.56 Favored 'General case' 0 C--O 1.25 1.13 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.608 -177.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' GLN . . . . . 0.54 ' N ' HD12 ' A' ' 366' ' ' LEU . 28.5 tp60 -82.05 88.08 6.44 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.191 0.996 . . . . 0.0 110.133 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -153.02 39.79 0.72 Allowed Glycine 0 C--O 1.223 -0.538 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.403 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 3.2 p -99.54 -20.43 16.39 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.608 -0.796 . . . . 0.0 111.187 -177.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.413 ' H ' ' CD ' ' A' ' 370' ' ' GLU . 1.9 pm0 -75.91 79.9 2.8 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.408 0.623 . . . . 0.0 110.113 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -147.57 -103.05 0.31 Allowed Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -79.84 98.48 7.1 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 117.156 0.478 . . . . 0.0 109.826 170.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.567 ' H ' ' HD2' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -93.66 -16.76 23.97 Favored 'General case' 0 C--O 1.238 0.496 0 O-C-N 123.732 0.645 . . . . 0.0 110.15 -177.109 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.453 HG13 ' HG2' ' A' ' 373' ' ' LYS . 30.9 m -114.67 153.35 16.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 O-C-N 123.918 0.761 . . . . 0.0 109.923 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.65 151.2 25.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.155 176.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.553 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.1 OUTLIER -82.94 176.81 8.99 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 176.095 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 10.5 t -106.14 153.66 21.78 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.837 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.9 t -53.87 119.81 5.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.515 0.326 . . . . 0.0 111.751 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 24.1 t -53.77 111.06 0.66 Allowed 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . 0.522 ' HB3' HG12 ' A' ' 410' ' ' VAL . 23.3 ptp -58.51 -12.6 4.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.226 0.536 . . . . 0.0 111.925 -175.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.414 ' CD2' ' HB3' ' A' ' 385' ' ' CYS . 15.3 m-85 -110.09 -15.83 13.93 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.612 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 72.76 -133.42 19.07 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -174.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . 0.438 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -88.11 -0.75 57.44 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 121.643 0.735 . . . . 0.0 111.244 177.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -75.82 -24.89 55.89 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.593 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.814 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 0.8 OUTLIER -61.38 129.72 42.58 Favored 'General case' 0 C--O 1.25 1.098 0 O-C-N 122.238 -0.289 . . . . 0.0 111.167 -179.258 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -71.46 -8.49 54.19 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.034 0.534 . . . . 0.0 110.138 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -69.95 113.05 6.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.862 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.501 ' HD2' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -113.21 -1.84 14.23 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -61.25 137.11 94.3 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.335 175.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -58.57 -20.89 52.14 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.649 2.233 . . . . 0.0 111.746 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.579 HG12 ' NE2' ' A' ' 395' ' ' HIS . 98.4 t -66.09 -42.36 91.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.22 178.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.699 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 83.9 t60 -57.7 -33.51 68.46 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.702 0.763 . . . . 0.0 110.655 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 34.5 m-85 -88.96 -18.91 26.46 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.877 -177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -75.33 -26.95 59.03 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.641 -178.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.63 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 2.2 p80 -114.3 -7.34 12.95 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.502 0.501 . . . . 0.0 112.273 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.63 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 96.5 m-85 -135.45 132.01 36.88 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.206 0.527 . . . . 0.0 111.665 174.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.553 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 69.3 m -85.38 154.14 22.06 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.606 174.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.662 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 31.5 m80 -128.07 158.21 71.62 Favored Pre-proline 0 N--CA 1.466 0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.496 -175.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 14.9 Cg_endo -52.96 100.53 0.05 OUTLIER 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 122.951 2.434 . . . . 0.0 111.594 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 119.01 11.86 7.36 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.661 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -106.25 145.06 32.07 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 41.3 t -54.04 -32.81 55.58 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.805 0.69 . . . . 0.0 111.29 -176.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -107.97 17.33 22.53 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -81.6 136.12 35.55 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 120.124 -0.631 . . . . 0.0 110.824 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -119.66 -55.62 0.25 Allowed Glycine 0 C--O 1.249 1.071 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.171 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 71.41 24.21 77.16 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.7 m -118.84 3.11 7.16 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.346 0 CA-C-O 121.567 0.699 . . . . 0.0 110.986 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.535 ' NE2' ' HB ' ' A' ' 410' ' ' VAL . 6.0 tt0 -84.32 153.03 23.75 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.124 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.465 HG13 ' N ' ' A' ' 410' ' ' VAL . 23.5 pt -55.32 -45.19 77.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 CA-C-O 121.426 0.632 . . . . 0.0 110.354 175.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.535 ' HB ' ' NE2' ' A' ' 408' ' ' GLN . 39.1 t -66.13 90.06 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 143.21 -42.09 1.11 Allowed Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.45 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 4.1 pt20 -95.64 -43.05 8.1 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.727 0.299 . . . . 0.0 111.155 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -170.49 141.1 1.88 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.681 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -134.43 10.73 3.77 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.364 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 77.5 p -68.29 -54.66 16.03 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.74 0.781 . . . . 0.0 111.076 -176.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 26.9 t70 179.44 -31.8 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.396 -1.274 . . . . 0.0 108.28 -169.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 27.3 t70 63.17 79.75 0.25 Allowed 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 124.736 1.214 . . . . 0.0 113.035 168.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -177.62 154.46 1.04 Allowed Pre-proline 0 N--CA 1.479 0.985 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.812 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -52.49 136.41 56.63 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.034 2.49 . . . . 0.0 111.282 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' GLU . . . . . 0.454 ' HG3' ' HG3' ' A' ' 439' ' ' ARG . 2.3 mp0 -75.62 148.54 38.69 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.949 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 8.3 t -52.18 134.86 40.64 Favored Pre-proline 0 N--CA 1.452 -0.34 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.412 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 421' ' ' CYS . 53.0 Cg_exo -57.24 -28.15 78.19 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.742 2.294 . . . . 0.0 111.952 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . 0.413 ' HB2' ' HA ' ' A' ' 427' ' ' CYS . 62.3 m-85 -99.1 5.55 46.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.873 -177.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 67.64 -156.03 52.65 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 -177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . 0.441 ' HG3' ' HA ' ' A' ' 442' ' ' THR . 55.1 Cg_endo -70.74 -16.53 33.44 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 122.329 2.02 . . . . 0.0 111.298 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 33.0 t -79.25 3.98 16.38 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.262 176.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' CYS . . . . . 0.949 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 50.5 t -55.1 117.28 3.33 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.108 0.563 . . . . 0.0 110.727 177.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -103.1 13.37 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.685 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 429' ' ' ARG . 8.4 mmm180 -71.99 105.46 3.89 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -87.96 97.45 10.96 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.142 -175.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -173.02 126.37 0.48 Allowed Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.458 ' O ' HG13 ' A' ' 436' ' ' ILE . 28.2 Cg_endo -62.58 -38.28 52.3 Favored 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.295 1.997 . . . . 0.0 112.12 -177.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.651 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 26.3 tp60 -63.94 -38.19 90.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.946 0.403 . . . . 0.0 110.34 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . 0.596 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 15.0 t60 -57.95 -48.3 80.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 122.262 1.03 . . . . 0.0 110.116 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -68.68 -15.24 63.46 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.345 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 432' ' ' PRO . 79.0 mt -86.67 -34.3 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 O-C-N 123.928 0.767 . . . . 0.0 110.628 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.651 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 21.9 mt-10 -86.62 -25.08 25.09 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.572 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -127.0 135.6 51.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.234 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' ARG . . . . . 0.454 ' HG3' ' HG3' ' A' ' 420' ' ' GLU . 25.2 ptt180 -91.2 134.94 34.14 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.65 0.594 . . . . 0.0 109.761 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.43 ' HD2' ' HB3' ' A' ' 427' ' ' CYS . 24.2 m80 -100.91 83.81 2.59 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.231 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -94.61 157.46 15.97 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.004 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' THR . . . . . 0.441 ' HA ' ' HG3' ' A' ' 425' ' ' PRO . 30.4 p -100.74 171.78 7.48 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -178.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.41 151.54 71.47 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.0 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' PRO . . . . . 0.514 ' O ' HG12 ' A' ' 445' ' ' VAL . 18.6 Cg_endo -59.29 -24.53 74.66 Favored 'Trans proline' 0 N--CA 1.483 0.868 0 C-N-CA 123.489 2.793 . . . . 0.0 111.24 -174.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 444' ' ' PRO . 3.5 p 56.53 7.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.734 1.614 . . . . 0.0 113.013 171.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 446' ' ' ARG . 15.0 ptt180 -126.88 170.48 12.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.174 -176.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -133.05 -36.59 1.01 Allowed 'General case' 0 C--N 1.306 -1.296 0 O-C-N 125.013 1.446 . . . . 0.0 110.896 173.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.477 0.884 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.421 177.524 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' ' ZN' . . . . . 0.814 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' ' ZN' . . . . . 0.746 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.289 0 CA-C-O 119.87 -0.406 . . . . 0.0 112.588 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 15.7 m -86.53 105.88 17.13 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.27 0.557 . . . . 0.0 109.974 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -106.97 106.02 16.34 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.319 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -137.52 112.38 8.96 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.586 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 4.4 m -137.15 156.32 48.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.154 0.502 . . . . 0.0 110.431 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -145.22 123.5 12.26 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 46.5 t -128.16 153.16 47.18 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 123.342 0.657 . . . . 0.0 110.059 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.04 132.65 32.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 120.736 0.303 . . . . 0.0 111.398 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 366' ' ' LEU . 2.5 pt? -132.96 -2.23 3.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.447 176.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -73.82 139.14 44.91 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.436 0.636 . . . . 0.0 110.692 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -179.89 42.88 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.193 177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 22.6 t -130.1 92.09 3.23 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 117.066 0.433 . . . . 0.0 110.938 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -101.7 -28.75 12.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.309 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 94.55 -102.17 2.83 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . 0.517 HD22 ' N ' ' A' ' 372' ' ' ASN . 0.9 OUTLIER -89.82 166.27 13.64 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.596 0.236 . . . . 0.0 111.051 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.558 ' HD2' HG13 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -84.11 -0.43 51.91 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.047 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.558 HG13 ' HD2' ' A' ' 373' ' ' LYS . 20.9 m -136.0 136.46 49.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 123.838 0.855 . . . . 0.0 109.327 166.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -90.38 139.69 30.43 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.958 -175.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.487 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -80.93 -175.67 5.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.492 0.663 . . . . 0.0 110.032 171.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.2 t -113.43 159.46 19.46 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 41.0 t -63.68 124.33 21.15 Favored 'General case' 0 C--O 1.244 0.775 0 O-C-N 121.975 -0.453 . . . . 0.0 111.226 -175.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.753 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 31.9 t -56.39 122.38 11.76 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 174.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . 0.418 ' HB3' HG12 ' A' ' 410' ' ' VAL . 26.5 ptm -55.1 -26.23 36.69 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.645 0.378 . . . . 0.0 111.566 -173.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.541 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 38.8 m-85 -110.01 -8.86 14.78 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.647 0.592 . . . . 0.0 110.657 178.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.46 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 69.78 -133.92 25.41 Favored Glycine 0 N--CA 1.436 -1.316 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.61 -176.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . 0.583 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -78.6 0.26 27.05 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 117.589 0.694 . . . . 0.0 111.166 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -94.7 -2.74 50.59 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.582 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.839 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 10.3 p -68.0 134.19 50.29 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 122.065 -0.397 . . . . 0.0 110.391 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -78.98 -14.11 59.4 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 123.26 0.624 . . . . 0.0 111.212 -176.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -72.5 128.31 35.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.049 0.452 . . . . 0.0 110.507 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.443 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.6 OUTLIER -120.27 -6.45 9.87 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.047 -176.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.413 HD22 ' HB ' ' A' ' 391' ' ' VAL . 5.2 p-10 -65.05 137.76 97.2 Favored Pre-proline 0 C--O 1.243 0.737 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.542 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -53.57 -34.63 73.76 Favored 'Trans proline' 0 C--O 1.238 0.519 0 C-N-CA 123.689 2.926 . . . . 0.0 112.793 -173.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.455 HG12 ' NE2' ' A' ' 395' ' ' HIS . 60.1 t -59.72 -34.68 56.27 Favored 'Isoleucine or valine' 0 C--N 1.348 0.532 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.683 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.649 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 82.6 t60 -55.21 -37.55 67.27 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-O 121.729 0.776 . . . . 0.0 111.33 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 62.2 m-85 -89.68 -20.86 23.13 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.459 -175.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -71.39 -24.11 62.0 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.878 -0.514 . . . . 0.0 110.035 -177.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.606 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 1.0 OUTLIER -119.33 -7.71 10.19 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 178.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.606 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 57.0 m-85 -133.55 126.37 30.86 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 175.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.487 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 38.1 m -90.06 158.93 17.09 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.66 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 13.3 m80 -129.55 157.69 75.68 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.078 -174.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.583 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 18.3 Cg_endo -54.31 118.09 4.65 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.898 2.398 . . . . 0.0 110.347 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 111.58 -1.71 27.7 Favored Glycine 0 C--N 1.32 -0.342 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.695 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -102.76 142.16 34.36 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 14.1 t -70.05 -21.97 63.12 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -95.56 -1.39 50.59 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.112 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -70.64 115.9 10.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.09 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -87.13 -49.82 3.87 Favored Glycine 0 C--O 1.224 -0.49 0 C-N-CA 120.173 -1.013 . . . . 0.0 111.702 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 65.02 39.01 96.12 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.318 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 21.6 m -129.01 22.1 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.423 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -112.66 145.32 40.65 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.812 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.455 HG13 ' N ' ' A' ' 410' ' ' VAL . 20.6 pt -58.46 -47.83 87.04 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 CA-C-O 121.281 0.562 . . . . 0.0 109.843 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.498 ' HA ' ' HG2' ' A' ' 414' ' ' GLU . 18.0 t -66.33 86.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 174.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 156.9 -41.23 0.55 Allowed Glycine 0 CA--C 1.5 -0.905 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.771 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.4 -38.53 5.68 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -173.13 121.58 0.37 Allowed 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.964 176.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . 0.498 ' HG2' ' HA ' ' A' ' 410' ' ' VAL . 36.8 mt-10 -86.65 -28.85 22.94 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.847 -175.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 416' ' ' ASP . 82.6 p -65.5 -86.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 415' ' ' THR . 18.9 t70 168.68 -68.87 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.989 0.899 . . . . 0.0 109.025 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -136.35 -18.9 1.47 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.074 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.523 ' HD2' ' O ' ' A' ' 437' ' ' GLU . 20.9 ptt180 -167.6 160.13 10.1 Favored Pre-proline 0 N--CA 1.467 0.384 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -169.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.59 151.03 72.54 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.83 1.687 . . . . 0.0 111.359 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' GLU . . . . . 0.479 ' HA ' ' HG2' ' A' ' 439' ' ' ARG . 10.7 tt0 -82.94 157.07 23.16 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.948 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 11.3 t -58.98 135.24 87.45 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.261 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.7 -13.28 35.85 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.343 2.029 . . . . 0.0 112.58 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -110.18 8.08 23.57 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.103 0.477 . . . . 0.0 110.429 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 63.94 -152.71 48.39 Favored Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.699 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.53 -4.38 15.19 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.847 2.365 . . . . 0.0 111.984 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 16.9 m -83.55 -2.52 56.2 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.583 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' CYS . . . . . 0.948 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 43.0 t -54.89 115.92 2.46 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.498 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -110.96 19.26 18.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.28 0.632 . . . . 0.0 110.482 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.645 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 1.1 mmp_? -69.62 101.87 1.73 Allowed 'General case' 0 C--O 1.255 1.365 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.274 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -75.04 82.83 2.26 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 123.603 0.761 . . . . 0.0 110.184 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 434' ' ' HIS . 16.5 t30 -163.23 112.08 1.02 Allowed Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.694 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -58.98 -41.4 62.08 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 C-N-CA 123.25 2.633 . . . . 0.0 112.567 -171.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.675 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 25.1 tp60 -57.45 -39.21 75.8 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 121.086 0.47 . . . . 0.0 110.33 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . 0.719 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 19.5 t60 -59.23 -52.27 66.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.677 0.751 . . . . 0.0 110.011 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.41 ' HA ' ' HE1' ' A' ' 440' ' ' HIS . 47.7 mtpt -61.25 -19.79 62.1 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.983 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 93.7 mt -84.47 -35.42 10.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.294 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.675 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 25.7 mt-10 -85.41 -50.92 6.91 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.45 -176.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -98.06 137.85 36.24 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.113 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' ARG . . . . . 0.663 ' NE ' HD21 ' A' ' 441' ' ' ASN . 18.5 ptt-85 -86.24 145.96 26.73 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.42 0.288 . . . . 0.0 110.56 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.629 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 71.7 m80 -118.22 86.04 2.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.387 0.613 . . . . 0.0 109.847 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' ASN . . . . . 0.663 HD21 ' NE ' ' A' ' 439' ' ' ARG . 83.5 m-20 -77.61 117.87 19.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.983 -176.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.2 m -125.79 155.49 40.98 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.463 0.477 . . . . 0.0 110.898 -173.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 443' ' ' LEU . 1.1 pp -107.21 153.9 40.81 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 177.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' PRO . . . . . 0.426 ' O ' HG12 ' A' ' 445' ' ' VAL . 38.1 Cg_endo -64.84 -11.98 32.0 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.167 1.911 . . . . 0.0 113.273 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 444' ' ' PRO . 6.1 p 51.02 28.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.19 0.996 . . . . 0.0 112.309 174.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.426 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 36.9 mmt180 -85.66 144.96 27.53 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.853 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -84.09 85.54 7.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.464 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--N 1.309 -1.188 0 CA-C-O 122.119 0.961 . . . . 0.0 110.202 177.492 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' ' ZN' . . . . . 0.839 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' ' ZN' . . . . . 0.812 'ZN ' ' HG ' ' A' ' 421' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.517 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 25.9 t -77.34 127.25 32.25 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.912 0.419 . . . . 0.0 110.288 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -104.67 -9.96 17.83 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.089 0.471 . . . . 0.0 110.779 175.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -69.74 80.08 0.44 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.237 0.542 . . . . 0.0 110.83 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 11.6 m -82.01 154.02 25.89 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.326 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -125.77 -177.44 3.92 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 40.6 t -139.31 163.53 32.24 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.36 151.9 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 174.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . 0.549 ' O ' ' HG3' ' A' ' 367' ' ' GLN . 2.1 pp -54.45 -23.38 15.84 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.635 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 366' ' ' LEU . 0.8 OUTLIER 55.95 -4.99 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 177.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 366' ' ' LEU . . . -76.28 73.97 1.73 Allowed Glycine 0 C--O 1.22 -0.732 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 175.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 19.7 m -136.32 102.75 5.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.707 -0.746 . . . . 0.0 110.208 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -102.01 147.52 26.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.123 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 110.58 31.06 3.09 Favored Glycine 0 C--O 1.224 -0.52 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.474 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -175.17 164.35 3.27 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 122.303 0.241 . . . . 0.0 111.26 -173.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.462 ' N ' ' HD3' ' A' ' 373' ' ' LYS . 3.2 mppt? -90.49 -60.43 1.92 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 11.9 m -91.93 139.79 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.623 ' N ' ' HD2' ' A' ' 375' ' ' LYS . 8.7 mptt -92.62 -39.99 11.01 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.858 0.837 . . . . 0.0 110.417 -177.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -130.28 167.54 18.32 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.054 173.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 9.0 t -120.95 145.52 47.63 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 172.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 46.3 m -47.73 122.24 4.75 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 123.452 0.47 . . . . 0.0 111.218 -175.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.921 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 11.9 t -47.54 120.46 3.31 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 27.6 ptm -61.5 -11.75 12.18 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.08 0.552 . . . . 0.0 110.317 -176.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.494 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 75.0 m-85 -115.27 -13.89 11.71 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.994 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.424 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 65.77 -120.59 17.2 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.076 -1.059 . . . . 0.0 110.793 -177.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . 0.467 ' HB2' ' HG3' ' A' ' 399' ' ' PRO . . . -92.18 5.73 49.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.548 0.689 . . . . 0.0 110.66 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -89.36 -15.23 33.81 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.302 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.921 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 2.4 p -78.8 123.85 27.61 Favored 'General case' 0 C--O 1.248 0.974 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.881 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -83.44 15.65 2.95 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.92 0.488 . . . . 0.0 111.686 -174.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -84.06 130.14 34.88 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.085 0.469 . . . . 0.0 110.409 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -104.01 -33.22 8.88 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 123.152 0.581 . . . . 0.0 109.676 -178.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -45.91 135.58 6.51 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.683 -177.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.74 -17.61 55.85 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 121.914 1.743 . . . . 0.0 112.062 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.482 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 86.3 t -67.9 -37.42 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.904 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.67 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 77.5 t60 -60.96 -29.32 69.58 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.868 0.842 . . . . 0.0 110.017 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 60.6 m-85 -92.8 -13.07 29.67 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.004 -177.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -78.77 -23.64 45.17 Favored 'General case' 0 C--N 1.343 0.313 0 O-C-N 121.768 -0.583 . . . . 0.0 111.617 -177.451 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.447 ' HD2' ' HG3' ' A' ' 394' ' ' GLN . 5.5 p80 -118.41 -19.76 8.74 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.438 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 377' ' ' THR . 67.7 m-85 -123.54 127.7 48.69 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.512 0.672 . . . . 0.0 110.675 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.556 ' O ' ' HB2' ' A' ' 379' ' ' CYS . 54.2 p -78.36 163.21 25.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.752 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.714 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 61.0 m80 -138.24 161.82 57.18 Favored Pre-proline 0 N--CA 1.465 0.308 0 O-C-N 122.293 -0.254 . . . . 0.0 110.479 -176.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 11.3 Cg_endo -51.58 104.98 0.1 OUTLIER 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 122.937 2.425 . . . . 0.0 112.156 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 124.55 -9.35 8.2 Favored Glycine 0 CA--C 1.524 0.604 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.701 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -95.8 157.05 16.07 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 122.601 -0.352 . . . . 0.0 111.324 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 20.0 m -69.02 -25.87 64.71 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.831 0.707 . . . . 0.0 112.061 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.67 8.97 40.64 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.318 -0.239 . . . . 0.0 110.524 -177.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -103.09 139.45 38.6 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.447 0.467 . . . . 0.0 110.665 -178.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -172.6 17.24 0.05 OUTLIER Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.609 176.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 52.09 51.83 38.91 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 31.8 m -67.16 -28.61 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.401 0.619 . . . . 0.0 111.384 -174.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -113.72 163.43 15.02 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.554 0.742 . . . . 0.0 109.676 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.51 HG13 ' N ' ' A' ' 410' ' ' VAL . 21.2 pt -60.68 -49.1 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.833 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.51 ' N ' HG13 ' A' ' 409' ' ' ILE . 11.3 p -69.77 115.17 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 O-C-N 124.019 0.824 . . . . 0.0 109.51 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 132.85 -33.34 2.63 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -173.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.446 ' HG3' ' N ' ' A' ' 413' ' ' ASP . 15.0 pt20 -113.2 -48.27 2.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.803 -0.699 . . . . 0.0 110.129 174.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.446 ' N ' ' HG3' ' A' ' 412' ' ' GLN . 19.7 t70 179.83 136.43 0.11 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.081 0.863 . . . . 0.0 109.486 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -107.38 -7.76 16.54 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.806 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 64.4 p -87.8 -81.18 0.25 Allowed 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.638 0.586 . . . . 0.0 112.153 -168.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.8 t70 169.94 -52.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -169.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -169.92 -31.73 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.031 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.516 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 29.1 ptt180 -133.01 163.75 48.84 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.758 -173.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.35 151.08 42.56 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.566 2.178 . . . . 0.0 111.18 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.95 158.73 30.08 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.496 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.82 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 49.3 t -69.37 131.25 90.29 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.297 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.87 -16.45 25.93 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.269 2.646 . . . . 0.0 112.647 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -111.86 12.81 20.91 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.63 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 59.83 -151.74 36.91 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.789 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -77.43 -21.83 11.32 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.547 2.165 . . . . 0.0 112.324 178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 36.0 t -76.36 4.16 9.54 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.924 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' CYS . . . . . 0.82 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 49.7 t -49.61 116.73 1.88 Allowed 'General case' 0 C--O 1.219 -0.547 0 O-C-N 124.358 1.036 . . . . 0.0 110.957 176.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -107.77 16.21 23.82 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.653 0.739 . . . . 0.0 110.347 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -76.64 88.45 3.32 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.027 178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -73.79 92.3 2.02 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.305 0.574 . . . . 0.0 111.289 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . 0.48 HD21 ' HB3' ' A' ' 433' ' ' GLN . 47.4 t30 -153.74 126.41 4.02 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.484 ' O ' HG13 ' A' ' 436' ' ' ILE . 18.4 Cg_endo -58.63 -39.75 79.83 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 121.804 1.669 . . . . 0.0 111.537 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.48 ' HB3' HD21 ' A' ' 431' ' ' ASN . 23.7 tp60 -69.1 -26.26 64.83 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.695 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . 0.753 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 48.3 t60 -64.61 -61.89 1.92 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.114 0.483 . . . . 0.0 110.518 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.477 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 0.0 OUTLIER -61.39 -18.59 59.48 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.441 -178.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 432' ' ' PRO . 66.1 mt -71.96 -56.38 10.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.192 0.52 . . . . 0.0 111.701 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 418' ' ' ARG . 9.7 mm-40 -76.26 -28.08 56.95 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -112.27 123.09 49.51 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.256 0.347 . . . . 0.0 111.409 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' ARG . . . . . 0.516 ' HD3' ' O ' ' A' ' 418' ' ' ARG . 1.2 ptm180 -78.16 126.99 31.61 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.575 0.547 . . . . 0.0 110.346 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.565 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.1 m80 -103.18 85.62 2.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.36 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' ASN . . . . . 0.502 HD21 ' CZ ' ' A' ' 439' ' ' ARG . 93.4 m-20 -68.75 117.59 10.65 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.616 -176.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.0 m -133.35 154.12 51.0 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -176.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.502 HD13 ' HB ' ' A' ' 445' ' ' VAL . 1.4 pp -108.81 148.02 36.99 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.913 176.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -64.71 -47.24 5.55 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.49 1.46 . . . . 0.0 113.072 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.502 ' HB ' HD13 ' A' ' 443' ' ' LEU . 9.8 p 44.45 29.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-O 122.013 0.911 . . . . 0.0 111.425 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 448' ' ' VAL . 24.4 tpt180 -83.95 92.87 7.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.296 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 14.1 m120 47.92 -76.21 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.826 1.251 . . . . 0.0 113.166 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 446' ' ' ARG . 33.5 m . . . . . 0 C--O 1.238 0.496 0 CA-C-O 121.851 0.834 . . . . 0.0 110.299 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' ' ZN' . . . . . 0.843 'ZN ' ' HG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' ' ZN' . . . . . 0.78 'ZN ' ' SG ' ' A' ' 421' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.11 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 34.0 p -67.07 -9.5 40.05 Favored 'General case' 0 C--O 1.242 0.659 0 O-C-N 122.545 -0.385 . . . . 0.0 111.725 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -75.01 -12.56 60.36 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.414 0.686 . . . . 0.0 110.25 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -54.54 97.51 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.355 0.598 . . . . 0.0 110.457 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 6.9 p -140.54 124.35 17.22 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.649 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -66.78 164.38 17.29 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.364 0.602 . . . . 0.0 111.054 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 14.4 m -60.55 -24.07 65.1 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 122.099 0.952 . . . . 0.0 110.485 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 12.2 p -130.75 156.44 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.543 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . 0.644 HD12 ' N ' ' A' ' 367' ' ' GLN . 1.7 pp -53.36 -27.34 23.2 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 122.151 -0.343 . . . . 0.0 111.017 176.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' GLN . . . . . 0.644 ' N ' HD12 ' A' ' 366' ' ' LEU . 24.3 tp60 67.81 -68.43 0.16 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 124.44 1.096 . . . . 0.0 111.609 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -171.81 101.23 0.16 Allowed Glycine 0 C--N 1.313 -0.708 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 49.2 m -81.33 71.22 8.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.693 0.759 . . . . 0.0 110.967 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -92.01 41.32 1.07 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.521 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 101.48 -56.23 0.72 Allowed Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -168.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -113.99 125.59 54.19 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.534 ' HD3' ' H ' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -88.61 -12.24 43.18 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.983 0.42 . . . . 0.0 110.231 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.442 HG13 ' HG2' ' A' ' 373' ' ' LYS . 32.9 m -117.07 157.49 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.391 176.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.444 ' O ' ' HD2' ' A' ' 375' ' ' LYS . 1.2 pptp? -90.8 152.87 20.61 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.64 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.43 HH21 ' CG ' ' A' ' 401' ' ' ASP . 0.7 OUTLIER -88.86 161.88 16.46 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.865 0.841 . . . . 0.0 110.453 177.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 9.6 t -98.72 144.53 27.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.611 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 35.4 m -62.56 122.68 16.41 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.081 0.863 . . . . 0.0 112.668 -168.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.79 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 47.1 t -58.2 110.82 1.02 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.915 171.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . 0.5 ' HB3' HG12 ' A' ' 410' ' ' VAL . 23.3 ptm -59.81 -25.98 65.4 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.134 0.271 . . . . 0.0 110.947 -174.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 53.1 m-85 -95.18 -14.85 23.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.578 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 57.91 -117.7 11.0 Favored Glycine 0 C--O 1.216 -0.985 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.439 178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -87.29 -3.71 59.05 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.169 0.509 . . . . 0.0 111.608 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -83.31 -25.17 31.77 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.04 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.808 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 6.3 p -70.68 120.71 16.69 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 174.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -79.61 1.41 26.23 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.65 0.594 . . . . 0.0 111.763 -170.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.53 ' HA ' ' NE ' ' A' ' 387' ' ' ARG . 2.4 mmp_? -62.98 129.16 39.16 Favored 'General case' 0 C--O 1.244 0.802 0 O-C-N 123.532 0.52 . . . . 0.0 110.595 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.494 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -112.52 -11.79 13.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.094 -175.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -67.06 138.68 95.01 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.497 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.98 -23.74 78.04 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.074 1.849 . . . . 0.0 111.526 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.467 ' HA ' ' HG2' ' A' ' 394' ' ' GLN . 60.1 t -60.69 -41.65 89.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.716 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 48.5 t60 -53.63 -33.91 56.73 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.534 0.521 . . . . 0.0 110.911 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -95.86 -19.31 19.68 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.409 -175.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.467 ' HG2' ' HA ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -70.77 -25.38 62.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.503 0.192 . . . . 0.0 111.25 -177.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.585 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 0.8 OUTLIER -120.85 -8.77 9.38 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.585 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 93.0 m-85 -133.15 133.09 42.4 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.793 176.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 17.6 p -88.34 149.94 23.48 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.151 0.58 . . . . 0.0 110.042 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.455 ' H ' ' HB3' ' A' ' 401' ' ' ASP . 42.6 m80 -125.56 160.86 53.78 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.213 -174.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.15 93.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.499 2.133 . . . . 0.0 110.374 175.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 136.6 -23.51 3.25 Favored Glycine 0 C--O 1.238 0.402 0 O-C-N 123.995 0.809 . . . . 0.0 111.473 -175.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . 0.455 ' HB3' ' H ' ' A' ' 398' ' ' HIS . 15.2 t70 -76.89 133.57 39.25 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 32.0 t -63.35 -13.82 43.37 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -172.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.71 12.42 31.01 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.402 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -73.28 111.2 8.18 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 120.478 0.18 . . . . 0.0 110.648 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -84.91 -56.58 2.43 Favored Glycine 0 C--O 1.223 -0.587 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.195 -177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 67.48 16.46 67.44 Favored Glycine 0 CA--C 1.538 1.475 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.9 m -100.92 -9.44 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 121.057 0.456 . . . . 0.0 110.392 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 412' ' ' GLN . 6.9 tt0 -83.22 140.75 32.35 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.371 176.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 24.9 pt -49.33 -45.1 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 O-C-N 123.458 0.474 . . . . 0.0 110.675 175.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.5 HG12 ' HB3' ' A' ' 380' ' ' MET . 59.8 t -74.22 82.2 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 173.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 150.8 -51.98 0.51 Allowed Glycine 0 C--N 1.315 -0.587 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.199 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 4.8 pt20 -78.51 -49.93 12.51 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 12.0 t70 177.7 142.4 0.09 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -87.44 -11.1 50.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.766 -170.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 68.7 p -101.15 116.81 33.68 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.782 -0.574 . . . . 0.0 111.067 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -73.38 -52.89 12.19 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.411 ' OD1' ' HD2' ' A' ' 439' ' ' ARG . 19.2 p-10 -135.95 -32.54 0.88 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.444 174.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.631 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 17.4 ptt180 -146.17 172.46 5.24 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.318 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.599 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 21.1 Cg_endo -62.03 140.52 84.8 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 121.098 1.199 . . . . 0.0 111.687 175.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' GLU . . . . . 0.68 ' HG3' ' ND2' ' A' ' 441' ' ' ASN . 0.4 OUTLIER -74.02 160.1 31.77 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.392 0.433 . . . . 0.0 110.297 178.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.983 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 2.6 t -63.51 135.31 96.2 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.46 -2.88 6.74 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.499 2.133 . . . . 0.0 112.804 -177.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . 0.622 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 65.0 m-85 -125.84 14.96 8.04 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.066 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 64.51 -159.76 41.41 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.777 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.93 -14.48 38.76 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.968 1.779 . . . . 0.0 111.878 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 36.0 t -70.73 -17.82 62.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' CYS . . . . . 0.983 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 17.5 t -57.43 115.4 2.7 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -114.78 25.01 11.29 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.447 0.642 . . . . 0.0 109.416 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.705 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 2.0 mmp_? -59.77 99.31 0.06 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -80.18 96.71 6.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.114 0.959 . . . . 0.0 110.316 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -160.22 125.74 2.29 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.894 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.589 ' O ' HG13 ' A' ' 436' ' ' ILE . 20.1 Cg_endo -59.72 -42.29 47.74 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 121.979 1.786 . . . . 0.0 111.992 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.606 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 25.3 tp60 -64.46 -37.44 87.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.124 0.488 . . . . 0.0 109.895 -177.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . 0.691 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.2 t60 -59.34 -53.89 52.98 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.521 0.676 . . . . 0.0 110.021 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -63.15 -15.65 57.52 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.681 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 432' ' ' PRO . 85.5 mt -82.59 -37.24 14.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.219 0.533 . . . . 0.0 111.13 176.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.606 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 27.0 mt-10 -82.78 -44.34 15.67 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.474 -175.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 419' ' ' PRO . 96.5 m-85 -111.5 147.19 35.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.523 -171.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' ARG . . . . . 0.683 ' NH2' HD21 ' A' ' 441' ' ' ASN . 0.0 OUTLIER -93.57 141.48 28.42 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.066 174.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.673 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 74.9 m80 -108.35 92.67 4.16 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 123.741 0.651 . . . . 0.0 109.43 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' ASN . . . . . 0.683 HD21 ' NH2' ' A' ' 439' ' ' ARG . 88.4 m-20 -67.97 98.49 0.76 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 -174.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.7 m -107.75 151.44 25.69 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 124.412 1.07 . . . . 0.0 109.531 -176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.463 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.6 OUTLIER -119.83 145.11 38.76 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-O 121.009 0.433 . . . . 0.0 110.146 -179.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' PRO . . . . . 0.536 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 54.5 Cg_endo -68.66 -20.13 40.89 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.28 2.654 . . . . 0.0 112.455 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.463 ' HB ' HD13 ' A' ' 443' ' ' LEU . 5.6 p 47.94 30.68 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.883 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.484 177.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.536 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 24.7 mmt180 -87.71 145.33 26.19 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.413 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 64.16 1.19 1.15 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.133 -0.939 . . . . 0.0 111.811 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 121.055 0.455 . . . . 0.0 110.391 -178.807 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' ' ZN' . . . . . 0.808 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' ' ZN' . . . . . 0.749 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 32.3 p -117.31 152.77 34.2 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.719 0.407 . . . . 0.0 109.997 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -78.61 93.63 4.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.096 0.474 . . . . 0.0 109.824 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -77.28 94.46 4.16 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.912 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 16.7 p -66.19 119.58 11.73 Favored 'General case' 0 C--O 1.241 0.629 0 O-C-N 123.872 0.732 . . . . 0.0 111.279 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -129.06 164.74 22.61 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.617 0.573 . . . . 0.0 109.523 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 13.0 p -51.29 145.12 8.61 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.562 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 48.4 t -63.35 83.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.923 0.868 . . . . 0.0 111.908 -174.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . 0.488 ' H ' HD23 ' A' ' 366' ' ' LEU . 2.1 pt? -82.28 -24.71 34.58 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 172.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 14.7 tp60 65.79 -74.32 0.06 Allowed 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.5 0.72 . . . . 0.0 112.599 171.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -52.27 -26.64 21.94 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 115.082 0.793 . . . . 0.0 115.082 -172.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 47.6 m -114.17 22.93 13.35 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.145 -0.621 . . . . 0.0 111.585 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -126.33 147.3 49.76 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 88.43 -69.43 2.76 Favored Glycine 0 CA--C 1.505 -0.585 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.805 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -113.45 97.35 6.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 110.012 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.79 -9.19 14.49 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 123.336 0.654 . . . . 0.0 110.908 -177.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 19.7 m -70.23 142.16 16.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.871 0.844 . . . . 0.0 109.26 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.4 154.94 18.87 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.427 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.8 OUTLIER -124.88 162.24 24.84 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 121.556 0.693 . . . . 0.0 111.071 -178.021 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 15.3 t -117.2 155.3 29.63 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.899 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 15.9 m -57.78 121.64 10.94 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -170.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.749 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 11.5 t -60.74 116.75 4.65 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.063 173.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . 0.564 ' HB2' HG22 ' A' ' 410' ' ' VAL . 31.6 ttp -50.86 -40.71 56.86 Favored 'General case' 0 C--O 1.25 1.084 0 C-N-CA 122.778 0.431 . . . . 0.0 111.2 -176.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.475 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 26.1 m-85 -91.96 -14.52 29.37 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.192 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.441 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 60.69 -119.61 19.38 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -80.92 -5.8 57.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.477 0.656 . . . . 0.0 111.495 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -86.18 -15.39 41.13 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.995 -174.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.924 ' HG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 6.9 p -74.74 131.82 41.13 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.133 0.492 . . . . 0.0 110.129 176.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -87.52 18.22 4.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.533 0.682 . . . . 0.0 111.405 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -87.36 121.93 30.45 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.679 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.483 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -121.99 2.74 9.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.69 0.757 . . . . 0.0 109.681 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.415 HD22 ' HB ' ' A' ' 391' ' ' VAL . 5.2 p-10 -63.37 135.6 96.32 Favored Pre-proline 0 N--CA 1.44 -0.949 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.305 174.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -54.93 -29.52 64.44 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.227 2.618 . . . . 0.0 111.408 -172.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.608 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 98.8 t -65.08 -34.07 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.682 -178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.55 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 84.7 t60 -63.67 -24.66 67.88 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.062 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -95.83 -15.4 22.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.868 0.467 . . . . 0.0 110.807 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.608 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -80.18 -25.68 39.61 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.25 -177.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.615 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 1.7 p80 -114.31 -19.95 11.05 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.615 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 59.3 m-85 -126.94 127.76 45.36 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 122.395 1.093 . . . . 0.0 111.614 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.427 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 8.8 p -81.6 158.03 24.51 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.655 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.723 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 46.4 m80 -137.02 159.07 71.43 Favored Pre-proline 0 C--N 1.315 -0.902 0 C-N-CA 123.644 0.778 . . . . 0.0 110.288 -174.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -56.85 102.24 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.024 1.816 . . . . 0.0 110.546 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 124.75 -0.3 8.5 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.027 -174.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -100.12 143.83 29.86 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.7 t -61.9 -29.95 70.56 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 123.32 0.387 . . . . 0.0 111.5 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.95 9.2 43.34 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.24 0.543 . . . . 0.0 110.776 -174.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -81.53 151.64 27.65 Favored 'General case' 0 C--O 1.248 0.997 0 O-C-N 121.948 -0.47 . . . . 0.0 110.887 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -160.49 -44.48 0.02 OUTLIER Glycine 0 C--O 1.227 -0.313 0 CA-C-O 121.409 0.45 . . . . 0.0 112.766 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 89.13 38.62 6.71 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -174.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 32.0 m -102.91 -1.05 9.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.729 0 CA-C-O 121.578 0.704 . . . . 0.0 112.127 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.475 ' O ' ' HG2' ' A' ' 412' ' ' GLN . 9.4 tt0 -90.42 133.19 35.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.891 176.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.496 HG13 ' N ' ' A' ' 410' ' ' VAL . 30.2 pt -50.08 -47.41 24.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 O-C-N 123.547 0.529 . . . . 0.0 109.958 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.564 HG22 ' HB2' ' A' ' 380' ' ' MET . 7.7 p -78.13 81.78 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.906 0.86 . . . . 0.0 108.821 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 154.45 -30.24 0.7 Allowed Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.003 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 4.1 pt20 -114.22 -46.24 3.0 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-O 121.174 0.511 . . . . 0.0 110.065 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.426 ' N ' ' HG3' ' A' ' 412' ' ' GLN . 5.1 p-10 179.87 126.52 0.08 Allowed 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . 0.422 ' HA ' ' HB ' ' A' ' 409' ' ' ILE . 46.8 mt-10 -82.45 -47.15 12.58 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 120.855 0.359 . . . . 0.0 111.245 -169.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.554 ' HA ' ' NH2' ' A' ' 439' ' ' ARG . 46.5 p -139.9 -95.27 0.16 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.901 -176.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 19.0 t70 170.0 -76.3 0.0 OUTLIER 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -171.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -139.64 0.12 1.8 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.793 0.806 . . . . 0.0 109.751 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.518 ' O ' ' HB ' ' A' ' 415' ' ' THR . 36.3 ptt180 -170.14 150.99 3.76 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.68 -172.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.61 157.08 40.38 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.413 2.075 . . . . 0.0 112.41 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' GLU . . . . . 0.527 ' HG3' ' HG3' ' A' ' 439' ' ' ARG . 2.1 mp0 -72.9 147.75 45.02 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.395 0.434 . . . . 0.0 111.396 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.974 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 4.3 t -58.96 131.73 86.83 Favored Pre-proline 0 C--O 1.243 0.733 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.959 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -58.23 -22.66 58.19 Favored 'Trans proline' 0 N--CA 1.48 0.714 0 C-N-CA 123.041 2.494 . . . . 0.0 112.631 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -97.04 -5.64 37.11 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.615 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 75.45 -154.31 45.65 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.109 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.4 -16.91 39.39 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 121.996 1.797 . . . . 0.0 111.908 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 22.8 t -79.56 4.38 16.01 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.443 0.64 . . . . 0.0 111.04 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' CYS . . . . . 0.974 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 45.5 t -55.99 116.35 2.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.998 178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -107.59 22.54 15.82 Favored 'General case' 0 C--O 1.248 1.018 0 O-C-N 123.61 0.569 . . . . 0.0 110.419 178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -69.41 104.44 2.29 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -80.66 98.1 7.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.04 -174.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . 0.524 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 64.7 t30 -176.0 129.06 0.37 Allowed Pre-proline 0 CA--C 1.522 -0.128 0 C-N-CA 123.715 0.806 . . . . 0.0 109.84 176.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.524 ' HD2' ' OD1' ' A' ' 431' ' ' ASN . 18.4 Cg_endo -60.45 -43.66 32.3 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.714 1.609 . . . . 0.0 111.543 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.628 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 22.8 tp60 -60.88 -34.92 75.36 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . 0.702 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 51.5 t60 -56.67 -59.22 5.32 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 123.65 0.594 . . . . 0.0 111.522 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.434 ' HD3' ' H ' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -61.67 -11.42 11.66 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.048 178.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 432' ' ' PRO . 81.0 mt -83.74 -40.98 16.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.369 0.604 . . . . 0.0 110.929 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.628 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 23.4 mt-10 -78.9 -34.25 44.87 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.978 -176.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -114.77 132.11 56.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.84 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' ARG . . . . . 0.554 ' NH2' ' HA ' ' A' ' 415' ' ' THR . 13.2 ptt180 -84.09 124.5 31.17 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.562 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.751 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 33.1 m80 -100.14 86.29 3.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.207 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -77.86 135.67 37.95 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.342 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 3.1 p -111.64 133.25 54.02 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 123.703 0.801 . . . . 0.0 110.172 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.89 158.08 34.09 Favored Pre-proline 0 C--O 1.239 0.545 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -176.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' PRO . . . . . 0.561 ' HG3' HG23 ' A' ' 448' ' ' VAL . 17.7 Cg_endo -59.17 -24.75 75.34 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.809 2.339 . . . . 0.0 112.2 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 444' ' ' PRO . 3.7 p 49.62 21.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.491 0.717 . . . . 0.0 111.874 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.436 ' HG2' ' OD1' ' A' ' 447' ' ' ASN . 48.5 ttt180 -166.64 141.23 4.17 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . 0.436 ' OD1' ' HG2' ' A' ' 446' ' ' ARG . 4.2 m-20 63.56 -83.61 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.32 1.013 . . . . 0.0 111.454 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.561 HG23 ' HG3' ' A' ' 444' ' ' PRO . 35.3 m . . . . . 0 N--CA 1.474 0.773 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.884 -174.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' ' ZN' . . . . . 0.924 'ZN ' ' HG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' ' ZN' . . . . . 0.821 'ZN ' ' HG ' ' A' ' 421' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.853 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 19.3 t -136.27 150.19 48.81 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 360' ' ' LYS . 0.7 OUTLIER -87.7 169.64 11.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 123.602 0.563 . . . . 0.0 109.626 179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -139.03 77.63 1.63 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.682 0.753 . . . . 0.0 110.188 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 20.2 p -100.0 175.22 5.84 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.249 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -65.98 101.86 0.73 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.359 0.6 . . . . 0.0 109.682 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 33.5 t -62.39 118.85 8.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.914 -176.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.0 p -86.02 71.46 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 122.089 0.947 . . . . 0.0 109.144 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . 0.427 HD12 ' N ' ' A' ' 367' ' ' GLN . 4.6 pp -63.26 -26.57 68.84 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.496 -175.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' GLN . . . . . 0.427 ' N ' HD12 ' A' ' 366' ' ' LEU . 0.4 OUTLIER -113.1 87.64 2.64 Favored 'General case' 0 C--O 1.25 1.087 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 174.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 153.71 -19.16 0.68 Allowed Glycine 0 CA--C 1.503 -0.671 0 O-C-N 123.183 0.302 . . . . 0.0 112.881 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 69.6 m -70.09 77.12 0.51 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.405 0.621 . . . . 0.0 110.209 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -86.2 -64.15 1.2 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.692 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -153.45 39.19 0.71 Allowed Glycine 0 C--N 1.316 -0.538 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -155.23 158.06 38.27 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.131 -0.534 . . . . 0.0 110.074 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -93.06 -45.16 8.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.774 0.797 . . . . 0.0 110.465 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 28.8 m -121.46 156.92 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.287 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -97.59 132.54 43.16 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.263 0.554 . . . . 0.0 110.615 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.16 161.69 14.32 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.308 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 14.9 t -103.69 147.16 27.57 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 21.1 m -54.99 125.92 22.41 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.358 0.599 . . . . 0.0 111.964 -174.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.755 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 45.9 t -56.81 124.09 17.3 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.647 174.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 34.3 ttp -50.59 -47.6 58.03 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.343 0.592 . . . . 0.0 111.372 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.515 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 56.5 m-85 -88.43 -9.79 51.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.344 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.607 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 67.87 -130.81 28.07 Favored Glycine 0 CA--C 1.501 -0.805 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -172.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . 0.505 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -80.73 -7.87 59.49 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.935 0.874 . . . . 0.0 110.913 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -79.99 -9.59 59.7 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.697 -176.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.79 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 3.7 p -63.06 136.53 57.85 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 123.583 0.552 . . . . 0.0 110.872 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -79.06 4.9 13.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.249 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -84.81 136.62 33.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.87 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.422 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.7 OUTLIER -123.7 -7.93 7.93 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.311 0.577 . . . . 0.0 110.409 179.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -66.74 139.27 95.74 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.514 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -60.59 -22.46 72.5 Favored 'Trans proline' 0 N--CA 1.48 0.698 0 C-N-CA 122.681 2.254 . . . . 0.0 111.314 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.422 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 99.3 t -63.42 -39.77 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.28 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.768 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 86.1 t60 -59.53 -31.66 69.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 0.0 110.131 178.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -91.0 -11.4 39.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.666 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 1.9 pp0? -82.87 -26.77 31.28 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.942 0.401 . . . . 0.0 110.567 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -110.57 -17.2 13.47 Favored 'General case' 0 C--O 1.24 0.588 0 O-C-N 121.634 -0.666 . . . . 0.0 111.862 176.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 377' ' ' THR . 20.1 m-30 -125.11 135.23 52.47 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.273 0.488 . . . . 0.0 111.467 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 20.8 p -83.37 156.51 22.96 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 123.648 0.593 . . . . 0.0 110.269 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.585 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 40.7 m80 -135.61 159.89 69.75 Favored Pre-proline 0 C--O 1.221 -0.421 0 C-N-CA 122.51 0.324 . . . . 0.0 110.956 -174.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.505 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 18.7 Cg_endo -56.48 114.75 2.05 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.965 1.777 . . . . 0.0 110.832 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.08 2.98 48.67 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 -174.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . 0.441 ' HB3' ' H ' ' A' ' 398' ' ' HIS . 20.7 t70 -101.62 155.95 17.79 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.381 -0.482 . . . . 0.0 109.915 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 32.0 t -59.49 -37.09 77.34 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.812 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -106.36 15.05 26.58 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.333 -167.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -84.34 149.77 25.82 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -179.93 -16.02 0.03 OUTLIER Glycine 0 C--O 1.239 0.419 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.52 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 80.26 36.36 24.3 Favored Glycine 0 N--CA 1.462 0.393 0 O-C-N 121.357 -1.084 . . . . 0.0 111.561 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 33.7 m -77.72 -6.28 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 124.485 0.756 . . . . 0.0 110.417 -178.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -106.7 134.49 49.77 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.658 0.783 . . . . 0.0 110.506 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 6.3 pt -54.31 -50.2 58.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.18 115.16 5.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 121.822 0.82 . . . . 0.0 110.85 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 125.11 -14.72 7.41 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.04 -172.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.25 -36.54 0.44 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 121.013 -0.275 . . . . 0.0 111.729 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -165.72 134.6 3.22 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 110.493 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -136.46 31.92 2.83 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.89 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 77.2 p -71.77 -60.98 1.95 Allowed 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.021 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 417' ' ' ASP . 17.9 t70 -168.41 -31.4 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.04 178.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 416' ' ' ASP . 16.9 t0 80.62 78.81 0.04 OUTLIER 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.066 0.947 . . . . 0.0 111.287 173.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.4 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 25.6 ptt180 178.43 158.7 0.61 Allowed Pre-proline 0 CA--C 1.514 -0.423 0 CA-C-N 113.988 -1.46 . . . . 0.0 108.845 172.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 31.0 Cg_endo -63.15 151.1 86.52 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.263 1.975 . . . . 0.0 111.452 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' GLU . . . . . 0.583 ' HG2' ' HG3' ' A' ' 439' ' ' ARG . 36.7 mt-10 -85.05 154.26 22.2 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.385 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.971 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 8.2 t -58.58 133.69 85.84 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.046 -178.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 421' ' ' CYS . 52.6 Cg_exo -56.48 -29.18 77.1 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.047 2.498 . . . . 0.0 112.715 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . 0.563 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 51.5 m-85 -98.25 6.88 46.97 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.53 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 62.52 -151.27 46.6 Favored Glycine 0 CA--C 1.52 0.354 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.85 -15.74 29.68 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.287 1.991 . . . . 0.0 112.366 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 31.4 t -73.45 -10.19 59.47 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.624 0.726 . . . . 0.0 110.048 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' CYS . . . . . 0.971 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 42.5 t -62.38 118.62 7.73 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.189 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -125.58 23.0 7.52 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.098 0.874 . . . . 0.0 109.021 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -56.71 117.1 3.58 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.554 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -67.08 97.46 0.51 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.414 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . 0.518 HD21 ' HB3' ' A' ' 433' ' ' GLN . 62.4 t30 -178.06 121.11 0.25 Allowed Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 123.443 0.697 . . . . 0.0 109.7 173.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.15 -27.8 28.97 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 121.502 1.468 . . . . 0.0 111.866 -178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.623 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 27.0 tp60 -72.34 -34.18 67.85 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . 0.626 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 24.5 t60 -57.56 -56.61 19.71 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.859 178.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -63.21 -20.06 65.09 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.242 -177.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . . . . . . . . . 50.2 mt -78.41 -41.45 25.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 C-N-CA 122.703 0.401 . . . . 0.0 110.092 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.623 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 22.7 mt-10 -79.41 -45.68 19.03 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.815 -175.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -101.45 138.82 37.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.64 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' ARG . . . . . 0.583 ' HG3' ' HG2' ' A' ' 420' ' ' GLU . 19.1 ptt180 -92.25 145.18 24.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.515 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -119.33 98.86 6.35 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -110.2 168.61 9.31 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 4.1 p -116.99 131.99 56.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.417 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 2.5 pp -120.12 151.0 52.4 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.217 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' PRO . . . . . 0.542 ' O ' HG12 ' A' ' 445' ' ' VAL . 16.5 Cg_endo -56.79 -42.37 65.56 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.898 2.399 . . . . 0.0 112.686 -171.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 444' ' ' PRO . 2.5 p 51.4 12.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 124.582 1.176 . . . . 0.0 111.127 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 446' ' ' ARG . 0.0 OUTLIER -84.06 -43.49 15.04 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -170.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -107.78 24.04 13.53 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.563 0.697 . . . . 0.0 110.955 -175.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.479 1.011 0 CA-C-O 121.021 0.439 . . . . 0.0 110.648 -179.788 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' ' ZN' . . . . . 0.79 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' ' ZN' . . . . . 0.931 'ZN ' ' HG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 21.4 p -92.18 -21.7 20.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.106 0.479 . . . . 0.0 111.228 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.754 ' HA ' ' HE2' ' A' ' 360' ' ' LYS . 0.6 OUTLIER 62.69 12.21 5.42 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.987 178.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -94.79 117.88 30.86 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.828 -173.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 17.2 p -119.18 139.78 51.27 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 173.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -74.49 97.43 3.11 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 120.872 0.368 . . . . 0.0 111.611 -176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 20.5 p -66.28 108.51 2.34 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.995 176.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 365' ' ' VAL . 7.5 p -61.55 107.05 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 121.055 0.455 . . . . 0.0 110.775 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 3.6 pp -76.59 -16.05 59.69 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.619 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -81.51 157.88 24.68 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 123.768 0.667 . . . . 0.0 109.958 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 91.55 22.43 31.51 Favored Glycine 0 C--O 1.229 -0.211 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.507 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 22.6 t -132.1 24.65 4.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.479 ' CD ' ' H ' ' A' ' 370' ' ' GLU . 4.6 mp0 -59.56 -60.67 3.48 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 116.273 -0.422 . . . . 0.0 109.943 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 62.88 32.15 82.9 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.531 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -152.26 156.9 40.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.788 0.328 . . . . 0.0 110.73 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.514 ' HD3' ' H ' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -134.9 13.83 3.63 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 173.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.93 157.45 22.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.687 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.58 164.18 13.08 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.472 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.2 OUTLIER -115.05 174.09 6.16 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.325 0.583 . . . . 0.0 110.906 177.068 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 13.4 t -127.15 157.47 39.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.876 176.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 69.6 p -50.61 122.37 7.09 Favored 'General case' 0 C--O 1.249 1.028 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -170.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.845 ' HG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 53.0 t -65.13 115.22 5.27 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 168.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . 0.802 ' HA ' ' HA2' ' A' ' 411' ' ' GLY . 44.3 ttp -51.89 -42.97 63.13 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.596 0.712 . . . . 0.0 111.624 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.563 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 24.8 m-85 -87.63 -9.06 55.32 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.794 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.617 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 62.5 -130.71 43.75 Favored Glycine 0 N--CA 1.439 -1.127 0 CA-C-O 119.248 -0.751 . . . . 0.0 112.521 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . 0.649 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -75.82 -10.25 59.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.405 0.621 . . . . 0.0 111.67 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -85.97 -5.65 59.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.676 -174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.797 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 4.7 p -65.64 132.62 49.27 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.12 0.486 . . . . 0.0 110.897 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -71.39 -11.88 61.12 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.405 0.621 . . . . 0.0 110.375 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -80.34 108.76 14.21 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.592 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.39 -3.3 21.21 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.34 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -63.18 140.41 97.67 Favored Pre-proline 0 C--O 1.233 0.189 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.025 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.72 -22.41 61.11 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 122.058 1.839 . . . . 0.0 110.901 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.57 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 96.6 t -66.7 -35.63 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.847 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.703 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 47.0 t60 -60.86 -30.82 70.36 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 121.892 -0.505 . . . . 0.0 109.668 177.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -90.82 -15.67 29.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.733 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -81.73 -19.45 41.4 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.509 -178.265 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.656 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 2.5 p80 -119.04 -10.53 9.81 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.656 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 86.9 m-85 -135.59 126.75 28.09 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 121.491 0.663 . . . . 0.0 111.111 176.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.472 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 25.3 m -72.15 154.45 41.05 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.004 176.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.591 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 55.2 m80 -134.99 166.26 30.5 Favored Pre-proline 0 C--N 1.322 -0.611 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.649 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 34.7 Cg_exo -40.04 -13.6 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 123.851 3.034 . . . . 0.0 115.782 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 398' ' ' HIS . . . -130.08 34.22 2.77 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . 0.428 ' HB3' ' H ' ' A' ' 398' ' ' HIS . 18.5 t70 -120.19 151.14 39.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.388 0.613 . . . . 0.0 109.823 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 23.3 t -64.42 -18.47 64.75 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -172.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -111.66 7.67 20.51 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -72.28 145.73 47.68 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.066 -0.653 . . . . 0.0 111.354 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -169.62 -45.24 0.03 OUTLIER Glycine 0 C--N 1.32 -0.346 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.859 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 92.72 33.3 7.52 Favored Glycine 0 C--O 1.237 0.338 0 C-N-CA 120.981 -0.628 . . . . 0.0 111.832 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.5 m -86.17 -17.27 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 O-C-N 122.609 -0.348 . . . . 0.0 110.69 -176.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -82.39 146.13 29.51 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.764 -176.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 410' ' ' VAL . 20.6 pt -52.76 -51.68 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-O 121.65 0.738 . . . . 0.0 110.786 178.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.548 HG22 ' HB2' ' A' ' 380' ' ' MET . 9.5 p -77.88 76.61 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.957 0 CA-C-O 122.651 1.215 . . . . 0.0 108.742 171.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.802 ' HA2' ' HA ' ' A' ' 380' ' ' MET . . . 177.2 -49.43 0.1 Allowed Glycine 0 C--O 1.218 -0.892 0 CA-C-N 114.044 -1.435 . . . . 0.0 110.433 -177.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 413' ' ' ASP . 4.2 pt20 -90.77 -54.74 3.85 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 171.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.491 ' N ' ' HG3' ' A' ' 412' ' ' GLN . 9.0 t70 170.65 143.13 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -90.14 5.69 45.81 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -171.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.453 HG22 ' HA ' ' A' ' 419' ' ' PRO . 43.9 p -94.81 125.74 39.67 Favored 'General case' 0 C--O 1.22 -0.489 0 O-C-N 122.006 -0.434 . . . . 0.0 111.234 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -69.62 -59.52 2.91 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.426 0.454 . . . . 0.0 109.941 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.406 ' CG ' ' HG2' ' A' ' 418' ' ' ARG . 19.2 p-10 -131.23 -20.05 2.74 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.498 177.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.51 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 13.9 ptt180 -166.63 165.03 10.11 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -175.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 40.6 Cg_endo -66.31 148.12 84.06 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.047 2.498 . . . . 0.0 111.195 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -75.0 151.88 38.76 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.572 0.701 . . . . 0.0 110.578 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.987 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 12.0 t -63.95 134.86 96.07 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.948 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.63 -5.77 9.3 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 122.169 1.912 . . . . 0.0 114.028 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -121.52 8.9 10.17 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.24 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 64.49 -154.12 48.5 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 119.835 -0.425 . . . . 0.0 112.527 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.43 -19.3 28.86 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.685 2.257 . . . . 0.0 111.711 178.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 36.5 t -74.13 -8.71 57.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.596 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' CYS . . . . . 0.987 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 48.7 t -49.84 117.83 2.51 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.277 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -112.68 22.24 14.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.46 0.648 . . . . 0.0 110.623 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -67.97 107.21 2.6 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.534 175.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -77.73 89.99 4.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.286 0.565 . . . . 0.0 111.567 -173.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -165.31 127.21 1.46 Allowed Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.258 176.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.558 ' O ' HG13 ' A' ' 436' ' ' ILE . 31.0 Cg_endo -63.16 -40.99 29.97 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.837 1.691 . . . . 0.0 111.592 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.448 HE21 ' HG2' ' A' ' 437' ' ' GLU . 23.8 tp60 -62.38 -37.09 84.42 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.766 0.317 . . . . 0.0 110.345 -176.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . 0.691 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 39.8 t60 -60.06 -56.78 17.48 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.958 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.466 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 23.1 mtpp -57.92 -21.6 44.47 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.641 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 432' ' ' PRO . 65.4 mt -81.23 -46.37 20.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 122.763 0.425 . . . . 0.0 110.797 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.448 ' HG2' HE21 ' A' ' 433' ' ' GLN . 7.2 mm-40 -84.02 -27.86 28.08 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -174.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -107.32 129.33 54.91 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 116.638 -0.256 . . . . 0.0 110.773 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' ARG . . . . . . . . . . . . . 22.0 ptt-85 -83.65 111.82 19.47 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.369 0.604 . . . . 0.0 110.859 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.725 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 63.8 m80 -87.53 112.53 22.33 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.525 176.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -114.66 125.56 53.88 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -171.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.6 p -88.9 124.43 34.2 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.504 ' CD1' ' HB ' ' A' ' 445' ' ' VAL . 1.4 pp -111.25 147.35 36.46 Favored Pre-proline 0 C--O 1.249 1.05 0 O-C-N 123.871 0.732 . . . . 0.0 111.76 -173.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' PRO . . . . . 0.424 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 28.4 Cg_endo -63.41 -30.68 72.61 Favored 'Trans proline' 0 C--N 1.325 -0.672 0 C-N-CA 123.041 2.494 . . . . 0.0 112.211 -175.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.504 ' HB ' ' CD1' ' A' ' 443' ' ' LEU . 8.7 p 43.33 30.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.739 0.816 . . . . 0.0 111.136 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.424 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 21.9 mmt180 -68.68 137.6 54.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.343 0.592 . . . . 0.0 111.553 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -74.09 86.37 1.86 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.023 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.448 -0.537 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.635 -179.496 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' ' ZN' . . . . . 0.845 'ZN ' ' HG ' ' A' ' 379' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' ' ZN' . . . . . 0.91 'ZN ' ' HG ' ' A' ' 421' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.406 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 40.4 t -73.64 146.77 44.34 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -97.31 113.46 25.09 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.908 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -137.82 82.28 1.91 Allowed 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.468 0.652 . . . . 0.0 110.759 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 23.7 p -80.91 142.26 33.73 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.716 0.77 . . . . 0.0 110.357 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -77.03 125.25 29.0 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 121.985 -0.447 . . . . 0.0 110.768 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 14.3 m -70.81 96.54 1.27 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.88 0.848 . . . . 0.0 110.532 177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.6 p -69.94 103.32 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.596 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 367' ' ' GLN . 2.9 pp -91.63 -15.96 27.77 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.77 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' GLN . . . . . 0.406 ' N ' HD12 ' A' ' 366' ' ' LEU . 6.3 tp-100 -71.06 87.99 0.77 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.492 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -127.79 16.79 6.13 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-O 122.224 0.902 . . . . 0.0 111.027 175.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 33.3 t -85.36 101.29 12.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.284 -0.458 . . . . 0.0 109.902 -176.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -84.16 -81.41 0.18 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.487 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 53.84 46.31 68.29 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.895 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -128.96 -174.34 3.23 Favored 'General case' 0 C--O 1.25 1.105 0 CA-C-O 120.809 0.338 . . . . 0.0 111.135 -174.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.52 ' HD3' ' H ' ' A' ' 373' ' ' LYS . 0.6 OUTLIER -115.86 -32.25 5.51 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 122.885 0.474 . . . . 0.0 110.464 175.03 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 12.5 m -121.64 -176.99 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -157.81 164.93 36.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.424 0.63 . . . . 0.0 109.525 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.477 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.0 OUTLIER -98.15 153.54 18.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.336 174.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.4 HG23 ' CD2' ' A' ' 396' ' ' PHE . 2.7 t -92.17 149.92 21.21 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.046 178.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.405 ' HB3' ' NE2' ' A' ' 408' ' ' GLN . 36.9 t -54.51 117.93 3.74 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.951 0.782 . . . . 0.0 111.752 -174.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.935 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 7.8 t -51.68 115.47 1.65 Allowed 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 170.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . 0.512 ' O ' HG22 ' A' ' 410' ' ' VAL . 26.0 ptm -57.15 -26.77 61.11 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.451 0.469 . . . . 0.0 111.321 -172.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.553 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 58.9 m-85 -102.78 -17.15 15.72 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 120.696 0.284 . . . . 0.0 110.677 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.422 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 66.41 -114.37 6.45 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.814 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -83.08 -7.29 59.66 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.996 -0.709 . . . . 0.0 110.745 178.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 381' ' ' TYR . 36.4 m-80 -83.88 -24.49 30.81 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.632 -176.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.935 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.8 p -67.2 120.99 14.68 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.593 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -78.96 4.32 14.62 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.391 1.057 . . . . 0.0 110.891 -174.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 31.7 mmm180 -80.96 119.86 24.02 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.699 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.457 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.9 OUTLIER -117.23 -1.73 11.77 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -176.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -60.99 142.58 92.74 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.352 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.68 -27.7 85.58 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.367 2.045 . . . . 0.0 110.384 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.469 ' O ' ' CD2' ' A' ' 395' ' ' HIS . 96.4 t -64.72 -41.07 91.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 O-C-N 123.79 0.681 . . . . 0.0 110.398 -178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.662 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 58.2 t60 -56.23 -34.0 65.93 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 39.6 m-85 -88.28 -25.05 23.01 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.198 0.523 . . . . 0.0 110.762 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -66.97 -19.37 65.71 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.595 -175.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.513 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 8.6 p80 -125.86 -17.75 5.31 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.621 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.513 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 26.3 m-85 -125.64 129.03 48.78 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 120.857 0.361 . . . . 0.0 110.898 174.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.477 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 13.7 p -84.08 160.82 20.86 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.396 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.732 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 43.9 m80 -133.44 159.18 73.58 Favored Pre-proline 0 C--N 1.342 0.271 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.667 -174.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -51.6 113.23 1.06 Allowed 'Trans proline' 0 C--O 1.238 0.517 0 C-N-CA 122.625 2.217 . . . . 0.0 112.242 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 110.66 -8.42 30.06 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.957 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -86.76 148.69 25.31 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.598 0.713 . . . . 0.0 110.869 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 46.1 t -56.71 -29.69 62.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.314 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -107.4 17.17 23.12 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.655 -175.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -92.46 120.6 33.1 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -103.26 -57.61 0.76 Allowed Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.501 176.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 66.51 50.12 51.55 Favored Glycine 0 N--CA 1.463 0.494 0 CA-C-N 115.253 -0.473 . . . . 0.0 112.232 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.3 m -112.35 -1.35 9.77 Favored 'Isoleucine or valine' 0 C--O 1.249 1.028 0 O-C-N 122.008 -0.701 . . . . 0.0 112.405 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.405 ' NE2' ' HB3' ' A' ' 378' ' ' SER . 28.0 pt20 -77.67 175.92 9.47 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.993 176.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.505 HG13 ' H ' ' A' ' 410' ' ' VAL . 4.7 pt -65.48 -61.66 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-O 120.874 0.369 . . . . 0.0 110.637 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 380' ' ' MET . 8.0 p -64.88 118.98 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-O 121.686 0.755 . . . . 0.0 110.382 -175.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 127.01 -63.64 0.6 Allowed Glycine 0 C--O 1.242 0.608 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -169.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.62 -40.75 15.87 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.006 0.403 . . . . 0.0 110.935 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -168.75 129.57 1.21 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.105 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 410' ' ' VAL . 40.1 mt-10 -100.89 4.64 42.85 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.71 -172.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 54.2 p -103.18 -75.44 0.61 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.254 -0.178 . . . . 0.0 111.418 -175.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -161.08 -62.7 0.06 Allowed 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 123.064 0.546 . . . . 0.0 109.925 -175.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -138.53 -14.64 1.26 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.799 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 13.7 ptt180 -171.95 154.15 3.4 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 122.432 0.293 . . . . 0.0 110.314 -173.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.94 147.85 24.8 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.516 2.144 . . . . 0.0 112.317 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.47 152.79 25.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.67 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 17.1 t -59.03 129.41 85.99 Favored Pre-proline 0 C--O 1.244 0.785 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.927 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.89 -6.73 18.83 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 122.351 2.034 . . . . 0.0 111.745 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . 0.587 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 52.8 m-85 -108.27 8.97 28.05 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.027 176.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 62.72 -159.76 34.56 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.914 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.1 -20.74 24.75 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.076 2.517 . . . . 0.0 111.079 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 16.4 t -76.01 -4.25 40.22 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.755 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' CYS . . . . . 0.781 ' SG ' ' NE2' ' A' ' 434' ' ' HIS . 43.2 t -56.97 123.82 16.48 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 123.426 0.691 . . . . 0.0 112.028 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -126.94 28.97 5.72 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.573 ' HG2' ' SG ' ' A' ' 427' ' ' CYS . 20.9 mmm180 -68.69 101.35 1.29 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.658 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -67.86 90.8 0.3 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.394 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . 0.486 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 59.8 t30 -162.7 127.91 2.14 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.878 174.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.486 ' HD2' ' OD1' ' A' ' 431' ' ' ASN . 18.5 Cg_endo -60.59 -43.06 35.06 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 122.099 1.866 . . . . 0.0 112.392 -177.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.429 HE21 ' HG2' ' A' ' 437' ' ' GLU . 22.4 tp60 -63.44 -32.34 73.76 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.789 -177.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . 0.781 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 43.8 t60 -58.13 -59.83 4.68 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.828 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -12.36 60.76 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.448 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 432' ' ' PRO . 62.8 mt -76.7 -51.27 19.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.198 0.523 . . . . 0.0 110.671 175.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.429 ' HG2' HE21 ' A' ' 433' ' ' GLN . 7.9 mm-40 -72.95 -49.62 28.21 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.061 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -98.59 138.3 35.98 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.412 0.445 . . . . 0.0 111.276 -173.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' ARG . . . . . 0.458 HH11 ' HD2' ' A' ' 439' ' ' ARG . 11.8 ptt180 -94.96 145.27 25.04 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.463 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 31.1 m80 -120.33 108.75 14.54 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -176.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -95.69 131.79 41.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.054 0.454 . . . . 0.0 109.975 -177.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 10.2 p -114.13 147.35 38.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.262 -175.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.489 HD13 ' HB ' ' A' ' 445' ' ' VAL . 1.2 pp -149.99 148.28 24.58 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.485 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.38 -25.74 11.0 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.962 2.441 . . . . 0.0 112.578 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.489 ' HB ' HD13 ' A' ' 443' ' ' LEU . 7.9 p 46.63 27.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 122.443 1.116 . . . . 0.0 111.932 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 -87.81 -28.6 21.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.644 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -63.69 -32.19 73.59 Favored 'General case' 0 CA--C 1.555 1.14 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.5 -176.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 C--N 1.318 -0.772 0 O-C-N 122.218 -0.301 . . . . 0.0 110.514 178.741 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' ' ZN' . . . . . 0.817 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' ' ZN' . . . . . 0.752 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.043 0 N-CA-C 112.376 -0.289 . . . . 0.0 112.376 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 38.1 m -65.74 134.55 53.4 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 117.25 0.525 . . . . 0.0 110.176 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -119.87 148.94 42.87 Favored 'General case' 0 C--O 1.248 1.019 0 C-N-CA 122.651 0.38 . . . . 0.0 110.368 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -161.47 129.04 4.12 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 123.451 0.469 . . . . 0.0 110.804 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 25.1 p -103.71 131.83 50.52 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.08 176.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -70.35 111.18 5.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.496 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 28.9 t -69.79 107.67 3.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 35.9 t -75.31 80.29 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . 0.423 ' H ' HD23 ' A' ' 366' ' ' LEU . 2.3 pt? -60.38 -33.58 72.67 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.708 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -152.42 156.77 40.15 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.754 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -174.98 125.67 1.11 Allowed Glycine 0 CA--C 1.508 -0.396 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 14.8 m -62.4 -52.37 63.85 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.618 0.246 . . . . 0.0 110.464 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 44.47 86.01 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 O-C-N 123.953 0.783 . . . . 0.0 110.172 -176.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 150.55 -64.9 0.38 Allowed Glycine 0 C--N 1.309 -0.971 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -101.75 103.23 13.97 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 122.108 0.956 . . . . 0.0 109.281 171.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -76.3 -28.64 57.04 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 5.3 m -139.08 161.18 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 113.53 -1.668 . . . . 0.0 108.019 175.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.584 ' N ' ' HD2' ' A' ' 375' ' ' LYS . 8.9 mptt -90.11 -31.22 17.2 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.431 0.634 . . . . 0.0 109.393 -172.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.474 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.1 OUTLIER -114.47 155.76 25.8 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.234 172.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 12.2 t -108.97 152.95 24.27 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.076 0.86 . . . . 0.0 109.29 175.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.404 ' OG ' HG22 ' A' ' 407' ' ' VAL . 45.7 m -51.52 122.73 8.46 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 121.161 0.505 . . . . 0.0 111.483 -174.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.85 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 54.0 t -51.3 123.15 9.0 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.937 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 23.8 ptm -55.42 -25.05 33.72 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.185 0.594 . . . . 0.0 111.324 -174.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.543 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 37.5 m-85 -116.88 -8.07 11.35 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.813 177.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 379' ' ' CYS . . . 63.05 -123.98 31.32 Favored Glycine 0 C--O 1.242 0.644 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.863 -177.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -82.06 -9.71 59.46 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.303 0.241 . . . . 0.0 111.056 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -77.05 -30.29 55.57 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.806 0.336 . . . . 0.0 111.193 -175.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.85 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 4.5 p -65.94 115.82 6.43 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.24 176.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -76.28 2.36 13.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.856 0.836 . . . . 0.0 110.944 -175.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -65.92 124.0 21.33 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.048 172.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.512 ' HD2' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -125.61 3.02 7.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.168 0.509 . . . . 0.0 110.464 -176.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -61.43 139.86 94.83 Favored Pre-proline 0 C--O 1.247 0.957 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.186 172.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.69 -25.13 80.34 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 122.934 2.423 . . . . 0.0 112.346 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.564 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 95.9 t -64.24 -37.18 79.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.573 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.762 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 26.0 t60 -58.64 -27.36 64.66 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.143 0.497 . . . . 0.0 110.644 177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -98.09 -7.96 28.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.668 -177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -84.18 -17.05 41.24 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.041 0.448 . . . . 0.0 110.959 -176.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.476 ' ND1' ' CD1' ' A' ' 396' ' ' PHE . 7.8 p80 -126.58 -16.65 5.25 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 176.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.532 ' CD2' ' HA ' ' A' ' 379' ' ' CYS . 63.5 m-85 -125.07 128.03 47.85 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.675 0.75 . . . . 0.0 112.408 174.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.474 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 20.1 p -80.01 165.38 22.63 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.483 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -136.97 158.29 73.11 Favored Pre-proline 0 C--O 1.245 0.864 0 O-C-N 123.203 0.314 . . . . 0.0 110.318 -175.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -54.38 97.28 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.153 2.569 . . . . 0.0 110.728 -178.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 121.93 17.14 3.84 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 123.76 0.663 . . . . 0.0 111.457 -174.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -117.24 151.08 37.66 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 122.215 -0.579 . . . . 0.0 110.208 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 35.2 t -57.76 -36.78 72.57 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.168 -176.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -92.79 9.05 36.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.22 0.533 . . . . 0.0 111.253 -172.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -96.9 146.81 24.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.789 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 160.81 41.82 0.02 OUTLIER Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.55 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . 0.432 ' HA2' ' OE1' ' A' ' 412' ' ' GLN . . . 57.89 41.52 94.23 Favored Glycine 0 N--CA 1.464 0.501 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.69 -177.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.404 HG22 ' OG ' ' A' ' 378' ' ' SER . 9.7 m -80.74 -13.66 12.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.428 0.632 . . . . 0.0 109.496 -175.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -139.39 129.77 25.54 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 9.1 pt -48.59 -45.95 14.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.97 0.891 . . . . 0.0 110.614 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 19.3 t -67.54 105.84 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 379' ' ' CYS . . . 157.37 -48.95 0.44 Allowed Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -175.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.588 ' H ' ' NE2' ' A' ' 412' ' ' GLN . 0.7 OUTLIER -118.07 -42.49 2.81 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 122.925 0.49 . . . . 0.0 110.616 177.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -170.17 136.45 1.42 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 122.848 0.459 . . . . 0.0 110.585 173.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.9 21.67 3.06 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.113 0.965 . . . . 0.0 110.751 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 35.5 p -127.38 -71.8 0.66 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.388 0.614 . . . . 0.0 110.655 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.5 t70 170.33 -51.83 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.101 -172.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -178.92 -26.85 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 114.175 -1.375 . . . . 0.0 110.242 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 20.9 ptt180 -142.98 160.02 54.3 Favored Pre-proline 0 C--O 1.216 -0.689 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.099 -170.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.76 159.22 48.95 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 121.652 1.568 . . . . 0.0 112.037 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' GLU . . . . . 0.406 ' HG3' ' CZ ' ' A' ' 439' ' ' ARG . 40.8 mt-10 -73.51 155.24 39.39 Favored 'General case' 0 C--O 1.248 0.995 0 O-C-N 121.918 -0.489 . . . . 0.0 110.907 177.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.77 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 16.1 t -61.7 133.64 93.61 Favored Pre-proline 0 N--CA 1.443 -0.785 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.359 176.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.17 -9.05 22.15 Favored 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 122.41 2.074 . . . . 0.0 112.743 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -116.5 12.2 15.07 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.086 0.554 . . . . 0.0 110.113 177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 58.38 -153.55 27.45 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 116.5 -0.318 . . . . 0.0 112.497 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.87 -13.99 24.08 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.158 2.572 . . . . 0.0 112.474 173.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 32.2 t -70.17 -14.06 62.47 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.568 173.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' CYS . . . . . 0.81 ' SG ' 'ZN ' ' A' ' 450' ' ' ' ZN' . 51.5 t -49.76 137.02 16.78 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.256 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -138.12 20.57 2.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.501 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -63.96 104.1 0.67 Allowed 'General case' 0 C--O 1.24 0.604 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.676 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 430' ' ' LYS . 18.9 ptpt -62.24 95.88 0.07 Allowed 'General case' 0 C--O 1.249 1.055 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.011 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . 0.465 HD21 ' HB3' ' A' ' 433' ' ' GLN . 61.4 t30 -177.98 123.2 0.26 Allowed Pre-proline 0 C--O 1.238 0.475 0 CA-C-O 120.659 0.266 . . . . 0.0 110.496 176.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.08 -39.2 40.99 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.755 2.303 . . . . 0.0 111.83 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.617 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 25.8 tp60 -64.46 -32.79 74.56 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.466 0.65 . . . . 0.0 110.655 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . 0.574 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 35.8 t60 -55.96 -59.95 4.17 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.094 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.404 ' H ' ' HD3' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -59.11 -19.01 40.73 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.972 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.487 HD12 ' HA ' ' A' ' 433' ' ' GLN . 77.3 mt -75.09 -43.84 44.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.596 0.713 . . . . 0.0 110.878 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.617 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 19.6 mt-10 -82.66 -40.4 20.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.28 -174.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -106.78 128.87 54.61 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.224 -175.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' ARG . . . . . 0.406 ' CZ ' ' HG3' ' A' ' 420' ' ' GLU . 15.3 ptt-85 -85.4 116.4 23.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.894 0.854 . . . . 0.0 110.185 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.745 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 37.0 m80 -90.82 86.08 6.21 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.101 178.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -70.49 104.23 2.7 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.464 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 6.8 m -114.06 160.25 19.1 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.702 -171.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.476 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.5 OUTLIER -135.12 157.24 77.31 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.769 179.157 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' PRO . . . . . 0.41 ' O ' HG12 ' A' ' 445' ' ' VAL . 18.7 Cg_endo -60.0 -42.28 45.72 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 122.06 1.84 . . . . 0.0 112.036 -175.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.476 ' HB ' HD13 ' A' ' 443' ' ' LEU . 2.7 p 50.37 15.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 124.347 1.029 . . . . 0.0 112.513 177.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.41 133.56 46.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 -176.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . 0.525 HD22 ' N ' ' A' ' 447' ' ' ASN . 0.8 OUTLIER -73.29 86.23 1.45 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.971 -178.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.321 -0.638 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.89 178.542 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' ' ZN' . . . . . 0.765 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' ' ZN' . . . . . 0.81 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.858 0 N-CA-C 112.201 -0.36 . . . . 0.0 112.201 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 39.3 t -159.76 122.95 3.57 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.812 0.339 . . . . 0.0 111.321 -176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.48 108.81 18.94 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 172.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -105.18 101.12 10.69 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.829 0.347 . . . . 0.0 110.432 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 16.5 p -70.86 129.79 39.97 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.175 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -87.87 123.11 32.29 Favored 'General case' 0 C--O 1.249 1.075 0 C-N-CA 122.668 0.387 . . . . 0.0 110.412 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 30.8 p -73.46 173.7 9.25 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 123.736 0.648 . . . . 0.0 110.355 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.45 117.09 47.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.177 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 367' ' ' GLN . 3.1 pp -109.87 -23.13 11.53 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' GLN . . . . . 0.513 ' N ' HD12 ' A' ' 366' ' ' LEU . 35.1 tt0 -62.87 98.57 0.13 Allowed 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 151.53 -39.77 0.79 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -175.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 30.6 m -81.94 88.59 6.36 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 172.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.541 ' HG3' ' ND2' ' A' ' 372' ' ' ASN . 9.9 pt-20 -132.56 35.79 3.6 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.425 0.631 . . . . 0.0 110.949 -170.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 74.21 -77.57 1.01 Allowed Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . 0.541 ' ND2' ' HG3' ' A' ' 370' ' ' GLU . 0.1 OUTLIER -63.62 152.71 38.15 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 110.664 -0.125 . . . . 0.0 110.664 178.059 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.517 ' N ' ' HD3' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -92.13 -51.68 5.06 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 20.1 m -110.08 140.17 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.952 0.882 . . . . 0.0 109.588 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.726 ' N ' ' HD3' ' A' ' 375' ' ' LYS . 0.0 OUTLIER -98.8 -25.35 14.68 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.823 -178.69 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.7 158.86 33.74 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.212 173.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.629 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 12.9 m -101.0 139.94 35.99 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.66 173.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 49.7 m -54.83 122.98 11.96 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.609 -0.682 . . . . 0.0 110.023 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.772 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 18.4 t -50.16 123.3 8.12 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.199 0.523 . . . . 0.0 110.296 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . . . . . . . . . 25.8 ptm -60.31 -17.84 45.56 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.188 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.591 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 38.0 m-85 -112.92 -11.05 13.47 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.75 177.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.407 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 65.43 -131.07 35.06 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.262 -177.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -75.75 -11.68 60.04 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.072 0.463 . . . . 0.0 110.71 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -80.22 -9.58 59.73 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -173.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.848 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 8.2 p -75.31 133.52 41.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.765 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -84.08 14.13 4.47 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.552 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -96.51 121.16 38.03 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.698 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.474 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -108.43 -22.16 12.42 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.328 -178.162 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -44.67 136.84 4.38 Favored Pre-proline 0 N--CA 1.474 0.775 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.087 177.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -58.7 -23.77 67.68 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.011 2.474 . . . . 0.0 112.348 -176.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.629 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 74.0 t -67.65 -35.42 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.657 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.631 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 62.0 t60 -62.89 -19.85 64.58 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.69 -0.631 . . . . 0.0 109.794 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 90.7 m-85 -97.45 -7.53 31.42 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.74 -178.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.629 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -87.83 -19.81 26.93 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.045 0.45 . . . . 0.0 110.901 -178.029 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.458 ' ND1' ' CD2' ' A' ' 396' ' ' PHE . 7.4 p80 -121.5 -15.23 8.08 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.239 176.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.629 ' HA ' ' O ' ' A' ' 377' ' ' THR . 78.7 m-85 -133.57 127.55 33.35 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.779 0.8 . . . . 0.0 111.753 173.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 46.9 p -80.58 161.05 24.94 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 174.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.662 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 53.6 m80 -137.42 157.96 73.03 Favored Pre-proline 0 C--O 1.249 1.044 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -49.77 101.58 0.05 OUTLIER 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.199 2.599 . . . . 0.0 111.553 -176.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 122.41 -0.29 10.37 Favored Glycine 0 C--O 1.243 0.664 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.259 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -93.7 149.15 21.47 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 34.8 m -62.84 -20.53 65.17 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.522 0.514 . . . . 0.0 111.755 -175.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.76 -3.02 28.84 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -78.49 123.04 26.62 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 120.82 0.343 . . . . 0.0 111.458 -172.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -118.03 -30.67 1.72 Allowed Glycine 0 C--O 1.244 0.776 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 70.15 29.93 70.08 Favored Glycine 0 N--CA 1.463 0.489 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.41 -6.08 10.36 Favored 'Isoleucine or valine' 0 C--O 1.252 1.222 0 C-N-CA 123.559 0.744 . . . . 0.0 110.989 -174.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.529 ' O ' ' HG2' ' A' ' 412' ' ' GLN . 9.8 tt0 -83.61 131.66 34.95 Favored 'General case' 0 C--O 1.217 -0.611 0 O-C-N 122.176 -0.328 . . . . 0.0 110.322 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 12.6 pt -46.64 -47.56 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 122.989 0.516 . . . . 0.0 110.442 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . . . . . . . . . 13.3 t -77.81 109.86 12.87 Favored 'Isoleucine or valine' 0 C--O 1.252 1.23 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 130.78 -43.02 1.33 Allowed Glycine 0 C--N 1.319 -0.371 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -173.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 15.3 pt20 -97.86 -52.59 3.68 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.508 ' N ' ' HG3' ' A' ' 412' ' ' GLN . 31.1 t70 -169.64 118.45 0.63 Allowed 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -90.98 11.18 23.69 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.126 -166.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 76.5 p -65.61 166.95 9.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.197 0.522 . . . . 0.0 111.52 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 417' ' ' ASP . 10.8 t70 -66.44 -11.84 54.04 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.317 -175.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 416' ' ' ASP . 37.4 t70 80.7 63.32 0.02 OUTLIER 'General case' 0 C--O 1.243 0.761 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.917 173.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.515 ' HG3' ' CG ' ' A' ' 439' ' ' ARG . 14.6 ptt180 -179.12 153.8 0.75 Allowed Pre-proline 0 C--O 1.25 1.091 0 C-N-CA 124.001 0.921 . . . . 0.0 108.984 177.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -65.1 153.77 76.67 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.741 2.294 . . . . 0.0 111.163 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -74.44 161.0 30.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.655 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 18.7 t -58.72 134.23 86.4 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.493 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.42 -19.64 65.52 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.158 1.905 . . . . 0.0 112.18 -178.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 18.2 m-85 -93.77 -5.54 48.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.06 0.457 . . . . 0.0 110.169 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 75.05 -162.53 53.82 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -173.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.91 -12.42 26.16 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.366 2.044 . . . . 0.0 111.958 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 51.1 m -73.8 -9.02 58.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.031 0.443 . . . . 0.0 110.336 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' CYS . . . . . 0.797 ' SG ' 'ZN ' ' A' ' 450' ' ' ' ZN' . 51.0 t -50.89 117.88 2.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.971 178.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -106.03 7.99 32.16 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 122.036 0.922 . . . . 0.0 110.142 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -66.51 109.82 2.92 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . 0.465 ' HB2' ' NZ ' ' A' ' 430' ' ' LYS . 10.2 mtmp? -100.46 18.96 17.71 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -171.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . 0.493 ' OD1' ' HD2' ' A' ' 432' ' ' PRO . 61.7 t30 -68.44 125.95 92.19 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 172.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.515 ' O ' HG13 ' A' ' 436' ' ' ILE . 17.8 Cg_endo -57.08 -41.27 76.45 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.629 2.219 . . . . 0.0 111.801 -177.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.575 ' O ' ' HG2' ' A' ' 437' ' ' GLU . 24.9 tp60 -64.6 -38.05 89.67 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -177.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . 0.726 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 25.0 t60 -59.14 -52.75 64.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.089 178.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -57.63 -31.0 65.83 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.3 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 432' ' ' PRO . 65.1 mt -70.99 -42.7 76.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.257 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 433' ' ' GLN . 6.8 mm-40 -76.09 -38.18 57.27 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . 0.49 ' HB3' ' HA ' ' A' ' 421' ' ' CYS . 85.7 m-85 -114.85 150.69 35.16 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -171.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' ARG . . . . . 0.54 ' NH1' HD21 ' A' ' 441' ' ' ASN . 36.8 mtm180 -95.25 123.62 38.86 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 124.248 0.968 . . . . 0.0 110.776 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.477 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 71.4 m80 -99.5 85.78 3.23 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' ASN . . . . . 0.54 HD21 ' NH1' ' A' ' 439' ' ' ARG . 74.4 m-20 -107.52 151.74 25.17 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -176.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 7.5 p -98.12 147.98 24.02 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.996 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 2.6 pp -148.52 156.79 42.13 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 110.728 -0.101 . . . . 0.0 110.728 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' PRO . . . . . 0.55 ' HB2' ' HG2' ' A' ' 446' ' ' ARG . 21.1 Cg_endo -60.08 -28.53 87.21 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.933 2.422 . . . . 0.0 112.912 -174.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 444' ' ' PRO . 7.2 p 47.66 31.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 O-C-N 124.012 0.82 . . . . 0.0 111.183 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.55 ' HG2' ' HB2' ' A' ' 444' ' ' PRO . 26.4 mmt180 -86.67 163.01 17.62 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.703 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 60.51 44.24 12.04 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 10.0 m . . . . . 0 C--O 1.235 0.31 0 C-N-CA 124.548 1.139 . . . . 0.0 111.666 177.156 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' ' ZN' . . . . . 0.848 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' ' ZN' . . . . . 0.797 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.78 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 13.0 p -60.93 102.22 0.19 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.276 0.56 . . . . 0.0 111.528 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -143.66 95.36 2.73 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 123.54 0.736 . . . . 0.0 110.093 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -170.4 107.2 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.63 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 9.2 m -71.31 161.64 30.74 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -61.46 125.15 22.75 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 4.5 p -59.16 98.13 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.1 0.476 . . . . 0.0 111.291 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 35.7 t -73.13 90.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.458 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.3 pp -94.17 18.45 10.84 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.216 -178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -56.81 101.15 0.05 Allowed 'General case' 0 C--O 1.222 -0.343 0 O-C-N 123.752 0.657 . . . . 0.0 111.138 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -86.08 71.66 2.81 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.706 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 48.8 m -130.68 93.87 3.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.574 0.702 . . . . 0.0 110.552 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -108.48 156.61 19.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.85 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 104.2 43.15 1.79 Allowed Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -175.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . 0.536 ' HB3' ' O ' ' A' ' 374' ' ' VAL . 65.0 m-20 -113.86 134.31 54.88 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 114.661 -0.769 . . . . 0.0 111.342 -171.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.606 ' HD3' HG13 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -88.35 -25.16 22.88 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.55 1.167 . . . . 0.0 109.133 171.103 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.606 HG13 ' HD3' ' A' ' 373' ' ' LYS . 19.9 m -139.5 153.98 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 166.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.573 ' N ' ' HD2' ' A' ' 375' ' ' LYS . 3.6 mptp? -66.83 -49.67 65.01 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 121.531 0.682 . . . . 0.0 109.312 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.488 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.3 OUTLIER -143.23 144.23 32.07 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.548 174.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 5.2 t -97.27 143.2 28.28 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.904 173.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 58.5 m -54.74 123.08 12.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.319 0.58 . . . . 0.0 112.052 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.837 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 29.3 t -49.47 107.97 0.17 Allowed 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.226 176.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . 0.546 ' HB3' HG12 ' A' ' 410' ' ' VAL . 22.4 ptp -54.55 -27.3 37.59 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -93.93 -16.63 23.8 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.083 0.468 . . . . 0.0 109.998 178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.6 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 66.35 -126.43 28.06 Favored Glycine 0 C--O 1.235 0.161 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -176.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -91.27 4.5 52.17 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.678 0.391 . . . . 0.0 110.829 177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -88.52 -15.1 36.11 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.782 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.837 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 0.6 OUTLIER -67.94 131.61 45.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 0.0 110.397 177.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -82.65 21.11 1.03 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.281 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -95.99 121.99 38.33 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.653 176.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.418 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -107.82 -25.91 11.02 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 124.565 1.166 . . . . 0.0 108.534 -177.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -48.07 139.94 9.42 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.845 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.14 -22.34 67.41 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 121.849 1.699 . . . . 0.0 112.073 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.417 HG12 ' NE2' ' A' ' 395' ' ' HIS . 88.8 t -66.33 -34.73 72.11 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.865 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.726 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 70.9 t60 -59.82 -37.81 80.24 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.937 0.399 . . . . 0.0 110.153 175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -86.23 -18.2 32.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.35 -176.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -29.28 61.08 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -175.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.677 ' HD1' ' HD1' ' A' ' 396' ' ' PHE . 1.0 OUTLIER -109.68 -16.51 13.91 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.575 176.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.677 ' HD1' ' HD1' ' A' ' 395' ' ' HIS . 72.5 m-85 -122.35 127.84 50.26 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-O 120.74 0.305 . . . . 0.0 110.945 176.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.488 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 16.8 p -78.37 156.43 29.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 122.874 0.47 . . . . 0.0 110.027 175.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.686 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 51.0 m80 -132.02 159.02 73.9 Favored Pre-proline 0 N--CA 1.476 0.836 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.997 -176.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -52.37 102.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.679 2.253 . . . . 0.0 111.954 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 121.23 -1.37 11.56 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.737 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -98.12 151.45 20.37 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 122.035 0.921 . . . . 0.0 110.503 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 29.7 p -63.36 -29.11 70.47 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.163 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -104.73 15.86 27.11 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.226 -173.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -83.97 148.75 26.73 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -142.13 -50.18 0.04 OUTLIER Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.37 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 68.35 24.05 74.97 Favored Glycine 0 C--O 1.221 -0.668 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.652 -173.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 35.3 m -104.73 11.55 8.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.319 0 CA-C-O 121.741 0.782 . . . . 0.0 110.234 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.485 ' O ' ' HG2' ' A' ' 412' ' ' GLN . 8.0 tt0 -104.26 141.54 36.12 Favored 'General case' 0 C--O 1.247 0.937 0 C-N-CA 123.676 0.791 . . . . 0.0 110.235 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.479 HG13 ' N ' ' A' ' 410' ' ' VAL . 35.5 pt -53.92 -45.02 63.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.547 ' HA ' ' HG2' ' A' ' 414' ' ' GLU . 57.6 t -68.0 91.79 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 175.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 143.94 -51.83 0.63 Allowed Glycine 0 CA--C 1.509 -0.343 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 4.3 pt20 -90.79 -46.42 8.23 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.626 0.727 . . . . 0.0 110.3 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -177.67 121.01 0.11 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . 0.547 ' HG2' ' HA ' ' A' ' 410' ' ' VAL . 25.6 mt-10 -88.39 -35.88 16.88 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.571 -169.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 56.8 p -135.04 136.1 41.81 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 122.783 0.433 . . . . 0.0 111.187 -173.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -49.28 -59.15 3.94 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.318 1.011 . . . . 0.0 110.168 173.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -147.42 -43.56 0.17 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.353 175.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.492 ' O ' ' HD3' ' A' ' 439' ' ' ARG . 24.7 ptt180 -122.09 165.89 18.98 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.191 -176.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 61.3 Cg_endo -72.68 146.23 42.96 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.217 1.945 . . . . 0.0 112.052 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' GLU . . . . . 0.581 ' HG2' ' ND2' ' A' ' 441' ' ' ASN . 47.2 mt-10 -61.38 155.24 22.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.884 0.373 . . . . 0.0 111.357 175.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.956 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 8.3 t -66.62 136.7 94.85 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 421' ' ' CYS . 55.9 Cg_exo -53.21 -34.36 69.05 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.146 2.564 . . . . 0.0 112.69 -175.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . 0.501 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 74.8 m-85 -102.14 7.79 40.88 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.424 -176.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 71.04 -153.43 51.18 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.429 -0.35 . . . . 0.0 112.573 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.53 -19.02 49.11 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.538 2.159 . . . . 0.0 111.883 175.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 37.9 t -69.82 -19.58 63.47 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.599 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' CYS . . . . . 0.956 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 40.9 t -56.03 115.55 2.48 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.769 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -109.14 16.61 22.38 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 123.835 0.709 . . . . 0.0 109.483 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.527 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 2.4 mmp_? -53.71 93.23 0.01 OUTLIER 'General case' 0 C--O 1.246 0.884 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 173.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . 0.413 ' H ' ' HG2' ' A' ' 430' ' ' LYS . 14.4 ptpt -75.95 79.16 2.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.313 -174.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . 0.486 HD21 ' HB3' ' A' ' 433' ' ' GLN . 48.5 t30 -150.9 123.36 4.09 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.336 174.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.509 ' O ' HG13 ' A' ' 436' ' ' ILE . 23.2 Cg_endo -62.79 -33.16 77.08 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.19 1.926 . . . . 0.0 111.314 -175.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.486 ' HB3' HD21 ' A' ' 431' ' ' ASN . 21.4 tp60 -68.16 -38.65 82.32 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . 0.574 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 29.8 t60 -59.93 -53.85 53.06 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.948 0.88 . . . . 0.0 109.229 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.426 ' O ' ' NH1' ' A' ' 418' ' ' ARG . 51.1 mtpt -62.99 -14.69 50.8 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.307 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 432' ' ' PRO . 48.3 mt -86.31 -45.33 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 123.235 0.334 . . . . 0.0 110.546 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.448 ' HG2' HE21 ' A' ' 433' ' ' GLN . 30.1 mm-40 -76.8 -29.45 56.0 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 122.437 -0.164 . . . . 0.0 111.294 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -113.95 137.29 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 123.093 0.557 . . . . 0.0 109.87 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 418' ' ' ARG . 1.0 OUTLIER -94.47 130.3 40.9 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.078 178.167 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -106.17 86.07 2.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.595 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' ASN . . . . . 0.581 ' ND2' ' HG2' ' A' ' 420' ' ' GLU . 46.7 m-80 -69.85 135.47 49.63 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.332 -173.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 28.9 p -135.86 173.14 12.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.601 0.715 . . . . 0.0 110.448 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 443' ' ' LEU . 1.3 pp -137.12 146.46 54.57 Favored Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 122.028 -0.42 . . . . 0.0 110.284 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' PRO . . . . . 0.417 ' O ' HG12 ' A' ' 445' ' ' VAL . 27.2 Cg_endo -62.14 -44.54 19.17 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 122.901 2.401 . . . . 0.0 112.359 -175.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.453 ' HB ' HD13 ' A' ' 443' ' ' LEU . 5.9 p 48.21 26.27 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 124.444 1.098 . . . . 0.0 112.035 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 447' ' ' ASN . 27.8 mmm180 -92.5 167.81 11.69 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 446' ' ' ARG . 7.3 t30 74.43 -42.71 0.51 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.816 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 C--O 1.244 0.796 0 C-N-CA 123.128 0.571 . . . . 0.0 111.374 178.489 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' ' ZN' . . . . . 0.785 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' ' ZN' . . . . . 0.833 'ZN ' ' HG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.119 0 CA-C-O 119.495 -0.614 . . . . 0.0 111.651 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.5 m -73.73 98.88 3.01 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.079 0.517 . . . . 0.0 110.271 -177.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -125.46 156.29 39.14 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.97 0.414 . . . . 0.0 110.044 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -82.03 53.33 2.19 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-O 122.293 1.044 . . . . 0.0 110.579 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 31.3 p -74.81 120.28 20.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.279 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -70.07 108.77 4.23 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 23.3 t -82.57 108.0 15.63 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.22 100.9 8.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 O-C-N 123.728 0.643 . . . . 0.0 110.224 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.6 pp -93.44 -4.82 50.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.652 0.739 . . . . 0.0 110.659 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -58.44 108.66 0.65 Allowed 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.495 0.718 . . . . 0.0 110.553 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 68.98 43.53 72.53 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 51.0 m -147.59 107.61 4.02 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.263 0.225 . . . . 0.0 110.644 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' ' 370' ' ' GLU . 0.0 OUTLIER -90.82 -22.77 20.83 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 123.94 0.775 . . . . 0.0 110.057 177.244 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 168.19 -30.98 0.18 Allowed Glycine 0 N--CA 1.439 -1.139 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -87.84 174.04 8.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.394 -0.403 . . . . 0.0 110.105 175.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.439 ' H ' ' HD2' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -127.96 0.42 5.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.604 171.526 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 30.4 m -149.54 175.91 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 114.854 -1.067 . . . . 0.0 108.483 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.56 168.08 18.3 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.266 0.555 . . . . 0.0 110.897 173.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.617 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.1 OUTLIER -77.57 167.43 21.63 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 122.009 0.909 . . . . 0.0 111.264 -177.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 5.4 t -111.51 162.53 15.01 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.491 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 24.8 t -57.59 116.91 3.68 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.954 0.502 . . . . 0.0 111.699 -176.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 25.1 t -51.96 117.28 2.64 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 172.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . 0.426 ' HB2' HG12 ' A' ' 410' ' ' VAL . 23.2 ptm -58.93 -21.09 57.45 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.611 0.243 . . . . 0.0 111.005 -170.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.621 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 72.0 m-85 -109.61 -14.81 14.3 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.568 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 72.03 -134.94 22.26 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . 0.477 ' HB2' ' HG2' ' A' ' 399' ' ' PRO . . . -75.92 -1.27 24.68 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.842 0.354 . . . . 0.0 110.409 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -91.77 -10.48 39.82 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.621 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.838 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.2 p -73.59 126.05 29.38 Favored 'General case' 0 N--CA 1.449 -0.501 0 O-C-N 122.134 -0.354 . . . . 0.0 110.524 175.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -77.81 10.92 2.41 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.441 0.639 . . . . 0.0 111.896 -175.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -95.31 119.44 33.83 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.083 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.549 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -122.28 5.73 9.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.47 -178.145 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -63.73 136.6 96.79 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.197 174.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -49.6 -33.14 30.12 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.499 2.799 . . . . 0.0 112.534 -171.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.488 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 54.1 t -65.59 -34.91 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.702 -177.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.682 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 81.5 t60 -57.22 -31.78 65.85 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 122.068 -0.395 . . . . 0.0 110.208 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -89.78 -10.29 46.06 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 123.337 0.398 . . . . 0.0 111.973 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -82.61 -12.67 57.52 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.584 -0.447 . . . . 0.0 111.117 -175.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.431 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 3.6 p80 -128.97 -23.41 3.06 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 177.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.45 ' CD2' ' HA ' ' A' ' 379' ' ' CYS . 60.2 m-85 -123.12 127.32 48.54 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.317 0.579 . . . . 0.0 111.096 175.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.617 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 57.4 m -86.95 166.17 15.31 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.037 173.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.64 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 28.1 m80 -131.74 159.11 73.39 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 122.815 0.446 . . . . 0.0 110.667 -174.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.477 ' HG2' ' HB2' ' A' ' 383' ' ' ALA . 19.6 Cg_endo -55.73 97.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.432 2.088 . . . . 0.0 111.885 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.18 -30.43 2.81 Favored Glycine 0 CA--C 1.508 -0.37 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.219 -175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -66.57 143.07 57.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.013 -0.593 . . . . 0.0 109.658 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 12.2 t -64.82 -17.44 64.24 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.91 -174.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -108.4 7.49 27.07 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.218 0.207 . . . . 0.0 111.091 -174.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -86.65 127.77 34.96 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -126.47 -43.44 0.27 Allowed Glycine 0 CA--C 1.5 -0.874 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 89.55 25.47 27.88 Favored Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 111.914 -0.474 . . . . 0.0 111.914 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 20.3 m -72.92 -16.23 17.71 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.17 0 CA-C-O 121.573 0.701 . . . . 0.0 110.1 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -81.13 138.44 35.9 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.943 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.516 HG13 HG23 ' A' ' 410' ' ' VAL . 23.3 pt -57.53 -47.66 84.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.784 0.802 . . . . 0.0 110.924 174.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.516 HG23 HG13 ' A' ' 409' ' ' ILE . 25.7 t -72.67 123.85 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.791 -178.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 123.41 -25.4 6.29 Favored Glycine 0 CA--C 1.505 -0.576 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.194 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.55 -53.37 1.69 Allowed 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 115.086 -0.557 . . . . 0.0 109.694 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -171.29 127.04 0.67 Allowed 'General case' 0 C--O 1.243 0.738 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.39 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . 0.406 ' O ' ' NH2' ' A' ' 439' ' ' ARG . 7.5 mp0 -95.69 -14.92 23.02 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.251 -173.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 419' ' ' PRO . 52.0 p -79.5 145.65 33.1 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -91.99 -57.21 2.8 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 123.688 0.617 . . . . 0.0 109.61 174.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -129.81 -24.91 2.63 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.68 0.752 . . . . 0.0 109.958 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.541 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 28.0 ptt180 -154.68 165.32 18.36 Favored Pre-proline 0 C--O 1.247 0.97 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.139 -175.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.541 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 39.3 Cg_endo -67.18 143.61 65.59 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 122.901 2.4 . . . . 0.0 112.541 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -67.18 151.92 46.67 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 123.248 0.343 . . . . 0.0 110.865 174.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.8 ' SG ' 'ZN ' ' A' ' 450' ' ' ' ZN' . 27.9 t -63.55 136.3 96.65 Favored Pre-proline 0 C--N 1.317 -0.813 0 O-C-N 123.622 0.576 . . . . 0.0 109.866 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -61.78 -13.28 29.58 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.836 2.357 . . . . 0.0 112.365 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -111.59 8.89 21.09 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 57.32 -149.93 30.75 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 -172.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.89 -1.87 11.96 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.436 2.091 . . . . 0.0 111.88 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 17.3 t -84.05 -2.45 56.71 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.825 0.822 . . . . 0.0 109.121 175.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' CYS . . . . . 0.832 ' HG ' 'ZN ' ' A' ' 450' ' ' ' ZN' . 44.7 t -49.35 117.49 2.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.386 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -108.29 11.5 27.2 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.998 176.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -75.15 93.8 2.85 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -79.18 83.28 5.26 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.491 -175.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -144.34 122.94 6.92 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.522 ' O ' HG13 ' A' ' 436' ' ' ILE . 18.3 Cg_endo -59.08 -38.23 88.32 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.822 1.681 . . . . 0.0 112.885 -175.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.599 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 24.9 tp60 -65.45 -40.06 92.77 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.965 -0.46 . . . . 0.0 109.785 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . 0.563 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 26.1 t60 -57.9 -53.77 54.47 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.699 0.761 . . . . 0.0 110.452 177.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -61.02 -18.22 56.57 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.975 -1.466 . . . . 0.0 111.889 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 432' ' ' PRO . 52.3 mt -84.3 -41.84 16.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.676 178.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.599 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 23.8 mt-10 -79.21 -45.5 19.73 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.135 0.493 . . . . 0.0 110.847 -175.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -97.14 145.41 26.04 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.459 -174.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' ARG . . . . . 0.481 ' NH1' HD21 ' A' ' 441' ' ' ASN . 16.7 ptt180 -92.32 118.31 30.78 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.354 0.597 . . . . 0.0 110.213 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.67 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 76.2 m80 -92.9 78.55 4.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.002 175.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' ASN . . . . . 0.481 HD21 ' NH1' ' A' ' 439' ' ' ARG . 2.2 m-20 -66.63 105.58 1.57 Allowed 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.763 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 2.0 p -81.92 121.89 27.06 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 443' ' ' LEU . 2.2 pp -87.65 145.66 37.57 Favored Pre-proline 0 C--O 1.246 0.89 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.907 -173.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.65 -32.16 19.6 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.103 2.535 . . . . 0.0 112.543 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.443 ' HB ' HD13 ' A' ' 443' ' ' LEU . 9.3 p 43.05 32.98 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 122.911 1.339 . . . . 0.0 109.941 -176.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -92.24 158.01 16.37 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.937 -1.102 . . . . 0.0 110.284 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 59.87 21.62 10.56 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 171.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--O 1.224 -0.248 0 O-C-N 123.563 0.539 . . . . 0.0 109.692 179.928 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' ' ZN' . . . . . 0.818 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' ' ZN' . . . . . 0.832 'ZN ' ' HG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.472 0 CA-C-O 120.7 0.056 . . . . 0.0 113.083 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.5 t -109.33 -55.8 2.37 Favored 'General case' 0 C--O 1.246 0.92 0 O-C-N 122.195 -0.591 . . . . 0.0 110.996 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.77 9.74 3.06 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.793 0.837 . . . . 0.0 111.48 -177.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -85.26 76.93 10.1 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 174.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 27.2 p -92.29 119.36 31.8 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 125.376 1.673 . . . . 0.0 111.714 -172.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -112.58 141.54 46.22 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.052 175.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 6.1 p -136.9 151.08 48.66 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.691 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 23.0 t -81.49 89.44 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.758 0 O-C-N 123.265 0.353 . . . . 0.0 110.077 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 4.1 pp -77.82 -18.38 56.39 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.195 0.522 . . . . 0.0 110.497 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -98.0 -165.02 1.2 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.394 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 93.71 -59.56 2.14 Favored Glycine 0 C--O 1.239 0.455 0 CA-C-O 122.067 0.815 . . . . 0.0 111.285 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 33.0 t -84.27 84.81 7.49 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -91.47 -31.33 16.02 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.995 -173.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 94.6 32.08 7.49 Favored Glycine 0 CA--C 1.505 -0.569 0 CA-C-O 122.042 0.801 . . . . 0.0 111.386 -175.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -161.83 145.44 12.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.176 -1.012 . . . . 0.0 108.289 -178.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.482 ' H ' ' HD2' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -79.73 -23.51 42.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.487 0.492 . . . . 0.0 111.418 -175.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 23.7 m -84.15 162.76 2.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 173.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.575 ' HG2' ' H ' ' A' ' 376' ' ' ARG . 0.1 OUTLIER -130.73 -66.43 0.76 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.287 0.565 . . . . 0.0 110.89 177.229 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.575 ' H ' ' HG2' ' A' ' 375' ' ' LYS . 0.1 OUTLIER -145.2 165.87 27.11 Favored 'General case' 0 C--O 1.25 1.122 0 O-C-N 121.779 -0.576 . . . . 0.0 111.184 178.701 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 14.3 t -134.14 162.81 31.1 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 12.4 m -54.59 117.7 3.57 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.638 0.732 . . . . 0.0 110.679 -175.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.769 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 39.6 t -51.23 120.95 5.48 Favored 'General case' 0 C--N 1.359 0.992 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.085 175.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . 0.587 ' O ' HG12 ' A' ' 410' ' ' VAL . 27.2 ptm -58.81 -23.18 60.07 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.609 0.719 . . . . 0.0 111.122 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.605 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 35.1 m-85 -103.23 -15.71 15.92 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 121.075 -1.016 . . . . 0.0 109.902 175.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.528 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 64.6 -131.74 37.76 Favored Glycine 0 CA--C 1.498 -1.028 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.797 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -75.75 -4.87 42.89 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 122.65 0.38 . . . . 0.0 111.214 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -86.86 -5.33 59.14 Favored 'General case' 0 C--O 1.248 1.022 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.715 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.819 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 6.4 p -81.2 123.58 28.57 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.649 0.738 . . . . 0.0 111.43 176.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -82.13 10.72 6.22 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.911 0.862 . . . . 0.0 110.95 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.55 HH21 ' ND2' ' A' ' 389' ' ' ASN . 31.4 mmm180 -84.02 124.09 30.7 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.13 174.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.491 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -116.46 -5.3 11.73 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.422 -176.595 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.55 ' ND2' HH21 ' A' ' 387' ' ' ARG . 20.7 p-10 -58.73 137.59 86.68 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.217 176.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -60.01 -24.19 75.68 Favored 'Trans proline' 0 CA--C 1.518 -0.297 0 C-N-CA 122.178 1.919 . . . . 0.0 111.252 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.546 HG12 ' NE2' ' A' ' 395' ' ' HIS . 93.4 t -66.62 -42.17 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.129 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.709 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 82.3 t60 -54.53 -35.05 62.78 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 120.381 -0.527 . . . . 0.0 110.459 178.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 24.6 m-85 -88.08 -24.04 23.54 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.771 -176.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -72.83 -20.26 61.17 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.949 -177.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.698 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 1.9 p80 -118.22 -8.71 10.58 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 176.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.698 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 88.0 m-85 -137.65 127.28 25.21 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.333 0.587 . . . . 0.0 110.767 176.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 46.2 m -85.78 159.2 19.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.964 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.628 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 39.2 m80 -128.1 153.02 78.52 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.811 -174.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -50.77 112.34 0.74 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.311 2.007 . . . . 0.0 112.701 -174.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 117.65 -5.57 16.62 Favored Glycine 0 C--O 1.237 0.34 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.075 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -95.67 145.41 25.29 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.322 0.582 . . . . 0.0 109.922 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 42.0 t -57.81 -30.91 66.08 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.293 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -94.29 2.61 55.85 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.758 -174.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -82.54 153.59 25.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -141.18 -37.42 0.09 OUTLIER Glycine 0 C--O 1.24 0.516 0 CA-C-O 121.805 0.669 . . . . 0.0 113.099 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 74.13 23.44 76.02 Favored Glycine 0 C--O 1.212 -1.233 0 CA-C-O 122.489 1.049 . . . . 0.0 111.867 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 33.8 m -79.27 -16.11 13.32 Favored 'Isoleucine or valine' 0 C--N 1.35 0.616 0 CA-C-O 121.765 0.793 . . . . 0.0 110.678 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -90.9 121.86 33.1 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.525 HG13 HG23 ' A' ' 410' ' ' VAL . 12.7 pt -45.65 -47.93 4.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 123.205 0.315 . . . . 0.0 111.331 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.687 ' HA ' ' HG2' ' A' ' 414' ' ' GLU . 17.3 t -72.84 115.28 13.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 O-C-N 123.776 0.673 . . . . 0.0 109.954 -177.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 144.05 -49.77 0.69 Allowed Glycine 0 CA--C 1.498 -1.029 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.892 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.401 ' HG2' ' N ' ' A' ' 413' ' ' ASP . 5.1 pm0 -127.75 -46.04 1.44 Allowed 'General case' 0 C--O 1.238 0.475 0 O-C-N 122.162 -0.611 . . . . 0.0 111.321 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.401 ' N ' ' HG2' ' A' ' 412' ' ' GLN . 7.4 m-20 -125.19 92.79 3.71 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 122.518 0.327 . . . . 0.0 110.383 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . 0.687 ' HG2' ' HA ' ' A' ' 410' ' ' VAL . 43.0 mt-10 -94.52 36.01 1.19 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.525 -177.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 54.0 p -64.17 130.68 44.89 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.906 -175.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -59.46 -18.32 38.67 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.414 0.626 . . . . 0.0 110.754 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 35.8 t70 79.4 57.94 0.02 OUTLIER 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.418 -1.265 . . . . 0.0 110.252 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -175.75 152.89 1.35 Allowed Pre-proline 0 N--CA 1.443 -0.816 0 CA-C-N 114.336 -1.302 . . . . 0.0 109.094 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -55.42 145.53 67.52 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.071 1.847 . . . . 0.0 112.203 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' GLU . . . . . 0.431 ' HG2' ' ND2' ' A' ' 441' ' ' ASN . 42.5 mt-10 -74.37 150.88 39.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 172.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 5.5 t -59.48 127.37 84.55 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 421' ' ' CYS . 50.9 Cg_exo -54.95 -23.6 35.51 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.344 2.029 . . . . 0.0 113.219 -176.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 87.7 m-85 -102.34 18.01 22.08 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.239 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 59.03 -156.07 25.46 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.579 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . 0.411 ' HG3' ' HG ' ' A' ' 443' ' ' LEU . 57.0 Cg_endo -73.68 -9.68 22.83 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.654 2.236 . . . . 0.0 111.083 175.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 32.1 t -73.87 -8.86 57.68 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.52 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 23.1 t -62.94 115.64 4.58 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.399 0.619 . . . . 0.0 109.545 176.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -109.13 21.51 17.07 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.782 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 0.2 OUTLIER -64.02 92.18 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 177.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -68.79 91.44 0.45 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.851 0.834 . . . . 0.0 111.393 -174.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . 0.441 HD21 ' HB3' ' A' ' 433' ' ' GLN . 63.1 t30 -161.98 123.54 1.63 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.811 173.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.478 ' O ' HG13 ' A' ' 436' ' ' ILE . 33.4 Cg_endo -63.91 -36.52 49.4 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.752 2.302 . . . . 0.0 110.599 -178.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.668 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 22.4 tp60 -65.31 -37.01 85.82 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . 0.667 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 12.3 t60 -63.3 -49.35 74.37 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 121.683 0.754 . . . . 0.0 109.575 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.481 ' HA ' ' CE1' ' A' ' 440' ' ' HIS . 53.8 mtpt -66.72 -7.1 18.62 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.078 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 432' ' ' PRO . 42.6 mt -94.97 -42.94 12.85 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.752 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.668 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 22.8 mt-10 -68.76 -37.55 79.46 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.83 0.824 . . . . 0.0 110.555 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -117.55 138.66 51.76 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.551 -177.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' ARG . . . . . 0.403 ' HG3' HD21 ' A' ' 441' ' ' ASN . 15.2 ptt180 -89.38 118.61 29.17 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.712 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 22.3 m80 -94.21 99.34 11.62 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' ASN . . . . . 0.431 ' ND2' ' HG2' ' A' ' 420' ' ' GLU . 35.6 m-80 -91.43 106.08 18.24 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.56 -175.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.98 138.32 39.57 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.552 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.5 OUTLIER -118.53 149.81 46.87 Favored Pre-proline 0 C--O 1.248 1.011 0 CA-C-O 120.963 0.411 . . . . 0.0 111.771 -171.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.52 -18.32 12.25 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 123.042 2.494 . . . . 0.0 111.859 175.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.552 ' HB ' HD13 ' A' ' 443' ' ' LEU . 10.0 p 43.03 30.33 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.245 0 CA-C-O 122.315 1.055 . . . . 0.0 111.715 -178.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -108.39 -33.37 7.1 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.509 -174.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -81.65 -27.79 33.92 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.128 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--O 1.206 -1.237 0 O-C-N 123.755 0.659 . . . . 0.0 109.669 179.508 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' ' ZN' . . . . . 0.819 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' ' ZN' . . . . . 0.789 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.443 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 32.6 t 70.77 -65.96 0.31 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.296 1.038 . . . . 0.0 111.197 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -73.43 89.12 1.62 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.871 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -82.95 115.44 21.8 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 174.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 7.0 m -57.98 156.43 9.24 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 124.009 0.818 . . . . 0.0 110.951 -176.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -102.69 136.46 42.48 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 123.145 0.578 . . . . 0.0 110.072 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 11.3 p -72.63 149.22 44.1 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.446 -176.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.03 118.65 59.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 C-N-CA 122.965 0.506 . . . . 0.0 110.445 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.6 pp -100.42 -4.46 28.91 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 122.155 -0.341 . . . . 0.0 111.336 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -53.59 137.91 35.68 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 119.05 -8.07 12.63 Favored Glycine 0 N--CA 1.468 0.819 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -174.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 48.0 t -104.11 119.02 38.05 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -54.47 -28.96 48.24 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.219 0.949 . . . . 0.0 109.782 174.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 120.19 -93.37 0.54 Allowed Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -170.66 171.94 6.04 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.478 ' HD2' HG13 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -83.05 -6.9 59.67 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-O 121.518 0.675 . . . . 0.0 110.079 176.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.478 HG13 ' HD2' ' A' ' 373' ' ' LYS . 35.8 m -120.19 155.02 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 171.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.11 162.6 13.96 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.1 159.23 20.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.136 174.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 12.6 t -101.83 149.38 24.25 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 9.7 t -57.93 111.86 1.3 Allowed 'General case' 0 C--O 1.244 0.796 0 O-C-N 123.355 0.41 . . . . 0.0 110.193 -171.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.782 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 30.9 t -51.36 108.96 0.29 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . 0.63 ' HB2' HG22 ' A' ' 410' ' ' VAL . 14.5 ptp -60.43 -13.62 14.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.988 0.423 . . . . 0.0 110.665 -176.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.448 ' CB ' ' HB3' ' A' ' 385' ' ' CYS . 36.3 m-85 -93.59 -27.05 16.83 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.079 175.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.411 ' O ' ' HD2' ' A' ' 398' ' ' HIS . . . 60.28 -117.93 13.05 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.415 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -84.29 -9.67 58.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.17 -0.606 . . . . 0.0 111.505 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -78.95 -26.67 43.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.2 -176.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.796 ' SG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 13.5 p -73.87 111.57 9.15 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.426 172.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -84.98 12.39 7.66 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.38 0.609 . . . . 0.0 110.143 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -65.11 125.47 25.04 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 172.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.5 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.5 OUTLIER -119.72 0.75 10.98 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.028 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -66.05 133.86 94.83 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.117 173.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.9 -22.08 67.06 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.547 2.165 . . . . 0.0 112.292 -174.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.576 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 74.9 t -67.85 -38.32 79.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.129 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.576 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 85.0 t60 -62.88 -26.69 68.9 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 120.864 0.364 . . . . 0.0 110.051 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -92.46 -19.57 21.88 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.281 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -73.79 -23.69 59.72 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.872 -177.111 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.595 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 2.4 p80 -116.7 -11.89 10.93 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 177.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.595 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 93.8 m-85 -131.94 131.71 42.88 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 122.126 -0.359 . . . . 0.0 111.549 175.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 22.2 p -84.38 153.95 23.14 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.369 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 399' ' ' PRO . 69.3 m80 -136.32 159.87 69.09 Favored Pre-proline 0 C--O 1.221 -0.44 0 O-C-N 122.339 -0.225 . . . . 0.0 110.524 -173.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 17.4 Cg_endo -54.43 103.08 0.09 OUTLIER 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.25 1.966 . . . . 0.0 111.614 -178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 129.62 -23.68 4.74 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -76.27 151.09 36.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.231 -0.484 . . . . 0.0 110.78 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 13.5 m -67.15 -22.83 65.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.523 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -110.99 15.56 21.66 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.285 -173.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -74.03 141.7 45.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.823 -178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -114.27 -57.46 0.38 Allowed Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.962 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 64.0 14.82 57.13 Favored Glycine 0 C--O 1.216 -1.001 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -174.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 35.9 m -89.56 -15.14 8.91 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-N 115.497 -0.351 . . . . 0.0 111.383 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -75.61 132.45 40.65 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.784 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.49 HG13 ' H ' ' A' ' 410' ' ' VAL . 5.1 pt -46.59 -56.95 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 123.089 0.243 . . . . 0.0 111.03 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 380' ' ' MET . 11.0 p -76.4 116.06 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 134.64 -49.39 0.9 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -168.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.416 ' HG3' ' N ' ' A' ' 413' ' ' ASP . 3.8 pt20 -102.3 -52.36 3.15 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 176.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.416 ' N ' ' HG3' ' A' ' 412' ' ' GLN . 35.1 t70 -165.7 125.35 1.73 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.845 0.831 . . . . 0.0 110.187 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -87.58 13.37 10.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.852 -162.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 72.6 p -85.77 -178.43 6.61 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 117.85 0.295 . . . . 0.0 110.514 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -68.15 -13.9 62.57 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.335 -177.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 36.7 t70 68.85 74.09 0.26 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.425 0.631 . . . . 0.0 110.181 -174.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.493 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 19.3 ptt180 -162.88 158.82 18.99 Favored Pre-proline 0 C--O 1.246 0.91 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.493 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 35.8 Cg_endo -63.32 136.57 56.07 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.644 2.229 . . . . 0.0 111.644 -176.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' GLU . . . . . 0.435 ' HG2' ' HE ' ' A' ' 439' ' ' ARG . 51.7 mt-10 -70.58 147.76 48.91 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 121.797 -0.564 . . . . 0.0 110.121 175.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 1.001 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 11.9 t -54.82 137.56 64.34 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.396 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.74 -14.38 26.46 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.158 1.906 . . . . 0.0 112.494 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -113.27 10.31 18.46 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.116 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 59.36 -151.19 36.21 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-O 119.598 -0.557 . . . . 0.0 111.85 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.14 -13.02 28.42 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.664 2.243 . . . . 0.0 112.344 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 38.0 t -79.87 1.24 27.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.485 176.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' CYS . . . . . 1.001 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 48.0 t -60.02 116.72 4.36 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.974 -1.012 . . . . 0.0 111.127 177.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -114.42 23.56 12.68 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.983 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -69.04 108.42 3.54 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.762 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -77.29 84.15 3.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.142 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 434' ' ' HIS . 61.5 t30 -156.47 121.07 2.39 Favored Pre-proline 0 C--O 1.236 0.364 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.428 175.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.445 ' O ' HG13 ' A' ' 436' ' ' ILE . 18.7 Cg_endo -58.76 -43.32 45.2 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.423 2.082 . . . . 0.0 112.708 -175.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.44 ' O ' ' HG2' ' A' ' 437' ' ' GLU . 28.9 tp60 -67.94 -26.35 65.92 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.93 0.769 . . . . 0.0 109.744 -175.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . 0.715 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 59.6 t60 -60.55 -59.37 5.5 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 122.816 0.446 . . . . 0.0 111.494 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.409 ' HD3' ' H ' ' A' ' 435' ' ' LYS . 0.0 OUTLIER -59.47 -25.6 64.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.668 0.27 . . . . 0.0 111.025 179.395 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 432' ' ' PRO . 67.0 mt -70.18 -46.46 72.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.007 0.432 . . . . 0.0 111.09 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 433' ' ' GLN . 11.8 mm-40 -76.31 -53.9 7.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.944 -176.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -91.62 144.62 25.34 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.374 0.421 . . . . 0.0 110.516 -176.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' ARG . . . . . 0.47 ' HB3' ' HG3' ' A' ' 418' ' ' ARG . 17.7 ptt180 -89.94 137.03 32.68 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.663 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 61.7 m80 -111.72 79.9 1.26 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.281 0.562 . . . . 0.0 109.674 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' ASN . . . . . 0.47 HD21 ' NE ' ' A' ' 439' ' ' ARG . 85.8 m-20 -74.86 129.45 37.7 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.069 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 17.2 p -86.56 140.4 29.92 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 121.804 -0.56 . . . . 0.0 109.841 -177.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.472 HD13 ' HB ' ' A' ' 445' ' ' VAL . 1.2 pp -109.04 151.84 42.15 Favored Pre-proline 0 C--N 1.312 -1.046 0 O-C-N 123.858 0.724 . . . . 0.0 110.114 -175.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.54 -49.06 4.8 Favored 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 122.288 1.992 . . . . 0.0 112.082 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.472 ' HB ' HD13 ' A' ' 443' ' ' LEU . 11.3 p 40.07 39.59 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.87 0.843 . . . . 0.0 109.751 -174.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 23.2 tpt180 -89.91 161.66 15.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.368 -173.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -56.52 -35.83 68.5 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.026 0.441 . . . . 0.0 110.739 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 C--O 1.252 1.199 0 CA-C-O 121.128 0.49 . . . . 0.0 111.821 176.751 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' ' ZN' . . . . . 0.796 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' ' ZN' . . . . . 0.842 'ZN ' ' HG ' ' A' ' 421' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 46.6 t -145.33 162.1 38.04 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.69 111.37 24.02 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 172.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -78.67 8.68 4.96 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 124.167 0.917 . . . . 0.0 112.079 -174.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 24.8 p -58.87 108.7 0.69 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.486 0.66 . . . . 0.0 109.342 169.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -121.56 100.7 7.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.258 -167.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 10.8 t -166.13 173.95 9.78 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.568 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 375' ' ' LYS . 19.7 t -96.84 142.4 14.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.522 -172.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 367' ' ' GLN . 3.8 pp -89.57 -49.91 6.39 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.544 0.527 . . . . 0.0 109.609 174.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' GLN . . . . . 0.516 ' N ' HD12 ' A' ' 366' ' ' LEU . 23.8 tp60 -96.96 81.97 3.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.406 0.622 . . . . 0.0 109.426 174.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 138.54 34.97 0.17 Allowed Glycine 0 C--O 1.241 0.568 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.024 -172.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 22.0 t -75.77 111.07 10.73 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.242 0.544 . . . . 0.0 111.077 -177.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -146.2 -70.14 0.26 Allowed 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.357 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -177.71 32.92 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 CA-C-O 121.455 0.475 . . . . 0.0 112.326 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -118.37 161.37 20.07 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.752 -0.724 . . . . 0.0 109.612 -174.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.42 ' HD3' HG13 ' A' ' 374' ' ' VAL . 0.1 OUTLIER -101.04 -16.52 17.09 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.091 178.591 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.42 HG13 ' HD3' ' A' ' 373' ' ' LYS . 27.6 m -136.65 154.48 32.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.667 170.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.515 ' HB3' HG11 ' A' ' 365' ' ' VAL . 1.5 pptp? -91.9 157.75 16.67 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 121.62 -0.675 . . . . 0.0 109.99 175.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.592 ' HB3' ' N ' ' A' ' 397' ' ' SER . 0.8 OUTLIER -81.31 148.52 29.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.399 0.619 . . . . 0.0 111.116 -178.02 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 11.9 t -101.3 152.91 20.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.966 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 410' ' ' VAL . 14.0 t -54.53 119.48 5.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.741 0.305 . . . . 0.0 111.723 -171.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.89 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 26.3 t -59.29 109.78 0.94 Allowed 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . 0.606 ' HA ' ' HA2' ' A' ' 411' ' ' GLY . 24.8 ptm -54.53 -29.86 51.94 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.364 -176.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.534 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 51.9 m-85 -98.23 -16.65 19.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.54 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' A' ' 385' ' ' CYS . . . 62.89 -116.26 9.14 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.874 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -90.34 7.79 36.71 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.854 0.359 . . . . 0.0 111.221 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -98.49 -22.55 15.95 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.447 0.299 . . . . 0.0 110.852 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.89 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 1.8 p -65.18 131.55 46.82 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.142 176.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -80.59 12.31 3.18 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.383 0.611 . . . . 0.0 112.067 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -92.66 112.16 24.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.649 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.442 ' N ' ' HD3' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -100.05 -24.09 14.7 Favored 'General case' 0 C--O 1.221 -0.419 0 O-C-N 123.855 0.722 . . . . 0.0 109.316 -179.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -47.49 138.85 8.57 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.707 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.47 -21.82 69.48 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.453 2.102 . . . . 0.0 111.464 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.577 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 93.3 t -66.7 -36.91 78.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.436 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.668 ' NE2' ' SG ' ' A' ' 385' ' ' CYS . 82.1 t60 -58.66 -38.26 77.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.293 174.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -87.56 -4.99 58.95 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.923 -176.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.577 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -85.71 -24.48 26.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.039 -0.413 . . . . 0.0 110.465 178.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.422 ' HD1' ' HD2' ' A' ' 396' ' ' PHE . 1.2 p80 -110.96 -23.76 10.77 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.493 175.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.422 ' HD2' ' HD1' ' A' ' 395' ' ' HIS . 90.8 m-85 -120.27 129.03 53.86 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.597 0.713 . . . . 0.0 111.997 178.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.592 ' N ' ' HB3' ' A' ' 376' ' ' ARG . 11.8 p -82.17 157.84 23.84 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.365 175.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.463 ' H ' ' HB3' ' A' ' 401' ' ' ASP . 58.9 m80 -136.09 162.2 58.01 Favored Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -170.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.07 100.63 0.08 OUTLIER 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.778 2.318 . . . . 0.0 111.059 177.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 109.54 24.33 5.92 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.476 -174.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . 0.463 ' HB3' ' H ' ' A' ' 398' ' ' HIS . 20.7 t70 -119.97 150.5 40.42 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 122.303 0.241 . . . . 0.0 110.478 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 17.7 t -54.37 -41.1 68.78 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.277 0.631 . . . . 0.0 111.791 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -104.08 16.41 26.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.759 -167.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -72.5 154.43 40.83 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.531 0.205 . . . . 0.0 110.603 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -146.15 -55.36 0.02 OUTLIER Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.096 -1.049 . . . . 0.0 110.939 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 65.26 22.11 68.88 Favored Glycine 0 C--O 1.238 0.347 0 CA-C-O 119.935 -0.369 . . . . 0.0 112.911 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 24.9 m -106.97 -11.43 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 121.939 0.876 . . . . 0.0 111.436 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . 0.521 ' O ' ' HG2' ' A' ' 412' ' ' GLN . 6.7 tt0 -83.45 151.49 25.44 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.487 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 20.2 pt -48.53 -46.08 14.7 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 CA-C-O 122.066 0.936 . . . . 0.0 109.75 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.511 HG13 ' HB3' ' A' ' 380' ' ' MET . 48.5 t -75.59 82.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 172.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 380' ' ' MET . . . 147.55 -48.17 0.65 Allowed Glycine 0 C--O 1.243 0.719 0 CA-C-N 116.02 -0.536 . . . . 0.0 113.183 177.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 408' ' ' GLN . 4.2 pt20 -83.11 -47.21 11.88 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 117.16 0.48 . . . . 0.0 109.733 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.409 ' N ' ' HG3' ' A' ' 412' ' ' GLN . 10.8 t70 178.18 148.06 0.17 Allowed 'General case' 0 C--O 1.234 0.237 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 176.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -75.57 -11.29 59.99 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 123.501 0.5 . . . . 0.0 111.76 -172.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 24.5 p -72.56 141.84 48.43 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.953 0.883 . . . . 0.0 111.574 -176.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.48 ' HB2' ' HD3' ' A' ' 439' ' ' ARG . 2.1 m-20 -68.43 -39.75 81.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.072 -177.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 12.0 t70 81.98 50.81 0.02 OUTLIER 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.0 -174.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -153.25 158.59 32.77 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.026 176.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' A' ' 438' ' ' TYR . 80.4 Cg_exo -48.03 141.85 16.63 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.89 2.394 . . . . 0.0 112.69 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' GLU . . . . . 0.434 ' HG2' HD21 ' A' ' 441' ' ' ASN . 38.5 mt-10 -83.27 143.2 30.56 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.753 ' SG ' 'ZN ' ' A' ' 450' ' ' ' ZN' . 34.8 t -59.61 126.96 84.18 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.22 7.12 1.21 Allowed 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.576 2.184 . . . . 0.0 112.835 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -120.31 5.1 10.73 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 64.9 -162.99 38.05 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -178.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.6 -15.34 27.4 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.008 2.472 . . . . 0.0 112.489 176.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 40.4 t -70.52 -13.16 62.0 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.044 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' CYS . . . . . 0.788 ' SG ' 'ZN ' ' A' ' 450' ' ' ' ZN' . 46.6 t -48.66 118.02 2.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.836 0.854 . . . . 0.0 110.612 -178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -113.84 18.41 17.38 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 122.899 0.479 . . . . 0.0 109.918 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.478 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 4.3 mmp_? -66.52 96.58 0.38 Allowed 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.798 175.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . 0.525 ' HB2' ' NZ ' ' A' ' 430' ' ' LYS . 10.1 mtmp? -69.05 93.55 0.59 Allowed 'General case' 0 C--O 1.241 0.614 0 O-C-N 123.371 0.419 . . . . 0.0 110.283 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . 0.482 HD21 ' HB3' ' A' ' 433' ' ' GLN . 54.6 t30 -157.9 122.91 2.3 Favored Pre-proline 0 C--N 1.318 -0.764 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.463 ' O ' HG13 ' A' ' 436' ' ' ILE . 33.4 Cg_endo -63.43 -35.74 59.29 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.487 2.125 . . . . 0.0 112.056 -177.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.64 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 23.4 tp60 -68.45 -41.62 79.97 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -175.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . 0.607 ' NE2' ' SG ' ' A' ' 421' ' ' CYS . 5.0 t60 -56.2 -51.2 68.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.433 0.635 . . . . 0.0 110.132 178.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -67.18 -13.76 62.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.402 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 432' ' ' PRO . 40.2 mt -89.84 -34.87 6.94 Favored 'Isoleucine or valine' 0 C--O 1.251 1.153 0 C-N-CA 122.704 0.402 . . . . 0.0 110.146 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.64 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 27.9 mt-10 -83.77 -45.54 13.22 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.298 0.571 . . . . 0.0 111.12 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 419' ' ' PRO . 19.1 m-85 -103.32 147.1 27.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.229 -174.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' ARG . . . . . 0.48 ' HD3' ' HB2' ' A' ' 416' ' ' ASP . 17.0 ptt180 -93.69 114.02 26.23 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.589 177.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.659 ' HE2' ' HG ' ' A' ' 421' ' ' CYS . 79.6 m80 -81.66 85.01 6.63 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' ASN . . . . . 0.434 HD21 ' HG2' ' A' ' 420' ' ' GLU . 89.0 m-20 -67.32 103.57 1.3 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.361 -173.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 1.5 m -104.47 159.35 15.81 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.132 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.557 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.5 OUTLIER -135.75 144.83 50.48 Favored Pre-proline 0 C--N 1.32 -0.684 0 O-C-N 121.66 -0.65 . . . . 0.0 111.828 -176.061 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -64.22 -29.21 64.34 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 123.435 2.757 . . . . 0.0 110.834 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.557 ' HB ' HD13 ' A' ' 443' ' ' LEU . 7.3 p 35.9 69.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 124.823 1.327 . . . . 0.0 110.591 -175.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -56.68 157.34 5.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.455 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -66.78 -26.77 67.12 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.104 0.877 . . . . 0.0 110.54 -175.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.472 0.668 0 O-C-N 123.273 0.358 . . . . 0.0 110.917 179.432 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' ' ZN' . . . . . 0.773 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' ' ZN' . . . . . 0.788 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.859 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 10.0 p -163.28 132.96 4.21 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -122.57 58.1 1.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -65.9 126.55 28.88 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.733 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 40.8 p -91.49 139.03 31.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.337 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.38 89.69 0.06 Allowed 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 12.5 t -79.1 80.49 5.45 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.892 0.854 . . . . 0.0 110.876 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.9 p -72.49 112.17 7.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.428 174.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.2 pp -142.88 2.86 1.38 Allowed 'General case' 0 C--O 1.244 0.768 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -170.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -47.13 147.85 1.34 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-O 120.483 0.182 . . . . 0.0 111.295 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . -63.52 149.58 50.12 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 116.433 -0.349 . . . . 0.0 112.909 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 34.0 m -131.2 3.42 4.32 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-O 121.147 0.499 . . . . 0.0 109.949 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 370' ' ' GLU . 0.0 OUTLIER -88.07 -0.86 57.57 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.782 -178.334 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 78.58 23.48 64.79 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.262 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -135.93 158.31 44.71 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 122.668 0.387 . . . . 0.0 110.403 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.612 ' HG2' HG13 ' A' ' 374' ' ' VAL . 0.0 OUTLIER -84.91 -13.04 52.06 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 122.118 -0.364 . . . . 0.0 110.133 176.744 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . 0.612 HG13 ' HG2' ' A' ' 373' ' ' LYS . 28.5 m -130.96 158.84 43.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.173 0.511 . . . . 0.0 110.116 177.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.99 154.39 27.72 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 170.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . 0.568 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 0.8 OUTLIER -69.5 148.42 49.52 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-O 122.039 0.923 . . . . 0.0 110.683 -175.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 5.4 t -96.2 153.65 17.68 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.233 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.1 m -64.22 122.67 17.2 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.075 0.464 . . . . 0.0 111.166 -170.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.94 ' SG ' ' SG ' ' A' ' 385' ' ' CYS . 15.4 t -49.92 123.61 8.42 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.729 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . 0.45 ' O ' HG12 ' A' ' 410' ' ' VAL . 20.8 ptm -56.0 -29.47 60.36 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.217 0.532 . . . . 0.0 111.072 -172.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . 0.554 ' HB2' ' HB3' ' A' ' 385' ' ' CYS . 39.2 m-85 -98.73 -14.85 19.58 Favored 'General case' 0 C--O 1.255 1.391 0 CA-C-O 119.051 -0.5 . . . . 0.0 110.439 176.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 62.49 -107.51 1.65 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . . . . . . . . . . . -84.3 -13.71 51.73 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . 0.526 ' HB2' ' HB3' ' A' ' 381' ' ' TYR . 38.9 m-80 -81.49 -26.01 35.55 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -174.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.94 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 6.4 p -66.65 113.89 5.15 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.035 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -85.49 9.48 15.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.935 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 387' ' ' ARG . 27.8 mmt180 -62.46 134.13 55.99 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.957 176.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.527 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.3 OUTLIER -118.97 -7.64 10.36 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 124.105 0.878 . . . . 0.0 110.406 -171.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -67.47 137.09 93.33 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.057 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -60.68 -30.67 90.89 Favored 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 121.576 1.517 . . . . 0.0 110.946 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.402 HG12 ' NE2' ' A' ' 395' ' ' HIS . 87.9 t -59.17 -40.68 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.896 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.691 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 85.6 t60 -54.95 -43.9 73.85 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 120.771 0.319 . . . . 0.0 110.441 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -82.23 -25.15 34.4 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.493 -177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -66.67 -27.88 68.01 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.686 0.279 . . . . 0.0 110.783 -175.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.634 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 1.1 p80 -119.09 -3.98 10.6 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.634 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 39.6 m-85 -139.33 126.59 21.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.442 0.639 . . . . 0.0 109.989 177.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.568 ' OG ' ' HB2' ' A' ' 376' ' ' ARG . 70.7 m -83.46 158.63 21.98 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 123.261 0.624 . . . . 0.0 111.031 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.614 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 27.0 m80 -127.65 162.03 51.62 Favored Pre-proline 0 C--O 1.222 -0.354 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 14.8 Cg_endo -55.11 106.34 0.18 Allowed 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 121.829 1.686 . . . . 0.0 111.219 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 120.03 -1.14 13.28 Favored Glycine 0 C--N 1.319 -0.368 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.47 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -94.98 148.98 21.74 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 22.7 t -62.48 -30.4 71.23 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.402 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.99 2.4 51.46 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.9 0.381 . . . . 0.0 110.726 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -80.52 140.29 35.93 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.591 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -168.93 25.51 0.11 Allowed Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.579 179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 52.66 43.98 59.85 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.778 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 19.5 m -74.9 -10.79 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.302 0.573 . . . . 0.0 109.766 -178.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -122.38 136.66 54.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 174.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.431 HG13 ' N ' ' A' ' 410' ' ' VAL . 13.0 pt -55.53 -47.93 78.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.3 0.571 . . . . 0.0 110.671 176.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.606 ' HA ' ' HG2' ' A' ' 414' ' ' GLU . 13.3 t -70.27 113.88 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.872 177.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 130.75 -40.6 1.63 Allowed Glycine 0 N--CA 1.443 -0.866 0 O-C-N 123.839 0.712 . . . . 0.0 111.691 -173.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.41 -43.89 4.23 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 122.918 0.487 . . . . 0.0 110.711 178.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -167.91 124.94 1.12 Allowed 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.004 0.522 . . . . 0.0 109.804 175.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . 0.606 ' HG2' ' HA ' ' A' ' 410' ' ' VAL . 21.1 mt-10 -101.28 0.1 36.69 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 122.646 0.378 . . . . 0.0 111.985 -170.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 41.4 p -133.99 -77.17 0.47 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.063 0.458 . . . . 0.0 111.501 -170.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 29.8 t70 177.39 -42.95 0.01 OUTLIER 'General case' 0 C--O 1.241 0.636 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 -172.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 21.7 t70 175.32 -27.75 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.488 -1.233 . . . . 0.0 109.66 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.422 ' HB2' ' HD2' ' A' ' 419' ' ' PRO . 24.1 ptt180 -138.17 165.67 31.61 Favored Pre-proline 0 N--CA 1.449 -0.476 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.977 -174.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 418' ' ' ARG . 62.1 Cg_endo -75.72 162.52 35.15 Favored 'Trans proline' 0 C--O 1.244 0.783 0 C-N-CA 121.221 1.281 . . . . 0.0 110.957 177.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.64 158.27 33.92 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.689 0.757 . . . . 0.0 109.502 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 6.6 t -65.86 136.7 95.81 Favored Pre-proline 0 N--CA 1.453 -0.305 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 175.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.17 -16.92 42.95 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.269 1.313 . . . . 0.0 112.772 -177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -115.11 15.71 17.08 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.851 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 57.72 -152.03 27.97 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.995 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.45 -14.8 34.24 Favored 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 121.973 1.782 . . . . 0.0 111.535 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 19.9 t -82.08 2.2 32.33 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.92 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 49.8 t -60.25 124.17 19.46 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.362 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -121.56 66.42 0.89 Allowed 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.563 0.697 . . . . 0.0 110.117 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.463 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 2.3 mmp_? -108.8 108.79 19.73 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . 0.469 ' HB2' ' NZ ' ' A' ' 430' ' ' LYS . 4.8 ttmp? -70.13 82.06 0.51 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.057 -0.402 . . . . 0.0 110.741 -176.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . 0.526 HD21 ' HB3' ' A' ' 433' ' ' GLN . 60.8 t30 -166.36 123.99 1.04 Allowed Pre-proline 0 C--N 1.323 -0.58 0 C-N-CA 123.012 0.525 . . . . 0.0 110.247 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.517 ' O ' HG13 ' A' ' 436' ' ' ILE . 42.6 Cg_endo -68.2 -32.56 26.76 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.088 1.859 . . . . 0.0 112.3 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.647 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 23.6 tp60 -68.94 -36.23 77.72 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.935 -0.478 . . . . 0.0 109.845 -179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . 0.636 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 39.9 t60 -53.59 -56.1 20.02 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.023 0.916 . . . . 0.0 110.579 176.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.4 ' HA ' ' HE1' ' A' ' 440' ' ' HIS . 24.2 mtpp -60.46 -16.51 37.24 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.761 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 432' ' ' PRO . 58.1 mt -87.81 -28.86 5.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.426 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.647 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 29.1 mt-10 -90.33 -32.95 16.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.757 -175.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -114.39 129.75 56.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.13 0.491 . . . . 0.0 109.818 -174.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 419' ' ' PRO . 15.7 ptt180 -79.13 118.9 21.53 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.007 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.4 ' HE1' ' HA ' ' A' ' 435' ' ' LYS . 66.5 m80 -98.96 90.58 4.68 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 175.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -67.3 107.75 2.5 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.655 0.74 . . . . 0.0 110.452 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 1.3 p -99.32 122.89 43.08 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.252 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . 0.42 HD13 ' HB ' ' A' ' 445' ' ' VAL . 0.4 OUTLIER -133.16 157.09 79.13 Favored Pre-proline 0 C--O 1.215 -0.711 0 O-C-N 123.933 0.771 . . . . 0.0 110.02 -173.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' PRO . . . . . 0.404 ' O ' HG12 ' A' ' 445' ' ' VAL . 18.5 Cg_endo -56.17 -37.68 96.17 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 121.713 1.609 . . . . 0.0 111.584 -174.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.42 ' HB ' HD13 ' A' ' 443' ' ' LEU . 5.3 p 46.84 20.66 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.051 1.34 . . . . 0.0 112.633 177.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . . . . . . . . . 47.0 mmt-85 -68.79 128.99 38.63 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.379 -0.826 . . . . 0.0 110.452 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -84.39 -17.53 39.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.393 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 C--O 1.237 0.406 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.067 178.482 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' ' ZN' . . . . . 0.799 'ZN ' ' SG ' ' A' ' 385' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' ' ZN' . . . . . 0.763 'ZN ' ' HG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.753 0 CA-C-O 119.954 -0.359 . . . . 0.0 112.262 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 7.1 p -68.76 98.5 0.92 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 117.534 0.667 . . . . 0.0 110.063 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -109.77 91.98 3.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.523 0.678 . . . . 0.0 109.878 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -146.25 113.0 6.02 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.749 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' THR . . . . . . . . . . . . . 42.1 p -70.74 133.72 46.83 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.801 0.688 . . . . 0.0 112.269 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -98.57 -11.88 21.72 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.029 177.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' SER . . . . . . . . . . . . . 50.2 m 74.21 -40.16 0.44 Allowed 'General case' 0 C--O 1.249 1.057 0 C-N-CA 124.267 1.027 . . . . 0.0 110.625 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 23.7 t -76.82 80.57 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 121.779 0.799 . . . . 0.0 110.17 175.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -60.85 -25.92 66.99 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.896 -176.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -80.89 -17.47 50.51 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 93.79 132.67 6.49 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.81 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 34.1 t -83.28 9.16 11.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.793 0.33 . . . . 0.0 110.632 -176.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -69.6 111.32 5.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.376 0.608 . . . . 0.0 110.96 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . -100.0 -135.07 8.76 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.024 -0.989 . . . . 0.0 113.053 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -161.85 151.65 16.6 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 117.868 0.834 . . . . 0.0 111.399 -169.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' LYS . . . . . 0.519 ' HD3' ' H ' ' A' ' 373' ' ' LYS . 0.0 OUTLIER -99.69 11.98 37.79 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 123.914 0.759 . . . . 0.0 110.791 -179.086 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' VAL . . . . . . . . . . . . . 25.2 m -125.23 162.98 26.84 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-O 119.359 -0.353 . . . . 0.0 110.859 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -122.14 166.84 13.93 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 123.993 0.808 . . . . 0.0 109.605 175.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.46 169.48 10.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.57 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 396' ' ' PHE . 6.2 t -130.89 165.71 22.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.816 175.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 411' ' ' GLY . 16.4 m -59.53 113.02 2.0 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -172.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.865 ' HG ' 'ZN ' ' A' ' 449' ' ' ' ZN' . 49.1 t -52.55 114.9 1.53 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' MET . . . . . 0.633 ' HB2' HG12 ' A' ' 410' ' ' VAL . 26.7 ptm -53.29 -26.94 20.38 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.239 -173.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -91.73 -25.43 19.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 61.55 -115.9 8.58 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.116 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' ALA . . . . . 0.44 ' HB2' ' HG3' ' A' ' 399' ' ' PRO . . . -79.37 -6.25 56.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.919 0.39 . . . . 0.0 111.086 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -87.87 -28.68 21.43 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -173.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' CYS . . . . . 0.834 ' SG ' ' SG ' ' A' ' 379' ' ' CYS . 4.8 p -71.39 129.65 39.34 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -94.42 17.22 13.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.449 -174.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -70.26 145.27 51.44 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' LYS . . . . . 0.561 ' HD3' ' H ' ' A' ' 388' ' ' LYS . 0.0 OUTLIER -130.52 -1.08 4.4 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.086 0.469 . . . . 0.0 110.136 178.388 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -76.89 134.76 68.1 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.888 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.57 -20.49 70.88 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.716 2.277 . . . . 0.0 111.467 -173.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.591 ' O ' ' HG3' ' A' ' 394' ' ' GLN . 59.2 t -66.21 -44.32 91.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.745 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' HIS . . . . . 0.594 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 84.3 t60 -57.47 -28.01 62.99 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.027 0.441 . . . . 0.0 110.111 178.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 396' ' ' PHE . 81.6 m-85 -96.47 -13.9 22.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.879 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.591 ' HG3' ' O ' ' A' ' 391' ' ' VAL . 0.0 OUTLIER -76.46 -18.68 58.66 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.617 -176.125 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' HIS . . . . . 0.558 ' ND1' ' HD1' ' A' ' 396' ' ' PHE . 6.8 p80 -122.81 -21.66 5.52 Favored 'General case' 0 C--O 1.245 0.816 0 O-C-N 123.167 0.292 . . . . 0.0 111.698 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' PHE . . . . . 0.558 ' HD1' ' ND1' ' A' ' 395' ' ' HIS . 48.0 m-85 -128.11 126.82 41.9 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 117.799 0.272 . . . . 0.0 111.044 176.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.422 ' OG ' ' HB2' ' A' ' 403' ' ' ASP . 68.9 m -87.88 165.17 15.46 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.415 0.626 . . . . 0.0 111.238 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' HIS . . . . . 0.668 ' NE2' ' SG ' ' A' ' 379' ' ' CYS . 42.7 m80 -132.72 164.56 42.86 Favored Pre-proline 0 C--O 1.233 0.23 0 C-N-CA 123.173 0.589 . . . . 0.0 110.117 -174.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 398' ' ' HIS . 19.0 Cg_endo -55.03 93.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.072 2.515 . . . . 0.0 111.152 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 132.58 15.3 1.42 Allowed Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.07 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -121.46 149.11 43.53 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' SER . . . . . . . . . . . . . 34.7 t -63.24 -33.01 74.56 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.481 0.312 . . . . 0.0 111.114 -174.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' ASP . . . . . 0.422 ' HB2' ' OG ' ' A' ' 397' ' ' SER . 1.5 m-20 -90.73 9.73 28.79 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.188 0.518 . . . . 0.0 111.288 -175.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -91.82 129.25 37.83 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.343 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -156.07 9.04 0.28 Allowed Glycine 0 CA--C 1.505 -0.574 0 C-N-CA 120.81 -0.709 . . . . 0.0 113.675 -176.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' GLY . . . . . . . . . . . . . . . 60.06 41.91 98.21 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 120.289 -0.957 . . . . 0.0 112.365 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 27.9 m -70.69 -18.76 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 115.096 -0.552 . . . . 0.0 110.247 -177.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -125.36 126.95 45.84 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.216 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 3.0 pt -49.57 -48.06 20.39 Favored 'Isoleucine or valine' 0 C--N 1.353 0.748 0 C-N-CA 122.941 0.497 . . . . 0.0 110.539 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' VAL . . . . . 0.633 HG12 ' HB2' ' A' ' 380' ' ' MET . 5.9 t -78.89 81.58 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 172.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 378' ' ' SER . . . 160.8 28.22 0.02 OUTLIER Glycine 0 CA--C 1.495 -1.178 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.634 -172.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 413' ' ' ASP . 0.0 OUTLIER -179.27 -50.45 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -176.24 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 412' ' ' GLN . 53.7 t0 172.68 131.65 0.02 OUTLIER 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.778 1.231 . . . . 0.0 108.939 175.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.39 -1.23 52.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.971 -171.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . 0.606 HG22 ' HA ' ' A' ' 419' ' ' PRO . 41.6 p -60.12 131.81 52.0 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -174.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -70.76 -64.79 0.83 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.204 171.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -142.85 10.61 1.79 Allowed 'General case' 0 C--N 1.347 0.465 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 172.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 437' ' ' GLU . 29.1 ptt180 -173.2 159.23 3.39 Favored Pre-proline 0 C--O 1.242 0.683 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.579 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.606 ' HA ' HG22 ' A' ' 415' ' ' THR . 55.4 Cg_endo -68.56 154.8 70.88 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.029 2.486 . . . . 0.0 112.38 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -74.54 143.35 44.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.894 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' A' ' 427' ' ' CYS . 11.6 t -57.84 133.68 83.2 Favored Pre-proline 0 C--N 1.317 -0.829 0 O-C-N 123.8 0.687 . . . . 0.0 109.571 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.7 -16.09 46.33 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 121.79 1.66 . . . . 0.0 113.092 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 427' ' ' CYS . 29.3 m-85 -112.94 12.58 19.38 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 122.732 0.413 . . . . 0.0 110.033 179.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' GLY . . . . . . . . . . . . . . . 56.57 -148.76 29.97 Favored Glycine 0 C--O 1.248 1.006 0 C-N-CA 121.321 -0.466 . . . . 0.0 113.162 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.18 -14.23 28.64 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.883 2.388 . . . . 0.0 112.044 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' SER . . . . . . . . . . . . . 34.1 t -76.04 -10.49 59.46 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.609 177.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' A' ' 421' ' ' CYS . 51.2 t -58.33 118.48 5.58 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.37 177.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -119.49 22.58 11.63 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 124.101 0.876 . . . . 0.0 109.774 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' ARG . . . . . 0.811 ' HA ' ' HE ' ' A' ' 429' ' ' ARG . 0.5 OUTLIER -63.74 109.41 1.7 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -71.51 94.55 1.3 Allowed 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.674 0.608 . . . . 0.0 111.151 -177.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . 0.52 HD21 ' HB3' ' A' ' 433' ' ' GLN . 63.3 t30 -169.47 124.88 0.73 Allowed Pre-proline 0 N--CA 1.469 0.481 0 O-C-N 124.437 1.086 . . . . 0.0 108.832 176.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.509 ' O ' HG13 ' A' ' 436' ' ' ILE . 34.3 Cg_endo -65.45 -33.58 46.45 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.39 2.06 . . . . 0.0 111.53 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' GLN . . . . . 0.587 ' O ' ' HG3' ' A' ' 437' ' ' GLU . 24.2 tp60 -68.6 -32.3 72.09 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.07 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . 0.715 ' NE2' ' SG ' ' A' ' 427' ' ' CYS . 41.8 t60 -62.71 -58.22 8.23 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.484 -178.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -55.36 -19.74 9.82 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.501 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 432' ' ' PRO . 64.5 mt -80.64 -42.64 20.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 O-C-N 123.724 0.64 . . . . 0.0 109.812 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 433' ' ' GLN . 22.3 mt-10 -78.74 -46.97 17.74 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 -174.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -106.45 135.36 48.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.43 0.633 . . . . 0.0 110.678 -174.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 419' ' ' PRO . 16.0 ptt180 -84.78 133.85 34.34 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.55 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -107.12 85.68 2.18 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 121.247 0.546 . . . . 0.0 109.853 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -70.65 117.65 12.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.673 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' THR . . . . . . . . . . . . . 1.9 m -129.81 152.73 48.99 Favored 'General case' 0 C--O 1.247 0.926 0 O-C-N 123.712 0.632 . . . . 0.0 110.412 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' LEU . . . . . . . . . . . . . 1.1 pp -106.22 154.85 39.42 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' PRO . . . . . 0.443 ' O ' HG12 ' A' ' 445' ' ' VAL . 12.7 Cg_endo -55.46 -39.71 89.55 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.475 2.117 . . . . 0.0 112.981 -173.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 444' ' ' PRO . 4.4 p 49.42 21.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 124.497 1.123 . . . . 0.0 111.277 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' ARG . . . . . 0.461 ' HG3' ' ND2' ' A' ' 447' ' ' ASN . 28.3 tpt180 -137.82 149.78 46.63 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -176.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . 0.461 ' ND2' ' HG3' ' A' ' 446' ' ' ARG . 59.7 m-80 65.5 20.28 11.67 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.902 0.881 . . . . 0.0 111.056 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 CA--C 1.542 0.67 0 CA-C-O 120.918 0.39 . . . . 0.0 110.867 -177.377 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' ' ZN' . . . . . 0.865 'ZN ' ' HG ' ' A' ' 379' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' ' ZN' . . . . . 0.737 'ZN ' ' SG ' ' A' ' 427' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_